This O
site O
is O
conserved O
among O
isolates O
of O
HIV-2 O
and O
the O
closely O
related O
simian O
immunodeficiency O
virus O
, O
and O
transfection O
assays O
show O
this O
site O
to O
mediate O
HIV-2 O
enhancer O
activation O
following O
stimulation O
of O
monocytic B
but O
not O
T-cell B
lines I
. O

Only O
stably O
transfected B
target I
cells I
exhibited O
cytolytic O
susceptibility O
, O
despite O
expression O
of O
equivalent O
levels O
of O
E1A O
proteins O
in O
Ad-infected B
targets I
. O

This O
differential O
effect O
of O
E1A O
expression O
on O
the O
cytolytic O
phenotypes O
of O
infected O
and O
stably O
transfected O
human O
cells O
suggests O
that O
human O
NK O
cells O
provide O
an O
effective O
immunologic O
barrier O
against O
the O
in O
vivo O
survival O
and O
neoplastic O
progression O
of O
E1A-immortalized B
cells I
that O
may O
emerge O
from O
the O
reservoir O
of O
persistently O
infected O
cells O
in O
the O
human O
host O
. O

We O
show O
here O
that O
estrogens O
also O
reduce O
the O
number O
of O
erythroid O
progenitor O
cells O
in O
primary B
human I
bone I
marrow I
cultures I
. O

In O
coimmunoprecipitation O
experiments O
using O
transfected O
COS B
cells I
, O
GATA-1 O
and O
ER O
associate O
in O
a O
ligand-dependent O
manner O
. O

We O
have O
shown O
that O
interleukin-1 O
( O
IL-1 O
) O
and O
IL-2 O
control O
IL-2 O
receptor O
alpha O
( O
IL-2R O
alpha O
) O
gene O
transcription O
in O
CD4-CD8- B
murine I
T I
lymphocyte I
precursors I
. O

Here O
we O
map O
the O
cis-acting O
elements O
that O
mediate O
interleukin O
responsiveness O
of O
the O
mouse O
IL-2R O
alpha O
gene O
using O
a O
thymic B
lymphoma-derived I
hybridoma I
( O
PC60 B
) O
. O

Similar O
activities O
were O
also O
observed O
in O
a O
transformed B
human I
lymphocyte I
line I
, O
termed O
YT B
. O

The O
cell O
cycle-dependent O
transcription O
factor O
, O
E2F-1 O
, O
regulates O
the O
cyclin O
-like O
species O
of O
the O
DNA O
repair O
enzyme O
uracil-DNA O
glycosylase O
( O
UDG O
) O
gene O
in O
human B
osteosarcoma I
( I
Saos-2 I
) I
cells I
. O

Overexpression O
of O
UDG O
in O
Saos B
2 I
cells I
was O
observed O
to O
delay O
growth O
late O
in O
G1 O
phase O
and O
transiently O
arrest O
these O
cells O
from O
progressing O
into O
the O
S O
phase O
. O

Cellular O
and O
molecular O
mechanisms O
of O
IFN-gamma O
production O
induced O
by O
IL-2 O
and O
IL-12 O
in O
a O
human B
NK I
cell I
line I
. O

Although O
it O
has O
been O
reported O
that O
there O
are O
some O
T B
cell I
lines I
that O
produce O
IFN-gamma O
in O
response O
to O
IL-2 O
and O
IL-12 O
stimulation O
, O
there O
has O
as O
yet O
been O
no O
report O
of O
a O
natural B
killer I
( I
NK I
) I
cell I
line I
that O
responds O
in O
a O
similar O
manner O
. O

In O
this O
report O
we O
present O
evidence O
that O
the O
cell B
line I
NK3.3 I
derived O
from O
human O
NK O
cells O
, O
responds O
to O
both O
IL-2 O
and O
IL-12 O
, O
as O
measured O
by O
increases O
in O
IFN-gamma O
and O
granulocyte-macrophage O
colony-stimulating O
factor O
( O
GM-CSF O
) O
cytoplasmic O
mRNA O
and O
protein O
expression O
. O

To O
investigate O
the O
signaling O
pathways O
involved O
in O
the O
gene O
induction O
, O
five O
inhibitors O
, O
cyclosporin O
A O
( O
CsA O
) O
, O
transforming O
growth O
factor-beta O
, O
cycloheximide O
, O
genistein O
, O
and O
staurosporine O
A O
, O
were O
used O
in O
analyzing O
the O
effects O
of O
IL-2 O
and O
IL-12 O
on O
NK3.3 B
cells I
. O

These O
data O
indicate O
that O
IL-2 O
and O
IL-12 O
may O
have O
distinct O
signaling O
pathways O
leading O
to O
the O
induction O
of O
IFN-gamma O
and O
GM-CSF O
gene O
expression O
, O
and O
that O
the O
NK3.3 B
cell I
line I
may O
serve O
as O
a O
novel O
model O
for O
dissecting O
the O
biochemical O
and O
molecular O
events O
involved O
in O
these O
pathways O
. O

Although O
removal O
of O
the O
first O
67 O
amino O
acids O
of O
p95vav O
activates O
its O
transforming O
potential O
in O
NIH B
3T3 I
cells I
, O
this O
region O
appears O
to O
be O
required O
for O
its O
function O
in O
T O
cells O
. O

To O
further O
dissect O
p95vav O
involvement O
in O
TCR O
signaling O
, O
we O
analyzed O
various O
Jurkat B
mutants I
deficient O
in O
TCR O
signaling O
function O
or O
TCR O
expression O
and O
showed O
that O
an O
intact O
TCR O
signaling O
pathway O
is O
required O
for O
p95vav O
to O
function O
. O

PEBP2 O
alpha O
A1 O
and O
alpha O
B1 O
enhanced O
the O
expression O
of O
the O
GM-CSF O
promoter-driven O
reporter O
plasmid O
in O
unstimulated B
and I
12-O-tetradecanoylphorbol I
13-acetate/phytohemagglutinin-stimulated I
human I
Jurkat I
T I
cells I
. O

Northern O
blot O
analysis O
indicated O
the O
expression O
of O
human O
PEBP2 O
alpha O
A O
, O
alpha O
B O
( O
AML1 O
) O
, O
and O
beta O
genes O
in O
Jurkat B
cells I
. O

An O
additional O
significant O
finding O
was O
than O
TNF O
mRNA O
induced O
in O
primed B
cells I
was O
much O
more O
stable O
than O
in O
unprimed B
cells I
( O
T1/2 O
increased O
6-8-fold O
) O
. O

H-89 O
substantially O
suppressed O
LPS-induced O
TNF O
mRNA O
accumulation O
in O
unprimed B
cells I
, O
but O
had O
no O
effect O
on O
primed B
monocytes I
following O
LPS O
stimulation O
. O

TAL1 O
expression O
by O
erythroid O
cells O
in O
vivo O
and O
in O
chemical-induced B
erythroleukemia I
cell I
lines I
in O
vivo O
suggested O
the O
gene O
might O
regulate O
aspects O
of O
erythroid O
differentiation O
. O

These O
results O
indicate O
that O
Epo O
acts O
at O
both O
transcriptional O
and O
posttranscriptional O
levels O
on O
the O
TAL1 O
locus O
in O
Friend B
virus-induced I
erythroblasts I
and O
establish O
a O
link O
between O
Epo O
signaling O
mechanisms O
and O
a O
member O
of O
a O
family O
of O
transcription O
factors O
involved O
in O
the O
differentiation O
of O
diverse O
cell O
lineages O
. O

Nonradioactive O
quantification O
of O
glucocorticoid O
receptor O
expression O
during O
differentiation O
of O
human O
monocytic O
cells O
( O
U937 B
) O
. O

This O
technique O
was O
successfully O
applied O
to O
evaluate O
differences O
in O
glucocorticoid O
receptor O
expression O
in O
U937 B
cells I
before O
and O
after O
the O
addition O
of O
potent O
differentiation O
inducers O
: O
12-O-tetradecanoylphorbol O
13-acetate O
( O
TPA O
) O
and O
a O
combination O
of O
all-trans O
retinoic O
acid O
( O
RA O
) O
and O
1 O
, O
25-dihydroxyvitamin O
D2 O
( O
VD O
) O
. O

The O
150 O
bp O
hEpoR O
promoter O
exhibited O
high O
and O
low O
activity O
in O
erythroid O
OCIM1 B
and O
K562 B
cells I
, O
respectively O
, O
reflecting O
the O
high O
and O
low O
levels O
of O
constitutive O
hEpoR O
expression O
. O

By O
increasing O
GATA-1 O
levels O
via O
co-transfection O
, O
we O
were O
able O
to O
transactivate O
the O
hEpoR O
promoter O
in O
K562 B
cells I
and O
non-erythroid O
cells O
, O
but O
not O
in O
the O
highly O
active O
OCIM1 O
cells O
, O
although O
GATA-1 O
mRNA O
levels O
were O
comparable O
in O
OCIM1 B
and O
K562 B
. O

Overexpression O
of O
DR-nm23 O
, O
a O
protein O
encoded O
by O
a O
member O
of O
the O
nm23 O
gene O
family O
, O
inhibits O
granulocyte O
differentiation O
and O
induces O
apoptosis O
in O
32Dc13 B
myeloid I
cells I
. O

DR-nm23 O
mRNA O
is O
preferentially O
expressed O
at O
early O
stages O
of O
myeloid O
differentiation O
of O
highly B
purified I
CD34+ I
cells I
. O

Its O
constitutive O
expression O
in O
the O
myeloid B
precursor I
32Dc13 I
cell I
line I
, O
which O
is O
growth-factor O
dependent O
for O
both O
proliferation O
and O
differentiation O
, O
results O
in O
inhibition O
of O
granulocytic O
differentiation O
induced O
by O
granulocyte O
colony-stimulating O
factor O
and O
causes O
apoptotic O
cell O
death O
. O

We O
observed O
that O
Fc O
gamma O
RI O
transcript O
levels O
in O
monoblast-like B
U937 I
cells I
were O
elevated O
within O
3 O
hr O
and O
peaked O
12 O
hr O
after O
exposure O
to O
IFN-gamma O
. O

Treatment O
of O
U937 B
with O
IFN-gamma O
for O
9 O
hr O
in O
the O
presence O
of O
cycloheximide O
led O
to O
super-induction O
of O
Fc O
gamma O
RI O
expression O
. O

Transient O
transfections O
of O
CAT O
reporter O
gene O
constructs O
containing O
various O
Fc O
gamma O
RIC O
promoter O
sequences O
into O
U937 B
cells I
revealed O
that O
a O
20-bp O
region O
surrounding O
the O
transcription O
start O
site O
( O
-7 O
to O
+13 O
) O
was O
capable O
of O
mediating O
transcription O
initiation O
and O
that O
an O
IFN-gamma O
responsive O
element O
( O
GIRE O
) O
was O
present O
within O
74 O
bp O
upstream O
of O
the O
transcription O
initiation O
site O
. O

Double-stranded O
GIRE O
sequence O
, O
but O
not O
a O
scrambled O
sequence O
, O
was O
specifically O
bound O
by O
nuclear O
proteins O
from O
IFN-gamma B
treated I
U937 I
cells I
. O

Gel O
shift O
experiments O
further O
showed O
that O
the O
STAT1 O
alpha O
protein O
bound O
to O
the O
Fc O
gamma O
RIC O
GIRE O
in O
response O
to O
IFN-gamma O
treatment O
of O
U937 B
cells I
. O

Whereas O
the O
Jak O
kinases O
Jak1 O
and O
Jak3 O
and O
the O
signal O
transducer O
and O
activator O
of O
transcription O
proteins O
Stat3 O
and O
Stat5 O
are O
activated O
in O
normal O
T O
cells O
in O
response O
to O
IL-2 O
, O
this O
signaling O
pathway O
was O
constitutively O
activated O
in O
HTLV-I-transformed B
cells I
. O

In O
HTLV-I-infected B
cord I
blood I
lymphocytes I
, O
the O
transition O
from O
IL-2 O
-dependent O
to O
IL-2 O
-independent O
growth O
correlated O
with O
the O
acquisition O
of O
a O
constitutively O
activated O
Jak O
-STAT O
pathway O
, O
which O
suggests O
that O
this O
pathway O
participates O
in O
HTLV-I-mediated O
T O
cell O
transformation O
. O

To O
test O
the O
hypothesis O
that O
nitric O
oxide O
( O
NO O
) O
limits O
endothelial O
activation O
, O
we O
treated O
cytokine-stimulated B
human I
saphenous I
vein I
endothelial I
cells I
with O
several O
NO O
donors O
and O
assessed O
their O
effects O
on O
the O
inducible O
expression O
of O
vascular O
cell O
adhesion O
molecule-1 O
( O
VCAM-1 O
) O
. O

Previous O
work O
has O
shown O
that O
in O
Jurkat B
T I
cells I
, O
a O
set O
of O
widely O
expressed O
transcription O
factors O
( O
the O
ICK-1 O
family O
) O
affect O
the O
GOS19 O
promoter O
. O

In O
this O
communication O
, O
we O
provide O
evidence O
that O
the O
pathway O
of O
induction O
in O
the O
macrophage B
cell I
line I
U937 B
is O
different O
from O
that O
in O
Jurkat B
cells I
. O

Furthermore O
, O
we O
show O
that O
the O
ICK-1 O
binding O
site O
does O
not O
confer O
negative O
regulation O
in O
U937 B
cells I
. O

Interaction O
of O
nuclear O
extracts O
from O
various B
cell I
lines I
and O
tissue O
with O
the O
MNP O
site O
leads O
to O
the O
formation O
of O
fast-migrating O
protein-DNA O
complexes O
with O
similar O
but O
distinct O
electrophoretic O
mobilities O
. O

A O
mutation O
of O
the O
MNP O
site O
which O
does O
not O
abrogate O
ICK-1 O
binding O
inactivates O
the O
GOS19.1 O
promoter O
in O
U937 B
cells I
and O
reduces O
its O
activity O
by O
fourfold O
in O
Jurkat B
cells I
. O

RB O
and O
a O
novel O
E2F-1 O
binding O
protein O
in O
MHC B
class I
II I
deficient I
B-cell I
lines I
and O
normal O
IFN-gamma O
induction O
of O
the O
class O
IL O
transactivator O
CIITA O
in O
class B
II I
non-inducible I
RB-defective I
tumor I
lines I
. O

The O
class O
II O
proteins O
are O
expressed O
constitutively O
on O
B-cells O
and O
EBV-transformed B
B-cells I
, I
and O
are O
inducible O
by O
IFN-gamma O
on O
a O
wide O
variety O
of O
cell O
types O
. O

RB-defective B
tumor I
lines I
are O
non-inducible O
for O
MHC O
class O
II O
by O
IFN-gamma O
, O
or O
very O
weakly O
inducible O
, O
but O
transfection O
of O
2 O
different O
lines O
with O
RB O
expression O
vectors O
re-establishes O
or O
substantially O
enhances O
class O
II O
inducibility O
. O

CIITA O
mRNA O
is O
normally O
inducible O
by O
IFN-gamma O
in O
class B
II I
non-inducible I
, I
RB-defective I
lines I
, O
and O
in O
one O
line O
, O
re-expression O
of O
RB O
has O
no O
effect O
on O
CIITA O
mRNA O
induction O
levels O
. O

Thus O
, O
the O
block O
in O
MHC O
class O
II O
inducibility O
in O
RB-defective B
cells I
is O
not O
due O
to O
a O
block O
in O
CIITA O
inducibility O
. O

In O
the O
human B
monocytic I
cell I
line I
THP-1 I
, O
either O
integrin O
-dependent O
cell O
adhesion O
to O
fibronectin O
or O
ligation O
of O
beta O
1 O
integrins O
with O
antibodies O
causes O
a O
rapid O
and O
intense O
tyrosine O
phosphorylation O
of O
two O
sets O
of O
proteins O
of O
about O
65-75 O
and O
120-125 O
kDa O
. O

To O
determine O
if O
New O
World O
primates O
express O
an O
inhibitor O
that O
influences O
glucocorticoid O
receptor O
( O
GR O
) O
binding O
characteristics O
, O
we O
examined O
[ O
3H O
] O
dexamethasone O
binding O
in O
cytosol O
prepared O
from O
B95-8 B
lymphoid I
cells I
, O
derived O
from O
the O
cotton O
top O
tamarin O
( O
Saguinus O
oedipus O
) O
, O
in O
combination O
with O
cytosol O
prepared O
from O
human O
or O
rat O
tissues O
. O

B95-8 O
cytosol O
inhibited O
specific O
binding O
of O
[ O
3H O
] O
dexamethasone O
( O
P O
< O
0.01 O
) O
when O
mixed O
with O
cytosol O
prepared O
from O
either O
a O
human B
lymphoid I
cell I
line I
( O
HL B
) O
or O
rat O
thymus O
. O

The O
results O
further O
demonstrated O
the O
activation O
of O
S6 O
kinase O
( O
pp90rsk O
) O
, O
evidenced O
by O
phosphorylation O
of O
S6 O
and O
serum O
response O
factor O
( O
SRF O
) O
peptides O
, O
in O
PWM B
treated I
B I
cells I
. O

A O
conserved O
motif O
in O
the O
promoters O
of O
several O
cytokines O
expressed O
by O
human B
Th2-type I
lymphocytes I
. O

In O
transfection O
assays O
, O
the O
human O
GM-CSF O
element O
has O
a O
strong O
positive O
effect O
on O
the O
expression O
of O
a O
reporter O
gene O
by O
the O
human B
T I
cell I
line I
Jurkat B
J6 I
upon O
stimulation O
. O

cDNA O
cloning O
of O
a O
NGFI-B/nur77-related O
transcription O
factor O
from O
an O
apoptotic B
human I
T I
cell I
line I
. O

A O
human B
T I
lymphoid I
cell I
line I
, O
PEER B
, O
dies O
by O
apoptosis O
in O
the O
presence O
of O
PMA O
and O
calcium O
ionophore O
. O

A O
new O
gene O
, O
TINUR O
, O
was O
cloned O
from O
apoptotic B
PEER I
cells I
. O

Aspirin O
inhibits O
nuclear O
factor-kappa O
B O
mobilization O
and O
monocyte O
adhesion O
in O
stimulated B
human I
endothelial I
cells I
. O

Since O
salicylates O
have O
been O
reported O
to O
inhibit O
NF-kappa O
B O
activation O
by O
preventing O
the O
degradation O
of O
its O
inhibitor O
I O
kappa O
B O
, O
we O
studied O
a O
potential O
inhibition O
of O
this O
pathway O
by O
acetylsalicylate O
( O
aspirin O
) O
in O
human B
umbilical I
vein I
endothelial I
cells I
( O
HUVECs B
) O
. O

As O
a O
functional O
consequence O
, O
adhesion O
of O
U937 B
monocytes I
to O
TNF-stimulated B
HUVECs I
was O
markedly O
reduced O
by O
aspirin O
due O
to O
suppression O
of O
VCAM-1 O
and O
E-selectin O
upregulation O
. O

Furthermore O
, O
the O
phosphorylated O
I O
kappa O
B O
alpha O
from O
calyculin B
A-treated I
cells I
, O
but O
not O
that O
from O
TNF-alpha-stimulated B
cells I
, O
is O
sensitive O
to O
PP-2A O
in O
vitro O
, O
suggesting O
the O
existence O
of O
fundamental O
differences O
in O
the O
phosphorylation O
of O
I O
kappa O
B O
alpha O
induced O
by O
the O
two O
different O
NF-kappa O
B O
inducers O
. O

We O
show O
that O
in O
transiently B
transfected I
erythroid I
cells I
, O
deletion O
of O
the O
alpha-globin O
G O
+ O
C-rich O
5 O
' O
flanking O
region O
has O
no O
effect O
on O
alpha-globin O
promoter O
activity O
. O

Costimulation O
of O
human B
CD4+ I
T I
cells I
with O
LFA-3 O
and O
B7 O
induce O
distinct O
effects O
on O
AP-1 O
and O
NF-kappa O
B O
transcription O
factors O
. O

We O
have O
earlier O
shown O
that O
stimulation O
of O
human B
CD4+ I
T I
cells I
with O
SEA O
presented O
on O
Chinese B
hamster I
ovary I
( I
CHO I
) I
-DR I
transfectants I
coexpressing O
either O
B7 O
or O
LFA-3 O
resulted O
in O
distinct O
cytokine O
profiles O
. O

We O
now O
demonstrate O
that O
B7 O
, O
but O
not O
LFA-3 O
, O
strongly O
costimulated O
IL-2 O
transcription O
and O
mRNA O
expression O
in O
CD4+ B
T I
cells I
. O

Gel-shift O
analysis O
demonstrated O
that O
stimulation O
of O
CD4+ B
T I
cells I
with O
CHO-DR O
and O
staphylococcal O
enterotoxin O
A O
was O
sufficient O
to O
induce O
significant O
amounts O
of O
NF-kappa O
B O
binding O
proteins O
, O
whereas O
induction O
of O
AP-1 O
binding O
proteins O
required O
costimulation O
. O

The O
CHO-DR/B7/LFA-3 B
triple I
transfectant I
induced O
a O
further O
increase O
in O
AP-1 O
and O
NF-kappa O
B O
binding O
proteins O
compared O
with O
the O
double B
transfectants I
. O

Super-shift O
analysis O
revealed O
that O
the O
NF-kappa O
B O
complex O
of O
costimulated B
CD4+ I
T I
cells I
contained O
large O
amounts O
of O
p50 O
, O
substantial O
amounts O
of O
p65 O
, O
and O
marginal O
levels O
of O
c-Rel O
proteins O
. O

This O
study O
investigated O
the O
effect O
of O
TCDD O
on O
expression O
of O
the O
CD19 O
gene O
in O
a O
human B
B I
lymphocyte I
cell I
line I
. O

Northern O
blot O
analysis O
showed O
that O
TCDD O
treatment O
decreased O
steady O
state O
levels O
of O
CD19 O
mRNA O
by O
67 O
% O
in O
the O
IM-9 B
cell I
line I
. O

We O
recently O
identified O
a O
differentiation O
inhibitory O
factor O
( O
I-factor O
) O
in O
mouse B
myeloid I
leukemia I
M1 I
cells I
as O
a O
murine O
homolog O
of O
the O
human O
nm23-H2 O
gene O
product O
. O

In O
the O
present O
experiment O
, O
we O
examined O
the O
effect O
of O
nm23 O
proteins O
on O
various O
differentiation O
induction O
systems O
of O
human O
leukemic O
cells O
including O
HL-60 B
, I
U937 I
, I
HEL/S I
, I
KU812F I
, I
K562 I
, I
and I
HEL I
cells I
. O

Native O
human O
erythrocyte O
NDP O
kinase O
protein O
inhibited O
the O
induction O
of O
erythroid O
differentiation O
of O
HEL B
, I
KU812 I
and I
K562 I
cells I
, O
but O
not O
the O
induction O
of O
monocytic O
or O
granulocytic O
differentiation O
of O
HL-60 B
, I
U937 I
and I
HEL/S I
cells I
. O

The O
erythroid O
differentiation O
of O
HEL B
cells I
was O
inhibited O
by O
recombinant O
human O
nm23-H1 O
, O
-H2 O
, O
mouse O
nm23-M1 O
, O
and O
-M2 O
proteins O
. O

Moreover O
, O
both O
the O
mutant O
nm23-H2His O
protein O
and O
truncated O
nm23-H2 O
protein O
containing O
N-terminal O
( O
1-60 O
) O
peptide O
, O
which O
do O
not O
have O
NDP O
kinase O
activity O
, O
also O
inhibited O
erythroid O
differentiation O
of O
HEL B
cells I
. O

These O
results O
suggest O
that O
( O
1 O
) O
the O
differentiation O
inhibitory O
activity O
of O
I-factor/nm23 O
protein O
is O
not O
restricted O
to O
monocytic O
differentiation O
of O
M1 B
cells I
, O
( O
2 O
) O
the O
inhibitory O
activity O
is O
exhibited O
without O
species O
specificity O
, O
and O
( O
3 O
) O
the O
differentiation O
inhibitory O
activity O
of O
the O
nm23/NDP O
kinase O
protein O
is O
independent O
of O
its O
enzyme O
activity O
and O
requires O
the O
presence O
of O
N-terminal O
peptides O
. O

Similar O
inhibition O
of O
NFAT O
-1-mediated O
gene O
expression O
was O
observed O
in O
a O
second O
cell B
line I
, O
which O
is O
stably O
transfected O
with O
NFAT-1 O
regulatory O
elements O
linked O
to O
the O
reporter O
gene O
for O
sCD8 O
. O

At O
10 O
microM O
, O
both O
compounds O
inhibited O
IL-2 O
mRNA O
and O
protein O
levels O
in O
the O
NFAT-1-linked B
lac-Z I
transfectants I
, O
and O
in O
human O
lymphocytes O
. O

Transcriptional O
regulation O
of O
the O
vacuolar O
H O
( O
+ O
) O
-ATPase O
B2 O
subunit O
gene O
in O
differentiating B
THP-1 I
cells I
. O

We O
examined O
mRNA O
levels O
of O
various O
V-ATPase O
subunits O
during O
differentiation O
of O
both O
native O
monocytes O
and O
the O
cell B
line I
THP-1 B
, O
and O
found O
that O
transcriptional O
and O
post-transcriptional O
mechanisms O
could O
account O
for O
increases O
in O
cell O
V-ATPase O
content O
. O

We O
transfected O
promoter-luciferase O
reporter O
plasmids O
into O
THP-1 B
cells I
to O
define O
sequences O
that O
mediate O
transcriptional O
control O
during O
monocyte O
differentiation O
. O

We O
found O
that O
sequences O
downstream O
from O
the O
transcriptional O
start O
site O
were O
sufficient O
to O
confer O
increased O
expression O
during O
THP-1 B
differentiation O
. O

Synergy O
between O
signal O
transduction O
pathways O
is O
obligatory O
for O
expression O
of O
c-fos O
in O
B B
and I
T I
cell I
lines I
: O
implication O
for O
c-fos O
control O
via O
surface O
immunoglobulin O
and O
T O
cell O
antigen O
receptors O
. O

We O
have O
examined O
the O
function O
of O
these O
elements O
in O
Burkitt B
's I
lymphoma I
cells I
( O
Ramos B
and O
Daudi B
) O
as O
well O
as O
a O
T B
lymphocytic I
cell I
line I
( O
Jurkat B
) O
. O

The O
main O
difference O
between O
Ramos B
( O
B O
cells O
) O
and O
Jurkat B
( O
T O
cells O
) O
in O
the O
regulation O
of O
c-fos O
is O
that O
cAMP O
plus O
calcium O
is O
strongly O
synergistic O
in O
Jurkat B
and O
is O
without O
effect O
in O
Ramos B
. O

We O
show O
in O
this O
work O
that O
mutations O
in O
either O
the O
purine-rich O
region O
of O
the O
CLEO O
element O
or O
the O
NF-kappa O
B O
site O
result O
in O
reduced O
PMA/Ca2+ O
activation O
of O
a O
620-bp O
human O
GM-CSF O
promoter-luciferase O
reporter O
construct O
in O
Jurkat B
T I
cells I
by O
65 O
% O
and O
50 O
% O
, O
respectively O
. O

Abnormal O
regulation O
of O
the O
IL-2 O
promoter O
in O
lpr O
CD4-CD8- B
T I
lymphocytes I
results O
in O
constitutive O
expression O
of O
a O
novel O
nuclear O
factor O
of O
activated O
T O
cells-binding O
factor O
. O

The O
inert O
quality O
of O
MRL-Ipr/Ipr B
( I
Ipr I
) I
peripheral I
CD4-CD8- I
( I
CD4-8- I
) I
T I
cells I
manifests O
primarily O
as O
an O
inability O
to O
proliferate O
or O
produce O
IL-2 O
in O
response O
to O
TCR O
or O
mitogenic O
stimulation O
. O

We O
, O
therefore O
, O
compared O
the O
activation O
state O
of O
the O
IL-2 O
gene O
promoter O
region O
in O
freshly O
isolated O
and O
stimulated O
Ipr B
CD4-8- I
T I
cells I
with O
that O
of O
normal O
T O
lymphocytes O
. O

Levels O
of O
the O
octamer O
, O
NF-kappa O
B O
( O
p50-p65 O
heterodimer O
) O
, O
and O
AP-1 O
transcriptional O
factors O
are O
constitutively O
elevated O
in O
freshly O
isolated O
Ipr B
CD4-8- I
T I
cells I
, O
consistent O
with O
the O
activated O
phenotype O
of O
these O
cells O
. O

Upon O
stimulation O
with O
mitogens O
, O
formation O
of O
the O
transactivating O
complex O
, O
nuclear O
factor O
of O
activated O
T O
cells O
( O
NF-AT O
) O
, O
occurs O
with O
normal O
kinetics O
in O
Ipr B
CD4-8- I
T I
cells I
. O

Furthermore O
, O
nuclear O
extracts O
from O
Ipr B
CD4-8- I
T I
cells I
display O
high O
levels O
of O
a O
novel O
specific O
binding O
activity O
at O
the O
NF-AT O
site O
, O
which O
is O
present O
at O
much O
lower O
levels O
in O
freshly O
isolated O
normal O
T O
lymphocytes O
. O

Upon O
mitogenic O
stimulation O
, O
the O
binding O
activity O
of O
the O
novel O
NF-AT-binding O
factor O
is O
rapidly O
down-regulated O
in O
normal O
T O
cells O
, O
but O
persists O
at O
high O
levels O
in O
Ipr B
CD4-8- I
T I
cells I
. O

These O
two O
abnormalities O
at O
the O
NF-AT O
site O
provide O
a O
potential O
mechanism O
to O
account O
for O
the O
defect O
in O
IL-2 O
production O
from O
Ipr B
CD4-8- I
T I
cells I
. O

CD30 O
cross-linking O
does O
not O
alter O
proliferation O
of O
ACH-2 B
cells I
and O
the O
induction O
of O
HIV O
expression O
is O
not O
mediated O
by O
endogenous O
TNF O
alpha/beta O
. O

This O
mechanism O
may O
be O
important O
in O
the O
activation O
of O
HIV O
expression O
from O
latently O
infected O
CD4+ B
T I
cells I
, O
especially O
in O
lymphoid O
organs O
where O
cell O
to O
cell O
contact O
is O
conducive O
to O
receptor-ligand O
interactions O
. O

The O
transactivation O
of O
multiple O
cis O
elements O
, O
especially O
S O
and O
X2 O
, O
of O
the O
DR O
alpha O
proximal O
promoter O
in O
group B
II I
CID I
cells I
is O
CIITA O
dependent O
. O

We O
have O
systematically O
analyzed O
the O
functional O
roles O
of O
these O
factor O
binding O
motifs O
of O
HS-40 O
by O
site-directed O
mutagenesis O
and O
transient O
expression O
assay O
in O
erythroid B
cell I
cultures I
. O

Three O
of O
these O
HS-40 O
enhancer O
motifs O
, O
5'NF-E2/AP1 O
, O
GT O
II O
, O
and O
GATA-1 O
( O
c O
) O
, O
positively O
regulate O
the O
zeta O
2-globin O
promoter O
activity O
in O
embryonic/fetal B
erythroid I
K562 I
cells I
and O
the O
adult O
alpha-globin O
promoter O
activity O
in O
adult B
erythroid I
MEL I
cells I
. O

On O
the O
other O
hand O
, O
the O
3'NF-E2/AP1 O
motif O
is O
able O
to O
exert O
both O
positive O
and O
negative O
regulatory O
effects O
on O
the O
zeta O
2-globin O
promoter O
activity O
in O
K562 B
cells I
, O
and O
this O
dual O
function O
appears O
to O
be O
modulated O
through O
differential O
binding O
of O
the O
ubiquitous O
AP1 O
factors O
and O
the O
erythroid-enriched O
NF-E2 O
factor O
. O

Mutation O
in O
the O
GATA-1 O
( O
d O
) O
motif O
, O
which O
exhibits O
an O
adult O
erythroid-specific O
genomic O
footprint O
, O
decreases O
the O
HS-40 O
enhancer O
function O
in O
dimethyl B
sulfoxide-induced I
MEL I
cells I
but O
not O
in O
K562 B
cells I
. O

Interleukin-2 O
promoter O
activity O
in O
Epstein-Barr B
virus-transformed I
B I
lymphocytes I
is O
controlled O
by O
nuclear O
factor-chi O
B O
. O

In O
the O
present O
study O
we O
analyzed O
the O
control O
of O
IL-2 O
promoter O
activity O
in O
Epstein-Barr B
virus I
( I
EBV I
) I
-transformed I
B I
cell I
clones I
which O
are O
capable O
of O
secreting O
IL-2 O
at O
a O
low O
level O
after O
stimulation O
with O
phorbol O
12-myristate O
13-acetate O
and O
the O
Ca2+ O
ionophore O
ionomycin O
. O

In O
EBV-transformed B
B I
clones I
, O
the O
chi O
B O
site O
exerted O
the O
strongest O
inducible O
activity O
; O
the O
NF-AT O
binding O
sites O
showed O
either O
no O
or O
only O
weak O
activity O
compared O
to O
Jurkat B
T I
cells I
. O

An O
IL-2 O
promoter O
bearing O
a O
defective O
NF-chi O
B O
site O
was O
completely O
inactive O
in O
EBV-transformed B
B I
cells I
, O
while O
it O
still O
had O
activity O
in O
Jurkat B
T I
cells I
. O

In O
seven O
EBV-B B
cell I
clones I
or O
lines O
differing O
in O
their O
capacity O
to O
secrete O
IL-2 O
, O
the O
activity O
of O
the O
IL-2 O
promoter O
correlated O
well O
with O
the O
status O
of O
IL-2 O
secretion O
. O

Similarly O
, O
a O
human O
immunodeficiency O
virus O
promoter O
, O
whose O
activity O
is O
controlled O
through O
chi O
B O
factors O
, O
was O
found O
to O
be O
active O
in O
the O
IL-2 B
producing I
EBV-B I
cells I
, O
but O
inactive O
in O
the O
non-IL-2-producing B
cells I
. O

Electrophoretic O
mobility O
shift O
assays O
using O
protein O
extracts O
from O
EBV-B B
cells I
and O
the O
IL-2 O
NF-chi O
B O
probe O
revealed O
the O
constitutive O
generation O
of O
chi O
B O
complexes O
in O
IL-2-secreting B
cells I
consisting O
mainly O
of O
heterodimeric O
p50/p65 O
complexes O
. O

A O
weaker O
chi O
B O
complex O
formation O
and O
faster-migrating O
complexes O
were O
detected O
in O
non-IL-2-secreting B
cells I
. O

These O
results O
demonstrate O
that O
the O
IL-2 O
NF-chi O
B O
site O
is O
indispensable O
for O
the O
activity O
of O
the O
IL-2 O
promoter O
in O
EBV-transformed B
B I
cells I
, O
whereas O
other O
transcription O
factors O
appear O
to O
be O
less O
important O
for O
IL-2 O
expression O
in O
these O
cells O
. O

Chemical O
cross-linking O
with O
125I-labeled O
TGF-beta O
1 O
showed O
an O
essentially O
normal O
TGF-beta O
receptor O
profile O
in O
EBV-positive B
and I
EBV-negative I
Burkitt I
's I
lymphoma I
cell I
lines I
, O
and O
these O
receptors O
were O
shown O
to O
be O
functional O
in O
transducing O
signals O
, O
as O
evidenced O
by O
the O
TGF-beta O
1 O
-mediated O
modulation O
of O
junB O
gene O
expression O
. O

However O
, O
TGF-beta O
1 O
did O
not O
induce O
dephosphorylation O
of O
pRb O
in O
EBV B
( I
or I
LMP-1 I
) I
-positive I
cells I
as O
opposed O
to O
EBV-negative B
cells I
, O
suggesting O
a O
dichotomy O
in O
the O
TGF-beta O
1 O
signaling O
pathway O
leading O
to O
separable O
gene O
regulatory O
and O
growth O
inhibitory O
responses O
. O

Furthermore O
, O
LMP-1 O
was O
found O
to O
induce O
the O
expression O
of O
cyclin O
D2 O
; O
normal O
B O
cells O
or O
EBV-negative B
Burkitt I
's I
lymphoma I
cells I
do O
not O
express O
D-type O
cyclins O
. O

In O
GD O
patients O
, O
the O
responses O
of O
peripheral O
blood O
mononuclear O
cells O
( O
PBMC O
) O
and O
TSH B
receptor I
( I
TSHR I
) I
-specific I
T I
cell I
lines I
to O
recombinant O
human O
TSHR O
extracellular O
domain O
, O
thyroglobulin O
, O
and O
TSHR O
peptides O
were O
examined O
on O
the O
day O
of O
surgery O
or O
RAI O
therapy O
( O
day O
0 O
) O
and O
also O
6-8 O
weeks O
and O
3-6 O
months O
thereafter O
. O

The O
reactivity O
of O
T B
cell I
lines I
in O
different O
groups O
reflected O
a O
pattern O
similar O
to O
PBMC O
after O
treatment O
. O

Subsequently O
, O
TCF-1-specific B
hybridomas I
could O
be O
prepared O
from O
the O
spleens O
of O
immunized O
knock-out O
mice O
. O

Transfection O
experiments O
with O
c-myc O
promoter O
constructs O
in O
both O
DHL-9 B
and O
Raji B
cells I
revealed O
that O
the O
PuF O
site O
functioned O
as O
a O
positive O
regulatory O
element O
in O
B O
cells O
with O
a O
drop O
in O
activity O
with O
mutation O
of O
this O
site O
. O

Access O
to O
this O
site O
is O
blocked O
in O
the O
normal O
silent O
c-myc O
allele O
; O
these O
data O
suggest O
that O
the O
Nm23H2 O
protein O
is O
involved O
in O
deregulation O
of O
the O
translocated O
c-myc O
allele O
in O
Burkitt B
's I
lymphoma I
cells I
. O

Utilizing O
transient O
transfection O
assays O
in O
the O
fetal B
erythroid I
cell I
line I
, O
K562 B
, O
we O
have O
shown O
that O
the O
core O
enhancer O
of O
hypersensitivity O
site O
2 O
can O
preferentially O
interact O
with O
the O
proximal O
gamma-promoter O
in O
the O
absence O
of O
the O
SSE O
, O
completely O
silencing O
a O
linked O
beta-promoter O
. O

However O
, O
this O
deletion O
mutation O
prevented O
the O
induced O
phosphorylation O
, O
degradative O
loss O
, O
and O
functional O
release O
of O
I O
kappa O
B O
alpha O
from O
NF-kappa O
B O
in O
Tax-expressing B
cells I
. O

Growth O
regulation O
and O
cellular O
changes O
during O
differentiation O
of O
human B
prostatic I
cancer I
LNCaP I
cells I
as O
induced O
by O
T O
lymphocyte-conditioned O
medium O
. O

Human B
prostatic I
epithelial I
cells I
from O
an O
androgen-dependent B
LNCaP I
cell I
line I
were O
examined O
in O
response O
to O
conditioned O
medium O
( O
CM O
) O
derived O
from O
phytohemagglutinin B
( I
PHA I
) I
-stimulated I
lymphocytes I
. O

Mapping O
of O
the O
interaction O
site O
of O
the O
defective O
transcription O
factor O
in O
the O
class B
II I
major I
histocompatibility I
complex I
mutant I
cell I
line I
clone-13 I
to O
the O
divergent O
X2-box O
. O

We O
have O
previously O
described O
a O
mutant B
B I
lymphoblastoid I
cell I
line I
, O
Clone-13 B
, I
that O
expresses O
HLA-DQ O
in O
the O
absence O
of O
HLA-DR O
and O
-DP O
. O

Moreover O
, O
replacement O
of O
the O
DQB O
X2-box O
with O
the O
DRA O
X2-box O
markedly O
diminished O
the O
activity O
of O
the O
DQB O
promoter O
in O
the O
mutant B
cell I
. O

None O
of O
the O
hybrid O
reporter O
constructs O
were O
defective O
when O
transfected O
into O
the O
wild-type O
, O
HLA-DR/-DQ B
positive I
parental I
cell I
line I
, O
Jijoye B
. O

Interleukin O
4 O
activates O
a O
signal O
transducer O
and O
activator O
of O
transcription O
( O
Stat O
) O
protein O
which O
interacts O
with O
an O
interferon-gamma O
activation O
site-like O
sequence O
upstream O
of O
the O
I O
epsilon O
exon O
in O
a O
human B
B I
cell I
line I
. O

Germ O
line O
C O
transcripts O
can O
be O
induced O
by O
IL-4 O
in O
the O
human B
B I
cell I
line I
, O
BL-2 B
. O

Utilizing O
a O
IFN-gamma O
activation O
site-like O
DNA O
sequence O
element O
located O
upstream O
of O
the O
I O
epsilon O
exon O
, O
we O
demonstrated O
by O
gel O
mobility O
shift O
assays O
that O
IL-4 O
induced O
a O
binding O
activity O
in O
the O
cytosol O
and O
nucleus O
of O
BL-2 B
cells I
. O

Congruous O
with O
the O
involvement O
of O
a O
Stat O
protein O
, O
IL-4 O
induced O
robust O
Janus O
kinase O
3 O
( O
JAK3 O
) O
activity O
in O
BL-2 B
cells I
. O

Cotransfection O
of O
JAK3 O
with O
IL-4 O
Stat O
into O
COS-7 B
cells I
produced O
an O
intracellular O
activity O
which O
bound O
the O
same O
IFN-gamma O
activation O
site-like O
sequence O
and O
comigrated O
with O
IL-4 O
NAF O
in O
electrophoretic O
mobility O
shift O
assay O
. O

Then O
the O
expression O
levels O
of O
AhR O
mRNA O
in O
various O
hematopoietic B
cell I
lines I
were O
examined O
together O
with O
those O
of O
Arnt O
and O
P450IA1 O
. O

AhR O
was O
expressed O
at O
high O
levels O
in O
monocytoid B
U937 I
, O
THP1 B
, O
and O
HEL/S B
cells I
, O
and O
at O
moderate O
levels O
in O
promyelocytic B
HL60 I
cells I
and O
erythroblastic B
HEL I
cells I
. O

However O
, O
it O
was O
not O
detected O
in O
lymphoid O
cells O
MOLT4 B
( O
T O
cell O
) O
and O
BALL1 B
( O
B O
cell O
) O
, O
nor O
in O
K562 B
erythroblasts I
. O

Furthermore O
, O
a O
specific O
induction O
of O
AhR O
during O
monocytic O
differentiation O
was O
investigated O
in O
HL60 B
and O
HEL B
cells I
. O

HL60 B
cells I
were O
induced O
to O
differentiate O
toward O
monocytes-macrophages O
by O
incubation O
with O
phorbol O
ester O
, O
showing O
a O
5- O
to O
2-fold O
increase O
of O
AhR O
mRNA O
. O

The O
HEL B
cells I
also O
exhibited O
a O
similar O
elevation O
of O
AhR O
mRNA O
level O
, O
when O
they O
had O
differentiated O
toward O
monocyte-macrophage O
cells O
by O
these O
combined O
inducers O
, O
but O
little O
change O
in O
the O
mRNA O
level O
was O
observed O
when O
the O
cells O
were O
induced O
to O
differentiate O
into O
other O
cell O
types O
. O

Treatment O
of O
the O
differentiated B
HL60 I
cells I
with O
3-methylcholanthrene O
, O
a O
ligand O
of O
AhR O
, O
induced O
the O
expression O
of O
the O
P450IA1 O
gene O
. O

Here O
, O
we O
report O
that O
PU.1 O
mRNA O
is O
upregulated O
during O
myeloid O
differentiation O
of O
human B
purified I
CD34+ I
cells I
and O
murine B
multipotential I
FDCP-mix I
A4 I
cells I
, O
suggesting O
that O
PU.1 O
is O
upregulated O
as O
an O
early O
event O
during O
differentiation O
of O
multipotential O
progenitor O
cells O
. O

PU.1 O
expression O
is O
maintained O
at O
stable O
levels O
during O
differentiation O
of O
myeloid B
cell I
lines I
U937 B
and O
HL-60 B
to O
monocytic O
and O
neutrophilic O
cells O
. O

In O
contrast O
to O
PU.1 O
, O
significant O
levels O
of O
Spi-B O
mRNA O
and O
protein O
are O
found O
only O
in O
some O
B-cell B
lines I
and O
spleen O
but O
are O
not O
found O
in O
myeloid B
cell I
lines I
, O
neutrophils O
, O
or O
macrophages O
. O

The O
function O
of O
the O
zeta-globin O
promoter O
was O
studied O
using O
a O
series O
of O
zeta-globin O
promoter O
deletion O
constructs O
to O
drive O
luciferase O
expression O
in O
transiently B
transfected I
human I
erythroleukemia I
cells I
. O

When O
transfected O
into O
K562 B
cells I
, O
which O
express O
zeta-globin O
, O
comparable O
amounts O
of O
activity O
were O
obtained O
from O
the O
-557 O
and O
-417 O
zeta-luciferase O
constructs O
and O
the O
alpha-luciferase O
constructs O
when O
no O
enhancers O
or O
the O
alpha-globin O
locus O
enhancers O
were O
used O
. O

When O
the O
constructs O
were O
transfected O
into O
OCIM1 B
cells I
, O
which O
do O
not O
express O
zeta-globin O
, O
the O
zeta-globin O
promoters O
were O
at O
best O
20 O
% O
as O
active O
as O
the O
alpha-globin O
promoters O
. O

When O
sequences O
from O
-417 O
to O
-207 O
5 O
' O
to O
the O
zeta-globin O
mRNA O
cap O
site O
were O
deleted O
, O
up O
to O
95 O
% O
of O
the O
zeta-globin O
promoter O
activity O
was O
lost O
in O
K562 B
cells I
. O

These O
experiments O
show O
the O
presence O
of O
a O
strong O
positive-acting O
element O
, O
located O
between O
-417 O
and O
-207 O
bp O
5 O
' O
to O
the O
zeta-globin O
mRNA O
cap O
site O
, O
is O
necessary O
for O
high-level O
promoter O
activity O
in O
K562 B
cells I
. O

In O
this O
study O
, O
we O
show O
that O
Tat- O
HIV-1 O
with O
wild-type O
LTRs O
can O
replicate O
in O
HeLa B
cells I
, O
and O
the O
virus O
produced O
from O
HeLa B
cells I
can O
infect O
primary O
peripheral O
blood O
lymphocytes O
and O
macrophages O
. O

However O
, O
this O
efficient O
propagation O
of O
the O
LTR-modified O
tat O
mutants O
was O
restricted O
to O
some O
lymphoid B
cell I
lines I
that O
have O
been O
transformed O
with O
other O
viruses O
. O

Here O
we O
show O
that O
the O
lymphoid-specific O
transcription O
factor O
Oct-2A O
plays O
a O
critical O
role O
in O
HLA-DRA O
gene O
expression O
in O
class B
II-positive I
B I
cell I
lines I
, O
and O
that O
the O
high O
mobility O
group O
protein O
( O
HMG O
) O
I/Y O
binds O
to O
multiple O
sites O
within O
the O
DRA O
promoter O
, O
including O
the O
Oct-2A O
binding O
site O
. O

Coexpression O
of O
HMG O
I/Y O
and O
Oct-2 O
in O
cell B
lines I
lacking O
Oct-2 O
results O
in O
high O
levels O
of O
HLA-DRA O
gene O
expression O
, O
and O
in O
vitro O
DNA-binding O
studies O
reveal O
that O
HMG O
I/Y O
stimulates O
Oct-2A O
binding O
to O
the O
HLA-DRA O
promoter O
. O

By O
contrast O
, O
Oct-2A O
is O
not O
involved O
in O
the O
IFN-gamma O
induction O
of O
the O
HLA-DRA O
gene O
in O
HeLa B
cells I
, O
but O
antisense O
HMG O
I/Y O
dramatically O
decreases O
the O
level O
of O
induction O
. O

In O
lymphoblastoid B
cell I
lines I
, O
six O
EBV-encoded O
nuclear O
antigens O
( O
EBNA1 O
, O
2 O
, O
3A O
, O
3B O
, O
3C O
, O
-LP O
) O
, O
three O
latent O
membrane O
proteins O
( O
LMP1 O
, O
2A O
, O
2B O
) O
, O
and O
two O
nuclear O
RNAs O
( O
EBERs O
) O
are O
expressed O
. O

A O
phenotypic O
drift O
from O
latency O
I O
to O
latency O
III O
has O
been O
observed O
previously O
in O
some O
BL B
cell I
lines I
. O

Further O
, O
the O
immunoprecipitated O
Jak O
2 O
obtained O
from O
IL-5-stimulated B
cells I
underwent O
autophosphorylation O
. O

An O
exogenously O
expressed O
Cbf O
alpha O
2-encoded O
subunit O
( O
CBF O
alpha O
2-451 O
) O
stimulated O
transcription O
from O
the O
SL3 O
enhancer O
in O
P19 O
and O
HeLa B
cells I
. O

The O
longest O
form O
, O
CBF O
beta-187 O
, O
increased O
the O
transcriptional O
stimulation O
by O
CBF O
alpha O
2-451 O
twofold O
in O
HeLa B
cells I
, O
although O
it O
had O
no O
effect O
in O
P19 B
cells I
. O

Furthermore O
, O
compounds O
such O
as O
tosylphenylalanyl O
chloromethyl O
ketone O
and O
pyrrolidinedithiocarbamate O
that O
are O
known O
to O
selectively O
inhibit O
NF O
kappa O
B O
activation O
block O
cytokine O
gene O
transcription O
in O
LPS-stimulated B
monocytes I
. O

I O
kappa O
B O
alpha O
is O
selectively O
modified O
in O
LMP-1-expressing B
B I
cells I
. O

These O
results O
indicate O
that O
LMP-1 O
activates O
NF-kappa O
B O
in O
B-cell B
lines I
by O
targeting O
I O
kappa O
B O
alpha O
. O

In O
HeLa B
cells I
stably O
transfected O
with O
the O
HIV-1 O
tat O
gene O
( O
HeLa-tat B
cells I
) O
, O
expression O
of O
the O
Tat O
protein O
enhanced O
both O
TNF O
-induced O
activation O
of O
NF-kappa O
B O
and O
TNF O
-mediated O
cytotoxicity O
. O

A O
similar O
potentiation O
of O
TNF O
effects O
was O
observed O
in O
Jurkat O
T O
cells O
and O
HeLa B
cells I
treated O
with O
soluble O
Tat O
protein O
. O

In O
both O
T O
cells O
and O
HeLa B
cells I
HIV-1 O
Tat O
suppressed O
the O
expression O
of O
Mn-dependent O
superoxide O
dismutase O
( O
Mn-SOD O
) O
, O
a O
mitochondrial O
enzyme O
that O
is O
part O
of O
the O
cellular O
defense O
system O
against O
oxidative O
stress O
. O

LBF2 O
was O
found O
only O
in O
epithelial B
cell I
lines I
, O
whereas O
LBF3 O
, O
LBF5 O
, O
LBF6 O
, O
and O
LBF7 O
were O
not O
cell O
type O
specific O
. O

Regulation O
and O
specificity O
of O
MNDA O
expression O
in O
monocytes O
, O
macrophages O
, O
and O
leukemia/B B
lymphoma I
cell I
lines I
. O

The O
specificity O
of O
MNDA O
expression O
for O
cells O
in O
the O
granulocyte-macrophage O
lineage O
was O
reexamined O
in O
cell B
lines I
established O
from O
patients O
with O
Philadelphia O
chromosome-positive O
chronic O
myeloid O
leukemia O
. O

By O
contrast O
, O
three O
lymphoblastoid B
cell I
lines I
( O
immortalized O
in O
vitro O
with O
Epstein-Barr O
virus O
) O
were O
weakly O
positive O
and O
MNDA O
was O
up-regulated O
by O
interferon-alpha O
( O
IFN-alpha O
) O
treatment O
. O

The O
results O
also O
reveal O
a O
discordance O
in O
certain O
MNDA B
positive I
cells I
between O
steady-state O
levels O
or O
changes O
in O
levels O
of O
protein O
and O
mRNA O
indicating O
that O
the O
regulation O
of O
MNDA O
expression O
occurs O
at O
more O
than O
one O
point O
. O

DNA-binding O
studies O
of O
the O
Epstein-Barr O
virus O
nuclear O
antigen O
2 O
( O
EBNA-2 O
) O
: O
evidence O
for O
complex O
formation O
by O
latent O
membrane O
protein O
gene O
promoter-binding O
proteins O
in O
EBNA-2-positive B
cell I
lines I
. O

We O
deduce O
from O
these O
results O
that O
EBNA-2-positive B
cells I
might O
indeed O
contain O
specific O
complexes O
bound O
to O
the O
LMP O
promoter O
which O
are O
, O
however O
, O
too O
labile O
to O
be O
detected O
in O
a O
standard O
gel O
retardation O
assay O
. O

We O
show O
that O
IL-6 O
signaling O
leads O
to O
marked O
increases O
in O
the O
synthesis O
and O
secretion O
of O
Ig O
in O
clonal B
human I
B I
cell I
lines I
and O
newly O
isolated O
polyclonal O
B O
lymphocytes O
in O
vitro O
. O

The O
IL-6-induced B
cells I
resemble O
plasma O
cells O
in O
ultrastructure O
and O
in O
reduced O
expression O
of O
surface O
MHC O
class O
II O
. O

We O
have O
previously O
shown O
that O
treatment O
of O
Jurkat B
T I
cells I
with O
phytohemaglutinin O
( O
PHA O
) O
and O
the O
phorbol O
ester O
, O
PMA O
, O
activated O
transcription O
initiation O
from O
the O
IL-3 O
gene O
. O

Stimulation O
of O
human B
CD4+ I
T-cell I
clones I
through O
the O
T-cell O
receptor O
( O
TcR O
) O
by O
high O
doses O
of O
specific O
peptide O
results O
in O
the O
induction O
of O
a O
long-lived O
state O
of O
nonresponsiveness O
that O
has O
been O
called O
anergy O
. O

This O
conclusion O
is O
discussed O
in O
relation O
to O
the O
mechanism O
of O
corticoid O
resistance O
in O
mouse B
and I
human I
lymphoma I
cells I
in O
culture O
. O

Distinct O
DNase-I O
hypersensitive O
sites O
are O
associated O
with O
TAL-1 O
transcription O
in O
erythroid B
and I
T-cell I
lines I
. O

To O
gain O
further O
insight O
into O
the O
molecular O
mechanisms O
that O
control O
tal-1 O
expression O
, O
we O
investigated O
tal-1 O
chromatin O
structure O
in O
erythroid/megakaryocytic B
cell I
lines I
and O
in O
T-cell B
lines I
either O
with O
or O
without O
tal-1 O
rearrangements O
. O

Tal-1 O
transcription O
was O
shown O
to O
be O
monoallelic O
in O
Jurkat B
, O
a O
T-cell O
line O
that O
expresses O
tal-1 O
in O
the O
absence O
of O
apparent O
genomic O
alteration O
of O
the O
locus O
. O

Methylation O
studies O
indicated O
that O
the O
tal-15 O
' O
GC-rich O
region O
behaves O
like O
a O
CpG O
island O
, O
hypomethylated O
in O
normal O
cells O
, O
and O
methylated O
de O
novo O
on O
transcriptionally O
inactive O
alleles O
in O
established B
cell I
lines I
. O

HS O
I O
, O
IV O
, O
and O
V O
were O
exclusively O
observed O
in O
the O
erythroid/megakaryocytic B
cell I
lines I
that O
express O
tal-1 O
from O
the O
promoters O
1a O
and O
1b O
. O

HS O
II O
was O
weak O
in O
hematopoietic B
cell I
lines I
, O
absent O
in O
Hela B
, O
and O
greatly O
enhanced O
in O
Jurkat B
, O
suggesting O
that O
this O
region O
might O
be O
implicated O
in O
the O
cis-activation O
of O
tal-1 O
promoter O
1b O
in O
this O
cell O
line O
. O

HS O
III O
was O
weak O
in O
HEL B
and O
Jurkat B
, O
and O
greatly O
enhanced O
in O
DU528 B
, O
a O
T-cell B
line I
that O
bears O
a O
t O
( O
1 O
; O
14 O
) O
and O
initiates O
tal-1 O
transcription O
within O
exon O
4 O
. O

Erythropoietin O
-dependent O
induction O
of O
hemoglobin O
synthesis O
in O
a O
cytokine-dependent B
cell I
line I
M-TAT B
. O

M-TAT B
is O
a O
cytokine-dependent B
cell I
line I
with O
the O
potential O
to O
differentiate O
along O
the O
erythroid O
and O
megakaryocytic O
lineages O
. O

We O
cultured O
M-TAT B
cells I
long O
term O
( O
> O
1 O
year O
) O
in O
the O
continuous O
presence O
of O
erythropoietin O
( O
EPO O
) O
, O
granulocyte-macrophage O
colony-stimulating O
factor O
( O
GM-CSF O
) O
, O
or O
stem O
cell O
factor O
( O
SCF O
) O
. O

These O
long O
term O
cultures O
are O
referred O
to O
as O
M-TAT/EPO B
, I
M-TAT/GM-CSF I
, I
and I
M-TAT/SCF I
cells I
, O
respectively O
. O

Hemoglobin O
concentration O
and O
gamma-globin O
and O
erythroid O
delta-aminolevulinate O
synthase O
mRNA O
levels O
were O
significantly O
higher O
in O
M-TAT/EPO B
cells I
than O
in O
M-TAT/GM-CSF B
cells I
. O

When O
the O
supplemented O
cytokine O
was O
switched O
from O
GM-CSF O
to O
EPO O
, O
hemoglobin O
synthesis O
in O
M-TAT/GM-CSF B
cells I
increased O
rapidly O
( O
within O
5 O
h O
) O
, O
and O
the O
level O
of O
GATA-1 O
mRNA O
increased O
. O

In O
contrast O
, O
the O
addition O
of O
GM-CSF O
to O
the O
M-TAT/EPO B
cell I
culture I
decreased O
the O
amount O
of O
hemoglobin O
, O
even O
in O
the O
presence O
of O
EPO O
, O
indicating O
that O
the O
EPO O
signal O
for O
erythroid O
differentiation O
is O
suppressed O
by O
GM-CSF O
. O

Thus O
, O
erythroid O
development O
of O
M-TAT B
cells I
is O
promoted O
by O
EPO O
and O
suppressed O
by O
GM-CSF O
. O

The O
binding O
of O
E2F O
at O
this O
region O
was O
detected O
by O
a O
gel-retardation O
assay O
and O
DNaseI O
footprinting O
in O
phytohemagglutinin-stimulated B
T-lymphocytes I
, O
which O
was O
coincident O
with O
the O
expression O
of O
cdc2 O
mRNA O
. O

It O
is O
now O
demonstrated O
that O
HIV-1 O
proviral O
latency O
in O
the O
monocytic B
cell I
line I
U1 I
, O
in O
which O
only O
extremely O
low O
levels O
of O
HIV-1 O
expression O
are O
detected O
in O
the O
baseline O
unstimulated O
state O
, O
is O
associated O
with O
alterations O
in O
nuclear O
factor-kappa O
B O
( O
NF-kappa O
B O
) O
moieties O
demonstrated O
in O
these O
cells O
by O
electrophoretic O
mobility O
shift O
assays O
( O
EMSAs O
) O
and O
in O
situ O
UV O
cross-linking O
studies O
. O

A O
predominance O
of O
p50 O
NF-kappa O
B O
moieties O
and O
possibly O
p50 O
homodimers O
or O
closely O
related O
species O
, O
rather O
than O
the O
p50-p56 O
heterodimer O
of O
NF-kappa O
B O
that O
is O
the O
predominant O
NF-kappa O
B O
species O
in O
most O
T O
lymphocytic O
and O
monocytic O
cells O
, O
is O
demonstrated O
in O
the O
nuclei O
of O
U1 B
cells I
. O

This O
pattern O
of O
NF-kappa O
B-related O
moieties O
differs O
from O
the O
latently B
infected I
T I
lymphocytic I
cell I
line I
ACH-2 I
, O
and O
from O
the O
U937 B
monocytic I
line I
, O
the O
parental B
cell I
line I
of O
the O
U1 B
cellular I
clone I
. O

Since O
most O
B B
cell I
clones I
immortalized O
with O
EBV O
virus O
can O
be O
induced O
to O
produce O
interleukin-2 O
, O
a O
typical O
T O
cell O
cytokine O
, O
we O
studied O
the O
role O
of O
different O
elements O
of O
the O
IL-2 O
promoter O
in O
such O
clones O
by O
transfection O
. O

It O
was O
found O
, O
in O
particular O
, O
that O
the O
element O
TCEd O
, O
which O
binds O
the O
transcription O
factor O
NF-kB O
, O
is O
very O
active O
in O
all O
three O
B B
clones I
tested O
. O

This O
element O
has O
no O
activity O
in O
T O
cells O
of O
the O
Jurkat B
line I
. O

The O
NFATd O
element O
, O
which O
binds O
the O
transcription O
factor O
NFAT-1 O
and O
is O
very O
active O
in O
T O
cells O
, O
is O
only O
weakly O
active O
in O
one O
B B
clone I
and O
not O
at O
all O
in O
another O
. O

Persistent O
HIV O
infection O
of O
U937 B
monocytic I
cells I
results O
in O
NF-kappa O
B O
activation O
. O

To O
limit O
expression O
of O
a O
transduced O
HIV-1 O
long O
terminal O
repeat O
( O
LTR O
) O
-IFNA2 O
( O
the O
new O
approved O
nomenclature O
for O
IFN O
genes O
is O
used O
throughout O
this O
article O
) O
hybrid O
gene O
to O
the O
HIV-1-infected B
cells I
, O
HIV-1 O
LTR O
was O
modified O
. O

Deletion O
of O
the O
NF-kappa O
B O
elements O
of O
the O
HIV-1 O
LTR O
significantly O
inhibited O
Tat O
-mediated O
transactivation O
in O
T-cell B
lines I
, O
as O
well O
as O
in O
a O
monocyte B
line I
, O
U937 B
. O

Insertion O
of O
this O
chimeric O
promoter O
( O
ISG15 O
LTR O
) O
upstream O
of O
the O
human O
IFNA2 O
gene O
directed O
high O
levels O
of O
IFN O
synthesis O
in O
Tat-expressing B
cells I
, O
while O
this O
promoter O
was O
not O
responsive O
to O
tumor O
necrosis O
factor O
alpha O
-mediated O
activation O
. O

ISG15-LTR-IFN O
hybrid O
gene O
inserted O
into O
the O
retrovirus O
vector O
was O
transduced O
into O
Jurkat B
and O
U937 B
cells I
. O

Selected O
transfected B
clones I
produced O
low O
levels O
of O
IFN O
A O
( O
IFNA O
) O
constitutively O
, O
and O
their O
abilities O
to O
express O
interleukin-2 O
and O
interleukin-2 O
receptor O
upon O
stimulation O
with O
phytohemagglutinin O
and O
phorbol O
myristate O
acetate O
were O
retained O
. O

Virus O
isolated O
from O
IFNA-producing B
cells I
was O
able O
to O
replicate O
in O
the O
U937 B
cells I
but O
did O
not O
replicate O
efficiently O
in O
U937 B
cells I
transduced O
with O
the O
IFNA O
gene O
. O

These O
results O
suggest O
that O
targeting O
IFN O
synthesis O
to O
HIV-1-infected B
cells I
is O
an O
attainable O
goal O
and O
that O
autocrine O
IFN O
synthesis O
results O
in O
a O
long-lasting O
and O
permanent O
suppression O
of O
HIV-1 O
replication O
. O

OBJECTIVES O
: O
To O
analyze O
the O
effect O
of O
retinoic O
acids O
( O
RA O
) O
on O
HIV-1 O
expression O
and O
correlate O
this O
effect O
with O
expression O
levels O
of O
RA O
receptors O
( O
RARs O
) O
in O
T-lymphoid B
and I
monocytoid I
cell I
lines I
. O

DESIGN O
AND O
METHODS O
: O
The O
effect O
of O
all-trans O
and O
9-cis O
RA O
on O
HIV-1 O
production O
in O
T-lymphoid B
( O
H9 B
, I
CEM I
) O
and O
monocytoid B
( I
U937 I
, I
THP-1 I
) I
cell I
lines I
was O
measured O
during O
acute O
and O
chronic O
infection O
. O

RESULTS O
: O
Both O
all-trans O
and O
9-cis O
RA O
inhibited O
virus O
replication O
in O
HIV-1 B
IIIB-infected I
monocytoid I
cells I
, O
in O
the O
presence O
and O
absence O
of O
the O
co-stimulatory O
agent O
phorbol O
myristate O
acetate O
( O
PMA O
) O
. O

The O
retinoids O
had O
weak O
or O
no O
stimulatory O
effects O
on O
HIV O
production O
by O
T-cell B
lines I
. O

HIV O
production O
by O
PMA-stimulated B
T-cell I
lines I
was O
inhibited O
by O
these O
retinoids O
. O

Human O
RAR O
alpha O
was O
expressed O
in O
H9 B
, O
U937 B
and O
THP-1 B
cells I
, O
but O
almost O
undetectable O
in O
CEM B
cells I
. O

Human O
RXR O
alpha O
was O
significantly O
expressed O
in O
U937 B
and I
THP-1 I
cells I
, O
weakly O
expressed O
in O
H9 B
cells I
and O
not O
detectable O
in O
CEM B
cells I
. O

After O
stimulation O
by O
PMA O
, O
RXR O
alpha O
expression O
increased O
in O
H9 B
and O
U937 B
cells I
but O
not O
in O
CEM B
cells I
. O

Human O
RAR O
alpha O
expression O
was O
unchanged O
in O
H9 B
and O
CEM B
cells I
, O
and O
elevated O
in O
U937 B
cells I
, O
after O
PMA O
stimulation O
. O

We O
have O
previously O
found O
that O
the O
normal O
developmental O
patterns O
of O
globin O
gene O
expression O
are O
recapitulated O
in O
an O
experimental O
system O
of O
primary B
cultures I
that O
support O
differentiation O
of O
erythroid O
progenitors O
. O

RESULTS O
: O
The O
results O
showed O
high O
GATA-1 O
binding O
activity O
and O
very O
low O
SP1 O
activity O
in O
the O
fetal B
liver I
cultures I
. O

To O
understand O
the O
extent O
to O
which O
ALD O
may O
mimic O
mitogenic O
stimulation O
, O
we O
studied O
cytoplasmic O
and O
nuclear O
signaling O
steps O
in O
ALD-treated B
T I
cells I
. O

Although O
we O
detected O
no O
IL-2 O
mRNA O
in O
ALD-treated B
cells I
, O
the O
nuclei O
of O
these O
cells O
contain O
proteins O
capable O
of O
binding O
to O
three O
regulatory O
sequences O
in O
the O
IL-2 O
promoter O
region O
: O
NFAT O
, O
NF O
kappa O
B O
, O
and O
AP-1 O
. O

Data O
is O
presented O
, O
using O
the O
potent O
and O
selective O
PKC O
inhibitor O
Ro O
31-8425 O
and O
transient O
expression O
of O
a O
constitutively O
active O
ras O
mutant O
, O
which O
clearly O
shows O
that O
PKC O
is O
not O
downstream O
of O
p21ras O
in O
the O
induction O
of O
NF-AT O
and O
AP-1 O
transcriptional O
activity O
and O
in O
the O
expression O
of O
IL-2 O
in O
human B
Jurkat I
T I
cells I
. O

In O
contrast O
, O
stat1 O
proteins O
were O
not O
tyrosine O
phosphorylated O
after O
IL-2 O
ligation O
, O
whereas O
tyrosine-phosphorylated O
stat1 O
proteins O
( O
91 O
and O
84 O
kDa O
proteins O
) O
were O
translocated O
to O
the O
nucleus O
following O
interferon-gamma O
treatment O
of O
HeLa B
cells I
. O

Taken O
together O
, O
we O
report O
that O
IL-2 O
induces O
tyrosine O
phosphorylation O
and O
subsequent O
nuclear O
translocation O
of O
stat3 O
and O
an O
as O
yet O
undefined O
84-kDa O
protein O
in O
antigen-specific B
human I
T I
cell I
lines I
. O

In O
this O
study O
, O
we O
demonstrate O
that O
Tax O
-stimulated O
nuclear O
expression O
of O
NF-kappa O
B O
in O
both O
HTLV-I-infected B
and I
Tax-transfected I
human I
T I
cells I
is O
associated O
with O
the O
phosphorylation O
and O
rapid O
proteolytic O
degradation O
of O
I O
kappa O
B O
alpha O
. O

In O
HeLa B
cells I
as O
well O
as O
in O
B O
cells O
, O
TNF-alpha O
rapidly O
induced O
nuclear O
translocation O
primarily O
of O
p50-p65 O
, O
but O
not O
of O
c-rel O
. O

Treatment O
of O
HL60 B
cells I
with O
various O
combinations O
of O
retinoids O
and O
1 O
alpha O
, O
25 O
dihydroxyvitamin O
D3 O
results O
in O
differentiation O
towards O
neutrophils O
or O
monocytes O
or O
a O
failure O
to O
differentiate O
and O
apoptosis O
. O

It O
is O
well O
documented O
that O
treatment O
of O
serum-grown B
HL60 I
cells I
with O
10 O
( O
-7 O
) O
M O
all-trans O
retinoic O
acid O
( O
all-trans O
RA O
) O
induces O
neutrophil O
differentiation O
, O
whereas O
treatment O
with O
10 O
( O
-7 O
) O
M O
1 O
alpha O
, O
25 O
dihydroxyvitamin O
D3 O
( O
D3 O
) O
induces O
differentiation O
towards O
monocytes O
. O

In O
recent O
investigations O
, O
using O
serum-free B
grown I
HL60 I
cells I
, O
we O
observed O
that O
all-trans O
RA O
, O
at O
10 O
( O
-7 O
) O
M O
, O
did O
not O
induce O
neutrophil O
differentiation O
and O
that O
all-trans O
RA O
, O
at O
10 O
( O
-8 O
) O
M O
, O
reduced O
the O
D3 O
concentration O
required O
for O
monocyte O
differentiation O
to O
5 O
x O
10 O
( O
-9 O
) O
M O
. O

In O
this O
study O
, O
co-operative O
interactions O
between O
all-trans O
and O
9-cis O
RA O
and O
D3 O
which O
promote O
neutrophil O
and O
monocyte O
differentiation O
of O
HL60 B
cells I
have O
been O
analysed O
in O
detail O
. O

Treatment O
of O
serum-free B
grown I
HL60 I
cells I
with O
5 O
x O
10 O
( O
-7 O
) O
M O
all-trans O
RA O
or O
9-cis O
RA O
resulted O
in O
sub-optimal O
neutrophil O
differentiation O
( O
up O
to O
25 O
% O
mature O
cells O
) O
. O

Culture O
of O
HL60 B
cells I
in O
5 O
x O
10 O
( O
-7 O
) O
M O
9-cis O
RA O
together O
with O
a O
wide O
range O
of O
concentrations O
of O
D3 O
resulted O
in O
promotion O
of O
neutrophil O
differentiation O
at O
10 O
( O
-15 O
) O
-10 O
( O
-12 O
) O
D3 O
, O
a O
failure O
to O
differentiate O
and O
apoptosis O
at O
10 O
( O
-11 O
) O
-10 O
( O
-10 O
) O
M O
D3 O
, O
followed O
by O
co-operativity O
between O
9-cis O
RA O
and O
5 O
x O
10 O
( O
-9 O
) O
M O
D3 O
in O
inducing O
monocyte O
differentiation O
in O
the O
absence O
of O
neutrophil O
differentiation O
. O

Similar O
results O
were O
obtained O
when O
HL60 B
cells I
were O
treated O
with O
5 O
x O
10 O
( O
-7 O
) O
all-trans O
RA O
together O
with O
a O
wide O
range O
of O
concentrations O
of O
D3 O
. O

Cross O
titration O
analyses O
of O
the O
effects O
of O
9-cis O
RA O
and O
D3 O
on O
HL60 B
cell I
differentiation O
were O
undertaken O
to O
determine O
the O
boundaries O
of O
the O
concentrations O
of O
each O
agent O
, O
alone O
and O
in O
combination O
, O
that O
give O
rise O
to O
optimal O
neutrophil O
and O
monocyte O
differentiation O
of O
HL60 B
cells I
. O

Using O
this O
technique O
we O
have O
isolated O
several O
differentially O
expressed O
sequence O
tags O
( O
DESTs O
) O
from O
the O
mouse B
thymocyte I
cell I
line I
WEHI B
7.2 I
. O

The O
discovery O
of O
EBV O
in O
certain O
T O
cell O
malignancies O
and O
the O
expression O
of O
the O
EBV O
receptor O
, O
CR2/CD21 O
, O
on O
a O
population O
of O
immature O
thymocytes O
, O
T B
lymphoblastoid I
cell I
lines I
, O
and O
childhood O
acute O
T O
lymphoblastic O
leukemia O
cells O
suggested O
that O
EBV-receptor O
interactions O
on O
T O
cells O
may O
be O
of O
importance O
. O

Consistent O
with O
the O
activity O
of O
B95-8 O
, O
EBNA-2 O
transcripts O
were O
identified O
within O
infected B
thymocyte I
populations I
. O

We O
distinguish O
the O
stimuli-specific O
pathways O
by O
showing O
that O
the O
oxidative O
stimuli O
trigger O
NF-kappa O
B O
activation O
in O
only O
one O
of O
two O
human B
T-cell I
lines I
( O
Wurzburg B
but O
not O
Jurkat B
) O
, O
whereas O
tumor O
necrosis O
factor O
alpha O
and O
phorbol O
12-myristate O
13-acetate O
readily O
stimulate O
in O
both O
lines O
. O

We O
include O
a O
redox-regulatory O
mechanism O
( O
s O
) O
in O
this O
common O
pathway O
to O
account O
for O
the O
previously O
demonstrated O
redox O
regulation O
of O
NF-kappa O
B O
activation O
in O
Jurkat B
cells I
( O
in O
which O
oxidants O
do O
n't O
activate O
NF-kappa O
B O
) O
; O
we O
put O
tyrosine O
phosphorylation O
in O
the O
common O
pathway O
by O
showing O
that O
kinase O
activity O
( O
inhibitable O
by O
herbimycin O
A O
and O
tyrphostin O
47 O
) O
is O
required O
for O
NF-kappa O
B O
activation O
by O
all O
stimuli O
tested O
in O
both O
cell O
lines O
. O

By O
fusing O
lymphoblastoid O
cells O
of O
an O
AGS O
patient O
that O
exhibited O
a O
microdeletion O
in O
the O
short O
arm O
of O
Chr O
20 O
encompassing O
bands O
p11.23 O
to O
p12.3 O
with O
rodent B
thermosensitive I
mutant I
cells I
( O
CHOtsH1-1 B
) O
deficient O
in-leucyl-tRNA O
synthetase O
, O
we O
isolated O
a O
somatic B
cell I
hybrid I
segregating O
the O
deleted O
human O
Chr O
20 O
. O

This O
hybrid O
clone O
, O
designated O
NR2 B
, O
was O
characterized O
by O
several O
methods O
, O
including O
PCR O
, O
with O
eight O
pairs O
of O
oligonucleotides O
mapped O
to O
Chr O
20 O
: O
D20S5 O
, O
D20S41 O
, O
D20S42 O
, O
D20S56 O
, O
D20S57 O
, O
D20S58 O
, O
adenosine O
deaminase O
( O
ADA O
) O
, O
and O
Prion O
protein O
( O
PRIP O
) O
; O
Restriction O
Fragment O
Length O
Polymorphism O
( O
RFLP O
) O
analyses O
with O
four O
genomic O
anonymous O
probes O
( O
D20S5 O
, O
cD3H12 O
, O
D20S17 O
, O
D20S18 O
) O
; O
and O
fluorescent O
in O
situ O
hybridization O
( O
FISH O
) O
with O
total O
human O
DNA O
and O
D20Z1 O
, O
a O
sequence O
specific O
to O
the O
human O
Chr O
20 O
centromere O
, O
as O
probes O
. O

The O
NR2 B
hybrid I
allowed O
us O
to O
exclude O
three O
candidate O
genes O
for O
AGS O
: O
hepatic O
nuclear O
factor O
3 O
beta O
( O
HNF3 O
beta O
) O
, O
paired O
box O
1 O
( O
PAX1 O
) O
, O
and O
cystatin O
C O
( O
CST3 O
) O
as O
shown O
by O
their O
localization O
outside O
of O
the O
deletion O
. O

The O
NR2 B
hybrid I
is O
a O
powerful O
tool O
for O
the O
mapping O
of O
new O
probes O
of O
this O
region O
, O
as O
well O
as O
for O
obtaining O
new O
informative O
probes O
specific O
for O
the O
deletion O
by O
subtractive O
cloning O
of O
the O
region O
. O

Western O
blot O
analysis O
showed O
that O
N-acetyl-cysteine O
reduced O
the O
accumulation O
of O
the O
47-kD O
mature O
glycoprotein O
in O
LPS-treated B
cells I
, O
a O
finding O
consistent O
with O
the O
results O
of O
the O
immunofluorescence O
studies O
. O

Here O
, O
we O
report O
on O
the O
identification O
of O
an O
enhancer O
element O
in O
the O
CD48 O
gene O
which O
reproducibly O
confers O
strong O
transcriptional O
activity O
only O
in O
EBV-positive B
B-lymphoblastoid I
cell I
lines I
. O

The O
element O
is O
not O
activated O
upon O
infection O
of O
established O
EBV-negative B
B-cell I
lines I
, O
indicating O
that O
EBV O
fails O
to O
drive O
these O
cells O
to O
a O
fully O
lymphoblastoid O
phenotype O
. O

Thapsigargin O
induces O
IL-2 O
receptor O
alpha-chain O
in O
human O
peripheral O
and O
Jurkat B
T I
cells I
via O
a O
protein O
kinase O
C O
-independent O
mechanism O
. O

TG O
plus O
phorbol O
myristate O
acetate O
( O
PMA O
) O
but O
not O
TG O
alone O
induced O
IL-2 O
in O
Jurkat B
T I
cells I
, O
suggesting O
that O
TG O
had O
no O
effect O
on O
protein O
kinase O
C O
( O
PKC O
) O
. O

However O
, O
TG O
induced O
increases O
in O
IL-2R O
alpha O
protein O
as O
well O
as O
IL-2R O
alpha O
mRNA O
in O
Jurkat B
T I
cells I
in O
a O
dose-dependent O
manner O
. O

Further O
, O
like O
PMA O
, O
TG O
markedly O
induced O
NF O
kappa O
B O
in O
Jurkat B
T I
cells I
. O

Pyrrolidine O
dithiocarbamate O
, O
a O
potent O
inhibitor O
of O
nuclear O
factor O
kappa O
B O
( O
NF-kappa O
B O
) O
activation O
, O
prevents O
apoptosis O
in O
human O
promyelocytic B
leukemia I
HL-60 I
cells I
and O
thymocytes O
. O

Treatment O
of O
a O
human B
promyelocytic I
leukemia I
cell I
line I
, O
HL-60 B
, O
with O
10 O
micrograms/mL O
etoposide O
or O
2 O
microM O
1-beta-D-arabinofuranosylcytosine O
induced O
NF-kappa O
B O
activation O
within O
1 O
hr O
and O
subsequently O
caused O
apoptosis O
within O
3-4 O
hr O
. O

A O
function O
for O
protein O
kinase O
C-zeta O
( O
PKC-zeta O
) O
, O
a O
member O
of O
the O
phorbol O
ester O
nonresponsive O
atypical O
protein O
kinase O
C O
subfamily O
, O
in O
modulating O
differentiation O
was O
examined O
in O
the O
leukemic B
U937 I
cell I
. O

Transfected O
U937 B
cells I
stably O
overexpressing O
PKC-zeta O
displayed O
a O
longer O
doubling O
time O
, O
lower O
saturation O
density O
at O
confluency O
, O
and O
an O
increase O
in O
adherence O
to O
plastic O
as O
compared O
to O
control B
cells I
. O

PKC-zeta B
cells I
expressed O
a O
more O
differentiated O
phenotype O
as O
assessed O
by O
changes O
in O
morphology O
, O
surface O
antigen O
expression O
, O
and O
lysosomal O
enzyme O
activities O
and O
were O
distinct O
from O
parental B
U937 I
cells I
stimulated O
to O
differentiate O
by O
exposure O
to O
phorbol O
esters O
. O

In O
contrast O
to O
parental O
U937 B
cells I
, O
PKC-zeta B
cells I
constitutively O
expressed O
mRNA O
transcripts O
for O
c-jun O
and O
a O
low O
mobility O
AP-1 O
binding O
activity O
. O

Increased O
expression O
of O
the O
c-jun O
protooncogene O
and O
an O
increase O
in O
AP-1 O
binding O
activity O
in O
PKC-zeta B
cells I
provides O
a O
potential O
mechanism O
for O
explaining O
the O
altered O
differentiation O
status O
of O
this O
cell O
. O

Two O
groups O
of O
U937 B
promonocytic I
cells I
were O
obtained O
by O
limiting O
dilution O
cloning O
which O
differed O
strikingly O
in O
their O
ability O
to O
support O
human O
immunodeficiency O
virus O
1 O
( O
HIV-1 O
) O
replication O
. O

`` B
Plus I
'' I
clones I
replicated O
the O
virus O
efficiently O
, O
whereas O
`` B
minus I
'' I
clones I
did O
not O
. O

Stimulation O
of O
plus B
clones I
liberated O
the O
classical O
p50-p65 O
complex O
from O
cytoplasmic O
pools O
, O
whereas O
minus B
clones I
produced O
an O
apparently O
novel O
, O
faster-migrating O
complex O
, O
as O
judged O
by O
electrophoretic O
mobility O
shift O
assays O
. O

These O
specific O
proteases O
are O
coordinately O
expressed O
and O
were O
present O
exclusively O
in O
the O
minus B
U937 I
clones I
, O
but O
not O
in O
the O
plus B
clones I
, O
as O
demonstrated O
in O
the O
case O
of O
cathepsin O
G O
. O

In O
addition O
, O
these O
proteases O
were O
detected O
in O
certain O
subclones O
of O
THP-1 B
and O
HL-60 B
cells I
and O
in O
primary O
monocytes O
, O
in O
each O
case O
correlating O
with O
the O
truncated O
from O
of O
p65 O
. O

It O
is O
possible O
that O
particular O
serine O
proteases O
may O
have O
inhibiting O
effects O
on O
the O
replication O
of O
HIV-1 O
in O
myelo-monocytic B
cells I
. O

The O
data O
also O
demonstrate O
that O
special O
precautions O
must O
be O
taken O
when O
making O
extracts O
from O
myelo-monocytic B
cells I
. O

Furthermore O
, O
expression O
of O
OBF-1 O
in O
HeLa B
cells I
selectively O
stimulates O
the O
activity O
of O
a O
natural O
immunoglobulin O
promoter O
in O
an O
octamer O
site O
-dependent O
manner O
. O

We O
now O
show O
that O
a O
depletion O
of O
intracellular O
glutathione O
in O
a O
human B
T I
cell I
line I
( O
Molt-4 B
) O
inhibits O
the O
activation O
and O
nuclear O
translocation O
of O
the O
transcription O
factor O
NF O
kappa O
B O
, O
whereas O
incubation O
with O
increasing O
extracellular O
concentrations O
of O
cysteine O
inhibits O
the O
DNA-binding O
and O
transactivating O
activity O
of O
NF O
kappa O
B O
. O

Two O
distinct O
signalling O
pathways O
are O
involved O
in O
the O
control O
of O
the O
biphasic O
junB O
transcription O
induced O
by O
interleukin-6 O
in O
the O
B B
cell I
hybridoma I
7TD1 I
. O

We O
have O
measured O
the O
level O
of O
junB O
mRNA O
in O
the O
B B
hybridoma I
cell I
line I
7TD1 I
, O
under O
interleukin-6 O
( O
IL-6 O
) O
stimulation O
. O

Altogether O
these O
data O
indicate O
that O
, O
in O
7TD1 B
cells I
, O
IL-6 O
controls O
junB O
transcription O
in O
a O
biphasic O
fashion O
by O
means O
of O
two O
separate O
transduction O
pathways O
. O

A O
newly O
established O
megakaryoblastic/erythroid B
cell I
line I
that O
differentiates O
to O
red O
cells O
in O
the O
presence O
of O
erythropoietin O
and O
produces O
platelet-like O
particles O
. O

In O
August O
, O
1992 O
, O
we O
established O
a O
leukemic B
cell I
line I
( O
NS-Meg B
) O
from O
a O
patient O
in O
megakaryoblastic O
transformation O
of O
Philadelphia O
chromosome-positive O
chronic O
myeloid O
leukemia O
. O

The O
NS-Meg B
cells I
were O
positive O
for O
alpha-naphthyl O
acetate O
esterase O
and O
periodic O
acid-Schiff O
( O
PAS O
) O
staining O
and O
for O
surface O
CD4 O
, O
CD7 O
, O
CD13 O
, O
CD34 O
, O
CD41a O
, O
and O
glycophorin O
A O
antigens O
. O

The O
NS-Meg B
cells I
spontaneously O
produced O
platelet-like O
particles O
which O
contained O
alpha-granules O
, O
mitochondria O
and O
dense O
bodies O
, O
strongly O
suggesting O
platelet O
production O
. O

Erythropoietin O
( O
Epo O
) O
, O
granulocyte/macrophage O
colony O
stimulating O
factor O
( O
GM-CSF O
) O
, O
and O
interleukin O
3 O
( O
IL-3 O
) O
promoted O
the O
growth O
of O
NS-Meg B
cells I
. O

These O
benzidine-positive B
cells I
were O
positive O
for O
hemoglobin O
F O
staining O
. O

Untreated O
NS-Meg B
cells I
expressed O
mRNA O
for O
the O
Epo O
receptor O
( O
EpoR O
) O
, O
for O
GATA-1 O
, O
and O
for O
alpha O
1 O
, O
alpha O
2 O
and O
gamma O
globin O
genes O
. O

These O
results O
indicate O
that O
NS-Meg B
cells I
undergo O
terminal O
differentiation O
of O
both O
megakaryocytic O
and O
erythroid O
lineages O
. O

This O
cell B
line I
should O
be O
a O
very O
useful O
tool O
for O
the O
investigation O
of O
both O
megakaryocytic O
and O
erythroid O
maturation O
. O

LTR O
-directed O
transcription O
was O
measured O
by O
using O
luciferase O
reporter O
constructs O
that O
were O
transiently O
transfected O
into O
cultured B
cells I
. O

The O
LTR O
from O
SIVsmmPBj14 O
was O
found O
to O
confer O
an O
increase O
in O
the O
kinetics O
of O
virus O
replication O
in O
cultured B
cells I
. O

Inclusion O
of O
this O
LTR O
in O
recombinant O
SIVs O
also O
resulted O
in O
a O
two- O
to O
threefold O
rise O
in O
the O
extent O
of O
cellular O
proliferation O
that O
was O
induced O
in O
quiescent B
simian I
peripheral I
blood I
mononuclear I
cells I
. O

In O
our O
studies O
, O
cells O
of O
the O
human B
monocytic I
line I
Mono B
Mac I
6 I
, O
cultured O
in O
medium O
containing O
fetal-calf O
serum O
and O
low O
levels O
of O
lipopolysaccharide O
( O
LPS O
) O
, O
also O
exhibit O
such O
'constitutive O
' O
NF-kappa O
B O
, O
as O
demonstrated O
by O
mobility-shift O
analysis O
of O
nuclear O
extracts O
. O

Using O
LPS-free O
and O
serum-free O
conditions O
, O
constitutive O
NF-kappa O
B O
can O
be O
detected O
in O
different O
cell B
lines I
of O
the O
monocytic O
lineage O
( O
HL60 B
, O
U937 B
, O
THP-1 B
, O
Mono B
Mac I
1 I
and O
Mono B
Mac I
6 I
) O
, O
but O
not O
in O
Molt B
4 I
T I
cells I
or O
K562 B
stem I
cells I
. O

When O
ordered O
according O
to O
stage O
of O
maturation O
, O
the O
amount O
of O
constitutive O
NF-kappa O
B O
was O
not O
increased O
in O
more O
mature B
cell I
lines I
. O

Furthermore O
, O
when O
inducing O
differentiation O
in O
Mono B
Mac I
6 I
cells I
, O
with O
vitamin O
D3 O
, O
no O
change O
in O
constitutive O
or O
inducible O
NF-kappa O
B O
can O
be O
detected O
. O

BFU-E-derived B
colonies I
increase O
progressively O
in O
size O
, O
as O
determined O
by O
cell O
number O
, O
from O
day O
7 O
to O
day O
14 O
of O
culture O
, O
with O
the O
greatest O
increase O
in O
colony O
size O
( O
10-fold O
expansion O
) O
occurring O
between O
day O
7 O
and O
day O
10 O
. O

SCL O
protein O
levels O
in O
BFU-E-derived B
cells I
were O
highest O
in O
day O
7 O
cells O
and O
decreased O
progressively O
from O
day O
7 O
to O
day O
14 O
of O
culture O
, O
suggesting O
an O
association O
of O
SCL O
with O
erythroid O
proliferation O
. O

In O
BFU-E-derived B
colonies I
cultured O
with O
Steel O
factor O
, O
colony O
size O
was O
significantly O
increased O
compared O
to O
control O
. O

gamma O
B*CaM-K O
and O
delta O
CaM-AI O
, O
known O
to O
exhibit O
constitutive O
Ca O
( O
2+ O
) O
-independent O
activity O
, O
were O
cotransfected O
( O
alone O
or O
in O
combination O
) O
in O
Jurkat B
T I
cells I
with O
a O
plasmid O
containing O
the O
intact O
IL-2 O
promoter O
driving O
the O
expression O
of O
the O
chloramphenicol O
acetyltransferase O
reporter O
gene O
. O

Induction O
of O
ICAM-1 O
and O
LFA-3 O
by O
Tax1 O
of O
human O
T-cell O
leukemia O
virus O
type O
1 O
and O
mechanism O
of O
down-regulation O
of O
ICAM-1 O
or O
LFA-1 O
in O
adult-T-cell-leukemia B
cell I
lines I
. O

The O
present O
study O
was O
undertaken O
to O
determine O
the O
role O
of O
HTLV-I O
TaxI O
in O
the O
up-regulation O
of O
ICAM-I O
and O
LFA-3 O
in O
human O
T O
cells O
transformed O
with O
HTLV-I O
and O
the O
mechanism O
of O
down-regulation O
of O
ICAM-I O
and O
LFA-I O
in O
ATL-derived B
cell I
lines I
. O

Induction O
of O
TaxI O
in O
a O
human B
T-cell I
line I
Jurkat I
carrying O
the O
TaxI O
gene O
under O
the O
metallothionein O
promoter O
led O
to O
increases O
in O
mRNA O
and O
surface O
expression O
of O
ICAM-I O
. O

The O
mechanism O
of O
down-regulation O
of O
ICAM-I O
or O
LFA-I O
in O
4 B
ATL I
cell I
lines I
was O
next O
examined O
. O

ICAM-I O
mRNA O
was O
quite O
low O
in O
MT-I B
, O
but O
no O
genomic O
changes O
were O
found O
. O

The O
CAT O
reporter O
with O
the O
ICAM-I O
promoter O
was O
inactive O
in O
MT-I B
. O

Finally O
, O
combined O
treatment O
of O
MT-I B
with O
5-azacytidine O
and O
IFN-gamma O
induced O
re-expression O
of O
ICAM-I O
. O

Collectively O
, O
( O
a O
) O
transcriptional O
factor O
( O
s O
) O
necessary O
for O
expression O
of O
ICAM-I O
gene O
may O
be O
repressed O
in O
MT-I B
through O
DNA O
methylation O
. O

Three O
other O
ATL B
cell I
lines I
( O
TL-OmI B
, O
H582 B
, O
HuT102 B
) O
were O
found O
to O
have O
little O
mRNA O
for O
the O
LFA-I O
beta O
chain O
( O
CD18 O
) O
. O

H582 B
and O
HuT102 B
were O
also O
negative O
for O
the O
LFA-I O
alpha O
chain O
( O
CDIIa O
) O
mRNA O
. O

Growth O
transformation O
of O
primary O
normal O
B-cells O
by O
mutant O
virus O
resulted O
in O
estrogen-dependent B
lymphoblastoid I
cell I
lines I
expressing O
the O
chimeric O
EBNA2 O
protein O
. O

Functional O
Myc-Max O
heterodimer O
is O
required O
for O
activation-induced O
apoptosis O
in O
T B
cell I
hybridomas I
. O

T B
cell I
hybridomas I
respond O
to O
activation O
signals O
by O
undergoing O
apoptotic O
cell O
death O
, O
and O
this O
is O
likely O
to O
represent O
comparable O
events O
related O
to O
tolerance O
induction O
in O
immature O
and O
mature O
T O
cells O
in O
vivo O
. O

The O
protein O
products O
of O
the O
Epstein-Barr O
virus O
( O
EBV O
) O
BMLF1 O
open O
reading O
frame O
have O
been O
characterized O
in O
the O
early O
productive O
cycle O
in O
B95-8 B
and O
Akata B
cells I
. O

We O
show O
that O
an O
inducible O
protein O
complex O
( O
Band O
A O
) O
binds O
to O
SRE O
DNA O
within O
10 O
min O
after O
mitogenic O
stimulation O
of O
human B
PBL-T I
, O
and O
becomes O
nondetectable O
by O
60 O
min O
. O

A O
protein O
that O
is O
phosphorylated O
on O
a O
tyrosine O
residue O
in O
resting B
PBL-T I
suppresses O
binding O
of O
a O
component O
of O
Band O
A O
to O
the O
SRE O
motif O
. O

RJ B
2.2.5 I
is O
a O
human B
B I
cell I
mutant I
derived O
from O
the O
Burkitt B
lymphoma I
Raji I
cell I
which O
is O
defective O
in O
the O
AIR-1 O
locus O
function O
. O

Interestingly O
, O
reexpression O
of O
human O
MHC O
class O
II O
genes O
in O
RJ B
2.2.5 I
x I
mouse I
spleen I
cell I
hybrids I
is O
associated O
with O
partial O
reversion O
of O
DRA O
promoter O
occupancy O
to O
the O
Raji O
pattern O
. O

DRA O
promoter O
occupancy O
in O
other O
class B
II-negative I
B I
cell I
lines I
, O
derived O
from O
patients O
with O
bare O
lymphocyte O
syndrome O
, O
is O
drastically O
different O
from O
the O
one O
observed O
in O
RJ B
2.2.5 I
and O
Raji B
cells I
. O

Moreover O
, O
the O
use O
of O
the O
DNase O
I O
as O
an O
in O
vivo O
footprinting O
agent O
reveals O
that O
the O
patients B
' I
cell I
lines I
do O
not O
display O
a O
completely O
`` O
bare O
promoter O
`` O
as O
previously O
reported O
using O
dimethyl O
sulfate O
as O
the O
footprinting O
agent O
. O

Thus O
, O
the O
use O
of O
DNase O
I O
allowed O
us O
, O
for O
the O
first O
time O
, O
to O
correlate O
the O
AIR-1 O
locus O
defect O
with O
class O
II O
promoter O
occupancy O
alterations O
and O
distinguish O
these O
alterations O
from O
the O
ones O
observed O
in O
phenotypically O
similar O
but O
genetically O
distinct O
MHC B
class I
II-negative I
cells I
. O

Coexpression O
of O
both O
proteins O
activated O
transcription O
of O
the O
-137 O
to O
-64 O
element O
in O
COS-7 B
cells I
. O

Isolation O
of O
cDNA O
clones O
for O
42 O
different O
Kruppel-related O
zinc O
finger O
proteins O
expressed O
in O
the O
human B
monoblast I
cell I
line I
U-937 I
. O

To O
study O
the O
complexity O
and O
structural O
characteristics O
of O
zinc O
finger O
proteins O
expressed O
during O
human O
hematopoiesis O
and O
to O
isolate O
novel O
regulators O
of O
blood O
cell O
development O
, O
a O
degenerate O
oligonucleotide O
probe O
specific O
for O
a O
consensus O
zinc O
finger O
peptide O
domain O
was O
used O
to O
isolate O
63 O
cDNA O
clones O
for O
Kruppel-related O
zinc O
finger O
genes O
from O
the O
human B
monoblast I
cell I
line I
U-937 I
. O

Northern O
blot O
analysis O
showed O
that O
a O
majority O
of O
these O
genes O
were O
expressed O
at O
comparable O
levels O
in O
U-937 B
and O
HeLa B
cells I
. O

Molt-4 B
cells I
( O
M4 B
) O
, O
a O
human B
T I
lymphocyte I
cell I
line I
, O
were O
incubated O
with O
different O
concentrations O
of O
two O
ALD O
, O
flurbiprofen O
and O
sodium O
diclofenac O
, O
and O
then O
exposed O
to O
BQ O
. O

Correlation O
of O
differentiation-inducing O
activity O
of O
retinoids O
on O
human B
leukemia I
cell I
lines I
HL-60 B
and O
NB4 B
. O

Retinoids O
, O
including O
all-trans-retinoic O
acid O
, O
its O
isomers O
, O
and O
fifty O
synthetic O
retinoids O
( O
retinobenzoic O
acids O
) O
, O
were O
tested O
for O
differentiation-inducing O
activity O
on O
human B
leukemia I
cell I
lines I
HL-60 B
and O
NB4 B
. O

A O
good O
linear O
correlation O
, O
with O
an O
r O
value O
of O
0.91 O
, O
between O
the O
ED50 O
values O
for O
the O
differentiation-inducing O
activity O
towards O
HL-60 B
cells I
and O
that O
towards O
NB4 B
cells I
was O
found O
. O

By O
primer O
extension O
analysis O
to O
discriminate O
two O
transcripts O
, O
we O
found O
that O
the O
levels O
of O
PAFR O
transcript O
1 O
( O
leukocyte-type O
) O
, O
but O
not O
PAFR O
transcript O
2 O
( O
tissue-type O
) O
, O
are O
upregulated O
by O
PAF O
as O
well O
as O
by O
12-O-tetradecanoylphorbol-13-acetate O
( O
TPA O
) O
in O
the O
human B
stomach I
cancer I
cell I
line I
( O
JR-St B
cells I
) O
which O
expresses O
both O
functional O
PAFR O
transcript O
1 O
and O
PAFR O
transcript O
2 O
endogenously O
. O

In O
this O
study O
, O
we O
demonstrate O
that O
nuclear O
factor O
( O
NF O
) O
-kappa O
B O
and O
NF-kappa O
B-like O
transcription O
factors O
are O
activated O
after O
cross-linking O
CD40 O
on O
resting O
human O
tonsillar O
B O
cells O
and O
on O
B B
cell I
lines I
. O

To O
determine O
if O
TPCK O
and O
TLCK O
inhibited O
LPS O
induction O
of O
TF O
expression O
, O
freshly O
isolated O
human O
monocytes O
and O
monocytic B
THP-1 I
cells I
were O
pretreated O
with O
these O
inhibitors O
for O
30 O
min O
before O
LPS O
stimulation O
. O

Analyses O
of O
hybrid B
cells I
show O
that O
TIMP O
, O
ZXDA O
, O
and O
ZXDB O
loci O
on O
the O
proximal O
short O
arm O
, O
and O
AR O
and O
PHKA1 O
loci O
on O
the O
long O
arm O
, O
are O
well O
expressed O
from O
the O
tiny O
ring O
X O
chromosome O
lacking O
XIST O
DNA O
. O

To O
reconcile O
these O
observations O
, O
we O
expressed O
a O
hybrid O
CD8-Nef O
protein O
in O
Jurkat B
cells I
. O

Activated O
Jurkat B
cells I
died O
by O
apoptosis O
, O
and O
only O
cells O
with O
mutated O
nef O
genes O
expressing O
truncated O
Nefs O
survived O
, O
which O
rendered O
Nef O
nonfunctional O
. O

The O
activity O
of O
constructs O
containing O
5 O
' O
deletion O
mutants O
of O
the O
alpha O
4 O
gene O
promoter O
was O
compared O
in O
transfection O
assays O
into O
cell B
lines I
that O
express O
alpha O
4 O
and O
cell B
lines I
that O
do O
not O
. O

The O
sequence O
between O
position O
-42 O
and O
-76 O
base O
pairs O
( O
bp O
) O
was O
required O
for O
efficient O
transcription O
in O
cells O
that O
express O
alpha O
4 O
, O
but O
it O
showed O
no O
activity O
in O
HeLa B
cells I
, O
which O
do O
not O
express O
alpha O
4 O
. O

Several O
antiandrogens O
show O
agonistic O
properties O
for O
a O
mutated O
androgen O
receptor O
( O
LNCaP B
cell I
variant I
) O
; O
trypsin O
digestion O
of O
antiandrogen-bound O
mutated O
receptor O
also O
resulted O
in O
a O
29-kDa O
fragment O
. O

Activation O
of O
nuclear O
factor O
kappa O
B O
in O
human B
neuroblastoma I
cell I
lines I
. O

Using O
neuroblastoma B
cell I
lines I
as O
models O
, O
we O
have O
shown O
that O
in O
neural O
cells O
NF-kappa O
B O
was O
present O
in O
the O
cytosol O
and O
translocated O
into O
nuclei O
as O
a O
result O
of O
TNF O
alpha O
treatment O
. O

However O
, O
reagents O
such O
as O
nerve O
growth O
factor O
( O
NGF O
) O
and O
the O
phorbol O
ester O
phorbol O
12-myristate O
13-acetate O
( O
PMA O
) O
, O
which O
induce O
phenotypical O
differentiation O
of O
the O
SH-SY5Y B
neuroblastoma I
cell I
line I
, O
activated O
NF-kappa O
B O
, O
but O
only O
in O
that O
particular O
cell B
line I
. O

In O
a O
NGF-responsive B
rat I
pheochromocytoma I
cell I
line I
, O
PC12 B
, O
PMA O
activated O
NF-kappa O
B O
, O
whereas O
NGF O
did O
not O
. O

In O
other O
neuroblastoma B
cell I
lines I
, O
such O
as O
SK-N-Be B
( I
2 I
) I
, O
the O
lack O
of O
PMA O
induction O
of O
differentiation O
was O
correlated O
with O
the O
lack O
of O
NF-kappa O
B O
activation O
. O

We O
found O
, O
moreover O
, O
that O
in O
SK-N-Be B
( I
2 I
) I
cells I
protein O
kinase O
C O
( O
PKC O
) O
enzymatic O
activity O
was O
much O
lower O
compared O
with O
that O
in O
a O
control B
cell I
line I
and O
that O
the O
low O
PKC O
enzymatic O
activity O
was O
due O
to O
low O
PKC O
protein O
expression O
. O

NF-kappa O
B O
was O
not O
activated O
by O
retinoic O
acid O
, O
which O
induced O
morphological O
differentiation O
of O
all O
the O
neuroblastoma B
cell I
lines I
used O
in O
the O
present O
study O
. O

We O
have O
cloned O
the O
gene O
for O
a O
new O
ets-related O
transcription O
factor O
, O
ERP O
( O
ets-related O
protein O
) O
, O
from O
the O
murine B
pre-B I
cell I
line I
BASC B
6C2 I
and O
from O
mouse O
lung O
tissue O
. O

By O
Southern O
hybridization O
analyses O
of O
somatic O
cell O
hybrid O
panels O
with O
murine O
cDNA O
probe O
, O
fluorescence O
chromosomal O
in O
situ O
hybridization O
( O
FISH O
) O
of O
human O
genomic O
clones O
, O
and O
analysis O
of O
recombinant B
inbred I
mouse I
strains I
, O
we O
have O
found O
single O
sites O
for O
EBF O
homologous O
sequences O
on O
human O
Chromosome O
( O
Chr O
) O
5 O
, O
band O
q34 O
, O
and O
on O
proximal O
mouse O
Chr O
11 O
, O
in O
an O
evolutionarily O
conserved O
region O
. O

Two O
cis-acting O
elements O
GM-kappa O
B/GC-box O
and O
CLE0 O
, O
of O
the O
granulocyte-macrophage O
colony-stimulating O
factor O
( O
GM-CSF O
) O
gene O
are O
required O
for O
maximal O
induction O
in O
Jurkat B
T I
cells I
by O
costimulation O
with O
phorbol-12-myristate O
acetate O
( O
PMA O
) O
and O
Ca2+ O
ionophore O
( O
A23187 O
) O
. O

Cotransfection O
of O
NF-kappa O
B O
( O
p50/p65 O
) O
- O
or O
AP-1 O
( O
c-Jun/c-Fos O
) O
- O
expression O
vectors O
into O
Jurkat B
cells I
with O
a O
luciferase O
reporter O
containing O
the O
GM-CSF O
promoter O
did O
not O
stimulate O
transcription O
from O
the O
GM-CSF O
promoter O
. O

Mouse B
thymoma I
line I
EL-4 I
cells I
produce O
cytokines O
such O
as O
interleukin O
( O
IL O
) O
-2 O
, O
IL-3 O
, O
IL-4 O
, O
IL-10 O
, O
and O
granulocyte-macrophage O
colony-stimulating O
factor O
in O
response O
to O
phorbol O
12-myristate O
13-acetate O
( O
PMA O
) O
. O

EL-4 B
cells I
also O
produce O
low O
levels O
of O
IL-5 O
when O
stimulated O
by O
PMA O
alone O
; O
however O
, O
cAMP O
greatly O
augments O
PMA-dependent O
IL-5 O
production O
. O

NF-kappa O
B-dependent O
and O
-independent O
pathways O
of O
HIV O
activation O
in O
a O
chronically B
infected I
T I
cell I
line I
. O

J B
delta I
K I
cells I
were O
isolated O
as O
a O
chronically B
infected I
survivor I
cell I
line I
, O
following O
infection O
of O
Jurkat B
CD4+ I
T I
cells I
with O
dl-NF O
, O
a O
mutated O
strain O
of O
human O
immunodeficiency O
virus O
type O
1 O
( O
HIV-1 O
) O
containing O
a O
deletion O
of O
the O
long O
terminal O
repeat O
( O
LTR O
) O
NF-kappa O
B O
sites O
. O

J B
delta I
K I
cells I
exhibited O
very O
low O
levels O
of O
constitutive O
HIV O
production O
. O

HIV-1 O
expression O
was O
activated O
from O
J B
delta I
K I
cells I
by O
treatment O
with O
phorbol O
myristate O
acetate O
( O
PMA O
) O
, O
sodium O
butyrate O
( O
NaB O
) O
, O
or O
hexamethylene O
bisacetamide O
( O
HMBA O
) O
, O
but O
not O
tumor O
necrosis O
factor O
alpha O
( O
TNF-alpha O
) O
, O
confirming O
the O
role O
of O
NF-kappa O
B O
in O
mediating O
TNF-alpha O
induction O
of O
HIV O
transcription O
. O

The O
strong O
induction O
of O
HIV O
expression O
by O
NaB O
or O
HMBA O
in O
J B
delta I
K I
cells I
clearly O
demonstrates O
the O
existence O
of O
NF-kappa O
B O
-independent O
mechanisms O
of O
HIV O
activation O
in O
chronically O
infected O
cells O
. O

J B
delta I
K I
cells I
may O
provide O
a O
useful O
model O
for O
characterizing O
NF-kappa O
B O
-independent O
transcriptional O
activation O
of O
the O
HIV O
LTR O
. O

Liposomes O
do O
not O
alter O
the O
suppressive O
action O
of O
MPL O
when O
placed O
in O
lymphocyte B
culture I
. O

Ii O
kappa O
B-1 O
is O
a O
positive O
regulatory O
element O
in O
B-cell B
lines I
and O
in O
the O
Ii-expressing B
T-cell I
line I
, O
H9 B
, O
but O
acts O
as O
a O
negative O
regulatory O
element O
in O
myelomonocytic B
and I
glia I
cell I
lines I
. O

In O
vivo O
protein-DNA O
contacts O
are O
detectable O
at O
Ii O
kappa O
B-1 O
in O
cell B
lines I
in O
which O
this O
site O
is O
functional O
as O
either O
a O
positive O
or O
negative O
regulator O
. O

Ii O
kappa O
B-2 O
is O
a O
site O
of O
positive O
regulation O
in O
B-cell B
lines I
and O
a O
site O
of O
negative O
regulation O
in O
H9 B
T I
cells I
, O
myelomonocytic B
, I
and I
glial I
cell I
lines I
. O

In O
vivo O
occupancy O
of O
this O
site O
is O
observed O
only O
in O
the O
H9 B
T-cell I
line I
. O

Effects O
of O
prostaglandin O
E2 O
on O
Th0-type B
human I
T I
cell I
clones I
: O
modulation O
of O
functions O
of O
nuclear O
proteins O
involved O
in O
cytokine O
production O
. O

The O
effects O
of O
prostaglandin O
E2 O
( O
PGE2 O
) O
on O
cytokine O
production O
and O
proliferation O
of O
the O
CD4+ B
human I
helper I
T I
cell I
clone I
SP-B21 I
were O
investigated O
. O

The O
P O
sequence O
of O
the O
human O
interleukin-4 O
( O
IL-4 O
) O
gene O
, O
which O
was O
defined O
as O
a O
responsive O
element O
for O
phorbol O
12-myristate O
13-acetate O
and O
calcium O
ionophore O
( O
A23187 O
) O
in O
Jurkat B
T I
cells I
, O
shares O
sequence O
similarity O
with O
the O
NF-kappa O
B O
and O
the O
NF-AT O
binding O
sites O
. O

NF-kappa O
B O
( O
P65 O
or O
P65/P50 O
heterodimer O
) O
bound O
to O
the O
P O
sequence O
in O
electrophoretic O
mobility O
shift O
assays O
( O
EMSA O
) O
and O
activated O
transcription O
through O
the O
P O
sequence O
when O
expression O
plasmids O
were O
cotransfected O
with O
P O
sequence-driven O
reporter O
plasmids O
in O
Jurkat B
T I
cells I
. O

The O
present O
work O
has O
studied O
mechanisms O
responsible O
for O
induction O
of O
early O
growth O
response O
1 O
( O
EGR-1 O
) O
gene O
expression O
during O
monocytic O
differentiation O
of O
U-937 B
myeloid I
leukemia I
cells I
. O

Differentiation O
of O
U-937 B
cells I
with O
12-O-tetradecanoylphorbol-13-acetate O
( O
TPA O
) O
, O
an O
activator O
of O
the O
serine/threonine O
protein O
kinase O
C O
, O
was O
associated O
with O
transcriptional O
activation O
of O
EGR-1 O
promoter-reporter O
constructs O
. O

In O
contrast O
, O
there O
was O
little O
effect O
of O
TPA O
on O
EGR-1 O
transcription O
in O
a O
TPA-resistant B
U-937 I
cell I
variant I
, O
designated O
TUR B
. O

Treatment O
of O
both O
U-937 B
and O
TUR B
cells I
with O
okadaic O
acid O
, O
an O
inhibitor O
of O
serine/threonine O
protein O
phosphatases O
1 O
and O
2A O
, O
was O
associated O
with O
induction O
of O
monocytic O
differentiation O
and O
EGR-1 O
transcription O
through O
the O
5'-most O
CArG O
element O
. O

In O
contrast O
, O
analysis O
of O
pp90rsk O
activity O
by O
phosphorylation O
of O
a O
peptide O
derived O
from O
S6 O
protein O
demonstrated O
stimulation O
of O
this O
kinase O
in O
TPA-treated B
U-937 I
, I
and I
not I
TUR I
, I
cells I
. O

Since O
kappa O
B O
motifs O
are O
present O
in O
VCAM-1 O
and O
intercellular O
adhesion O
molecule-1 O
( O
ICAM-1 O
) O
promoters O
, O
we O
used O
PDTC O
to O
study O
the O
regulatory O
mechanisms O
of O
VCAM-1 O
and O
ICAM-1 O
induction O
and O
subsequent O
monocyte O
adhesion O
in O
TNF-treated B
human I
umbilical I
vein I
endothelial I
cells I
( O
HUVECs B
) O
. O

PDTC O
or O
N-acetylcysteine O
dose O
dependently O
reduced O
TNF-induced O
VCAM-1 O
but O
not O
ICAM-1 O
surface O
protein O
( O
also O
in O
human O
umbilical O
arterial O
endothelial O
cells O
) O
and O
mRNA O
expression O
( O
by O
70 O
% O
at O
100 O
mumol/L O
PDTC O
) O
in O
HUVECs B
as O
assessed O
by O
flow O
cytometry O
and O
polymerase O
chain O
reaction O
. O

Gel-shift O
analysis O
in O
HUVECs B
demonstrated O
that O
PDTC O
prevented O
NF-kappa O
B O
mobilization O
by O
TNF O
, O
suggesting O
that O
only O
VCAM-1 O
induction O
was O
controlled O
by O
NF-kappa O
B O
. O

Since O
HUVECs B
released O
superoxide O
anions O
in O
response O
to O
TNF O
, O
and O
H2O2 O
induces O
VCAM-1 O
, O
PDTC O
may O
act O
as O
a O
radical O
scavenger O
. O

PDTC O
, O
apocynin O
, O
or O
SKF525a O
decreased O
adhesion O
of O
monocytic B
U937 I
cells I
to O
TNF-treated B
HUVECs I
( O
by O
75 O
% O
at O
100 O
mumol/L O
PDTC O
) O
. O

Inhibition O
by O
anti-VCAM-1 O
monoclonal O
antibody O
1G11 O
indicated O
that O
U937 B
adhesion O
was O
VCAM-1 O
dependent O
and O
suppression O
by O
antioxidants O
was O
due O
to O
reduced O
VCAM-1 O
induction O
. O

Sodium O
salicylate O
and O
aspirin O
also O
inhibited O
NF-kappa O
B O
-dependent O
transcription O
from O
the O
Ig O
kappa O
enhancer O
and O
the O
human O
immunodeficiency O
virus O
( O
HIV O
) O
long O
terminal O
repeat O
( O
LTR O
) O
in O
transfected B
T I
cells I
. O

Effects O
of O
the O
antisense O
myb O
expression O
on O
hemin- O
and O
erythropoietin- O
induced O
erythroid O
differentiation O
of O
K562 B
cells I
. O

In O
order O
to O
elucidate O
the O
role O
of O
c-myb O
gene O
in O
erythroid O
differentiation O
of O
K562 B
cell I
induced O
by O
hemin O
( O
Hm O
) O
and O
erythropoietin O
( O
Epo O
) O
, O
we O
constructed O
recombinant O
plasmid O
that O
could O
produce O
antisense O
myb O
RNA O
after O
induction O
with O
dexamethasone O
. O

During O
treatment O
with O
Hm O
, O
K562 B
cells I
constitutively O
expressed O
c-myb O
mRNA O
, O
and O
50 O
% O
of O
them O
began O
to O
synthesize O
hemoglobin O
( O
Hb O
) O
. O

Expression O
of O
antisense O
myb O
RNA O
reduced O
the O
amount O
of O
c-myb O
mRNA O
, O
and O
the O
percentage O
of O
Hb-synthesizing B
cells I
was O
decreased O
to O
20 O
% O
. O

In O
the O
presence O
of O
Epo O
, O
c-myb O
mRNA O
declined O
and O
20 O
% O
of O
K562 B
cells I
synthesized O
Hb O
regardless O
of O
antisense O
myb O
RNA O
expression O
. O

The O
amount O
of O
c-myb O
mRNA O
in O
K562 B
cells I
was O
reduced O
during O
the O
differentiation O
induced O
by O
Epo O
. O

It O
is O
supposed O
that O
the O
mechanism O
of O
Hm O
-induced O
differentiation O
is O
distinguished O
from O
that O
of O
Epo O
-induced O
differentiation O
in O
K562 B
cells I
. O

In O
addition O
, O
after O
novelty O
stress O
the O
HRBC O
group O
, O
but O
not O
the O
LPS B
group I
, O
showed O
increased O
ACTH O
and O
corticosterone O
levels O
. O

NM23 O
was O
identified O
in O
a O
system O
of O
murine B
melanoma I
cell I
lines I
, O
in O
which O
an O
inverse O
relationship O
was O
found O
between O
NM23 O
expression O
and O
metastatic O
ability O
. O

The O
present O
paper O
studies O
the O
expression O
of O
the O
NM23.H1 O
gene O
in O
cell B
lines I
which O
derive O
from O
primary O
or O
metastatic O
human O
malignant O
melanomas O
in O
relation O
to O
staging O
, O
infiltration O
degree O
, O
lymphocytic O
infiltration O
, O
cell O
morphology O
, O
cell O
pigmentation O
, O
karyotype O
, O
and O
disease-free O
survival O
. O

The O
level O
of O
mRNA O
expression O
of O
the O
NM23 O
gene O
is O
significantly O
lower O
in O
cell B
lines I
that O
derive O
from O
more O
infiltrating O
primary O
melanomas O
than O
in O
cell B
lines I
obtained O
from O
less O
infiltrating O
tumours O
. O

Moreover O
, O
cell B
lines I
derived O
from O
tumours O
of O
patients O
with O
a O
disease-free O
survival O
of O
more O
than O
24 O
months O
( O
24-58 O
months O
) O
express O
the O
NM23 O
gene O
at O
higher O
levels O
than O
cell B
lines I
obtained O
from O
melanomas O
of O
patients O
with O
a O
disease-free O
survival O
of O
less O
than O
24 O
months O
( O
6-15 O
months O
) O
. O

Fos O
kinase O
was O
rapidly O
activated O
after O
ligation O
of O
the O
CD3 O
and O
CD2 O
receptors O
in O
Jurkat B
and O
normal O
human O
T O
lymphocytes O
and O
in O
response O
to O
IL-6 O
and O
anti-IgM O
in O
the O
human B
B I
cell I
lines I
AF10 B
and O
Ramos B
, O
respectively O
. O

Antigenic O
specificities O
of O
human B
CD4+ I
T-cell I
clones I
recovered O
from O
recurrent O
genital O
herpes O
simplex O
virus O
type O
2 O
lesions O
. O

We O
have O
investigated O
the O
antigenic O
specificity O
of O
47 O
HSV-specific B
CD4+ I
T-cell I
clones I
recovered O
from O
the O
HSV-2 O
buttock O
and O
thigh O
lesions O
of O
five O
patients O
. O

Clones O
with O
proliferative O
responses O
to O
recombinant O
truncated O
glycoprotein O
B O
( O
gB O
) O
or O
gD O
of O
HSV-2 O
or O
purified O
natural O
gC O
of O
HSV-2 O
comprised O
a O
minority O
of O
the O
total O
number O
of O
HSV-specific B
clones I
isolated O
from O
lesions O
. O

The O
gC2- B
and I
gD2-specific I
CD4+ I
clones I
had O
cytotoxic O
activity O
. O

The O
antigenic O
specificity O
of O
an O
HLA B
DQ2-restricted I
, I
HSV-2 I
type-specific I
T-cell I
clone I
was O
mapped O
to O
amino O
acids O
425 O
to O
444 O
of O
VP16 O
of O
HSV-2 O
by O
sequential O
use O
of O
an O
intertypic O
recombinant O
virus O
containing O
VP16 O
of O
HSV-2 O
in O
an O
HSV-1 O
background O
, O
recombinant O
VP16 O
fusion O
proteins O
, O
and O
synthetic O
peptides O
. O

Each O
of O
the O
remaining O
four O
patients O
also O
yielded O
at O
least O
one O
type-specific B
T-cell I
clone I
reactive O
with O
an O
HSV-2 O
epitope O
mapping O
to O
approximately O
0.67 O
to O
0.73 O
map O
units O
. O

The O
antigenic O
specificities O
of O
lesion-derived B
CD4+ I
T-cell I
clones I
are O
quite O
diverse O
and O
include O
at O
least O
10 O
epitopes O
. O

Human B
T-cell I
clones I
reactive O
with O
gC O
and O
VP16 O
are O
reported O
here O
for O
the O
first O
time O
. O

These O
findings O
suggest O
that O
the O
basophils O
which O
appeared O
during O
the O
ATRA O
treatment O
are O
reactive O
in O
nature O
rather O
than O
a O
leukaemic B
clone I
. O

Using O
stable O
transfection O
of O
the O
monocytoid B
U937 I
cell I
line I
with O
a O
series O
of O
deletion O
mutants O
of O
the O
CD14 O
5 O
' O
upstream O
sequence O
coupled O
to O
a O
reporter O
gene O
construct O
, O
we O
show O
that O
bp O
-128 O
to O
-70 O
is O
the O
critical O
region O
for O
the O
induction O
of O
CD14 O
expression O
. O

An O
in O
vitro O
binding O
site O
selection O
procedure O
was O
used O
to O
determine O
DNA O
sequences O
preferentially O
bound O
by O
wild-type O
HLF O
and O
chimeric O
E2A-HLF O
proteins O
isolated O
from O
various O
t B
( I
17 I
; I
19 I
) I
-bearing I
leukemias I
. O

Similarly O
, O
Jurkat B
T I
cell I
lines I
deficient O
in O
CD3 O
or O
CD45 O
expression O
also O
gave O
impaired O
UV O
responses O
. O

Inhibition O
of O
the O
differentiation O
of O
human B
myeloid I
cell I
lines I
by O
redox O
changes O
induced O
through O
glutathione O
depletion O
. O

We O
have O
investigated O
the O
effect O
of O
redox O
changes O
in O
vivo O
on O
the O
differentiation O
of O
two O
human B
myeloid I
cell I
lines I
, O
HL-60 B
and O
KG-1 B
. O

To O
investigate O
the O
role O
of O
reactive O
oxygen O
species O
we O
studied O
the O
effects O
of O
alpha-lipoic O
acid O
and O
dihydrolipoic O
acid O
( O
natural O
thiol O
antioxidants O
) O
on O
the O
expression O
of O
c-fos O
mRNA O
in O
human B
Jurkat I
T I
cells I
. O

We O
tested O
the O
effects O
of O
BHA O
, O
a O
phenolic O
, O
lipid-soluble O
, O
chain-breaking O
antioxidant O
, O
and O
NAC O
, O
a O
known O
glutathione O
precursor O
with O
some O
direct O
free-radical O
scavenging O
properties O
as O
well O
, O
on O
the O
regulation O
of O
HIV-1 O
expression O
in O
latently O
infected O
U1 B
cells I
and O
in O
productively O
and O
chronically O
infected O
U937 B
cells I
. O

Both O
antioxidants O
inhibited O
TNF O
-or O
PMA-induced O
NF-kappa O
B O
activity O
in O
U1 B
cells I
, O
as O
well O
as O
the O
sustained O
NF-kappa O
B O
activity O
permanently O
induced O
by O
the O
virus O
itself O
in O
chronically O
HIV-infected O
U937 B
cells I
. O

This O
resulted O
in O
only O
a O
partial O
inhibition O
of O
TNF O
-or O
PMA- O
induced O
HIV O
replication O
in O
U1 B
cells I
, O
and O
no O
detectable O
effect O
on O
HIV O
replication O
in O
chronically B
infected I
U937 I
cells I
. O

We O
demonstrate O
that O
the O
staphylococcal O
superantigens O
toxic O
shock O
syndrome O
toxin-1 O
( O
TSST-1 O
) O
and O
staphylococcal O
enterotoxin O
A O
( O
SEA O
) O
activate O
HIV-1-LTR O
-driven O
transcription O
of O
chloramphenicol O
acetyl O
transferase O
in O
the O
human B
monocytic I
cell I
line I
THP-1 B
. O

Induction O
of O
HIV-1- O
LTR O
-driven O
transcription O
in O
THP-1 B
cells I
by O
superantigens O
was O
associated O
with O
the O
induction O
of O
nuclear O
factor-kappa O
B O
DNA-binding O
activity O
. O

Superantigens O
also O
increased O
viral O
protein O
secretion O
from O
the O
granulocyte-macrophage B
colony-stimulating I
factor-pretreated I
chronically I
infected I
human I
monocytic I
cell I
line I
U1 I
. O

Similar O
complexes O
are O
detected O
in O
nuclear O
extracts O
of O
Jurkat B
cells I
. O

Alpha-tocopherol O
inhibits O
agonist-induced O
monocytic O
cell O
adhesion O
to O
cultured B
human I
endothelial I
cells I
. O

Activation O
of O
the O
transcription O
factor O
NF-kappa O
B O
is O
reported O
to O
be O
necessary O
but O
not O
sufficient O
for O
E-selectin O
expression O
in O
EC B
. O

The O
novel O
astrocyte-derived O
kappa O
B-binding O
activity O
is O
retained O
on O
an O
HIV-1 O
Tat O
affinity O
column O
, O
while O
prototypical O
NF-kappa O
B O
from O
Jurkat B
T I
cells I
is O
not O
. O

Several O
human B
myeloid I
leukemia I
cell I
lines I
growing O
in O
vitro O
can O
be O
induced O
to O
differentiate O
to O
more O
mature O
monocyte/macrophage-like O
cells O
by O
treatment O
with O
protein O
kinase O
C O
-activating O
phorbol O
esters O
, O
such O
as O
PMA O
. O

In O
addition O
to O
PMA O
, O
cells O
of O
the O
THP-1 B
myeloid I
leukemia I
cell I
line I
acquire O
macrophage-like O
characteristics O
after O
treatment O
with O
all-trans O
retinoic O
acid O
( O
RA O
) O
. O

RA O
also O
enhanced O
lyn O
mRNA O
production O
rapidly O
in O
HL-60 B
, O
indicating O
that O
the O
activation O
of O
lyn O
gene O
expression O
is O
common O
in O
monocytic O
and O
granulocytic O
maturation O
of O
myeloid O
leukemia O
cells O
. O

To O
examine O
whether O
the O
AP-1 O
enhancer O
activity O
is O
involved O
in O
RA-induced O
monocytic O
differentiation O
, O
THP-1 B
cells I
were O
transiently O
transfected O
with O
a O
chloramphenicol O
acetyl O
transferase O
( O
CAT O
) O
-reporter O
gene O
containing O
5 O
copies O
of O
the O
AP-1 O
binding O
sites O
. O

To O
test O
this O
hypothesis O
, O
light-chain O
gene O
structure O
was O
examined O
in O
pre-B B
cells I
transformed O
by O
temperature-sensitive O
mutants O
of O
the O
Abelson O
virus O
and O
in O
derivatives O
that O
survive O
at O
the O
nonpermissive O
temperature O
because O
they O
express O
a O
human O
BCL-2 O
gene O
. O

One O
gene O
product O
, O
when O
overexpressed O
in O
Jurkat B
T I
cells I
, O
specifically O
induced O
transcription O
from O
the O
interleukin-2 O
enhancer O
, O
by O
activating O
the O
T-cell-specific O
transcription O
factors O
NF-AT O
and O
NF-IL2A O
. O

Aims O
of O
the O
study O
were O
to O
( O
1 O
) O
assess O
the O
potential O
role O
of O
the O
expression O
of O
these O
genes O
in O
the O
maintenance O
and O
expansion O
of O
the O
neoplastic B
clones I
and O
( O
2 O
) O
search O
for O
constitutional O
losses O
or O
rearrangements O
of O
one O
allele O
followed O
by O
a O
deletion O
of O
the O
second O
allele O
of O
the O
same O
genes O
in O
the O
leukemic O
cells O
. O

Northern O
blot O
analysis O
of O
poly O
( O
A O
) O
RNA O
purified O
from O
the O
human B
B I
cell I
line I
RPMI I
8226 I
and O
from O
activated O
T O
cells O
revealed O
a O
major O
mRNA O
transcript O
of O
2.2 O
kilobases O
. O

Reverse O
transcriptase-polymerase O
chain O
reaction O
was O
used O
to O
examine O
HB9 O
RNA O
transcripts O
in O
hematopoietic B
cell I
lines I
. O

HB9 O
RNA O
transcripts O
were O
most O
prevalent O
in O
several O
human B
B I
cell I
lines I
and O
K562 B
cells I
. O

To O
investigate O
the O
effects O
of O
human O
immunodeficiency O
virus O
type O
1 O
( O
HIV-1 O
) O
Tat O
on O
interleukin-2 O
( O
IL-2 O
) O
expression O
, O
we O
used O
IL-2 O
promoter-chloramphenicol O
acetyltransferase O
constructs O
and O
IL-2-secreting B
Jurkat I
T I
cells I
as O
a O
model O
system O
. O

Transient O
expression O
of O
HIV-1 O
Tat O
induced O
a O
five- O
to O
eightfold O
increase O
in O
IL-2 O
promoter O
activity O
in O
Jurkat B
T I
cells I
stimulated O
with O
phytohemagglutinin O
and O
phorbol O
myristate O
acetate O
. O

IL-2 O
secretion O
was O
increased O
more O
than O
twofold O
in O
both O
Jurkat B
T I
cells I
and O
primary B
T I
cells I
stimulated O
by O
extracellular O
HIV-1 O
Tat O
protein O
. O

Recent O
reports O
demonstrated O
that O
ionizing O
radiation O
in O
the O
dose O
range O
of O
2-50 O
Gy O
results O
in O
expression O
of O
NF-kappa O
B O
in O
human B
KG-1 I
myeloid I
leukemia I
cells I
and O
human O
B-lymphocyte O
precursor O
cells O
; O
the O
precise O
mechanism O
involved O
and O
the O
significance O
are O
not O
yet O
known O
. O

The O
present O
report O
demonstrates O
that O
even O
lower O
doses O
of O
ionizing O
radiation O
, O
0.25-2.0 O
Gy O
, O
are O
capable O
of O
inducing O
expression O
of O
NF-kappa O
B O
in O
EBV-transformed B
244B I
human I
lymphoblastoid I
cells I
. O

ATRA O
failed O
to O
induce O
CD38 O
expression O
in O
a O
mutant B
subclone I
of O
the O
HL-60 B
myeloid I
leukemia I
cell I
line I
( O
designated O
HL-60R B
) O
that O
is O
relatively O
resistant O
to O
ATRA-induced O
granulocytic O
differentiation O
. O

Retroviral O
vector-mediated O
transduction O
of O
RA O
receptor O
( O
RAR O
alpha O
) O
into O
this O
HL-60R B
subclone I
completely O
restored O
the O
sensitivity O
of O
these O
cells O
to O
ATRA O
in O
terms O
of O
their O
ability O
to O
express O
CD38 O
. O

In O
contrast O
, O
CD38 O
expression O
was O
not O
inducible O
by O
ATRA O
in O
HL-60R B
cells I
, O
transfected O
with O
a O
functional O
RAR O
beta O
, O
RAR O
gamma O
, O
or O
RXR O
alpha O
receptor O
. O

LIF O
induced O
a O
dose-dependent O
increase O
in O
p24 O
antigen O
production O
in O
the O
chronically B
infected I
promonocytic I
cell I
line I
U1 I
. O

NF-kB O
levels O
were O
higher O
in O
unstimulated B
U1 I
cells I
as O
compared O
to O
the O
parent B
cell I
line I
U937 B
. O

Mechanisms O
involved O
in O
the O
inhibition O
of O
growth O
of O
a O
human B
B I
lymphoma I
cell I
line I
, O
B104 B
, O
by O
anti-MHC O
class O
II O
antibodies O
. O

The O
mechanisms O
involved O
in O
the O
inhibition O
of O
growth O
of O
a O
human B
B I
lymphoma I
cell I
line I
, O
B104 B
, O
by O
anti-MHC O
class O
II O
antibodies O
( O
Ab O
) O
were O
compared O
with O
those O
in O
anti-IgM O
Ab O
-induced O
B104 O
growth O
inhibition O
. O

Two O
anti-MHC O
class O
II O
Ab O
, O
L227 O
and O
2.06 O
, O
inhibited O
the O
growth O
of O
B104 B
cells I
, O
although O
2.06 O
, O
but O
not O
L227 O
, O
needed O
to O
be O
further O
cross-linked O
with O
a O
goat O
anti-mouse O
IgG O
Ab O
( O
GAM O
) O
to O
show O
the O
effect O
. O

The O
inhibition O
of O
B104 B
cell I
growth O
induced O
by O
anti-MHC O
class O
II O
Ab O
was O
Ca O
( O
2+ O
) O
-independent O
and O
not O
inhibited O
by O
actinomycin O
D O
or O
cyclosporin O
A O
, O
and O
cell O
cycle O
arrest O
at O
the O
G2/M O
interphase O
was O
not O
observed O
. O

These O
features O
are O
very O
different O
from O
those O
observed O
in O
B104 B
cell I
death O
induced O
by O
anti-IgM O
Ab O
. O

These O
parameters O
were O
examined O
in O
normal O
and O
Epstein-Barr B
virus-immortalized I
human I
B I
cells I
and O
compared O
with O
1 B
alpha I
, I
25- I
( I
OH I
) I
2D3-responsive I
cells I
of O
the O
T O
and O
monocytic O
lineages O
. O

1 O
alpha O
, O
25- O
( O
OH O
) O
2D3 O
inhibited O
CD23 O
expression O
in O
U937 B
cells I
, O
yet O
failed O
to O
modulate O
CD23 O
expression O
in O
B O
cells O
. O

Furthermore O
, O
1 O
alpha O
, O
25- O
( O
OH O
) O
2D3 O
induced O
24-hydroxylase O
mRNA O
expression O
and O
metabolic O
activity O
in O
both O
U937 B
cells I
and O
lectin-activated O
T O
cells O
, O
yet O
failed O
to O
induce O
24-hydroxylase O
mRNA O
or O
its O
metabolic O
activity O
in O
B O
cells O
. O

Two O
other O
sites O
display O
disparate O
effects O
on O
IL-2 O
gene O
expression O
in O
different O
T B
leukemia I
cell I
lines I
: O
the O
distal O
purine O
box O
( O
-291 O
to O
-277 O
) O
and O
the O
proximal O
purine O
box O
sites O
( O
-145 O
to O
-128 O
) O
. O

Finally O
, O
the O
AP-1 O
( O
-186 O
to O
-176 O
) O
and O
the O
kappa O
B O
sites O
( O
-206 O
to O
-195 O
) O
respond O
to O
different O
cellular O
activation O
in O
EL4 B
cells I
. O

A O
DNA O
fragment O
containing O
128 O
bp O
of O
upstream O
sequence O
had O
strong O
, O
monocyte-specific O
promoter O
activity O
in O
the O
CD14 B
positive I
monocytic I
cell I
line I
Mono B
Mac I
6 I
as O
compared O
to O
the O
nonmonocytic B
cell I
lines I
HeLa B
and O
REX B
. O

We O
observed O
that O
FK506 O
suppressed O
the O
transcription O
of O
a O
chemotactic O
cytokine O
, O
interleukin-8 O
( O
IL-8 O
) O
in O
a O
human B
T I
cell I
line I
, O
Jurkat B
cells I
, O
activated O
by O
phorbol O
12-myristate O
13-acetate O
( O
PMA O
) O
and O
calcium O
( O
Ca2+ O
) O
ionophore O
( O
ionomycin O
) O
. O

Anti-CD28-stimulated B
T I
cells I
produced O
significant O
amounts O
of O
IL-8 O
; O
additionally O
, O
costimulation O
with O
anti-CD3 O
and O
anti-CD28 O
Abs O
resulted O
in O
a O
synergistic O
induction O
of O
IL-8 O
secretion O
. O

All-trans O
retinoic O
acid O
and O
1 O
alpha O
, O
25-dihydroxyvitamin O
D3 O
co-operate O
to O
promote O
differentiation O
of O
the O
human B
promyeloid I
leukemia I
cell I
line I
HL60 B
to O
monocytes O
. O

All-trans O
retinoic O
acid O
( O
RA O
) O
induces O
differentiation O
of O
HL60 B
cells I
to O
neutrophils O
and O
is O
used O
to O
treat O
acute O
promyelocytic O
leukemia O
. O

We O
observed O
that O
RA O
did O
not O
induced O
neutrophil O
differentiation O
in O
serum-free B
grown I
HL60 I
cells I
whereas O
50 O
nM O
1 O
alpha O
, O
25-dihydroxyvitamin O
D3 O
( O
D3 O
) O
induced O
maximal O
monocyte O
differentiation O
. O

Twenty-four O
hour O
treatment O
with O
10 O
nM O
RA B
primed I
cells I
for O
response O
to O
5 O
nM O
D3 O
; O
the O
reverse O
sequence O
being O
ineffective O
. O

To O
make O
clear O
the O
roles O
of O
RA O
and O
RAR O
alpha O
in O
the O
normal O
hematopoiesis O
, O
I O
have O
introduced O
the O
construct O
of O
human O
RAR O
alpha O
( O
hRAR O
alpha O
) O
into O
murine O
bone O
marrow O
cells O
with O
retroviral O
vector O
, O
and O
selected O
infected O
cells O
with O
drug O
resistant O
marker O
( O
Neo O
( O
r O
) O
) O
cultured O
on O
the O
stroma B
cell I
line I
( O
PA6-neo B
) O
, O
and O
analyzed O
the O
behavior O
of O
infected O
cells O
. O

RAR O
alpha O
infected O
cells O
were O
also O
able O
to O
differentiate O
into O
mature O
macrophages O
in O
the O
both O
of O
long O
term O
culture O
and O
IL3 B
colony I
. O

Thrombin O
stimulation O
of O
the O
T B
leukemic I
cell I
line I
Jurkat I
induced O
a O
transient O
increase O
in O
[ O
Ca2+ O
] O
i O
. O

Furthermore O
, O
hirudin O
and O
anti-thrombin O
III O
inhibited O
the O
thrombin-induced O
[ O
Ca2+ O
] O
i O
rise O
in O
Jurkat B
T I
cells I
. O

Several O
cell O
lines O
of O
hematopoietic O
origin O
including O
the O
leukemic B
T I
cell I
line I
HPB.ALL I
and O
the O
erythroleukemic B
cell I
line I
K562 I
were O
responsive O
to O
thrombin O
, O
whereas O
others O
such O
as O
THP1 B
, O
a O
myelomonocytic B
cell I
line I
, O
and O
BL2 B
, I
a O
Burkitt B
lymphoma I
were O
refractory O
to O
thrombin O
or O
TRP O
stimulation O
. O

We O
found O
that O
activation O
of O
Jurkat B
T I
cells I
by O
a O
combination O
of O
phytohemagglutinin O
and O
phorbol O
12-myristate O
13-acetate O
led O
to O
a O
dramatic O
inhibition O
of O
thrombin O
receptor O
mRNA O
expression O
and O
to O
a O
concomitant O
loss O
of O
the O
thrombin O
response O
. O

Finally O
, O
we O
demonstrate O
that O
thrombin O
and O
TRP O
enhanced O
CD69 O
expression O
and O
interleukin O
2 O
production O
induced O
by O
T O
cell O
receptor O
cross-linking O
in O
both O
Jurkat B
T I
cells I
and O
peripheral O
blood O
lymphocytes O
. O

Senescent B
human I
T I
lymphocyte I
cultures I
are O
unable O
to O
undergo O
proliferation O
, O
but O
show O
no O
difference O
from O
early B
passage I
cells I
in O
cytotoxic O
function O
or O
surface O
antigenic O
profile O
. O

A O
second O
feature O
of O
senescent B
T I
cells I
is O
the O
dramatic O
reduction O
in O
hsp70 O
production O
in O
response O
to O
heat O
shock O
. O

Interestingly O
, O
the O
progressive O
decline O
in O
the O
heat O
shock O
response O
of O
cultured B
T I
cells I
correlates O
with O
the O
percent O
proliferative O
life O
span O
completed O
rather O
than O
with O
the O
actual O
proliferative O
activity O
at O
the O
time O
of O
heat O
shock O
. O

Involvement O
of O
phospholipase O
D O
in O
the O
activation O
of O
transcription O
factor O
AP-1 O
in O
human B
T I
lymphoid I
Jurkat I
cells I
. O

We O
have O
examined O
the O
possibility O
that O
stimulation O
of O
phospholipase O
D O
( O
PLD O
) O
may O
regulate O
activation O
of O
transcription O
factor O
AP-1 O
in O
human O
T O
cells O
by O
transfecting O
human O
T B
lymphocyte I
Jurkat I
cells I
with O
a O
plasmid O
containing O
an O
AP-1 O
enhancer O
element O
and O
a O
chloramphenicol O
acetyltransferase O
reporter O
gene O
. O

We O
have O
detected O
activatable O
PLD O
in O
Jurkat B
cells I
, O
and O
we O
have O
found O
that O
addition O
of O
phosphatidic O
acid O
( O
PA O
) O
, O
the O
physiologic O
product O
of O
PLD O
action O
on O
phospholipids O
, O
is O
rapidly O
incorporated O
into O
Jurkat B
cells I
and O
leads O
to O
activation O
of O
transcription O
factor O
AP-1 O
. O

Treatment O
of O
Jurkat B
cells I
with O
anti-CD3 O
mAb O
activated O
both O
PLD O
and O
transcription O
factor O
AP-1 O
. O

We O
found O
a O
good O
correlation O
in O
the O
transfected B
cells I
between O
PLD O
activation O
and O
induction O
of O
AP-1 O
enhancer O
activity O
under O
different O
experimental O
conditions O
. O

An O
ability O
of O
the O
Epstein-Barr O
virus O
latent O
membrane O
protein O
LMP1 O
to O
enhance O
the O
survival O
of O
infected O
B O
cells O
through O
upregulation O
of O
the O
bcl-2 O
oncogene O
was O
first O
suggested O
by O
experiments O
involving O
gene O
transfection O
and O
the O
selection O
of O
stable O
LMP1+ B
clones I
( O
S.Henderson O
, O
M. O
Rowe O
, O
C.Gregory O
, O
F.Wang O
, O
E.Kieff O
, O
and O
A.Rickinson O
, O
Cell O
65 O
: O
1107-1115 O
, O
1991 O
) O
. O

However O
, O
it O
was O
not O
possible O
to O
ascertain O
whether O
Bcl-2 O
upregulation O
was O
a O
specific O
consequence O
of O
LMP1 O
expression O
or O
an O
artifact O
of O
the O
selection O
procedure O
whereby O
rare O
Bcl-2+ B
cells I
already O
present O
in O
the O
starting O
population O
might O
best O
be O
able O
to O
tolerate O
the O
potentially O
toxic O
effects O
of O
LMP1 O
. O

In O
the O
first O
approach O
, O
stable O
clones O
of O
two O
B-cell B
lines I
carrying O
an O
LMP1 O
gene O
under O
the O
control O
of O
an O
inducible O
metallothionein O
promoter O
were O
induced O
to O
express O
LMP1 O
in O
all O
cells O
. O

All O
six O
B-cell B
lines I
tested O
showed O
NF-kappa O
B O
activation O
in O
response O
to O
LMP1 O
expression O
, O
and O
this O
was O
followed O
in O
five O
of O
six O
lines O
by O
expression O
of O
ICAM-1 O
and O
Bcl-2 O
. O

In O
the O
same O
experiments O
, O
all O
three O
non- O
B-cell B
lines I
showed O
NF-kappa O
B O
activation O
and O
ICAM-1 O
upregulation O
but O
never O
any O
effect O
upon O
Bcl-2 O
. O

Long-term O
inositol O
phosphate O
release O
, O
but O
not O
tyrosine O
kinase O
activity O
, O
correlates O
with O
IL-2 O
secretion O
and O
NF-AT O
induction O
in O
anti-CD3-activated B
peripheral I
human I
T I
lymphocytes I
. O

Induction O
of O
proto-oncogene O
and O
cytokine O
expression O
in O
human O
peripheral O
blood O
monocytes O
and O
the O
monocytic B
cell I
line I
THP-1 B
after O
stimulation O
with O
mycoplasma-derived O
material O
MDHM O
. O

The O
induced O
expression O
of O
IL-1 O
beta O
and O
TNF O
alpha O
mRNA O
in O
the O
monocytic O
THP-1 B
cell I
line I
increased O
as O
quickly O
as O
in O
primary O
cells O
. O

In O
contrast O
to O
PBMo O
, O
THP-1 B
and O
14 O
other O
monocytic/myeloid B
leukemia-derived I
cell I
lines I
did O
not O
secrete O
measurable O
amounts O
of O
the O
cytokines O
upon O
treatment O
with O
MDHM O
. O

In O
THP-1 B
cells I
c-jun O
mRNA O
expression O
increased O
after O
incubation O
with O
MDHM O
while O
positive O
c-fos O
expression O
remained O
unaffected O
. O

c-myc O
mRNA O
expression O
, O
constitutively O
high O
in O
THP-1 B
cells I
, O
was O
induced O
in O
MDHM-stimulated O
PBMo O
. O

In O
conclusion O
, O
MDHM-stimulated O
induction O
of O
cytokine O
mRNA O
expression O
was O
accompanied O
by O
different O
proto-oncogene O
responses O
in O
PBMo O
and O
THP-1 B
cells I
. O

A O
500-bp O
fragment O
encompassing O
this O
hypersensitive O
site O
( O
nt O
4481 O
to O
4982 O
) O
exhibited O
transcription-enhancing O
activity O
( O
two- O
to O
threefold O
) O
when O
it O
was O
cloned O
in O
its O
natural O
position O
with O
respect O
to O
the O
HIV-1 O
promoter O
after O
transient O
transfection O
in O
U937 B
and O
CEM B
cells I
. O

As O
a O
functional O
correlate O
of O
this O
finding O
, O
transient O
co-transfection O
of O
HIV-1 O
LTR O
reporter O
constructs O
in O
a O
different O
T B
cell I
line I
demonstrated O
that O
v-src O
activated O
this O
promoter O
in O
a O
kappa O
B-dependent O
manner O
. O

Human O
herpesvirus O
6 O
( O
HHV-6 O
) O
is O
a O
lymphotropic O
herpesvirus O
, O
and O
in O
vitro O
, O
it O
can O
productively O
infect O
human O
CD4+ B
T I
cells I
as O
HIV-1 O
. O

When O
cotransfected O
with O
the O
HIV O
LTR O
CAT O
into O
CV-1 B
cells I
, O
both O
the O
pCD41 O
and O
pGD41 O
clones O
trans-activated O
the O
HIV O
LTR O
. O

Wild-type O
Chinese B
hamster I
ovary I
( I
CHO I
) I
-K1 I
cells I
can O
be O
activated O
by O
endotoxin O
to O
release O
arachidonate O
following O
transfection O
with O
human O
CD14 O
( O
CHO/CD14 O
) O
. O

We O
sought O
to O
determine O
if O
this O
pathway O
were O
present O
in O
CHO/CD14 B
cells I
and O
to O
elucidate O
the O
relationship O
of O
NF-kappa O
B O
activation O
to O
the O
CD14 O
receptor O
system O
. O

LPS-stimulated O
translocation O
of O
NF-kappa O
B O
in O
CHO/CD14 B
cells I
resembled O
the O
same O
response O
in O
the O
murine B
macrophage-like I
cell I
line I
RAW B
264.7 I
. O

Protein O
synthesis O
inhibitors O
and O
corticosteroids O
, O
which O
suppress O
arachidonate O
release O
and O
the O
synthesis O
of O
proinflammatory O
cytokines O
, O
had O
no O
effect O
on O
translocation O
of O
NF-kappa O
B O
in O
CHO/ O
CD14 O
or O
RAW B
264.7 I
cells I
, O
demonstrating O
that O
NF-kappa O
B O
translocation O
is O
an O
early O
event O
. O

Although O
TK O
activity O
was O
consistently O
observed O
by O
immunoblotting O
extracts O
from O
activated O
RAW B
264.7 I
cells I
, O
LPS-induced O
phosphotyrosine O
residues O
were O
not O
observed O
from O
similarly O
treated O
CHO/CD14 B
cells I
. O

Furthermore O
, O
the O
TK O
inhibitors O
herbimycin O
A O
and O
genistein O
failed O
to O
inhibit O
translocation O
of O
NF-kappa O
B O
in O
CHO/CD14 B
or O
RAW B
264.7 I
cells I
, O
although O
both O
of O
these O
agents O
inhibited O
LPS-induced O
TK O
activity O
in O
RAW B
264.7 I
cells I
. O

In O
addition O
, O
a O
human B
breast I
carcinoma I
cell I
line I
( O
ZR-75-1 B
) O
, O
which O
expresses O
the O
progesterone O
receptor O
, O
was O
analysed O
throughout O
. O

The O
ZR-75-1 B
cell I
line I
showed O
an O
expression O
of O
642 O
fmol/mg O
whereas O
lymphocytes O
of O
pregnant O
women O
showed O
an O
expression O
< O
or O
= O
4 O
fmol/mg O
. O

Stimulation O
of O
the O
human B
monocytic I
cell I
line I
Mono B
Mac I
6 I
with O
lipopolysaccharide O
( O
LPS O
) O
leads O
to O
rapid O
and O
transient O
expression O
of O
cytokines O
like O
tumor O
necrosis O
factor O
( O
TNF O
) O
. O

The O
CD14 O
LPS O
receptor O
is O
, O
however O
, O
up-regulated O
( O
not O
down-regulated O
) O
in O
tolerant B
cells I
, O
and O
LPS O
can O
, O
in O
fact O
, O
still O
lead O
to O
activation O
of O
tolerant B
cells I
as O
evidenced O
by O
mobilization O
of O
the O
transcription O
factor O
nuclear O
factor O
kappa O
B O
( O
NF-kappa O
B O
) O
. O

Resolution O
of O
the O
NF-kappa O
B O
complex O
in O
gel O
shift O
analysis O
shows O
that O
the O
binding O
protein O
, O
mobilized O
in O
naive B
Mono I
Mac I
6 I
cells I
, O
consists O
mainly O
of O
p50-p65 O
heterodimers O
, O
while O
in O
tolerant B
cells I
, O
the O
p50 O
homodimer O
is O
predominant O
. O

Reporter O
gene O
analysis O
reveals O
that O
the O
NF-kappa O
B O
complex O
mobilized O
in O
tolerant B
cells I
is O
functionally O
inactive O
in O
that O
NF-kappa O
B-dependent O
luciferase O
constructs O
containing O
the O
human O
immunodeficiency O
virus O
long O
terminal O
repeat O
or O
the O
TNF O
5'-region O
show O
only O
minimal O
transactivation O
after O
LPS O
stimulation O
. O

Similar O
to O
Mono B
Mac I
6 I
cells I
, O
primary O
blood O
monocytes O
, O
when O
precultured O
with O
a O
low O
dose O
of O
LPS O
, O
also O
become O
tolerant O
and O
produce O
little O
TNF O
after O
LPS O
stimulation O
. O

Analysis O
of O
Oct2-isoform O
expression O
in O
lipopolysaccharide-stimulated B
B I
lymphocytes I
. O

The O
frequency O
of O
Oct2-positive B
clones I
was O
1/15 O
, O
000 O
in O
both O
libraries O
. O

More O
frequent O
use O
of O
the O
classical O
Oct2a O
and O
Oct2b O
isoforms O
was O
observed O
in O
the O
lipopolysaccharide-stimulated B
B I
cells I
, O
while O
a O
preference O
for O
the O
Oct2ab O
and O
Oct2ba O
isoforms O
was O
observed O
in O
lipopolysaccharide B
plus I
phorbol-di-butyrate-treated I
cells I
. O

Analyses O
with O
cultured B
cells I
and O
cell-free O
systems O
have O
provided O
strong O
evidence O
that O
GATA-1 O
is O
involved O
in O
control O
of O
globin O
gene O
expression O
during O
erythroid O
differentiation O
. O

Nuclei O
from O
GATA-1 B
-mutant I
embryonic I
stem I
cells I
can O
still O
be O
reprogrammed O
to O
express O
their O
globin O
genes O
in O
erythroid O
heterokaryons O
, O
indicating O
that O
de O
novo O
induction O
of O
GATA-1 O
is O
not O
required O
for O
globin O
gene O
activation O
following O
cell O
fusion O
. O

The O
role O
of O
the O
human O
immunodeficiency O
virus O
( O
HIV-1 O
) O
Nef O
protein O
in O
T O
cell O
activation O
pathways O
was O
investigated O
using O
a O
Jurkat B
CD4+ I
cell I
line I
stably O
transfected O
with O
a O
Nef O
expression O
vector O
. O

These O
parameters O
were O
not O
modified O
by O
Nef O
expression O
in O
Jurkat B
cells I
, O
whereas O
stimulation O
with O
the O
same O
stimuli O
resulted O
in O
partial O
inhibition O
of O
LTR O
activation O
in O
Nef+ B
Jurkat I
cells I
. O

Retinoic O
acid O
downmodulates O
erythroid O
differentiation O
and O
GATA1 O
expression O
in O
purified B
adult-progenitor I
culture I
. O

In O
clonogenetic B
fetal I
calf I
serum-supplemented I
( I
FCS+ I
) I
or I
-nonsupplemented I
( I
FCS- I
) I
culture I
treated O
with O
saturating O
levels O
of O
interleukin-3 O
( O
IL-3 O
) O
granulocyte-macrophage O
colony-stimulating O
factor O
( O
GM-CSF O
) O
and O
erythropoietin O
( O
Ep O
) O
( O
combined O
with O
c-kit O
ligand O
in O
FCS O
( O
- O
) O
-culture O
conditions O
) O
, O
RA O
induces O
a O
dramatic O
dose-dependent O
shift O
from O
erythroid O
to O
granulomonocytic O
colony O
formation O
, O
the O
latter O
colonies O
being O
essentially O
represented O
by O
granulocytic B
clones I
. O

This O
shift O
is O
apparently O
not O
caused O
by O
a O
recruitment O
phenomenon O
, O
because O
in O
FCS+ B
culture I
, O
the O
total O
number O
of O
colonies O
is O
not O
significantly O
modified O
by O
RA O
addition O
. O

In O
FCS- B
liquid-suspension I
culture I
supplemented O
with O
saturating O
Ep O
level O
and O
low-dose O
IL-3/GM-CSF O
, O
adult O
HPC O
undergo O
unilineage O
erythropoietic O
differentiation O
: O
Here O
again O
, O
treatment O
with O
high-dose O
RA O
induces O
a O
shift O
from O
the O
erythroid O
to O
granulocytic O
differentiation O
pathway O
. O

Induction O
of O
phosphatidylinositol O
turnover O
and O
EGR-1 O
mRNA O
expression O
by O
crosslinking O
of O
surface O
IgM O
and O
IgD O
in O
the O
human B
B I
cell I
line I
B104 I
. O

We O
have O
previously O
shown O
that O
a O
human B
B I
lymphoma I
cell I
line I
, I
B104 I
, O
expressed O
surface O
IgM O
( O
sIgM O
) O
and O
surface O
IgD O
( O
sIgD O
) O
, O
and O
that O
crosslinking O
of O
sIgM O
and O
sIgD O
by O
anti-IgM O
antibody O
( O
Ab O
) O
and O
anti-IgD O
Ab O
, O
respectively O
, O
induced O
Ca2+ O
influx O
to O
almost O
the O
same O
degree O
, O
whereas O
only O
sIgM O
-crosslinking O
caused O
B104 B
cell I
death O
. O

Here O
, O
we O
investigated O
the O
accumulation O
of O
cyclic O
AMP O
( O
cAMP O
) O
, O
the O
hydrolysis O
of O
inositol O
phosphates O
, O
protein O
kinase O
C O
( O
PKC O
) O
activity O
and O
the O
induction O
of O
Egr-1 O
and O
c-fos O
mRNA O
expression O
by O
sIgM- O
and O
sIgD-crosslinking O
to O
examine O
differences O
in O
the O
signals O
mediated O
through O
sIgM O
and O
sIgD O
in O
B104 B
cells I
. O

Cyclosporin O
A O
( O
CsA O
) O
and O
FK506 O
rescued O
B104 B
cells I
from O
death O
induced O
by O
anti-IgM O
Ab O
, O
but O
did O
not O
affect O
the O
expression O
of O
Egr-1 O
and O
c-fos O
mRNA O
, O
showing O
that O
CsA O
and O
FK506 O
affect O
signal O
transducers O
differently O
from O
or O
downstream O
to O
these O
molecules O
. O

The O
difference O
in O
signals O
transduced O
through O
sIgM O
and O
sIgD O
in O
B104 B
cells I
is O
discussed O
. O

Interspecies O
somatic B
cell I
hybrids I
were O
generated O
by O
fusing O
the O
mouse B
T-lymphoma I
cell I
line I
, O
BW5147 B
, O
with O
normal O
human O
T O
lymphocytes O
at O
different O
stages O
of O
differentiation O
. O

Thymocytes O
, O
activated O
peripheral O
T O
lymphocytes O
, O
or O
an O
activated B
T-cell I
clone I
were O
used O
as O
human O
partners O
, O
respectively O
, O
in O
three O
independent O
fusions O
. O

Irrespective O
of O
the O
human O
cell O
partner O
used O
for O
fusion O
, O
a O
certain O
number O
of O
hybrids B
lost O
CD5 O
surface O
expression O
over O
a O
period O
of O
time O
in O
culture O
. O

Induction O
of O
the O
CD11b O
gene O
during O
activation O
of O
the O
monocytic B
cell I
line I
U937 I
requires O
a O
novel O
nuclear O
factor O
MS-2 O
[ O
published O
erratum O
appears O
in O
J O
Immunol O
1999 O
Jul O
15 O
; O
163 O
( O
2 O
) O
: O
1091 O
] O

Mutation O
of O
these O
elements O
indicated O
that O
two O
, O
MS-2beta O
and O
MS-2gamma O
, O
are O
critical O
to O
the O
induction O
of O
the O
CD11b O
gene O
during O
differentiation O
of O
the O
pro-monocytic B
cell I
line I
U937 I
. O

Electrophoretic O
mobility O
shift O
assays O
indicate O
that O
MS-2beta O
and O
MS-2gamma O
interact O
with O
nuclear O
factors O
that O
are O
induced O
during O
U937 B
differentiation O
. O

Interferon O
augments O
PML O
and O
PML/RAR O
alpha O
expression O
in O
normal O
myeloid O
and O
acute O
promyelocytic O
cells O
and O
cooperates O
with O
all-trans O
retinoic O
acid O
to O
induce O
maturation O
of O
a O
retinoid-resistant B
promyelocytic I
cell I
line I
. O

We O
report O
here O
that O
PML O
is O
expressed O
at O
low O
levels O
or O
not O
expressed O
in O
normal O
circulating O
human O
monocytes O
, O
lymphocytes O
, O
and O
polymorphonucleate O
cells O
, O
but O
is O
markedly O
induced O
by O
interferon O
; O
that O
PML O
and O
PML/RAR O
alpha O
expression O
is O
augmented O
by O
interferon O
in O
the O
NB4 B
APL I
cell I
line I
, O
which O
carries O
the O
t O
( O
15 O
; O
17 O
) O
, O
and O
in O
APL O
blasts O
from O
patients O
; O
that O
interferon O
inhibits O
growth O
and O
survival O
of O
NB4 O
APL O
cells O
in O
cooperation O
with O
RA O
; O
that O
interferons O
alone O
have O
minimal O
maturation O
effect O
on O
NB4 B
cells I
; O
and O
, O
finally O
, O
that O
interferon O
gamma O
, O
but O
not O
alpha O
or O
beta O
, O
induces O
maturation O
and O
growth O
suppression O
of O
NB4 B
cells I
with O
de O
novo O
retinoid O
resistance O
, O
and O
partially O
restores O
RA O
response O
. O

Effects O
of O
Ara-C O
on O
neutral O
sphingomyelinase O
and O
mitogen- O
and O
stress- O
activated O
protein O
kinases O
in O
T-lymphocyte B
cell I
lines I
. O

Neutral O
SMase O
activity O
was O
assessed O
in O
membranes O
from O
Jurkat B
, O
a O
human B
T-cell I
line I
, O
and O
EL4 B
, O
a O
murine B
T-cell I
line I
. O

Ara-C O
activated O
SMase O
with O
10 O
minutes O
in O
both O
Jurkat O
and O
EL4 B
cells I
, O
while O
phorbol O
ester O
( O
PMA O
) O
had O
no O
effect O
. O

PMA O
, O
but O
not O
Ara-C O
or O
ceramides O
, O
activated O
ERK O
MAPKS O
, O
in O
Jurkat B
and O
EL4 B
. O

PMA O
acted O
synergistically O
with O
ionomycin O
to O
activate O
JNK O
MAPKs O
in O
Jurkat B
and O
EL4 B
within O
10 O
minutes O
. O

Thus O
, O
ceramide O
is O
not O
a O
positive O
signal O
for O
ERK O
activation O
in O
T-cell B
lines I
. O

Studies O
of O
pluripotent B
islet I
cultures I
. O

The O
present O
review O
summarizes O
these O
findings O
, O
with O
a O
special O
focus O
on O
our O
own O
studies O
on O
pluripotent B
endocrine I
cultures I
of O
rat O
pancreas O
. O

However O
, O
the O
monocyte-derived B
DC I
were O
not O
terminally B
differentiated I
cells I
; O
they O
could O
still O
convert O
to O
macrophages O
in O
response O
to O
M-CSF O
. O

Flow O
cytometry O
analyses O
on O
cultured O
cells O
that O
were O
treated O
with O
tepoxalin O
or O
antisense O
oligonucleotides O
to O
the O
P65/p50 O
subunit O
of O
NF-kappa O
B O
, O
and O
then O
stimulated O
with O
PMA O
, O
revealed O
a O
reduced O
expression O
of O
CD11b/CD18 O
on O
monocytic B
HL60 I
cells I
, O
and O
endothelial O
adhesion O
molecule-1 O
( O
CD62E O
) O
and O
vascular O
adhesion O
molecule-1 O
( O
CD106 O
) O
on O
human O
umbilical O
vein O
endothelial O
cells O
. O

The O
monoclonal O
antibody O
( O
mAb O
) O
J393 O
induces O
apoptosis O
in O
Jurkat B
T-cells I
. O

While O
Jurkat B
cells I
co-expressed O
two O
discrete O
cell-surface O
isoforms O
of O
CD43 O
, O
recognized O
by O
mAb O
J393 O
and O
mAb O
G10-2 O
, O
respectively O
, O
only O
J393/CD43 O
signaled O
apoptosis O
. O

Treatment O
with O
soluble O
, O
bivalent O
mAb O
J393 O
killed O
25-50 O
% O
of O
the O
cell B
population I
, O
while O
concomitant O
engagement O
of O
either O
the O
CD3.TcR O
complex O
or O
the O
integrins O
CD18 O
and O
CD29 O
significantly O
potentiated O
this O
effect O
. O

Treatment O
of O
Jurkat B
cells I
with O
mAb O
J393 O
induced O
tyrosine O
phosphorylation O
of O
specific O
protein O
substrates O
that O
underwent O
hyperphosphorylation O
upon O
antigen O
receptor O
costimulation O
. O

The O
interferon O
regulatory O
factor-1 O
( O
IRF-1 O
) O
gene O
is O
both O
an O
immediate-early O
G1 O
phase O
gene O
and O
an O
S O
phase O
gene O
inducible O
by O
PRL O
in O
rat B
Nb2 I
T I
lymphocytes I
. O

Upon O
transfection O
into O
Nb2 B
T I
cells I
, O
1.7 O
kilobases O
( O
kb O
) O
of O
IRF-1 O
5'-flanking O
DNA O
linked O
to O
a O
chloramphenicol O
acetyl O
transferase O
( O
CAT O
) O
reporter O
gene O
mediated O
a O
30-fold O
induction O
of O
CAT O
enzyme O
activity O
in O
response O
to O
24 O
h O
of O
PRL O
stimulation O
. O

Regulation O
of O
the O
BZLF1 O
promoter O
of O
Epstein-Barr O
virus O
by O
second O
messengers O
in O
anti-immunoglobulin-treated B
B I
cells I
. O

SCL O
protein O
production O
was O
examined O
in O
a O
variety O
of O
hemopoietic B
cell I
lines I
by O
immunoblotting O
using O
specific O
polyclonal O
antisera O
. O

SCL O
protein O
was O
detected O
in O
erythroid B
, I
megakaryocyte I
, I
mast I
and I
early I
myeloid I
cell I
lines I
, O
as O
well O
as O
in O
several O
lymphoid B
leukemia I
cell I
lines I
which O
are O
known O
to O
harbor O
SCL O
gene O
rearrangements O
. O

This O
size O
discrepancy O
appeared O
to O
be O
due O
to O
cell-specific O
translational O
regulation O
, O
since O
overexpression O
of O
a O
retrovirally O
transfected O
SCL O
gene O
yielded O
the O
higher O
molecular O
weight O
forms O
in O
most O
cell B
lines I
( O
GP+E-86 B
, O
AT2.5 B
, O
M1 B
) O
but O
only O
the O
22 O
kDa O
form O
in O
the O
myeloid B
cell I
line I
, O
WEHI-3B/D+ B
. O

Overexpression O
of O
full-length O
SCL O
protein O
in O
the O
lymphoid B
cell I
lines I
, O
SupT1 O
and O
Raji O
, O
did O
not O
alter O
cell O
phenotype O
and O
there O
was O
no O
evidence O
for O
autoregulation O
of O
SCL O
transcription O
. O

The O
regulatory O
role O
of O
protein O
tyrosine O
phosphatases O
( O
PTPases O
) O
in O
this O
process O
was O
explored O
by O
studying O
the O
effects O
of O
a O
powerful O
PTPase O
inhibitor O
, O
vanadate O
peroxide O
( O
pervanadate O
) O
, O
on O
the O
activation O
cascade O
of O
Jurkat B
human I
leukaemic I
T-cells I
. O

This O
effect O
required O
surface O
expression O
of O
the O
CD45 O
PTPase O
and O
was O
not O
observed O
in O
CD45-deficient B
variants I
of O
Jurkat B
cells I
. O

In O
the O
CD45-negative B
variant I
, O
the O
effect O
of O
pervanadate O
on O
tyrosine O
phosphorylation O
was O
globally O
decreased O
and O
some O
phosphorylated O
substrates O
were O
specifically O
missing O
. O

TCR O
signaling O
was O
triggered O
by O
treating O
Jurkat B
T I
cells I
with O
PHA O
or O
anti-CD3 O
Abs O
, O
and O
NF-kappaB O
activation O
was O
monitored O
by O
electrophoretic O
mobility O
shift O
assays O
and/or O
by O
kappaB O
-dependent O
reporter O
assays O
. O

We O
have O
shown O
elsewhere O
that O
both O
the O
major O
immediate-early O
gene O
( O
MIE O
) O
and O
lytic O
cycle O
infectious O
progeny O
virus O
expression O
can O
be O
induced O
in O
otherwise O
nonpermissive O
monocyte-like B
U-937 I
cell I
cultures I
infected O
with O
either O
human O
CMV O
( O
HCMV O
) O
or O
simian O
CMV O
( O
SCMV O
) O
by O
treatment O
with O
the O
phorbol O
ester O
12-O-tetradecanoylphorbol-13-acetate O
( O
TPA O
) O
. O

Therefore O
, O
to O
evaluate O
the O
mechanism O
of O
TPA O
responsiveness O
of O
the O
SNE O
motifs O
and O
of O
a O
related O
16-bp O
SEE O
( O
SRF/ETS O
element O
) O
motif O
found O
in O
the O
HCMV O
and O
chimpanzee O
CMV O
MIE O
enhancers O
, O
we O
have O
examined O
the O
functional O
responses O
and O
protein O
binding O
properties O
of O
multimerized O
wild-type O
and O
mutant O
elements O
added O
upstream O
to O
the O
SCMV O
MIE O
or O
simian O
virus O
40 O
minimal O
promoter O
regions O
in O
the O
U-937 B
, O
K-562 B
, O
HL-60 B
, O
THP-1 B
, O
and O
Jurkat B
cell I
lines I
. O

This O
protein O
complex O
was O
more O
abundant O
in O
U-937 O
, O
K-562 O
, O
and O
HeLa O
cell O
extracts O
than O
in O
Raji B
, O
HF B
, O
BALB/c B
3T3 I
, O
or O
HL-60 B
cells I
, O
but O
the O
binding O
activity O
was O
altered O
only O
twofold O
after O
TPA O
treatment O
. O

A O
40-fold O
stimulation O
of O
chloramphenicol O
acetyltransferase O
activity O
mediated O
by O
four O
tandem O
repeats O
of O
the O
SNE O
could O
be O
induced O
within O
2 O
h O
( O
and O
up O
to O
250-fold O
within O
6 O
h O
) O
after O
addition O
of O
TPA O
in O
DNA-transfected B
U-937 I
cells I
, O
indicating O
that O
the O
stimulation O
appeared O
likely O
to O
be O
a O
true O
protein O
kinase O
C O
-mediated O
signal O
transduction O
event O
rather O
than O
a O
differentiation O
response O
. O

In O
this O
report O
, O
we O
describe O
the O
phenotype O
of O
mouse B
transgenic I
lines I
obtained O
by O
inducing O
tal-1 O
protein O
expression O
in O
lymphoid O
tissues O
using O
the O
LCK O
promoter O
. O

Primary B
lymphocyte I
cultures I
showed O
partial O
independence O
from O
exogenous O
growth O
stimuli O
and O
increased O
resistance O
to O
low-serum O
apoptosis O
. O

In O
this O
investigation O
an O
enhanced O
and O
prolonged O
IL-2 O
and O
IL-2 O
mRNA O
response O
was O
also O
detected O
in O
both O
stimulated O
( O
T O
cell O
mitogens O
or O
alloantigens O
) O
murine O
splenocytes O
and O
in O
the O
stimulated O
murine B
T I
cell I
line I
EL-4 I
in O
the O
presence O
of O
ciprofloxacin O
( O
5-80 O
micrograms/ml O
) O
as O
compared O
to O
control O
cells O
without O
antibiotics O
. O

Human O
T-cell O
leukemia O
virus O
type O
I O
( O
HTLV-I O
) O
is O
the O
etiologic O
agent O
of O
the O
adult O
T-cell O
leukemia O
, O
an O
aggressive O
and O
often O
fatal O
malignancy O
of O
activated B
human I
CD4 I
T I
cells I
. O

In O
this O
study O
, O
we O
demonstrate O
that O
HTLV-I O
Tax O
can O
physically O
associate O
with O
p100 O
, O
the O
product O
of O
the O
Rel-related O
NF-kappa O
B2 O
gene O
, O
both O
in O
transfected B
cells I
and O
in O
HTLV-I-infected B
leukemic I
T-cell I
lines I
. O

In O
previous O
studies O
, O
it O
was O
shown O
that O
the O
fusion O
region O
of O
the O
pml/RAR-alpha O
protein O
, O
expressed O
by O
acute B
promyelocytic I
leukemia I
( I
APL I
) I
cells I
, O
can O
be O
specifically O
recognized O
in O
vitro O
by O
donor O
( O
D. O
E. O
) O
CD4 B
T I
cells I
in O
a O
HLA O
class O
II O
DR11-restricted O
fashion O
. O

We O
then O
generated O
new O
donor O
anti-pml/RAR-alpha B
CD4 I
( I
+ I
) I
T-cell I
clones I
. O

One O
clone O
( O
C3/5 B
, I
CD3 I
( I
+ I
) I
, I
CD4 I
( I
+ I
) I
, I
CD8 I
( I
- I
) I
) O
was O
selected O
for O
further O
analysis O
. O

Clone B
C3/5 I
showed O
specific O
proliferation O
, O
cytotoxicity O
, O
and O
cytokine O
( O
tumor O
necrosis O
factor O
alpha O
, O
granulocyte-macrophage O
colony-stimulating O
factor O
) O
production O
when O
challenged O
with O
autologous B
lymphoblastic I
cell I
lines I
pulsed O
with O
peptide O
BCR1/25 O
. O

C3/5 B
cells I
developed O
specific O
proliferation O
and O
cytotoxicity O
when O
challenged O
with O
peptide-pulsed B
lymphoblastic I
cell I
lines I
and O
peripheral O
blood O
lymphocytes O
from O
the O
four O
DR11 O
( O
+ O
) O
APL O
patients O
. O

APL O
blasts O
, O
available O
only O
from O
patients O
F.R. O
and O
P.G. O
, O
were O
not O
lysed O
by O
C3/5 B
and O
were O
unable O
to O
present O
peptide O
BCR1/25 O
. O

Incubation O
of O
APL B
cells I
with O
IFN-gamma O
failed O
to O
induce O
HLA O
class O
II O
molecules O
and O
recognition O
by O
the O
C3/5 B
clone I
. O

Since O
APL B
cells I
do O
not O
express O
HLA O
class O
II O
molecules O
, O
we O
tested O
in O
two O
donors O
( O
D.E. O
and O
C.H.R. O
) O
and O
in O
patients O
S.R.and O
P.G.whether O
the O
use O
of O
9-mer O
peptides O
( O
BCR1/9 O
) O
would O
generate O
a O
CD8 O
/HLA O
class O
I O
-restricted O
response O
. O

No O
peptide-specific B
T-cell I
line I
or O
clone O
could O
be O
generated O
from O
both O
donors O
and O
patients O
. O

S107 B
plasmacytoma I
cells I
, O
which O
express O
CD40 O
but O
are O
defective O
for O
the O
nuclear O
appearance O
of O
p50/p65-NF-kappaB O
, O
do O
not O
express O
RelB O
after O
CD40 O
stimulation O
. O

In O
S107 B
cells I
stably O
transfected O
with O
relB O
genes O
, O
stimulation O
of O
nuclear O
RelB O
translocation O
by O
CD40 O
was O
observed O
. O

The O
level O
of O
SP140 O
mRNA O
in O
myeloid B
precursor I
cell I
lines I
HL60 B
and O
NB4 B
markedly O
increased O
in O
response O
to O
chemically O
induced O
cellular O
differentiation O
. O

Immunohistochemical O
techniques O
were O
used O
to O
demonstrate O
that O
SP140 O
localized O
to O
the O
NB O
in O
differentiated O
HL60 B
and O
NB4 B
cells I
. O

In O
this O
report O
, O
we O
demonstrate O
that O
the O
PB1 O
element O
alone O
confers O
inducibility O
on O
a O
heterologous O
promoter O
following O
transfection O
into O
human B
Jurkat I
T I
cells I
. O

Inhibition O
of O
nuclear O
factor O
kappa O
B O
subunit O
p65 O
mRNA O
accumulation O
in O
lipopolysaccharide-stimulated B
human I
monocytic I
cells I
treated O
with O
sodium O
salicylate O
. O

To O
examine O
the O
mechanisms O
by O
which O
salicylates O
affect O
cytokine O
gene O
transcription O
, O
the O
amount O
of O
active O
and O
inactive O
NF-kappa O
B O
and O
NF-kappa O
B O
mRNA O
, O
in O
Porphyromonas O
gingivalis O
lipopolysaccharide-stimulated B
human I
monocytic I
cells I
was O
assessed O
. O

We O
observed O
that O
dexamethasone O
dramatically O
inhibited O
RANTES O
mRNA O
expression O
dose O
dependently O
in O
anti-CD3 B
activated I
Hut-78 I
T I
cells I
and O
human O
PBMCs O
. O

We O
now O
show O
that O
in O
EBV-transformed B
B I
lymphocytes I
most O
of O
TRAF1 O
or O
TRAF3 O
and O
5 O
% O
of O
TRAF2 O
are O
associated O
with O
LMP1 O
and O
that O
most O
of O
LMP1 O
is O
associated O
with O
TRAF1 O
or O
TRAF3 O
. O

Lack O
of O
IL-12 O
signaling O
in O
human B
allergen-specific I
Th2 I
cells I
. O

IL-12 O
is O
a O
powerful O
skewer O
of O
CD4+ O
T O
cell O
responses O
toward O
the O
Th1 O
phenotype O
by O
inducing O
IFN-gamma O
production O
in O
naive B
Th I
cells I
. O

In O
the O
present O
study O
we O
addressed O
the O
question O
of O
whether O
IL-12 O
can O
reverse O
established O
Th2 O
responses O
into O
Th1/Th0 O
responses O
by O
inducing O
IFN-gamma O
production O
in O
memory B
Th2 I
cells I
. O

To O
this O
aim O
, O
allergen-specific B
CD4+ I
T I
cell I
clones I
( O
TCC B
) O
were O
generated O
from O
the O
peripheral O
blood O
of O
three O
atopic O
patients O
, O
and O
their O
cytokine O
profiles O
were O
analyzed O
. O

The O
majority O
of O
these O
TCC B
exhibited O
a O
strongly O
polarized O
Th2 O
cytokine O
profile O
, O
and O
the O
production O
of O
IFN-gamma O
could O
not O
be O
induced O
by O
exogenous O
IL-12 O
. O

Only O
those O
TCC B
with O
low O
IFN-gamma O
levels O
in O
the O
absence O
of O
IL-12 O
responded O
to O
IL-12 O
by O
additional O
enhancement O
of O
IFN-gamma O
production O
. O

The O
IL-12 O
nonresponsiveness O
of O
the O
Th2 B
clones I
was O
further O
evident O
by O
the O
total O
lack O
of O
IL-12 O
-induced O
phosphorylation O
of O
STAT4 O
( O
signal O
transducer O
and O
activator O
of O
transcription-4 O
) O
, O
a O
transcription O
factor O
that O
is O
typically O
involved O
in O
IL-12 O
signaling O
. O

Consequently O
, O
IL-12 O
also O
failed O
to O
induce O
the O
DNA-binding O
activity O
of O
STAT4-containing O
complexes O
in O
the O
nuclei O
of O
these O
Th2 B
clones I
. O

All O
TCC B
expressed O
equal O
levels O
of O
the O
low-affinity O
IL-12R O
beta1 O
subunit O
. O

The O
apparent O
high O
frequency O
of O
IL-12-nonresponsive B
Th I
cells I
within O
the O
allergen-specific O
populations O
in O
atopic O
patients O
predicts O
a O
limited O
skewing O
potential O
of O
IL-12 O
in O
the O
case O
of O
established O
Th2 O
responses O
, O
but O
only O
affecting O
newly O
recruited O
naive O
Th B
cells I
. O

MAbs O
against O
the O
dUTPase O
reacted O
with O
a O
protein O
of O
approximately O
31 O
kDa O
in O
12-O-tetradecanoyl-phorbol-13-acetate B
( I
TPA I
) I
-stimulated I
B I
cells I
harbouring O
either O
type O
1 O
or O
type O
2 O
EBV O
. O

Mutations O
in O
this O
site O
which O
eliminate O
PU.1 O
binding O
decrease O
M-CSF O
receptor O
promoter O
activity O
significantly O
in O
macrophage B
cell I
lines I
only O
. O

A O
Western O
blot O
analysis O
was O
used O
to O
investigate O
HER-2/neu O
expression O
, O
whereas O
a O
chromium-release O
assay O
using O
the O
K562 B
cell I
line I
as O
target O
was O
used O
to O
measure O
natural O
killer O
( O
NK O
) O
cell O
activity O
. O

Signaling O
via O
IL-2 O
and O
IL-4 O
in O
JAK3-deficient B
severe I
combined I
immunodeficiency I
lymphocytes I
: O
JAK3 O
-dependent O
and O
independent O
pathways O
. O

Here O
, O
we O
have O
studied O
IL-2 O
and O
IL-4 O
signaling O
in O
B B
cell I
lines I
lacking O
JAK3 O
. O

In O
germinal O
centers O
GC O
, O
p50 O
, O
p52 O
, O
and O
RelB O
were O
found O
in O
the O
nuclei O
of O
FDC O
only O
and O
were O
not O
detected O
in O
the O
nuclei O
of O
CD68+ B
cells I
. O

In O
T O
cell O
areas O
, O
p50 O
, O
p52 O
, O
and O
RelB O
were O
found O
in O
the O
nuclei O
of O
HLA-DR+ B
cells I
with O
an O
antigen-presenting O
cell O
( O
APC O
) O
morphology O
. O

p52 O
and O
RelB O
were O
detected O
in O
the O
nuclei O
in O
both O
CD1a+ B
and O
CD68+ B
cells I
from O
the O
T O
cell O
area O
, O
whereas O
p50 O
was O
found O
only O
in O
CD68- B
and I
CD1a- I
cells I
. O

These O
results O
show O
that O
, O
physiologically O
, O
high O
levels O
of O
nuclear O
of O
p50 O
, O
p52 O
and O
RelB O
are O
restricted O
to O
accessory O
cells O
of O
the O
immune O
system O
, O
which O
include O
FDC O
in O
GC O
, O
and O
DC O
and O
macrophages O
in O
the O
T O
cell O
zone O
, O
that O
specialized O
scavenger O
macrophages O
from O
GC O
do O
not O
have O
detectable O
levels O
of O
p52 O
and O
RelB O
, O
whereas O
macrophages O
from O
the O
T O
cell O
area O
, O
known O
to O
present O
the O
antigen O
to O
T O
cells O
, O
do O
have O
both O
nuclear O
p52 O
and O
RelB O
, O
and O
that O
in O
the O
T O
cell O
zone O
, O
p52 O
and O
RelB O
are O
located O
in O
nuclei O
of O
both O
CD1a+ B
, O
CD68+ B
or O
both O
, O
cells O
APC O
, O
whereas O
p50 O
is O
restricted O
to O
CD1a- O
and O
CD68- O
APC O
. O

The O
human B
myeloid I
leukemia I
cell I
lines I
, O
HL-60 B
, O
U937 B
, O
and O
THP-1 B
, O
express O
similar O
levels O
of O
immunochemically O
detectable O
MNDA O
. O

The O
effect O
of O
interferon O
alpha O
on O
the O
MNDA O
mRNA O
is O
also O
observed O
in O
the O
cell B
lines I
HL-60 B
, O
U937 B
, O
and O
THP-1 B
. O

The O
MNDA O
mRNA O
level O
in O
the O
myeloid B
cell I
lines I
was O
also O
unaffected O
by O
the O
latter O
four O
agents O
. O

Induction O
of O
differentiation O
in O
the O
myeloid B
cell I
lines I
with O
phorbol O
ester O
induces O
monocyte O
differentiation O
which O
was O
accompanied O
by O
a O
decrease O
in O
MNDA O
mRNA O
level O
. O

The O
ability O
of O
interferon O
alpha O
to O
up-regulate O
MNDA O
mRNA O
in O
phorbol O
ester O
treated O
myeloid B
cell I
lines I
is O
consistent O
with O
the O
observations O
made O
in O
primary O
monocytes O
. O

Cotransfection O
of O
a O
YB-1 O
expression O
plasmid O
increases O
HTLV-I O
basal O
transcription O
approximately O
14-fold O
in O
Jurkat B
T I
lymphocytes I
. O

HIV-1 O
LTR O
activity O
in O
human B
CD40-activated I
B I
lymphocytes I
is O
dependent O
on O
NF-kappaB O
. O

CD40-stimulated B
human I
B I
lymphocytes I
are O
highly O
permissive O
to O
a O
productive O
infection O
by O
the O
human O
immunodeficiency O
virus O
type O
1 O
. O

Transient O
expression O
assays O
with O
plasmids O
containing O
deleted O
parts O
of O
the O
LTR O
region O
linked O
to O
a O
reporter O
gene O
showed O
that O
the O
NF-kappaB O
binding O
site O
was O
essential O
for O
HIV-1 O
LTR O
activity O
in O
CD40-stimulated B
B I
lymphocytes I
. O

In O
addition O
, O
electrophoretic O
mobility O
shift O
and O
supershift O
assays O
revealed O
that O
important O
NF-kappaB O
binding O
activity O
composed O
of O
at O
least O
p50 O
, O
p65 O
, O
and O
c-Rel O
NF-kappaB O
subunits O
was O
present O
in O
nuclei O
of O
CD40-stimulated B
B I
cells I
. O

Susceptibility O
to O
natural O
killer O
cells O
and O
down O
regulation O
of O
MHC O
class O
I O
expression O
in O
adenovirus B
12 I
transformed I
cells I
are O
regulated O
by O
different O
E1A O
domains O
. O

Furthermore O
, O
these O
cell B
lines I
appear O
resistant O
to O
lysis O
by O
natural O
killer O
( O
NK O
) O
cells O
. O

To O
determine O
the O
E1A O
domain O
( O
s O
) O
responsible O
for O
these O
properties O
several O
cell B
lines I
were O
created O
by O
transforming O
baby B
rat I
kidney I
( I
BRK I
) I
cells I
with O
a O
set O
of O
plasmids O
expressing O
different O
Ad2/Ad12 O
hybrid O
E1A O
gene O
products O
. O

Susceptibility O
of O
these O
transformed O
cell B
lines I
to O
NK O
cells O
was O
determined O
by O
cytolytic O
assays O
. O

The O
results O
obtained O
suggest O
that O
two O
Ad12 O
E1A O
domains O
are O
required O
to O
induce O
resistance O
of O
the O
cell B
lines I
to O
NK O
cells O
. O

In O
the O
erythroleukemia B
cell I
line I
K562 I
, O
due O
to O
the O
absence O
of O
Spi-B O
, O
only O
PU.1 O
bound O
to O
the O
Btk O
promoter O
. O

However O
, O
mutation O
of O
the O
PU O
box O
had O
no O
effect O
in O
the O
T-cell B
line I
Jurkat I
, O
where O
none O
of O
the O
Spi-1 O
family O
members O
is O
expressed O
. O

Studies O
of O
cell B
lines I
representing O
endocrine O
, O
fibroblast O
, O
and O
lymphoid O
lineages O
using O
polyclonal O
antisera O
to O
detect O
E2A O
proteins O
have O
suggested O
that O
significant O
E2A O
protein O
expression O
is O
restricted O
to O
B-lymphocytes O
. O

In O
contrast O
to O
previous O
results O
obtained O
using O
polyclonal O
antiseras O
to O
detect O
Pan/ O
E2A O
proteins O
, O
we O
report O
comparable O
levels O
of O
Pan O
proteins O
in O
GH/PRL- B
and I
insulin-producing I
, I
B- I
and I
T-lymphocyte I
cells I
. O

Therefore O
we O
first O
examined O
the O
participation O
of O
NF-kappa O
B O
in O
germline B
C I
epsilon I
transcription O
in O
a O
human B
Burkitt I
lymphoma I
B I
cell I
line I
, O
DND39 B
. O

Stimulation O
of O
DND39 B
cells I
with O
IL-4 O
or O
anti-CD40 O
monoclonal O
antibody O
( O
mAb O
) O
activated O
phosphatidylinositol O
3-kinase O
and O
subsequently O
induced O
nuclear O
expression O
of O
NF-kappa O
B O
, O
which O
was O
identified O
by O
electrophoretic O
mobility O
shift O
assays O
. O

Although O
inhibition O
of O
IL-4-driven B
germline I
C I
epsilon I
transcription O
by O
NAC O
was O
not O
sufficient O
, O
the O
agent O
remarkably O
diminished O
anti-CD40 O
mAb O
-mediated O
up-regulation O
of O
germline O
C O
epsilon O
transcription O
. O

These O
results O
indicate O
that O
NF-kappa O
B O
activity O
is O
commonly O
inducible O
in O
DND39 B
cells I
by O
IL-4 O
and O
anti-CD40 O
mAb O
and O
suggest O
that O
NF-kappa O
B O
sensitive O
to O
NAC O
may O
play O
a O
role O
in O
regulating O
IgE O
synthesis O
in O
B O
cells O
. O

However O
, O
compared O
to O
VD O
, O
their O
antiproliferative O
effect O
is O
up O
to O
30-fold O
higher O
on O
human O
peripheral O
blood O
mononuclear O
cells O
and O
even O
up O
to O
300-fold O
higher O
on O
human B
breast I
cancer I
MCF-7 I
cells I
. O

We O
have O
investigated O
the O
inductions O
of O
the O
IE O
genes O
in O
response O
to O
calcium O
signals O
in O
Jurkat B
cells I
( O
in O
the O
presence O
of O
activated O
p21 O
( O
ras O
) O
) O
and O
their O
correlated O
consequences O
. O

We O
overexpressed O
in O
the O
Jurkat B
T-cell I
line I
ZAP-70 O
mutated O
on O
Tyr-492 O
and O
Tyr-493 O
in O
the O
putative O
regulatory O
loop O
of O
its O
kinase O
domain O
. O

Furthermore O
, O
overexpression O
and O
constitutive O
nuclear O
localization O
of O
NF-AT O
, O
but O
not O
Jun O
, O
Fos O
, O
NF-kappaB O
, O
Oct O
or O
Ets O
family O
members O
, O
renders O
the O
interleukin-2 O
enhancer O
in O
Jurkat B
T I
lymphocytes I
resistant O
to O
FK506 O
and O
cyclosporin O
A O
. O

We O
measured O
effects O
on O
the O
HIV-1 O
LTR O
in O
T B
cell I
lines I
that O
were O
stimulated O
with O
antibodies O
against O
CD45 O
and O
in O
those O
that O
lacked O
the O
expression O
of O
CD45 O
on O
their O
surfaces O
. O

Granulocyte-macrophage O
colony-stimulating O
factor O
( O
GM-CSF O
) O
and O
interleukin-2 O
( O
IL-2 O
) O
are O
produced O
by O
stimulation O
with O
phorbol-12-myristate O
acetate O
( O
PMA O
) O
and O
calcium O
ionophore O
( O
A23187 O
) O
in O
human B
T I
cell I
leukemia I
Jurkat I
cells I
. O

Transfection O
of O
an O
expression O
vector O
containing O
ORF2 O
but O
not O
full O
length O
cDNA O
was O
able O
to O
transform O
NIH3T3 B
cells I
and O
induce O
tumors O
in O
nude O
mice O
. O

Bcd O
mRNA O
transcripts O
of O
< O
or O
= O
2.6 O
kb O
were O
selectively O
expressed O
in O
PBL B
and O
testis O
of O
healthy O
individuals O
. O

Bcd O
transcripts O
were O
detected O
in O
all O
normal O
PBL O
samples O
tested O
but O
not O
in O
several O
malignant B
human I
B-cell I
lines I
and O
not O
in O
50 O
% O
of O
B-cells O
from O
B-CLL O
patients O
. O

Expression O
of O
Egr-1 O
correlates O
with O
the O
transformed O
phenotype O
and O
the O
type O
of O
viral O
latency O
in O
EBV B
genome I
positive I
lymphoid I
cell I
lines I
. O

In O
this O
paper O
we O
have O
investigated O
the O
role O
of O
Egr-1 O
in O
B O
cell O
growth O
regulation O
by O
examining O
the O
gene O
expression O
in O
a O
panel O
of O
B B
cell I
lines I
, O
including O
both O
EBV O
genome O
negative O
and O
EBV B
carrying I
cell I
lines I
. O

Egr-1 O
expression O
correlates O
with O
the O
cellular O
phenotype O
and O
the O
specific O
pattern O
of O
viral O
latency O
established O
within O
the O
individual B
cell I
lines I
. O

Thus O
, O
constitutive O
activation O
of O
Egr-1 O
gene O
is O
invariably O
associated O
with O
unrestricted O
expression O
of O
viral O
latent O
genes O
in O
all O
group B
III I
EBV I
genome I
carrying I
cell I
lines I
. O

In O
contrast O
, O
Egr-1 O
expression O
is O
abrogated O
in O
group B
I I
Burkitt I
tumor I
cells I
, O
irrespective O
of O
the O
EBV O
genome O
carrying O
status O
. O

Activated O
viral O
gene O
expression O
associated O
with O
phenotypic O
conversion O
of O
group B
I I
cell I
lines I
in O
to O
group B
II I
or O
III B
restores O
the O
Egr-1 O
gene O
expression O
. O

IL-10 O
also O
activated O
Stat5 O
in O
Ba/F3 B
cells I
that O
stably O
expressed O
the O
murine O
IL-10 O
receptor O
. O

We O
have O
used O
differential O
hybridization O
analysis O
of O
a O
cDNA O
library O
constructed O
from O
the O
murine O
RA-inducible B
MPRO I
promyelocyte I
cell I
line I
to O
identify O
immediate-early O
genes O
induced O
by O
RA O
during O
granulocytic O
differentiation O
. O

E3 O
transcripts O
were O
RA-inducible O
in O
HL60 B
cells I
, O
but O
not O
in O
an O
RA-resistant B
subclone I
, O
HL60R B
, O
that O
harbors O
a O
mutated O
RAR O
alpha O
gene O
. O

However O
, O
when O
HL60R B
cells I
were O
transduced O
with O
a O
functional O
copy O
of O
the O
RAR O
alpha O
gene O
, O
RA O
induced O
a O
10-fold O
increase O
in O
E3 O
mRNA O
levels O
. O

The O
molecular O
mechanism O
underlying O
IL-2 O
transcriptional O
blockade O
in O
anergic B
T I
cell I
clones I
is O
not O
fully O
understood O
. O

Peripheral O
blood O
lymphocytes O
( O
PBL O
) O
and O
alloreactive B
T I
cell I
lines I
of O
two O
male O
infants O
born O
to O
consanguinous O
parents O
and O
presenting O
with O
severe O
combined O
immunodeficiency O
( O
SCID O
) O
showed O
a O
pronounced O
deficiency O
in O
T O
cell O
activation O
. O

oriP O
is O
essential O
for O
EBNA O
gene O
promoter O
activity O
in O
Epstein-Barr B
virus-immortalized I
lymphoblastoid I
cell I
lines I
. O

In O
this O
study O
, O
the O
region O
upstream O
of O
Cp O
was O
analyzed O
for O
the O
presence O
of O
cis O
elements O
involved O
in O
regulating O
the O
activities O
of O
the O
EBNA O
gene O
promoters O
in O
established O
in B
vitro I
immortalized I
lymphoblastoid I
cell I
lines I
( O
LCLs B
) O
. O

It O
was O
determined O
that O
oriP O
, O
the O
origin O
for O
episomal O
maintenance O
during O
latency O
, O
is O
essential O
for O
efficient O
transcription O
initiation O
from O
either O
Cp O
or O
Wp O
in O
LCLs B
, O
as O
well O
as O
in O
some O
Burkitt B
's I
lymphoma I
cell I
lines I
. O

Deletion O
of O
the O
EBNA2-dependent O
enhancer O
located O
upstream O
of O
Cp O
resulted O
in O
a O
ca. O
two- O
to O
fivefold O
reduction O
in O
Cp O
activity O
in O
the O
LCLs B
assayed O
. O

The O
identification O
of O
oriP O
and O
the O
EBNA2-dependent O
enhancer O
as O
the O
major O
positive O
cis O
elements O
involved O
in O
regulating O
Cp O
activity O
in O
LCL B
suggests O
that O
EBNA O
gene O
transcription O
is O
largely O
autoregulated O
by O
EBNA O
1 O
and O
EBNA O
2 O
. O

We O
have O
found O
that O
, O
in O
the O
human O
pro-monocytic B
cell I
line I
, O
THP-1 B
, O
the O
lipopolysaccharide-induced O
expression O
of O
interleukin O
1beta O
is O
dependent O
on O
tyrosine O
kinase O
activation O
. O

A O
direct O
temporal O
correlation O
exists O
between O
HIV O
infection O
and O
the O
appearance O
of O
NF-kappaB O
DNA-binding O
activity O
in O
myelomonoblastic B
PLB-985 I
cells I
. O

To O
examine O
the O
molecular O
basis O
of O
constitutive O
NF-kappaB O
DNA-binding O
activity O
in O
HIV1 O
-infected O
cells O
, O
we O
analyzed O
the O
phosphorylation O
and O
turnover O
of O
IkappaBalpha O
protein O
, O
the O
activity O
of O
the O
double-stranded O
RNA-dependent O
protein O
kinase O
( O
PKR O
) O
and O
the O
intracellular O
levels O
of O
NF-kappaB O
subunits O
in O
the O
PLB-985 B
and O
U937 B
myeloid I
cell I
models I
. O

Constitutive O
PKR O
activity O
was O
also O
detected O
in O
HIV-1-infected B
cells I
as O
a O
result O
of O
low-level O
IFN O
production O
, O
since O
the O
addition O
of O
anti-IFN-alpha/beta O
antibody O
to O
the O
cells O
decreased O
PKR O
expression O
. O

Furthermore O
, O
the O
analysis O
of O
IkappaBalpha O
turnover O
demonstrated O
an O
increased O
degradation O
of O
IkappaBalpha O
in O
HIV-1-infected B
cells I
that O
may O
account O
for O
the O
constitutive O
DNA O
binding O
activity O
. O

A O
dramatic O
increase O
in O
the O
intracellular O
levels O
of O
NF-kappaB O
subunits O
c-Rel O
and O
NF-kappaB2 O
p100 O
and O
a O
moderate O
increase O
in O
NF-kappaB2 O
p52 O
and O
RelA O
( O
p65 O
) O
were O
detected O
in O
HIV-1-infected B
cells I
, O
whereas O
NF-kappaB1 O
p105/p50 O
levels O
were O
not O
altered O
relative O
to O
the O
levels O
in O
uninfected O
cells O
. O

Enhanced O
turnover O
of O
IkappaBalpha O
and O
the O
accumulation O
of O
NF-kappaB/Rel O
proteins O
may O
contribute O
to O
the O
chronically O
activated O
state O
of O
HIV-1-infected B
cells I
. O

In O
HeLa B
nonpituitary I
cells I
, O
c-Jun O
alone O
activated O
the O
rPRL O
promoter O
via O
the O
most O
proximal O
GHF-1/Pit-1 O
binding O
site O
, O
footprint O
I O
, O
and O
synergized O
with O
GHF-1 O
. O

ATRA O
induces O
both O
in O
vitro O
and O
in O
vivo O
differentiation O
of O
APL B
cells I
into O
mature O
granulocytes O
. O

The O
NB4 B
cell I
line I
, O
which O
is O
derived O
from O
the O
bone O
marrow O
of O
a O
patient O
with O
APL O
during O
relapse O
, O
can O
be O
used O
as O
a O
model O
system O
to O
study O
the O
growth O
and O
differentiation O
of O
APL B
cells I
. O

In O
addition O
to O
NB4 O
cells O
, O
ATRA O
also O
activated O
IRF-1 O
gene O
expression O
in O
HL-60 B
, O
U937 B
, O
and O
THP-1 B
cells I
, O
which O
all O
respond O
to O
ATRA O
by O
growth O
inhibition O
. O

A O
more O
than O
additive O
increase O
in O
IRF-1 O
gene O
expression O
was O
seen O
with O
ATRA O
and O
IFN-gamma O
in O
NB4 B
cells I
. O

The O
ATRA-induced O
expression O
of O
IRF-1 O
, O
an O
activator O
of O
transcription O
and O
repressor O
of O
transformation O
, O
may O
be O
one O
of O
the O
molecular O
mechanisms O
of O
ATRA-induced O
growth O
inhibition O
, O
and O
the O
basis O
for O
the O
synergistic O
actions O
of O
ATRA O
and O
IFNs O
in O
myeloid B
leukemia I
cells I
. O

When O
expressed O
in O
Jurkat B
T I
cells I
, O
recombinant O
NFAT1 O
is O
regulated O
, O
as O
expected O
, O
by O
the O
calmodulin-dependent O
phosphatase O
calcineurin O
, O
and O
its O
function O
is O
inhibited O
by O
the O
immunosuppressive O
agent O
cyclosporin O
A O
( O
CsA O
) O
. O

Transactivation O
by O
recombinant O
NFAT1 O
in O
Jurkat B
T I
cells I
requires O
dual O
stimulation O
with O
ionomycin O
and O
phorbol O
12-myristate O
13-acetate O
; O
this O
activity O
is O
potentiated O
by O
coexpression O
of O
constitutively O
active O
calcineurin O
and O
is O
inhibited O
by O
CsA O
. O

When O
expressed O
in O
COS B
cells I
, O
however O
, O
NFAT1 O
is O
capable O
of O
transactivation O
, O
but O
it O
is O
not O
regulated O
correctly O
: O
its O
subcellular O
localization O
and O
transcriptional O
function O
are O
not O
affected O
by O
stimulation O
of O
the O
COS B
cells I
with O
ionomycin O
and O
phorbol O
12-myristate O
13-acetate O
. O

Loss O
of O
heterozygosity O
in O
PB O
granulocytes O
would O
be O
masked O
by O
the O
presence O
of O
significant O
numbers O
of O
normal O
granulocytes O
not O
derived O
from O
the O
malignant B
clone I
. O

These O
results O
show O
that O
, O
in O
the O
vast O
majority O
of O
patients O
presented O
here O
, O
the O
failure O
to O
detect O
loss O
of O
heterozygosity O
can O
not O
be O
attributed O
to O
the O
presence O
of O
normal B
polyclonal I
granulocytes I
. O

Interleukin-6 O
( O
IL-6 O
) O
mediates O
autocrine O
and O
paracrine O
growth O
of O
multiple B
myeloma I
( I
MM I
) I
cells I
and O
inhibits O
tumor O
cell O
apoptosis O
. O

Abnormalities O
of O
retinoblastoma O
protein O
( O
pRB O
) O
and O
mutations O
of O
RB O
gene O
have O
been O
reported O
in O
up O
to O
70 O
% O
of O
MM O
patients O
and O
80 O
% O
of O
MM-derived B
cell I
lines I
. O

Both O
phosphorylated O
and O
dephosphorylated O
pRB O
were O
expressed O
in O
all O
serum-starved O
MM O
patient O
cells O
and O
MM-derived B
cell I
lines I
, O
but O
pRB O
was O
predominantly O
in O
its O
phosphorylated O
form O
. O

In O
MM B
cells I
that O
proliferated O
in O
response O
to O
IL-6 O
, O
exogenous O
IL-6 O
downregulated O
dephosphorylated O
pRB O
and O
decreased O
dephosphorylated O
pRB-E2F O
complexes O
. O

Importantly O
, O
culture O
of O
MM B
cells I
with O
RB O
antisense O
, O
but O
not O
RB O
sense O
, O
oligonucleotide O
( O
ODN O
) O
triggered O
IL-6 O
secretion O
and O
proliferation O
in O
MM B
cells I
; O
however O
, O
proliferation O
was O
only O
partially O
inhibited O
by O
neutralizing O
anti-IL-6 O
monoclonal O
antibody O
( O
MoAb O
) O
. O

In O
contrast O
to O
MM B
cells I
, O
normal O
splenic O
B O
cells O
express O
dephosphorylated O
pRB O
. O

Although O
CD40 O
ligand O
( O
CD40L O
) O
triggers O
a O
shift O
from O
dephosphorylated O
to O
phosphorylated O
pRB O
and O
proliferation O
of O
B O
cells O
, O
the O
addition O
of O
exogenous O
IL-6 O
to O
CD40L O
-treated O
B O
cells O
does O
not O
alter O
either O
pRB O
or O
proliferation O
, O
as O
observed O
in O
MM B
cells I
. O

These O
results O
suggest O
that O
phosphorylated O
pRB O
is O
constitutively O
expressed O
in O
MM B
cells I
and O
that O
IL-6 O
further O
shifts O
pRB O
from O
its O
dephosphorylated O
to O
its O
phosphorylated O
form O
, O
thereby O
promoting O
MM O
cell O
growth O
via O
two O
mechanisms O
; O
by O
decreasing O
the O
amount O
of O
E2F O
bound O
by O
dephosphorylated O
pRB O
due O
to O
reduced O
dephosphorylated O
pRB O
, O
thereby O
releasing O
growth O
arrest O
; O
and O
by O
upregulating O
IL-6 O
secretion O
by O
MM B
cells I
and O
related O
IL-6 O
-mediated O
autocrine O
tumor O
cell O
growth O
. O

Various O
modes O
of O
basic O
helix-loop-helix O
protein O
-mediated O
regulation O
of O
murine O
leukemia O
virus O
transcription O
in O
lymphoid B
cell I
lines I
. O

In O
lymphoid B
cell I
lines I
only O
, O
the O
E O
( O
gre O
) O
-binding O
protein O
complexes O
included O
ALF1 O
or O
HEB O
and O
E2A O
basic O
helix-loop-helix O
proteins O
. O

In O
T- B
and I
B-cell I
lines I
, O
the O
E O
( O
gre O
) O
motifs O
were O
of O
major O
importance O
for O
Akv O
MLV O
transcriptional O
activity O
, O
while O
the O
EA/S O
motif O
had O
some O
effect O
. O

In O
contrast O
, O
neither O
E O
( O
gre O
) O
nor O
EA/S O
motifs O
contributed O
pronouncedly O
to O
Akv O
MLV O
transcription O
in O
NIH B
3T3 I
cells I
lacking O
DNA-binding O
ALF1 O
or O
HEB O
and O
E2A O
proteins O
. O

Moreover O
, O
ectopic O
Id1 O
repressed O
E O
( O
gre O
) O
-directed O
but O
not O
EA/S O
-directed O
MLV O
transcription O
in O
lymphoid B
cell I
lines I
. O

In O
conclusion O
, O
E O
( O
gre O
) O
motifs O
and O
interacting O
basic O
helix-loop-helix O
proteins O
are O
important O
determinants O
for O
MLV O
transcriptional O
activity O
in O
lymphocytic B
cell I
lines I
. O

Moreover O
, O
when O
introduced O
into O
murine B
pro-B I
lymphocytes I
, O
the O
oncogenic O
E2A-HLF O
fusion O
protein O
reversed O
both O
interleukin-3-dependent O
and O
p53-mediated O
apoptosis O
. O

In O
this O
study O
we O
show O
that O
the O
structurally O
unrelated O
antioxidant O
agents O
pyrrolidine O
dithiocarbamate O
( O
PDTC O
) O
, O
butylated O
hydroxyanisole O
, O
and O
Nacetylcysteine O
activated O
JNK O
( O
c-Jun O
NH2-terminal O
kinase O
) O
in O
Jurkat B
T I
cells I
. O

Treatment O
of O
the O
mature B
B-cell I
line I
BAL-17 I
with O
either O
anti-immunoglobulin O
M O
or O
phorbol O
12-myristate O
13-acetate O
leads O
to O
an O
increase O
in O
bcl-2 O
expression O
that O
is O
mediated O
by O
the O
CRE O
site O
. O

Treatment O
of O
the O
more O
immature B
B-cell I
line I
, O
Ramos B
, O
with O
phorbol O
esters O
rescues O
the O
cells O
from O
calcium-dependent O
apoptosis O
. O

To O
further O
characterize O
NFAT O
function O
in O
human O
B O
cells O
and O
to O
demonstrate O
cytokine O
gene O
specificity O
of O
NFAT O
proteins O
, O
we O
report O
here O
the O
isolation O
and O
characterization O
of O
a O
cDNA O
clone O
from O
the O
Raji B
B I
cell I
line I
. O

Transient O
expression O
of O
NFATc.beta O
was O
capable O
of O
activating O
an O
interleukin-2 O
NFAT-driven O
reporter O
gene O
in O
stimulated B
Jurkat I
cells I
in O
a O
CsA-sensitive O
manner O
. O

The O
SH3 O
domains O
of O
Grb2 O
form O
a O
stable O
complex O
with O
SOS1 O
and O
two O
proteins O
of O
75 O
kD O
and O
120 O
kD O
, O
which O
undergo O
tyrosine O
phosphorylation O
in O
Fc B
gamma I
RIIA I
stimulated I
cells I
. O

Constitutive O
expression O
of O
specific O
interferon O
isotypes O
in O
peripheral O
blood O
leukocytes O
from O
normal O
individuals O
and O
in O
promonocytic B
U937 I
cells I
. O

The O
activated O
form O
of O
the O
interferon-induced O
transcription O
factor O
complex O
ISGF3 O
was O
also O
detected O
in O
nuclear O
extracts O
from O
uninduced B
cells I
. O

Culture O
supernatants O
from O
uninduced B
U937 I
cells I
were O
also O
found O
to O
activate O
an O
ISRE O
cloned O
upstream O
of O
the O
luciferase O
reporter O
gene O
, O
indicating O
the O
presence O
of O
endogenous O
IFN O
activity O
equivalent O
to O
approximately O
0.3 O
to O
0.5 O
IU/mL O
. O

Tyloxapol O
inhibits O
activation O
of O
the O
transcription O
factor O
nuclear O
factor-kappa O
B O
( O
NK-kappa O
B O
) O
, O
reduces O
resting O
secretion O
of O
the O
cytokine O
interleukin-8 O
( O
IL-8 O
) O
in O
cultured B
human I
monocytes I
, O
and O
inhibits O
lipopolysaccharide O
( O
LPS O
) O
-stimulated O
release O
of O
tumor O
necrosis O
factor-alpha O
( O
TNF-alpha O
) O
, O
IL-1 O
beta O
, O
IL-6 O
, O
IL-8 O
, O
granulocyte-macrophage O
colony-stimulating O
factor O
( O
GM-CSF O
) O
, O
and O
the O
eiconsanoids O
thromboxane O
A2 O
and O
leukotriene O
B4 O
( O
LTB4 O
) O
. O

Induction O
of O
NF-kappaB O
-dependent O
gene O
expression O
in O
transiently O
transfected O
human B
monocytic I
THP-1 I
cells I
and O
human O
umbilical O
vein O
endothelial O
cells O
was O
inhibited O
by O
elevated O
cAMP O
and O
by O
overexpression O
of O
the O
catalytic O
subunit O
of O
protein O
kinase O
A O
( O
PKA O
) O
. O

We O
observed O
that O
in O
a O
monocytic B
( I
U937 I
) I
and O
a O
bronchial B
epithelial I
( I
H292 I
) I
cell-line I
dexamethasone O
strongly O
suppressed O
basal O
and O
induced O
ICAM-1 O
expression O
. O

No O
glucocorticoid O
recognition O
sequences O
are O
present O
in O
this O
promoter O
region O
and O
dexamethasone O
is O
still O
able O
to O
repress O
transcription O
when O
the O
multimerized O
NF-kappa O
B O
sequence O
is O
transactivated O
by O
TNF-alpha O
upon O
transfection O
in O
293 B
cells I
. O

By O
using O
a O
DNA O
sequence O
selected O
for O
its O
ability O
to O
bind O
recombinant O
BCL-6 O
in O
vitro O
, O
we O
show O
here O
that O
BCL-6 O
is O
present O
in O
DNA-binding O
complexes O
in O
nuclear O
extracts O
from O
various O
B-cell B
lines I
. O

Both O
compounds O
modulate O
the O
growth O
of O
purified B
FL I
HPCs I
, O
which O
show O
a O
dose-dependent O
shift O
from O
mixed/erythroid/monocytic O
to O
granulocytic O
colony O
formation O
. O

Studies O
on O
unicellular B
and I
paired I
daughter I
cell I
culture I
unequivocally O
indicate O
that O
the O
shift O
is O
mediated O
by O
modulation O
of O
the O
HPC O
differentiation O
program O
to O
the O
granulopoietic O
pathway O
( O
rather O
than O
RA-induced O
down-modulation O
of O
multipotent O
/erythroid/monocytic O
HPC O
growth O
coupled O
with O
recruitment O
of O
granulocytic O
HPCs O
) O
. O

ATRA O
and O
9-cis O
RA O
also O
exert O
their O
effect O
on O
the O
proliferation O
of O
primitive O
HPCs O
( O
high-proliferative B
potential I
colony-forming I
cells I
[ O
HPP-CFCs B
] O
) O
and O
putative O
hematopoietic O
stem O
cells O
( O
HSCs O
; O
assayed O
in O
Dexter-type O
long-term O
culture O
) O
. O

High O
concentrations O
of O
either O
compound O
( O
1 O
) O
drastically O
reduced O
the O
number O
of O
primary O
HPP-CFC B
colonies I
and O
totally O
abolished O
their O
recloning O
capacity O
and O
( O
2 O
) O
inhibited O
HSC O
proliferation O
. O

Altogether O
, O
these O
results O
suggest O
that O
ATRA/9-cis O
RA O
may O
play O
a O
key O
role O
in O
FL O
hematopoiesis O
via O
a O
dual O
effect O
hypothetically O
mediated O
by O
interaction O
with O
the O
RAR/RXR O
heterodimer O
, O
ie O
, O
inhibition O
of O
HSC/ B
primitive I
HPC I
proliferation O
and O
induction O
of O
CFU-GEMM/ O
BFU-E/CFU-M O
shift O
from O
the O
multipotent/erythroid/monocytic O
to O
the O
granulocytic-neutrophilic O
differentiation O
program O
. O

In O
this O
report O
, O
we O
demonstrate O
that O
the O
corresponding O
mutations O
in O
murine O
calcineurin O
render O
the O
T O
cell O
receptor O
signal O
transduction O
cascade O
CsA O
resistant O
in O
human B
Jurkat I
T I
cells I
. O

The O
extent O
to O
which O
peptides O
containing O
chemically O
and O
post-translationally O
modified O
amino O
acid O
side O
chains O
are O
recognized O
by O
primed B
CTL I
has O
not O
been O
clearly O
defined O
. O

PU.1 O
is O
completely O
absent O
from O
peripheral O
T O
cells O
and O
most O
T B
cell I
lines I
based O
on O
sensitive O
RT-PCR O
assays O
. O

Finally O
, O
both O
PU.1 O
and O
Spi-B O
function O
as O
transcriptional O
activators O
of O
the O
immunoglobulin O
light-chain O
enhancer O
E O
lambda O
2.4 O
when O
coexpressed O
with O
Pip O
( O
PU.1-interaction O
partner O
) O
in O
NIH-3T3 B
cells I
. O

Chloramphenicol O
acetyltransferase O
( O
CAT O
) O
activities O
directed O
by O
5 O
' O
upstream O
promoter O
were O
detected O
preferentially O
in O
perforin-expressing B
cell I
lines I
. O

A O
construct O
termed O
PFP5a O
containing O
-795 O
bp O
exhibited O
the O
highest O
CAT O
activity O
, O
and O
PFP9a20 O
containing O
only O
-73 O
bp O
also O
produced O
significantly O
high O
CAT O
activity O
in O
CTLL-R8 B
cells I
. O

When O
single-point O
mutation O
was O
introduced O
to O
each O
GC O
box O
, O
EBS O
, O
and O
GT O
box O
in O
PFP9a20 O
, O
at O
least O
3-fold O
less O
CAT O
activity O
was O
observed O
in O
CTLL-R8 B
cells I
. O

Here O
, O
using O
the O
murine B
B-cell I
lymphoma I
cell I
line I
A20 B
, O
we O
show O
that O
the O
TNF-alpha O
gene O
is O
regulated O
in O
a O
cell-type-specific O
manner O
. O

In O
A20 B
B I
cells I
, O
the O
TNF-alpha O
gene O
is O
not O
regulated O
by O
NFATp O
bound O
to O
the O
kappa O
3 O
element O
. O

This O
new O
site O
plays O
a O
critical O
role O
in O
the O
calcium-mediated O
, O
cyclosporin O
A-sensitive O
induction O
of O
TNF-alpha O
in O
both O
A20 B
B I
cells I
and O
Ar-5 B
cells I
. O

Defective O
transcription O
of O
the O
IL-2 O
gene O
is O
associated O
with O
impaired O
expression O
of O
c-Fos O
, O
FosB O
, O
and O
JunB O
in O
anergic B
T I
helper I
1 I
cells I
. O

Anergic B
CD4+ I
Th I
cells I
do O
not O
produce O
IL-2 O
when O
challenged O
with O
Ag-pulsed B
accessory I
cells I
because O
of O
a O
transcriptional O
defect O
. O

In O
this O
work O
, O
we O
report O
that O
these O
anergic B
T I
cells I
are O
defective O
in O
their O
ability O
to O
up-regulate O
protein O
binding O
and O
transactivation O
at O
two O
critical O
IL-2 O
DNA O
enhancer O
elements O
: O
NF-AT O
( O
nuclear O
factor O
of O
activated O
T O
cells O
; O
a O
sequence O
that O
binds O
a O
heterotrimeric O
NFATp O
, O
Fos O
, O
and O
Jun O
protein O
complex O
) O
and O
Activator O
Protein-1 O
( O
AP-1 O
) O
( O
that O
binds O
Fos O
and O
Jun O
heterodimers O
) O
. O

Western O
blot O
analysis O
of O
nuclear O
extracts O
showed O
that O
the O
impaired O
DNA-protein O
interactions O
in O
anergic B
T I
cells I
were O
associated O
with O
poor O
expression O
of O
the O
inducible O
AP-1 O
family O
members O
c-Fos O
, O
FosB O
, O
and O
JunB O
. O

However O
, O
the O
reduced O
expression O
of O
these O
proteins O
was O
not O
the O
result O
of O
a O
global O
TCR/CD3 O
-signaling O
defect O
because O
CD3 O
cross-linking O
induced O
an O
equivalent O
increase O
in O
intracellular-free O
calcium O
ions O
, O
as O
well O
as O
NFATp O
dephosphorylation O
, O
translocation O
to O
the O
nucleus O
, O
and O
DNA O
binding O
in O
both O
normal O
and O
anergic B
T I
cells I
. O

Thus O
, O
defective O
IL-2 O
gene O
transcription O
appears O
to O
be O
due O
, O
at O
least O
in O
part O
, O
to O
a O
selective O
block O
in O
the O
expression O
of O
the O
AP-1 O
Fos O
and O
Jun O
family O
members O
in O
anergic B
T I
cells I
. O

Enzymatic O
assay O
of O
alpha-galactosidase O
in O
blood O
leucocytes O
, O
skin O
fibroblasts O
, O
Epstein-Barr B
virus I
transformed I
lymphoid I
cell I
lines I
, O
and O
hair O
follicles O
of O
the O
twins O
and O
their O
parents O
confirmed O
the O
heterozygous O
status O
of O
the O
twins O
and O
indicated O
that O
Fabry O
disease O
had O
occurred O
as O
a O
result O
of O
a O
de O
novo O
mutation O
. O

A O
4- O
or O
10-bp O
insertion O
between O
muE3 O
and O
muB O
inactivated O
the O
mu O
enhancer O
in O
S194 B
plasma I
cells I
but O
did O
not O
affect O
in O
vitro O
binding O
of O
Ets-1 O
, O
PU.1 O
, O
or O
the O
muE3-binding O
protein O
TFE3 O
, O
alone O
or O
in O
pairwise O
combinations O
. O

Using O
this O
system O
, O
we O
observed O
that O
CD28 O
stimulation O
by O
B7-transfected B
CHO I
cells I
induced O
a O
proliferative O
response O
in O
T O
cells O
that O
was O
not O
accompanied O
by O
measurable O
IL-2 O
production O
. O

We O
have O
studied O
the O
regulation O
of O
sialoadhesin O
expression O
in O
vitro O
and O
show O
that O
glucocorticoids O
( O
GC O
) O
induce O
sialoadhesin O
expression O
on O
freshly O
isolated O
rat O
macrophages O
and O
the O
rat B
macrophage I
cell I
line I
R2 I
. O

Expression O
of O
the O
human O
immunodeficiency O
virus O
type O
1 O
( O
HIV O
) O
protease O
in O
cultured B
cells I
leads O
to O
apoptosis O
, O
preceded O
by O
cleavage O
of O
bcl-2 O
, O
a O
key O
negative O
regulator O
of O
cell O
death O
. O

In O
contrast O
to O
freshly O
isolated O
T O
cells O
, O
in O
vitro-cultured B
T I
cells I
did O
not O
require O
costimulation O
for O
cytokine O
secretion O
in O
response O
to O
anti-CD3 O
alone O
. O

Comparison O
of O
the O
dose O
response O
to O
anti-CD3 O
stimulation O
demonstrated O
that O
half-maximal O
induction O
of O
IL-2 O
was O
achieved O
using O
the O
same O
dose O
of O
anti-CD3 O
for O
both O
freshly O
isolated O
and O
cultured B
T I
cells I
. O

Using O
a O
PKC O
-specific O
inhibitor O
, O
GF109203X O
, O
or O
PKC-depleted B
T I
cells I
, O
we O
found O
that O
a O
large O
part O
of O
the O
anti-CD3 O
-induced O
ERK O
activation O
is O
PKC O
dependent O
. O

Aclacinomycin O
( O
ACLA O
) O
and O
doxorubicin O
( O
DOX O
) O
were O
used O
at O
subtoxic O
concentrations O
to O
induce O
erythroid O
differentiation O
in O
the O
human B
leukemic I
cell I
line I
K562 I
. O

In O
contrast O
, O
in O
DOX-treated B
cells I
, O
the O
transcription O
rate O
of O
these O
genes O
was O
unchanged O
in O
comparison O
with O
control O
cells O
. O

Because O
the O
increase O
in O
erythroid O
mRNA O
steady-state O
level O
in O
anthracycline-treated O
cells O
was O
inhibited O
by O
cycloheximide O
, O
this O
suggests O
that O
transcriptional O
activation O
in O
ACLA-treated B
cells I
and O
mRNA O
stabilization O
in O
DOX-treated O
cells O
were O
dependent O
on O
de O
novo O
protein O
synthesis O
. O

Finally O
, O
GATA-1 O
protein O
level O
was O
shown O
to O
be O
increased O
in O
ACLA-treated B
but I
not I
in I
DOX-treated I
cells I
. O

Interleukin-7 O
signaling O
in O
human B
B I
cell I
precursor I
acute I
lymphoblastic I
leukemia I
cells I
and O
murine B
BAF3 I
cells I
involves O
activation O
of O
STAT1 O
and O
STAT5 O
mediated O
via O
the O
interleukin-7 O
receptor O
alpha O
chain O
. O

We O
investigated O
which O
STAT O
complexes O
are O
formed O
upon O
stimulation O
of O
B B
cell I
precursor I
acute I
lymphoblastic I
leukemia I
( I
BCP-ALL I
) I
cells I
with O
IL-7 O
. O

Gel O
retardation O
assays O
with O
STAT-binding O
oligonucleotides O
showed O
that O
IL-7 O
induces O
the O
formation O
of O
two O
major O
STAT O
complexes O
in O
BCP-ALL B
cells I
. O

To O
determine O
the O
contribution O
of O
the O
cytoplasmic O
domain O
of O
the O
IL-7 O
receptor O
alpha O
chain O
( O
IL-7R O
alpha O
) O
to O
activation O
of O
STAT O
proteins O
, O
transfectants O
of O
the O
murine B
pro-B I
cell I
line I
BAF3 I
were O
made O
that O
express O
chimeric O
receptors O
consisting O
of O
the O
extracellular O
domain O
of O
human O
granulocyte O
colony-stimulating O
factor O
receptor O
( O
G-CSF-R O
) O
and O
the O
transmembrane O
and O
intracellular O
domains O
of O
human O
IL-7R O
alpha O
. O

The O
percentage O
of O
cells O
expressing O
CD40 O
in O
T B
and I
B I
cell I
co-cultures I
increased O
from O
4.2 O
% O
to O
13.8 O
% O
after O
oligo O
stimulation O
in O
patients O
, O
while O
it O
increased O
form O
4.7 O
% O
to O
48.6 O
% O
in O
healthy O
controls O
. O

The O
proportion O
of O
CD40 B
cells I
( O
26 O
% O
) O
in O
a O
resting B
B-cell I
preparation I
from O
hepatitis O
B O
patients O
decreased O
to O
zero O
after O
a O
5-day O
culture O
with O
sequence O
I O
, O
but O
IgG O
levels O
in O
the O
culture O
supernatant O
increased O
. O

Accordingly O
, O
increased O
AP-1 O
DNA-binding O
activity O
and O
AP-1 O
-dependent O
transcriptional O
activity O
were O
detected O
exclusively O
in O
IL-2-stimulated B
cells I
. O

This O
indicates O
that O
functional O
differences O
observed O
in O
IL-2- B
and I
IL-12-stimulated I
cells I
may O
depend O
, O
at O
least O
in O
part O
, O
on O
differential O
gene O
regulation O
. O

This O
was O
unambiguously O
demonstrated O
by O
the O
fact O
that O
plasmacytoma B
x I
B I
cell I
hybrids I
carrying O
an O
AIR-1 O
locus O
derived O
from O
CIITA-expressing B
cells I
do O
not O
express O
CIITA-specific O
transcripts O
. O

Transfection O
of O
a O
cDNA O
containing O
the O
human O
CIITA O
coding O
sequence O
under O
the O
control O
of O
an O
heterologous O
promoter O
restores O
expression O
of O
human O
MHC O
class O
II O
genes O
in O
the O
hybrids O
and O
is O
responsible O
for O
de O
novo O
expression O
of O
mouse O
MHC O
class O
II O
genes O
in O
both O
the O
mouse B
plasmacytoma I
cell I
line I
and O
the O
hybrids B
. O

Interestingly O
, O
in O
CIITA-transfected B
cell I
hybrids I
, O
cell O
surface O
expression O
of O
the O
human O
HLA-DQ O
heterodimer O
was O
not O
observed O
. O

This O
result O
was O
not O
attributable O
to O
lack O
of O
HLA-DQ O
alpha O
or O
-DQ O
beta O
transcription O
, O
because O
both O
transcripts O
were O
present O
in O
the O
CIITA-transfected B
hybrids I
, O
although O
at O
reduced O
levels O
. O

BCL-2-deficient B
T I
cells I
demonstrate O
accelerated O
cell O
cycle O
progression O
and O
increased O
apoptosis O
following O
activation O
. O

Third O
, O
a O
coimmunoprecipitation O
assay O
showed O
that O
in O
HTLV-1-infected B
human I
T I
lymphocytes I
, O
Tax O
and O
TFIIA O
were O
associated O
. O

Inhibition O
of O
transcription O
factor O
Stat1 O
activity O
in O
mononuclear B
cell I
cultures I
and O
T O
cells O
by O
the O
cyclic O
AMP O
signaling O
pathway O
. O

The O
regulation O
of O
transcription O
factors O
belonging O
to O
the O
signal O
transducer O
and O
activator O
of O
transcription O
( O
STAT O
) O
family O
was O
analyzed O
in O
PHA-activated B
mononuclear I
cells I
and O
in O
purified B
T I
cells I
activated O
by O
cross-linking O
cell O
surface O
CD3 O
. O

Suppression O
of O
c-jun O
by O
antisense O
oligonucleotides O
inhibits O
cell O
adhesion O
but O
not O
respiratory O
burst O
during O
phorbol O
ester-induced O
differentiation O
of O
U937 B
human I
monoblastic I
cells I
. O

We O
studied O
the O
role O
of O
the O
immediate O
early O
gene O
c-jun O
in O
cell O
proliferation O
and O
phorbol O
12-myristate O
13-acetate O
( O
PMA O
) O
-induced O
differentiation O
in O
U937 B
human I
monoblastic I
cells I
, O
using O
c-jun O
-specific O
antisense O
( O
AS O
) O
phosphorothioate O
oligonucleotides O
. O

These O
results O
suggest O
a O
critical O
role O
of O
c-jun O
in O
both O
cell O
proliferation O
and O
PMA-induced O
cell O
adhesion O
but O
not O
in O
PMA-induced O
respiratory O
burst O
in O
U937 B
cells I
. O

Sublethal O
levels O
of O
oxidative O
stress O
stimulate O
transcriptional O
activation O
of O
c-jun O
and O
suppress O
IL-2 O
promoter O
activation O
in O
Jurkat B
T I
cells I
. O

The O
present O
results O
show O
that O
Jurkat B
T I
cells I
acutely O
exposed O
to O
micromolar O
concentrations O
of O
H2O2 O
exhibit O
substantial O
increases O
in O
AP-1 O
binding O
activity O
and O
the O
expression O
of O
c-jun O
but O
not O
c-fos O
mRNA O
. O

Functional O
activation O
of O
gene O
expression O
by O
Pb O
was O
confirmed O
using O
primary B
CD4+ I
T I
cells I
transfected O
with O
an O
NF-kappa O
B O
dependent O
reporter O
gene O
construct O
. O

Pb O
did O
not O
activate O
NF-kappa O
B O
in O
4 O
different O
T B
cell I
lines I
, O
suggesting O
that O
lymphoid O
cell O
lines O
may O
not O
be O
reliable O
surrogates O
for O
the O
study O
of O
transcriptional O
activation O
in O
human O
T O
cells O
. O

Tyrosine O
kinase O
and O
cAMP-dependent O
protein O
kinase O
activities O
in O
CD40-activated B
human I
B I
lymphocytes I
. O

The O
nature O
of O
CD40 O
-dependent O
signals O
in O
proliferating O
fresh O
human B
Epstein-Barr I
virus-negative I
B I
lymphocytes I
is O
currently O
unknown O
. O

Treatment O
of O
the O
acute B
promyelocytic I
( I
APL I
) I
cell I
line I
NB4 B
with O
interferon O
alpha O
( O
IFN O
( O
alpha O
) O
) O
, O
as O
well O
as O
IFN O
( O
beta O
) O
and O
gamma O
, O
results O
in O
an O
increased O
expression O
of O
the O
transcripts O
coding O
for O
retinoic-acid O
receptor O
type O
alpha O
( O
RAR O
( O
alpha O
) O
) O
and O
the O
leukemia-specific O
retinoic O
acid O
receptor O
PML-RAR O
. O

The O
IFN O
-dependent O
increase O
in O
RAR O
( O
alpha O
) O
levels O
and O
the O
enhancing O
effect O
of O
the O
cytokine O
on O
retinoid-dependent O
granulocytic O
markers O
expression O
may O
be O
a O
characteristic O
of O
PML-RAR B
positive I
cells I
, O
since O
the O
phenomena O
are O
not O
observed O
in O
HL-60 B
promyelocytes I
. O

Interferons O
as O
well O
as O
retinoids O
inhibit O
the O
growth O
of O
NB4 B
cells I
, O
although O
the O
2 O
classes O
of O
compounds O
do O
not O
significantly O
interact O
in O
terms O
of O
anti-proliferative O
activity O
. O

By O
using O
70Z/3-derived B
pre-B-cell I
lines I
either O
lacking O
or O
expressing O
human O
CD14 O
( O
the O
LPS O
receptor O
) O
, O
it O
was O
observed O
that O
expression O
of O
human O
CD14 O
imparted O
responsiveness O
to O
LPS O
but O
not O
to O
OspA O
or O
spirochetal O
lipopeptides O
( O
assessed O
by O
induction O
of O
NF-kappa O
B O
and O
expression O
of O
surface O
immunoglobulin O
M O
) O
. O

The O
PML O
gene O
product O
has O
been O
localized O
to O
subnuclear B
dot-like I
structures I
variously O
termed O
PODs O
, O
ND10s O
, O
Kr O
bodies O
, O
or O
PML O
nuclear O
bodies O
( O
PML O
NBs O
) O
. O

Although O
LYSP100 O
is O
expressed O
only O
in O
lymphoid O
cells O
, O
LANDs O
could O
be O
visualized O
in O
HeLa B
cells I
by O
transfection O
of O
a O
LYSP100 O
cDNA O
. O

Early O
studies O
in O
murine O
T B
cell I
lines I
indicated O
that O
transcriptional O
transactivation O
functions O
encoded O
in O
the O
glucocorticoid O
receptor O
( O
GR O
) O
N-terminal O
domain O
are O
required O
for O
glucocorticoid-mediated O
apoptosis O
. O

However O
, O
more O
recent O
studies O
in O
human B
T I
cell I
lines I
have O
suggested O
that O
the O
N-terminal O
domain O
is O
not O
necessary O
for O
steroid-regulated O
apoptosis O
and O
that O
GR O
-mediated O
transrepression O
may O
be O
the O
more O
critical O
mechanism O
. O

To O
better O
understand O
the O
contribution O
of O
the O
GR O
N-terminal O
transactivation O
domain O
in O
mediating O
murine O
thymocyte O
apoptosis O
, O
we O
stably O
transfected O
GR O
, O
GR O
variants O
, O
and O
the O
androgen O
receptor O
( O
AR O
) O
into O
receptor-negative B
S49 I
murine I
thymoma I
cells I
. O

In O
contrast O
, O
we O
found O
that O
AR O
can O
initiate O
apoptosis O
in O
S49 B
cells I
after O
treatment O
with O
5 O
alpha-dihydrotestosterone O
, O
despite O
its O
relative O
inability O
to O
induce O
high O
level O
expression O
of O
MMTV O
. O

We O
found O
that O
GIG18 O
was O
rapidly O
induced O
to O
comparable O
levels O
by O
both O
AR O
and O
GR O
, O
demonstrating O
that O
AR O
can O
indeed O
function O
as O
a O
transcriptional O
activator O
in O
S49 B
cells I
and O
, O
moreover O
, O
that O
GIG18 O
induction O
may O
be O
a O
marker O
of O
early O
apoptotic O
events O
in O
steroid-treated O
cells O
. O

IL-2- O
, O
IL-12- O
, O
and O
IFN-alpha-mediated O
signaling O
pathways O
were O
analyzed O
in O
primary O
NK O
cells O
and O
in O
the O
NK3.3 B
cell I
line I
. O

IL-2 O
induced O
less O
STAT1 O
alpha O
activation O
and O
IFN-alpha O
induced O
greater O
STAT5 O
activation O
in O
NK3.3 B
cells I
compared O
with O
preactivated B
primary I
NK I
cells I
. O

In O
NK3.3 B
cells I
, O
IL-2 O
induced O
comparable O
formation O
of O
c-fos O
promoter O
sis-inducible O
element O
IFN-gamma-activated O
sequence-binding O
complexes O
containing O
STAT3 O
alone O
with O
complexes O
containing O
STAT3 O
and O
STAT1 O
alpha O
, O
while O
in O
preactivated B
primary I
NK I
cells I
, O
it O
preferentially O
induced O
complexes O
containing O
STAT3 O
and O
STAT1 O
alpha O
. O

Thus O
, O
signaling O
in O
NK3.3 B
cells I
is O
not O
always O
identical O
with O
that O
in O
primary O
NK O
cells O
. O

However O
, O
supershift O
analyses O
using O
the O
c-fos O
promoter O
sis-inducible O
element O
probe O
showed O
that O
IL-12 O
activated O
STAT4 O
, O
STAT1 O
alpha O
, O
and O
STAT3 O
, O
and O
induced O
complexes O
containing O
STAT4 O
only O
, O
STAT4 O
with O
STAT1 O
alpha O
, O
STAT3 O
with O
STAT1 O
alpha O
, O
or O
STAT1 O
alpha O
only O
in O
preactivated B
primary I
NK I
cells I
. O

Finally O
, O
IL-2 O
induced O
tyrosine O
phosphorylation O
of O
JAK1 O
and O
JAK3 O
, O
while O
IL-12 O
induced O
phosphorylation O
of O
JAK2 O
and O
TYK2 O
in O
both O
preactivated B
primary I
NK I
and I
NK3.3 I
cells I
. O

Vitamin O
D3- O
and O
retinoic O
acid-induced O
monocytic O
differentiation O
: O
interactions O
between O
the O
endogenous O
vitamin O
D3 O
receptor O
, O
retinoic O
acid O
receptors O
, O
and O
retinoid O
X O
receptors O
in O
U-937 B
cells I
. O

Therefore O
, O
we O
analyzed O
the O
expression O
, O
DNA O
binding O
, O
and O
transcriptional O
activity O
of O
the O
endogenous O
RA O
and O
VitD3 O
receptors O
[ O
retinoic O
acid O
receptors O
( O
RARs O
) O
, O
retinoid O
X O
receptors O
( O
RXRs O
) O
, O
and O
VitD3 O
receptor O
( O
VDR O
) O
] O
in O
the O
U-937 B
cell I
line I
, O
in O
which O
RA O
and O
VitD3 O
induce O
distinct O
monocytic O
differentiation O
pathways O
. O

Also O
, O
VitD3 O
inhibited O
the O
expression O
of O
CD23 O
and O
CD49f O
, O
characteristic O
markers O
of O
retinoid-induced O
U-937 B
cell I
differentiation O
. O

C/EBP O
activators O
are O
required O
for O
HIV-1 O
replication O
and O
proviral O
induction O
in O
monocytic B
cell I
lines I
. O

Ectopic O
expression O
of O
the O
dominant O
negative O
C/EBP O
protein O
LIP O
inhibited O
HIV-1 O
mRNA O
and O
virus O
production O
in O
activated B
U1 I
cells I
, O
demonstrating O
that O
C/EBP O
proteins O
are O
required O
for O
provirus O
induction O
. O

U1 B
lines I
overexpressing O
C/EBP O
activator O
NF-IL-6 O
produced O
more O
viral O
mRNA O
and O
virus O
particles O
following O
cellular O
activation O
than O
control B
lines I
, O
demonstrating O
that O
C/EBP O
proteins O
are O
limiting O
for O
virus O
transcription O
. O

HIV-1 O
harboring O
mutations O
within O
two O
C/EBP O
sites O
were O
crippled O
in O
their O
ability O
to O
replicate O
in O
U937 B
promonocytic I
cells I
, O
indicating O
that O
these O
sites O
are O
required O
for O
replication O
. O

IL-13 O
induces O
phosphorylation O
and O
activation O
of O
JAK2 O
Janus O
kinase O
in O
human B
colon I
carcinoma I
cell I
lines I
: O
similarities O
between O
IL-4 O
and O
IL-13 O
signaling O
. O

We O
have O
recently O
reported O
that O
IL-13R O
may O
share O
a O
component O
with O
IL-4R O
. O
Here O
we O
report O
that O
both O
IL-4 O
and O
IL-13 O
share O
signaling O
events O
in O
human B
colon I
carcinoma I
cell I
lines I
( O
HT-29 B
and O
WiDr B
) O
. O

IL-4 O
also O
stimulated O
all O
three O
kinases O
and O
substrates O
, O
but O
unlike O
in O
immune O
cells O
, O
IL-4 O
did O
not O
involve O
JAK3 O
activation O
for O
its O
signaling O
in O
colon B
cancer I
cell I
lines I
. O

125I-IL-13 O
did O
not O
bind O
to O
colon B
cancer I
cell I
lines I
, O
but O
unlabeled O
IL-13 O
competed O
for O
the O
binding O
of O
125I-IL-4 O
. O

Differential O
regulation O
of O
IL-6 O
gene O
transcription O
and O
expression O
by O
IL-4 O
and O
IL-10 O
in O
human B
monocytic I
cell I
lines I
. O

To O
investigate O
the O
molecular O
mechanism O
of O
the O
inhibitory O
effect O
on O
transcriptional O
or O
post-transcriptional O
regulation O
of O
IL-6 O
gene O
expression O
by O
IL-4 O
and O
IL-10 O
, O
we O
studied O
IL-6 O
production O
, O
expression O
level O
of O
IL-6 O
mRNA O
, O
IL-6 O
promoter O
activity O
, O
transcriptional O
activity O
of O
NF-kappaB O
and O
NF-IL-6 O
, O
and O
IL-6 O
mRNA O
stability O
in O
human B
monocytic I
cell I
lines I
, O
THP-1 B
and O
U937 B
, O
stimulated O
by O
PMA O
and O
LPS O
in O
the O
absence O
or O
the O
presence O
of O
IL-4 O
or O
IL-10 O
. O

Both O
IL-4 O
and O
IL-10 O
were O
seen O
to O
inhibit O
IL-6 O
production O
and O
the O
expression O
of O
IL-6 O
mRNA O
in O
both O
monocytic B
cell I
lines I
studied O
. O

Therefore O
, O
we O
conclude O
that O
IL-4 O
and O
IL-10 O
inhibit O
IL-6 O
production O
by O
different O
mechanisms O
in O
human B
monocytic I
cell I
lines I
. O

IL-2 O
production O
by O
CsA-treated B
cells I
is O
therefore O
dramatically O
reduced O
. O

Incubation O
of O
B-chronic B
lymphocytic I
leukemia I
( I
B-CLL I
) I
cells I
with O
phorbol O
esters O
resulted O
in O
the O
phosphorylation O
of O
two O
major O
PKC O
substrates O
, O
MARCKS O
( O
myristoylated O
, O
alanine-rich O
C O
kinase O
substrate O
) O
and O
MRP O
( O
MARCKS-related O
protein O
) O
, O
and O
of O
a O
third O
protein O
, O
with O
an O
apparent O
m.w. O
of O
60 O
, O
000 O
that O
was O
the O
most O
prominent O
protein O
kinase O
C O
substrate O
in O
these O
cells O
. O

Two-dimensional O
electrophoretic O
analysis O
of O
the O
protein O
phosphorylation O
pattern O
from O
the O
B B
cell I
line I
CESS I
demonstrated O
the O
identity O
between O
the O
p60 O
protein O
expressed O
in O
this O
cell O
line O
and O
that O
expressed O
in O
B-CLL B
cells I
. O

p60 O
was O
purified O
from O
CESS B
cells I
and O
peptide O
microsequencing O
of O
this O
protein O
revealed O
that O
it O
was O
lymphocyte-specific O
protein O
1 O
( O
LSP1 O
) O
, O
that O
is O
here O
characterized O
as O
the O
most O
prominent O
protein O
kinase O
C O
substrate O
in O
B O
cells O
. O

The O
signaling O
capabilities O
of O
the O
IL-10R O
for O
activating O
specific O
STAT O
proteins O
and O
inducing O
gene O
transcription O
were O
defined O
by O
reconstitution O
of O
receptor O
functions O
in O
transfected B
tissue I
culture I
cells I
. O

COS-1 B
cells I
, O
co-expressing O
the O
human O
IL-10R O
and O
individual O
STAT O
proteins O
, O
confirmed O
a O
preference O
of O
the O
IL-10R O
for O
STAT3 O
and O
STAT1 O
. O

In O
this O
study O
, O
the O
IFN-gamma O
induction O
of O
MHC O
class O
II O
gene O
expression O
in O
primary O
cultures O
of O
thymic B
epithelial I
cells I
( O
TEC B
) O
was O
analyzed O
. O

The O
resulting O
occupancy O
displays O
strong O
similarities O
with O
the O
one O
observed O
in O
the O
MHC O
class O
II-constitutive O
B O
cells O
, O
represented O
by O
both O
the O
Burkitt B
lymphoma I
line I
Raji I
and O
normal O
tonsil- O
derived O
B O
cells O
. O

However O
, O
some O
peculiar O
differences O
were O
observed O
between O
the O
TEC B
, O
either O
IFN-gamma O
-induced O
or O
not O
, O
and O
the O
constitutive O
B B
cells I
. O

A O
stable O
transformant O
of O
the O
PLAP O
reporter O
gene O
derived O
from O
human B
monocytic I
cell I
line I
showed O
very O
little O
activity O
on O
the O
promoter O
before O
stimulation O
, O
whereas O
LPS O
stimulation O
led O
to O
a O
dramatic O
increase O
in O
PLAP O
activity O
. O

Western O
blotting O
analysis O
with O
anti-I O
kappa O
B-alpha O
antibody O
indicated O
that O
E3330 O
inhibited O
degradation O
of O
I O
kappa O
B-alpha O
, O
which O
is O
an O
inhibitory O
protein O
of O
NF-kappa O
B O
, O
in O
LPS-stimulated B
monocytes I
. O

This O
transactivation O
domain O
was O
found O
to O
be O
inactivated O
by O
a O
naturally O
occurring O
frameshift O
mutation O
in O
one O
PAX-5 O
allele O
of O
the O
acute B
lymphoblastic I
leukemia I
cell I
line I
REH I
. O

Second O
messenger O
up-regulation O
of O
androgen O
receptor O
gene O
transcription O
is O
absent O
in O
androgen B
insensitive I
human I
prostatic I
carcinoma I
cell I
lines I
, O
PC-3 B
and O
DU-145 B
. O

After O
20 O
h O
of O
stimulation O
with O
8-bromo-cAMP O
, O
AR O
mRNA O
was O
upregulated O
in O
LNCaP B
but O
not O
in O
either O
PC-3 B
or O
DU-145 B
cell I
lines I
. O

The O
ability O
to O
regulate O
AR O
gene O
transcription O
via O
the O
second O
messenger O
pathway O
is O
lost O
in O
the O
PC-3 B
and I
DU-145 I
cell I
lines I
. O

These O
binding O
studies O
were O
paralleled O
by O
specific O
T O
cell O
recognition O
of O
the O
class O
II-peptide O
complex O
, O
in O
which O
the O
substituted O
peptide O
abolished O
T O
cell O
reactivity O
, O
which O
was O
directed O
to O
the O
DQ3.2-peptide O
complex O
, O
whereas O
the O
same O
T B
cell I
clone I
recognized O
the O
substituted O
peptide O
presented O
by O
DQ3.3 O
, O
a O
class O
II O
restriction O
element O
differing O
from O
DQ3.2 O
only O
at O
residue O
57 O
. O

We O
report O
here O
that O
a O
DNA-binding O
factor O
containing O
STAT1 O
also O
becomes O
activated O
in O
human O
peripheral O
blood O
T O
lymphocytes O
or O
Jurkat B
cells I
, O
although O
not O
until O
1-2 O
h O
after O
stimulation O
. O

Activation O
is O
delayed O
a O
further O
1-2 O
hr O
when O
mononuclear B
cell I
cultures I
are O
stimulated O
by O
an O
antigen O
which O
requires O
processing O
. O

Neutralizing O
antiserum O
against O
IFN-gamma O
, O
but O
not O
other O
cytokines O
tested O
, O
blocked O
activation O
of O
the O
factor O
almost O
completely O
, O
and O
IFN-gamma O
was O
found O
in O
the O
culture O
supernatants O
of O
stimulated B
cells I
at O
levels O
at O
which O
recombinant O
IFN-gamma O
could O
activate O
the O
factor O
in O
naive O
cells O
. O

While O
Jurkat B
cells I
both O
secrete O
and O
respond O
to O
IFN-gamma O
in O
an O
autocrine O
loop O
, O
it O
seems O
likely O
that O
the O
responding O
cells O
may O
differ O
from O
those O
synthesizing O
this O
cytokine O
in O
the O
mononuclear B
cell I
cultures I
in O
the O
light O
of O
the O
recent O
report O
that O
Th1 B
cells I
lack O
the O
IFN-gamma O
receptor O
chain O
necessary O
for O
activation O
of O
STAT1 O
( O
Pernis O
, O
A. O
, O
Gupta O
, O
S. O
, O
Gollob O
, O
K.J. O
, O
Garfein O
, O
E. O
, O
Coffman O
, O
R.L. O
, O
Schindler O
, O
C. O
, O
and O
Rothman O
, O
P. O
, O
Science O
1995. O
269 O
: O
245 O
) O
. O

Absence O
of O
T-cell- O
and O
B-cell-specific O
transcription O
factors O
TCF-1 O
, O
GATA-3 O
, O
and O
BSAP O
in O
Hodgkin B
's I
Reed-Sternberg I
cells I
. O

Based O
on O
the O
presence O
of O
T O
cell O
receptor-beta O
( O
TcR-beta O
) O
gene O
rearrangements O
in O
L428 B
and I
HDLM-1 I
cells I
, O
the O
expression O
of O
CD2 O
in O
HDLM-1 B
cells I
, O
and O
the O
presence O
of O
immunoglobulin O
heavy-chain O
( O
IgH O
) O
gene O
rearrangement O
in O
KM-H2 B
cells I
, O
some O
researchers O
have O
concluded O
that O
these O
long-term B
cell I
lines I
derived O
from O
patients O
with O
Hodgkin O
's O
disease O
are O
lymphoid O
in O
nature O
. O

The O
information O
obtained O
from O
these O
cell B
lines I
has O
also O
been O
used O
in O
arguments O
for O
a O
lymphoid O
origin O
of O
H-RS B
cells I
in O
tissue O
despite O
the O
frequent O
absence O
of O
lymphoid O
markers O
and O
Ig/TcR O
gene O
rearrangements O
in O
these O
cells O
. O

We O
questioned O
whether O
one O
can O
use O
the O
limited O
expression O
of O
lymphoid O
markers O
or O
the O
limited O
gene O
rearrangement O
to O
conclude O
that O
H-RS B
cells I
have O
a O
lymphoid O
origin O
, O
because O
these O
markers O
may O
be O
aberrant O
in O
tumor O
cells O
. O

In O
this O
study O
, O
we O
examined O
the O
expression O
of O
two O
T-cell-specific O
transcription O
factors O
( O
TCF-1 O
and O
GATA-3 O
) O
and O
one O
B-cell-specific O
transcription O
factor O
( O
BSAP O
) O
in O
cultured B
H-RS I
cells I
by O
using O
a O
gel O
mobility O
shift O
assay O
. O

The O
sensitivity O
and O
specificity O
of O
this O
assay O
for O
determination O
of O
cell B
lineage I
have O
been O
established O
in O
a O
large O
number O
of O
cultured B
human I
and I
murine I
cell I
lines I
. O

All O
three O
types O
of O
H-RS B
cell I
lines I
were O
consistently O
negative O
for O
BSAP O
, O
TCF-1 O
, O
and O
GATA-3 O
. O

The O
absence O
of O
GATA-3 O
was O
confirmed O
in O
H-RS B
cells I
in O
tissues O
by O
an O
in O
situ O
hybridization O
technique O
. O

Virtually O
all O
B-cell B
lines I
, O
with O
the O
exception O
of O
some O
myeloma B
cell I
lines I
, O
are O
positive O
for O
BSAP O
, O
which O
is O
the O
transcription O
factor O
for O
promoters O
for O
several O
B-cell O
markers O
, O
including O
VpreB1 O
, O
lambda O
5 O
, O
CD19 O
, O
and O
CD20 O
. O

All O
T-cell B
lines I
tested O
were O
positive O
for O
TCF-1 O
and O
GATA-3 O
, O
which O
are O
the O
transcription O
factors O
for O
promoters O
for O
several O
T-cell-restricted O
markers O
, O
including O
CD2 O
, O
CD3 O
, O
TcR O
, O
and O
lck O
. O

The O
absence O
of O
BSAP O
, O
TCF-1 O
, O
and O
GATA-3 O
clearly O
indicates O
an O
underlying O
difference O
between O
H-RS B
cells I
and O
lymphoid O
cells O
. O

Expression O
of O
constitutively O
active O
Raf-1 O
or O
MEK1 O
in O
Jurkat B
T I
cells I
enhanced O
the O
stimulation O
of O
IL-2 O
promoter O
-driven O
transcription O
stimulated O
by O
a O
calcium O
ionophore O
and O
PMA O
, O
and O
together O
with O
a O
calcium O
ionophore O
the O
expression O
of O
each O
protein O
was O
sufficient O
to O
stimulate O
NF-AT O
activity O
. O

The O
genetic O
elements O
and O
regulatory O
mechanisms O
responsible O
for O
human O
interleukin O
9 O
( O
IL-9 O
) O
gene O
expression O
in O
a O
human B
T I
cell I
leukemia I
virus I
type I
I-transformed I
human I
T I
cell I
line I
, O
C5MJ2 B
, O
were O
investigated O
. O

Transient O
expression O
of O
the O
luciferase O
reporter O
gene O
linked O
to O
serially O
deleted O
sequences O
of O
the O
5'-flanking O
region O
of O
the O
IL-9 O
gene O
has O
revealed O
several O
positive O
and O
negative O
regulatory O
elements O
involved O
in O
the O
basal O
and O
inducible O
expression O
of O
the O
IL-9 O
gene O
in O
C5MJ2 B
cells I
. O

A O
proximal O
region O
between O
-46 O
and O
-80 O
was O
identified O
as O
the O
minimum O
sequence O
for O
the O
basal O
and O
inducible O
expression O
of O
the O
IL-9 O
gene O
in O
C5MJ2 B
cells I
. O

GM3 O
also O
caused O
selective O
inhibition O
of O
the O
human O
T-cell O
lymphotrophic O
virus-1 O
Tax O
transactivator-induced O
luciferase O
activity O
from O
a O
reporter O
construct O
driven O
by O
the O
GM-CSF O
promoter O
in O
Jurkat B
T I
cells I
. O

Finally O
, O
GM3 O
greatly O
reduced O
the O
concentration O
of O
endogenous O
GM-CSF O
mRNA O
induced O
by O
different O
stimuli O
in O
Jurkat B
T I
cells I
but O
did O
not O
affect O
interleukin O
3 O
mRNA O
levels O
in O
the O
same O
cells O
. O

Reversible O
differentiation O
of O
human B
monoblastic I
leukemia I
U937 I
cells I
by O
ML-9 O
, O
an O
inhibitor O
of O
myosin O
light O
chain O
kinase O
. O

Human B
monoblastic I
leukemia I
U937 I
cells I
are O
induced O
to O
differentiate O
into O
monocytes O
and O
macrophages O
by O
various O
agents O
. O

We O
have O
shown O
that O
1- O
( O
5-chloronaphthalene-1-sulfonyl O
) O
-1H-hexahydro-1 O
, O
4-diazepine O
hydrochloride O
( O
ML-9 O
) O
, O
an O
inhibitor O
of O
myosin O
light O
chain O
kinase O
, O
induces O
differentiation O
of O
monocytoid B
leukemia I
cell I
lines I
U937 B
and O
THP-1 B
but O
not O
of O
myeloblastic B
leukemic I
ML-1 I
cell I
or O
erythroleukemia B
K562 I
cells I
. O

ML-9 O
induced O
nitroblue O
tetrazolium O
( O
NBT O
) O
-reducing O
activity O
of O
U937 B
cell I
more O
rapidly O
than O
VD3 O
: O
This O
differentiation O
marker O
was O
induced O
significantly O
after O
incubation O
with O
ML-9 O
and O
VD3 O
for O
4 O
hours O
and O
1 O
day O
, O
respectively O
. O

The O
growth O
inhibition O
of O
U937 B
cells I
by O
ML-9 O
was O
also O
reversible O
. O

Similar O
effects O
were O
observed O
in O
another O
line O
of O
human B
monoblastic I
cells I
, O
THP-1 B
. O

ML-9 O
had O
little O
or O
no O
effect O
on O
the O
morphology O
of O
U937 B
cells I
but O
increased O
the O
expression O
of O
monocyte-macrophage O
lineage-associated O
surface O
antigen O
, O
CD14 O
, O
to O
some O
extent O
. O

it O
became O
irreversible O
, O
however O
, O
upon O
simultaneous O
treatment O
with O
dexamethasone O
and O
transforming O
growth O
factor-beta O
1 O
( O
TGF-beta O
1 O
) O
, O
which O
did O
not O
induce O
differentiation O
of O
U937 B
cells I
but O
caused O
growth O
arrest O
of O
the O
cells O
in O
the O
G0/G1 O
phase O
of O
the O
cell O
cycle O
. O

Modulation O
of O
endogenous O
IL-1 O
beta O
and O
IL-1 O
receptor O
antagonist O
results O
in O
opposing O
effects O
on O
HIV O
expression O
in O
chronically B
infected I
monocytic I
cells I
. O

The O
present O
study O
examines O
the O
mechanisms O
involved O
in O
LPS-mediated O
induction O
of O
HIV O
expression O
in O
U1 B
cells I
, O
a O
promonocytic B
cell I
line I
chronically O
infected O
with O
HIV O
. O

Stimulation O
of O
U1 B
cells I
by O
LPS O
alone O
induced O
minimal O
levels O
of O
HIV O
expression O
, O
which O
was O
significantly O
enhanced O
by O
granulocyte-macrophage O
colony-stimulating O
factor O
( O
GM-CSF O
) O
. O

Costimulation O
of O
U1 B
cells I
with O
LPS O
plus O
GM-CSF O
resulted O
in O
the O
accumulation O
of O
steady-state O
levels O
of O
HIV O
RNA O
; O
however O
, O
only O
a O
weak O
induction O
of O
HIV O
long O
terminal O
repeat O
-driven O
transcription O
, O
which O
was O
not O
associated O
with O
the O
activation O
of O
the O
cellular O
transcription O
factor O
nuclear O
factor-kappa O
B O
, O
was O
noted O
. O

IL-1 O
receptor O
antagonist O
( O
ra O
) O
inhibited O
LPS O
enhancement O
of O
HIV O
expression O
in O
GM-CSF-stimulated B
cells I
, O
suggesting O
that O
endogenous O
IL-1 O
was O
involved O
in O
LPS-mediated O
viral O
production O
. O

Herpesvirus B
saimiri I
immortalized I
gamma I
delta I
T I
cell I
line I
activated O
by O
IL-12 O
. O

To O
gain O
further O
knowledge O
of O
the O
IL-12R O
complex O
and O
the O
IL-12 O
signal O
transduction O
pathway O
in O
cytotoxic O
T O
cells O
, O
we O
studied O
a O
number O
of O
human B
T I
cell I
lines I
that O
had O
been O
transformed O
to O
permanent O
growth O
with O
Herpesvirus O
saimiri O
, O
an O
oncogenic O
virus O
of O
nonhuman O
primates O
. O

This O
paper O
reports O
the O
expression O
of O
IL-12R O
on O
a O
human B
gamma I
delta I
T I
cell I
line I
that O
responds O
to O
IL-12 O
with O
enhanced O
cytolytic O
activity O
and O
increased O
expression O
of O
cytolytic O
effector O
molecules O
granzyme O
B O
and O
perforin O
. O

In O
addition O
to O
finding O
hLH-2 O
expression O
in O
all O
cases O
of O
CML O
, O
expression O
was O
observed O
in O
lymphoid O
malignancies O
and O
myeloid B
cell I
lines I
, O
but O
not O
in O
primary O
cases O
of O
acute O
myelogenous O
leukaemia O
. O

In O
humans O
infected O
with O
the O
HIV-1 O
virus O
there O
may O
be O
a O
disproportionate O
severity O
of O
signs O
and O
symptoms O
of O
illness O
compared O
to O
the O
fraction O
of O
CD4+ B
infected I
T-lymphoid I
cells I
. O

In O
vitro O
, O
chronically B
HIV-infected I
cells I
of O
the O
lymphoid B
CEM I
line I
displayed O
resistance O
to O
glucocorticoid-induced O
apoptosis O
. O

p45 O
mRNA O
is O
also O
expressed O
in O
HL-60 B
promyelocytes I
, O
albeit O
the O
expression O
level O
is O
much O
lower O
than O
that O
of O
the O
granulocyte O
fraction O
. O

HL-60 B
cells I
were O
found O
to O
express O
mafK O
mRNA O
, O
indicating O
the O
presence O
of O
genuine O
NF-E2 O
complex O
in O
the O
cells O
. O

Expression O
of O
c-fos O
and O
c-jun O
proteins O
and O
AP-1 O
binding O
activity O
during O
cell O
cycle O
progression O
of O
HL60 B
cells I
and O
phytohemagglutinin-stimulated B
lymphocytes I
. O

We O
have O
used O
Western O
blotting O
to O
investigate O
the O
presence O
of O
these O
proteins O
during O
the O
cell O
cycles O
of O
two O
different O
cellular B
systems I
: O
a O
continuously B
growing I
myeloid I
leukemic I
cell I
line I
, O
HL60 B
, O
and O
normal O
cells O
stimulated O
into O
cycle O
, O
phyto- B
hemagglutinin I
( I
PHA I
) I
-stimulated I
normal I
human I
peripheral I
blood I
lymphocytes I
( O
PBL O
) O
. O

We O
found O
nuclear O
p62c-fos O
, O
p39c-jun O
, O
and O
AP-1 O
binding O
activity O
throughout O
the O
cell O
cycle O
both O
in O
HL60 B
cells I
and O
in O
PHA-stimulated B
PBL I
, O
and O
we O
postulate O
that O
these O
proteins O
are O
required O
throughout O
the O
cell O
cycle O
and O
not O
transiently O
in O
the O
G0 O
to O
G1 O
transition O
as O
previous O
mRNA O
studies O
have O
indicated O
. O

We O
demonstrated O
an O
uncoupling O
of O
AP-1 O
binding O
activity O
from O
p62c-fos O
, O
and O
p39c-jun O
AP-1 O
activity O
was O
expressed O
more O
strongly O
in O
the O
G1- O
and O
G2/M-phase O
enriched O
samples O
than O
in O
the O
S-phase O
enriched O
samples O
of O
HL60 B
cells I
, O
while O
levels O
of O
nuclear O
p62c-fos O
and O
p39c-jun O
were O
constant O
. O

We O
also O
observed O
that O
cytoplasmic O
p62c-fos O
and O
p39c-jun O
were O
present O
in O
HL60 B
cells I
and O
PHA-stimulated B
PBL I
. O

Here O
we O
show O
that O
the O
murine O
PU.1 O
promoter O
is O
also O
specifically O
and O
highly O
functional O
in O
B B
cell I
lines I
as O
well O
. O

Finally O
, O
we O
show O
that O
the O
B O
cell O
coactivator O
OBF-1/Bob1/OCA-B O
is O
only O
expressed O
in O
B O
cells O
and O
not O
in O
myeloid O
cells O
, O
and O
that O
OBF-1/Bob1/OCA-B O
can O
transactivate O
the O
PU.1 O
promoter O
in O
HeLa B
and O
myeloid O
cells O
. O

Inhibition O
of O
p105 O
processing O
by O
NF-kappaB O
proteins O
in O
transiently B
transfected I
cells I
. O

Transient O
transfection O
studies O
performed O
in O
COS7 B
cells I
revealed O
that O
the O
newly O
synthesized O
p105 O
protein O
appears O
to O
be O
more O
rapidly O
processed O
compared O
to O
its O
accumulated O
form O
that O
is O
already O
associated O
with O
the O
processed O
product O
p50 O
. O

We O
further O
demonstrate O
that O
p105 O
undergoes O
degradation O
in O
lipopolysaccharide-stimulated B
human I
monocytic I
cells I
. O

Maximal O
inhibition O
of O
p24 O
antigen O
production O
in O
T-lymphocytic B
ACH-2 I
cells I
was O
47 O
% O
with O
r-hTBP-1 O
and O
42 O
% O
with O
rhu O
TNFR O
: O
Fc O
. O

r-hTBP-1 O
and O
rhu O
TNFR O
: O
Fc O
also O
decreased O
p24 O
antigen O
synthesized O
by O
U1 B
cells I
in O
response O
to O
other O
stimuli O
, O
including O
phytohemagglutinin O
( O
PHA O
) O
-induced O
supernatant O
, O
granulocyte-macrophage O
colony-stimulating O
factor O
, O
interleukin-6 O
, O
and O
TNF O
. O

Addition O
of O
r-hTBP-1 O
to O
U1 B
cells I
during O
the O
last O
4 O
h O
of O
a O
24 O
h O
incubation O
with O
PMA O
still O
inhibited O
p24 O
antigen O
production O
by O
15 O
% O
. O

U1 B
cells I
stimulated O
with O
10 O
( O
-7 O
) O
M O
PMA O
released O
approximately O
1 O
ng/ml O
endogenous O
TBP-1 O
with O
an O
initial O
peak O
observed O
at O
1 O
h O
and O
a O
second O
peak O
at O
24 O
h O
after O
PMA O
stimulation O
. O

Both O
r-hTBP-1 O
and O
rhu O
TNFR O
: O
Fc O
blocked O
PMA O
induction O
of O
nuclear O
factor O
( O
NK O
) O
- O
kappa O
B O
DNA-binding O
activity O
in O
U1 B
cells I
in O
association O
with O
decreases O
in O
HIV-1 O
replication O
. O

We O
find O
that O
both O
chromatin O
and O
cell O
extracts O
derived O
from O
human B
T-cell I
leukemia I
virus I
type I
1-infected I
human I
T I
lymphocytes I
support O
higher O
levels O
of O
5S O
rRNA O
and O
tRNA O
gene O
transcription O
than O
chromatin O
or O
extracts O
from O
uninfected O
T O
lymphocytes O
. O

In O
the O
present O
study O
using O
specific O
antibodies O
, O
we O
analyzed O
the O
expression O
of O
the O
RXR O
alpha O
protein O
in O
blood O
mononuclear O
cells O
from O
acute O
myeloid O
patients O
( O
AML O
) O
( O
10 O
cases O
) O
and O
from O
myelomonocytic B
cell I
lines I
arrested O
at O
different O
stages O
of O
differentiation O
. O

We O
observed O
that O
the O
RXR O
alpha O
expression O
increased O
during O
myelomonocytic O
differentiation O
, O
since O
the O
highest O
levels O
were O
found O
in O
AML O
samples O
and O
in O
myelomonocytic B
cell I
lines I
having O
the O
highest O
amounts O
of O
monocytic O
precursors O
. O

We O
also O
demonstrated O
that O
fresh O
leukemic O
cells O
, O
whatever O
their O
stage O
of O
differentiation O
, O
as O
well O
as O
myelomonocytic B
cell I
lines I
, O
respond O
to O
VD O
by O
an O
increase O
in O
RXR O
alpha O
levels O
. O

When O
unstimulated B
HeLa I
cells I
are O
ruptured O
in O
hypotonic O
buffer O
without O
salt O
or O
detergent O
, O
immunoadsorption O
of O
either O
STAT1 O
or O
STAT2 O
from O
the O
resulting O
cytosol O
yields O
coimmunoadsorption O
of O
the O
other O
STAT O
protein O
. O

It O
is O
also O
expressed O
in O
transformed B
B-cells I
. O

We O
have O
previously O
identified O
a O
new O
transcription O
factor O
family O
( O
the O
MNP O
family O
) O
whose O
expression O
is O
crucial O
for O
the O
induction O
of O
MIP-1 O
alpha O
transcription O
during O
cellular O
activation O
and O
in O
transformed B
B I
cells I
. O

Monocytes O
and O
transformed B
B-cells I
normally O
express O
MNP-1 O
strongly O
and O
MNP-2 O
weakly O
, O
while O
T-cells O
strongly O
express O
only O
MNP-2 O
. O

Recently O
, O
we O
reported O
that O
HIV-1 O
tat O
downregulates O
MIP-1 O
alpha O
expression O
in O
Jurkat B
T-cells I
. O

In O
this O
report O
we O
show O
induction O
of O
MNP-1 O
in O
Jurkat B
T-cells I
expressing O
HIV-1 O
tat O
. O

Expression O
of O
neither O
HTLV-1 O
tax O
in O
Jurkat B
T-cells I
nor O
EBV O
in O
B-cells O
had O
any O
effect O
on O
MNP-1 O
or O
MNP-2 O
expression O
, O
showing O
that O
the O
effect O
is O
specific O
for O
HIV-1 O
tat O
. O

BCR O
-induced O
increases O
in O
CD44 O
mRNA O
expression O
and O
transcription O
levels O
are O
shown O
to O
occur O
in O
EGR1-expressing B
but I
not I
in I
nonexpressing I
subclones I
of O
the O
B-cell B
line I
WEHI-231 B
. O

Kinetics O
of O
egr-1 O
transcription O
and O
the O
appearance O
of O
nuclear O
EGR1 O
protein O
precede O
CD44 O
induction O
and O
occur O
within O
30 O
min O
after O
stimulation O
in O
the O
EGR1-expressing B
subclone I
. O

The O
EGR1 O
binding O
motif O
was O
shown O
to O
be O
necessary O
for O
stimulus-induced O
expression O
of O
a O
CD44 O
promoter-chloramphenicol O
acetyltransferase O
reporter O
construct O
in O
nontransformed O
B O
lymphocytes O
and O
was O
required O
for O
transactivation O
by O
an O
EGR1 O
expression O
vector O
in O
a O
B-cell B
line I
. O

In O
human B
Jurkat I
T I
cells I
and O
its O
subclone O
Wurzburg B
cells I
oxidant O
challenge O
elevated O
[ O
Ca2+ O
] O
i O
by O
mobilizing O
Ca2+ O
from O
intracellular O
stores O
. O

In O
Jurkat B
cells I
this O
effect O
was O
rapid O
and O
transient O
, O
but O
in O
Wurzburg B
cells I
the O
response O
was O
slow O
and O
sustained O
. O

H2O2-induced O
NF-kappaB O
activation O
in O
Wurzburg B
cells I
was O
not O
influenced O
by O
the O
presence O
of O
extracellular O
EGTA O
but O
was O
totally O
inhibited O
in O
cells O
that O
were O
loaded O
with O
esterified O
EGTA O
. O

In O
Jurkat B
cells I
that O
are O
not O
sensitive O
to O
H2O2-induced O
NF-kappaB O
activation O
, O
H2O2 O
potentiated O
NF-kappaB O
activation O
in O
the O
presence O
of O
sustained O
high O
[ O
Ca2+ O
] O
i O
following O
thapsigargin O
treatment O
. O

Human B
T-cell I
leukemia I
virus I
type I
I I
( I
HTLV-I I
) I
-infected I
T-cell I
lines I
constitutively O
produce O
high O
levels O
of O
interleukin-1alpha O
( O
IL-1alpha O
) O
. O

To O
analyze O
the O
mechanisms O
that O
lead O
to O
the O
expression O
of O
IL-1alpha O
in O
HTLV-I-infected B
cell I
lines I
, O
we O
studied O
regulatory O
regions O
of O
the O
human O
IL-1alpha O
promoter O
involved O
in O
activation O
of O
the O
IL-1alpha O
gene O
. O

IL-1alpha O
promoter O
constructs O
drive O
transcription O
of O
the O
chloramphenicol O
acetyltransferase O
( O
CAT O
) O
reporter O
gene O
in O
HTLV-I-positive B
MT-2 I
cells I
, O
which O
constitutively O
produce O
IL-1alpha O
. O

In O
a O
cotransfection O
assay O
, O
the O
Tax O
protein O
of O
both O
HTLV-I O
and O
HTLV-II O
specifically O
activated O
transcription O
from O
the O
IL-1alpha O
promoter O
in O
an O
uninfected B
Jurkat I
cell I
line I
. O

We O
found O
that O
two O
IL-1alpha O
kappaB-like O
sites O
( O
positions O
-1 O
, O
065 O
to O
-1 O
, O
056 O
and O
+646 O
to O
+655 O
) O
specifically O
formed O
a O
complex O
with O
NF-kappaB O
-containing O
nuclear O
extract O
from O
MT-2 B
cells I
and O
that O
NF-kappaB O
bound O
with O
higher O
affinity O
to O
the O
3 O
' O
NF-kappaB O
binding O
site O
than O
to O
the O
5 O
' O
NF-kappaB O
site O
. O

Moreover O
, O
deletion O
of O
either O
5 O
' O
or O
3 O
' O
NF-kappaB O
sites O
reduced O
IL-1alpha O
promoter O
activity O
in O
MT-2 B
cells I
and O
transactivation O
of O
the O
IL-1alpha O
promoter O
by O
exogenous O
NF-kappaB O
and O
Tax O
in O
Jurkat B
cells I
. O

Furthermore O
, O
transient-cotransfection O
assay O
demonstrated O
that O
PU.1 O
( O
and O
not O
Elf-1 O
) O
can O
transactivate O
the O
c-fes O
promoter O
in O
nonmyeloid B
cell I
lines I
. O

IL-10 O
inhibits O
nuclear O
factor-kappa O
B/Rel O
nuclear O
activity O
in O
CD3-stimulated B
human I
peripheral I
T I
lymphocytes I
. O

On O
the O
other O
hand O
, O
the O
up-regulation O
of O
CD80 O
Ag O
, O
found O
on O
monocytes O
obtained O
from O
PBMC O
incubated O
with O
OKT3 O
, O
is O
not O
detected O
after O
addition O
of O
IL-10 O
, O
and O
the O
anti-CD28 O
mAb O
CLB-CD28/1 O
restores O
the O
NF-kappa O
B/Rel O
nuclear O
activity O
in O
IL-10-inhibited B
lymphocytes I
. O

Our O
results O
demonstrate O
that O
IL-10 O
can O
inhibit O
the O
induction O
of O
NF-kappa O
B/Rel O
nuclear O
activity O
in O
CD3-stimulated B
T I
lymphocytes I
. O

In O
a O
panel O
of O
32 O
B-cell B
lines I
, O
A-myb O
was O
very O
strongly O
expressed O
in O
most O
Burkitt O
's O
lymphoma O
( O
BL O
) O
cell O
lines O
, O
but O
weak O
or O
negative O
in O
2 O
pre-B O
acute O
lymphoblastic O
leukemia O
( O
ALL O
) O
, O
4 O
non-Hodgkin O
's O
lymphoma O
( O
NHL O
) O
, O
6 O
Epstein-Barr B
virus-immortalized I
lymphoblastoid I
cell I
lines I
, O
and O
6 O
myeloma B
lines I
. O

Finally O
, O
we O
have O
studied O
the O
progression O
of O
one O
case O
of O
CLL O
into O
Richter O
's O
syndrome O
and O
have O
found O
that O
the O
Richter B
's I
cells I
expressed O
about O
25-fold O
less O
A-myb O
RNA O
than O
the O
CLL B
cells I
from O
the O
same O
patient. O
The O
pattern O
of O
c-myb O
and O
B-myb O
was O
clearly O
distinct O
from O
that O
of O
A-myb O
. O

C-myb O
and O
B-myb O
were O
expressed O
in O
all O
neoplastic O
groups O
, O
except O
in O
CLL B
cells I
. O

This O
expression O
may O
in O
part O
reflect O
expression O
of O
A-myb O
by O
the O
normal O
germinal O
center O
B O
cells O
that O
are O
the O
normal O
counterpart O
of O
these O
transformed B
B I
cells I
. O

Although O
GM-CSF O
receptor O
is O
devoid O
of O
tyrosine O
kinase O
enzymatic O
activity O
, O
GM-CSF-induced B
peripheral I
blood I
polymorphonuclear I
leukocytes I
( O
PMN O
) O
functional O
activation O
is O
mediated O
by O
the O
phosphorylation O
of O
a O
large O
number O
of O
intracellular O
signaling O
molecules O
. O

Epstein-Barr O
virus O
nuclear O
antigen O
2 O
( O
EBNA2 O
) O
-oestrogen O
receptor O
fusion O
proteins O
complement O
the O
EBNA2-deficient O
Epstein-Barr O
virus O
strain O
P3HR1 O
in O
transformation O
of O
primary O
B O
cells O
but O
suppress O
growth O
of O
human B
B I
cell I
lymphoma I
lines I
. O

Unexpectedly O
, O
expression O
of O
the O
same O
EBNA2 O
-oestrogen O
receptor O
fusion O
protein O
in O
established B
human I
B I
cell I
lymphoma I
lines I
resulted O
in O
growth O
retardation O
or O
growth O
arrest O
upon O
the O
addition O
of O
oestrogen O
. O

By O
titrating O
the O
oestrogen O
concentration O
in O
these O
stably B
transfected I
cells I
, O
the O
growth O
retarding O
and O
the O
transactivating O
function O
of O
the O
chimeric O
proteins O
could O
not O
be O
dissociated O
. O

We O
propose O
that O
growth O
inhibition O
of O
established O
B B
cell I
lymphoma I
lines I
is O
a O
novel O
function O
of O
EBNA2 O
which O
has O
not O
been O
detected O
in O
the O
absence O
of O
an O
inducible O
system O
. O

It O
remains O
open O
whether O
the O
growth O
retarding O
property O
of O
the O
EBNA2-oestrogen O
receptor O
fusion O
protein O
in O
B B
cell I
lymphoma I
lines I
is O
due O
to O
unphysiologically O
high O
expression O
of O
the O
chimeric O
protein O
or O
to O
interference O
with O
a O
cellular O
programme O
driving O
proliferation O
in O
these O
cell B
lines I
. O

To O
investigate O
the O
regulation O
of O
IL-13 O
gene O
expression O
by O
T O
cells O
, O
we O
isolated O
and O
sequenced O
the O
human O
IL-13 O
gene O
, O
analyzed O
its O
5'-flanking O
region O
for O
potential O
transcriptional O
activation O
elements O
, O
and O
examined O
its O
expression O
in O
nontransformed B
T-lineage I
cell I
populations I
. O

Similar O
to O
IL-4 O
, O
IL-13 O
mRNA O
expression O
was O
highest O
in O
T-cell B
populations I
enriched O
for O
cells O
that O
had O
previously O
been O
primed O
in O
vivo O
or O
in O
vitro O
, O
indicating O
that O
priming O
increases O
the O
expression O
of O
the O
IL-13 O
and O
IL-4 O
genes O
in O
a O
coordinate O
manner O
. O

Because O
the O
primed B
T I
cells I
contain O
higher O
levels O
of O
nuclear O
NF-ATp O
, O
capable O
of O
binding O
to O
P O
elements O
of O
the O
IL-4 O
and O
IL-13 O
promoters O
, O
than O
do O
freshly-isolated O
T O
cells O
, O
the O
NF-AT-binding O
P O
elements O
are O
attractive O
candidates O
to O
mediate O
the O
coordinate O
expression O
of O
these O
two O
cytokine O
genes O
. O

Interestingly O
, O
the O
nuclear O
factor O
of O
activated O
T O
cell O
sites O
are O
much O
less O
important O
in O
normal O
T O
cells O
than O
in O
Jurkat B
T I
cells I
. O

We O
conclude O
that O
IL-2 O
transcriptional O
regulation O
differs O
in O
tumor B
cell I
lines I
compared O
with O
normal O
T O
cells O
and O
that O
different O
costimulatory O
signals O
converge O
on O
the O
same O
cis-elements O
in O
the O
IL-2 O
promoter O
. O

The O
RAR-RXR O
as O
well O
as O
the O
RXR-RXR O
pathway O
is O
involved O
in O
signaling O
growth O
inhibition O
of O
human B
CD34+ I
erythroid I
progenitor I
cells I
. O

The O
present O
study O
, O
using O
highly O
enriched O
human O
CD34+ O
as O
well O
as O
Lin- B
murine I
bone I
marrow I
progenitor I
cells I
, O
demonstrates O
a O
potent O
inhibitory O
effect O
of O
9-cis-RA O
on O
burst-forming O
unit-erythroid O
( O
BFU-E O
) O
colony O
formation O
regardless O
of O
the O
cytokine O
stimulating O
growth O
. O

AM580 O
, O
a O
stable O
benzoic O
derivative O
of O
retinoic O
acid O
, O
has O
powerful O
and O
selective O
cyto-differentiating O
effects O
on O
acute B
promyelocytic I
leukemia I
cells I
. O

Paradoxically O
, O
APL B
cells I
express O
PML-RAR O
, O
an O
aberrant O
form O
of O
the O
retinoic O
acid O
receptor O
type O
alpha O
( O
RAR O
alpha O
) O
derived O
from O
the O
leukemia-specific O
t O
( O
15 O
; O
17 O
) O
chromosomal O
translocation O
. O

We O
show O
here O
that O
AM580 O
, O
a O
stable O
retinobenzoic O
derivative O
originally O
synthesized O
as O
a O
RAR O
alpha O
agonist O
, O
is O
a O
powerful O
inducer O
of O
granulocytic O
maturation O
in O
NB4 B
, O
an O
APL-derived B
cell I
line I
, O
and O
in O
freshly O
isolated O
APL O
blasts O
. O

After O
treatment O
of O
APL B
cells I
with O
AM580 O
either O
alone O
or O
in O
combination O
with O
granulocyte O
colony-stimulating O
factor O
( O
G-CSF O
) O
, O
the O
compound O
induces O
granulocytic O
maturation O
, O
as O
assessed O
by O
determination O
of O
the O
levels O
of O
leukocyte O
alkaline O
phosphatase O
, O
CD11b O
, O
CD33 O
, O
and O
G-CSF O
receptor O
mRNA O
, O
at O
concentrations O
that O
are O
10- O
to O
100-fold O
lower O
than O
those O
of O
ATRA O
necessary O
to O
produce O
similar O
effects O
. O

By O
contrast O
, O
AM580 O
is O
not O
effective O
as O
ATRA O
in O
modulating O
the O
expression O
of O
these O
differentiation O
markers O
in O
the O
HL-60 B
cell I
line I
and O
in O
freshly O
isolated O
granulocytes O
obtained O
from O
the O
peripheral O
blood O
of O
chronic O
myelogenous O
leukemia O
patients O
during O
the O
stable O
phase O
of O
the O
disease O
. O

In O
NB4 B
cells I
, O
two O
other O
synthetic O
nonselective O
RAR O
ligands O
are O
capable O
of O
inducing O
LAP O
as O
much O
as O
AM580 O
, O
whereas O
RAR O
beta- O
or O
RAR O
gamma-specific O
ligands O
are O
totally O
ineffective O
. O

Binding O
experiments O
, O
using O
COS-7 B
cells I
transiently O
transfected O
with O
PML-RAR O
and O
the O
normal O
RAR O
alpha O
, O
show O
that O
AM580 O
has O
a O
lower O
affinity O
than O
ATRA O
for O
both O
receptors O
. O

We O
hypothesized O
that O
an O
intracellular O
vitamin O
D O
binding O
protein O
( O
IDBP O
) O
, O
present O
in O
both O
nuclear O
and O
cytoplasmic O
fractions O
of O
NWP B
cells I
, O
or O
another O
protein O
( O
s O
) O
may O
cause O
or O
contribute O
to O
the O
steroid O
hormone-resistant O
state O
in O
NWP B
by O
disruption O
of O
the O
receptor O
dimerization O
process O
and/or O
by O
interference O
of O
receptor O
complex O
binding O
to O
the O
consensus O
response O
elements O
present O
in O
the O
enhancer O
regions O
of O
steroid-responsive O
genes O
. O

Nuclear O
and O
post-nuclear O
extracts O
were O
prepared O
from O
two O
B-lymphoblastoid B
cell I
lines I
known O
to O
be O
representative O
of O
the O
vitamin B
D-resistant I
and O
wild B
type I
phenotypes I
, O
respectively O
. O

In O
addition O
, O
vitamin O
D-resistant O
cell O
nuclear O
extract O
contained O
a O
protein O
( O
s O
) O
which O
was O
bound O
specifically O
to O
the O
VDRE O
and O
was O
capable O
of O
completely O
inhibiting O
VDR-RXR-VDRE O
complex O
formation O
; O
these O
effects O
were O
not O
demonstrated O
with O
nuclear O
extract O
from O
the O
wild B
type I
cell I
line I
or O
with O
the O
post-nuclear O
extract O
of O
the O
vitamin B
D-resistant I
cell I
line I
. O

We O
conclude O
that O
a O
VDRE-binding O
protein O
( O
s O
) O
, O
distinct O
from O
IDBP O
and O
present O
in O
nuclear O
extract O
of O
cells O
from O
a O
prototypical B
vitamin I
D-resistant I
NWP I
, O
is O
capable O
of O
inhibiting O
normal O
VDR-RXR O
heterodimer O
binding O
to O
the O
VDRE O
. O

Like O
IkappaBalpha O
, O
Tax O
-mediated O
breakdown O
of O
IkappaBbeta O
in O
transfected B
T I
lymphocytes I
is O
blocked O
either O
by O
cell-permeable O
proteasome O
inhibitors O
or O
by O
mutation O
Of O
IkappaBbeta O
at O
two O
serine O
residues O
present O
within O
its O
N-terminal O
region O
. O

These O
findings O
with O
IkappaBbeta O
provide O
a O
potential O
mechanism O
for O
the O
constitutive O
activation O
of O
NF-kappaB O
in O
Tax-expressing B
cells I
. O

We O
investigated O
the O
regulation O
of O
thymidine O
kinase O
in O
phytohemagglutinin-stimulated B
normal I
human I
lymphocytes I
and O
in O
the O
p16-negative B
human I
acute I
lymphoblastic I
leukemia I
cell I
lines I
, O
MOLT-4 B
and O
CEM B
. O

Compared O
to O
normal O
lymphocytes O
, O
MOLT-4 B
and I
CEM I
cells I
exhibited O
an O
altered O
cell O
cycle O
regulation O
of O
thymidine O
kinase O
, O
a O
much O
higher O
intracellular O
activity O
of O
this O
enzyme O
, O
and O
higher O
thymidine O
kinase O
mRNA O
expression O
. O

Transient O
expression O
of O
p16 O
in O
normal O
human O
lymphocytes O
caused O
arrest O
in O
G1 O
, O
but O
was O
without O
effect O
on O
the O
cell O
growth O
of O
MOLT-4 B
and I
CEM I
cells I
, O
although O
all O
of O
them O
express O
functional O
retinoblastoma O
protein O
. O

Nevertheless O
, O
in O
the O
two O
leukemia B
cell I
lines I
transient O
overexpression O
of O
p16 O
reestablished O
the O
normal O
regulation O
of O
thymidine O
kinase O
, O
paralleled O
by O
an O
increase O
of O
the O
underphosphorylated O
form O
of O
retinoblastoma O
protein O
and O
decrease O
of O
free O
E2F O
bound O
to O
its O
motif O
in O
the O
thymidine O
kinase O
promoter O
. O

We O
have O
isolated O
a O
novel O
cDNA O
clone O
encoding O
interferon O
( O
IFN O
) O
consensus O
sequence-binding O
protein O
in O
adult B
T-cell I
leukemia I
cell I
line I
or O
activated O
T O
cells O
( O
ICSAT O
) O
; O
this O
protein O
is O
the O
human O
homolog O
of O
the O
recently O
cloned O
Pip/LSIRF O
. O

Among O
T-cell B
lines I
investigated O
, O
ICSAT O
was O
abundantly O
expressed O
in O
human B
T-cell I
leukemia I
virus I
type I
1 I
( I
HTLV-1 I
) I
-infected I
T I
cells I
. O

When O
the O
HTLV-1 O
tax O
gene O
was O
expressed O
or O
phorbol O
myristake O
acetate-A23187 O
stimulation O
was O
used O
, O
ICSAT O
expression O
was O
induced O
in O
Jurkat B
cells I
which O
otherwise O
do O
not O
express O
ICSAT O
. O

To O
study O
the O
functional O
role O
of O
ICSAT O
, O
we O
performed O
cotransfection O
experiments O
with O
the O
human B
embryonal I
carcinoma I
cell I
line I
N-Tera2 I
. O

Regulation O
of O
[ O
Ca2+ O
] O
i O
rise O
activated O
by O
doxepin-sensitive O
H1-histamine O
receptors O
in O
Jurkat B
cells I
, O
cloned B
human I
T I
lymphocytes I
. O

To O
clarify O
the O
presence O
of O
histamine O
receptor O
and O
its O
transmembrane O
mechanism O
in O
human O
T O
lymphocytes O
, O
we O
investigated O
the O
effects O
of O
agonists O
or O
antagonists O
of O
histamine O
receptor O
subtypes O
and O
bacterial O
toxins O
on O
intracellular O
concentration O
of O
Ca2+ O
[ O
Ca2+ O
] O
i O
) O
, O
[ O
3H O
] O
pyrilamine O
binding O
and O
c-fos O
mRNA O
expression O
in O
Jurkat B
cells I
, O
cloned O
human O
T O
lymphocytes O
. O

Western O
Blot O
analysis O
using O
antibodies O
against O
subunits O
of O
GTP-binding O
proteins O
indicated O
that O
Gq/G11 O
richly O
existed O
in O
Jurkat B
cells I
. O

Here O
, O
we O
describe O
the O
effect O
of O
383-bp O
( O
delta383 O
) O
and O
99-bp O
( O
delta99 O
) O
sequences O
containing O
the O
PYBF-binding O
site O
on O
transcription O
from O
various O
globin O
and O
non-globin O
promoters O
, O
using O
a O
transient O
assay O
with O
the O
cat O
reporter O
gene O
in O
murine B
erythroleukemia I
( I
MEL I
) I
cells I
, O
a O
cell O
line O
with O
abundant O
PYBF O
activity O
. O

All O
mutants O
, O
including O
one O
extensively O
mutagenized O
strain O
entirely O
missing O
the O
NF-kappaB O
and O
four O
Spl O
binding O
elements O
, O
replicated O
with O
wild-type O
kinetics O
and O
to O
a O
wild-type O
level O
in O
peripheral B
blood I
mononuclear I
cell I
cultures I
in O
50 O
to O
100 O
% O
of O
the O
experiments O
. O

One O
group O
of O
mutants O
replicated O
very O
similarly O
to O
SIVmac239 O
in O
kinetics O
and O
yield O
in O
CEMxl74 B
cells I
( O
2x O
NFKappaB O
> O
or O
= O
SlVmac239 O
approximately O
deltaNFkappaB O
approximately O
deltaSpl234 O
approximately O
substNFkappaB O
approximately O
substSpl2 O
approximately O
substSp23 O
) O
, O
while O
a O
second O
group O
replicated O
with O
delayed O
or O
slightly O
delayed O
kinetics O
in O
CEMxl74 B
cells I
( O
SIVmac239 O
> O
substSp34 O
> O
deltaNFkappaBdeltaSpl234 O
approximately O
deltaNFkappaBdeltaSp1 O
> O
substSpl234 O
) O
. O

Reversions O
or O
additional O
mutations O
were O
not O
detected O
in O
the O
U3 O
and O
R O
regions O
of O
proviral O
DNA O
from O
CEMxl74 B
cells I
infected O
with O
the O
SIVmac239 O
mutants O
. O

Similar O
results O
were O
obtained O
when O
mutants O
of O
SIVmacMER O
( O
a O
macrophage-competent O
derivative O
of O
SIVmac239 O
) O
were O
tested O
in O
peripheral O
blood O
mononuclear O
cell O
and O
CEMx174 B
cultures I
. O

Thus O
, O
changes O
in O
the O
Sp1 O
binding O
sites O
had O
the O
most O
dramatic O
effects O
on O
SIVmac O
replication O
in O
primary B
macrophage I
cultures I
. O

As O
reported O
here O
, O
structure-function O
analysis O
of O
the O
CAML O
gene O
in O
Jurkat B
T I
cells I
indicates O
that O
two O
of O
CAML O
's O
putative O
membrane-spanning O
domains O
are O
necessary O
and O
sufficient O
for O
the O
modulation O
of O
intracellular O
calcium O
. O

In O
the O
nuclei O
of O
EBV-transformed B
lymphoblastoid I
cell I
lines I
EBNA-5 O
is O
preferentially O
targetted O
to O
distinct O
nuclear O
foci O
. O

We O
have O
recently O
shown O
that O
infection O
of O
Epstein-Barr B
virus I
( I
EBV I
) I
genome-positive I
B I
cells I
by O
human O
herpesvirus O
6 O
( O
HHV-6 O
) O
results O
in O
the O
expression O
of O
the O
immediate-early O
EBV O
Zebra O
gene O
, O
followed O
by O
virus O
replication O
( O
L.Flamand O
, O
I.Stefanescu O
, O
D.V.Ablashi O
, O
and O
J.Menezes O
, O
J.Virol.67 O
: O
6768-6777 O
, O
1993 O
) O
. O

Using O
human B
B- I
or I
T-cell I
lines I
transfected O
with O
ZpCat O
reporter O
gene O
constructs O
, O
we O
demonstrate O
that O
a O
region O
designated O
the O
ZII O
domain O
of O
Zp O
is O
the O
target O
of O
HHV-6 O
transactivation O
. O

Regulation O
of O
the O
nuclear O
factor O
of O
activated O
T O
cells O
in O
stably O
transfected O
Jurkat B
cell I
clones I
. O

Two O
Jurkat B
cell I
clones I
have O
been O
stably O
transfected O
with O
a O
reporter O
vector O
for O
the O
nuclear O
factor O
of O
activated O
T O
cells O
( O
NFAT O
) O
. O

These O
stable O
Jurkat B
cell I
clones I
provide O
a O
convenient O
and O
sensitive O
tool O
to O
study O
NFAT O
regulation O
. O

We O
show O
that O
repression O
is O
strongly O
dependent O
on O
the O
type O
of O
enhancer O
present O
in O
the O
reporter O
plasmid O
as O
well O
as O
on O
the O
cell B
line I
tested O
. O

The O
second O
was O
to O
suppress O
the O
permanent O
NF-kappaB O
translocation O
induced O
by O
HIV-1 O
replication O
itself O
in O
chronically B
infected I
U937 I
cells I
, O
using O
a O
specific O
proteasome O
inhibitor O
( O
Z-LLL-H O
) O
. O

The O
third O
approach O
was O
to O
monitor O
the O
replication O
competence O
in O
U937 B
cells I
of O
an O
infectious O
HIV-1 O
provirus O
carrying O
point O
mutations O
in O
the O
kappaB-responsive O
elements O
of O
both O
long O
terminal O
repeats O
. O

Compared O
with O
its O
wild-type O
counterpart O
, O
this O
mutated O
provirus O
showed O
a O
profoundly O
decreased O
, O
Z-LLL-H-insensitive O
transcriptional O
and O
replicative O
activity O
in O
U937 B
monocytes I
. O

The O
expression O
of O
cell O
surface O
markers O
including O
the O
interleukin O
2 O
receptor O
alpha O
( O
IL-2R O
alpha O
) O
chain O
( O
CD25 O
) O
, O
CD69 O
and O
L-selectin O
( O
CD62 O
) O
is O
normal O
in O
mitogen-activated B
Rel-/- I
T I
cells I
, O
but O
cytokine O
production O
is O
impaired O
. O

In O
Rel-/- B
splenic I
T I
cell I
cultures I
stimulated O
with O
phorbol O
12-myristate O
13-acetate O
and O
ionomycin O
, O
the O
levels O
of O
IL-3 O
, O
IL-5 O
, O
granulocyte- O
macrophage O
colony-stimulating O
factor O
( O
GM-CSF O
) O
, O
tumor O
necrosis O
factor O
alpha O
( O
TNF-alpha O
) O
, O
and O
gamma O
interferon O
( O
IFN-gamma O
) O
were O
only O
2- O
to O
3-fold O
lower O
compared O
with O
normal O
T O
cells O
. O

In O
contrast O
, O
anti-CD3 O
and O
anti-CD28 O
stimulated O
Rel-/- B
T I
cells I
, O
which O
fail O
to O
proliferate O
, O
make O
little O
or O
no O
detectable O
cytokines O
. O

Exogenous O
IL-2 O
, O
which O
restitutes O
the O
proliferative O
response O
of O
the O
anti-CD3- B
and I
anti-CD28-treated I
Rel-/- I
T I
cells I
, O
restores O
production O
of O
IL-5 O
, O
TNF-alpha O
, O
and O
IFN-gamma O
, O
but O
not O
IL-3 O
and O
GM-CSF O
expression O
to O
approximately O
normal O
levels O
. O

In O
contrast O
to O
mitogen-activated B
Rel-/- I
T I
cells I
, O
lipopolysaccharide-stimulated O
Rel-/- B
macrophages I
produce O
higher O
than O
normal O
levels O
of O
GM-CSF O
. O

In O
vivo O
anergized B
CD4+ I
T I
cells I
express O
perturbed O
AP-1 O
and O
NF-kappa O
B O
transcription O
factors O
. O

Large O
amounts O
of O
AP-1 O
and O
NF-kappa O
B O
and O
significant O
quantities O
of O
NF-AT O
were O
induced O
in O
SEA-activated B
CD4+ I
spleen I
T I
cells I
, O
whereas O
Oct-1 O
and O
Oct-2 O
DNA O
binding O
activity O
was O
similar O
in O
both O
resting O
and O
activated O
T O
cells O
. O

Further O
, O
in O
normal O
and O
CD45- B
or I
Lck-deficient I
cell I
lines I
, O
Fas O
stimulation O
results O
in O
activation O
of O
Jun O
kinase O
( O
JNK O
) O
, O
a O
proposed O
mediator O
of O
stress O
activation O
pathways O
. O

Antisense O
inhibition O
of O
vitamin O
D O
receptor O
expression O
induces O
apoptosis O
in O
monoblastoid B
U937 I
cells I
. O

The O
active O
vitamin O
D3 O
metabolite O
1 O
, O
25-dihydroxycholecalciferol O
( O
1 O
, O
25 O
( O
OH O
) O
2D3 O
) O
acts O
as O
an O
antiproliferative O
and O
differentiating O
agent O
for O
the O
monoblastoid B
cell I
line I
U937 I
and O
as O
an O
important O
immunologic O
mediator O
implicated O
particularly O
in O
the O
function O
of O
cells O
belonging O
to O
the O
monocyte/macrophage O
lineage O
. O

The O
objective O
of O
this O
study O
was O
to O
develop O
U937 B
transfectants O
expressing O
antisense O
VDR O
mRNA O
, O
and O
to O
use O
these O
to O
examine O
the O
role O
of O
1 O
, O
25 O
( O
OH O
) O
2D3 O
-VDR O
interaction O
in O
this O
lineage O
. O

A O
2-kb O
VDR O
cDNA O
insert O
( O
including O
the O
complete O
VDR O
coding O
region O
) O
was O
cloned O
in O
an O
antisense O
orientation O
into O
the O
EBV O
episomal O
vector O
pMEP4 O
under O
the O
control O
of O
an O
inducible O
promoter O
and O
transfected O
into O
U937 B
. O

The O
resultant B
cell I
line I
, O
DH42 B
, O
was O
hygromycin O
resistant O
, O
contained O
VDR O
cDNA O
, O
expressed O
fewer O
VDRs O
than O
controls O
, O
and O
showed O
a O
substantial O
decrease O
in O
antiproliferative O
response O
to O
1 O
, O
25 O
( O
OH O
) O
2D3 O
. O

We O
now O
report O
that O
galectin-3 O
is O
abundantly O
expressed O
in O
a O
number O
of O
human B
T I
lymphotropic I
virus I
( I
HTLV I
) I
-I-infected I
human I
T I
cell I
lines I
, O
including O
F6T B
, O
HUT B
102 I
, O
K3T B
, O
MT-2 B
, O
and O
SLB-I B
, O
but O
is O
not O
expressed O
in O
non-HTLV-I-infected B
T I
cell I
lines I
such O
as O
Jurkat B
, O
CEM B
, O
and O
MOLT-4 B
. O

The O
up-regulation O
of O
galectin-3 O
expression O
appeared O
to O
correlate O
well O
with O
HTLV-I O
gene O
expression O
, O
as O
undetectable O
or O
very O
low O
levels O
of O
galectin-3 O
were O
found O
in O
the O
S1T B
and I
ATL-1K I
cell I
lines I
, O
which O
are O
nonproductively O
infected O
with O
HTLV-I O
. O

Transfection O
of O
human B
promonocytic I
U-937 I
cells I
with O
an O
HTLV-I O
Tax O
expression O
vector O
induced O
galectin-3 O
expression O
in O
this O
cell O
line O
. O

Since O
promoter O
elements O
controlling O
collagenase O
transcription O
in O
monocytic O
cells O
have O
not O
been O
previously O
defined O
, O
we O
sought O
to O
delineate O
responsive O
cis-acting O
elements O
of O
the O
collagenase O
promoter O
in O
transiently O
transfected O
human B
( I
U937 I
) I
and I
murine I
( I
J774 I
) I
monocytic I
cell I
lines I
. O

Consistent O
with O
this O
notion O
, O
we O
found O
that O
LPS O
stimulated O
AP-1 O
-mediated O
transcription O
of O
a O
transfected O
reporter O
gene O
in O
the O
murine B
macrophage I
cell I
line I
RAW I
264.7 I
. O

LPS O
treatment O
of O
RAW B
264.7 I
cells I
, O
murine O
bone O
marrow-derived O
macrophages O
, O
and O
the O
human B
monocyte I
cell I
line I
THP-1 I
resulted O
in O
rapid O
activation O
of O
the O
p46 O
and O
p54 O
isoforms O
of O
JNK O
. O

Binding O
of O
LPS- O
LPS O
binding O
protein O
( O
LBP O
) O
complexes O
to O
CD14 O
, O
a O
surface O
receptor O
that O
mediates O
many O
LPS O
responses O
, O
was O
found O
to O
be O
crucial O
, O
as O
pretreatment O
of O
THP-1 B
cells I
with O
the O
monoclonal O
antibody O
60b O
, O
which O
blocks O
this O
binding O
, O
inhibited O
JNK O
activation O
. O

In O
this O
study O
, O
we O
report O
that O
both O
Exosurf O
and O
Survanta O
suppress O
TNF O
mRNA O
and O
secretion O
( O
85 O
+/- O
4 O
% O
mean O
percent O
inhibition O
+/- O
SEM O
by O
Exosurf O
; O
71 O
+/- O
6 O
% O
by O
Survanta O
) O
by O
endotoxin-stimulated B
THP-1 I
, O
a O
human B
monocytic I
cell I
line I
. O

Because O
surfactant O
downregulated O
inflammatory O
cytokine O
production O
similarly O
in O
both O
normal O
human O
alveolar O
macrophages O
and O
the O
THP-1 B
cell I
line I
, O
we O
used O
this O
cell B
line I
to O
investigate O
whether O
surfactant O
affected O
transcriptional O
mechanisms O
. O

The O
presence O
of O
both O
p65 O
and O
p50 O
NF-kappa O
B O
components O
in O
LPS-activated O
THP-1 B
cells I
was O
confirmed O
by O
specific O
antibody O
induction O
of O
supershifts O
in O
mobility O
assays O
. O

mBob1 O
is O
B-cell O
restricted O
, O
and O
is O
found O
in O
all O
B-cell B
lines I
representing O
different O
stages O
of O
B-cell O
differentiation O
. O

Our O
results O
indicate O
that O
gp120 O
enhances O
ICAM-1 O
gene O
expression O
in O
primary O
rat O
astrocytes O
, O
primary O
human O
astrocytes O
, O
a O
human B
astroglioma I
cell I
line I
CRT I
, O
and O
primary O
rat O
microglia O
. O

Although O
IL-10 O
alone O
did O
not O
induce O
HIV-1 O
replication O
, O
in O
the O
presence O
of O
TNF-alpha O
, O
IL-10 O
markedly O
enhanced O
virion O
production O
from O
a O
chronically O
infected O
promonocytic B
cell I
line I
( O
U1 B
) O
and O
in O
acutely O
infected O
monocyte-derived O
macrophages O
. O

Here O
, O
we O
studied O
the O
role O
of O
serine/threonine O
phosphatases O
in O
STAT3 O
signaling O
in O
human B
antigen-specific I
CD4 I
( I
+ I
) I
T I
cell I
lines I
and O
cutaneous B
T I
cell I
lymphoma I
lines I
, O
expressing O
a O
constitutively O
activated O
STAT3 O
. O

We O
have O
focused O
on O
the O
study O
of O
the O
signal O
transduction O
pathways O
triggered O
by O
CD23 O
in O
human O
monocytes O
and O
the O
promonocytic B
cell I
line I
U937 I
. O

METHODS O
: O
CD23 O
was O
cross-linked O
in O
human O
monocytes O
and O
U937 B
cells I
with O
IgE O
immune O
complexes O
. O

Suppression O
of O
TNFalpha O
-mediated O
NFkappaB O
activity O
by O
myricetin O
and O
other O
flavonoids O
through O
downregulating O
the O
activity O
of O
IKK O
in O
ECV304 B
cells I
. O

In O
this O
study O
, O
the O
effects O
of O
flavonoids O
on O
NFkappaB O
/inhibitor-kappaB O
( O
IkappaB O
) O
system O
in O
ECV304 B
cells I
activated O
with O
tumor O
necrosis O
factor-alpha O
( O
TNFalpha O
) O
were O
examined O
. O

Furthermore O
, O
myricetin O
was O
also O
found O
to O
inhibit O
NFkappaB O
activity O
correlated O
with O
suppression O
of O
monocyte O
adhesion O
to O
ECV304 B
cells I
. O

We O
have O
examined O
the O
influence O
of O
the O
affinity O
and O
concentration O
of O
exogenous O
peptide O
and O
the O
density O
of O
specific O
MHC O
molecules O
on O
the O
proliferation O
of O
a O
CD4+ B
, I
DQA1*0501/DQB1*0201 I
( I
DQ2.1 I
) I
-restricted I
, I
HSV-2-specific I
T I
cell I
clone I
. O

MHC O
class O
II O
density O
on O
the O
APC O
was O
modified O
using O
DQ2 B
homo I
-and I
heterozygous I
B-LCLs I
as O
APCs O
, O
however O
this O
variation O
of O
MHC O
concentration O
had O
no O
effect O
on O
T O
cell O
proliferation O
. O

We O
interpret O
this O
as O
a O
reflection O
of O
a O
low O
threshold O
for O
activation O
of O
the O
T B
cell I
clone I
, O
in O
which O
peptide- O
MHC O
avidity O
is O
the O
over-riding O
determinant O
of O
the O
strength O
of O
ligand O
signal O
. O

Recently O
, O
we O
and O
others O
have O
shown O
that O
thrombopoietin O
induces O
rapid O
tyrosine O
phosphorylation O
of O
Jak2 O
and O
other O
proteins O
in O
human O
platelets O
and O
BaF3 B
cells I
, O
genetically O
engineered O
to O
express O
c-Mpl O
, O
a O
receptor O
for O
thrombopoietin O
. O

Thrombopoietin O
also O
induced O
tyrosine O
phosphorylation O
of O
Stat3 O
and O
Stat5 O
in O
FDCP-2 B
cells I
genetically O
engineered O
to O
constitutively O
express O
human O
c-Mpl O
. O

Recent O
studies O
have O
defined O
genetic O
alterations O
commonly O
associated O
with O
transformed B
lymphocytes I
. O

The O
dysregulated O
expression O
of O
cytokines O
during O
malignancy O
can O
result O
in O
the O
augmentation O
of O
growth O
of O
transformed B
lymphocytes I
, O
as O
well O
as O
an O
alteration O
of O
the O
anti-tumor O
immune O
response O
. O

However O
, O
when O
used O
simultaneously O
, O
DHEA O
and O
LPS O
0.2 O
ng/ml O
displayed O
a O
synergistic O
effect O
on O
monocyte O
cytotoxicity O
against O
cancerous B
cell I
lines I
, O
IL-1 O
secretion O
, O
reactive O
nitrogen O
intermediate O
release O
, O
complement O
receptor-1 O
cell-surface O
protein O
, O
and O
TNF-alpha O
protein O
to O
levels O
comparable O
with O
levels O
obtained O
using O
LPS O
1.0 O
microgram/ml O
. O

Finally O
, O
Scatchard O
plot O
analysis O
demonstrated O
the O
presence O
of O
a O
DHEA O
receptor O
in O
monocytes O
, O
suggesting O
that O
DHEA O
effects O
on O
LPS-stimulated B
monocytes I
are O
mediated O
through O
a O
receptor-dependent O
process O
. O

Forced O
expression O
of O
SOCS-1 O
in O
a O
macrophage B
cell I
line I
, O
RAW264 B
, O
markedly O
suppressed O
trans-activation O
of O
an O
IL-4-inducible O
reporter O
as O
well O
as O
IL-6- O
and O
IFN-gamma-induced O
reporter O
gene O
activity O
. O

The O
luciferase O
reporter O
gene O
under O
the O
control O
of O
the O
5 O
' O
flanking O
region O
of O
0.7 O
kb O
was O
strongly O
induced O
upon O
activation O
with O
anti-CD3 O
or O
PHA O
plus O
PMA O
only O
in O
SCM-1-producer B
T I
cell I
lines I
through O
a O
cyclosporin O
A-sensitive O
mechanism O
. O

In O
electrophoretic O
mobility O
shift O
assays O
using O
the O
E1 O
oligonucleotide O
as O
probe O
, O
nuclear O
extracts O
from O
unstimulated O
T O
and O
B B
cell I
lines I
formed O
a O
constitutive O
complex O
termed O
complex O
I O
, O
while O
nuclear O
extracts O
from O
stimulated O
SCM-1-producer B
T I
cell I
lines I
formed O
a O
higher O
mobility O
complex O
termed O
complex O
II O
with O
a O
concomitant O
decrease O
in O
complex O
I O
. O

The O
shift O
from O
complex O
I O
to O
complex O
II O
seen O
only O
in O
SCM-1-producer B
T I
cell I
lines I
upon O
activation O
was O
completely O
suppressed O
by O
cyclosporin O
A O
. O

One-hybrid O
assays O
in O
yeast O
isolated O
NF-ATp O
as O
an O
E1 O
binding O
protein O
, O
and O
transfection O
of O
NF-ATp O
into O
T B
and I
B I
cell I
lines I
strongly O
enhanced O
the O
activation-dependent O
SCM-1 O
promoter O
activity O
. O

Here O
, O
we O
have O
investigated O
the O
regulation O
of O
HIV-1 O
expression O
by O
dopamine O
in O
Jurkat B
T I
cells I
and O
in O
primary O
blood O
mononuclear O
cells O
( O
PBMC O
) O
. O

In O
contrast O
, O
APC O
pulsed O
with O
Ala-substituted O
peptides O
430-444 O
, O
442A O
or O
433-442A O
at O
neutral O
pH O
failed O
to O
stimulate O
the O
T B
cell I
clone I
, O
while O
APC O
pulsed O
at O
acidic O
pH O
and O
subsequently O
washed O
led O
to O
successful O
T O
cell O
activation O
. O

The O
Ala-substituted O
peptide O
was O
recognized O
by O
the O
T B
cell I
clone I
at O
neutral O
pH O
only O
when O
it O
was O
present O
in O
the O
APC B
culture I
throughout O
the O
stimulation O
process O
. O

A O
reporter O
construct O
containing O
the O
5'-flanking O
region O
of O
the O
mouse O
TNF-alpha O
gene O
displayed O
weak O
activity O
when O
transfected O
into O
RAW264.7 B
macrophage-like I
cells I
. O

In O
RAW264.7 B
cells I
, O
the O
binding O
was O
constitutive O
, O
however O
, O
in O
bone B
marrow-derived I
macrophages I
binding O
activity O
was O
shown O
to O
be O
interferon-gamma O
inducible O
. O

Due O
to O
its O
location O
within O
this O
cluster O
and O
its O
biologic O
role O
in O
Ig O
class O
switching O
and O
Th2 B
cell I
differentiation O
, O
the O
IL-4 O
gene O
has O
emerged O
as O
one O
major O
candidate O
for O
the O
atopy O
gene O
. O

In O
one O
model O
, O
polymorphisms O
within O
IL-4 O
regulatory O
elements O
might O
result O
in O
overexpression O
of O
the O
gene O
, O
amplifying O
Th2 B
cell I
differentiation O
and O
class O
switching O
to O
IgE O
. O

Oral O
administration O
of O
276 O
mumol O
cortisol O
to O
normal O
subjects O
also O
decreased O
LPS-induced O
IL-1ra O
synthesis O
in O
cultured B
monocytes I
. O

Aberrant O
TCL1 O
expression O
has O
been O
implicated O
in O
T O
cell O
leukemia/lymphoma O
development O
, O
and O
its O
expression O
also O
has O
been O
seen O
in O
many O
established O
B B
cell I
tumor I
lines I
. O

Consistent O
with O
a O
role O
for O
STATs O
in O
Qp O
function O
, O
Qp O
using O
Burkitt B
's I
lymphoma I
Rael I
cells I
and O
cultured O
nasopharyngeal O
carcinoma O
( O
NPC O
) O
cells O
contained O
nuclear O
STAT O
protein O
. O

We O
investigated O
whether O
the O
inability O
to O
maintain O
EBV-positive B
NPC I
cell I
lines I
in O
culture O
was O
related O
to O
Qp O
activity O
. O

Passaging O
of O
the O
NPC B
cell I
line I
HK666 I
led O
to O
activation O
of O
expression O
of O
BZLF1 O
, O
which O
encodes O
Zta O
and O
loss O
of O
Qp O
function O
. O

Reactive O
oxygen O
intermediate-release O
of O
fibre-exposed B
monocytes I
increases O
inflammatory O
cytokine-mRNA O
level O
, O
protein O
tyrosine O
kinase O
and O
NF-kappaB O
activity O
in O
co-cultured B
bronchial I
epithelial I
cells I
( O
BEAS-2B B
) O
. O

For O
measuring O
the O
contribution O
of O
macrophages O
to O
the O
release O
of O
inflammatory O
mediators O
by O
bronchial O
epithelial O
cells O
, O
we O
established O
an O
in O
vitro O
model O
of O
co-cultured O
blood O
monocytes O
( O
BM O
) O
and O
BEAS-2B B
cells I
in O
a O
transwell O
system O
( O
Costar O
) O
. O

We O
observed O
an O
increase O
in O
protein O
tyrosine O
kinase O
activity O
( O
up O
to O
1.8 O
+/- O
0.5-fold O
) O
and O
NF-kappaB O
protein O
activity O
in O
BEAS-2B O
cells O
after O
particle O
or O
fibre O
exposure O
of O
co-cultured B
BM I
. O

We O
show O
here O
that O
the O
response O
of O
the O
HIV-1 O
long O
terminal O
repeat O
( O
LTR O
) O
to O
mitogenic O
or O
Tat O
-mediated O
activation O
is O
sensitive O
to O
the O
suppressive O
action O
of O
a O
Herpesvirus B
saimiri I
( I
HVS I
) I
-transformed I
CD8+ I
T I
cell I
clone I
from O
an O
HIV-infected O
individual O
and O
supernatants O
from O
CD8+ O
T O
cells O
of O
HIV-1-infected O
asymptomatic O
subjects O
( O
CD4+ O
> O
350/microliters O
) O
. O

Inhibition O
of O
NF-kappa O
B O
activation O
in O
human B
T-cell I
lines I
by O
anetholdithiolthione O
. O

PMA O
and O
TNF O
alpha O
induced O
activation O
of O
( O
NF O
) O
-kappa O
B O
in O
human O
Jurkat B
T-cells I
was O
partially O
inhibited O
by O
ADT O
( O
0.1 O
mM O
) O
pretreatment O
. O

ADT O
( O
0.1 O
mM O
) O
also O
inhibited O
H2O2 O
induced O
activation O
of O
the O
transcription O
factor O
in O
the O
peroxide B
sensitive I
human I
Wurzburg I
T-cells I
. O

Furthermore O
, O
ADT O
treated O
Wurzburg B
cells I
had O
significantly O
higher O
glutathione O
levels O
as O
compared O
with O
untreated O
cells O
. O

H2O2 O
induced O
lipid O
peroxidation O
in O
Wurzburg B
cells I
was O
remarkably O
inhibited O
by O
ADT O
pretreatment O
. O

Immunoblotting O
experiments O
with O
U937 B
cells I
demonstrate O
that O
PKC-zeta O
is O
present O
in O
these O
cells O
, O
and O
its O
expression O
can O
be O
downmodulated O
by O
antisense O
oligonucleotides O
( O
AO O
) O
. O

Induction O
of O
Bcl-x O
( O
L O
) O
expression O
by O
human O
T-cell O
leukemia O
virus O
type O
1 O
Tax O
through O
NF-kappaB O
in O
apoptosis-resistant B
T-cell I
transfectants I
with O
Tax O
. O

We O
have O
recently O
shown O
that O
the O
expression O
of O
Tax O
protected O
the O
mouse B
T-cell I
line I
CTLL-2 I
against O
apoptosis O
induced O
by O
interleukin-2 O
( O
IL-2 O
) O
deprivation O
and O
converted O
its O
growth O
from O
being O
IL-2 O
dependent O
to O
being O
IL-2 O
independent O
. O

In O
this O
study O
, O
we O
demonstrate O
that O
constitutive O
expression O
of O
bcl-xl O
but O
not O
bcl-2 O
, O
bcl-xs O
, O
bak O
, O
bad O
, O
or O
bax O
was O
associated O
with O
apoptosis O
resistance O
after O
IL-2 O
deprivation O
in O
CTLL-2 B
cells I
that O
expressed O
Tax O
. O

Our O
findings O
suggest O
that O
constitutive O
expression O
of O
Bcl-x O
( O
L O
) O
induced O
by O
Tax O
through O
the O
NF-kappaB O
pathway O
contributes O
to O
the O
inhibition O
of O
apoptosis O
in O
CTLL-2 B
cells I
after O
IL-2 O
deprivation O
. O

Furthermore O
, O
recruitment O
of O
EKLF O
to O
5'HS3 O
only O
occurred O
in O
beta-globin-expressing O
murine O
erythroid O
leukemia O
cells O
, O
whereas O
recruitment O
of O
EKLF O
to O
5'HS2 O
occurred O
in O
both O
gamma-globin-expressing B
K562 I
cells I
and O
murine O
erythroid O
leukemia O
cells O
. O

Transient O
transfection O
studies O
in O
HeLa B
cells I
, O
an O
E O
( O
2 O
) O
receptor-negative O
line O
, O
suggest O
that O
E O
( O
2 O
) O
inhibits O
TNF O
gene O
expression O
through O
an O
effect O
mediated O
by O
estrogen O
receptor O
beta O
( O
ERbeta O
) O
. O

We O
also O
report O
that O
in O
RAW B
264.7 I
cells I
, O
an O
E O
( O
2 O
) O
receptor-positive O
murine O
monocytic O
line O
, O
E O
( O
2 O
) O
downregulates O
cytokine-induced O
TNF O
gene O
expression O
by O
decreasing O
the O
activity O
of O
the O
Jun O
NH O
( O
2 O
) O
-terminal O
kinase O
( O
JNK O
) O
. O

Here O
, O
we O
show O
that O
CD3 O
ligation O
by O
mAb O
and O
Staphylococcal O
enterotoxin O
( O
SE O
) O
induce O
a O
rapid O
, O
gradually O
accumulating O
, O
long-lasting O
tyrosine O
, O
and O
serine O
phosphorylation O
of O
Stat3 O
( O
but O
not O
Stat5 O
) O
in O
allogen-specific B
human I
CD4+ I
T I
cell I
lines I
. O

We O
report O
that O
both O
natural O
and O
synthetic O
PPARgamma O
agonists O
induce O
time- O
and O
dose-dependent O
increases O
in O
aP2 O
mRNA O
in O
both O
primary O
human O
monocytes O
and O
the O
monocytic B
cell I
line I
, O
THP-1 B
. O

In O
this O
study O
, O
we O
demonstrate O
that O
stress-activated O
protein O
kinases O
( O
SAPK O
) O
are O
activated O
after O
CD40 O
cross-linking O
on O
various O
B B
cell I
lines I
or O
human O
tonsillar O
B O
cells O
. O

Using O
CD45- B
or I
CD3-negative I
variants I
of O
the O
Jurkat B
leukemic I
T-cell I
line I
we O
show O
that O
the O
different O
biochemical O
events O
induced O
by O
pervanadate O
appeared O
to O
be O
dependent O
on O
the O
presence O
at O
the O
cell O
surface O
of O
either O
CD45 O
or O
CD3 O
. O

Vitamin O
D O
analogs O
, O
20-Epi-22-oxa-24a O
, O
26a O
, O
27a O
, O
-trihomo-1alpha O
, O
25 O
( O
OH O
) O
2-vitamin O
D3 O
, O
1 O
, O
24 O
( O
OH O
) O
2-22-ene-24-cyclopropyl-vitamin O
D3 O
and O
1alpha O
, O
25 O
( O
OH O
) O
2-lumisterol3 O
prime O
NB4 B
leukemia I
cells I
for O
monocytic O
differentiation O
via O
nongenomic O
signaling O
pathways O
, O
involving O
calcium O
and O
calpain O
. O

Here O
we O
demonstrate O
that O
these O
analogs O
, O
as O
well O
as O
the O
6-cis-locked O
conformer O
, O
1alpha B
, I
25-dihydroxy-lumisterol3 I
( I
JN I
) I
prime I
NB4 I
cells I
for O
monocytic O
differentiation O
. O

In O
this O
study O
, O
we O
show O
that O
MIP-1alpha O
is O
selectively O
expressed O
and O
secreted O
in O
the O
tax B
transfected I
Jurkat I
cell I
line I
upon O
mitogen O
stimulation O
. O

Induced O
MIP-1alpha O
expression O
and O
secretion O
in O
PMA/PHA B
stimulated I
tax I
transfected I
cells I
correlate O
with O
the O
noninduction O
of O
MNP-1 O
transcription O
factor O
, O
which O
is O
intimately O
involved O
in O
downmodulating O
the O
MIP-1alpha O
gene O
. O

Addition O
of O
exogenous O
TNF O
to O
the O
intermediate B
thymocyte I
cultures I
induces O
NF-kappaB O
activity O
and O
is O
sufficient O
to O
promote O
HIV O
replication O
in O
the O
cocultures O
with O
TEC O
. O

In O
human B
THP-1 I
monocytic I
leukemia I
cells I
cultured O
with O
RA O
( O
0.05 O
to O
500 O
nmol/L O
) O
, O
MCP-1 O
expression O
was O
induced O
rapidly O
, O
significantly O
, O
and O
dose-dependently O
by O
as O
much O
as O
165-fold O
. O

RA O
's O
effect O
on O
MCP-1 O
expression O
in O
human O
elutriated O
monocytes O
were O
similar O
to O
that O
observed O
in O
the O
THP-1 B
cells I
. O

Using O
the O
technique O
of O
reverse O
transcription-polymerase O
chain O
reaction O
( O
PCR O
) O
with O
RNA O
isolated O
from O
lymphoid B
cell I
lines I
of O
the O
patient O
and O
of O
controls O
, O
no O
evidence O
was O
found O
that O
IVS1-10TC O
abnormally O
disrupted O
mRNA O
splicing O
or O
caused O
the O
absence O
of O
BRCA1 O
mRNA O
. O

To O
address O
the O
question O
of O
DC O
lineage O
and O
to O
determine O
what O
genes O
are O
involved O
in O
lineage O
commitment O
, O
we O
have O
generated O
a O
series O
of O
GM-CSF-responsive B
cell I
lines I
that O
can O
be O
induced O
to O
differentiate O
in O
a O
homogeneous O
manner O
in O
vitro O
. O

The O
cloned B
cell I
lines I
are O
derived O
from O
12-day O
fetal O
liver O
and O
are O
transformed O
with O
a O
truncated O
form O
of O
c-myb O
, O
which O
lacks O
the O
normal O
autoregulatory O
sequences O
. O

As O
far O
as O
we O
know O
, O
these O
myb-transformed B
hemopoi-etic I
cells I
( O
MTHC B
) O
differ O
from O
normal O
only O
in O
the O
unregulated O
expression O
of O
myb O
, O
a O
gene O
whose O
expression O
is O
obligatory O
for O
proliferation O
of O
hemopoietic O
cells O
. O

MTHC B
in O
the O
presence O
of O
TNF-alpha O
and O
IL-4 O
will O
differentiate O
into O
cells O
that O
have O
many O
of O
the O
properties O
of O
macrophages O
. O

When O
the O
same O
MTHC B
lines I
are O
exposed O
to O
TNF-alpha O
in O
combination O
with O
IFN-gamma O
, O
the O
cells O
instead O
become O
DC O
. O

The O
differentiated O
DC O
are O
potent O
presenters O
of O
antigen O
in O
mixed O
lymphocyte O
reactions O
and O
of O
soluble O
antigen O
to O
specific O
T B
cell I
lines I
. O

We O
have O
used O
this O
MTHC B
system I
to O
analyze O
differences O
in O
gene O
expression O
as O
the O
cells O
mature O
along O
the O
DC O
and O
macrophage O
pathways O
. O

We O
discuss O
the O
utility O
of O
MTHC B
in O
analyzing O
the O
relationships O
between O
DC O
and O
macrophages O
, O
and O
suggest O
that O
DC O
and O
macrophages O
represent O
extreme O
phenotypes O
in O
a O
spectrum O
of O
antigen O
handling O
cells O
that O
are O
somewhat O
interchangeable O
, O
depending O
on O
their O
immediate O
environment O
. O

By O
functionally O
expressing O
receptor O
mutants O
in O
the O
murine B
pro-B I
cell I
line I
Ba/F3 B
, O
we O
could O
show O
that O
phosphorylated O
tyrosine O
residues O
within O
the O
IL-4R O
alpha O
chain O
are O
dispensable O
for O
IL-4 O
-induced O
STAT5 O
activity O
. O

A O
dominant-negative O
version O
of O
STAT5b O
, O
but O
not O
of O
STAT5a O
, O
interfered O
with O
IL-4 O
-induced O
DNA O
synthesis O
in O
Ba/F3 B
cells I
, O
suggesting O
an O
involvement O
of O
STAT5b O
in O
the O
control O
of O
cell O
proliferation O
through O
IL-4R O
. O

Immunoprecipitation O
of O
epitope-labeled O
BKO O
demonstrated O
for O
the O
formation O
of O
a O
tight O
complex O
with O
endogenous O
B O
subunit O
in O
Jurkat B
cells I
, O
consistent O
with O
an O
inhibitory O
mechanism O
that O
involves O
the O
sequestration O
of O
the O
B O
subunit O
. O

Evaluation O
of O
monoclonal O
anti-D O
reagents O
using O
D B
variant I
cells I
. O

Monoclonal O
anti-D O
antibodies O
submitted O
to O
the O
Third O
Monoclonal O
International O
Workshop O
were O
evaluated O
against O
a O
number O
of O
D B
variant I
cells I
using O
standard O
serological O
techniques O
. O

The O
monoclonal O
antibodies O
were O
able O
to O
discriminate O
between O
the O
cells O
of O
Categories B
Va I
, I
VI I
and I
DFR I
but I
not I
Category I
III I
cells I
. O

The O
Rh B
: I
33 I
cells I
behaved O
as O
normal O
Rh O
( O
D O
) O
positive O
cells O
. O

Examination O
of O
lymphoid O
tissues O
showed O
a O
low O
level O
of O
expression O
in O
a O
population O
of O
normal O
mande B
B I
lymphocytes I
but O
not O
in O
germinal O
center O
cells O
or O
plasma O
cells O
. O

The O
`` O
natural O
'' O
PPAR O
activator O
15d-PGJ O
( O
2 O
) O
had O
the O
greatest O
potency O
and O
was O
the O
only O
tested O
molecule O
capable O
of O
partially O
inhibiting O
the O
induced O
expression O
of O
E-selectin O
and O
neutrophil-like O
HL60 B
cell I
binding O
to O
PMA-activated O
HAECs O
. O

The O
proteins O
may O
prove O
useful O
in O
protecting O
adenovirus O
gene O
therapy O
vectors O
and O
transplanted B
cells I
from O
the O
immune O
system O
. O

In O
the O
cell B
line I
HT93A I
, O
which O
is O
capable O
of O
differentiating O
towards O
both O
the O
eosinophil O
and O
neutrophil O
lineages O
in O
response O
to O
retinoic O
acid O
( O
RA O
) O
, O
C/EBPalpha O
mRNA O
expression O
decreased O
significantly O
concomitant O
with O
eosinophilic O
and O
neutrophilic O
differentiation O
, O
whereas O
C/EBPbeta O
expression O
was O
markedly O
increased O
. O

To O
determine O
the O
functionality O
of O
both O
the O
C/EBP- O
and O
GATA- O
binding O
sites O
, O
we O
analyzed O
whether O
C/EBPbeta O
and O
GATA-1 O
can O
stimulate O
the O
MBP O
promoter O
in O
the O
C/EBPbeta B
and I
GATA-1 I
negative I
Jurkat I
T-cell I
line I
. O

Whereas O
the O
CRE O
site O
was O
essential O
in O
mediating O
the O
negative O
activity O
of O
the O
upstream O
regulatory O
region O
in O
Jurkat B
but O
not O
in O
HeLa B
cells I
, O
mutation O
of O
the O
Sp1/AP-2 O
site O
decreased O
promoter O
activity O
in O
both O
cell O
lines O
. O

Electrophoretic O
mobility O
shift O
assay O
analysis O
of O
proteins O
binding O
to O
the O
CRE O
site O
identified O
both O
ATF-1 O
and O
ATF-2 O
in O
Jurkat B
cells I
. O

In O
this O
study O
, O
we O
investigate O
the O
role O
of O
TNFalpha O
-inducible O
reactive O
oxygen O
species O
( O
ROS O
) O
in O
IL-8 O
expression O
by O
`` O
monocyte-like O
'' O
U937 B
histiocytic I
lymphoma I
cells I
. O

TNFalpha O
is O
a O
rapid O
activator O
of O
IL-8 O
gene O
expression O
by O
U937 B
, O
producing O
a O
50-fold O
induction O
of O
mRNA O
within O
1 O
hour O
of O
treatment O
. O

Induction O
of O
a O
functional O
vitamin O
D O
receptor O
in O
all-trans-retinoic O
acid-induced O
monocytic O
differentiation O
of O
M2-type B
leukemic I
blast I
cells I
. O

M0/M1 B
leukemic I
cells I
are O
not O
sensitive O
to O
differentiating O
agents O
, O
whereas O
M3 B
leukemic I
cells I
are O
induced O
to O
undergo O
granulocytic O
differentiation O
after O
ATRA O
treatment O
but O
are O
not O
sensitive O
to O
VD O
. O

M2 B
leukemic I
blast I
cells I
behave O
differently O
because O
they O
undergo O
monocytic O
differentiation O
with O
both O
the O
differentiation O
inducers O
. O

To O
gain O
some O
insight O
into O
the O
maturation O
of O
M2-type O
leukemic O
cells O
, O
we O
studied O
the O
molecular O
mechanisms O
underlying O
monocytic O
differentiation O
induced O
by O
ATRA O
and O
VD O
in O
spontaneous O
M2 B
blast I
cells I
as O
well O
as O
in O
Kasumi-1 B
cells I
( O
an O
acute B
myeloid I
leukemia I
M2-type I
cell I
line I
) O
. O

VDR O
is O
functionally O
active O
in O
ATRA-treated O
Kasumi-1 B
cells I
because O
it O
efficiently O
heterodimerizes O
with O
retinoid O
X O
receptor O
, O
binds O
to O
a O
DR3-type O
vitamin O
D-responsive O
element O
, O
and O
activates O
the O
transcription O
of O
a O
vitamin O
D-responsive O
element-regulated O
reporter O
gene O
. O

Consistent O
with O
these O
findings O
, O
VD-responsive O
genes O
are O
induced O
by O
ATRA O
treatment O
of O
Kasumi-1 B
cells I
, O
suggesting O
that O
the O
genetic O
program O
underlying O
monocytic O
differentiation O
is O
activated O
. O

The O
molecular O
mechanism O
by O
which O
ATRA O
increases O
the O
nuclear O
abundance O
of O
a O
functional O
VDR O
is O
still O
unknown O
, O
but O
our O
data O
clearly O
indicate O
that O
the O
M2 B
leukemic I
cell I
context O
is O
only O
permissive O
of O
monocytic O
differentiation O
. O

By O
using O
Jurkat B
and O
primary O
human O
T O
lymphocytes O
, O
we O
demonstrate O
that O
the O
simultaneous O
activation O
of O
two O
second O
messengers O
of O
the O
TCR O
-initiated O
signal O
transduction O
, O
protein O
kinase O
C O
( O
PKC O
) O
and O
calcineurin O
, O
results O
in O
the O
synergistic O
activation O
of O
the O
IkappaBalpha O
kinase O
( O
IKK O
) O
complex O
but O
not O
of O
another O
putative O
IkappaBalpha O
kinase O
, O
p90 O
( O
rsk O
) O
. O

mRNA O
levels O
for O
IL-13R O
alpha1 O
, O
but O
not O
IL-4R O
alpha O
, O
were O
markedly O
decreased O
in O
in B
vitro I
monocyte-derived I
macrophages I
( O
MDMac B
) O
, O
and O
with O
increasing O
time O
of O
monocytes O
in O
culture O
correlated O
with O
the O
loss O
of O
IL-13 O
regulation O
of O
lipopolysaccharide-induced O
TNF-alpha O
production O
. O

Analysis O
of O
cell B
lines I
Daudi B
and O
THP-1 B
that O
differentially O
express O
gamma O
( O
c O
) O
and O
IL-13R O
alpha1 O
showed O
that O
IL-13 O
can O
activate O
STAT6 O
in O
IL-13R B
alpha1-positive I
THP-1 I
cells I
but O
not O
in O
gamma B
( I
c I
) I
-positive I
, I
IL-13R I
alpha1-negative I
Daudi I
cells I
. O

IL-13 O
activation O
of O
STAT6 O
was O
reduced O
in O
MDMac B
which O
was O
associated O
with O
diminished O
IL-13 O
-induced O
expression O
of O
CD23 O
and O
MHC O
class O
II O
. O

However O
, O
with O
reduced O
IL-13R O
alpha1 O
expression O
and O
low O
nuclear O
STAT6 O
activity O
, O
some O
IL-13 O
-induced O
responses O
were O
unaltered O
in O
magnitude O
in O
MDMac B
. O

In O
the O
absence O
of O
functional O
IL-13R O
alpha1 O
and O
gamma O
( O
c O
) O
, O
IL-13 O
must O
signal O
through O
an O
alternative O
receptor O
complex O
on O
MDMac B
. O

Experiments O
with O
a O
blocking O
antibody O
to O
IL-4R O
alpha O
showed O
that O
this O
chain O
remains O
an O
essential O
component O
of O
the O
IL-13 O
receptor O
complex O
on O
MDMac B
. O

To O
determine O
whether O
CIF O
blocks O
at O
the O
level O
of O
IL2 O
transcription O
, O
we O
introduced O
reporter O
plasmids O
into O
the O
human B
T I
leukemia I
cell I
line I
Jurkat I
by O
transient O
transfection O
. O

Heat O
shock O
induces O
HIV-1 O
replication O
in O
chronically O
infected O
promyelocyte B
cell I
line I
OM10.1 I
. O

OM10.1 B
, O
a O
promyelocyte B
cell I
line I
latently O
infected O
with O
HIV-1 O
, O
has O
been O
developed O
as O
a O
model O
for O
studying O
the O
mechanism O
of O
viral O
latency O
and O
the O
activation O
of O
virus O
expression O
. O

In O
particular O
, O
staurosporine O
achieved O
approximately O
90 O
% O
inhibition O
of O
the O
HIV-1 O
antigen O
expression O
in O
heat B
shock-treated I
OM10.1 I
at O
a O
non-toxic O
concentration O
. O

The O
transcriptional O
mechanisms O
that O
drive O
colony-forming B
unit I
granulocyte-macrophage I
( I
CFU-GM I
) I
myeloid I
progenitors I
to O
differentiate O
into O
cells O
of O
either O
the O
granulocytic O
or O
monocytic O
lineage O
are O
not O
fully O
understood O
. O

These O
complexes O
arise O
in O
a O
developmentally O
regulated O
pattern O
, O
peaking O
at O
the O
promyelocyte O
stage O
, O
or O
in O
cell B
model I
systems I
, O
appearing O
soon O
after O
the O
induction O
of O
monocytic O
differentiation O
. O

Transcriptional O
inhibition O
by O
interleukin-6 O
of O
the O
class O
A O
macrophage O
scavenger O
receptor O
in O
macrophages O
derived O
from O
human O
peripheral O
monocytes O
and O
the O
THP-1 B
monocytic I
cell I
line I
. O

When O
treated O
with O
IL-6 O
, O
macrophages O
derived O
from O
peripheral O
monocytes O
and O
phorbol B
12-myristate I
13-acetate I
( I
PMA I
) I
-differentiated I
THP-1 I
monocytic I
cells I
showed O
significantly O
reduced O
uptake O
and/or O
binding O
of O
the O
MSR O
ligand O
, O
acetylated O
LDL O
. O

Analysis O
of O
MSR O
promoter O
activity O
in O
THP-1 B
cells I
transfected O
with O
an O
MSR O
promoter-reporter O
gene O
construct O
demonstrated O
decreased O
activity O
of O
the O
MSR O
promoter O
in O
IL-6 O
-treated O
THP-1 B
macrophages O
. O

Consistent O
with O
reduced O
levels O
of O
Oct-1 O
DNA O
binding O
activity O
in O
the O
Rb-transformed B
cell I
lines I
, O
interleukin O
8 O
expression O
is O
higher O
in O
these O
cell O
lines O
. O

BLPs O
were O
found O
to O
induce O
apoptosis O
in O
THP-1 B
monocytic I
cells I
through O
human O
Toll-like O
receptor-2 O
( O
hTLR2 O
) O
. O

BLPs O
also O
initiated O
apoptosis O
in O
an O
epithelial B
cell I
line I
transfected O
with O
hTLR2 O
. O

We O
have O
studied O
the O
effects O
of O
prednisone O
( O
PDN O
) O
, O
deflazacort O
( O
DFC O
) O
, O
and O
dexamethasone O
( O
DXM O
) O
on O
the O
production O
of O
cytokines O
( O
IL-2 O
, O
IL-6 O
, O
TNF-alpha O
, O
IL-10 O
) O
by O
peripheral O
T O
lymphocytes O
, O
and O
the O
effects O
on O
the O
inhibition O
of O
NF-kB O
DNA O
binding O
activity O
by O
activated B
Jurkat I
cell I
line I
. O

The O
data O
obtained O
show O
that O
the O
three O
GCH O
molecules O
exert O
an O
immunosuppression O
on O
cytokine O
production O
by O
T O
lymphocytes O
and O
a O
strong O
decrease O
in O
the O
nuclear O
translocation O
of O
NF-kB O
in O
Jurkat B
cells I
; O
moreover O
, O
( O
a O
) O
not O
all O
the O
cytokines O
investigated O
were O
affected O
, O
and O
not O
with O
the O
same O
intensity O
, O
by O
the O
three O
GCH O
and O
( O
b O
) O
DXM O
inhibited O
the O
binding O
activity O
of O
NF-kB O
less O
than O
that O
of O
DFC O
and O
PDN O
. O

In O
contrast O
, O
BCL-6 O
was O
expressed O
only O
in O
a O
small O
percentage O
of O
Hodgkin B
and I
Reed-Sternberg I
cells I
in O
about O
30 O
% O
of O
classical O
HD O
cases O
. O

In O
selenium-deprived B
Jurkat I
and O
ESb-L B
T I
lymphocytes I
, O
supplementation O
of O
selenium O
led O
to O
a O
substantial O
increase O
of O
GPX O
activity O
. O

To O
accomplish O
this O
, O
we O
first O
analyzed O
the O
pattern O
of O
TNFalpha O
and O
IL-10 O
inhibition O
by O
dexamethasone O
in O
LPS-stimulated B
whole-blood I
cell I
cultures I
. O

In O
addition O
, O
we O
evaluated O
the O
effect O
of O
dexamethasone O
on O
phorbolmyristate-acetate-stimulated O
IL-1 O
receptor O
antagonist O
secretion O
by O
the O
human B
monocytic I
cell I
line I
U937 I
. O

Finally O
, O
we O
investigated O
whether O
the O
modulation O
of O
corticosensitivity O
in O
TNFalpha- B
and I
IL-10-pretreated I
U937 I
cells I
was O
related O
to O
a O
change O
of O
the O
glucocorticoid O
receptor O
concentration O
and O
affinity O
. O

Block O
of O
granulocytic O
differentiation O
of O
32Dcl3 B
cells I
by O
AML1/ETO O
( O
MTG8 O
) O
but O
not O
by O
highly O
expressed O
Bcl-2 O
. O

To O
evaluate O
whether O
this O
enhancement O
is O
the O
primary O
role O
of O
AML1/ETO O
in O
leukemogenesis O
, O
effects O
of O
over-expression O
of O
Bcl-2 O
in O
the O
murine B
myeloid I
precursor I
cell I
line I
, O
32Dcl3 B
, O
were O
examined O
. O

When O
32Dcl3 B
cells I
expressing O
exogenous O
Bcl-2 O
were O
induced O
to O
differentiate O
, O
the O
onset O
of O
morphological O
differentiation O
was O
delayed O
. O

On O
the O
contrary O
, O
32Dcl3 B
cells I
stably O
expressing O
AML1/ETO O
were O
completely O
resistant O
to O
differentiation O
and O
continued O
to O
grow O
in O
the O
presence O
of O
G-CSF O
. O

Restoration O
of O
terminal O
differentiation O
in O
the O
mouse B
erythroleukemia I
( I
MEL I
) I
cells I
requires O
a O
decline O
in O
the O
level O
of O
PU.1 O
, O
indicating O
that O
PU.1 O
can O
block O
erythroid O
differentiation O
. O

Both O
the O
DNA O
binding O
and O
transactivation O
domains O
of O
PU.1 O
are O
required O
for O
repression O
and O
both O
domains O
are O
also O
needed O
to O
block O
terminal O
differentiation O
in O
MEL B
cells I
. O

Furthermore O
, O
introduction O
of O
exogenous O
GATA-1 O
in O
both O
MEL B
cells I
and O
Xenopus O
embryos O
and O
explants O
relieves O
the O
block O
to O
erythroid O
differentiation O
imposed O
by O
PU.1 O
. O

In O
contrast O
to O
IL-12 O
, O
no O
up-regulation O
of O
IRF-1 O
was O
found O
in O
IL-4-stimulated B
cells I
, O
and O
IL-4 O
did O
not O
block O
IL-12 O
-dependent O
up-regulation O
of O
IRF-1 O
. O

Regulation O
of O
low O
shear O
flow-induced O
HAEC B
VCAM-1 O
expression O
and O
monocyte O
adhesion O
. O

We O
recently O
reported O
that O
prolonged O
exposure O
of O
human O
aortic O
endothelial O
cells O
( O
HAEC B
) O
to O
low O
shear O
stress O
flow O
patterns O
is O
associated O
with O
a O
sustained O
increase O
in O
the O
activated O
form O
of O
the O
transcriptional O
regulator O
nuclear O
factor-kappaB O
( O
NF-kappaB O
) O
. O

Before O
exposure O
to O
low O
shear O
( O
2 O
dyn/cm2 O
) O
for O
6 O
h O
, O
HAEC B
were O
preincubated O
with O
or O
without O
the O
antioxidants O
pyrrolidine O
dithiocarbamate O
( O
PDTC O
) O
or O
N-acetyl-L-cysteine O
( O
NAC O
) O
. O

The O
NF90 O
protein O
was O
found O
to O
be O
expressed O
not O
only O
in O
T-cells O
, O
but O
also O
in O
nonimmune B
HeLa I
cells I
. O

In O
HeLa B
cells I
, O
the O
protein O
was O
almost O
exclusively O
localized O
to O
the O
ribosome O
salt O
wash O
fraction O
of O
cell O
lysates O
. O

AP-1 O
but O
not O
NF-IL-6 O
DNA O
binding O
activity O
was O
also O
detected O
in O
C5a-stimulated B
PBMC I
; O
however O
, O
its O
delayed O
expression O
( O
maximal O
at O
4 O
hours O
) O
suggested O
a O
less O
important O
role O
in O
the O
rapid O
production O
of O
IL-8 O
. O

The O
correlation O
between O
C5a-induced O
kappaB O
binding O
activity O
and O
IL-8 O
gene O
expression O
was O
examined O
in O
the O
RAW264.7 B
macrophage I
cells I
using O
reporter O
genes O
directed O
by O
the O
kappaB O
sequence O
from O
IkappaBalpha O
and O
IL-8 O
promoter O
regions O
. O

Pertussis O
toxin O
, O
which O
ADP-ribosylates O
the O
Gi O
proteins O
known O
to O
couple O
to O
the O
C5a O
receptor O
, O
produced O
minimal O
inhibition O
of O
C5a-induced O
IL-8 O
expression O
and O
had O
little O
effect O
on O
C5a-induced O
calcium O
mobilization O
in O
RAW264.7 B
cells I
. O

The O
signal O
transduction O
events O
triggered O
by O
cross-linking O
of O
the O
CD40 O
receptor O
have O
been O
widely O
studied O
in O
B B
cell I
lines I
, O
but O
little O
is O
known O
about O
signaling O
following O
CD40 O
stimulation O
of O
monocytes O
and O
resting B
tonsillar I
B I
cells I
. O

However O
, O
the O
components O
of O
the O
NF-kappaB O
complexes O
were O
different O
in O
monocytes O
and O
B O
cells O
, O
because O
p50 O
is O
part O
of O
the O
NF-kappaB O
complex O
induced O
by O
CD40 O
triggering O
in O
both O
monocytes O
and O
B O
cells O
, O
whereas O
p65 O
was O
only O
induced O
in O
B O
cells O
. O
In O
contrast O
, O
although O
the O
Janus O
kinase O
3 O
tyrosine O
kinase O
was O
associated O
with O
CD40 O
molecules O
in O
both O
monocytes O
and O
resting O
B O
cells O
, O
Janus O
kinase O
3 O
phosphorylation O
induction O
was O
observed O
only O
in O
CD40-activated B
monocytes I
, O
with O
subsequent O
induction O
of O
STAT5a O
DNA O
binding O
activity O
in O
the O
nucleus O
. O

Although O
erythroid O
progenitors O
appear O
to O
be O
the O
principal O
EPO-responsive O
cell O
type O
in O
vivo O
due O
to O
the O
restricted O
expression O
of O
the O
EPOR O
, O
many O
growth B
factor-dependent I
cell I
lines I
expressing O
the O
EPOR O
can O
respond O
to O
EPO O
by O
activating O
many O
or O
all O
of O
these O
pathways O
. O

In O
the O
present O
study O
, O
we O
have O
identified O
a O
cellular O
context O
( O
the O
interleukin-2 B
[ I
IL-2 I
] I
-dependent I
HT-2 I
line I
) O
in O
which O
the O
EPO O
stimulation O
of O
the O
EPOR O
fails O
to O
support O
cellular O
proliferation O
, O
STAT-5 O
induction O
, O
or O
MAPK O
activation O
, O
despite O
efficient O
phosphorylation O
of O
the O
EPOR O
and O
JAK2 O
and O
inhibition O
of O
apoptosis O
after O
withdrawal O
of O
IL-2 O
. O

Interestingly O
, O
when O
we O
fused O
HT-2 B
cells I
expressing O
the O
EPOR O
with O
Ba/F3 B
cells I
in O
a O
complementation O
assay O
, O
the O
resulting O
hybridomas B
proliferated O
and O
potently O
activated O
STAT-5 O
and O
MAPK O
in O
response O
to O
EPO O
. O

Moreover O
, O
Ba/F3 B
cells I
apparently O
express O
this O
factor O
( O
s O
) O
and O
somatic O
fusions O
can O
, O
therefore O
, O
confer O
EPO O
-responsiveness O
to O
HT-2 B
cells I
that O
lack O
this O
factor O
. O

HIV-1 O
expressing O
IkappaB-alphaS32/36A O
down-regulates O
viral O
expression O
and O
is O
highly O
attenuated O
in O
both O
Jurkat B
and O
peripheral O
blood O
mononuclear O
cells O
. O

Various O
stimuli O
of O
T O
cells O
that O
induce O
the O
activity O
of O
TAD-A O
also O
enhance O
the O
activity O
of O
TAD-B O
, O
but O
, O
unlike O
TAD-A O
, O
TAD-B O
remains O
unphosphorylated O
by O
protein O
from O
12-O-tetradecanoyl B
12-phorbol I
13-acetate-stimulated I
T I
cells I
. O

Selection O
and O
long-term O
persistence O
of O
reactive O
CTL B
clones I
during O
an O
EBV O
chronic O
response O
are O
determined O
by O
avidity O
, O
CD8 O
variable O
contribution O
compensating O
for O
differences O
in O
TCR O
affinities O
. O

To O
address O
this O
question O
, O
we O
took O
advantage O
of O
a O
panel O
of O
CD8+ B
T I
cell I
clones I
from O
the O
joint O
of O
a O
rheumatoid O
arthritis O
patient O
and O
selected O
for O
their O
reactivity O
against O
a O
single O
MHC/peptide O
complex O
. O

beta-Catenin O
and O
LEF-1 O
complexes O
can O
activate O
reporter O
gene O
expression O
in O
a O
transformed B
T-lymphocyte I
cell I
line I
( O
Jurkat B
) O
but O
not O
in O
normal O
T O
lymphocytes O
, O
even O
though O
both O
factors O
are O
nuclear O
. O

Transcriptional O
targeting O
of O
retroviral O
vectors O
to O
the O
erythroblastic O
progeny O
of O
transduced B
hematopoietic I
stem I
cells I
. O

The O
modified O
vectors O
were O
used O
to O
transduce O
human B
hematopoietic I
cell I
lines I
, O
cord O
blood-derived O
CD34 O
( O
+ O
) O
stem/progenitor O
cells O
, O
and O
murine B
bone I
marrow I
repopulating I
stem I
cells I
. O

The O
expression O
of O
appropriate O
reporter O
genes O
( O
triangle O
upLNGFR O
, O
EGFP O
) O
was O
analyzed O
in O
the O
differentiated O
progeny O
of O
transduced B
stem I
cells I
in O
vitro O
, O
in O
liquid O
culture O
as O
well O
as O
in O
clonogenic O
assay O
, O
and O
in O
vivo O
, O
after O
bone O
marrow O
transplantation O
in O
lethally O
irradiated O
mice O
. O

The O
GATA-1 O
autoregulatory O
enhancer O
effectively O
restricts O
the O
expression O
of O
the O
LTR-driven O
proviral O
transcription O
unit O
to O
the O
erythroblastic O
progeny O
of O
both O
human O
progenitors O
and O
mouse-repopulating B
stem I
cells I
. O

Enhancer O
replacement O
is O
therefore O
an O
effective O
strategy O
to O
target O
expression O
of O
a O
retroviral O
transgene O
to O
a O
specific O
progeny O
of O
transduced B
hematopoietic I
stem I
cells I
. O

Unlike O
TNFR1 O
, O
LMP1 O
can O
interact O
directly O
with O
receptor-interacting O
protein O
( O
RIP O
) O
and O
stably O
associates O
with O
RIP O
in O
EBV-transformed B
lymphoblastoid I
cell I
lines I
. O

Despite O
constitutive O
association O
with O
TRADD O
or O
RIP O
, O
LMP1 O
does O
not O
induce O
apoptosis O
in O
EBV-negative B
Burkitt I
lymphoma I
or I
human I
embryonic I
kidney I
293 I
cells I
. O

Signal O
transduction O
pathways O
in O
normal O
human O
monocytes O
stimulated O
by O
cytokines O
and O
mediators O
: O
comparative O
study O
with O
normal O
human O
neutrophils O
or O
transformed B
cells I
and O
the O
putative O
roles O
in O
functionality O
and O
cell O
biology O
. O

Possible O
roles O
of O
ERK O
in O
proliferation O
of O
transformed B
cells I
were O
also O
suggested O
. O

We O
searched O
for O
proteins O
that O
interact O
with O
Ras O
in O
interleukin B
( I
IL I
) I
-2-stimulated I
or I
IL-2-deprived I
cells I
, O
and O
found O
that O
the O
transcription O
factor O
Aiolos O
interacts O
with O
Ras O
. O

Co-transfection O
experiments O
confirm O
that O
Aiolos O
induces O
Bcl-2 O
expression O
and O
prevents O
apoptosis O
in O
IL-2-deprived B
cells I
. O

HTLV-1-transformed B
T-cell I
lines I
expressed O
higher O
amounts O
of O
STAT1 O
, O
STAT3 O
and O
STAT5 O
RNA O
and O
proteins O
than O
virus-negative O
T O
cells O
. O

The O
expression O
of O
STAT1 O
and O
STAT5 O
in O
a O
human B
T-cell I
line I
was O
induced O
by O
Tax O
. O

METHODS O
: O
Allergen-specific B
T-cell I
clones I
and O
T-cell B
hybridomas I
were O
established O
from O
the O
peripheral O
blood O
lymphocytes O
of O
patients O
with O
asthma O
, O
and O
the O
transcriptional O
regulation O
of O
the O
IL-5 O
gene O
was O
investigated O
with O
transient O
transfection O
and O
electrophoretic O
mobility O
shift O
analysis O
. O

RESULTS O
: O
A O
human O
IL-5 O
promoter/enhancer-luciferase O
gene O
construct O
, O
pIL-5 O
( O
-511 O
) O
Luc O
, O
was O
transcribed O
on O
activation O
of O
IL-5-producing B
T-cell I
clones I
, O
but O
not O
IL-5-nonproducing B
clones I
. O

pIL-5 O
( O
-511 O
) O
Luc O
was O
transcribed O
by O
T-cell B
hybridomas I
derived O
from O
fusion O
between O
IL-5-producing B
T-cell I
clones I
and O
an O
IL-5 B
gene-nonexpressing I
T-cell I
line I
, O
but O
not O
by O
hybridomas B
derived O
from O
IL-5-nonproducing B
T-cell I
clones I
. O

Our O
data O
demonstrate O
that O
those O
cell B
lines I
lacking O
capability O
to O
form O
metastatic O
tumors O
in O
vivo O
are O
susceptible O
to O
TNF O
induced O
apoptosis O
in O
vitro O
. O

However O
, O
cell B
lines I
with O
high O
metastatic O
potential O
are O
resistant O
to O
TNF O
in O
vitro O
. O

Furthermore O
, O
the O
same O
cell B
lines I
were O
resistant O
to O
cytolytic O
action O
of O
other O
cytotoxic O
proteins O
secreted O
by O
LAK B
cells I
. O

This O
finding O
may O
provide O
a O
tool O
to O
improve O
current O
protocols O
of O
immunotherapy O
and O
insights O
to O
how O
tumor O
cells O
are O
or O
are O
not O
killed O
by O
LAK B
cells I
. O

To O
determine O
the O
diversity O
in O
X-chromosome O
methylation O
patterns O
, O
which O
reflect O
Lyonization O
, O
assessed O
by O
the O
HUMARA O
assay O
in O
the O
supposedly O
normal O
population O
, O
we O
analyzed O
granulocytes O
and O
T B
cells I
from O
97 O
relatively O
young O
( O
18- O
to O
35-year-old O
) O
healthy O
female O
volunteers O
. O

We O
found O
that O
the O
methylation O
patterns O
in O
the O
two O
HUMARA O
alleles O
were O
distributed O
even O
more O
widely O
, O
both O
in O
granuloctyes O
and O
in O
T B
cells I
, O
than O
previously O
reported O
with O
other O
methods O
. O

We O
also O
found O
that O
the O
deviation O
of O
methylation O
in O
granulocytes O
and O
T B
cells I
was O
well O
correlated O
. O

Thus O
, O
we O
conclude O
that O
appropriate O
controls O
from O
the O
same O
individuals O
, O
such O
as O
T B
cells I
in O
the O
case O
of O
stem O
cell O
disorders O
, O
should O
always O
be O
employed O
to O
conclusively O
determine O
whether O
certain O
cells O
of O
hematopoietic O
origin O
are O
clonal O
. O

Downregulation O
of O
Wilms O
' O
tumor O
gene O
( O
WT1 O
) O
is O
not O
a O
prerequisite O
for O
erythroid O
or O
megakaryocytic O
differentiation O
of O
the O
leukemic B
cell I
line I
K562 I
. O

A O
high O
expression O
of O
WT1 O
has O
been O
detected O
in O
a O
range O
of O
acute O
leukemias O
, O
and O
WT1 O
is O
downregulated O
during O
induced O
differentiation O
of O
some O
leukemic B
cell I
lines I
. O

Overexpression O
of O
WT1 O
in O
some O
myeloid B
cell I
lines I
confers O
resistance O
to O
differentiation O
induction O
. O

In O
this O
study O
, O
each O
of O
the O
four O
different O
isoforms O
of O
WT1 O
was O
constitutively O
overexpressed O
in O
the O
leukemic B
cell I
line I
K562 I
. O

K562 B
cells I
express O
endogenous O
WT1 O
, O
which O
is O
downregulated O
as O
a O
response O
to O
induced O
differentiation O
along O
the O
erythroid O
and O
megakaryocytic O
pathways O
. O

We O
now O
demonstrate O
that O
a O
forced O
exogenous O
expression O
of O
the O
four O
different O
isoforms O
of O
WT1 O
in O
K562 B
does O
not O
affect O
the O
differentiation O
response O
, O
as O
judged O
by O
accumulation O
of O
hemoglobin O
in O
response O
to O
hemin O
or O
the O
expression O
of O
megakaryocytic O
cell O
surface O
markers O
in O
response O
to O
12-O-tetradecanoylphorbol-13-acetate O
( O
TPA O
) O
. O

We O
conclude O
that O
downregulation O
of O
WT1 O
during O
induced O
differentiation O
of O
K562 B
cells I
is O
not O
a O
prerequisite O
for O
erythroid O
or O
megakaryocytic O
differentiation O
of O
these O
cells O
. O

Interleukin O
( O
IL O
) O
-4 O
plays O
an O
important O
role O
in O
IgE O
synthesis O
in O
B O
cells O
and O
in O
Th2 O
differentiation O
in O
T B
cells I
. O

Furthermore O
, O
SLP-76 O
and O
Vav O
have O
a O
synergistic O
effect O
on O
interleukin O
( O
IL O
) O
-2 O
promoter O
activity O
in O
T B
cells I
. O

Overexpression O
of O
SLP-76 O
in O
the O
Jurkat B
T I
cell I
line I
potentiates O
the O
activities O
of O
both O
nuclear O
factor O
of O
activated O
T O
cells O
and O
AP-1 O
transcription O
factors O
. O

Cell O
surface O
expression O
of O
Jagged1 O
in O
c-Rel-expressing B
cell I
monolayers I
led O
to O
a O
functional O
interaction O
with O
lymphocytes O
expressing O
the O
Notch1/TAN-1 O
receptor O
. O

This O
correlated O
with O
the O
initiation O
of O
signaling O
downstream O
of O
Notch O
, O
as O
evidenced O
by O
increased O
levels O
of O
HES-1 O
transcripts O
in O
co-cultivated B
T I
cells I
and O
of O
CD23 O
transcripts O
in O
co-cultivated O
B O
cells O
. O

To O
begin O
to O
elucidate O
the O
mechanisms O
that O
regulate O
the O
transcription O
of O
cytokine O
genes O
, O
we O
wanted O
to O
determine O
which O
transcription O
factors O
are O
activated O
by O
PGN O
in O
mouse B
RAW264.7 I
and O
human B
THP-1 I
macrophage I
cells I
. O

A O
cell B
culture I
system I
was O
then O
employed O
that O
permitted O
the O
differentiation O
of O
Th O
effectors O
from O
resting O
memory O
T O
cells O
by O
short O
term O
priming O
. O

Th2 B
cells I
could O
be O
induced O
in O
all O
healthy O
controls O
by O
priming O
with O
anti-CD28 O
in O
the O
absence O
of O
TCR O
ligation O
. O

To O
evaluate O
the O
effect O
of O
UV O
light O
on O
cytochrome O
P4501A1 O
gene O
expression O
, O
we O
studied O
the O
induction O
of O
CYP1A1 O
mRNA O
by O
UV O
irradiation O
of O
cultured B
human I
keratinocytes I
( O
HaCaT B
cell I
line I
) O
, O
primary O
human O
blood O
lymphocytes O
and O
mouse B
Hepa-1 I
cells I
. O

The O
results O
show O
that O
the O
CYP1A1 O
mRNA O
level O
induced O
by O
UV O
in O
the O
presence O
of O
tryptophan O
was O
higher O
than O
that O
induced O
by O
UV O
alone O
in O
both O
HaCaT B
cells I
and O
lymphocytes O
after O
3 O
h O
of O
incubation O
post-UV O
irradiation O
. O

To O
find O
out O
if O
the O
induction O
by O
UV O
light O
is O
caused O
by O
the O
formation O
of O
an O
Ah O
receptor O
ligand O
, O
Hepa-1 B
wild-type I
and I
Ah I
receptor I
deficient I
c12 I
cell I
lines I
were O
applied O
. O

Wild-type B
( I
wt I
) I
cells I
were O
inducible O
either O
by O
the O
tryptophan O
photoproduct O
6-formylindolo O
[ O
3 O
, O
2-b O
] O
carbazole O
( O
FICZ O
) O
or O
by O
UV-irradiation O
but O
very O
low O
or O
undetectable O
levels O
were O
observed O
in O
the O
c12 O
cells O
. O

Protein O
kinase O
B O
( O
c-Akt O
) O
, O
phosphatidylinositol O
3-kinase O
, O
and O
STAT5 O
are O
activated O
by O
erythropoietin O
( O
EPO O
) O
in O
HCD57 B
erythroid I
cells I
but O
are O
constitutively O
active O
in O
an O
EPO-independent B
, I
apoptosis-resistant I
subclone I
( O
HCD57-SREI B
cells I
) O
. O

We O
found O
that O
erythropoietin O
( O
EPO O
) O
and O
stem O
cell O
factor O
( O
SCF O
) O
activated O
protein O
kinase O
B O
( O
PKB/Akt O
) O
in O
EPO-dependent B
HCD57 I
erythroid I
cells I
. O

To O
better O
understand O
signals O
controlling O
proliferation O
and O
viability O
, O
erythroid O
cells O
that O
resist O
apoptosis O
in O
the O
absence O
of O
EPO O
were O
subcloned O
and O
characterized O
( O
HCD57-SREI B
cells I
) O
. O

Constitutive O
activations O
of O
PKB/Akt O
, O
STAT5a O
, O
and O
STAT5b O
were O
noted O
in O
these O
EPO-independent B
cells I
. O

The O
LY294002 O
study O
showed O
that O
proliferation O
and O
viability O
of O
both O
HCD57-SREI B
and O
HCD57 B
cells I
correlated O
with O
the O
activity O
of O
PKB/Akt O
; O
however O
, O
PKB/Akt O
activity O
alone O
did O
not O
protect O
these O
cells O
from O
apoptosis O
. O

Treatment O
of O
HCD57 B
cells I
with O
SCF O
also O
activated O
PKB/Akt O
, O
but O
did O
not O
protect O
from O
apoptosis O
. O

Constitutive O
STAT5 O
activity O
, O
activated O
through O
an O
unknown O
pathway O
not O
including O
JAK2 O
or O
EPOR O
, O
may O
act O
in O
concert O
with O
the O
constitutive O
PI3-kinase O
/PKB/Akt O
pathway O
to O
protect O
the O
EPO-independent B
HCD57-SREI I
cells I
from O
apoptosis O
and O
promote O
limited O
proliferation O
. O

Enforced O
expression O
of O
Id3 O
, O
which O
has O
the O
capacity O
to O
inhibit O
many O
basic O
helix-loop-helix O
( O
bHLH O
) O
transcription O
factors O
, O
in O
human O
CD34 O
( O
+ O
) O
hematopoietic O
progenitor O
cells O
that O
have O
not O
undergone O
T O
cell O
receptor O
( O
TCR O
) O
gene O
rearrangements O
inhibits O
development O
of O
the O
transduced O
cells O
into O
TCRalpha B
beta I
and I
gamma I
delta I
cells I
in O
a O
fetal B
thymic I
organ I
culture I
( O
FTOC B
) O
. O

Here O
we O
document O
that O
overexpression O
of O
Id3 O
, O
in O
progenitors O
that O
have O
initiated O
TCR O
gene O
rearrangements O
( O
pre-T O
cells O
) O
, O
inhibits O
development O
into O
TCRalpha B
beta I
but O
not O
into O
TCRgamma B
delta I
T I
cells I
. O

These O
observations O
suggest O
possible O
mechanisms O
by O
which O
Id3 O
overexpression O
can O
differentially O
affect O
development O
of O
pre-T O
cells O
into O
TCRalpha B
beta I
and I
gamma I
delta I
cells I
. O

We O
also O
observed O
that O
cell O
surface O
CD4 O
( O
- O
) O
CD8 O
( O
- O
) O
CD3 O
( O
- O
) O
cells O
with O
rearranged O
TCR O
genes O
developed O
from O
Id3-transduced B
but O
not O
from O
control-transduced B
pre-T I
cells I
in O
an O
FTOC B
. O

Intriguingly O
, O
surface O
expression O
of O
LT-alpha1beta2 O
is O
up-regulated O
on O
a O
T B
cell I
line I
acutely O
infected O
with O
HIV-1 O
, O
suggesting O
a O
positive O
feedback O
loop O
between O
HIV-1 O
infection O
, O
LT-alpha1beta2 O
expression O
, O
and O
HIV-1 O
replication O
. O

OBJECTIVE O
: O
To O
create O
monoclonal O
anti-endothelial O
cell O
antibodies O
( O
mAECA O
) O
from O
a O
patient O
with O
Takayasu O
arteritis O
to O
evaluate O
their O
ability O
to O
activate O
human B
umbilical I
vein I
endothelial I
cells I
( O
HUVEC B
) O
, O
and O
to O
characterize O
the O
mechanism O
of O
EC O
activation O
. O

Activity O
against O
macrovascular B
EC I
( O
HUVEC B
) O
and O
microvascular B
EC I
( O
human B
bone I
marrow I
EC I
immortalized I
by I
SV40 I
) O
antigens O
was O
detected O
by O
enzyme-linked O
immunosorbent O
assay O
. O

The O
activated B
EC I
were O
examined O
for O
the O
adherence O
of O
a O
monocytic B
cell I
line I
( O
U937 B
) O
, O
as O
well O
as O
for O
expression O
of O
vascular O
cell O
adhesion O
molecule O
1 O
, O
intercellular O
adhesion O
molecule O
1 O
, O
and O
E-selectin O
. O

In O
addition O
, O
nuclear O
extracts O
of O
the O
mAECA-treated B
EC I
were O
analyzed O
for O
the O
induction O
of O
translocation O
of O
nuclear O
factor O
kappaB O
( O
NF-kappaB O
) O
, O
using O
a O
specific O
NF-kappaB O
oligoprobe O
in O
an O
electrophoretic O
mobility O
shift O
assay O
. O

RESULTS O
: O
Six O
mAECA O
were O
selected O
, O
the O
mixture O
of O
which O
produced O
100 O
% O
inhibition O
of O
binding O
of O
the O
original O
IgG O
( O
from O
the O
patient O
with O
Takayasu O
arteritis O
) O
to O
HUVEC B
. O

All O
mAECA O
possessed O
high O
activity O
against O
macrovascular B
EC I
, O
but O
none O
had O
significant O
antimicrovascular O
EC O
activity O
. O

Four O
of O
the O
6 O
mAECA O
activated B
EC I
, O
manifested O
by O
increased O
IL-6 O
and O
vWF O
secretion O
. O

However O
NF-ATs O
appear O
in O
the O
nuclei O
of O
IL-4- B
, I
IL-5- I
, I
or I
ionomycin-stimulated I
eosinophils I
. O

Only O
NF-AT1 O
and O
NF-AT4 O
, O
but O
not O
NF-AT2 O
and O
NF-AT3 O
, O
have O
translocated O
into O
the O
nuclei O
in O
IL-4- B
or I
IL-5-stimulated I
eosinophils I
. O

These O
findings O
delineate O
a O
novel O
pathway O
in O
the O
cytokine O
network O
in O
which O
Th2 B
lymphocytes I
`` O
control O
'' O
eosinophils O
via O
the O
release O
of O
IL-4 O
and O
IL-5 O
, O
and O
activation O
of O
NF-AT O
in O
eosinophils O
. O

The O
findings O
also O
suggest O
that O
a O
later O
feedback O
`` O
talking O
'' O
may O
exist O
between O
eosinophils O
and O
Th2 B
lymphocytes I
. O

Finally O
, O
PPARalpha O
activators O
significantly O
reduced O
adhesion O
of O
U937 B
cells I
to O
cultured O
human O
ECs O
. O

A O
silent O
mutation O
in O
codon O
10 O
of O
exon O
1 O
, O
detected O
in O
ER-negative B
and I
ER-positive I
human I
breast I
cancer I
cell I
lines I
, O
in O
breast O
tumors O
and O
blood O
DNA O
from O
breast O
cancer O
patients O
, O
has O
been O
recognized O
as O
a O
polymorphic O
site O
. O

Compared O
with O
monocytes O
adherent O
on O
plastic O
surfaces O
, O
freshly O
isolated O
cells O
allowed O
to O
adhere O
either O
to O
fibronectin- O
or O
laminin-coated O
flasks O
exhibited O
an O
increased O
STAT1 O
binding O
activity O
both O
in O
control O
and O
in O
IFN-gamma-treated B
cells I
. O

Interestingly O
, O
early O
treatment O
( O
day O
0 O
HPCs O
) O
with O
alpha-PML O
reduced O
the O
number O
of O
both O
erythroid B
and I
granulocytic I
colonies I
, O
whereas O
late O
treatment O
( O
day O
5 O
culture O
) O
reduced O
erythroid O
, O
but O
not O
granulocytic O
, O
clonogenesis O
. O

The O
purpose O
of O
this O
study O
was O
to O
evaluate O
whether O
the O
mitogen-activated O
protein O
kinase O
( O
MAPK O
) O
signaling O
pathway O
contributes O
to O
12-O-tetradecanoylphorbol-13-acetate O
( O
TPA O
) O
-induced O
mononuclear O
differentiation O
in O
the O
human B
myeloblastic I
leukemia I
ML-1 I
cells I
. O

Furthermore O
, O
PD98059 O
completely O
blocked O
the O
TPA-induced O
differentiation O
of O
ML-1 B
cells I
, O
as O
assessed O
by O
a O
number O
of O
features O
associated O
with O
mononuclear O
differentiation O
including O
changes O
in O
morphology O
, O
nonspecific O
esterase O
activity O
, O
phagocytic O
ability O
, O
NADPH O
oxidase O
activity O
, O
mitochondrial O
respiration O
, O
and O
c-jun O
mRNA O
inducibility O
. O

As O
HSF1 O
can O
function O
as O
both O
an O
activator O
of O
heat O
shock O
genes O
and O
a O
repressor O
of O
non-heat O
shock O
genes O
such O
as O
IL1B O
and O
c- O
fos O
, O
we O
have O
examined O
the O
potential O
role O
of O
HSF1 O
in O
the O
effects O
of O
NSAIDs O
on O
gene O
expression O
in O
a O
human O
monocytic B
cell I
line I
THP-1 I
. O

Immortalization O
of O
CD4 O
( O
+ O
) O
and O
CD8 O
( O
+ O
) O
T O
lymphocytes O
by O
human O
T-cell O
leukemia O
virus O
type O
1 O
Tax O
mutants O
expressed O
in O
a O
functional B
molecular I
clone I
. O

The O
human O
T-cell O
leukemia O
virus O
type O
1 O
( O
HTLV-1 O
) O
transcriptional O
trans-activator O
Tax O
has O
been O
demonstrated O
to O
have O
transforming O
activity O
in O
multiple B
cell I
culture I
and O
transgenic-mouse O
models O
. O

Fibroblast O
growth O
factor-1 O
( O
FGF-1 O
) O
enhances O
IL-2 O
production O
and O
nuclear O
translocation O
of O
NF-kappaB O
in O
FGF B
receptor-bearing I
Jurkat I
T I
cells I
. O

To O
understand O
the O
action O
of O
FGF-1 O
in O
T O
cells O
, O
studies O
were O
initiated O
in O
Jurkat B
T I
cells I
that O
express O
the O
signaling O
isoform O
of O
FGF O
receptor-1 O
. O

These O
experiments O
show O
that O
FGF-1 O
stimulation O
of O
Jurkat B
T I
cells I
provides O
a O
second O
signal O
that O
augments O
TCR-mediated O
IL-2 O
production O
. O

The O
signaling O
events O
that O
link O
FGF O
receptor-1 O
engagement O
and O
NF-kappaB O
activation O
in O
Jurkat B
are O
probably O
distinct O
from O
the O
CD28 O
costimulation O
pathway O
, O
since O
FGF-1 O
-induced O
Rel/kappaB O
binding O
proteins O
do O
not O
contain O
significant O
levels O
of O
c-Rel O
and O
are O
not O
identical O
with O
the O
CD28 O
response O
complex O
. O

In O
this O
paper O
, O
we O
show O
that O
HCMV O
down O
regulates O
gamma O
interferon O
( O
IFN-gamma O
) O
-induced O
HLA-DR O
expression O
in O
U373 B
MG I
astrocytoma I
cells I
due O
to O
a O
defect O
downstream O
of O
STAT1 O
phosphorylation O
and O
nuclear O
translocation O
. O

This O
defect O
leads O
to O
the O
absence O
of O
presentation O
of O
the O
major O
immediate-early O
protein O
IE1 O
to O
specific O
CD4 B
( I
+ I
) I
T-cell I
clones I
when O
U373 B
MG I
cells I
, O
used O
as O
antigen-presenting O
cells O
, O
are O
treated O
with O
IFN-gamma O
plus O
HCMV O
. O

However O
, O
presentation O
of O
endogenously O
synthesized O
IE1 O
can O
be O
restored O
when O
U373 B
MG I
cells I
are O
transfected O
with O
CIITA O
prior O
to O
infection O
with O
HCMV O
. O

Previously O
we O
reported O
that O
3-deazaadenosine O
( O
DZA O
) O
, O
a O
potent O
inhibitor O
and O
substrate O
for O
S-adenosylhomocysteine O
hydrolase O
inhibits O
bacterial O
lipopolysaccharide-induced O
transcription O
of O
tumor O
necrosis O
factor-alpha O
and O
interleukin-1beta O
in O
mouse B
macrophage I
RAW I
264.7 I
cells I
. O

Taken O
together O
, O
DZA O
promotes O
the O
proteolytic O
degradation O
of O
IkappaBalpha O
, O
but O
not O
IkappaBbeta O
, O
resulting O
in O
an O
increase O
of O
DNA O
binding O
activity O
of O
NF-kappaB O
in O
the O
nucleus O
in O
the O
absence O
of O
its O
transcriptional O
activity O
in O
RAW B
264.7 I
cells I
. O

METHODS O
: O
Eight O
malignant B
lymphocytic I
cell I
lines I
and O
primary B
cultures I
of O
lymphocytic O
leukemia O
and O
lymphoma O
cells O
were O
treated O
with O
As2O3 O
, O
with O
or O
without O
dithiothreitol O
( O
DTT O
) O
or O
buthionine O
sulfoximine O
( O
BSO O
) O
( O
an O
inhibitor O
of O
glutathione O
synthesis O
) O
. O

By O
comparing O
the O
expression O
of O
genes O
controlling O
apoptosis O
, O
including O
those O
encoding O
several O
members O
of O
the O
BCL-2 O
family O
of O
proteins O
, O
the O
known O
relative O
resistance O
of O
EBV-immortalized B
B-cell I
lines I
to O
apoptosis O
induced O
by O
low O
serum O
was O
found O
to O
correlate O
with O
expression O
of O
both O
BCL-2 O
and O
A20 O
. O

Dex O
acted O
directly O
on O
erythroid O
progenitors O
and O
maintained O
the O
colony-forming O
capacity O
of O
the O
progenitor O
cells O
expanded O
in O
liquid B
cultures I
. O

Sustained O
proliferation O
of O
erythroid O
progenitors O
could O
be O
induced O
equally O
well O
from O
purified B
erythroid I
burst-forming I
units I
( O
BFU-E B
) O
, O
from O
CD34 O
( O
+ O
) O
blast O
cells O
, O
and O
from O
bone O
marrow O
depleted O
from O
CD34 O
( O
+ O
) O
cells O
. O

In O
T B
cell I
hybridomas I
, O
both O
T O
cell O
activators O
and O
glucocorticoids O
induce O
apoptosis O
. O

Here O
we O
report O
SOCS-3 O
expression O
in O
response O
to O
IL-2 O
in O
both O
T-cell B
lines I
and O
human O
peripheral O
blood O
lymphocytes O
. O

Both O
alpha- O
and O
beta-bound O
complexes O
are O
found O
only O
in O
lymphoid O
tissues O
, O
in O
CD28+ O
T O
cells O
, O
and O
in O
some O
transformed B
B I
cells I
. O

In O
vivo O
expanded O
CD4+CD28null B
and I
CD8+CD28null I
T I
cells I
uniformly O
lack O
alpha- O
and O
beta- O
bound O
complexes O
, O
resembling O
the O
pattern O
seen O
in O
chronically O
activated O
cells O
and O
not O
of O
senescent O
cells O
. O

After O
preincubation O
of O
permeabilized B
cells I
with O
a O
Ran O
mutant O
that O
can O
not O
hydrolyze O
GTP O
( O
RanQ69L O
) O
, O
cytosol O
supports O
NFAT O
export O
, O
but O
CRM1 O
and O
Ran O
alone O
do O
not O
. O

Unicellular-unilineage B
erythropoietic I
cultures I
: O
molecular O
analysis O
of O
regulatory O
gene O
expression O
at O
sibling O
cell O
level O
. O

In O
addition O
, O
competitive O
single-cell O
RT-PCR O
was O
used O
to O
assay O
CD34 O
mRNA O
transcripts O
in O
sibling B
CD34 I
( I
+ I
) I
CD38 I
( I
- I
) I
cells I
differentiating O
in O
unilineage B
erythroid I
cultures I
: O
this O
analysis O
allowed O
us O
to O
semiquantitate O
the O
gradual O
downmodulation O
of O
CD34 O
mRNA O
from O
progenitor O
cells O
through O
their O
differentiating B
erythroid I
progeny I
. O

Differences O
in O
phosphorylation O
of O
the O
IL-2R O
associated O
JAK/STAT O
proteins O
between O
HTLV-I B
( I
+ I
) I
, I
IL-2-independent I
and I
IL-2-dependent I
cell I
lines I
and O
uncultured O
leukemic O
cells O
from O
patients O
with O
adult O
T-cell O
lymphoma/leukemia O
. O

To O
determine O
activation O
status O
of O
the O
IL-2R O
-associated O
( O
Jak/STAT O
) O
pathway O
in O
the O
HTLV-I B
infected I
cells I
, O
we O
examined O
tyrosine O
phosphorylation O
of O
Jak3 O
, O
STAT3 O
, O
and O
STAT5 O
in O
several O
HTLV-I B
( I
+ I
) I
T-cell I
lines I
and O
in O
uncultured O
leukemic O
T O
cells O
isolated O
from O
patients O
with O
adult O
T-cell O
lymphoma/leukemia O
( O
ATLL O
) O
. O

Constitutive O
basal O
phosphorylation O
of O
Jak3 O
and O
, O
usually O
, O
STAT3 O
and O
STAT5 O
was O
detected O
in O
all O
four O
IL-2-independent B
cell I
lines I
tested O
, O
but O
in O
none O
of O
the O
three O
IL-2-dependent B
cell I
lines I
. O

However O
, O
stimulation O
with O
IL-2 O
resulted O
in O
Jak3 O
and O
STAT5 O
phosphorylation O
in O
both O
leukemic O
ATLL O
cells O
and O
IL-2-dependent B
lines I
. O

Furthermore O
, O
expression O
of O
SHP-1 O
phosphatase O
which O
is O
a O
negative O
regulator O
of O
cytokine O
receptor O
signaling O
, O
was O
lost O
in O
most O
IL-2 B
independent I
cell I
lines I
( O
3/4 O
) O
but O
not O
in O
the O
leukemic O
ATLL O
cells O
( O
0/3 O
) O
. O

Finally O
, O
the O
HTLV-I B
( I
+ I
) I
T-cell I
lines I
( O
313 O
) O
but O
not O
the O
control O
, O
HTLV-I B
( I
- I
) I
T-cell I
lines I
were O
resistant O
to O
rapamycin O
and O
its O
novel O
analog O
RAD O
. O

By O
examining O
in O
vitro-differentiated B
embryonic I
stem I
cells I
, O
we O
showed O
previously O
that O
in O
the O
absence O
of O
GATA-1 O
, O
committed B
erythroid I
precursors I
fail O
to O
complete O
maturation O
and O
instead O
undergo O
apoptosis O
. O

Consistent O
with O
a O
role O
for O
bcl-xL O
in O
mediating O
GATA-1 O
-induced O
erythroid O
cell O
survival O
, O
in O
vitro-differentiated B
bcl-xL-/- I
embryonic I
stem I
cells I
fail O
to O
generate O
viable O
mature O
definitive O
erythroid O
cells O
, O
a O
phenotype O
resembling O
that O
of O
GATA-1 O
gene O
disruption O
. O

However O
, O
we O
report O
in O
vitro O
experimental O
studies O
in O
which O
IL-10 B
primed I
leukocytes I
and O
led O
to O
an O
enhanced O
production O
of O
tumor O
necrosis O
factor O
( O
TNF O
) O
upon O
further O
stimulation O
by O
lipopolysaccharide O
( O
LPS O
) O
. O

Forced O
expression O
of O
E2F1 O
could O
induce O
expression O
of O
all O
members O
of O
the O
endogenous O
MCM O
genes O
in O
rat B
embryonal I
fibroblast I
REF52 I
cells I
. O

Cells O
from O
the O
human B
monocytic I
leukemia I
cell I
line I
THP-1 B
differentiate O
towards O
a O
macrophage-like O
phenotype O
when O
stimulated O
with O
phorbol O
12-myristate O
-13- O
acetate O
( O
PMA O
) O
, O
1 O
, O
25-dihydroxy-vitamin O
D3 O
, O
and O
various O
other O
agents O
. O

We O
demonstrate O
here O
that O
the O
expression O
of O
the O
lysosomal O
enzyme O
acid O
sphingomyelinase O
( O
ASM O
; O
E.C.3.1.4.12 O
) O
is O
induced O
during O
this O
process O
and O
is O
strongly O
elevated O
in O
differentiated O
THP-1 B
cells I
, O
as O
well O
as O
in O
differentiated O
human O
mononuclear O
phagocytes O
. O

These O
factors O
are O
present O
in O
nuclear O
extracts O
prepared O
from O
both O
induced O
and O
uninduced O
THP-1 B
cells I
. O

However O
, O
the O
intensity O
of O
the O
complex O
formed O
appeared O
to O
increase O
when O
nuclear O
extracts O
from O
PMA-treated B
cells I
were O
used O
. O

We O
have O
used O
this O
DNA O
fragment O
to O
isolate O
and O
purify O
a O
60-kDa O
protein O
binding O
to O
this O
fragment O
and O
obtained O
its O
amino-terminal O
sequence O
, O
which O
was O
used O
to O
design O
degenerate O
probes O
to O
screen O
a O
cDNA O
library O
from O
THP-1 B
cells I
. O

Characterization O
of O
this O
cDNA O
clone O
revealed O
that O
its O
induction O
was O
dependent O
on O
LPS O
activation O
of O
THP-1 B
cells I
; O
hence O
, O
the O
name O
LPS-induced O
TNF-alpha O
factor O
( O
LITAF O
) O
. O

Inhibition O
of O
LITAF O
mRNA O
expression O
in O
THP-1 B
cells I
resulted O
in O
a O
reduction O
of O
TNF-alpha O
transcripts O
. O

Importantly O
, O
it O
was O
also O
present O
in O
the O
nucleus O
of O
HeLa B
cells I
, O
which O
lack O
HNF1 O
, O
and O
in O
the O
cytoplasm O
of O
fibroblasts O
that O
have O
little O
or O
no O
tetrahydrobiopterin O
. O

Transfection O
of O
Jurkat B
cells I
with O
the O
NF-kappaB O
subunits O
p50 O
and O
p65 O
confers O
resistance O
against O
Fas-mediated O
apoptosis O
. O

Furthermore O
, O
inhibition O
of O
NF-kappaB O
activation O
by O
a O
soluble O
peptide O
inhibitor O
rendered O
a O
T B
cell I
hybridoma I
more O
susceptible O
to O
TCR-mediated O
apoptosis O
. O

Concanavalin O
A-activated O
cycling B
T I
cell I
blasts I
from O
mice O
that O
are O
transgenic O
for O
the O
dominant O
IkappaB O
molecule O
have O
increased O
sensitivity O
to O
Fas-mediated O
apoptosis O
, O
associated O
with O
a O
down-regulation O
of O
NF-kappaB O
complexes O
in O
the O
nucleus O
. O

The O
activation O
of O
STAT3 O
was O
not O
found O
in O
human O
eosinophils O
, O
monocytes O
, O
and O
HL-60 B
cells I
, O
although O
the O
STAT3 O
protein O
was O
expressed O
in O
these O
cells O
. O

We O
investigated O
whether O
E2 O
and O
Prog O
could O
interfere O
with O
TNF-alpha O
-induced O
apoptosis O
of O
the O
monoblastoid B
U937 I
cell I
line I
. O

Treatment O
with O
E2 O
or O
Prog O
increased O
survival O
and O
prevented O
apoptosis O
induced O
by O
TNF-alpha O
in O
both O
undifferentiated O
and O
macrophage-like O
PMA-differentiated B
U937 I
cells I
, O
as O
assessed O
by O
trypan O
blue O
exclusion O
cell O
counting O
, O
thymidine O
incorporation O
, O
AnnexinV O
labeling O
, O
followed O
by O
flow O
cytometry O
and O
DNA O
fragmentation O
studies O
. O

Other O
steroid O
receptor O
drugs O
such O
as O
Raloxifene O
, O
RU486 O
, O
or O
the O
ICI O
182 O
, O
780 O
in O
PMA-differentiated B
cells I
displayed O
agonist O
activity O
by O
preventing O
TNF-alpha O
-induced O
apoptosis O
as O
efficiently O
as O
the O
hormones O
alone O
, O
providing O
further O
evidence O
to O
the O
notion O
that O
steroid O
receptor O
drugs O
may O
manifest O
agonist O
or O
antagonist O
activities O
depending O
on O
the O
cellular O
context O
in O
which O
they O
are O
studied O
. O

Treatment O
with O
E2 O
was O
also O
associated O
with O
a O
time-dependent O
decrease O
in O
the O
mRNA O
level O
of O
the O
proapoptotic O
Nip-2 O
protein O
, O
supporting O
the O
hypothesis O
that O
hormone O
responsiveness O
of O
U937 B
cells I
is O
mediated O
by O
target O
gene O
transcription O
. O

Together O
, O
these O
results O
demonstrate O
that O
ER O
and O
PR O
can O
be O
activated O
by O
endogenous O
or O
exogenous O
ligands O
to O
induce O
a O
genetic O
response O
that O
impairs O
TNF-alpha O
-induced O
apoptosis O
in O
U937 B
cells I
. O

Their O
retinoidal O
activity O
were O
examined O
in O
terms O
of O
the O
differentiation-inducing O
ability O
toward O
human B
promyelocytic I
leukemia I
HL-60 I
cells I
. O

Erythroid O
gene O
expression O
is O
differentially O
regulated O
by O
erythropoietin O
, O
haemin O
and O
delta-aminolaevulinic O
acid O
in O
UT-7 B
cells I
. O

The O
UT-7 B
cell I
line I
exhibits O
both O
erythroid O
and O
megakaryocytic O
characteristics O
and O
can O
be O
induced O
to O
differentiate O
along O
the O
erythroid O
pathway O
by O
Epo O
or O
the O
megakaryocytic O
pathway O
by O
phorbol O
myristic O
acetate O
. O

We O
have O
compared O
the O
effects O
of O
Epo O
and O
the O
chemical O
inducers O
, O
delta-aminolaevulinic O
acid O
( O
delta-ALA O
) O
and O
haemin O
on O
the O
differentiation O
capacity O
of O
UT-7 B
cells I
. O

These O
results O
suggest O
that O
haemoglobin O
production O
in O
UT-7 B
cells I
is O
limited O
by O
a O
deficiency O
of O
erythroid-specific O
aminolaevulinic O
acid O
synthase O
( O
ALAS-E O
) O
activity O
or O
globin O
synthesis O
as O
a O
consequence O
of O
their O
immaturity O
as O
a O
multipotential B
cell I
line I
. O

In O
this O
study O
, O
the O
influence O
of O
the O
sequences O
located O
between O
-3134 O
and O
-2987 O
on O
the O
transcriptional O
activity O
of O
the O
proIL-1beta O
gene O
in O
LPS-stimulated B
Raw I
264.7 I
cells I
was O
examined O
in O
detail O
. O

Stimulation O
of O
HUVEC B
with O
thrombin O
resulted O
in O
dose- O
and O
time-dependent O
increases O
in O
ICAM-1 O
mRNA O
and O
cell O
surface O
expression O
and O
in O
ICAM-1 O
-dependent O
endothelial O
adhesivity O
toward O
polymorphonuclear O
leukocytes O
. O

Here O
we O
demonstrate O
that O
both O
Smad6 O
and O
Smad7 O
are O
human O
bone O
morphogenetic O
protein-2 O
( O
hBMP-2 O
) O
-inducible O
antagonists O
of O
hBMP-2 O
-induced O
growth O
arrest O
and O
apoptosis O
in O
mouse B
B I
cell I
hybridoma I
HS-72 B
cells I
. O

We O
previously O
reported O
that O
Smad7 O
is O
an O
activin O
A-inducible O
antagonist O
of O
activin O
A-induced O
growth O
arrest O
and O
apoptosis O
in O
HS-72 B
cells I
. O

Interestingly O
, O
although O
mRNA O
expression O
of O
Smad6 O
was O
induced O
by O
activin O
A O
in O
HS-72 B
cells I
, O
Smad6 O
showed O
no O
antagonistic O
effect O
on O
activin O
A-induced O
growth O
arrest O
and O
apoptosis O
. O

Moreover O
, O
we O
found O
that O
the O
ectopic O
expression O
of O
Smad7 O
, O
but O
not O
Smad6 O
, O
inhibited O
the O
activin O
A-induced O
Smad2 O
phosphorylation O
in O
HS-72 B
cells I
. O

The O
interactions O
of O
Hsp60-specific B
T I
cells I
with O
arterial O
endothelial O
cells O
( O
EC O
) O
require O
expression O
of O
both O
Hsp60 O
and O
certain O
adhesion O
molecules O
shown O
to O
be O
induced O
simultaneously O
in O
EC O
by O
mechanical O
and O
other O
types O
of O
stress O
. O

PROBLEM O
: O
The O
mechanisms O
of O
the O
immunosuppressive O
and O
immunosuppression-inducing O
capacities O
of O
Jeg-3 B
human I
choriocarcinoma I
cell I
line I
supernatants O
( O
HCSs O
) O
are O
not O
yet O
completely O
understood O
. O

RESULTS O
: O
Phorbol-myristate-acetate O
and O
ionomycine O
strongly O
increase O
the O
percent-age O
of O
IL-2+ B
cells I
; O
an O
additional O
50 O
% O
HCSs O
significantly O
suppresses O
the O
percentage O
to O
, O
or O
below O
the O
level O
of O
unstimulated O
cells O
. O

Apoptosis-resistant B
T I
cells I
have O
a O
deficiency O
in O
NF-kappaB O
-mediated O
induction O
of O
Fas O
ligand O
transcription O
. O

To O
gain O
a O
better O
understanding O
of O
the O
transcriptional O
events O
that O
regulate O
this O
expression O
, O
we O
took O
advantage O
of O
our O
previously O
described O
mutant B
Jurkat I
cells I
. O

This O
failure O
to O
degrade O
IkappaBalpha O
may O
underlie O
both O
the O
observed O
decrease O
in O
NFkappaB O
induction O
and O
the O
IL-2 O
receptor O
expression O
in O
TNF-treated B
T I
cells I
during O
aging O
. O

In O
this O
study O
, O
we O
show O
that O
HLA O
class O
I O
-mediated O
induction O
of O
cell O
proliferation O
correlates O
with O
inactivation O
of O
the O
Rb O
protein O
in O
the O
T B
cell I
line I
Jurkat I
as O
well O
as O
human O
aortic O
endothelial O
cells O
. O

In O
Jurkat B
T-cells I
, O
PG490 O
inhibits O
PMA/Iono-stimulated O
IL-2 O
transcription O
. O

Unexpected O
and O
coordinated O
expression O
of O
Spi-1 O
, O
Fli-1 O
, O
and O
megakaryocytic O
genes O
in O
four O
Epo-dependent B
cell I
lines I
established O
from O
transgenic O
mice O
displaying O
erythroid-specific O
expression O
of O
a O
thermosensitive O
SV40 O
T O
antigen O
. O

Most O
erythroleukemic B
cell I
lines I
established O
in O
vitro O
coexpress O
erythrocytic O
and O
megakaryocytic O
markers O
that O
often O
are O
associated O
with O
expression O
of O
Spi-1 O
and/or O
Fli-1 O
transcription O
factors O
known O
as O
transactivators O
of O
megakaryocyte-specific O
promoters O
. O

In O
the O
present O
study O
, O
we O
examined O
the O
possibility O
of O
establishing O
new B
cell I
lines I
keeping O
strictly O
erythroid-specific O
properties O
in O
vitro O
through O
the O
targeted O
and O
conditional O
immortalization O
of O
erythrocytic O
progenitors O
. O

As O
expected O
, O
these O
transgenic O
mice O
developed O
splenomegaly O
due O
to O
the O
massive O
amplification O
of O
Ter B
119 I
positive I
erythroid I
nucleated I
cells I
expressing O
T O
antigen O
. O

Despite O
this O
drastic O
effect O
in O
vivo O
, O
the O
in O
vitro O
immortalization O
of O
erythropoietin-dependent O
erythroid O
progenitors O
unexpectedly O
occurred O
at O
low O
frequency O
, O
and O
all O
four O
cell B
lines I
established O
expressed O
both O
erythrocytic O
( O
globins O
) O
and O
megakaryocytic O
markers O
( O
glycoprotein O
IIb O
, O
platelet O
factor O
4 O
) O
as O
well O
as O
Spi-1 O
and O
Fli-1 O
transcripts O
at O
permissive O
temperature O
. O

Interestingly O
, O
enhanced O
expression O
of O
Spi-1 O
and O
Fli-1 O
genes O
already O
was O
detected O
in O
the O
Ter B
119 I
positive I
cell I
population I
of O
transgenic O
mice O
spleen O
in O
vivo O
. O

However O
, O
like O
normal B
Ter I
119 I
erythroid I
cells I
, O
these O
Ter B
119 I
positive I
cells I
from O
transgenic O
mice O
still O
expressed O
high O
levels O
of O
beta-globin O
and O
very O
low O
or O
undetectable O
glycoprotein O
IIb O
and O
platelet O
factor O
4 O
megakaryocytic O
transcripts O
. O

Taken O
together O
, O
these O
data O
indicate O
that O
the O
unexpected O
expression O
of O
megakaryocytic O
genes O
is O
a O
specific O
property O
of O
immortalized B
cells I
that O
can O
not O
be O
explained O
only O
by O
enhanced O
expression O
of O
Spi-1 O
and/or O
Fli-1 O
genes O
. O

A O
novel O
Ets O
protein O
was O
isolated O
by O
yeast O
one-hybrid O
screening O
of O
a O
cDNA O
library O
made O
from O
lipopolysaccharide-stimulated B
mouse I
splenic I
B I
cells I
, O
using O
the O
SP6 O
kappa O
promoter O
kappaY O
element O
as O
a O
bait O
. O

Spi-C O
interacted O
with O
DNA O
similarly O
to O
PU.1 O
as O
judged O
by O
methylation O
interference O
, O
band-shift O
and O
site O
selection O
analysis O
, O
and O
activated O
transcription O
of O
a O
kappaY O
element O
reporter O
gene O
upon O
co-transfection O
of O
HeLa B
cells I
. O

Furthermore O
, O
pre-B B
cell I
and I
plasma I
cell I
lines I
were O
Spi-C O
-negative O
, O
suggesting O
that O
Spi-C O
might O
be O
a O
regulatory O
molecule O
during O
a O
specific O
phase O
of O
B O
lymphoid O
development O
. O

To O
determine O
whether O
positive O
autoregulation O
is O
a O
necessary O
component O
of O
glucocorticoid-induced O
cell O
death O
, O
a O
wild-type O
GR O
gene O
under O
the O
control O
of O
a O
tetracycline-regulated O
promoter O
was O
stably O
transfected O
into O
glucocorticoid-resistant B
cells I
lacking O
endogenous O
functional O
receptor O
. O

Transfectants B
grown O
in O
the O
presence O
of O
tetracycline O
contained O
about O
15 O
, O
000 O
receptors/cell O
, O
a O
value O
approximately O
equal O
to O
basal O
level O
GR O
expression O
in O
glucocorticoid-sensitive B
6TG1.1 I
cells I
before O
steroid O
treatment O
. O

In O
the O
absence O
of O
tetracycline O
, O
GR O
mRNA O
and O
protein O
expression O
increased O
2-3-fold O
, O
and O
cells O
expressed O
48 O
, O
000 O
receptors O
, O
a O
level O
nearly O
equivalent O
to O
that O
present O
in O
6TG1.1 B
cells I
after O
18 O
h O
of O
autoinduction O
. O

These O
studies O
therefore O
suggest O
that O
basal O
level O
GR O
expression O
is O
inadequate O
to O
mediate O
glucocorticoid-induced O
apoptosis O
in O
glucocorticoid-sensitive B
T I
cells I
and O
that O
positive O
autoregulation O
is O
a O
necessary O
component O
of O
this O
process O
. O

We O
found O
that O
leukemic O
cells O
from O
ATL O
patients O
, O
like O
HTLV-I-infected B
T-cell I
lines I
, O
display O
constitutive O
NF-kappaB O
DNA O
binding O
activity O
and O
increased O
degradation O
of O
IkappaBalpha O
( O
an O
inhibitor O
of O
NF-kappaB O
) O
. O

Whereas O
the O
NF-kappaB O
binding O
activity O
in O
Tax-expressing B
T-cell I
lines I
consisted O
mostly O
of O
p50/c-Rel O
, O
fresh O
ATL O
samples O
contained O
p50/p50 O
and O
p50/p65 O
heterodimers O
. O

One O
T-cell B
line I
derived O
from O
ATL O
leukemic O
cells O
, O
TL-Om1 O
, O
displayed O
constitutive O
NF-kappaB O
activity O
, O
as O
well O
as O
enhanced O
degradation O
of O
IkappaBalpha O
, O
despite O
the O
lack O
of O
detectable O
Tax O
expression O
. O

Therefore O
, O
this O
study O
was O
designed O
to O
analyze O
the O
role O
of O
Lck O
in O
IFN-alpha O
signaling O
by O
using O
the O
Jurkat O
, O
JCam O
( O
an O
Lck-defective B
cell I
line I
derived O
from O
Jurkat B
) O
, O
and O
JCam/Lck B
( O
JCam B
cells I
with O
Lck O
restored O
) O
. O

Furthermore O
, O
STATs1 O
and O
-3 O
are O
effectively O
phosphorylated O
and O
activated O
to O
bind O
DNA O
in O
the O
absence O
of O
Lck O
expression O
in O
IFN-alpha-treated B
cells I
. O

Selective O
activation O
and O
functional O
significance O
of O
p38alpha O
mitogen-activated O
protein O
kinase O
in O
lipopolysaccharide-stimulated B
neutrophils I
. O

We O
took O
advantage O
of O
our O
monoclonal O
model O
of O
germinal O
center O
B O
cell O
differentiation O
, O
IgM+ B
IgD+ I
CL-01 I
cells I
, O
to O
define O
the O
role O
of O
the O
I O
gamma O
3 O
evolutionarily O
conserved O
sequence O
( O
ECS O
) O
in O
the O
germline O
transcriptional O
activation O
of O
the O
human O
C O
gamma O
3 O
gene O
. O

Reporter O
luciferase O
gene O
vectors O
containing O
the O
human O
gamma O
3 O
ECS O
were O
used O
to O
transfect O
CL-01 B
cells I
, O
which O
have O
been O
shown O
to O
undergo O
Smu O
-- O
> O
S O
gamma O
3 O
DNA O
recombination O
, O
upon O
engagement O
of O
CD40 O
by O
CD40 O
ligand O
( O
CD40L O
) O
and O
exposure O
to O
IL-4 O
. O

In O
these O
transfected O
CL-01 B
cells I
, O
CD40 O
: O
CD40L O
engagement O
and O
exposure O
to O
IL-4 O
synergistically O
induced O
gamma O
3 O
ECS-dependent O
luciferase O
reporter O
gene O
activation O
. O

We O
show O
here O
that O
expression O
of O
CIITA O
in O
MHC B
class I
II I
-cells I
triggers O
occupation O
of O
the O
promoters O
by O
these O
complexes O
. O

GrpL O
can O
be O
coimmunoprecipitated O
with O
SLP-76 O
but O
not O
with O
Sos1 O
or O
Sos2 O
from O
Jurkat B
cell I
lysates O
. O

A O
functional O
role O
of O
the O
GrpL-SLP-76 O
complex O
is O
suggested O
by O
the O
ability O
of O
GrpL O
to O
act O
alone O
or O
in O
concert O
with O
SLP-76 O
to O
augment O
NF-AT O
activation O
in O
Jurkat B
T O
cells O
. O

We O
examined O
chemokine O
gene O
expression O
following O
the O
differentiation O
of O
a O
monocyte O
, O
macrophage B
cell I
lineage I
. O

The O
human B
monoblastic I
cell I
line I
, O
U937 B
was O
differentiated O
to O
macrophages O
by O
the O
treatment O
with O
either O
phorbol O
12-myristate O
13-acetate O
( O
PMA O
) O
, O
retinoic O
acid O
( O
RA O
) O
, O
or O
vitamin O
D3 O
( O
VitD3 O
) O
. O

The O
gene O
expression O
of O
interferon O
( O
IFN O
) O
-inducible O
protein O
10 O
( O
IP-10 O
) O
( O
a O
CXC O
chemokine O
) O
was O
markedly O
augmented O
by O
the O
IFNgamma O
treatment O
in O
PMA O
-or O
RA-differentiated O
U937 B
cells I
, O
but O
only O
marginally O
in O
undifferentiated O
or O
VitD3-treated B
cells I
. O

In O
contrast O
, O
another O
inducible O
gene O
expression O
of O
monocyte O
chemotactic O
protein-1 O
( O
a O
CC O
chemokine O
) O
and O
the O
activation O
of O
the O
transcriptional O
factor O
( O
FcRFgamma O
) O
bound O
to O
the O
gamma O
response O
region O
were O
similarly O
or O
less O
abundantly O
induced O
by O
IFNgamma O
treatment O
in O
PMA O
-or O
RA-differentiated O
U937 B
cells I
, O
indicating O
that O
increased O
IP-10 O
mRNA O
induction O
was O
not O
due O
to O
the O
augmented O
ability O
of O
the O
cells O
to O
respond O
to O
the O
presence O
of O
IFNgamma O
. O

Increased O
expression O
of O
IFNgamma O
-induced O
IP-10 O
mRNA O
following O
the O
differentiation O
of O
U937 B
cells I
was O
mediated O
largely O
by O
augmented O
transcriptional O
activity O
of O
the O
gene O
and O
was O
related O
to O
differentiation-dependent O
changes O
of O
the O
proteins O
bound O
to O
IFN O
stimulus O
response O
element O
( O
ISRE O
) O
and O
kB O
sites O
, O
suggesting O
that O
these O
nuclear O
proteins O
may O
determine O
the O
IP-10 O
mRNA O
inducibility O
by O
IFNgamma O
. O

We O
report O
here O
the O
cleavage O
of O
the O
transcription O
factor O
SP1 O
in O
the O
human B
Burkitt I
lymphoma I
cell I
line I
BL60 I
during O
anti-IgM O
-induced O
apoptosis O
. O

CD40 O
expression O
was O
confirmed O
in O
7 O
human B
MM I
cell I
lines I
established O
from O
immunogenic O
primary O
tumors O
or O
metastases O
, O
whereas O
11 O
cell B
lines I
established O
from O
advanced O
stages O
were O
CD40 O
negative O
. O

CD40 O
ligation O
on O
MM O
by O
CD40L-transfected B
murine I
L-cells I
or O
by O
a O
soluble O
CD40L O
fusion O
protein O
up-regulated O
their O
expression O
of O
intercellular O
adhesion O
molecule-1 O
and O
MHC O
class O
I O
and O
class O
II O
molecules O
and O
their O
secretion O
of O
IL-6 O
, O
IL-8 O
, O
tumor O
necrosis O
factor-a O
, O
and O
granulocyte O
macrophage O
colony-stimulating O
factor O
and O
also O
induced O
a O
rapid O
activation O
of O
the O
transcription O
factor O
nuclear O
factor O
kappaB O
. O

Furthermore O
, O
CD40 O
ligation O
of O
a O
HLA-A2+ B
, I
MelanA/MART1+ I
MM I
cell I
line I
enhanced O
its O
susceptibility O
to O
specific O
lysis O
by O
a O
HLA-A2-restricted B
, I
MelanA/MART-1-specific I
CTL I
clone I
. O

These O
include O
overrepresentation O
of O
clinically O
aggressive O
histologic O
types O
and O
frequent O
infection O
of O
Reed-Sternberg B
( I
RS I
) I
cells I
by O
Epstein-Barr O
virus O
( O
EBV O
) O
. O

Recently O
, O
we O
have O
reported O
that O
the O
histogenesis O
of O
HD O
of O
the O
general O
population O
may O
be O
assessed O
by O
monitoring O
the O
expression O
pattern O
of O
BCL-6 O
, O
a O
transcription O
factor O
expressed O
in O
germinal B
center I
( I
GC I
) I
B I
cells I
, O
and O
of O
CD138/syndecan-1 O
( O
syn-1 O
) O
, O
a O
proteoglycan O
associated O
with O
post-GC O
, O
terminal O
B-cell O
differentiation O
. O

We O
have O
found O
that O
RS B
cells I
of O
all O
histologic O
categories O
of O
HIV-HD O
consistently O
display O
the O
BCL-6 O
( O
- O
) O
/syn-1 O
( O
+ O
) O
phenotype O
and O
thus O
reflect O
post-GC B
B I
cells I
. O

Although O
BCL-6 O
( O
- O
) O
/syn-1 O
( O
+ O
) O
RS B
cells I
of O
HIV-HD O
express O
CD40 O
, O
they O
are O
not O
surrounded O
by O
CD40 O
ligand-positive O
( O
CD40L+ O
) O
reactive O
T O
lymphocytes O
, O
which O
, O
in O
HD O
of O
the O
general O
population O
, O
are O
thought O
to O
regulate O
the O
disease O
phenotype O
through O
CD40 O
/CD40L O
interactions O
. O

Conversely O
, O
RS B
cells I
of O
virtually O
all O
HIV-HD O
express O
the O
EBV-encoded O
latent O
membrane O
protein O
1 O
( O
LMP1 O
) O
, O
which O
, O
being O
functionally O
homologous O
to O
CD40 O
, O
may O
contribute O
, O
at O
least O
in O
part O
, O
to O
the O
modulation O
of O
the O
HIV-HD O
phenotype O
. O

In O
this O
report O
, O
we O
have O
analyzed O
the O
response O
of O
the O
hematopoietic B
precursor I
cell I
line I
32Dcl3 I
, O
expressing O
either O
the O
normal O
protein O
MDS1/EVI1 O
or O
the O
fusion O
protein O
AML1/MDS1/EVI1 O
, O
to O
factors O
that O
control O
cell O
differentiation O
or O
cell O
replication O
. O

The O
32Dcl3 B
cells I
are O
IL-3 O
-dependent O
for O
growth O
and O
they O
differentiate O
into O
granulocytes O
when O
exposed O
to O
G-CSF O
. O

This O
effect O
is O
similar O
to O
that O
previously O
described O
by O
others O
for O
32Dcl3 B
cells I
that O
express O
transgenic O
Evil O
. O

Furthermore O
, O
we O
show O
that O
whereas O
the O
expression O
of O
the O
fusion O
protein O
AML1/MDS1/EVI1 O
completely O
abrogates O
the O
growth-inhibitory O
effect O
of O
TGF-beta1 O
and O
allows O
32Dcl3 B
cells I
to O
proliferate O
, O
expression O
of O
the O
normal O
protein O
MDS1/EVI1 O
has O
the O
opposite O
effect O
, O
and O
it O
strengthens O
the O
response O
of O
cells O
to O
the O
growth-inhibitory O
effect O
of O
TGF-beta1 O
. O

On O
first O
encounter O
with O
antigen O
, O
naive O
CD4+ O
T O
helper O
( O
Th O
) O
cells O
differentiate O
into O
cytokine-producing B
effector I
cells I
. O

Th1 O
cells O
produce O
IL-2 O
and O
IFN-gamma O
, O
whereas O
Th2 B
cells I
produce O
IL-4 O
, O
IL-5 O
, O
IL-6 O
, O
IL-10 O
, O
and O
IL-13 O
. O

In O
contrast O
, O
in O
C57MG B
fibroblast I
cells I
, O
lithium O
inactivates O
GSK-3beta O
and O
induces O
Tcf-controlled O
transcription O
. O

Overexpression O
of O
SIT O
in O
Jurkat B
cells I
downmodulates O
T O
cell O
receptor- O
and O
phytohemagglutinin-mediated O
activation O
of O
the O
nuclear O
factor O
of O
activated O
T O
cells O
( O
NF-AT O
) O
by O
interfering O
with O
signaling O
processes O
that O
are O
probably O
located O
upstream O
of O
activation O
of O
phospholipase O
C O
. O

The O
Epstein-Barr O
virus O
nuclear O
antigen O
2 O
( O
EBNA2 O
) O
, O
a O
protein O
required O
for O
B O
lymphocyte O
immortalization O
, O
induces O
the O
synthesis O
of O
type O
I O
interferon O
in O
Burkitt B
's I
lymphoma I
cell I
lines I
. O

We O
investigated O
the O
function O
of O
conditionally O
expressed O
EBNA2 O
in O
the O
context O
of O
the O
IFN O
response O
in O
Burkitt B
's I
lymphoma I
cell I
lines I
. O

EBNA2 O
-dependent O
transcriptional O
induction O
of O
the O
IFN-beta O
promoter O
occurred O
in O
EBV-negative B
Burkitt I
's I
lymphoma I
cells I
, O
indicating O
that O
other O
EBV O
genes O
were O
not O
required O
for O
the O
induction O
of O
IFN-beta O
synthesis O
. O

Similar O
glucocorticoid-mediated O
potentiation O
was O
observed O
with O
5-day O
M O
phi O
uptake O
of O
alternative O
apoptotic O
`` O
targets O
'' O
( O
eosinophils O
and O
Jurkat B
T I
cells I
) O
and O
in O
uptake O
of O
apoptotic O
neutrophils O
by O
alternative O
phagocytes O
( O
human O
glomerular O
mesangial O
cells O
and O
murine B
M I
phi I
elicited O
into O
the O
peritoneum O
or O
derived O
from O
bone O
marrow O
) O
. O

Furthermore O
, O
longer-term O
potentiation O
by O
methylprednisolone O
was O
observed O
in O
maturing B
human I
monocyte-derived I
M I
phi I
, O
with O
greater O
increases O
in O
5-day O
M B
phi I
uptake O
of O
apoptotic O
cells O
being O
observed O
the O
earlier O
glucocorticoids O
were O
added O
during O
monocyte O
maturation O
into O
M B
phi I
. O

1 O
, O
25-Dihydroxyvitamin O
D3 O
induces O
differentiation O
of O
a O
retinoic B
acid-resistant I
acute I
promyelocytic I
leukemia I
cell I
line I
( O
UF-1 B
) O
associated O
with O
expression O
of O
p21 O
( O
WAF1/CIP1 O
) O
and O
p27 O
( O
KIP1 O
) O
. O

The O
cyclin-dependent O
kinase O
( O
cdk O
) O
inhibitor O
p21 O
( O
WAF1/CIP1 O
) O
has O
a O
vitamin O
D3-responsive O
element O
( O
VDRE O
) O
in O
its O
promoter O
, O
and O
1 O
, O
25 O
( O
OH O
) O
2D3 O
enhances O
the O
expression O
of O
p21 O
( O
WAF1/CIP1 O
) O
and O
induces O
differentiation O
of O
selected O
myeloid B
leukemic I
cell I
lines I
. O

We O
have O
recently O
established O
a O
novel O
APL B
cell I
line I
( O
UF-1 B
) O
with O
features O
of O
RA O
resistance O
. O

1 O
, O
25 O
( O
OH O
) O
2D3 O
can O
induce O
growth O
inhibition O
and O
G1 O
arrest O
of O
UF-1 B
cells I
, O
resulting O
in O
differentiation O
of O
these O
cells O
toward O
granulocytes O
. O

Western O
blot O
experiments O
showed O
that O
p21 O
( O
WAF1/CIP1 O
) O
protein O
levels O
increased O
and O
became O
detectable O
after O
12 O
hours O
of O
1 O
, O
25 O
( O
OH O
) O
2D3 O
treatment O
and O
induction O
of O
p27 O
( O
KIP1 O
) O
protein O
was O
much O
more O
gradual O
and O
sustained O
in O
UF-1 B
cells I
. O

In O
contrast O
, O
RA O
alone O
can O
induce O
G1 O
arrest O
of O
UF-1 B
cells I
; O
however O
, O
it O
did O
not O
result O
in O
an O
increase O
of O
p21 O
( O
WAF1/CIP1 O
) O
and O
p27 O
( O
KIP1 O
) O
transcript O
and O
protein O
expression O
in O
RA-resistant O
cells O
. O

Taken O
together O
, O
we O
conclude O
that O
1 O
, O
25 O
( O
OH O
) O
2D3 O
induces O
increased O
expression O
of O
cdk O
inhibitors O
, O
which O
mediates O
a O
G1 O
arrest O
, O
and O
this O
may O
be O
associated O
with O
differentiation O
of O
RA-resistant O
UF-1 B
cells I
toward O
mature O
granulocytes O
. O

Treatment O
of O
human B
umbilical I
vein I
endothelial I
cell I
( I
HUVEC I
) I
monolayers I
for O
6 O
hours O
with O
0.2 O
mmol/L O
diamide O
and O
1 O
mmol/L O
buthionine O
sulfoximine O
( O
BSO O
) O
decreased O
GSH O
levels O
and O
increased O
the O
ratio O
of O
GSSG O
to O
GSH O
without O
cell O
toxicity O
. O

Diamide O
plus O
BSO-induced O
thiol/disulfide O
imbalance O
was O
associated O
with O
a O
biphasic O
increase O
in O
neutrophil O
adhesion O
to O
HUVECs B
with O
peak O
responses O
observed O
at O
15 O
minutes O
( O
phase O
1 O
) O
and O
240 O
minutes O
( O
phase O
2 O
) O
. O

Surface O
expression O
of O
intercellular O
adhesion O
molecule-1 O
, O
P-selectin O
, O
and O
E-selectin O
on O
HUVECs B
correlated O
with O
the O
phase O
1 O
and O
2 O
neutrophil O
adhesion O
responses O
. O

When O
cells O
were O
cultured O
in O
the O
presence O
of O
progesterone O
they O
released O
a O
soluble O
factor O
that O
inhibited O
cellular O
immunoreactions O
( O
MLR O
, O
CRC O
) O
and O
cellular O
proliferation O
as O
measured O
by O
thymidine O
incorporation O
by O
spleen-cell B
culture I
. O

This O
factor O
also O
inhibited O
the O
synthesis O
of O
anti-DNP O
antibodies O
by O
a O
mouse B
hybridoma I
and O
diminished O
the O
proportion O
of O
cells O
in O
phase O
S O
. O

However O
, O
the O
percentage O
of O
asymmetric O
molecules O
produced O
by O
the O
hybridoma B
remained O
unaltered O
. O

Because O
the O
translation O
rate O
is O
an O
important O
determinant O
of O
cell O
proliferation O
, O
we O
have O
investigated O
translation O
initiation O
during O
human O
myeloid O
cell O
differentiation O
using O
the O
HL-60 B
promyelocytic I
leukemia I
cell I
line I
and O
the O
U-937 B
monoblastic I
cell I
line I
. O

Induction O
of O
HL-60 B
and O
U-937 B
cell O
differentiation O
into O
monocytes/macrophages O
by O
IFN-gamma O
or O
PMA O
results O
in O
a O
dephosphorylation O
and O
consequent O
activation O
of O
4E-BP1 O
. O

Dephosphorylation O
of O
4E-BP1 O
was O
also O
observed O
when O
U-937 B
cells I
were O
induced O
to O
differentiate O
into O
monocytes/macrophages O
following O
treatment O
with O
retinoic O
acid O
or O
DMSO O
. O

In O
contrast O
, O
treatment O
of O
HL-60 B
cells I
with O
retinoic O
acid O
or O
DMSO O
, O
which O
results O
in O
a O
granulocytic O
differentiation O
of O
these O
cells O
, O
decreases O
4E-BP1 O
amount O
without O
affecting O
its O
phosphorylation O
and O
strongly O
increases O
4E-BP2 O
amount O
. O

In O
this O
study O
, O
transient O
cotransfection O
of O
several O
GPIX O
promoter/reporter O
constructs O
into O
293T B
kidney I
fibroblasts I
with O
a O
Fli-1 O
expression O
vector O
shows O
that O
the O
oncogenic O
protein O
Fli-1 O
can O
transactivate O
the O
GPIX O
promoter O
when O
an O
intact O
GPIX O
Ets O
site O
is O
present O
. O

Cobalt O
chloride-induced O
signaling O
in O
endothelium O
leading O
to O
the O
augmented O
adherence O
of O
sickle O
red O
blood O
cells O
and O
transendothelial O
migration O
of O
monocyte-like B
HL-60 I
cells I
is O
blocked O
by O
PAF-receptor O
antagonist O
. O

Additionally O
, O
CoCl2 O
caused O
a O
two- O
to O
threefold O
increase O
in O
the O
rate O
of O
transendothelial O
migration O
of O
monocyte-like B
HL-60 I
cells I
and O
a O
twentyfold O
increase O
in O
phosphorylation O
of O
platelet O
endothelial O
cell O
adhesion O
molecules O
( O
PECAM-1 O
) O
. O

Bacterial O
lipopolysaccharide O
activates O
nuclear O
factor-kappaB O
through O
interleukin-1 O
signaling O
mediators O
in O
cultured B
human I
dermal I
endothelial I
cells I
and O
mononuclear O
phagocytes O
. O

Here O
we O
investigated O
the O
role O
and O
involvement O
of O
interleukin-1 O
( O
IL-1 O
) O
and O
tumor O
necrosis O
factor O
( O
TNF-alpha O
) O
signal O
transducer O
molecules O
in O
LPS O
signaling O
in O
human O
dermal O
microvessel O
endothelial O
cells O
( O
HDMEC O
) O
and O
THP-1 B
monocytic I
cells I
. O

LPS O
stimulation O
of O
HDMEC O
and O
THP-1 B
cells I
initiated O
an O
IL-1 O
receptor O
-like O
NF-kappaB O
signaling O
cascade O
. O

TLR2 O
and O
TLR4 O
were O
expressed O
on O
the O
cell O
surface O
of O
HDMEC O
and O
THP-1 B
cells I
. O

RA O
receptor O
activation O
appears O
critical O
to O
regulating O
important O
aspects O
of O
hematopoiesis O
, O
since O
transducing O
a O
COOH-terminally O
truncated O
RARalpha O
exhibiting O
dominant-negative O
activity O
( O
RARalpha403 O
) O
into O
normal O
mouse O
bone O
marrow O
generates O
hematopoietic B
growth I
factor-dependent I
cell I
lines I
frozen O
at O
the O
multipotent O
progenitor O
( O
EML O
) O
or O
committed O
promyelocyte O
( O
MPRO O
) O
stages O
. O

We O
investigated O
expression O
of O
the O
IL-2Ralpha O
in O
bronchoalveolar O
lavage O
( O
BAL O
) O
cells O
in O
active O
pulmonary O
tuberculosis O
, O
and O
evaluated O
the O
mechanism O
Mycobacterium O
tuberculosis O
induces O
in O
the O
IL-2Ralpha O
using O
the O
THP-1 B
mononuclear I
phagocyte I
cell I
line I
. O

In O
this O
study O
we O
examined O
the O
influence O
of O
local O
estrogen O
metabolism O
on O
the O
differentiation O
of O
HL60 B
cells I
and O
normal O
primitive O
myeloid O
progenitor O
cells O
. O

Quantitative O
thin-layer O
chromatography O
( O
TLC O
) O
analyses O
showed O
that O
HL60 B
and O
normal O
cells O
are O
able O
to O
generate O
estrone O
( O
E1 O
) O
from O
estradiol O
( O
E2 O
) O
. O

Conversion O
of O
E2 O
to O
E1 O
was O
upregulated O
within O
24 O
hours O
when O
HL60 B
cells I
were O
treated O
with O
either O
all-trans O
retinoic O
acid O
or O
D3 O
at O
doses O
that O
induce O
their O
differentiation O
toward O
neutrophils O
or O
monocytes O
, O
respectively O
. O

When O
HL60 B
cells I
or O
normal O
myeloid O
progenitor O
cells O
were O
exposed O
to O
exogenous O
E1 O
they O
became O
more O
sensitive O
to O
the O
differentiation-inducing O
effects O
of O
D3 O
. O

We O
have O
found O
that O
it O
is O
phosphorylated O
, O
predominantly O
on O
serine O
residues O
, O
when O
transiently O
overexpressed O
in O
293 B
cells I
. O

Overexpression O
of O
wild-type O
Grf40 O
in O
Jurkat B
cells I
induced O
a O
significant O
increase O
of O
SLP-76-dependent O
interleukin O
( O
IL O
) O
-2 O
promoter O
and O
nuclear O
factor O
of O
activated O
T O
cell O
( O
NF-AT O
) O
activation O
upon O
T O
cell O
receptor O
( O
TCR O
) O
stimulation O
, O
whereas O
the O
COOH-terminal O
SH3-deleted O
Grf40 O
mutant O
lacked O
any O
recognizable O
increase O
in O
IL-2 O
promoter O
activity O
. O

Engagement O
of O
natural O
cytotoxicity O
programs O
regulates O
AP-1 O
expression O
in O
the O
NKL B
human I
NK I
cell I
line I
. O

Using O
transcription O
analysis O
, O
such O
as O
multiplex O
messenger O
assays O
, O
we O
show O
here O
that O
natural O
cytotoxicity O
exerted O
by O
the O
human B
NKL I
cell I
line I
correlates O
with O
mRNA O
accumulation O
of O
very O
early O
activator O
protein O
( O
AP O
) O
-1 O
transcription O
factor O
genes O
such O
as O
JunB O
, O
FosB O
and O
c-Fos O
. O

We O
have O
previously O
shown O
that O
protein O
kinase O
C O
( O
PKC O
) O
activation O
( O
with O
phorbol O
ester O
( O
PMA O
) O
alone O
) O
specifically O
induces O
differentiation O
of O
primary B
human I
CD34+ I
hemopoietic I
progenitor I
cells I
( O
HPC B
) O
to O
mature O
DC O
. O

We O
now O
find O
that O
cytokine-driven O
( O
granulocyte-macrophage O
CSF O
and O
TNF-alpha O
) O
CD34+ O
HPC B
-- O
> O
DC O
differentiation O
is O
preferentially O
blocked O
by O
inhibitors O
of O
PKC O
activation O
. O

To O
further O
identify O
intracellular O
signals O
and O
downstream O
events O
important O
in O
CD34+ B
HPC I
-- O
> O
DC O
differentiation O
we O
have O
characterized O
a O
human O
leukemic O
cell O
line O
model O
of O
this O
process O
. O

The O
CD34+ B
myelomonocytic I
cell I
line I
KG1 B
differentiates O
into O
dendritic-like O
cells O
in O
response O
to O
granulocyte-macrophage O
CSF O
plus O
TNF-alpha O
, O
or O
PMA O
( O
with O
or O
without O
the O
calcium O
ionophore O
ionomycin O
, O
or O
TNF-alpha O
) O
, O
with O
different O
stimuli O
mediating O
different O
aspects O
of O
the O
process O
. O

Phenotypic O
DC O
characteristics O
of O
KG1 B
dendritic-like I
cells I
include O
morphology O
( O
loosely O
adherent O
cells O
with O
long O
neurite O
processes O
) O
, O
MHC O
I+/ O
MHC O
IIbright/CD83+/CD86+/ O
CD14 O
- O
surface O
Ag O
expression O
, O
and O
RelB O
and O
DC O
-CK1 O
gene O
expression O
. O

Comparison O
of O
KG1 B
to O
the O
PMA-unresponsive B
subline I
KG1a I
reveals O
differences O
in O
expression O
of O
TNF O
receptors O
1 O
and O
2 O
; O
PKC O
isoforms O
alpha O
, O
beta O
I O
, O
beta O
II O
, O
and O
mu O
; O
and O
RelB O
, O
suggesting O
that O
these O
components/pathways O
are O
important O
for O
DC O
differentiation O
. O

Together O
, O
these O
findings O
demonstrate O
that O
cytokine O
or O
phorbol O
ester O
stimulation O
of O
KG1 B
is O
a O
model O
of O
human B
CD34+ I
HPC I
to O
DC O
differentiation O
and O
suggest O
that O
specific O
intracellular O
signaling O
pathways O
mediate O
specific O
events O
in O
DC O
lineage O
commitment O
. O

Detection O
of O
NF-ATc.alpha O
mRNA O
is O
strictly O
dependent O
on O
cell O
activation O
signals O
in O
both O
T B
and I
mast I
cell I
lines I
. O

Thus O
CTL B
clones I
that O
recognized O
the O
viral O
, O
self O
, O
and O
bacterial O
peptides O
expressed O
a O
highly O
restricted O
alphabeta O
TCR O
phenotype O
. O

The O
CTL B
clones I
that O
recognized O
viral O
and O
self O
peptides O
were O
more O
oligoclonal O
, O
whereas O
clones O
that O
strictly O
recognized O
the O
viral O
peptide O
displayed O
a O
diverse O
TCR O
profile O
. O

The O
described O
crossreactions O
show O
that O
human O
antiviral O
, O
CD8 O
( O
+ O
) O
CTL O
responses O
can O
be O
shaped O
by O
peptide O
ligands O
derived O
from O
autoantigens O
and O
environmental O
bacterial O
antigens O
, O
thereby O
providing O
a O
firm O
structural O
basis O
for O
molecular O
mimicry O
involving O
class O
I-restricted B
CTLs I
in O
the O
pathogenesis O
of O
autoimmune O
disease O
. O

Recent O
reports O
have O
suggested O
a O
previously O
unexpected O
variability O
in O
the O
expression O
of O
the O
dominant B
neoplastic I
clone I
in O
myeloproliferative O
disorders O
( O
MPD O
) O
. O

Purified B
human I
peripheral I
T I
cells I
or O
Jurkat B
T I
cells I
were O
stimulated O
with O
Chinese O
hamster O
ovary O
( O
CHO O
) O
cells O
expressing O
either O
human O
CD80 O
( O
CHO-CD80 O
) O
or O
human O
CD86 O
( O
CHO-CD86 O
) O
or O
with O
anti-CD28 O
monoclonal O
antibody O
( O
mAb O
) O
. O

In O
the O
presence O
of O
phorbol O
12-myristate O
13-acetate O
, O
both O
CHO-CD80 O
and O
CHO-CD86 O
, O
like O
anti-CD28 O
mAb O
, O
were O
capable O
of O
stimulating O
cytokine O
production O
from O
both O
human O
peripheral O
T O
cells O
and O
Jurkat B
T I
cells I
. O

Surprisingly O
, O
although O
stimulation O
of O
Jurkat B
T I
cells I
with O
either O
CHO-CD80 O
or O
anti-CD28 O
mAb O
resulted O
in O
robust O
tyrosine O
phosphorylation O
of O
CD28 O
itself O
, O
ligation O
with O
CHO-CD86 O
was O
unable O
to O
induce O
detectable O
CD28 O
tyrosyl O
phosphorylation O
over O
a O
range O
of O
stimulation O
conditions O
. O

Expression O
studies O
revealed O
that O
HMG-I O
( O
Y O
) O
is O
ubiquitously O
expressed O
in O
human O
tissues O
that O
do O
not O
express O
beta-globin O
, O
being O
present O
in O
48 O
of O
50 O
tissues O
and O
six O
hematopoietic B
cell I
lines I
examined O
. O

Apart O
from O
clear-cut O
defects O
in O
the O
synthesis O
of O
mRNAs O
for O
Th2-type O
lymphokines O
, O
such O
as O
IL-4 O
, O
IL-5 O
, O
IL-10 O
and O
IL-13 O
, O
in O
primary O
and O
secondary O
stimulations O
of O
spleen O
cells O
in O
vitro O
, O
of O
a O
distinct O
impaired O
deletion O
of O
V B
beta I
11+/CD4+ I
T I
lymphocytes I
from O
these O
mice O
was O
detected O
after O
superantigen O
injection O
. O

In O
human O
peripheral O
blood O
NK O
cells O
, O
genistein O
at O
< O
0.5 O
micromol/L O
and O
DG O
and O
GG O
at O
0.1-10 O
micromol/L O
enhanced O
NK O
cell-mediated O
K562 B
cancer I
cell I
killing O
significantly O
( O
P O
< O
0.05 O
) O
. O

Unstimulated O
MRL-lpr/lpr B
and I
C3H-gld/gld I
CD4 I
( I
- I
) I
CD8 I
( I
- I
) I
T I
cells I
constitutively O
contained O
high O
levels O
of O
two O
proteins O
that O
bound O
to O
the O
FLRE O
. O

Although O
overexpressed O
Egr-1 O
was O
ineffective O
, O
overexpressed O
Egr-2 O
was O
as O
potent O
as O
Egr-3 O
in O
inducing O
fasL O
promoter-dependent O
reporter O
constructs O
in O
T O
cell O
hybridomas O
and O
HeLa O
cells O
, O
and O
both O
up-regulated O
endogenous O
fasL O
mRNA O
in O
HeLa B
cells I
. O

FasL-dependent O
reporter O
constructs O
in O
MRL-lpr/lpr B
and I
C3H-gld/gld I
CD4 I
( I
- I
) I
CD8 I
( I
- I
) I
T I
cells I
were O
constitutively O
active O
, O
and O
this O
activity O
was O
largely O
prevented O
by O
mutation O
of O
the O
critical O
Egr O
family O
binding O
element O
. O

Thus O
, O
Egr-2 O
, O
in O
addition O
to O
Egr-3 O
, O
regulates O
FasL O
expression O
in O
activated O
normal O
T O
cells O
, O
and O
Egr-2 O
is O
likely O
to O
play O
a O
direct O
role O
in O
aberrant O
fasL O
up-regulation O
in O
lpr/lpr B
and I
gld/gld I
CD4 I
( I
- I
) I
CD8 I
( I
- I
) I
T I
cells I
. O

Paradoxically O
, O
removal O
of O
interdomain O
B O
( O
to O
create O
the O
construct O
designated O
Delta O
) O
, O
containing O
the O
Y292 O
, O
Y315 O
, O
and O
Y319 O
sites O
, O
did O
not O
eliminate O
the O
ability O
of O
ZAP-70 O
to O
induce O
multiple O
gene O
reporters O
in O
Syk-deficient B
DT-40 I
B I
cells I
and O
ZAP-70/Syk-deficient B
Jurkat I
cells I
. O

The O
cells O
used O
were O
the O
BLIN-1 B
pre-B I
cell I
line I
expressing O
low O
levels O
of O
cell O
surface O
mu O
heavy O
chain O
associated O
with O
surrogate O
light O
chain O
and O
the O
1E8 O
immature O
B O
cell O
line O
expressing O
cell O
surface O
mu/kappa O
. O

Lysates O
from O
CD19 O
cross-linked O
1E8 B
cells I
induced O
robust O
phosphorylation O
of O
an O
Elk-1 O
fusion O
protein O
in O
vitro O
, O
whereas O
no O
phosphorylation O
of O
Elk-1 O
fusion O
protein O
occurred O
using O
lysates O
from O
CD19 B
cross-linked I
BLIN-1 I
cells I
. O

An O
electrophoretic O
mobility O
shift O
assay O
employing O
AP-1 O
and O
NF-kappaB O
consensus O
oligonucleotides O
was O
used O
to O
demonstrate O
that O
AP-1 O
-binding O
activity O
increased O
, O
while O
constitutive O
NF-kappaB O
-binding O
activity O
was O
not O
enhanced O
, O
following O
2 O
h O
of O
CD19 O
cross-linking O
in O
1E8 B
cells I
. O
Supershift O
experiments O
revealed O
that O
JunD O
and O
c-Fos O
proteins O
mediated O
anti- O
CD19 O
induced O
AP-1 O
-binding O
activity O
in O
1E8 B
cells I
. O

In O
contrast O
, O
CD19 O
cross-linking O
in O
BLIN-1 B
cells I
resulted O
in O
the O
induction O
of O
NF-kappaB O
, O
but O
had O
no O
apparent O
effect O
on O
AP-1 O
-binding O
activity O
. O

Nevertheless O
, O
none O
of O
the O
genes O
originally O
thought O
to O
be O
regulated O
by O
Oct2 O
were O
affected O
in O
their O
expression O
in O
Oct2-deficient B
B I
cells I
. O

Whereas O
CD36 O
and O
mEI O
were O
expressed O
in O
all O
hematopoetic B
cell I
lines I
containing O
Oct2 O
, O
. O

RFX-B O
complements O
the O
predominant O
BLS O
complementation O
group O
( O
group O
B O
) O
and O
was O
found O
to O
be O
mutant O
in O
cell B
lines I
from O
this O
BLS O
group O
. O

Although O
NF-kappaB/Rel O
factors O
are O
known O
to O
induce O
the O
expression O
of O
T-cell O
growth O
factor O
interleukin O
( O
IL O
) O
-2 O
, O
it O
is O
unclear O
how O
they O
participate O
in O
the O
IL-2 O
-independent O
growth O
of O
HTLV-I-transformed B
cells I
. O

These O
results O
raise O
the O
possibility O
that O
NF-kappaB/Rel O
may O
participate O
in O
the O
growth O
control O
of O
HTLV-I-transformed B
T I
cells I
by O
regulating O
genes O
driven O
by O
both O
kappaB O
and O
certain O
STAT O
enhancers O
. O

To O
investigate O
the O
events O
involved O
in O
activation-induced O
Fas O
upregulation O
, O
we O
have O
examined O
mRNA O
accumulation O
, O
fas O
promoter O
activity O
, O
and O
protein O
expression O
in O
the O
Jurkat B
T-cell I
line I
treated O
with O
phorbol O
myristate O
acetate O
and O
ionomycin O
( O
P/I O
) O
, O
pharmacological O
mimics O
of O
T-cell O
receptor O
activation O
. O

Although O
resting B
Jurkat I
cells I
express O
Fas O
, O
Fas O
mRNA O
was O
induced O
approximately O
10-fold O
in O
2 O
h O
upon O
P/I O
stimulation O
. O

The O
functional O
contribution O
of O
the O
kappaB-Sp1 O
composite O
site O
in O
P/I-inducible O
fas O
promoter O
activation O
was O
verified O
by O
using O
kappaB- O
Sp1 O
concatamers O
( O
-295 O
to O
-286 O
) O
in O
a O
thymidine O
kinase O
promoter-driven O
reporter O
construct O
and O
native O
promoter O
constructs O
in O
Jurkat B
cells I
overexpressing O
IkappaB-alpha O
. O

Fusion O
of O
anergic O
murine O
T O
cells O
to O
human O
Jurkat O
T O
leukemia O
cells O
and O
formation O
of O
heterokaryons B
failed O
to O
result O
in O
a O
complementation O
of O
this O
signaling O
defect O
and O
restoration O
of O
murine O
IL-2 O
mRNA O
inducibility O
. O

Heterokaryons B
formed O
by O
the O
fusion O
of O
anergic O
murine O
T O
cells O
to O
normal O
murine O
T O
cells O
also O
failed O
to O
accumulate O
intracellular O
IL-2 O
protein O
in O
response O
to O
stimulation O
either O
with O
the O
combination O
of O
CD3 O
and O
CD28 O
mAbs O
or O
with O
ionomycin O
plus O
a O
protein O
kinase O
C O
-activating O
phorbol O
ester O
. O

Comparison O
of O
HTLV-I O
basal O
transcription O
and O
expression O
of O
CREB/ATF-1/CREM O
family O
members O
in O
peripheral O
blood O
mononuclear O
cells O
and O
Jurkat B
T I
cells I
. O

Using O
mitogen O
stimulated O
and O
quiescent O
peripheral O
blood O
mononuclear O
cells O
( O
PBMC O
) O
and O
Jurkat B
cells I
, O
we O
compared O
differences O
in O
basal O
transcription O
and O
amounts O
and O
binding O
of O
transcription O
factors O
with O
TRE-1 O
. O

We O
demonstrate O
that O
amounts O
of O
transcriptionally O
active O
phosphorylated O
CREB O
protein O
( O
P-CREB O
) O
differ O
between O
activated O
PBMC O
and O
Jurkat B
cells I
. O

Following O
stimulation O
, O
P-CREB O
levels O
remain O
elevated O
in O
PBMC O
for O
up O
to O
24 O
hours O
whereas O
CREB O
is O
dephosphorylated O
in O
Jurkat B
cells I
within O
4 O
hours O
following O
stimulation O
. O

The O
differences O
in O
P-CREB O
levels O
between O
PBMC O
and O
Jurkat B
cells I
were O
directly O
correlated O
with O
basal O
transcription O
of O
HTLV-I O
in O
the O
two O
cell O
types O
. O

These O
data O
demonstrate O
that O
PBMC O
differentially O
regulate O
basal O
HTLV-I O
transcription O
compared O
with O
Jurkat B
T I
cells I
, O
and O
this O
differential O
regulation O
is O
due O
, O
in O
part O
to O
differential O
phosphorylation O
and O
binding O
of O
CREB/ATF-1 O
to O
TRE-1 O
in O
the O
HTLV-I O
promoter O
. O

Anoxia/reoxygenation-induced O
tolerance O
with O
respect O
to O
polymorphonuclear O
leukocyte O
adhesion O
to O
cultured B
endothelial I
cells I
. O

Exposing O
human B
umbilical I
vein I
endothelial I
cells I
( O
HUVECs B
) O
to O
anoxia/reoxygenation O
( O
A/R O
) O
results O
in O
an O
increase O
in O
polymorphonuclear O
leukocyte O
( O
PMN O
) O
adhesion O
to O
HUVECs B
. O

This O
A/R-induced O
hyperadhesion O
is O
completely O
prevented O
by O
a O
previous O
( O
24 O
hours O
earlier O
) O
exposure O
of O
HUVECs B
to O
A/R O
. O

Exposing O
HUVECs B
to O
A/R O
induces O
an O
increase O
in O
nuclear O
factor O
kappaB O
( O
NF-kappaB O
) O
in O
HUVEC O
nuclei O
within O
4 O
hours O
. O

Interfering O
with O
either O
NF-kappaB O
activation O
( O
proteasome O
inhibitor O
) O
or O
translocation O
( O
double-stranded O
oligonucleotides O
containing O
NF-kappaB O
binding O
sequence O
) O
prevents O
the O
development O
of O
A/R O
tolerance O
( O
ie O
, O
the O
increase O
in O
A/R-induced O
PMN O
adhesion O
to O
HUVECs B
is O
the O
same O
after O
the O
first O
and O
second O
A/R O
challenges O
) O
. O

NO O
production O
by O
HUVECs B
is O
increased O
after O
the O
second O
A/R O
challenge O
, O
but O
not O
after O
the O
first O
A/R O
challenge O
. O

However O
, O
while O
HUVECs B
contained O
endothelial O
NOS O
protein O
, O
no O
inducible O
NOS O
was O
detected O
in O
either O
tolerant O
or O
nontolerant O
cells O
. O

Further O
studies O
indicated O
that O
inhibition O
of O
GTP-cyclohydrolase O
I O
( O
an O
enzyme O
involved O
in O
de O
novo O
synthesis O
of O
an O
important O
cofactor O
for O
NOS O
activity O
, O
tetrahydrobiopterin O
) O
prevented O
the O
generation O
of O
NO O
in O
A/R-tolerant B
cells I
. O

A/R O
also O
induced O
an O
oxidant O
stress O
in O
naive O
HUVECs B
, O
but O
not O
in O
A/R-tolerant B
HUVECs I
. O

Furthermore O
, O
ectopic O
expression O
of O
EBF O
in O
HeLa B
cells I
activated O
a O
B29 O
promoter-controlled O
reporter O
construct O
13-fold O
and O
induced O
a O
low O
level O
of O
expression O
from O
the O
endogenous O
B29 O
gene O
. O

Finally O
, O
mutations O
in O
the O
EBF O
binding O
sites O
diminished O
B29 O
promoter O
activity O
in O
pre-B O
cells O
while O
the O
same O
mutations O
did O
not O
have O
as O
striking O
an O
effect O
on O
the O
promoter O
function O
in O
B-cell B
lines I
of O
later O
differentiation O
stages O
. O

Delta-opioid O
receptors O
expressed O
by O
Jurkat B
T I
cells I
enhance O
IL-2 O
secretion O
by O
increasing O
AP-1 O
complexes O
and O
activity O
of O
the O
NF-AT/AP-1-binding O
promoter O
element O
. O

We O
therefore O
created O
and O
studied O
a O
T B
cell I
line I
expressing O
the O
cloned O
delta-opioid O
receptor O
( O
DOR1 O
) O
. O

In O
the O
present O
study O
, O
we O
have O
characterized O
the O
transcriptional O
induction O
of O
p40 O
by O
CD40 O
ligation O
in O
a O
human B
B I
lymphoblastoid I
cell I
line I
, O
Daudi B
, O
and O
a O
human B
acute I
monocytic I
leukemia I
cell I
line I
, O
THP-1 B
. O

Electrophoretic O
mobility O
shift O
assay O
revealed O
that O
the O
potential O
NF-kappaB O
binding O
sequence O
which O
is O
located O
around O
120 O
bp O
upstream O
of O
the O
transcription O
initiation O
site O
in O
murine O
and O
human O
p40 O
genes O
formed O
an O
NF-kappaB O
complex O
with O
nuclear O
extract O
from O
Daudi B
cells I
stimulated O
by O
CD40 O
ligation O
. O

Moreover O
, O
transfection O
of O
Daudi B
cells I
with O
the O
polymerized O
NF-kappaB O
binding O
sequence O
ligated O
to O
a O
thymidine O
kinase/chloramphenicol O
acetyltransferase O
( O
CAT O
) O
reporter O
plasmid O
greatly O
induced O
CAT O
activity O
, O
but O
transfection O
with O
the O
polymerized O
mutated O
NF-kappaB O
binding O
sequence O
did O
not O
. O

The O
GATA-3 O
transcription O
factor O
is O
required O
for O
development O
of O
the O
T-cell B
lineage I
and O
Th2 O
cytokine O
gene O
expression O
in O
CD4 O
T-cells O
. O

CD23 O
expression O
and O
IgE O
synthesis O
by O
IL-4 O
were O
augmented O
in O
Ile50-bearing B
PBMC I
, O
compared O
with O
those O
bearing O
Val50 O
. O

A O
novel O
growth-factor-dependent B
myeloid I
cell I
line I
derived O
from O
mouse O
bone O
marrow O
cells O
contains O
progenitors O
endowed O
with O
high O
proliferative O
potential O
. O

Constitutive O
expression O
of O
human O
colony-stimulating O
factor-1 O
receptor O
( O
CSF-1R O
) O
confers O
long-lasting O
CSF-1 O
-dependent O
proliferation O
to O
mouse B
myeloid I
cell I
lines I
. O

Then O
bone O
marrow O
cells O
from O
transgenic O
mice O
were O
plated O
onto O
MS-5 O
stromal O
cells O
expressing O
the O
membrane O
form O
of O
human O
CSF-1 O
( O
2M-1 B
cells I
) O
in O
order O
to O
combine O
the O
hematopoietic O
supporting O
properties O
of O
stromal O
cells O
and O
the O
proliferative O
effects O
of O
CSF-1 O
. O

Thus O
, O
we O
were O
able O
to O
derive O
a O
hematopoietic B
cell I
line I
, O
called O
47.10 B
, O
that O
grew O
indefinitely O
under O
these O
conditions O
, O
whereas O
no O
cell O
line O
could O
be O
developed O
from O
nontransgenic O
mice O
. O

Proliferation O
of O
47.10 B
cells I
is O
severely O
affected O
by O
neutralizing O
anti-CSF-1R O
monoclonal O
antibodies O
. O

Morphologic O
and O
cytofluorometry O
analysis O
established O
that O
most O
47.10 B
cells I
are O
immature O
myelomonocytic O
cells O
. O

Consistent O
with O
this O
phenotype O
, O
the O
myeloid O
transcription O
factor O
PU.1 O
, O
but O
not O
the O
erythroid O
transcription O
factor O
GATA-1 O
, O
is O
expressed O
in O
47.10 B
cells I
. O

A O
few O
47.10 B
cells I
( O
3-5 O
% O
) O
do O
not O
express O
lineage O
specific O
markers O
; O
they O
differentiate O
spontaneously O
to O
lineage-positive B
cells I
after O
replating O
on O
2M-1 B
cells I
. O

In O
agar O
cultures O
, O
47.10 B
cells I
form O
7- O
and O
14-day O
colonies O
in O
response O
to O
a O
cocktail O
of O
granulocyte/macrophage O
colony-stimulating O
factor O
( O
2.5 O
ng/mL O
) O
, O
interleukin-3 O
( O
1 O
ng/mL O
) O
, O
and O
mouse O
CSF-1 O
( O
10 O
ng/mL O
) O
. O

Under O
these O
conditions O
, O
about O
0.5 O
% O
of O
47.10 B
cells I
formed O
large O
14-day O
colonies O
( O
> O
1 O
mm O
) O
composed O
of O
mature O
monocytes O
and O
granulocytes O
, O
reflecting O
the O
presence O
of O
progenitors O
endowed O
with O
high O
proliferative O
potential O
( O
HPP-47.10 B
cells I
) O
. O

In O
conclusion O
, O
we O
have O
characterized O
a O
novel O
continuous B
myeloid I
cell I
line I
presenting O
a O
hierarchical O
structure O
similar O
to O
that O
of O
the O
bone B
marrow I
progenitor I
cell I
compartment I
. O

Human O
T-cell O
leukemia O
virus O
type O
1 O
tax O
protein O
abrogates O
interleukin-2 O
dependence O
in O
a O
mouse B
T-cell I
line I
. O

We O
examined O
the O
effect O
of O
Tax O
activity O
on O
the O
growth O
of O
the O
interleukin-2 B
( I
IL-2 I
) I
-dependent I
T-cell I
line I
CTLL-2 B
. O

Stable O
expression O
of O
Tax O
in O
CTLL-2 B
transformed O
cell O
growth O
from O
being O
IL-2 O
dependent O
to O
IL-2 O
independent O
. O

Accessing O
Epstein-Barr O
virus-specific O
T-cell O
memory O
with O
peptide-loaded B
dendritic I
cells I
. O

The O
conventional O
means O
of O
studying O
Epstein-Barr O
virus O
( O
EBV O
) O
-induced O
cytotoxic O
T-lymphocyte O
( O
CTL O
) O
memory O
, O
by O
in O
vitro O
stimulation O
with O
the O
latently O
infected O
autologous O
lymphoblastoid B
cell I
line I
( O
LCL B
) O
, O
has O
important O
limitations O
. O

Here O
we O
describe O
an O
alternative O
approach O
, O
based O
on O
in O
vitro O
stimulation O
with O
epitope B
peptide-loaded I
dendritic I
cells I
( O
DCs B
) O
, O
which O
allows O
one O
to O
probe O
the O
CTL O
repertoire O
for O
any O
individual O
reactivity O
of O
choice O
; O
this O
method O
proved O
significantly O
more O
efficient O
than O
stimulation O
with O
peptide O
alone O
. O

We O
further O
show O
that O
subdominant O
latent O
cycle O
reactivities O
to O
epitopes O
in O
the O
latent O
membrane O
protein O
LMP2 O
, O
though O
rarely O
undetectable O
in O
LCL B
-stimulated O
populations O
, O
can O
be O
reactivated O
by O
DC O
stimulation O
and O
selectively O
expanded O
as O
polyclonal O
CTL B
lines I
; O
the O
adoptive O
transfer O
of O
such O
preparations O
may O
be O
of O
value O
in O
targeting O
certain O
EBV-positive O
malignancies O
. O

We O
previously O
demonstrated O
that O
GRbeta O
could O
antagonize O
GRalpha O
-mediated O
transactivation O
of O
a O
glucocorticoid-responsive O
element O
( O
GRE O
) O
-driven O
reporter O
gene O
in O
COS-7 B
cells I
. O

Surprisingly O
, O
overexpression O
of O
GRbeta O
in O
Jurkat B
cells I
did O
not O
cause O
significant O
inhibition O
of O
GRalpha O
-induced O
transactivation O
of O
a O
GRE-dependent O
luciferase O
reporter O
gene O
either O
. O

GRbeta O
can O
neither O
antagonize O
GRalpha O
-mediated O
transactivation O
nor O
transrepression O
in O
Jurkat B
cells I
, O
indicating O
a O
cell O
type-specific O
pattern O
of O
GRbeta O
-mediated O
antiglucocorticoid O
activity O
. O

Extinction O
of O
immunoglobulin O
gene O
expression O
in O
B O
cells O
upon O
fusion O
with O
HeLa B
cells I
is O
preceded O
by O
rapid O
nuclear O
depletion O
of O
essential O
transcription O
factors O
and O
is O
accompanied O
by O
widespread O
inactivation O
of O
genes O
expressed O
in O
a O
B O
cell-specific O
manner O
. O

Here O
we O
demonstrate O
that O
fusion O
of O
HeLa B
cells I
with O
either O
diploid O
or O
tetraploid O
B O
cells O
( O
Daudi B
) O
results O
in O
widespread O
extinction O
of O
several O
other O
B O
cell-encoded O
genes O
that O
are O
expressed O
in O
a O
B O
cell-specific O
manner O
. O

By O
isolating O
Daudi B
x I
HeLa I
heterokaryons I
a O
few O
hours O
after O
fusion O
, O
we O
have O
studied O
the O
initial O
fate O
of O
two O
B O
cell-specific O
transcription O
factors O
involved O
in O
Ig O
gene O
transcription O
, O
Oct-2 O
and O
NF-kappa O
B O
. O

This O
report O
provides O
the O
first O
demonstration O
that O
upon O
fusion O
with O
HeLa B
cells I
, O
the O
nuclear O
contents O
of O
B O
cell-expressed O
transcription O
factors O
are O
depleted O
within O
a O
few O
hours O
with O
kinetics O
that O
are O
as O
fast O
or O
faster O
than O
that O
of O
Ig O
gene O
extinction O
. O

We O
suggest O
that O
extinction O
of O
Ig O
genes O
is O
part O
of O
a O
global O
mechanism O
that O
suppresses O
the O
differentiation O
program O
foreign O
to O
the O
HeLa B
phenotype I
. O

Allergen-specific O
T O
cells O
in O
atopic O
patients O
are O
polarized O
IL-4-producing B
Th2 I
cells I
, O
promoting O
IgE O
synthesis O
by O
B O
cells O
. O

In O
a O
series O
of O
electrophoretic O
mobility O
shift O
assays O
with O
protein O
extracts O
of O
highly B
polarized I
Th2 I
clones I
from O
atopics O
and O
Th1 B
clones I
from O
controls O
we O
compared O
DNA-binding O
activities O
at O
the O
two O
NFAT-binding O
elements O
P0 O
and O
P1 O
of O
the O
crucial O
proximal O
human O
IL-4 O
promoter O
. O

At O
the O
most O
proximal O
P0 O
site O
, O
NFAT-containing O
complexes O
devoid O
of O
NFAT2 O
were O
readily O
inducible O
in O
the O
Th1 B
clones I
, O
but O
hardly O
or O
not O
in O
the O
Th2 B
clones I
. O

In O
contrast O
, O
both O
in O
Th1 B
and I
Th2 I
clones I
NFAT-containing O
complexes O
were O
strongly O
inducible O
at O
the O
P1 O
site O
, O
consisting O
of O
NFAT2 O
and O
a O
P0 O
-compatible O
NFAT O
activity O
, O
without O
apparent O
differences O
between O
Th1 B
and I
Th2 I
clones I
. O

Like O
in O
Th2 B
clones I
, O
suppressed O
NFAT- O
P0 O
complex O
formation O
was O
observed O
also O
at O
the O
polyclonal O
level O
in O
peripheral O
blood O
mononuclear O
cells O
( O
PBMC O
) O
of O
three O
of O
five O
severe O
atopic O
dermatitis O
patients O
with O
strongly O
elevated O
serum O
IgE O
levels O
, O
but O
not O
in O
control O
PBMC O
. O

A O
role O
for O
changes O
in O
immunophilins O
, O
causing O
glucocorticoid O
resistance O
in O
neotropical O
primates O
, O
is O
supported O
by O
the O
following O
: O
the O
changes O
in O
FKBP51 O
and O
FKBP52 O
were O
observed O
in O
cells O
from O
other O
neotropical O
primates O
with O
glucocorticoid O
resistance O
; O
the O
elevated O
level O
of O
FKBP51 O
was O
reflected O
in O
an O
abundance O
of O
FKBP51 O
in O
heat O
shock O
protein O
90 O
complexes O
in O
SML O
; O
when O
cytosols O
of O
SML O
and O
L929 B
cells I
were O
mixed O
, O
the O
decrease O
in O
GR O
binding O
was O
associated O
with O
incorporation O
of O
FKBP51 O
into O
GR O
heterocomplexes O
; O
the O
effect O
of O
SML O
cytosol O
on O
GR O
binding O
was O
reproduced O
with O
cytosol O
from O
COS B
cells I
expressing O
squirrel O
monkey O
FKBP51 O
; O
and O
both O
the O
effect O
of O
SML O
cytosol O
on O
GR O
binding O
and O
the O
incorporation O
of O
FKBP51 O
into O
GR O
heterocomplexes O
were O
blocked O
by O
FK506 O
. O

GR O
number O
in O
the O
patient O
's O
transformed B
lymphocytes I
was O
approximately O
one O
half O
that O
of O
control O
cells O
with O
a O
approximately O
10-fold O
reduction O
in O
binding O
affinity O
for O
dexamethasone O
. O

In O
vitro O
apoptosis O
induction O
in O
CLL B
cells I
was O
delayed O
in O
response O
to O
GCs O
, O
but O
not O
to O
other O
apoptosis O
inducers O
. O

To O
characterize O
the O
human O
elk-1 O
promoter O
, O
we O
mapped O
the O
transcriptional O
start O
site O
and O
isolated O
elk-1-specific B
genomic I
phage I
clones I
that O
contained O
extensive O
upstream O
and O
downstream O
sequences O
. O

Seven O
of O
15 O
fibroblast B
lines I
were O
heterozygous O
for O
polymorphic O
alleles O
, O
and O
the O
expression O
patterns O
were O
variable O
, O
i.e. O
, O
equal O
, O
unequal O
or O
monoallelic O
paternal O
expression O
in O
three O
, O
two O
and O
two O
cases O
, O
respectively O
. O

Precursor O
frequency O
of O
anti-SSB B
T I
cells I
was O
1 O
: O
77 O
, O
040 O
and O
1 O
: O
115 O
, O
000 O
in O
2 O
healthy O
subjects O
and O
1 O
: O
230 O
, O
250 O
and O
1 O
: O
103 O
, O
034 O
in O
two O
patients O
with O
SS O
. O

Anti-La B
( I
SSB I
) I
specific I
T I
cells I
occur O
in O
a O
significant O
proportion O
of O
controls O
and O
in O
some O
patients O
with O
SS O
. O

The O
function O
of O
SSB B
T I
cells I
in O
controls O
remains O
to O
be O
defined O
. O

Anti-rheumatic O
compound O
aurothioglucose O
inhibits O
tumor O
necrosis O
factor-alpha O
-induced O
HIV-1 O
replication O
in O
latently O
infected O
OM10.1 B
and I
Ach2 I
cells I
. O

In O
this O
report O
we O
have O
examined O
the O
efficacy O
of O
the O
gold O
compound O
AuTG O
as O
an O
inhibitor O
of O
HIV O
replication O
in O
latently O
infected O
OM10.1 B
and I
Ach2 I
cells I
. O

Tumor O
necrosis O
factor O
( O
TNF O
) O
-alpha O
-induced O
HIV-1 O
replication O
in O
OM10.1 B
or O
Ach2 B
cells I
was O
significantly O
inhibited O
by O
non-cytotoxic O
doses O
of O
AuTG O
( O
> O
10 O
microM O
in O
OM10.1 O
cells O
and O
> O
25 O
F.M O
in O
Ach2 B
cells I
) O
, O
while O
25 O
microM O
of O
the O
counter-anion O
thioglucose O
( O
TG O
) O
or O
gold O
compound O
containing O
divalent O
gold O
ion O
, O
HAuCl3 O
, O
had O
no O
effect O
. O

LysoPC O
inhibited O
the O
TF O
activity O
of O
Mono B
Mac-6 I
cells I
to O
a O
similar O
extent O
as O
in O
the O
monocytes O
. O

Inhibition O
of O
NF-kappaB O
activity O
in O
a O
T B
cell I
hybridoma I
leads O
to O
decreased O
FasL O
expression O
and O
apoptosis O
upon O
T O
cell O
receptor O
stimulation O
. O

This O
GAG O
also O
possesses O
immunomodulatory O
activity O
in O
vivo O
and O
can O
antagonize O
the O
capacity O
of O
IFN-gamma O
to O
induce O
class O
II O
MHC O
antigen O
expression O
, O
and O
to O
up-regulate O
intercellular O
adhesion O
molecule-1 O
, O
by O
cultured B
endothelial I
cells I
. O

Results O
from O
this O
study O
indicate O
that O
soluble O
, O
heparin-like O
GAGs O
can O
block O
IFN-gamma O
-dependent O
up-regulation O
of O
MCP-1 O
production O
by O
cultured B
endothelial I
cells I
, O
and O
can O
also O
antagonize O
the O
leucocyte-activating O
and O
migration-promoting O
properties O
of O
pre-existing O
MCP-1 O
. O

The O
binding O
of O
these O
proteins O
to O
the O
regulatory O
region O
of O
IL-2 O
gene O
in O
vitro O
and O
stimulation O
of O
the O
IL-2mRNA O
synthesis O
in O
splenic B
T-lymphocytes I
culture I
in O
normal O
conditions O
were O
shown O
. O

IFN-alpha O
also O
sensitized B
T I
cells I
to O
IL-2 O
-induced O
proliferation O
, O
further O
suggesting O
that O
IFN-alpha O
may O
be O
involved O
in O
the O
regulation O
of O
T-cell O
mitogenesis O
. O

Lactobacilli O
, O
a O
component O
of O
the O
normal O
vaginal O
flora O
, O
can O
activate O
the O
human O
immunodeficiency O
virus O
( O
HIV O
) O
-1 O
long O
terminal O
repeat O
( O
LTR O
) O
in O
the O
Jurkat B
T I
lymphocyte I
and O
THP-1 B
macrophage I
cell I
lines I
. O

Activation O
of O
the O
LTR O
in O
Jurkat B
cells I
was O
strongly O
enhanced O
by O
vanadate O
and O
inhibited O
by O
catalase O
, O
implicating O
H2O2 O
. O

We O
compared O
U-937 B
cell I
adhesion O
and O
adhesion O
molecule O
expression O
in O
human O
umbilical O
venous O
( O
HUVECs O
) O
and O
arterial O
( O
HUAECs O
) O
endothelial O
cells O
exposed O
to O
tumor O
necrosis O
factor O
( O
TNF O
) O
, O
interleukin-1 O
, O
and O
lipopolysaccharide O
( O
LPS O
) O
. O

TNF O
and O
LPS O
stimulated O
vascular O
cell O
adhesion O
molecule O
( O
VCAM O
) O
-1 O
surface O
expression O
and O
adhesion O
of O
U-937 B
monocyte-like I
cells I
to O
HUVECs O
but O
not O
to O
HUAECs O
. O

Interleukin-1 O
stimulated O
U-937 B
cell I
adhesion O
to O
and O
VCAM-1 O
surface O
expression O
in O
both O
HUVECs O
and O
HUAECs O
. O

Pyrrolidinedithiocarbamate O
and O
the O
proteasome O
inhibitor O
MG-132 O
blocked O
TNF O
-and O
LPS-stimulated O
U-937 B
cell I
adhesion O
to O
HUVECs O
. O

Cytoplasmic O
AR O
do O
not O
translocate O
to O
the O
nucleus O
of O
T O
cells O
in O
the O
presence O
of O
testosterone O
, O
in O
contrast O
to O
cytoplasmic O
AR O
in O
human B
cancer I
LNCaP I
cells I
. O

No O
constitutive O
tyrosine O
phosphorylation O
was O
detected O
on O
any O
STAT O
in O
CLL B
cells I
. O

To O
assess O
the O
phosphorylation O
of O
serine O
residues O
of O
STAT1 O
and O
STAT3 O
in O
CLL B
cells I
, O
we O
raised O
antibodies O
that O
specifically O
recognize O
the O
form O
of O
STAT1 O
phosphorylated O
on O
ser-727 O
and O
the O
form O
of O
STAT3 O
phosphorylated O
on O
ser-727 O
. O

The O
serine O
phosphorylation O
of O
these O
STATs O
was O
a O
continuous O
process O
, O
as O
incubation O
of O
CLL B
cells I
with O
the O
kinase O
inhibitor O
H7 O
led O
to O
the O
dephosphorylation O
of O
these O
serine O
residues O
. O

G. O
vaginalis O
lysates O
also O
activated O
HIV O
expression O
in O
certain O
T B
cell I
lines I
. O

The O
X-inactivation O
patterns O
of O
circulating O
PMNCs O
and O
T O
lymphocytes O
as O
well O
as O
individual O
granulocyte B
colonies I
grown O
in O
vitro O
from O
bone O
marrow O
cells O
were O
analyzed O
. O

The O
development O
of O
ringed O
sideroblasts O
in O
erythroid B
colonies I
by O
iron O
staining O
and O
their O
X-inactivation O
pattern O
were O
also O
examined O
. O

In O
granulocyte B
colonies I
, O
however O
, O
two O
different O
X-inactivation O
patterns O
were O
observed O
in O
all O
patients O
, O
indicating O
that O
non-clonal O
progenitor O
cells O
remained O
in O
the O
bone O
marrow O
. O

All O
erythroid B
colonies I
consisted O
of O
ringed O
sideroblasts O
exclusively O
showed O
one O
pattern O
dominant O
in O
those O
of O
PMNCs O
. O

We O
isolated O
mouse O
Notch-1 O
in O
a O
yeast O
two-hybrid O
screen O
with O
Nur77 O
, O
which O
is O
a O
protein O
that O
has O
been O
shown O
previously O
to O
be O
required O
for O
apoptosis O
in O
T B
cell I
lines I
. O

The O
data O
presented O
below O
indicate O
that O
Notch-1 O
expression O
provides O
significant O
protection O
to O
T B
cell I
lines I
from O
TCR O
-mediated O
apoptosis O
. O

Addition O
of O
exogenous O
IL-2 O
to O
IL-10-treated B
cells I
significantly O
reversed O
the O
antiproliferative O
effects O
of O
IL-10 O
. O

Furthermore O
, O
the O
ability O
to O
suppress O
IL-1RI O
and O
IL-1RII O
mRNA O
levels O
was O
not O
unique O
to O
IFN-gamma O
because O
IL-10 O
also O
inhibited O
expression O
of O
these O
genes O
in O
IL-4/IL-13-stimulated B
monocytes I
. O

We O
previously O
reported O
that O
dexamethasone O
( O
DEX O
) O
, O
a O
synthetic O
glucocorticoid O
, O
causes O
apoptosis O
in O
mature B
Th I
cell I
lines I
, O
and O
that O
this O
induction O
of O
cell O
death O
is O
prevented O
by O
specific O
cytokines O
, O
namely O
, O
by O
IL-2 O
in O
Th1 O
cells O
and O
by O
IL-4 O
in O
Th2 O
cells O
. O

We O
identified O
a O
cell-type-specific O
differential O
response O
: O
CREB O
, O
CTF O
, O
OTF-1 O
, O
OFT-2 O
, O
and O
NF-kappa O
B O
genes O
were O
strongly O
induced O
1 O
to O
4 O
hours O
after O
influenza O
A O
virus O
infection O
in O
the O
monocytic B
cell I
line I
Mono B
Mac I
6 I
, O
while O
in O
freshly O
prepared O
human O
monocytes O
no O
significant O
changes O
were O
detected O
. O

Three O
days O
after O
establishing O
high-density O
PBMC O
cultures O
( O
1.5 O
x O
10 O
( O
6 O
) O
cells/cm2 O
) O
, O
in O
serum-containing O
medium O
, O
small O
adherent B
colonies I
of O
tartrate B
resistant I
acid I
phosphatase I
positive I
( I
TRAP+ I
) I
cells I
emerge O
, O
amidst O
massive O
monocyte O
cell O
death O
. O

When O
cultured O
on O
bone O
, O
VR+ B
, I
TRAP+ I
cells I
of O
low O
multinuclearity O
appear O
and O
cover O
up O
to O
50 O
% O
of O
the O
surface O
. O

Adhesion O
of O
monocytoid B
U937 I
cells I
to O
LPS-treated O
endothelial O
cells O
was O
reduced O
concomitantly O
. O

Both O
Stat3 O
-activation O
and O
Stat3 O
-independent O
BCL2 O
downregulation O
are O
important O
for O
interleukin-6 O
-induced O
apoptosis O
of O
1A9-M B
cells I
. O

A O
unique O
subclone O
of O
a O
bone B
marrow-derived I
stromal I
cell I
line I
, O
BMS2.4 B
, O
produces O
soluble O
factors O
that O
inhibit O
proliferation O
of O
several O
types O
of O
hematopoietic B
cell I
lines I
. O

We O
used O
expression O
cloning O
to O
identify O
interleukin-6 O
( O
IL-6 O
) O
as O
one O
factor O
that O
suppressed O
growth O
of O
a O
pre-B-cell B
variant I
line I
, O
1A9-M B
. O

Moreover O
, O
IL-6 O
induced O
macrophage-differentiation O
and O
apoptosis O
of O
1A9-M B
cells I
. O

During O
this O
process O
, O
IL-6 O
downregulated O
expression O
of O
BCL2 O
in O
1A9-M B
cells I
and O
stimulated O
BCL-XL O
expression O
, O
but O
had O
no O
effect O
on O
p53 O
, O
Bax O
, O
or O
Bak O
gene O
expression O
. O

Mechanisms O
for O
transduction O
of O
IL-6 O
-induced O
signals O
were O
then O
evaluated O
in O
IL-6-stimulated B
1A9-M I
cells I
. O

The O
importance O
of O
BCL2 O
and O
Stat3 O
on O
IL-6 O
-induced O
macrophage-differentiation O
and O
apoptosis O
was O
studied O
with O
1A9-M B
cells I
expressing O
human O
BCL2 O
or O
a O
dominant-negative O
form O
of O
Stat3 O
, O
respectively O
. O

In O
this O
report O
, O
we O
show O
that O
Mycoplasma O
fermentans O
lipid-associated O
membrane O
proteins O
( O
LAMPf O
) O
induce O
the O
production O
of O
high O
levels O
of O
IL-8 O
by O
THP-1 B
( I
human I
monocyte I
) I
cells I
and O
PMN O
at O
the O
same O
extent O
as O
LPS O
. O

Since O
human O
immunodeficiency O
virus O
type O
1 O
( O
HIV-1 O
) O
replication O
is O
known O
to O
be O
favored O
under O
oxidative O
stress O
conditions O
, O
ex O
vivo O
experiments O
using O
uninfected O
PBMCs O
, O
primary O
monocytes O
or O
a O
latently O
infected O
promonocytic B
U1 I
cell I
line I
show O
that O
HIV-1 O
replication O
and O
reactivation O
, O
monitored O
by O
p24 O
antigen O
measurement O
, O
are O
inhibited O
by O
PAO O
in O
a O
time- O
and O
concentration-dependent O
manner O
. O

Pharmacological O
control O
of O
antigen O
responsiveness O
in O
genetically B
modified I
T I
lymphocytes I
. O

Jurkat B
T I
cells I
were O
stably O
transfected O
with O
a O
single O
vector O
encoding O
the O
tetracycline O
trans-activator O
protein O
, O
controlled O
by O
a O
constitutive O
promoter O
, O
and O
the O
chimeric O
TCR O
, O
under O
the O
control O
of O
a O
trans-activator O
protein-responsive O
promoter O
. O

Pharmacologic O
control O
of O
trans-gene O
expression O
in O
gene-modified B
T I
cells I
will O
not O
only O
facilitate O
new O
approaches O
to O
the O
study O
of O
different O
aspects O
of O
T O
cell O
biology O
, O
but O
will O
also O
provide O
the O
basis O
for O
new O
gene O
therapy O
strategies O
. O

Finally O
, O
we O
were O
able O
to O
generate O
a O
specific O
CD8+ B
CTL I
line I
against O
a O
K-RAS O
mutated O
peptide O
. O

The O
Epstein-Barr O
virus O
latent O
membrane O
protein O
1 O
( O
LMP1 O
) O
is O
essential O
for O
the O
transformation O
of O
B O
lymphocytes O
into O
lymphoblastoid B
cell I
lines I
. O

Signals O
from O
TES1 O
are O
sufficient O
to O
drive O
initial O
proliferation O
of O
infected O
resting O
B O
lymphocytes O
, O
but O
most O
lymphoblastoid O
cells O
infected O
with O
a O
virus O
that O
does O
not O
express O
the O
155 O
residues O
beyond O
TES1 O
fail O
to O
grow O
as O
long-term B
cell I
lines I
. O

TRADD O
associated O
with O
wild-type O
LMP1 O
but O
not O
with O
isoleucine-mutated O
LMP1 O
in O
mammalian O
cells O
, O
and O
TRADD O
constitutively O
associated O
with O
LMP1 O
in O
EBV-transformed B
cells I
. O

In O
this O
model O
system O
, O
the O
activities O
of O
late O
promoter-reporter O
fusions O
are O
measured O
following O
transient O
transfection O
into O
tissue B
culture I
cells I
expressing O
EBV O
during O
different O
stages O
of O
the O
lytic O
cycle O
. O

Our O
studies O
showed O
that O
levels O
of O
C/EBP O
epsilon O
mRNA O
were O
markedly O
increased O
in O
NB4 B
cells I
( O
promyelocytic B
leukemia I
line I
) O
, O
because O
they O
were O
induced O
by O
9-cis O
retinoic O
acid O
( O
9-cis O
RA O
) O
to O
differentiate O
towards O
granulocytes O
. O

Accumulation O
of O
C/EBP O
epsilon O
mRNA O
occurred O
as O
early O
as O
1 O
hour O
after O
exposure O
of O
NB4 B
cells I
to O
9-cis O
RA O
( O
5 O
x O
10 O
( O
-7 O
) O
mol/L O
) O
; O
and O
at O
48 O
hours O
, O
levels O
were O
increased O
by O
5.1-fold O
. O

NB4 B
cells I
pulse-exposed O
( O
30 O
minutes O
) O
to O
all-trans O
retinoic O
acid O
( O
ATRA O
) O
, O
washed O
, O
and O
cultured O
( O
3 O
days O
) O
with O
either O
dimethylsulfoxide O
( O
DMSO O
) O
or O
hexamethylene O
bisacetamide O
( O
HMBA O
) O
had O
a O
prominent O
increase O
in O
levels O
of O
C/EBP O
epsilon O
mRNA O
and O
an O
increase O
in O
granulocytic O
differentiation O
, O
but O
exposure O
to O
either O
DMSO O
or O
HMBA O
alone O
had O
no O
effect O
on O
base O
levels O
of O
C/EBP O
epsilon O
and O
did O
not O
induce O
differentiation O
. O

Macrophage-differentiation O
of O
NB4 B
reduced O
levels O
of O
C/EBP O
epsilon O
mRNA O
. O

ATRA O
also O
induced O
expression O
of O
C/EBP O
epsilon O
protein O
in O
NB4 B
cells I
, O
as O
shown O
by O
Western O
blotting O
. O

In O
contrast O
to O
the O
increase O
of O
C/EBP O
epsilon O
in O
9-cis O
RA-mediated O
granulocytic O
differentiation O
, O
the O
DMSO-induced O
differentiation O
of O
HL-60 B
cells I
down O
the O
granulocytic O
pathway O
was O
associated O
with O
an O
initial O
reduction O
of O
C/EBP O
epsilon O
mRNA O
levels O
. O

In O
summary O
, O
we O
have O
discovered O
that O
expression O
of O
C/EBP O
epsilon O
mRNA O
is O
markedly O
enhanced O
as O
the O
NB4 B
promyelocytes I
are O
induced O
by O
retinoids O
to O
differentiate O
towards O
granulocytes O
. O

Ab-associated O
changes O
in O
the O
uptake O
and O
cellular O
distribution O
of O
FITC-LPS O
were O
assessed O
by O
flow O
cytometry O
and O
laser O
scanning O
confocal O
microscopy O
in O
human B
CD14-transfected I
Chinese I
hamster I
ovary I
fibroblasts I
( O
CHO-CD14 B
cells I
) O
and O
human O
peripheral O
blood O
monocytes O
. O

O-side O
chain-specific O
mAb O
concurrently O
enhanced O
complement-dependent O
LPS O
uptake O
by O
monocytes O
through O
complement O
receptor-1 O
( O
CR1 O
) O
and O
uptake O
by O
CHO-CD14 B
cells I
involving O
another O
heat-labile O
serum O
factor O
( O
s O
) O
and O
cell-associated O
recognition O
molecule O
( O
s O
) O
. O

The O
modulation O
by O
anti-LPS O
mAbs O
of O
mCD14 O
-mediated O
LPS O
uptake O
was O
associated O
with O
inhibition O
of O
LPS-induced O
nuclear O
factor-kappaB O
( O
NF-kappaB O
) O
translocation O
and O
TNF-alpha O
secretion O
in O
CHO-CD14 B
cells I
and O
monocytes O
, O
respectively O
, O
while O
mAb O
enhancement O
of O
non- O
mCD14 O
-mediated O
LPS O
uptake O
stimulated O
these O
activities O
. O

Transfection O
of O
EL-4 B
cells I
with O
the O
IL-4 O
promoter-reporter O
constructs O
carrying O
mutated O
P-like O
elements O
showed O
that O
four O
P-like O
elements O
, O
CLE0 O
, O
P O
, O
P2 O
and O
P4 O
, O
but O
not O
P3 O
, O
were O
required O
for O
optimal O
activation O
of O
the O
IL-4 O
promoter O
. O

However O
, O
secretion O
of O
IL-2 O
by O
anti-CD3-stimulated B
cord I
blood I
mononuclear I
cells I
was O
still O
blunted O
compared O
with O
control O
cells O
from O
adults O
. O

In O
contrast O
, O
JNK O
activation O
in O
calcineurin-stimulated B
cells I
caused O
nuclear O
exclusion O
of O
NFAT4 O
. O

A O
murine B
T I
cell I
line I
, O
EL4 B
, O
was O
stimulated O
with O
IL-1 O
with O
and O
without O
pretreatment O
with O
different O
compounds O
known O
to O
influence O
the O
cellular O
redox O
status O
. O

The O
described O
conditions O
which O
inhibited O
or O
prevented O
the O
activation O
of O
the O
IL-1RI-associated O
kinase O
similarly O
impaired O
the O
activation O
of O
NF-kappa O
B O
in O
EL4 B
cells I
. O

Double-stimulation O
was O
used O
to O
demonstrate O
that O
, O
in O
a O
T B
lymphocytic I
cell I
line I
( O
CEM B
) O
, O
phorbol O
myristate O
acetate O
( O
PMA O
) O
rapidly O
induced O
NF-kappa O
B O
through O
a O
signaling O
pathway O
which O
did O
not O
involve O
reactive O
oxygen O
species O
( O
ROS O
) O
and O
was O
different O
from O
the O
activation O
triggered O
by O
either O
H2O2 O
or O
tumor O
necrosis O
factor-alpha O
( O
TNF-alpha O
) O
. O

GR6 O
is O
activated O
in O
the O
UCSD-AML1 B
cell I
line I
and O
in O
a O
leukemic B
sample I
, O
both O
of O
which O
carry O
a O
t O
( O
3 O
; O
3 O
) O
( O
q21 O
; O
q26 O
) O
. O

In O
UCSD-AML1 B
, O
we O
have O
also O
identified O
fusion O
transcripts O
between O
the O
ecotropic O
viral O
insertion O
site O
I O
( O
EVI1 O
) O
gene O
in O
3q26 O
and O
GR6 O
and O
between O
EVI1 O
and O
Ribophorin O
I O
that O
maps O
30 O
kb O
telomeric O
to O
GR6 O
in O
3q21 O
. O

In O
the O
present O
study O
, O
the O
expression O
of O
bcl-6 O
protein O
on O
normal O
epidermis O
, O
benign O
, O
and O
malignant O
tumors O
originating O
from O
epidermal O
cells O
, O
and O
squamous B
cell I
carcinoma I
( I
SCC I
) I
cell I
lines I
are O
investigated O
. O

With O
the O
use O
of O
immunohistochemistry O
, O
bcl-6 O
protein O
was O
shown O
to O
stain O
intensely O
on O
normal B
prickle I
cells I
, O
but O
none O
to O
only O
slightly O
on O
epidermal O
basal O
cells O
. O

Squamous O
cell O
carcinomas O
showed O
a O
variety O
of O
expression O
levels O
, O
while O
two O
undifferentiated O
spindle-shaped O
carcinomas O
and O
one O
undifferentiated O
SCC B
cell I
line I
remained O
unstained O
. O

Cotransfection O
of O
Sp3 O
along O
with O
CD11c O
promoter-luciferase O
constructs O
into O
Sp-deficient B
Drosophila I
Schneider I
2 I
cells I
showed O
that O
Sp3 O
could O
activate O
the O
CD11c O
promoter O
. O

Further O
, O
cotransfection O
analysis O
in O
Drosophila B
cells I
showed O
that O
Sp3 O
, O
as O
was O
previously O
shown O
for O
Sp1 O
, O
also O
synergizes O
with O
c-Jun O
to O
activate O
CD11c O
. O

Antisense O
experiments O
that O
knocked O
out O
endogenous O
Sp3 O
expression O
in O
the O
myelomocytic B
cell I
line I
, O
HL60 B
, O
revealed O
that O
Sp3 O
participates O
in O
activation O
of O
the O
CD11c O
and O
CD11b O
promoters O
in O
vivo O
. O

We O
have O
now O
studied O
Trident O
expression O
in O
cell B
lines I
, O
differentiating O
thymocytes O
and O
in O
lymphocytes O
derived O
from O
peripheral O
blood O
. O

Furthermore O
, O
compared O
with O
wild-type O
Id3 O
, O
an O
Id3 O
Asp5 O
mutant O
( O
mimicking O
phosphorylation O
) O
is O
unable O
to O
promote O
cell O
cycle O
S O
phase O
entry O
in O
transfected B
fibroblasts I
, O
whereas O
an O
Id3 O
Ala5 O
mutant O
( O
ablating O
phosphorylation O
) O
displays O
an O
activity O
significantly O
greater O
than O
that O
of O
wild-type O
Id3 O
protein O
. O

mNFATc O
complexed O
with O
AP-1 O
bound O
specifically O
to O
the O
murine O
IL-2 O
NFAT O
recognition O
sequence O
and O
activated O
transcription O
from O
the O
co-transfected O
IL-2 O
promoter O
in O
COS-7 B
cells I
. O

Ctx O
combined O
with O
TNFalpha O
or O
IL-1beta O
to O
produce O
a O
synergistic O
increase O
in O
p24 O
antigen O
production O
in O
U1 B
promonocytic I
cells I
. O

Transfection O
studies O
of O
LTR O
reporter O
constructs O
indicated O
that O
mutation O
of O
the O
DSE O
sites O
abrogated O
the O
LTR O
-mediated O
synergy O
induced O
by O
Ctx O
and O
TNFalpha O
, O
whereas O
the O
synergy O
induced O
by O
Ctx O
and O
IL-1beta O
was O
unaffected O
, O
suggesting O
TNFalpha O
and O
IL-1beta O
cooperate O
differently O
with O
the O
cAMP O
/PKA O
activation O
pathway O
to O
induce O
HIV-1 O
expression O
in O
U1 B
cells I
. O

These O
abnormalities O
can O
be O
reproduced O
by O
transfection O
of O
cell B
lines I
with O
the O
GCR-beta O
gene O
resulting O
in O
significant O
reduction O
of O
their O
GCR-alpha O
DNA O
binding O
capacity O
. O

Adherence-isolated B
monocytes I
showed O
constitutive O
DNA O
binding O
activity O
of O
NF-kappa O
B O
. O

Analysis O
of O
the O
binding O
proteins O
employing O
the O
-605 O
motif O
of O
the O
human O
TNF O
promoter O
( O
GGGGCTGTCCC O
) O
revealed O
that O
in O
tolerant O
cells O
of O
the O
human B
monocytic I
cell I
line I
Mono B
Mac I
6 I
there O
is O
a O
predominance O
of O
p50p50 O
of O
NF-kappa O
B O
. O

We O
now O
show O
that O
a O
mutant O
motif O
that O
exchanges O
the O
terminal O
3 O
' O
C O
for O
a O
G O
fails O
to O
bind O
the O
p50 O
homodimer O
that O
is O
upregulated O
in O
LPS O
toler O
ant O
human B
Mono I
Mac I
6 I
cells I
. O

The O
same O
is O
true O
for O
nuclear O
extracts O
taken O
from O
the O
murine B
P388D1 I
macrophage I
cell I
line I
when O
tested O
with O
the O
-516 O
motif O
of O
the O
murine O
TNF O
promoter O
( O
GGGGGCTTTCCC O
) O
. O

Conversely O
, O
the O
murine O
kappa O
light O
chain O
enhancer O
motif O
( O
GGGGACTTTCCG O
) O
does O
not O
efficiently O
bind O
the O
nuclear O
p50p50 O
from O
tolerant B
murine I
P388 I
macrophages I
. O

Cyclosporin O
A O
inhibits O
early O
mRNA O
expression O
of O
G0/G1 O
switch O
gene O
2 O
( O
G0S2 O
) O
in O
cultured B
human I
blood I
mononuclear I
cells I
. O

Using O
a O
sensitive O
, O
reverse O
transcription-polymerase O
chain O
reaction O
( O
RT-PCR O
) O
assay O
, O
G0S2 O
mRNA O
levels O
were O
assayed O
in O
cultured B
blood I
mononuclear I
cells I
. O

c-Rel O
and O
p65 O
subunits O
bind O
to O
an O
upstream O
NF-kappaB O
site O
in O
human O
granulocyte O
macrophage-colony O
stimulating O
factor O
promoter O
involved O
in O
phorbol O
ester O
response O
in O
5637 B
cells I
. O

To O
further O
clarify O
the O
complex O
transcriptional O
regulation O
of O
the O
human O
GM-CSF O
gene O
, O
which O
was O
extensively O
investigated O
in O
activated O
T O
cells O
, O
we O
have O
studied O
the O
role O
of O
an O
upstream O
NF-kappaB O
like O
site O
in O
the O
5637 B
non-lymphoid I
cell I
line I
, O
which O
derives O
from O
a O
bladder O
carcinoma O
and O
constitutively O
produces O
GM-CSF O
. O

We O
describe O
here O
a O
heterodimeric O
binding O
complex O
of O
NF-kappaB O
subunits O
( O
c-Rel O
and O
p65 O
) O
which O
is O
identical O
to O
the O
one O
obtained O
using O
the O
HIV-LTR-kappaB O
site O
as O
recognition O
sequence O
and O
different O
from O
the O
one O
( O
c-Rel O
and O
p50 O
) O
observed O
with O
nuclear O
extracts O
from O
Mo B
T-lymphoid I
HTLV-II I
infected I
cells I
. O

Stable O
transfection O
of O
U937 B
cells I
with O
sense O
or O
antisense O
RXR-alpha O
cDNA O
suggests O
a O
role O
for O
RXR-alpha O
in O
the O
control O
of O
monoblastic O
differentiation O
induced O
by O
retinoic O
acid O
and O
vitamin O
D O
. O

In O
this O
study O
, O
therefore O
, O
the O
human B
monoblastic I
leukemia I
cell I
line I
U937 I
has O
been O
used O
as O
a O
model O
system O
to O
investigate O
the O
role O
of O
one O
of O
the O
RXRs O
, O
RXR-alpha O
, O
in O
monoblast O
differentiation O
. O

RXR-alpha O
mRNA O
was O
present O
in O
untreated O
U937 B
cells I
, O
and O
levels O
increased O
after O
induction O
of O
differentiation O
with O
phorbol O
ester O
. O

The O
sense B
cell I
lines I
( O
U B
alpha I
S I
and O
its O
clonal O
derivative O
alpha O
G2S B
) O
showed O
increased O
sensitivity O
to O
RA O
, O
while O
the O
antisense B
cell I
lines I
( O
U B
alpha I
A I
and O
its O
clonal O
derivative O
alpha O
B5A B
) O
showed O
decreased O
sensitivity O
to O
RA O
, O
as O
demonstrated O
by O
growth O
inhibition O
and O
by O
regulation O
of O
an O
RA-responsive O
reporter O
gene O
. O

Both O
U B
alpha I
A I
and O
alpha O
B5A B
also O
failed O
to O
respond O
to O
another O
modulating O
agent O
, O
1 O
alpha O
, O
25-dihydroxycholecalciferol O
( O
DHCC O
) O
, O
but O
only O
U B
alpha I
S I
and O
not O
alpha O
G2S O
showed O
an O
enhanced O
response O
to O
DHCC O
. O

The O
combination O
of O
RA O
and O
DHCC O
together O
inhibited O
growth O
of O
both O
sense O
and O
antisense B
cell I
lines I
. O

In O
addition O
, O
alpha O
G2S O
exhibited O
increased O
expression O
of O
CD11b O
and O
CD54 O
, O
while O
alpha B
B5A I
cells I
showed O
increased O
expression O
of O
CD102 O
, O
suggesting O
that O
RXR-alpha O
has O
a O
role O
in O
regulating O
expression O
of O
cell O
adhesion O
molecules O
in O
U937 B
cells I
. O

The O
role O
of O
the O
viral O
trans-activator O
Tax O
protein O
in O
the O
induction O
of O
VCAM-1 O
was O
first O
indicated O
by O
the O
detection O
of O
this O
adhesion O
molecule O
on O
Jurkat B
T-cell I
clones I
stably O
expressing O
the O
tax O
gene O
. O

The O
effect O
of O
Tax O
on O
VCAM-1 O
gene O
transcription O
was O
next O
confirmed O
in O
JPX-9 B
cells I
, O
a O
subclone O
of O
Jurkat B
cells I
, O
carrying O
the O
tax O
sequences O
under O
the O
control O
of O
an O
inducible O
promoter O
. O

Finally O
, O
gel O
mobility O
shift O
assays O
demonstrated O
the O
nuclear O
translocation O
of O
proteins O
specifically O
bound O
to O
these O
two O
NF-kappaB O
motifs O
, O
confirming O
that O
VCAM-1 O
was O
induced O
on O
Tax-expressing B
cells I
in O
a O
kappaB O
-dependent O
manner O
. O

Tissue O
transglutaminase-dependent O
posttranslational O
modification O
of O
the O
retinoblastoma O
gene O
product O
in O
promonocytic B
cells I
undergoing O
apoptosis O
. O

In O
fact O
, O
by O
employing O
a O
novel O
haptenized O
lysis O
synthetic O
substrate O
which O
allows O
the O
isolation O
of O
glutaminyl-tTG O
substrates O
in O
vivo O
, O
we O
identified O
pRB O
as O
a O
potential O
tTG O
substrate O
in O
U937 B
cells I
undergoing O
apoptosis O
. O

In O
keeping O
with O
this O
finding O
, O
we O
showed O
that O
apoptosis O
of O
U937 B
cells I
is O
characterized O
by O
the O
rapid O
disappearance O
of O
the O
105 O
, O
000- O
to O
110 O
, O
000-molecular-weight O
pRB O
forms O
concomitantly O
with O
the O
appearance O
of O
a O
smear O
of O
immunoreactive O
products O
with O
a O
molecular O
weight O
of O
greater O
than O
250 O
, O
000 O
. O

The O
shift O
in O
pRB O
molecular O
weight O
was O
reproduced O
by O
adding O
exogenous O
purified O
tTG O
to O
extracts O
obtained O
from O
viable O
U937 B
cells I
and O
was O
prevented O
by O
dansylcadaverine O
, O
a O
potent O
enzyme O
inhibitor O
. O

The O
effect O
of O
the O
pRB O
posttranslational O
modification O
during O
apoptosis O
was O
investigated O
by O
determining O
the O
E2F-1 O
levels O
and O
by O
isolating O
and O
characterizing O
pRB-null B
clones I
from O
U937 B
cells I
. O

Notably O
, O
the O
lack O
of O
pRB O
in O
these O
U937-derived B
clones I
renders O
these O
p53-null B
cells I
highly O
resistant O
to O
apoptosis O
induced O
by O
serum O
withdrawal O
, O
calphostin O
C O
, O
and O
ceramide O
. O

NF-kappa O
B/Rel O
family O
members O
regulating O
the O
ICAM-1 O
promoter O
in O
monocytic B
THP-1 I
cells I
. O

In O
monocytic B
THP-1 I
cells I
TNF-alpha O
induced O
two O
nuclear O
complexes O
which O
in O
vitro O
bound O
to O
the O
ICAM-1 O
kappa O
B O
site O
. O

Although O
the O
growth O
rate O
was O
normal O
, O
the O
XP-B B
and I
XP-D I
cells I
contained O
reduced O
amounts O
of O
TFIIH O
. O

Extracts O
prepared O
from O
XP-B B
and I
XP-D I
lymphoblastoid I
cells I
exhibited O
similar O
transcription O
activity O
from O
the O
adenovirus O
major O
late O
promoter O
when O
compared O
to O
that O
in O
extracts O
from O
normal O
cells O
. O

Thus O
, O
we O
conclude O
that O
the O
XP-B B
and I
XP-D I
lymphoblastoid I
cells I
do O
not O
have O
impaired O
RNA O
transcription O
activity O
. O

Monocytic O
differentiation O
of O
HL-60 B
promyelocytic I
leukemia I
cells I
correlates O
with O
the O
induction O
of O
Bcl-xL O
. O

Treatment O
of O
human B
promyelocytic I
leukemia I
HL-60 I
cells I
with O
phorbol O
esters O
ultimately O
induces O
the O
differentiation O
of O
these O
cells O
along O
the O
monocyte/macrophage O
lineage O
, O
whereas O
treatment O
with O
retinoic O
acid O
or O
DMSO O
induces O
granulocytic/neutrophillic O
differentiation O
. O

In O
this O
study O
, O
we O
demonstrate O
the O
disparate O
fates O
of O
HL-60 B
cells I
treated O
with O
the O
phorbol O
ester O
12 O
, O
13-phorbol O
dibutyric O
acid O
( O
PDBu O
) O
or O
DMSO O
. O

After O
DMSO O
treatment O
, O
HL-60 B
cells I
eventually O
died O
via O
apoptosis O
, O
whereas O
the O
viability O
of O
PDBu-treated B
cells I
was O
not O
affected O
during O
the O
same O
interval O
. O

However O
, O
treatment O
of O
HL-60 B
cells I
with O
PDBu O
induced O
the O
rapid O
expression O
of O
the O
apoptosis O
suppressor O
protein O
Bcl-xL O
, O
whereas O
the O
expression O
of O
this O
protein O
remained O
unaltered O
in O
DMSO-treated O
cells O
. O

The O
generality O
of O
this O
finding O
was O
confirmed O
by O
the O
induction O
of O
Bcl-xL O
in O
human B
myeloid I
U-937 I
cells I
, O
human O
peripheral O
blood O
monocytes O
exposed O
to O
phorbol O
ester O
, O
and O
mouse B
thioglycollate-activated I
and I
resident I
peritoneal I
macrophages I
. O

PDBu-treated B
HL-60 I
cells I
remained O
viable O
for O
7 O
days O
and O
thereafter O
began O
to O
die O
via O
apoptosis O
, O
with O
a O
concomitant O
down-regulation O
of O
Bcl-xL O
. O

The O
effects O
of O
chemically O
prepared O
monochloramine O
( O
NH2Cl O
) O
on O
protein O
kinase O
C O
( O
PKC O
) O
and O
PKC O
-mediated O
cellular O
responses O
were O
studied O
in O
elicited O
rat O
peritoneal O
neutrophils O
and O
human B
Jurkat I
T I
cells I
. O

The O
NH2Cl-treated B
neutrophils I
showed O
a O
decrease O
in O
both O
PKC O
activity O
and O
PMA-induced O
phosphorylation O
of O
a O
47-kDa O
protein O
, O
which O
corresponds O
to O
the O
cytosolic O
factor O
of O
NADPH O
oxidase O
, O
p47 O
( O
phox O
) O
. O

Jurkat B
T I
cells I
pretreated O
with O
NH2Cl O
( O
20-70 O
microM O
) O
showed O
a O
decrease O
in O
the O
expression O
of O
the O
interleukin-2 O
receptor O
alpha O
chain O
following O
PMA O
stimulation O
. O

In O
CsA-treated B
leukocytes I
stimulated O
by O
calcium O
ionophore O
, O
the O
degree O
of O
reduction O
in O
CN O
activity O
was O
accompanied O
by O
a O
similar O
degree O
of O
inhibition O
of O
each O
event O
tested O
: O
dephosphorylation O
of O
nuclear O
factor O
of O
activated O
T O
cell O
proteins O
, O
nuclear O
DNA O
binding O
, O
activation O
of O
a O
transfected O
reporter O
gene O
construct O
, O
IFN-gamma O
and O
IL-2 O
mRNA O
accumulation O
, O
and O
IFN-gamma O
production O
. O

Furthermore O
, O
the O
degree O
of O
CN O
inhibition O
was O
reflected O
by O
a O
similar O
degree O
of O
reduction O
in O
lymphocyte O
proliferation O
and O
IFN-gamma O
production O
in O
the O
allogeneic B
mixed I
lymphocyte I
cultures I
. O

Selection O
of O
down-regulated O
sequences O
along O
the O
monocytic O
differentiation O
of O
leukemic B
HL60 I
cells I
. O

We O
have O
selected O
16 O
sequences O
and O
confirmed O
their O
down-regulation O
along O
the O
TPA-induced O
monocytic O
differentiation O
of O
HL60 B
cells I
. O

Here O
we O
show O
that O
in O
E29.1 B
T I
cell I
hybridoma I
I O
kappa O
B O
alpha O
and O
I O
kappa O
B O
beta O
are O
equally O
associated O
with O
p65 O
and O
that O
I O
kappa O
B O
beta O
is O
degraded O
in O
response O
to O
TNF O
alpha O
in O
contrast O
to O
what O
has O
been O
originally O
published O
. O

Basal O
activity O
of O
a O
3070 O
bp O
CRH O
promoter O
fragment O
was O
only O
seen O
in O
neuronal O
and O
lymphoblastoid B
cell I
lines I
. O

The O
pigment O
also O
inhibited O
apoptosis O
in O
dexamethasone-treated B
rat I
thymocytes I
and O
in O
UV-irradiated B
Jurkat I
cells I
as O
judged O
by O
DNA O
ladder O
formation O
, O
cellular O
morphological O
changes O
, O
and O
flow O
cytometry O
analysis O
. O

Complete O
suppression O
of O
AP-1 O
activity O
was O
observed O
in O
Con B
A-treated I
, I
proliferating I
thymocytes I
. O

Costimulation O
of O
phytohemagglutinin/anti-CD28 B
activated I
T I
lymphocytes I
with O
IL-7 O
induces O
a O
fivefold O
enhanced O
IL-2 O
-mRNA O
accumulation O
and O
a O
2.5-fold O
enhanced O
protein O
secretion O
. O

Furthermore O
, O
it O
is O
highly O
expressed O
in O
Burkitt B
's I
lymphoma I
cells I
and O
may O
participate O
in O
the O
pathogenesis O
of O
this O
disease O
. O

We O
have O
therefore O
investigated O
the O
transcriptional O
activity O
of O
A-MYB O
and O
its O
regulation O
in O
several O
human B
lymphoid I
cell I
lines I
using O
co-transfection O
assays O
and O
show O
that O
A-MYB O
is O
transcriptionally O
active O
in O
all O
the O
B B
cell I
lines I
studied O
, O
but O
not O
in O
T O
cells O
. O

In O
particular O
the O
best O
responder B
cell I
line I
was O
the O
Burkitt B
's I
cell I
line I
Namalwa I
. O

Finally O
, O
a O
110-kDa O
protein O
has O
been O
identified O
in O
the O
nuclei O
of O
all O
the O
B B
, I
but I
not I
T I
, I
cell I
lines I
that O
specifically O
binds O
to O
this O
A-MYB O
N-terminal O
domain O
. O

To O
identify O
such O
target O
genes O
, O
we O
established O
Egr-1-overexpressing B
transfectants I
from O
the O
murine B
B I
cell I
line I
K46 I
and O
from O
human B
Ramos I
B I
cells I
. O

All O
clones O
derived O
from O
K46 B
B I
cells I
showed O
increased O
expression O
of O
CD44 O
. O

Most O
interestingly O
, O
expression O
of O
CD95 O
( O
Fas/Apo-1 O
) O
and O
of O
CD23 O
was O
down-regulated O
in O
all O
K46 B
transfectants I
. O

Similarly O
, O
the O
Egr-1-expressing B
Ramos I
cells I
showed O
reduced O
levels O
of O
CD95 O
expression O
. O

We O
therefore O
compared O
the O
turnover O
of O
I O
kappa O
B O
alpha O
and O
I O
kappa O
B O
beta O
in O
mature O
B O
cells O
and O
HeLa B
cells I
. O

The O
half-life O
of O
both O
inhibitors O
is O
increased O
in O
HeLa B
cells I
. O

Repertoire O
selection O
was O
monitored O
by O
determining O
the O
TCR O
beta O
chain O
sequences O
of O
RAKFKQLLQ-specific B
CTL I
established O
from O
primary O
infected O
and O
healthy O
virus O
carriers O
. O

PCR O
analysis O
of O
spontaneous B
EBV-transformed I
lymphoblastoid I
cell I
lines I
( O
LCL B
) O
from O
three O
individuals O
with O
primary O
infection O
showed O
that O
two O
were O
infected O
with O
type O
A O
and O
one O
with O
type O
B O
EBV O
. O

Polyclonal B
and I
clonal I
CTL I
that O
were O
generated O
by O
stimulating O
peripheral O
blood O
mononuclear O
cells O
with O
an O
HLA B
B8+ I
homozygous I
LCL I
lysed I
T I
cell I
blasts I
pulsed O
with O
the O
peptide O
, O
RAKFKQLLQ O
; O
lysis O
of O
certain O
HLA O
B8+ O
LCL O
targets O
was O
associated O
with O
the O
abundance O
of O
BZLF1 O
transcripts O
. O

TCR O
beta O
analysis O
showed O
that O
while O
there O
was O
loop O
length O
restriction O
in O
the O
putative O
peptide O
contact O
site O
of O
all O
responding O
beta O
chains O
, O
diverse O
and O
unique B
( I
non-recurrent I
) I
TCR I
beta I
clonotypes I
were O
selected O
in O
individuals O
during O
primary O
infection O
and O
continued O
to O
emerge O
after O
long-term O
virus O
exposure O
. O

Molecular O
mechanisms O
of O
anoxia/reoxygenation-induced O
neutrophil O
adherence O
to O
cultured B
endothelial I
cells I
. O

The O
objectives O
of O
this O
study O
were O
to O
( O
1 O
) O
determine O
the O
time O
course O
of O
neutrophil O
adhesion O
to O
monolayers O
of O
human B
umbilical I
vein I
endothelial I
cells I
( O
HUVECs B
) O
that O
were O
exposed O
to O
60 O
minutes O
of O
anoxia O
followed O
by O
30 O
to O
600 O
minutes O
of O
reoxygenation O
and O
( O
2 O
) O
define O
the O
mechanisms O
responsible O
for O
both O
the O
early O
( O
minutes O
) O
and O
late O
( O
hours O
) O
hyperadhesivity O
of O
postanoxic B
HUVECs I
to O
human O
neutrophils O
. O

The O
results O
clearly O
demonstrate O
that O
anoxia/reoxygenation O
( O
A/R O
) O
leads O
to O
a O
biphasic O
increase O
in O
neutrophil O
adhesion O
to O
HUVECs B
, O
with O
peak O
responses O
occurring O
at O
30 O
minutes O
( O
phase O
1 O
) O
and O
240 O
minutes O
( O
phase O
2 O
) O
after O
reoxygenation O
. O

Surface O
expression O
of O
ICAM-1 O
, O
P-selectin O
, O
and O
E-selectin O
on O
HUVECs B
correlated O
with O
the O
phase-1 O
and O
-2 O
neutrophil O
adhesion O
responses O
. O

To O
define O
the O
CD40 O
signaling O
components O
upstream O
of O
NF-kappa O
B O
activation O
and O
the O
functional O
consequences O
downstream O
of O
NF-kappa O
B O
activation O
, O
we O
examined O
mouse B
B I
cell I
transfectants I
expressing O
wild-type O
or O
mutant O
human O
CD40 O
. O

The O
distribution O
of O
myeloid O
lineage-associated O
cytokine O
receptors O
and O
lysosomal O
proteins O
was O
analyzed O
in O
human B
CD34+ I
cord I
blood I
cell I
( I
CB I
) I
subsets I
at O
different O
stages O
of O
myeloid O
commitment O
by O
reverse-transcriptase O
polymerase O
chain O
reaction O
( O
RT-PCR O
) O
. O

The O
highly O
specific O
granulomonocyte-associated O
lysosomal O
proteins O
myeloperoxidase O
( O
MPO O
) O
and O
lysozyme O
( O
LZ O
) O
, O
as O
well O
as O
the O
transcription O
factor O
PU.1 O
, O
were O
already O
detectable O
in O
the O
most O
immature O
CD34+Thy-1+ B
subset I
. O

By O
contrast O
, O
the O
monocyte-macrophage O
colony O
stimulating O
factor O
( O
M-CSF O
) O
receptor O
was O
largely O
absent O
at O
this O
stage O
and O
in O
the O
CD34+Thy-1-CD45RA- B
subsets I
. O

The O
M-CSF O
receptor O
was O
first O
detectable O
in O
the O
myeloid-committed B
CD34+Thy-l-CD45RA+ I
subset I
. O

Different O
cocktails O
of O
the O
identified O
ligands O
were O
added O
to O
sorted B
CD34+Thy-1+ I
single I
cells I
. O

Addition O
of O
GM-CSF O
to O
this O
basic O
cocktail O
consistently O
increased O
the O
clonogenic O
capacity O
of O
single B
CD34+Thy-1+ I
cells I
, O
and O
this O
effect O
was O
further O
enhanced O
( O
up O
to O
72.3 O
+/- O
4.3 O
% O
on O
day O
7 O
) O
by O
the O
inclusion O
of O
TNF-alpha O
. O

In O
conclusion O
, O
the O
presence O
of O
myeloid-associated O
growth O
factor O
receptor O
transcripts O
in O
CD34+ B
CB I
subsets I
does O
not O
discriminate O
the O
various O
stages O
of O
differentiation O
, O
with O
the O
exception O
of O
the O
M-CSF O
receptor O
. O

In O
addition O
, O
we O
show O
that O
TNF-alpha O
is O
a O
potent O
costimulatory O
factor O
of O
the O
very O
immature B
CD34+Thy-1+ I
CB I
subset I
. O

Recent O
studies O
from O
our O
laboratory O
have O
indicated O
that O
protein O
tyrosine O
phosphatase O
( O
PTPase O
) O
inhibitors O
can O
down-modulate O
the O
tumor O
necrosis O
factor O
( O
TNF O
) O
-mediated O
activation O
of O
the O
nuclear O
transcription O
factor O
NF-kappa O
B O
in O
ML-1a B
, O
a O
monocytic B
cell I
line I
( O
Singh O
and O
Aggarwal O
, O
J. O
Biol. O
Chem. O
1995 O
: O
270 O
: O
10631 O
) O
. O

Like O
ML-1a B
, O
human B
dermal I
microvessel I
endothelial I
cells I
( O
MVEC B
) O
treated O
with O
TNF O
rapidly O
activated O
( O
within O
30 O
min O
) O
NF-kappa O
B O
; O
this O
effect O
was O
completely O
abolished O
by O
co-treatment O
with O
phenylarsine O
oxide O
( O
PAO O
) O
, O
a O
specific O
inhibitor O
of O
PTPase O
. O

The O
induction O
of O
ICAM-1 O
, O
VCAM-1 O
, O
and O
ELAM-1 O
by O
TNF O
in O
MVEC B
occurred O
within O
6 O
h O
and O
was O
also O
completely O
down-regulated O
by O
PAO O
in O
a O
dose-dependent O
manner O
. O

Consistent O
with O
these O
results O
, O
the O
attachment O
of O
monocytes O
to O
MVEC B
was O
also O
blocked O
by O
the O
PTPase O
inhibitors O
. O

This O
cooperation O
was O
also O
required O
to O
induce O
the O
sustained O
proliferation O
of O
differentiation-blocked B
erythroblasts I
in O
response O
to O
ligand O
activation O
of O
the O
endogenous O
tyrosine O
kinase O
receptor O
c-Kit O
. O

Cellular O
and O
molecular O
mechanisms O
of O
IL-5 O
synthesis O
in O
atopic O
diseases O
: O
a O
study O
with O
allergen-specific B
human I
helper I
T I
cells I
. O

METHODS O
: O
Allergen-specific B
T I
cell I
clones I
and O
T B
cell I
hybridomas I
were O
established O
from O
the O
peripheral O
blood O
lymphocytes O
of O
patients O
with O
asthma O
, O
and O
the O
responses O
to O
various O
stimuli O
were O
determined O
. O

A O
human O
IL-5 O
promoter/enhancer O
luciferase O
gene O
construct O
transfected O
into O
IL-5-producing B
T I
cell I
clones I
was O
clearly O
transcribed O
after O
stimulation O
, O
indicating O
that O
the O
515 O
base O
pair O
IL-5 O
gene O
segment O
upstream O
of O
the O
coding O
region O
was O
sufficient O
to O
respond O
to O
activating O
signals O
in O
human O
helper O
T O
cells O
. O

The O
same O
gene O
segment O
was O
not O
transcribed O
in O
IL-5-nonproducing B
T I
cell I
clones I
, O
suggesting O
that O
human O
T O
cell O
IL-5 O
synthesis O
is O
regulated O
at O
the O
transcriptional O
level O
. O

Experiments O
with O
T B
cell I
hybridomas I
confirmed O
these O
findings O
and O
suggested O
that O
a O
unique O
transcription O
factor O
may O
be O
essential O
for O
human O
IL-5 O
gene O
transcription O
. O

TF O
activity O
generated O
by O
both O
unstimulated B
and O
endotoxin-stimulated B
cells I
was O
significantly O
higher O
in O
transplant O
recipients O
than O
in O
control O
subjects O
( O
P O
< O
.05 O
) O
. O

Both O
cytokines O
induced O
assembly O
of O
STAT5A O
and O
STAT5B O
containing O
complexes O
capable O
of O
binding O
to O
the O
interferon-gamma O
activation O
sequence O
( O
GAS O
) O
, O
and O
these O
complexes O
rapidly O
translocated O
( O
within O
1 O
min O
) O
into O
the O
nucleus O
of O
IL-2- B
or I
IL-7-treated I
cells I
. O

The O
kinetics O
of O
this O
translocation O
were O
delayed O
in O
IL-7-treated B
as O
compared O
to O
IL-2-treated B
cells I
. O

HeLa B
cells I
stably O
or O
transiently O
transfected O
with O
mutant O
CIITA O
constructs O
showed O
up O
to O
99 O
% O
suppression O
of O
MHC O
class O
II O
antigen O
induction O
by O
IFN-gamma O
and O
marked O
suppression O
of O
HLA-DRA O
mRNA O
expression O
. O

NF-kappaB O
, O
which O
resides O
in O
an O
inactive O
, O
cytoplasmic O
complex O
in O
unstimulated B
cells I
, O
is O
activated O
by O
phosphorylation O
and O
degradation O
of O
its O
inhibitory O
subunit O
, O
IkappaB O
. O

RelB O
protein O
and O
mRNA O
were O
detected O
constitutively O
in O
lymphocytes O
and O
in O
activated O
monocytes O
, O
differentiated O
DC O
, O
and O
monocyte-derived B
DC I
. O

The O
CAML O
( O
calcium-modulator O
and O
cyclophilin O
ligand O
) O
protein O
is O
a O
coinducer O
of O
NF-AT O
activation O
when O
overexpressed O
in O
Jurkat B
T I
cells I
. O

Cross-linking O
of O
this O
lymphocyte-specific O
protein O
, O
designated O
TACI O
( O
transmembrane O
activator O
and O
CAML-interactor O
) O
, O
on O
the O
surface O
of O
transfected B
Jurkat I
cells I
with O
TACI-specific O
antibodies O
led O
to O
activation O
of O
the O
transcription O
factors O
NF-AT O
, O
AP-1 O
, O
and O
NFkappaB O
. O

Accordingly O
, O
we O
studied O
the O
role O
of O
NF-kappaB O
in O
germline O
Cepsilon O
transcription O
by O
using O
two O
human B
Burkitt I
's I
lymphoma I
B I
cell I
lines I
, O
DND39 B
and O
DG75 B
. O

In O
both O
cell B
lines I
, O
n-acetyl-L-cysteine O
( O
NAC O
) O
, O
a O
potent O
thiol O
antioxidant O
, O
inhibited O
the O
triggering O
of O
the O
nuclear O
expression O
of O
NF-kappaB O
by O
IL-4 O
and O
by O
anti-CD40 O
monoclonal O
antibody O
. O

Expression O
of O
HLA-DO O
in O
a O
class B
II+ I
and I
DM+ I
, I
DO- I
human I
T I
cell I
line I
caused O
the O
accumulation O
of O
class O
II-CLIP O
complexes O
, O
indicating O
that O
HLA-DO O
blocked O
DM O
function O
in O
vivo O
and O
suggesting O
that O
HLA-DO O
is O
an O
important O
modulator O
of O
class O
II-restricted O
antigen O
processing O
. O

In O
this O
study O
, O
we O
used O
a O
RT-PCR O
based O
approach O
to O
compare O
the O
stability O
of O
the O
big O
T O
and O
small O
t O
allele O
in O
normal O
heterozygous O
lymphocytes O
and O
the O
heterozygous B
cell I
lines I
NB4 B
( O
myeloid O
leukemia O
) O
and O
PC-3 B
and O
DU B
145 I
( O
prostate O
cancers O
) O
. O

The O
compound O
induced O
G1 O
arrest O
and O
granulocytic O
differentiation O
of O
HL-60 B
cells I
, O
although O
the O
differentiation-inducing O
effect O
was O
modest O
. O

Differanisole O
A O
and O
9-cis O
retinoic O
acid O
( O
9cisRA O
) O
synergistically O
inhibited O
the O
growth O
and O
induced O
functional O
and O
morphologic O
differentiation O
of O
HL-60 B
and I
NB4 I
cells I
, O
whereas O
the O
combined O
treatment O
with O
differanisole O
A O
and O
all-trans O
retinoic O
acid O
or O
1alpha O
, O
25-dihydroxyvitamin O
D3 O
was O
less O
effective O
. O

In O
this O
study O
, O
we O
evaluated O
the O
activation O
of O
JAK O
/STAT O
pathway O
upon O
human O
interleukin-5 O
( O
hIL-5 O
) O
stimulation O
of O
two O
different O
hIL-5-responsive B
cell I
lines I
, O
hIL-5 B
receptor I
alpha-subunit I
( I
hIL-5R I
alpha I
) I
cDNA-transfected I
TF-1 I
( O
TF-h5R B
alpha I
) O
and O
butyric-acid-treated B
YY-1 I
( O
YY-Bu B
) O
, O
and O
peripheral B
eosinophils I
. O

The O
aim O
of O
the O
present O
study O
was O
to O
investigate O
the O
effects O
of O
oxidized O
LDL O
( O
oxLDL O
) O
on O
the O
NF-kappa O
B O
system O
in O
human O
THP-1 B
monocytic I
cells I
as O
well O
as O
adherent O
monocytes O
. O

PURPOSE O
: O
To O
demonstrate O
that O
leukocyte O
adhesion O
to O
cultured B
corneal I
endothelial I
cells I
is O
mediated O
by O
the O
CD18 O
antigen O
, O
and O
to O
determine O
whether O
dexamethasone O
directly O
suppresses O
adhesion O
by O
inhibiting O
activation O
of O
nuclear O
factor O
kappa O
B O
( O
NFkappaB O
) O
. O

RESULTS O
: O
Neutrophil O
adhesion O
to O
cultured B
corneal I
endothelial I
cells I
increased O
significantly O
on O
exposure O
to O
TNFalpha O
( O
451.4+/-45.4 O
cells/mm2 O
, O
n O
= O
16 O
) O
compared O
to O
control O
( O
156.7+/-27.3 O
cells/mm2 O
, O
n O
= O
16 O
, O
P O
< O
0.01 O
) O
. O

Expression O
of O
BHRF1 O
in O
MCF-Fas B
cells I
conferred O
nearly O
complete O
resistance O
against O
both O
anti-Fas O
antibody O
and O
TNF-mediated O
apoptosis O
. O

The O
ability O
of O
BHRF1 O
to O
protect O
MCF-Fas B
cells I
from O
apoptosis O
induced O
by O
various O
stimuli O
was O
identical O
to O
that O
of O
Bcl-2 O
and O
Bcl-xL O
. O

Surprisingly O
, O
expression O
of O
neither O
BHRF1 O
nor O
Bcl-2 O
in O
a O
B-cell B
line I
, O
BJAB B
, O
protected O
the O
cells O
from O
anti-Fas-mediated O
apoptosis O
even O
though O
they O
increased O
the O
survival O
of O
serum-starved O
cells O
. O

In O
Jurkat B
T I
cells I
, O
induction O
of O
PIF O
DNA O
binding O
activity O
was O
rapidly O
induced O
, O
required O
de O
novo O
protein O
synthesis O
, O
and O
was O
sustained O
at O
a O
high O
level O
for O
at O
least O
23 O
h O
. O

Interestingly O
, O
PIF O
was O
constitutively O
activated O
in O
human B
T-cell I
leukemia I
virus I
type I
1-transformed I
MT-2 I
cells I
. O

In O
Jurkat B
cells I
, O
both O
sites O
were O
required O
for O
maximal O
IL-2Rbeta O
promoter O
activity O
, O
and O
in O
HeLaS3 O
cells O
, O
transfection O
of O
Egr-1 O
could O
drive O
activity O
of O
a O
reporter O
construct O
containing O
both O
sites O
. O

Moreover O
, O
Sp1 O
and O
Egr-1 O
could O
form O
a O
complex O
with O
kinetics O
that O
correlated O
with O
the O
production O
of O
Egr-1 O
in O
Jurkat B
cells I
upon O
PMA O
stimulation O
. O

Overexpression O
of O
HSF2-beta O
inhibits O
hemin O
-induced O
heat O
shock O
gene O
expression O
and O
erythroid O
differentiation O
in O
K562 B
cells I
. O

Acquisition O
of O
heat O
shock O
factor O
2 O
( O
HSF2 O
) O
DNA O
binding O
activity O
is O
accompanied O
by O
induced O
transcription O
of O
heat O
shock O
genes O
in O
hemin-treated O
K562 B
cells I
undergoing O
erythroid O
differentiation O
. O

We O
show O
that O
in O
parental O
K562 B
cells I
, O
the O
HSF2-alpha O
isoform O
is O
predominantly O
expressed O
and O
HSF2 O
can O
be O
activated O
upon O
hemin O
treatment O
. O

We O
suggest O
that O
HSF2-beta O
acts O
as O
a O
negative O
regulator O
of O
HSF2 O
activity O
during O
hemin-mediated O
erythroid O
differentiation O
of O
K562 B
cells I
. O

In O
addition O
, O
in O
vivo O
footprint O
analysis O
showed O
the O
putative O
X O
and O
Y O
boxes O
to O
be O
occupied O
by O
transcription O
factors O
in O
wild-type O
B O
cells O
, O
but O
not O
in O
RFX-deficient B
B I
cells I
. O

Bcl-2 O
protein O
inhibits O
bufalin-induced O
apoptosis O
through O
inhibition O
of O
mitogen-activated O
protein O
kinase O
activation O
in O
human B
leukemia I
U937 I
cells I
. O

In O
a O
previous O
study O
, O
we O
demonstrated O
that O
bufalin O
, O
which O
is O
an O
active O
principle O
of O
Chinese O
medicine O
, O
chan'su O
, O
caused O
apoptosis O
in O
human B
leukemia I
U937 I
cells I
by O
anomalous O
activation O
of O
mitogen-activated O
protein O
kinase O
( O
MAPK O
) O
via O
the O
signaling O
pathway O
of O
Ras O
, O
Raf-1 O
, O
and O
MAPK O
kinase-1 O
. O

Here O
, O
we O
report O
the O
effect O
of O
overexpression O
of O
bcl-2 O
in O
U937 B
cells I
on O
the O
signaling O
pathway O
of O
apoptosis O
that O
is O
induced O
by O
bufalin O
. O

The O
results O
indicated O
that O
the O
apoptosis O
induced O
by O
bufalin O
in O
U937 B
cells I
was O
significantly O
inhibited O
by O
overexpression O
of O
the O
Bcl-2 O
protein O
. O

Bufalin O
treatment O
activated O
activator O
protein-1 O
transcriptional O
activity O
; O
however O
, O
this O
activation O
was O
decreased O
to O
40 O
% O
in O
bcl-2 O
-overexpressed O
U937 B
cells I
. O

Human B
monocytic I
cell I
line I
THP-1 I
was O
treated O
with O
E. O
chaffeensis O
which O
had O
been O
preincubated O
with O
human O
anti-E. O
chaffeensis O
serum O
for O
2 O
h O
, O
and O
the O
levels O
of O
cytokine O
mRNAs O
were O
evaluated O
by O
competitive O
reverse O
transcription-PCR O
. O

Anti-E. O
chaffeensis O
antibody O
complexed O
with O
E. O
chaffeensis O
significantly O
enhanced O
mRNA O
expression O
of O
IL-1beta O
in O
THP-1 B
cells I
. O

Furthermore O
, O
prolonged O
degradation O
of O
IkappaB-alpha O
and O
activation O
of O
NF-kappaB O
were O
demonstrated O
in O
THP-1 B
cells I
exposed O
to O
anti-E. O
chaffeensis O
serum O
and O
E. O
chaffeensis O
. O

Characterization O
of O
interleukin-10 O
receptor O
expression O
on O
B-cell B
chronic I
lymphocytic I
leukemia I
cells I
. O

B-cell B
chronic I
lymphocytic I
leukemia I
( I
B-CLL I
) I
cells I
accumulate O
in O
vivo O
in O
the O
G0/G1 O
phase O
of O
the O
cell O
cycle O
, O
suggesting O
that O
their O
malignant O
expansion O
is O
due O
, O
at O
least O
in O
part O
, O
to O
a O
delay O
in O
cell O
death O
. O

The O
interleukin-10 O
( O
IL-10 O
) O
receptor O
is O
another O
member O
of O
the O
IFN O
receptor O
family O
, O
but O
its O
ligand O
, O
IL-10 O
, O
has O
been O
reported O
to O
induce O
apoptosis O
in O
B-CLL B
cells I
. O

In O
the O
current O
study O
, O
we O
undertook O
a O
biochemical O
analysis O
of O
IL-10 O
receptor O
expression O
on O
freshly O
isolated O
B-CLL B
cells I
and O
characterized O
the O
functional O
responsiveness O
of O
IL-10 O
binding O
to O
its O
constitutively O
expressed O
receptor O
. O

We O
show O
that O
B-CLL B
cells I
bind O
IL-10 O
with O
significant O
specificity O
and O
express O
between O
47 O
and O
127 O
IL-10 O
receptor O
sites O
per O
cell O
, O
with O
a O
dissociation O
constant O
in O
the O
range O
of O
168 O
to O
426 O
x O
10 O
( O
-12 O
) O
mol/L O
. O

Ligand O
binding O
and O
activation O
of O
the O
IL-10 O
receptor O
expressed O
on O
B-CLL B
cells I
results O
in O
the O
phosphorylation O
of O
signal O
transducer O
and O
activator O
of O
transcription O
1 O
( O
STAT1 O
) O
and O
STAT3 O
proteins O
. O

This O
pattern O
of O
STAT O
protein O
phosphorylation O
is O
identical O
to O
IL-10 O
receptor O
activation O
on O
normal O
cells O
and O
similar O
to O
IFN-alpha O
( O
STAT1 O
and O
STAT3 O
) O
and O
IFN-gamma O
( O
STAT1 O
) O
receptor O
activation O
in O
CLL B
. O

Further O
, O
in O
consecutive O
samples O
of O
fresh O
blood O
obtained O
from O
patients O
with O
B-CLL B
cells I
, O
the O
addition O
of O
IL-10 O
inhibited O
B-CLL B
proliferation O
, O
enhanced O
B-CLL B
differentiation O
, O
but O
did O
not O
induce O
apoptosis O
. O

We O
conclude O
that O
cytokines O
, O
which O
signal O
through O
the O
interferon O
family O
of O
receptors O
, O
have O
comparable O
functional O
effects O
on O
B-CLL B
cells I
. O

Previous O
work O
has O
demonstrated O
that O
SLP-76 O
, O
a O
Grb2-associated O
tyrosine-phosphorylated O
protein O
, O
augments O
Interleukin-2 O
promoter O
activity O
when O
overexpressed O
in O
the O
Jurkat B
T I
cell I
line I
. O

Interestingly O
, O
we O
find O
that O
in O
contrast O
to O
SLP-76 O
, O
overexpression O
of O
SLAP-130 O
diminishes O
T O
cell O
antigen O
receptor O
-induced O
activation O
of O
the O
interleukin-2 O
promoter O
in O
Jurkat B
T I
cells I
and O
interferes O
with O
the O
augmentation O
of O
interleukin-2 O
promoter O
activity O
seen O
when O
SLP-76 O
is O
overexpressed O
in O
these O
cells O
. O

Stimulation O
of O
the O
latently O
HIV-infected B
myelomonocytic I
cell I
line I
OM-10.1 O
with O
C. O
neoformans O
and O
C. O
albicans O
in O
the O
presence O
of O
pooled O
human O
serum O
caused O
a O
ratio-dependent O
increase O
in O
HIV O
production O
. O

Nuclear O
levels O
of O
NF-kappaB O
correlate O
with O
syncytium-forming O
capacity O
of O
8e51 B
cells I
, O
expressing O
a O
defective O
HIV O
virus O
. O

In O
this O
report O
we O
present O
the O
characterisation O
of O
NF-kappaB O
subunits O
engaged O
in O
complexes O
binding O
to O
the O
HIV-1 O
NF-kappaB O
site O
in O
human B
8e51 I
T-cells I
, O
that O
harbour O
a O
defective O
HIV-1 O
. O

The O
importance O
of O
NF-kappaB O
complexes O
in O
viral O
functions O
has O
been O
established O
comparing O
the O
level O
of O
NF-kappaB O
DNA-binding O
complexes O
with O
syncytia-forming O
activity O
of O
8e51 B
cells I
. O

In O
fact O
, O
8e51 B
cells I
that O
had O
almost O
lost O
their O
syncytia-forming O
capacity O
were O
found O
to O
contain O
at O
least O
10 O
times O
less O
active O
NF-kappaB O
DNA-binding O
complex O
than O
the O
actively O
fusing O
cells O
. O

IL-4 O
-dependent O
activation O
of O
Stat6 O
was O
also O
observed O
in O
HC11 B
mammary I
epithelial I
cells I
. O

The O
induction O
of O
this O
promoter O
was O
confirmed O
in O
COS7 B
cells I
. O

We O
have O
previously O
shown O
that O
ETS1 O
can O
transactivate O
GM-CSF O
in O
Jurkat B
T I
cells I
, O
but O
only O
after O
the O
cells O
have O
been O
stimulated O
by O
treatment O
with O
PMA O
and O
ionomycin O
, O
agents O
that O
mimic O
T O
cell O
activation O
. O

Thus O
we O
proposed O
that O
ETS1 O
, O
which O
is O
expressed O
constitutively O
in O
Jurkat B
cells I
, O
may O
act O
in O
concert O
with O
PMA/ionomycin O
inducible O
factors O
. O

Here O
we O
show O
that O
ETS1 O
can O
transactivate O
a O
GM-CSF O
reporter O
construct O
in O
unstimulated O
Jurkat B
cells I
, O
providing O
that O
either O
NFkappaB O
or O
AP1 O
transcription O
factors O
are O
supplied O
by O
co-transfection O
. O

The O
proportion O
of O
mature O
, O
TCRhigh O
thymocytes O
of O
the O
alphabeta O
lineage O
was O
reduced O
, O
and O
the O
remaining O
TCRhigh O
population O
contained O
an O
unusually O
high O
proportion O
of O
double-positive B
cells I
. O

IFN-gamma-primed B
lung I
fibroblasts I
costimulate O
T O
lymphocyte O
proliferation O
utilizing O
CD40 O
, O
but O
not O
the O
well-studied O
costimulatory O
molecules O
B7-1 O
and O
B7-2 O
. O

The O
regulation O
of O
NF-kappa O
B O
activation O
following O
the O
triggering O
of O
HLA-DR O
antigens O
by O
mAb O
L243 O
has O
been O
studied O
at O
various O
times O
in O
Raji B
cells I
. O

We O
here O
report O
that O
( O
i O
) O
like O
PML-RAR O
alpha O
expression O
, O
PLZF-RAR O
alpha O
expression O
blocks O
terminal O
differentiation O
of O
hematopoietic O
precursor O
cell O
lines O
( O
U937 B
and O
HL-60 B
) O
in O
response O
to O
different O
stimuli O
( O
vitamin O
D3 O
, O
transforming O
growth O
factor O
beta1 O
, O
and O
dimethyl O
sulfoxide O
) O
; O
( O
ii O
) O
PML-RAR O
alpha O
, O
but O
not O
PLZF-RAR O
alpha O
, O
increases O
RA O
sensitivity O
of O
hematopoietic O
precursor O
cells O
and O
restores O
RA O
sensitivity O
of O
RA-resistant O
hematopoietic O
cells O
; O
( O
iii O
) O
PML-RAR O
alpha O
and O
PLZF-RAR O
alpha O
have O
similar O
RA O
binding O
affinities O
; O
and O
( O
iv O
) O
PML-RAR O
alpha O
enhances O
the O
RA O
response O
of O
RA O
target O
genes O
( O
those O
for O
RAR O
beta O
, O
RAR O
gamma O
, O
and O
transglutaminase O
type O
II O
[ O
TGase O
] O
) O
in O
vivo O
, O
while O
PLZF-RAR O
alpha O
expression O
has O
either O
no O
effect O
( O
RAR O
beta O
) O
or O
an O
inhibitory O
activity O
( O
RAR O
gamma O
and O
type O
II O
TGase O
) O
. O

We O
have O
investigated O
the O
role O
of O
ascorbate O
, O
AFR O
and O
dehydroascorbate O
( O
DHA O
) O
in O
the O
activation O
of O
the O
NF-kappaB O
transcription O
factor O
in O
Jurkat B
T-cells I
stimulated O
by O
tumour O
necrosis O
factor-alpha O
( O
TNF-alpha O
) O
. O

Here O
we O
show O
, O
by O
electrophoretic O
mobility O
shift O
assays O
, O
that O
ascorbate O
increases O
the O
binding O
of O
NF-kappaB O
to O
DNA O
in O
TNF-alpha-stimulated B
Jurkat I
cells I
. O

The O
ability O
of O
ascorbate O
to O
enhance O
cytoplasmic O
inhibitory O
IkBalpha O
protein O
degradation O
correlates O
completely O
with O
its O
capacity O
to O
induce O
NF-kappaB O
binding O
to O
DNA O
and O
to O
potentiate O
NF-kappaB O
-mediated O
transactivation O
of O
the O
HIV-1 O
long O
terminal O
repeat O
promoter O
in O
TNF-alpha-stimulated B
Jurkat I
cells I
but O
not O
in O
cells O
stimulated O
with O
PMA O
plus O
ionomycin O
. O

Human O
cytomegalovirus O
induces O
interleukin-8 O
production O
by O
a O
human B
monocytic I
cell I
line I
, O
THP-1 B
, O
through O
acting O
concurrently O
on O
AP-1- O
and O
NF-kappaB-binding O
sites O
of O
the O
interleukin-8 O
gene O
. O

Cytomegalovirus O
( O
CMV O
) O
infection O
induced O
interleukin-8 O
( O
IL-8 O
) O
gene O
transcription O
in O
a O
human B
monocytic I
cell I
line I
, O
THP-1 B
cells I
, O
leading O
to O
IL-8 O
secretion O
. O

The O
monomeric O
polypeptide O
Flexi-12 O
is O
able O
to O
induce O
the O
proliferation O
of O
phytohemagglutinin B
( I
PHA I
) I
blasts I
, O
induce O
PHA B
blasts I
to O
secrete O
interferon-gamma O
( O
IFN-gamma O
) O
and O
additionally O
, O
by O
preincubation O
, O
enhance O
the O
killing O
of O
K562 O
targets O
by O
PBLs O
. O

Using O
a O
previously O
described O
mutant O
of O
the O
Jurkat B
T I
cell I
line I
, O
we O
show O
that O
proximal O
signaling O
events O
dependent O
on O
the O
presence O
of O
the O
CD45 O
tyrosine O
phosphatase O
are O
required O
for O
TCR O
-stimulated O
CD95 O
ligand O
expression O
. O

Three O
overlapping O
PCR O
products O
, O
covering O
the O
complete O
coding O
sequence O
of O
mRNA O
, O
were O
generated O
from O
lymphoblastoid B
cell I
lines I
, O
translated O
into O
35S-methionine O
labelled O
protein O
, O
and O
analysed O
by O
SDS-PAGE O
. O

Because O
antioxidants O
have O
been O
considered O
to O
be O
of O
antiatherosclerotic O
potential O
, O
we O
investigated O
the O
effects O
of O
alpha-tocopherol O
( O
TCP O
) O
and O
its O
acetate O
and O
succinate O
esters O
on O
monocyte O
adhesion O
to O
cytokine-stimulated B
human I
umbilical I
vein I
endothelial I
cells I
( O
HUVEC B
) O
. O

TCP O
succinate O
( O
20 O
microM O
, O
72 O
h O
) O
, O
but O
not O
TCP O
( O
200 O
microM O
, O
72 O
h O
) O
, O
reduced O
U-937 B
cell I
adhesion O
to O
TNF-alpha-stimulated B
( I
10 I
U/ml I
, I
6 I
h I
) I
HUVEC I
by O
30 O
% O
( O
P O
< O
0.025 O
) O
and O
to O
IL-1 B
beta-stimulated I
HUVEC I
by O
56 O
% O
( O
P O
< O
0.010 O
) O
. O

Electrophoretic O
mobility-shift O
assays O
of O
HUVEC B
nuclear O
proteins O
revealed O
a O
decrease O
in O
TNF-alpha-stimulated O
nuclear O
factor-kappa O
B O
( O
NF-kappa O
B O
) O
activation O
after O
pretreatment O
of O
HUVEC B
with O
TCP O
succinate O
but O
not O
with O
TCP O
, O
TCP O
acetate O
, O
or O
succinate O
alone O
. O

To O
further O
investigate O
the O
effects O
of O
E2a-Pbx1 O
on O
the O
B O
cell O
progenitors O
, O
we O
conditionally O
expressed O
E2a-Pbx1 O
under O
control O
of O
a O
metal O
response O
element O
in O
hematopoietic B
precursor I
cell I
lines I
in O
vitro O
. O

Constitutive O
expression O
of O
E2a-Pbx1 O
did O
not O
induce O
apoptosis O
or O
continued O
cycling O
of O
Rat-1 B
fibroblasts I
in O
low O
serum O
conditions O
. O

Retinoic O
acid O
treatment O
of O
HL60 B
promyelocytic I
leukemia I
cells I
for O
24 O
hr O
induced O
C/EBPepsilon O
mRNA O
levels O
by O
4-fold O
, O
while O
prolonged O
treatment O
gradually O
reduced O
mRNA O
expression O
to O
pretreatment O
levels O
. O

We O
previously O
showed O
that O
PO-B O
DNA-binding O
is O
progressively O
induced O
during O
differentiation O
of O
promyelomonocytic B
leukemic I
HL-60 I
cells I
to O
the O
macrophage-like O
lineage O
( O
with O
phorbol O
esters O
) O
. O

We O
now O
report O
that O
PO-B O
DNA-binding O
in O
HL-60 B
cells I
is O
similarly O
induced O
during O
differentiation O
to O
the O
granulocytic O
lineage O
( O
with O
either O
retinoic O
acid O
or O
dimethylsulfoxide O
) O
. O

Introduction O
of O
a O
cDNA O
expression O
library O
prepared O
from O
a O
human B
T-cell I
line I
into O
the O
Oct-2 O
-harboring O
tester O
strain O
allowed O
selection O
of O
three O
Lac+clones O
out O
of O
1 O
x O
10 O
( O
5 O
) O
transformants O
. O

Tap O
associated O
with O
Tip O
following O
transient O
expression O
in O
COS-1 B
cells I
and O
stable O
expression O
in O
human B
Jurkat-T I
cells I
. O

Expression O
of O
Tip O
and O
Tap O
in O
Jurkat-T B
cells I
induced O
dramatic O
cell O
aggregation O
. O

Surfactant O
protein O
A O
activates O
NF-kappa O
B O
in O
the O
THP-1 B
monocytic I
cell I
line I
. O

We O
used O
gel O
shift O
assays O
to O
determine O
whether O
SP-A O
activated O
NF-kappa O
B O
in O
the O
THP-1 B
cell I
line I
, O
a O
human B
monocytic I
cell I
line I
. O

Activation O
of O
NF-kappa O
B O
in O
THP-1 B
cells I
by O
SP-A O
doses O
as O
low O
as O
1 O
microgram/ml O
occurred O
within O
30 O
min O
of O
SP-A O
treatment O
, O
peaked O
at O
60 O
min O
, O
and O
then O
declined O
. O

Functional O
analysis O
of O
monocytic B
THP-1 I
cells I
transfected O
with O
plasmids O
containing O
various O
lengths O
of O
TNF-alpha O
promoter O
localized O
enhancer O
elements O
in O
a O
region O
( O
-182 O
to O
-37 O
base O
pairs O
( O
bp O
) O
) O
that O
were O
required O
for O
optimal O
transcription O
of O
the O
TNF-alpha O
gene O
in O
response O
to O
LPS O
. O

In O
unstimulated O
THP-1 B
, O
CRE-binding O
protein O
and O
, O
to O
a O
lesser O
extent O
, O
c-Jun O
complexes O
were O
found O
to O
bind O
to O
the O
CRE O
site O
. O

Rescue O
by O
cytokines O
of O
apoptotic O
cell O
death O
induced O
by O
IL-2 O
deprivation O
of O
human B
antigen-specific I
T I
cell I
clones I
. O

We O
have O
examined O
the O
effect O
of O
cytokines O
on O
IL-2 O
deprivation-induced O
apoptosis O
of O
human B
antigen-specific I
T I
helper I
clones I
with O
different O
cytokine O
production O
profiles O
. O

We O
found O
that O
IL-2 O
, O
interferon-alpha O
( O
IFN-alpha O
) O
, O
and O
IFN-beta O
inhibited O
IL-2 O
deprivation O
apoptosis O
in O
Th0 B
, I
Th1 I
, I
and I
Th2 I
clones I
. O

We O
also O
found O
that O
IL-2 O
protects O
T B
cell I
clones I
from O
IL-2 O
deprivation O
apoptosis O
accompanying O
active O
proliferation O
and O
enhanced O
expression O
of O
P53 O
, O
Rb O
and O
Bcl-xL O
proteins O
. O

In O
contrast O
, O
IFN-alpha/beta O
rescued O
T B
cell I
clones I
from O
apoptosis O
without O
active O
proliferation O
, O
and O
expression O
of O
apoptosis-associated O
proteins O
tested O
so O
far O
was O
unaffected O
. O

IFN-alpha/beta O
specifically O
induced O
tyrosine O
phosphorylation O
and O
translocation O
into O
nucleus O
of O
signal O
transducers O
and O
activators O
of O
transcription O
( O
STAT O
) O
2 O
protein O
in O
the O
T B
cell I
clones I
. O

In O
addition O
, O
over-expression O
of O
STAT2 O
by O
transfection O
of O
the O
cDNA O
prevented O
apoptosis O
of O
the O
T B
cell I
clones I
. O

Northern O
blot O
analysis O
showed O
that O
IL-10 O
reduced O
the O
accumulation O
of O
ICAM-1 O
mRNA O
in O
IFN-gamma-stimulated B
monocytes I
. O

Expression O
plasmids O
encoding O
regions O
of O
RFX5 O
fused O
to O
the O
GAL4 O
DNA O
binding O
domain O
activated O
transcription O
from O
a O
reporter O
construct O
containing O
GAL4 O
sites O
in O
a O
cotransfection O
assay O
in O
the O
Raji B
human I
B I
cell I
line I
. O

However O
, O
these O
plasmids O
produced O
transcriptional O
activity O
in O
HeLa B
cells I
only O
in O
conjunction O
with O
interferon O
gamma O
stimulation O
, O
a O
condition O
in O
which O
expression O
of O
both O
CIITA O
and O
class O
II O
major O
histocompatibility O
complex O
surface O
proteins O
are O
induced O
. O

Furthermore O
, O
these O
plasmids O
were O
not O
active O
in O
RJ2.2.5 B
, O
an O
in O
vitro O
mutagenized O
derivative O
of O
Raji B
in O
which O
both O
copies O
of O
CIITA O
are O
defective O
. O

Transcriptional O
activation O
by O
the O
RFX5 O
fusion O
protein O
could O
be O
restored O
in O
RJ2.2.5 B
by O
cotransfection O
with O
a O
CIITA O
expression O
plasmid O
. O

Accordingly O
, O
Jurkat B
T I
cells I
and O
primary O
CD45RA O
and O
CD45R0 O
CD4+ O
T O
cell O
subsets O
isolated O
from O
peripheral O
blood O
using O
immunomagnetic O
beads O
were O
cultured O
and O
analyzed O
by O
LM-PCR O
. O

Interestingly O
, O
an O
inducible O
footprint O
between O
-183 O
and O
-196 O
was O
consistently O
observed O
in O
Jurkat B
T I
cells I
and O
CD45RA O
and O
CD45R0 O
T O
helper O
subsets O
upon O
stimulation O
with O
phorbol O
12-myristate O
13-acetate+ O
phytohemagglutinin O
( O
PMA+ O
PHA O
) O
that O
was O
highly O
sensitive O
to O
treatment O
with O
corticosteroids O
. O

CholecystokininB O
receptor O
from O
human B
Jurkat I
lymphoblastic I
T I
cells I
is O
involved O
in O
activator O
protein-1 O
-responsive O
gene O
activation O
. O

The O
aim O
of O
this O
study O
was O
to O
analyze O
the O
role O
of O
cholecystokinin O
( O
CCK O
( O
B O
) O
) O
receptor O
in O
human B
lymphoblastic I
Jurkat I
T I
cells I
. O

For O
this O
purpose O
, O
we O
transiently O
transfected O
Jurkat B
T I
cells I
with O
the O
reporter O
plasmid O
p O
[ O
( O
TRE O
) O
3-tk-Luc O
] O
and O
found O
that O
CCK-8 O
was O
able O
to O
dose-dependently O
induce O
luciferase O
expression O
related O
to O
activator O
protein-1 O
( O
AP-1 O
) O
activation O
with O
a O
maximal O
response O
identical O
to O
that O
obtained O
with O
compounds O
known O
to O
activate O
AP-1 O
complex O
( O
quantitatively O
, O
the O
same O
level O
of O
induction O
was O
obtained O
with O
1 O
nM O
12-O-tetradecanoylphorbol-13-acetate O
, O
100 O
microM O
diacylglycerol O
, O
or O
4 O
nM O
epidermal O
growth O
factor O
) O
. O

This O
effect O
was O
confirmed O
in O
COS-7 O
cells O
transfected O
with O
the O
cDNA O
of O
CCK O
( O
B O
) O
receptor O
cloned O
from O
Jurkat B
T I
cells I
. O

To O
better O
understand O
the O
AP-1 O
-dependent O
luciferase O
expression O
in O
Jurkat B
T I
cells I
, O
we O
tested O
two O
specific O
inhibitors O
of O
serine/threonine O
phosphatases-1 O
and O
-2A O
: O
okadaic O
acid O
and O
calyculin O
A O
. O

In O
Jurkat B
T I
cells I
activated O
by O
phorbol-12-myristate-13-acetate O
and O
phytohemagglutinin O
, O
CCK-8 O
induced O
IL-2 O
expression O
. O

Our O
results O
indicate O
that O
CCK-8 O
exerts O
a O
trophic O
effect O
in O
Jurkat B
T I
cells I
through O
stimulation O
of O
CCK O
( O
B O
) O
receptors O
by O
modulation O
of O
expression O
of O
AP-1-regulated O
genes O
. O

Granulocyte-macrophage O
colony-stimulating O
factor O
( O
GM-CSF O
) O
regulates O
differentiation O
, O
survival O
, O
and O
proliferation O
of O
colony-forming B
unit-granulocyte-macrophage I
progenitor I
cells I
. O

We O
have O
demonstrated O
that O
the O
murine B
FDC-P1-derived I
cell I
line I
WT-19 B
transfected O
with O
the O
human O
GM-CSF O
receptor O
alpha O
and O
beta O
subunits O
( O
GM-CSFRalpha O
and O
beta O
) O
can O
be O
induced O
to O
differentiate O
by O
the O
addition O
of O
human O
GM-CSF O
( O
hGM-CSF O
) O
. O

By O
expressing O
a O
series O
of O
GM-CSFRalpha O
mutants O
in O
WT19 B
cells I
, O
we O
have O
determined O
the O
amino O
acid O
domains O
of O
the O
GM-CSFRalpha O
cytoplasmic O
domain O
that O
regulate O
cell O
differentiation O
, O
proliferation O
, O
and O
survival O
. O

The O
human B
monocytic I
cell I
line I
THP-1 B
mimics O
PAM O
in O
1 O
, O
25 O
( O
OH O
) O
2D3 O
synthesis O
and O
sensitivity O
to O
exogenous O
1 O
, O
25 O
( O
OH O
) O
2D3 O
. O

We O
utilized O
THP-1 B
cells I
to O
examine O
the O
response O
to O
1 O
, O
25 O
( O
OH O
) O
2D3 O
with O
macrophage O
activation O
. O

Activation O
of O
THP-1 B
cells I
with O
gamma-interferon O
( O
gamma-IFN O
) O
enhances O
1 O
, O
25 O
( O
OH O
) O
2D3 O
synthesis O
30-fold O
, O
blocks O
1 O
, O
25- O
( O
OH O
) O
2D3 O
suppression O
of O
its O
synthesis O
, O
and O
reduces O
by O
42.2 O
% O
1 O
, O
25- O
( O
OH O
) O
2D3 O
induction O
of O
its O
degradation O
. O

In O
THP-1 B
cells I
and O
in O
normal O
PBM O
, O
gamma-IFN O
inhibits O
1 O
, O
25- O
( O
OH O
) O
2D3 O
induction O
of O
24-hydroxylase O
mRNA O
levels O
without O
reducing O
mRNA O
stability O
, O
suggesting O
gamma-IFN O
inhibition O
of O
1 O
, O
25 O
( O
OH O
) O
2D3 O
transactivating O
function O
. O

CIITA O
is O
a O
positive O
regulator O
of O
class O
II O
major O
histocompatibility O
complex O
gene O
transcription O
that O
has O
been O
found O
to O
be O
defective O
in O
one O
of O
the O
five O
complementation O
groups O
of O
class B
II I
major I
histocompatibility I
complex-negative I
cell I
lines I
. O

Uncoupling O
of O
cell O
cycle O
arrest O
from O
the O
expression O
of O
monocytic O
differentiation O
markers O
in O
HL60 B
cell I
variants I
. O

Human B
leukemia I
HL60 I
cells I
respond O
to O
the O
presence O
of O
1 O
, O
25-dihydroxyvitamin O
D3 O
( O
1 O
, O
25D3 O
) O
by O
expressing O
a O
number O
of O
markers O
of O
the O
monocyte/macrophage O
phenotype O
and O
become O
arrested O
predominantly O
in O
the O
G1 O
phase O
of O
the O
cell O
cycle O
. O

We O
have O
recently O
reported O
a O
series O
( O
A O
) O
of O
1 O
, O
25D3-resistant O
variants O
of O
HL60 B
cells I
which O
proliferate O
in O
the O
presence O
of O
1 O
, O
25D3 O
and O
do O
not O
express O
differentiation O
markers O
( O
Exp. O
Cell O
Res. O
224 O
, O
312 O
, O
1996 O
) O
. O

Cells O
in O
the O
B O
series O
with O
4C O
DNA O
content O
( O
100B O
and O
200B O
) O
also O
differed O
from O
the O
A B
series I
4C I
cells I
by O
the O
absence O
of O
DNA O
binding O
by O
the O
full-length O
Sp1 O
transcription O
factor O
. O

However O
, O
B O
series O
cells O
resembled O
the O
A O
series O
cells O
in O
exhibiting O
faster O
growth O
rates O
than O
the O
parental O
HL60 B
cells I
and O
showed O
high O
levels O
of O
vitamin O
D O
receptor O
and O
retinoid O
receptor O
X O
proteins O
. O

Together O
, O
these O
results O
suggest O
that O
in O
future O
clinical O
gene O
therapy O
trials O
, O
a O
combined O
pharmacologic O
and O
genetic O
strategy O
like O
the O
one O
reported O
here O
may O
improve O
the O
survival O
of O
transduced B
cells I
and O
prolong O
clinical O
benefit O
. O

Upon O
activation O
of O
Jurkat B
T I
cells I
and O
primary O
murine O
thymocytes O
with O
phorbol O
esters O
and O
ionomycin O
, O
BOB.1/OBF.1 O
expression O
and O
transactivation O
function O
were O
induced O
. O

The O
methodology O
employed O
transient O
transfection O
of O
HEK B
293 I
cells I
with O
a O
cDNA O
for O
the O
52-kDa O
form O
of O
G O
( O
S O
) O
alpha O
under O
regulation O
by O
inducible O
metallothionein O
promoters O
. O

In O
this O
study O
, O
using O
a O
chromogenic O
assay O
, O
we O
have O
shown O
thrombin O
generation O
by O
apoptotic O
VSMCs O
expressing O
c-myc O
( O
VSMC-myc B
) O
with O
an O
area O
under O
the O
thrombin O
-generation O
curve O
( O
AUC O
) O
of O
305 O
+/- O
17 O
nmol O
x O
min/L O
and O
a O
peak O
thrombin O
( O
PT O
) O
of O
154 O
+/- O
9 O
nmol/L O
. O

The O
thrombin O
-generating O
potential O
of O
the O
apoptotic B
VSMC-myc I
cells I
was O
greater O
than O
that O
of O
unactivated O
platelets O
( O
P O
= O
.003 O
for O
AUC O
; O
P O
= O
.0002 O
for O
PT O
) O
and O
similar O
to O
calcium-ionophore O
activated O
platelets O
( O
AUC O
of O
332 O
+/- O
15 O
nmol O
x O
min/L O
, O
P O
= O
.3 O
; O
PT O
of O
172 O
+/- O
8 O
nmol/L O
, O
P O
= O
.2 O
) O
. O

VSMC-myc B
cells I
maintained O
in O
serum O
generated O
less O
thrombin O
than O
after O
serum O
withdrawal O
( O
P O
= O
.0002 O
for O
AUC O
and O
PT O
) O
. O

However O
, O
the O
experimentally O
derived O
B-lymphoblastoid B
cell I
line I
, O
clone B
13 I
, O
expresses O
high O
levels O
of O
HLADQ O
in O
the O
absence O
of O
HLA-DR O
and O
HLA-DP O
, O
despite O
its O
mapping O
by O
complementation O
analysis O
to O
this O
group O
. O

We O
report O
here O
that O
ectopic O
expression O
of O
CIITA O
cDNAs O
derived O
by O
reverse O
transcriptase O
polymerase O
chain O
reaction O
from O
clone B
13 I
do O
not O
restore O
expression O
of O
HLA-DQ O
in O
another O
CIITA-deficient B
cell I
line I
, O
RJ2.2.5 B
. O

In O
addition O
, O
no O
CIITA O
protein O
is O
detectable O
in O
clone B
13 I
nuclear O
extracts O
. O

In O
contrast O
, O
somatic O
cell O
fusion O
between O
clone B
13 I
and O
RJ2.2.5 B
restored O
expression O
of O
the O
HLA-DQ O
haplotype O
encoded O
by O
the O
RJ2.2.5 O
DQB O
gene O
. O

We O
show O
that O
ligand-induced O
homodimerization O
of O
chimeric O
surface O
receptors O
consisting O
of O
the O
extracellular O
and O
transmembrane O
domains O
of O
the O
erythropoietin O
receptor O
and O
of O
the O
intracellular O
domain O
of O
IL-4Ralpha O
induces O
Janus O
kinase O
1 O
( O
Jak1 O
) O
activation O
, O
STAT6 O
activation O
, O
and O
Cepsilon O
germline O
transcripts O
in O
human B
B I
cell I
line I
BJAB I
. O

Similar O
results O
were O
obtained O
in O
hepatic B
HTC I
cells I
for O
the O
transactivation O
of O
the O
endogenous O
tyrosine O
amino O
transferase O
gene O
( O
TAT O
) O
, O
which O
encodes O
one O
of O
the O
enzymes O
involved O
in O
the O
glucocorticoid-dependent O
stimulation O
of O
neoglucogenesis O
. O

Indeed O
, O
secretion O
of O
the O
proinflammatory O
lymphokine O
interleukin-1beta O
was O
severely O
inhibited O
by O
dissociated O
glucocorticoids O
in O
human B
monocytic I
THP I
1 I
cells I
. O

Phorbol O
ester O
treatment O
of O
a O
pre-B B
cell I
line I
up-regulated O
CD19 O
expression O
, O
induced O
Egr-1 O
, O
and O
enhanced O
the O
footprint O
over O
the O
GC O
box O
. O

With O
the O
aim O
of O
identifying O
genetic O
targets O
for O
these O
transcription O
factors O
, O
we O
stably O
transfected O
cDNAs O
encoding O
EBF O
or O
a O
covalent O
homodimer O
of O
E47 O
, O
individually O
or O
together O
, O
into O
immature B
hematopoietic I
Ba/F3 I
cells I
, O
which O
lack O
both O
factors O
. O

In O
the O
T B
cell I
line I
CTLL2 I
, O
ligation O
of O
kit/IL-4R O
alpha O
induces O
cellular O
proliferation O
. O

Finally O
, O
in O
JAK-1-deficient B
HeLa I
cells I
, O
STAT6 O
activation O
by O
IL-4 O
is O
completely O
abolished O
. O

Histamine O
modulates O
the O
expression O
of O
c-fos O
through O
cyclic O
AMP O
production O
via O
the O
H2 O
receptor O
in O
the O
human B
promonocytic I
cell I
line I
U937 I
. O

We O
examined O
the O
effects O
of O
histamine O
and O
its O
agonists O
on O
the O
expression O
of O
the O
c-fos O
and O
c-myc O
proto-oncogenes O
at O
the O
transcriptional O
and O
translational O
levels O
in O
the O
human B
promonocytic I
U937 I
cell I
line I
. O

In O
addition O
, O
dibutyryl O
cAMP O
inhibited O
cell O
growth O
in O
a O
dose-dependent O
manner O
, O
whereas O
histamine O
failed O
to O
affect O
proliferation O
and O
differentiation O
of O
U937 B
cells I
. O

These O
results O
indicate O
that O
histamine O
activates O
several O
mechanisms O
involved O
in O
the O
induction O
of O
differentiation O
, O
such O
as O
cAMP O
and O
c-fos O
production O
, O
but O
fails O
to O
promote O
differentiation O
of O
U937 B
cells I
, O
apparently O
due O
to O
the O
rapid O
desensitization O
of O
H2 O
receptors O
. O

Triggering O
of O
HLA O
class O
II O
antigens O
by O
the O
anti-HLA-DR O
monoclonal O
antibody O
( O
mAb O
) O
L243 O
significantly O
( O
P O
< O
0.05 O
) O
and O
differentially O
enhanced O
the O
release O
of O
tumor O
necrosis O
factor O
alpha O
( O
TNF-alpha O
) O
by O
the O
non-Hodgkin O
's O
lymphoma O
cells O
Ri-I B
, O
Ci-I B
, O
and O
Sc-I B
, O
which O
are O
at O
a O
distinct O
stage O
of O
B-cell O
differentiation O
, O
and O
by O
the O
more O
mature O
Burkitt B
lymphoma I
cell I
Raji I
; O
in O
contrast O
, O
it O
did O
not O
induce O
TNF-alpha O
release O
by O
the O
pre-B O
leukemia O
cells O
Nalm-6 B
and O
BV173 B
. O

In O
contrast O
, O
released O
TNF-alpha O
was O
not O
responsible O
for O
the O
homotypic O
aggregation O
of O
Ri-I B
, O
Ci-I B
, O
Sc-I B
, O
and O
Raji B
cells I
induced O
by O
mAb O
L243 O
, O
and O
it O
did O
not O
affect O
the O
proliferation O
of O
B O
cells O
investigated O
. O

Transcription O
factor O
GATA-3 O
is O
differentially O
expressed O
in O
murine B
Th1 I
and I
Th2 I
cells I
and O
controls O
Th2-specific O
expression O
of O
the O
interleukin-5 O
gene O
. O

We O
previously O
established O
a O
critical O
role O
for O
the O
transcription O
factor O
GATA-3 O
in O
IL-5 O
promoter O
activation O
in O
EL-4 B
cells I
, O
which O
express O
both O
Th1- O
and O
Th2-type O
cytokines O
. O

Whereas O
mutations O
in O
the O
GATA-3 O
site O
abolished O
antigen- O
or O
cAMP- O
stimulated O
IL-5 O
promoter O
activation O
in O
Th2 O
cells O
, O
ectopic O
expression O
of O
GATA-3 O
in O
Th1 O
cells O
or O
in O
a O
non-lymphoid B
, I
non-IL-5-producing I
cell I
line I
activated O
the O
IL-5 O
promoter O
. O

Using O
homologous O
recombination O
, O
both O
EKLF O
alleles O
in O
murine B
embryonic I
stem I
( I
ES I
) I
cells I
were O
inactivated O
. O

These O
EKLF-/- B
ES I
cells I
were O
capable O
of O
undergoing O
in O
vitro O
differentiation O
to O
form O
definitive O
erythroid O
colonies O
that O
were O
similar O
in O
size O
and O
number O
to O
those O
formed O
by O
wild-type O
ES O
cells O
. O

However O
, O
the O
EKLF-/- B
colonies I
were O
poorly O
hemoglobinized O
and O
enucleated O
erythrocytes O
in O
these O
colonies O
contained O
numerous O
Heinz O
bodies O
. O

The O
ratio O
of O
adult O
beta-globin/alpha-globin O
mRNA O
in O
the O
mutant B
ES I
cells I
was O
1/15 O
of O
that O
in O
wild-type O
ES O
cells O
. O

When O
the O
EKLF-/- B
cells I
were O
injected O
into O
blastocysts O
, O
they O
did O
not O
contribute O
at O
a O
detectable O
level O
to O
the O
mature O
erythrocyte O
compartment O
of O
the O
chimeric O
animals O
, O
based O
on O
analysis O
of O
glucose O
phosphate O
isomerase-1 O
( O
GPI-1 O
) O
isozymes O
and O
hemoglobins O
that O
distinguish O
ES O
cell-derived O
erythrocytes O
from O
host O
blastocyst-derived O
erythrocytes O
. O

This O
indicated O
that O
the O
EKLF-/- B
erythrocytes I
in O
adult O
animals O
must O
be O
short-lived O
, O
apparently O
due O
to O
the O
imbalance O
of O
beta- O
versus O
alpha-globin O
chains O
, O
leading O
to O
the O
precipitation O
of O
excess O
alpha-globin O
chains O
to O
form O
Heinz O
bodies O
. O

Consistent O
with O
this O
hypothesis O
, O
the O
short O
life O
span O
was O
ameliorated O
by O
introduction O
into O
the O
EKLF-/- B
ES I
cells I
of O
a O
human O
LCR/gamma-globin O
gene O
, O
as O
evidenced O
by O
the O
presence O
of O
ES O
cell-derived O
reticulocytes O
as O
well O
as O
mature O
erythrocytes O
in O
the O
blood O
of O
the O
chimeric O
animals O
. O

As O
the O
expression O
level O
of O
the O
RP1 O
gene O
in O
activated O
T O
cells O
and O
a O
spectrum O
of O
tumor-derived B
cell I
lines I
correlates O
with O
the O
proliferative O
status O
of O
the O
cells O
, O
members O
of O
the O
EB1-like O
gene O
family O
may O
not O
only O
be O
involved O
in O
the O
tumorigenesis O
of O
colorectal O
cancers O
but O
may O
also O
play O
a O
role O
in O
the O
proliferative O
control O
of O
normal O
cells O
. O

We O
show O
for O
human B
Jurkat I
T I
leukemia I
cells I
, O
as O
well O
as O
human O
and O
mouse O
primary O
T O
lymphocytes O
, O
that O
this O
inhibitory O
effect O
is O
accompanied O
by O
an O
impaired O
nuclear O
translocation O
of O
the O
Rel O
proteins O
c-Rel O
, O
RelA/p65 O
and O
NF-kappa O
B1/p50 O
, O
whereas O
the O
nuclear O
appearance O
of O
RelB O
remains O
unaffected O
. O

In O
an O
effort O
to O
further O
elucidate O
the O
biological O
effects O
of O
A O
beta O
towards O
microglia O
, O
we O
investigated O
the O
ability O
of O
A O
beta O
peptides O
to O
activate O
nuclear O
factor O
( O
NF O
) O
-kappa O
B O
in O
the O
N9 B
murine I
microglial I
cell I
line I
. O

Higher O
concentrations O
of O
A O
beta O
( O
25-35 O
) O
were O
effective O
by O
themselves O
in O
inducing O
NF-kappa O
B O
activation O
, O
both O
in O
the O
N9 B
microglial I
cell I
line I
and O
in O
rat B
primary I
microglia I
, O
as O
well O
as O
in O
human O
monocytes O
. O

Administration O
of O
dexamethasone O
to O
temporal B
artery-SCID I
chimeras I
for O
1 O
wk O
induced O
a O
partial O
suppression O
of O
T O
cell O
and O
macrophage O
function O
as O
indicated O
by O
the O
reduced O
tissue O
concentrations O
of O
IL-2 O
, O
IL-1beta O
, O
and O
IL-6 O
mRNA O
, O
and O
by O
the O
diminished O
expression O
of O
inducible O
NO O
synthase O
. O

A O
new O
mouse O
gene O
, O
SRG3 O
, O
related O
to O
the O
SWI3 O
of O
Saccharomyces O
cerevisiae O
, O
is O
required O
for O
apoptosis O
induced O
by O
glucocorticoids O
in O
a O
thymoma B
cell I
line I
. O

The O
expression O
of O
anti-sense O
RNA O
to O
SRG3 O
mRNA O
in O
a O
thymoma B
cell I
line I
, O
S49.1 B
, O
reduced O
the O
expression O
level O
of O
the O
SRG3 O
protein O
, O
and O
decreased O
the O
apoptotic O
cell O
death O
induced O
by O
glucocorticoids O
. O

These O
results O
suggest O
that O
the O
SRG3 O
protein O
is O
involved O
in O
the O
glucocorticoid-induced O
apoptosis O
in O
the O
thymoma B
cell I
line I
. O

Transcriptional O
induction O
of O
collagenase-1 O
in O
differentiated B
monocyte-like I
( I
U937 I
) I
cells I
is O
regulated O
by O
AP-1 O
and O
an O
upstream O
C/EBP-beta O
site O
. O

Chloramphenicol O
acetyltransferase O
expression O
constructs O
containing O
regions O
of O
the O
human O
collagenase-1 O
promoter O
were O
stably O
or O
transiently O
transfected O
into O
U937 B
cells I
, O
and O
reporter O
activity O
was O
assessed O
at O
various O
times O
after O
the O
onset O
of O
phorbol O
12-myristate O
13-acetate O
( O
PMA O
) O
-mediated O
differentiation O
. O

The O
AP-1 O
mutant O
constructs O
also O
showed O
delayed O
transcriptional O
activation O
in O
PMA-treated B
fibroblasts I
. O

Western O
and O
supershift O
analyses O
indicated O
that O
functional O
Jun O
and O
Fos O
proteins O
were O
present O
in O
nuclear O
extracts O
of O
PMA-differentiated B
U937 I
cells I
. O

Both O
truncated O
forms O
also O
bound O
to O
the O
transcription O
factor O
RBP-Jkappa O
in O
extracts O
prepared O
from O
human B
and I
murine I
T-ALL I
cell I
lines I
. O

EMS O
analyses O
performed O
with O
nuclear O
extracts O
from O
Tax-expressing B
Jurkat I
cells I
and O
HTLV-I-transformed O
peripheral O
blood O
mononuclear O
cells O
demonstrate O
that O
Tax O
prevents O
the O
formation O
of O
U1 O
( O
U1A/U1B O
) O
and O
U2 O
DNA-protein O
complexes O
. O

To O
get O
further O
insights O
into O
the O
molecular O
mechanisms O
underlying O
the O
biological O
activity O
of O
Tat O
, O
we O
investigated O
the O
effect O
of O
endogenous O
and O
exogenous O
Tat O
protein O
on O
c-fos O
gene O
expression O
in O
T B
lymphoblastoid I
( I
Jurkat I
) I
and I
monocytic I
( I
U937 I
) I
cell I
lines I
, O
as O
well O
as O
in O
primary O
peripheral O
blood O
mononuclear O
cells O
( O
PBMC O
) O
. O

Transient O
cotransfection O
of O
tat O
cDNA O
in O
sense O
orientation O
( O
tat/S O
) O
, O
together O
with O
a O
plasmid O
containing O
the O
c-fos O
promoter O
( O
FC3 O
, O
from- O
711 O
to O
+42 O
) O
in O
front O
of O
the O
bacterial O
chloramphenicol O
acetyltransferase O
( O
CAT O
) O
gene O
significantly O
enhanced O
CAT O
activity O
in O
Jurkat B
cells I
activated O
by O
the O
addition O
of O
15 O
% O
fetal O
calf O
serum O
( O
FCS O
) O
or O
5 O
micrograms/mL O
phytohemagglutinin O
plus O
10 O
( O
-7 O
) O
mol/L O
phorbol O
myristate O
acetate O
( O
PMA O
) O
and O
U937 B
cells I
activated O
by O
15 O
% O
FCS O
or O
10 O
( O
-7 O
) O
mol/L O
PMA O
. O

This O
effect O
was O
specifically O
due O
to O
Tat O
, O
since O
Jurkat B
and O
U937 B
cells I
cotransfected O
either O
with O
tat O
cDNA O
in O
antisense O
orientation O
( O
tat/AS O
) O
, O
tat O
carrying O
a O
mutation O
in O
the O
aminoacid O
cys22-gly22 O
( O
tat O
22/S O
) O
or O
with O
the O
backbone O
vector O
alone O
( O
pRPneo-SL3 O
) O
did O
not O
show O
any O
significant O
difference O
in O
c-fos O
promoter O
activity O
as O
compared O
to O
cells O
transfected O
with O
FC3 O
plasmid O
alone O
. O

Exogenous O
recombinant O
Tat O
protein O
was O
also O
able O
to O
upregulate O
c-fos O
promoter O
activity O
in O
serum-activated O
Jurkat O
and O
U937 B
cells I
, O
as O
well O
as O
endogenous O
c-fos O
mRNA O
expression O
and O
c-Fos O
protein O
synthesis O
in O
both O
serum-activated B
cell I
lines I
and O
primary O
PBMC O
. O

c-Fos O
protein O
was O
shown O
essential O
for O
an O
optimal O
transactivation O
of O
the O
HIV-1 O
long O
terminal O
repeat O
( O
LTR O
) O
by O
Tat O
: O
incubation O
of O
Jurkat B
cells I
with O
antisense O
, O
but O
not O
sense O
, O
c-fos O
oligonucleotides O
significantly O
reduced O
either O
the O
Tat O
-enhanced O
expression O
of O
an O
LTR-CAT O
reporter O
construct O
or O
the O
levels O
of O
gag O
p24 O
in O
the O
culture O
supernatants O
of O
Jurkat B
cells I
and O
PBMC O
acutely O
infected O
with O
HIV-1 O
. O

Synergistic O
transactivation O
of O
the O
LPS O
response O
element O
in O
Drosophila B
Schneider I
cells I
by O
coexpression O
of O
c-Fos O
, O
c-Jun O
, O
c-Rel O
, O
and O
p65 O
or O
c-Jun O
and O
p65 O
required O
the O
transactivation O
domains O
of O
c-Jun O
and O
p65 O
. O

The O
present O
study O
demonstrates O
that O
human O
THP-1 B
promonocytic I
cells I
, O
engineered O
by O
gene O
transfer O
to O
constitutively O
produce O
human O
growth O
hormone O
( O
hGH O
) O
, O
secreted O
depressed O
amounts O
of O
TNF-alpha O
in O
response O
to O
challenge O
by O
LPS O
. O

Inhibition O
of O
TNF-alpha O
production O
by O
THP-1-hGH-transfected B
cells I
cultured O
in O
the O
presence O
of O
LPS O
is O
dependent O
on O
a O
selective O
pathway O
, O
since O
no O
inhibition O
of O
TNF-alpha O
production O
was O
observed O
when O
cells O
were O
cultured O
in O
the O
presence O
of O
PMA O
. O

Inhibition O
of O
TNF-alpha O
secretion O
by O
LPS-stimulated B
THP-1-hGH I
cells I
was O
associated O
with O
a O
decrease O
in O
nuclear O
translocation O
of O
nuclear O
factor-kappaB O
. O

Previously O
, O
we O
showed O
that O
fibroblast O
conditioned O
medium O
( O
FCM O
) O
is O
able O
to O
inhibit O
both O
TNF O
mRNA O
accumulation O
and O
protein O
release O
in O
peripheral B
blood-derived I
human I
monocytes I
( O
PBM B
) O
stimulated O
with O
lipopolysaccharide O
( O
LPS O
) O
. O

We O
provide O
evidence O
that O
FCM O
strongly O
inhibits O
the O
LPS-induced O
NF-kappaB O
activation O
in O
PBM B
. O

Treatment O
by O
NE O
of O
ATP-depleted O
platelets O
or O
Chinese B
hamster I
ovary I
cells I
expressing O
human O
recombinant O
alphaIIbbeta3 O
clearly O
established O
that O
activation O
of O
the O
integrin O
was O
independent O
of O
signal O
transduction O
events O
and O
was O
concomitant O
with O
the O
proteolysis O
of O
alphaIIbH O
. O

Electrophoretic O
mobility O
shift O
( O
EMS O
) O
analyses O
utilizing O
oligonucleotides O
homologous O
to O
each O
of O
the O
21 O
bp O
repeat O
elements O
reacted O
with O
nuclear O
extracts O
derived O
from O
cell B
lines I
of O
lymphocytic O
, O
monocytic O
, O
neuronal O
, O
and O
glial O
cell O
origin O
have O
demonstrated O
differential O
binding O
of O
cellular O
factors O
to O
the O
three O
21 O
bp O
repeats O
( O
1-4 O
) O
. O

However O
, O
a O
unique O
DNA-protein O
complex O
was O
detected O
when O
the O
promoter O
central O
21 O
bp O
repeat O
was O
reacted O
with O
nuclear O
extracts O
derived O
from O
either O
the O
U-373 B
MG I
glioblastoma I
cell I
line I
or O
the O
THP-1 B
mature I
monocytic I
cell I
line I
. O

We O
show O
here O
by O
mobility-shift O
assay O
that O
E2F-containing O
DNA-binding O
complexes O
were O
detected O
in O
HTLV-I-infected B
T-cell I
lines I
and O
leukemic O
cells O
obtained O
from O
ATL O
patients O
but O
not O
in O
an O
uninfected B
T-cell I
line I
, O
Jurkat B
, O
and O
normal O
peripheral O
blood O
mononuclear O
cells O
. O

We O
demonstrate O
that O
expression O
of O
Tax O
can O
induce O
the O
E2F-containing O
DNA-binding O
complexes O
in O
Jurkat B
T I
cells I
. O

In O
murine B
Ba/F3 I
cells I
transfected O
with O
the O
human O
G-CSFR O
and O
NFS-60 B
cells I
constitutively O
expressing O
the O
murine O
G-CSFR O
, O
G-CSF O
induced O
tyrosine O
phosphorylation O
and O
activation O
of O
Jak1 O
, O
Jak2 O
, O
and O
Tyk2 O
. O

In O
the O
present O
study O
, O
we O
investigated O
the O
induction O
mechanism O
of O
SAA O
gene O
in O
THP-1 B
monocyte/macrophage I
cells I
which O
play O
a O
critical O
role O
in O
the O
development O
of O
atherosclerotic O
fatty O
streak O
and O
plaque O
formation O
. O

METHODS O
: O
THP-1 B
cells I
, O
a O
monocytic B
cell I
line I
, O
were O
transfected O
with O
the O
CMV O
IE O
genes O
. O

RESULTS O
: O
Interleukin-6 O
protein O
and O
mRNA O
production O
were O
significantly O
increased O
in O
cells O
transfected O
with O
the O
CMV O
IE O
genes O
and O
stimulated O
with O
LPS O
compared O
to O
LPS-stimulated B
control I
cells I
. O

A O
deletion O
construct O
that O
contains O
a O
NF-kappa O
B O
site O
but O
is O
missing O
the O
multiple O
response O
region O
demonstrated O
a O
continued O
increase O
in O
IL-6 O
luciferase O
activity O
in O
LPS-stimulated B
CMV I
transfected I
cells I
. O

Overexpression O
of O
ALY O
stimulates O
the O
activity O
of O
the O
TCR O
alpha O
enhancer O
complex O
reconstituted O
in O
transfected B
nonlymphoid I
HeLa I
cells I
, O
whereas O
down-regulation O
of O
ALY O
by O
anti-sense O
oligonucleotides O
virtually O
eliminates O
TCR O
alpha O
enhancer O
activity O
in O
T O
cells O
. O

The O
AML1a-transfected B
K562 I
cells I
had O
a O
reduced O
capacity O
to O
differentiate O
in O
the O
presence O
of O
sodium O
n-butyrate O
but O
not O
in O
the O
presence O
of O
other O
inducers O
, O
such O
as O
hemin O
, O
1-beta-D-arabinofuranosylcytosine O
, O
and O
herbimycin O
A O
. O

On O
the O
other O
hand O
, O
AML1b O
conferred O
a O
similar O
differentiation-inducing O
capacity O
upon O
K562 B
cells I
transfected O
with O
vector O
alone O
. O

Identification O
of O
sequence O
alterations O
in O
the O
upstream O
regulatory O
region O
of O
the O
estrogen O
receptor O
gene O
in O
an O
ER-negative B
breast I
cancer I
cell I
line I
. O

We O
have O
cloned O
and O
sequenced O
a O
portion O
of O
the O
ER O
upstream O
regulatory O
region O
from O
the O
ER-positive B
MCF-7 I
and O
the O
ER-negative B
MDA-MB-231 I
breast I
cancer I
cell I
lines I
to O
determine O
if O
sequence O
alterations O
in O
this O
region O
account O
for O
the O
ER O
-negative O
phenotype O
of O
some O
tumors O
. O

In O
the O
IL-4-producing B
Th0-like I
human I
Jurkat I
and O
mouse B
EL-4 I
cells I
, O
POS-1 O
( O
designated O
POS-1a O
) O
contains O
NF-IL6beta O
and O
Jun O
. O

In O
the O
mouse B
Th2 I
D10 I
cells I
and O
in O
the O
human B
Th2 I
clones I
, O
POS-1 O
( O
designated O
POS-1b O
) O
contains O
NF-IL6beta O
, O
Jun O
, O
and O
NF-ATc/p O
. O

In O
contrast O
, O
POS-1 O
was O
not O
found O
in O
nuclear O
extracts O
of O
human B
Th1 I
clones I
. O

Cell-to-cell O
contact O
between O
peripheral O
blood O
lymphocytes O
and O
transfected B
human I
colonic I
carcinoma I
cell I
line I
HT29 I
activates O
transcription O
of O
the O
long O
terminal O
repeats O
( O
LTR O
) O
of O
human O
immunodeficiency O
virus O
. O

Possible O
role O
of O
nuclear O
factor-kappa O
B O
activity O
in O
germline O
C O
epsilon O
transcription O
in O
a O
human B
Burkitt I
lymphoma I
B I
cell I
line I
. O

We O
report O
here O
that O
the O
signaling O
cascade O
triggered O
by O
interleukin-4 O
( O
IL-4 O
) O
or O
anti-CD40 O
monoclonal O
antibody O
( O
mAb O
) O
participates O
in O
NF-kappa O
B O
activation O
responsible O
for O
germline O
C O
epsilon O
transcription O
in O
a O
human B
Burkitt I
lymphoma I
B I
cell I
line I
, O
DND39 B
. O

Differentiation O
of O
U-937 B
promonocytic I
cells I
by O
etoposide O
and O
ICRF-193 O
, O
two O
antitumour O
DNA O
topoisomerase O
II O
inhibitors O
with O
different O
mechanisms O
of O
action O
. O

We O
have O
compared O
the O
action O
on O
U-937 B
human I
promonocytic I
leukemia I
cells I
of O
two O
DNA O
topoisomerase O
II O
inhibitors O
, O
namely O
the O
epipodophyllotoxin O
etoposide O
and O
the O
bisdioxopiperazine O
ICRF-193 O
. O

Using O
an O
erythroid B
cell I
line I
, O
we O
have O
tested O
the O
changes O
in O
the O
DNA O
binding O
activity O
of O
the O
lineage-restricted O
transcription O
factor O
GATA-1 O
through O
the O
cell O
cycle O
. O

Two O
distinct O
pathways O
of O
interleukin-5 O
synthesis O
in O
allergen-specific B
human I
T-cell I
clones I
are O
suppressed O
by O
glucocorticoids O
. O

To O
delineate O
the O
regulatory O
mechanisms O
of O
human O
IL-5 O
synthesis O
, O
we O
established O
allergen-specific B
CD4+ I
T-cell I
clones I
from O
asthmatic O
patients O
. O

Human O
IL-5 O
promoter/enhancer-luciferase O
gene O
construct O
transfected O
to O
T-cell B
clones I
was O
transcribed O
on O
either O
TCR O
or O
IL-2R O
stimulation O
and O
was O
clearly O
downregulated O
by O
dexamethasone O
, O
indicating O
that O
the O
approximately O
500-bp O
human O
IL-5 O
gene O
segment O
located O
5 O
' O
upstream O
of O
the O
coding O
region O
contains O
activation-inducible O
enhancer O
elements O
responsible O
for O
the O
regulation O
by O
GC O
. O

Itk O
, O
a O
T O
cell-specific O
tyrosine O
kinase O
, O
is O
required O
for O
CD2-mediated O
interleukin-2 O
promoter O
activation O
in O
the O
human B
T I
cell I
line I
Jurkat I
. O

In O
the O
present O
study O
, O
we O
have O
utilized O
a O
mutant B
Jak1-deficient I
HeLa I
cell I
line I
, O
E1C3 B
, O
and O
its O
parental B
Jak1-expressing I
counterpart I
, O
1D4 B
, O
to O
analyze O
the O
role O
of O
Jak1 O
in O
mediating O
IL-4-induced O
tyrosine O
phosphorylation O
events O
. O

IL-4 O
treatment O
rapidly O
induced O
tyrosine O
phosphorylation O
of O
insulin O
receptor O
substrate O
( O
IRS O
) O
-1 O
and O
IRS-2 O
in O
1D4 B
but O
not O
in O
E1C3 B
cells I
. O

IL-4 O
-mediated O
tyrosine O
phosphorylation O
of O
Stat6 O
was O
pronounced O
in O
1D4 B
cells I
, O
while O
no O
IL-4 O
-induced O
Stat6 O
phosphorylation O
was O
detected O
in O
E1C3 B
cells I
. O

IL-4 O
also O
induced O
Stat6 O
DNA O
binding O
activity O
from O
lysates O
of O
1D4 B
but O
not O
E1C3 B
cells I
utilizing O
a O
radiolabeled O
immunoglobulin O
heavy O
chain O
germline O
epsilon O
promotor O
sequence O
( O
Iepsilon O
) O
in O
an O
electrophoretic O
mobility O
shift O
assay O
. O

Reconstitution O
of O
Jak1 O
expression O
in O
E1C3 B
cells I
restored O
the O
ability O
of O
IL-4 O
to O
induce O
IRS O
and O
Stat6 O
tyrosine O
phosphorylation O
. O

One O
of O
these O
subregions O
, O
NRE O
gamma O
, O
is O
active O
in O
both O
HeLa B
cervical I
carcinoma I
cells I
and O
Huh7 B
hepatoma I
cells I
and O
was O
found O
to O
be O
bound O
by O
a O
protein O
factor O
present O
in O
both O
cell O
types O
. O

The O
mutant O
, O
containing O
a O
serine-to-alanine O
substitution O
in O
the O
DNA-binding O
domain O
of O
the O
protein O
, O
bound O
to O
several O
known O
ZEBRA-binding O
sites O
and O
activated O
transcription O
from O
reporters O
bearing O
known O
ZEBRA-responsive O
promoters O
but O
did O
not O
disrupt O
latency O
in O
EBV-infected B
cell I
lines I
. O

Pretreatment O
of O
ACH-2 B
T I
cells I
by O
NAC O
followed O
by O
stimulation O
with O
PMA O
, O
TNF-alpha O
, O
or O
hydrogen O
peroxide O
( O
H2O2 O
) O
resulted O
in O
strong O
suppression O
of O
NF-kappa O
B O
activation O
. O

In O
contrast O
, O
neither O
ascorbate O
nor O
AZT O
affected O
NF-kappa O
B O
activity O
under O
all O
three O
induction O
conditions O
in O
the O
ACH-2 B
cell I
line I
. O

Adenovirus O
E1B O
19K O
protein O
is O
required O
for O
efficient O
DNA O
replication O
in O
U937 B
cells I
. O

It O
has O
been O
shown O
that O
this O
E1B O
19K O
protein O
is O
not O
necessary O
for O
viral O
DNA O
replication O
in O
human B
cell I
lines I
, O
such O
as O
HeLa B
and O
KB B
. O

We O
reported O
here O
that O
the O
E1B O
19K O
mutant O
viruses O
were O
unable O
to O
replicate O
efficiently O
in O
a O
monocyte B
cell I
line I
, O
U937 B
. O

Viral O
DNA O
synthesis O
and O
late O
gene O
expression O
were O
found O
to O
be O
defective O
in O
U937 B
cells I
infected O
with O
E1B O
19K O
mutants O
compared O
with O
wild-type O
virus O
. O

Early O
viral O
RNA O
splicing O
patterns O
also O
differ O
between O
wild-type B
and I
dl337-infected I
cells I
. O

These O
results O
imply O
that O
E1B O
19K O
is O
required O
for O
efficient O
viral O
DNA O
replication O
in O
U937 B
cells I
. O

Inefficient O
DNA O
replication O
is O
also O
found O
in O
another O
monocyte B
cell I
line I
, O
THP-1 B

Overexpression O
of O
beta-adrenergic O
receptor O
kinase O
1 O
carboxyl-terminal O
peptide O
in O
JY25 B
cells I
also O
inhibited O
Raf-1 O
and O
ERK1 O
activity O
, O
indicating O
a O
direct O
involvement O
of O
G O
betagamma O
subunits O
in O
the O
signal O
transduction O
generated O
through O
activation O
of O
MAPK O
pathway O
by O
TCC O
assembly O
in O
the O
plasma O
membrane O
. O

Mutants O
of O
type O
5 O
adenovirus O
( O
Ad5 O
) O
with O
reiterated O
DNA O
sequences O
in O
the O
E1a O
region O
appeared O
in O
a O
human B
T-lymphocyte I
cell I
line I
, O
Molt-4 B
, O
persistently O
infected O
with O
H5sub304 O
, O
a O
deletion/substitution O
mutant O
that O
has O
a O
wild-type O
phenotype O
in O
viral O
replication O
. O

These O
E1a O
reiteration O
mutants O
could O
be O
propagated O
in O
HeLa B
, O
A549 B
, O
and O
KB B
cells I
; O
they O
were O
genetically O
stable O
; O
and O
they O
killed O
CREF B
cells I
at O
a O
strikingly O
high O
frequency O
. O

This O
degree O
of O
cell O
damage O
was O
not O
observed O
in O
Ad5wt O
or O
H5sub304 O
infection O
of O
CREF B
cells I
. O

T O
cells O
infiltrating O
a O
herpes O
simplex O
virus O
( O
HSV O
) O
lesion O
from O
a O
HLA O
DQ O
2 O
, O
7 O
individual O
yielded O
a O
virus-specific B
CD4+ I
clone I
restricted O
by O
DQ2 O
. O

Presentation O
of O
viral O
peptide O
and O
protein O
segregated O
with O
DQA1 O
allele O
, O
because O
cell O
lines O
bearing O
DQA1*0501/DQB1*0201 O
heterodimers O
presented O
antigen O
in O
proliferation O
and O
cytotoxicity O
assays O
much O
more O
efficiently O
than O
cell B
lines I
bearing O
DQA1*0201/DQB1*0201 O
. O

Inhibitor O
( O
IK O
) O
of O
IFN-gamma O
induced O
HLA O
class O
II O
antigens O
expression O
also O
inhibits O
HLA O
class O
II O
constitutive O
expression O
in O
the O
human B
Raji I
B I
cell I
line I
. O

Here O
we O
show O
that O
the O
IL-12 O
receptor O
( O
IL-12R O
) O
beta O
2 O
subunit O
, O
a O
recently O
cloned O
binding O
and O
signal O
transducing O
component O
of O
the O
IL-12R O
, O
is O
expressed O
on O
human B
Th1 I
but I
not I
Th2 I
clones I
and O
is O
induced O
during O
differentiation O
of O
human O
naive O
cells O
along O
the O
Th1 O
but O
not O
the O
Th2 O
pathway O
. O

Activation O
of O
the O
transcription O
factor O
NF-kappaB O
in O
lipopolysaccharide-stimulated B
U937 I
cells I
. O

In O
this O
paper O
, O
we O
demonstrate O
that O
the O
activation O
of O
NF-kappaB O
by O
LPS O
in O
a O
promonocytic B
cell I
line I
( O
U937 B
) O
followed O
a O
rather O
slow O
kinetics O
, O
depending O
on O
the O
rate O
of O
IkappaB-alpha O
inhibitor O
hydrolysis O
. O

The O
transduction O
pathway O
leading O
to O
NF-kappaB O
activation O
in O
U937 B
cells I
involved O
the O
intracellular O
generation O
of O
reactive O
oxygen O
species O
( O
ROS O
) O
, O
as O
demonstrated O
by O
the O
concomitant O
inhibitory O
effects O
of O
antioxidants O
on O
NF-kappaB O
activation O
and O
the O
emission O
of O
a O
fluorescent O
probe O
reacting O
intracellularly O
with O
hydrogen O
peroxide O
. O

However O
, O
the O
NF-kappaB O
activation O
pathway O
involving O
the O
acidic O
sphingomyelinase O
of O
the O
endolysosomial O
membrane O
did O
not O
seem O
to O
participate O
in O
the O
LPS-induced O
NF-kappaB O
activation O
in O
U937 B
cells I
. O

V3-BH10 O
, O
which O
consists O
of O
42 O
amino O
acids O
and O
has O
a O
loop O
structure O
, O
suppressed O
IL-2 O
-driven O
proliferation O
of O
all O
IL-2-dependent B
cells I
[ O
Kit225 B
, O
ED-40515 B
( I
+ I
) I
, O
KT-3 B
, O
7-day B
PHA-blasts I
, O
and O
fresh O
peripheral O
blood O
mononuclear O
cells O
] O
tested O
, O
whereas O
it O
did O
not O
suppress O
the O
cell O
growth O
of O
IL-2-independent B
cell I
lines I
( O
Hut102 B
, O
Molt-4 B
, O
and O
Jurkat B
) O
. O

In O
addition O
, O
V3-BH10 O
generated O
the O
arrest O
of O
Kit225 B
cells I
and O
also O
purified B
CD8-positive I
lymphocytes I
in O
G1 O
phase O
in O
the O
presence O
of O
IL-2 O
. O

Neither O
chromatin O
condensation O
nor O
DNA O
fragmentation O
was O
detected O
in O
Kit225 B
cells I
cultured O
with O
V3-BH10 O
and O
IL-2 O
. O

In O
addition O
to O
the O
existing O
isoform O
( O
Pax-5 O
, O
which O
we O
have O
named O
Pax-5a O
) O
, O
we O
have O
isolated O
three O
new O
isoforms O
, O
Pax-5b O
, O
Pax-5d O
, O
and O
Pax-5e O
, O
from O
murine O
spleen O
and O
B-lymphoid B
cell I
lines I
using O
library O
screenings O
and O
polymerase O
chain O
reaction O
amplification O
. O

Pax-5a O
was O
detectable O
in O
pro- B
, I
pre- I
, I
and I
mature I
B-cell I
lines I
, O
but O
not O
in O
two O
plasmacytomas O
; O
Pax-5b O
was O
shown O
to O
be O
present O
at O
low O
levels O
in O
mature B
B-cell I
lines I
and O
, O
unexpectedly O
, O
in O
one O
plasma O
cell O
line O
, O
but O
not O
in O
pro-B-cell B
or I
T-cell I
lines I
. O

Using O
this O
assay O
, O
we O
also O
showed O
that O
Pax-5d O
was O
present O
in O
nuclear O
extracts O
of O
some O
( O
but O
not O
all O
) O
B-lymphoid B
lines I
and O
interacts O
with O
the O
B-cell-specific O
activator O
protein-binding O
site O
. O

Reconstitution O
of O
T O
cell O
antigen O
receptor-induced O
Erk2 O
kinase O
activation O
in O
Lck-negative B
JCaM1 I
cells I
by O
Syk O
. O

Here O
we O
report O
that O
overexpression O
of O
Syk O
in O
the O
Lck-negative B
JCaM1 I
cells I
enabled O
the O
T O
cell O
antigen O
receptor/CD3 O
complex O
to O
induce O
a O
normal O
activation O
of O
the O
mitogen-activated O
protein O
kinase O
( O
MAPK O
) O
pathway O
and O
expression O
of O
a O
nuclear O
factor O
of O
activated O
T O
cells O
reporter O
construct O
. O

The O
results O
indicate O
that O
stimulation O
of O
NK O
cells O
, O
either O
freshly O
isolated O
from O
peripheral O
blood O
lymphocytes O
( O
PBL O
) O
or O
long-term B
cultured I
NK I
clones I
, O
with O
specific O
cell O
targets O
results O
in O
an O
increased O
binding O
activity O
of O
NF-kappa O
B O
and O
AP-1 O
transcription O
factors O
measured O
by O
gel O
retardation O
. O

Moreover O
, O
the O
inhibitors O
of O
serine O
proteases O
, O
N-alpha-tosyl-L-lysine O
chloromethyl O
ketone O
and O
N-alpha-tosyl-L-phenylalanine O
chloromethyl O
ketone O
, O
also O
blocked O
the O
cytolytic O
activity O
of O
NK O
cells O
against O
the O
sensitive O
target O
K562 B
. O

Characterization O
of O
a O
mutant B
cell I
line I
that O
does O
not O
activate O
NF-kappaB O
in O
response O
to O
multiple O
stimuli O
. O

In O
this O
study O
, O
we O
have O
characterized O
a O
cellular O
mutant O
, O
the O
70/Z3-derived B
1.3E2 I
murine I
pre-B I
cell I
line I
, O
that O
does O
not O
activate O
NF-kappaB O
in O
response O
to O
several O
stimuli O
. O

As O
well O
as O
culminating O
in O
the O
inducible O
phosphorylation O
of O
I O
kappaB O
alpha O
on O
serines O
32 O
and O
36 O
, O
all O
the O
stimuli O
that O
are O
inactive O
on O
1.3E2 B
cells I
exhibit O
a O
sensitivity O
to O
the O
antioxidant O
pyrrolidine O
dithiocarbamate O
( O
PDTC O
) O
. O

In O
contrast O
, O
stimuli O
such O
as O
hyperosmotic O
shock O
or O
phosphatase O
inhibitors O
, O
which O
use O
PDTC-insensitive O
pathways O
, O
induce O
I O
kappaB O
alpha O
degradation O
in O
1.3E2 B
. O

Analysis O
of O
the O
redox O
status O
of O
1.3E2 B
does O
not O
reveal O
any O
difference O
from O
wild-type B
70Z/3 I
. O

We O
also O
report O
that O
the O
human O
T-cell O
leukemia O
virus O
type O
1 O
( O
HTLV-1 O
) O
-derived O
Tax O
trans-activator O
induces O
NF-kappaB O
activity O
in O
1.3E2 B
, O
suggesting O
that O
this O
viral O
protein O
does O
not O
operate O
via O
the O
defective O
pathway O
. O

Finally O
, O
we O
show O
that O
two O
other O
I O
kappaB O
molecules O
, O
I O
kappaB O
beta O
and O
the O
recently O
identified O
I O
kappaB O
epsilon O
, O
are O
not O
degraded O
in O
the O
1.3E2 B
cell O
line O
following O
stimulation O
. O

Our O
results O
demonstrate O
that O
1.3E2 B
is O
a O
cellular O
transduction O
mutant O
exhibiting O
a O
defect O
in O
a O
step O
that O
is O
required O
by O
several O
different O
stimuli O
to O
activate O
NF-kappaB O
. O

In O
this O
manuscript O
we O
have O
investigated O
the O
molecular O
mechanisms O
by O
which O
T B
cell I
lines I
stimulated O
with O
phorbol O
12-myristate O
13-acetate O
( O
PMA O
) O
and O
phytohemagglutin O
( O
PHA O
) O
display O
significantly O
higher O
levels O
of O
NF-kappa O
B1 O
encoding O
transcripts O
than O
cells O
stimulated O
with O
tumor O
necrosis O
factor-alpha O
, O
despite O
the O
fact O
that O
both O
stimuli O
activate O
NF-kappa O
B O
. O

Furthermore O
, O
Egr-1 O
induction O
was O
required O
for O
endogenous O
NF-kappa O
B1 O
gene O
expression O
, O
since O
PMA/ O
PHA-stimulated B
T I
cell I
lines I
expressing O
antisense O
Egr-1 O
RNA O
were O
inhibited O
in O
their O
ability O
to O
upregulate O
NF-kappa O
B1 O
transcription O
. O

We O
have O
previously O
shown O
that O
NF-AT1 O
is O
constitutively O
active O
in O
Jurkat B
T I
cells I
stably O
transfected O
with O
the O
Tax O
cDNA O
, O
although O
the O
underlying O
molecular O
mechanism O
and O
physiological O
relevance O
of O
this O
finding O
remain O
unclear O
. O

These O
results O
suggest O
that O
activation O
of O
NF-AT1 O
in O
Tax-expressing B
and I
HTLV-I-transformed I
T I
cells I
results O
from O
its O
dephosphorylation O
, O
which O
in O
turn O
may O
be O
due O
to O
deregulation O
of O
calcineurin O

Using O
ATL-16T B
cells I
which O
express O
IL-5 O
mRNA O
, O
we O
have O
identified O
a O
region O
, O
within O
the O
human O
IL-5 O
gene O
promoter O
, O
that O
regulates O
IL-5 O
gene O
transcription O
. O

ATL-16T B
cells I
express O
mRNA O
of O
three O
GATA-binding O
proteins O
, O
hGATA-2 O
, O
hGATA-3 O
and O
hGATA-4 O
, O
and O
each O
of O
them O
has O
a O
potential O
to O
bind O
to O
the O
consensus O
( O
A/T O
) O
GATA O
( O
G/ O
A O
) O
motif O
. O

The O
electrophoretic O
mobility O
shift O
assay O
with O
extracts O
of O
COS B
cells I
expressing O
GATA-binding O
proteins O
showed O
that O
GATA-4 O
has O
the O
highest O
binding O
affinity O
to O
the O
-70 O
GATA O
site O
among O
the O
three O
GATA-binding O
proteins O
. O

In O
Jurkat B
cells I
, O
a O
human O
T-cell B
lymphoma I
cell I
line I
, O
tumor O
necrosis O
factor-alpha O
( O
TNF-alpha O
) O
induces O
NF O
kappaB O
activation O
that O
is O
inhibited O
by O
PDTC O
. O

Contrary O
to O
the O
results O
in O
Jurkat B
cells I
, O
PDTC O
did O
not O
inhibit O
tumor O
necrosis O
factor-alpha O
-induced O
NF O
kappaB O
activation O
in O
astrocytes O
; O
instead O
PDTC O
itself O
induces O
NF O
kappaB O
activation O
in O
astrocytes O
, O
and O
this O
may O
be O
related O
to O
scavenging O
of O
endogenously O
produced O
NO O
by O
the O
PDTC O
iron O
complex O
. O

Involvement O
of O
Stat3 O
in O
interleukin-6 O
-induced O
IgM O
production O
in O
a O
human B
B-cell I
line I
. O

IL-6 O
treatment O
of O
the O
human B
lymphoblastoid I
cell I
line I
, O
SKW6.4 B
, O
leads O
to O
increased O
IgM O
production O
. O

We O
have O
previously O
shown O
that O
IL-6 O
induces O
activation O
of O
JAK1 O
and O
JAK2 O
in O
human B
B I
cell I
lines I
. O

A O
chimeric O
IL-6 O
receptor O
, O
comprised O
of O
the O
intracellular O
tail O
of O
the O
IL-6 O
receptor O
subunit O
gp130 O
fused O
to O
the O
extracellular O
domain O
of O
the O
epidermal O
growth O
factor O
( O
EGF O
) O
receptor O
, O
was O
stably O
transfected O
into O
SKW6.4 B
cells I
. O

EGF O
treatment O
induced O
IgM O
production O
in O
cells O
transfected O
with O
an O
intact O
gp130 O
cytoplasmic O
tail O
, O
but O
not O
in O
untransfected B
cells I
or O
cells O
transfected O
with O
a O
cytoplasmic O
tail O
lacking O
all O
four O
signal O
transducers O
and O
activators O
of O
transcription O
( O
Stat O
) O
binding O
sites O
. O

Parental O
as O
well O
as O
transfected O
SKW6.4 B
cells I
were O
transiently O
transfected O
with O
an O
IgH-enhancer-luciferase O
construct O
. O

Transcriptional O
regulation O
of O
the O
ferritin O
heavy-chain O
gene O
: O
the O
activity O
of O
the O
CCAAT O
binding O
factor O
NF-Y O
is O
modulated O
in O
heme-treated B
Friend I
leukemia I
cells I
and O
during O
monocyte-to-macrophage O
differentiation O
. O

The O
ferritin O
H-chain O
gene O
promoter O
regulation O
was O
analyzed O
in O
heme-treated B
Friend I
leukemia I
cells I
( O
FLCs B
) O
and O
during O
monocyte-to-macrophage O
differentiation O
. O

In O
the O
majority O
of O
cell B
lines I
studied O
, O
the O
regulation O
of O
ferritin O
expression O
was O
exerted O
mostly O
at O
the O
translational O
level O
. O

We O
show O
here O
that O
the O
minimum O
region O
of O
the O
ferritin O
H-gene O
promoter O
that O
is O
able O
to O
confer O
transcriptional O
regulation O
by O
heme O
in O
FLCs B
to O
a O
reporter O
gene O
is O
77 O
nucleotides O
upstream O
of O
the O
TATA O
box O
. O

This O
cis O
element O
binds O
a O
protein O
complex O
referred O
to O
as O
HRF O
( O
heme-responsive O
factor O
) O
, O
which O
is O
greatly O
enhanced O
both O
in O
heme-treated O
FLCs B
and O
during O
monocyte-to-macrophage O
differentiation O
. O

The O
CCAAT O
element O
present O
in O
reverse O
orientation O
in O
this O
promoter O
region O
of O
the O
ferritin O
H-chain O
gene O
is O
necessary O
for O
binding O
and O
for O
gene O
activity O
, O
since O
a O
single O
point O
mutation O
is O
able O
to O
abolish O
the O
binding O
of O
HRF O
and O
the O
transcriptional O
activity O
in O
transfected B
cells I
. O

We O
have O
also O
observed O
a O
differential O
expression O
of O
the O
NF-YA O
subunit O
in O
heme-treated O
and O
control O
FLCs B
and O
during O
monocyte-to-macrophage O
differentiation O
. O

When O
mouse B
MPC11 I
plasmacytoma I
cells I
, O
in O
which O
the O
IgH O
3 O
' O
enhancer O
is O
active O
, O
are O
fused O
with O
fibroblasts O
, O
Ig O
expression O
is O
extinguished O
at O
the O
level O
of O
transcription O
. O

Here O
we O
show O
that O
in O
a O
MPC11 B
plasmacytoma I
x I
fibroblast I
environment I
, O
the O
IgH O
3 O
' O
enhancer O
is O
transcriptionally O
inactive O
. O

Moreover O
, O
the O
high O
expression O
level O
of O
c-myc O
, O
characteristic O
of O
the O
parental O
MPC11 B
cells I
carrying O
the O
t O
( O
12 O
; O
15 O
) O
translocation O
, O
is O
down-regulated O
in O
the O
hybrids O
to O
that O
in O
unfused O
fibroblasts O
. O

Activation O
of O
the O
NF-kappaB O
transcription O
factor O
in O
a O
T-lymphocytic B
cell I
line I
by O
hypochlorous O
acid O
. O

Treatment O
of O
a O
T-lymphocytic B
cell I
line I
with O
micromolar O
concentrations O
of O
HOCl O
promoted O
the O
appearance O
of O
transcription O
factor O
NF-kappaB O
( O
the O
heterodimer O
p50/p65 O
) O
in O
the O
nucleus O
of O
the O
cells O
, O
even O
in O
the O
absence O
of O
de O
novo O
protein O
synthesis O
. O

Moreover O
, O
ACH-2 B
cells I
treated O
with O
HOCl O
or O
H2O2 O
released O
tumour O
necrosis O
factor-alpha O
( O
TNF-alpha O
) O
in O
the O
supernatants O
. O

The O
importance O
of O
TNF-alpha O
release O
in O
NF-kappaB O
induction O
by O
HOCl O
or O
H2O2 O
was O
demonstrated O
by O
the O
fact O
that O
: O
( O
1 O
) O
the O
nuclear O
appearance O
of O
NF-kappaB O
was O
promoted O
in O
untreated B
cells I
; O
and O
( O
2 O
) O
synergism O
between O
TNF-alpha O
and O
HOCl O
was O
detected O
. O

Collectively O
, O
these O
results O
suggest O
that O
HOCl O
should O
be O
considered O
as O
an O
oxidative O
species O
capable O
of O
inducing O
NF-kappaB O
in O
a O
T-lymphocytic B
cell I
line I
through O
a O
transduction O
mechanism O
involving O
ROS O
, O
and O
having O
a O
long-distance O
effect O
through O
subsequent O
TNF-alpha O
release O
. O

In O
addition O
, O
we O
observed O
an O
altered O
expression O
level O
of O
AML1 O
along O
with O
the O
myeloid O
differentiation O
in O
several O
hemopoietic B
cell I
lines I
. O

The O
expression O
and O
binding O
activity O
of O
the O
Nfil3 O
protein O
( O
also O
called O
E4bp4 O
) O
, O
but O
not O
of O
Hlf O
, O
Dbp O
, O
or O
Tef O
, O
was O
found O
to O
be O
regulated O
by O
IL-3 O
in O
mouse B
pro-B I
cell I
lines I
( O
Baf-3 B
and O
FL5.12 B
) O
. O

Northern O
blot O
analyses O
indicated O
a O
highly O
restricted O
mRNA O
expression O
pattern O
, O
with O
the O
strongest O
expression O
occurring O
in O
promyelocyte B
and I
late-myeloblast-like I
cell I
lines I
. O

Transient O
tranfection O
of O
a O
promyelocyte B
cell I
line I
( O
NB4 B
) O
with O
a O
C/EBP-epsilon O
expression O
plasmid O
increased O
cell O
growth O
by O
sevenfold O
, O
while O
antisense O
C/EBP-epsilon O
caused O
a O
fivefold O
decrease O
in O
clonal O
growth O
of O
these O
cells O
. O

The O
binding O
of O
the O
A6H O
mAb O
induced O
a O
costimulatory O
signal O
in O
anti-CD3 B
activated I
T I
cells I
. O

As O
a O
first O
step O
in O
understanding O
the O
mechanism O
of O
decreased O
binding O
affinity O
in O
New O
World O
primates O
, O
we O
used O
reverse O
transcription-PCR O
to O
clone O
the O
glucocorticoid O
receptor O
from O
squirrel O
monkey O
liver O
and O
have O
compared O
the O
sequence O
to O
receptor O
sequences O
obtained O
from O
owl O
monkey O
liver O
, O
cotton-top B
tamarin I
B95-8 I
cells I
, O
and O
human O
lymphocytes O
. O

In O
this O
study O
we O
determined O
the O
effects O
of O
SAC O
on O
NF-kappa O
B O
activation O
in O
human O
T O
lymphocytes O
( O
Jurkat B
cells I
) O
induced O
by O
tumor O
necrosis O
factor O
alpha O
( O
TNF- O
alpha O
) O
and O
H2O2 O
. O

Our O
data O
suggest O
that O
SAC O
may O
act O
via O
antioxidant O
mechanisms O
to O
block O
NF-kappa O
B O
activation O
in O
Jurkat B
cells I
. O

Transcription O
factor O
effects O
on O
chromosome O
constitution O
of O
cell B
hybrids I
. O

When O
immunoglobulin B
( I
Ig I
) I
-secreting I
plasmacytomas I
are O
fused O
to O
a O
T-cell O
lymphoma O
, O
Ig O
gene O
expression O
ceases O
in O
greater O
than O
95 O
% O
of O
the O
resulting O
hybrids O
. O

The O
low O
frequency O
with O
which O
these O
Ig-expressing B
hybrids I
are O
recovered O
, O
along O
with O
the O
fact O
that O
cell O
fusions O
can O
lead O
to O
chromosome O
loss O
, O
led O
us O
to O
propose O
that O
this O
rare O
phenotype O
was O
due O
to O
loss O
of O
a O
T-cell-derived O
chromosome O
encoding O
a O
factor O
or O
factors O
with O
gene O
silencing O
activity O
. O

To O
identify O
the O
relevant O
chromosome O
, O
we O
have O
used O
a O
polymerase O
chain O
reaction O
( O
PCR O
) O
-assisted O
method O
of O
chromosome O
mapping O
to O
analyze O
both O
Ig-silenced B
( I
common I
) I
and I
Ig-expressing I
( I
rare I
) I
hybrids I
. O

IL-2 O
promoter O
activation O
in O
Jurkat B
T I
cells I
stimulated O
with O
superantigen O
presented O
by O
Raji B
B I
cells I
requires O
CD28 O
activation O
. O

In O
this O
study O
, O
a O
series O
of O
Burkitt B
's I
lymphoma I
( I
BL I
) I
cell I
lines I
were O
assayed O
for O
their O
expression O
of O
tissue O
inhibitor O
of O
metalloproteinases O
( O
TIMP O
) O
-1 O
. O

Results O
indicate O
that O
TIMP-1-positive B
BL I
lines I
show O
resistance O
to O
cold-shock-induced O
apoptosis O
. O

Furthermore O
, O
recombinant O
TIMP-1 O
, O
but O
not O
TIMP-2 O
or O
a O
synthetic O
metalloproteinase O
inhibitor O
( O
BB-94 O
) O
, O
confers O
resistance O
to O
apoptosis O
induced O
by O
both O
CD95-dependent O
and O
-independent O
( O
cold O
shock O
, O
serum O
deprivation O
, O
and O
gamma-radiation O
) O
pathways O
in O
TIMP-1-negative B
BL I
lines I
. O

Spi-1/PU.1 O
proto-oncogene O
induces O
opposite O
effects O
on O
monocytic O
and O
erythroid O
differentiation O
of O
K562 B
cells I
. O

To O
analyze O
the O
effects O
of O
ectopic O
expression O
of O
spi-1 O
on O
the O
proliferation/differentiation O
of O
human O
myeloid O
leukemia O
cells O
, O
K562 B
cells I
were O
stably O
transfected O
with O
a O
spi-1 O
expression O
vector O
. O

The O
transfected B
cell I
lines I
expressed O
elevated O
levels O
of O
spi-1 O
mRNA O
and O
protein O
and O
high O
Spi-1 O
-DNA O
binding O
activity O
. O

The O
spi-1 B
transfected I
cells I
showed O
reduced O
growth O
rates O
and O
reduced O
clonogenic O
cell O
growth O
. O

When O
the O
erythroid O
and O
monocytic O
differentiation O
markers O
were O
analyzed O
, O
spi-1 O
overexpression O
resulted O
in O
opposite O
effects O
: O
erythroid O
differentiation O
was O
significantly O
inhibited O
in O
spi-1 B
transfectants I
, O
while O
spi-1 O
overexpression O
increased O
the O
monocytic O
differentiation O
of O
cells O
. O

These O
results O
indicate O
a O
differential O
role O
of O
Spi-1 O
on O
the O
differentiation O
of O
human B
myeloid I
leukemia I
cells I
. O

During O
the O
differentiation O
process O
of O
cells O
from O
the O
monocytic B
cell I
line I
THP-1 I
we O
observed O
a O
transient O
transcriptional O
upregulation O
of O
a O
human O
carboxylesterase O
analyzed O
by O
means O
of O
Northern O
blots O
. O

In O
PMA-treated B
THP-1 I
cells I
we O
could O
detect O
three O
major O
transcription O
initiation O
sites O
as O
revealed O
by O
Nuclease O
Protection O
Assay O
carried O
out O
with O
two O
overlapping O
antisense O
RNA O
probes O
. O

We O
have O
recently O
cloned O
the O
carboxylesterase O
upstream O
sequence O
and O
showed O
its O
basal O
promoter O
activity O
in O
CHO B
cells I
. O

Taken O
together O
these O
data O
indicate O
that O
carboxylesterase O
gene O
transcription O
in O
THP-1 B
cells I
starts O
at O
multiple O
initiation O
sites O
and O
that O
Sp1 O
and O
IRBP O
may O
be O
critical O
factors O
for O
modulating O
the O
differentiation-dependent O
transcription O
of O
this O
human O
carboxylesterase O
gene O
. O

Enhanced O
differentiation O
of O
HL-60 B
leukemia I
cells I
to O
macrophages O
induced O
by O
ciprofibrate O
. O

Ciprofibrate O
, O
an O
hypolipidaemic O
peroxisome O
proliferator O
, O
induced O
differentiation O
of O
HL-60 B
cells I
. O

As O
occurs O
for O
HL-60 O
cell O
differentiation O
induced O
by O
high O
phorbol O
ester O
concentration O
, O
the O
ciprofibrate-induced O
phorbol O
ester-dependent O
differentiation O
of O
HL-60 B
cells I
proceeded O
through O
the O
monocytic/macrophage O
pathway O
and O
induced O
the O
phosphorylation O
of O
proteins O
with O
similar O
molecular O
weights O
suggesting O
that O
increased O
protein O
kinase O
C O
activity O
may O
be O
involved O
in O
the O
effect O
. O

The O
peroxisome O
proliferator-activated O
receptor O
( O
PPARalpha O
) O
transcription O
factor O
is O
expressed O
in O
HL-60 B
cells I
, O
but O
no O
changes O
were O
observed O
in O
its O
expression O
upon O
HL-60 O
cell O
differentiation O
. O

In O
attempting O
to O
investigate O
its O
effect O
on O
activation O
of O
T O
lymphocytes O
, O
we O
found O
triptolide O
induces O
apoptotic O
death O
of O
T B
cell I
hybridomas I
and O
peripheral O
T O
cells O
but O
not O
that O
of O
thymocytes O
. O

The O
present O
study O
demonstrates O
that O
AP-2 O
binding O
sequences O
are O
essential O
for O
increased O
transcription O
from O
the O
B2 O
promoter O
during O
monocyte-macrophage O
differentiation O
and O
that O
AP-2 O
, O
expressed O
exogenously O
in O
THP-1 B
and O
other O
cells O
, O
activates O
transcription O
from O
the O
B2 O
promoter O
. O

In O
mobility O
shift O
assays O
, O
a O
nuclear O
factor O
from O
THP-1 B
and O
U-937 B
cells I
was O
identified O
that O
binds O
to O
several O
AP-2 O
response O
elements O
within O
the O
B2 O
promoter O
, O
but O
does O
not O
react O
with O
AP-2 O
antibodies O
, O
and O
has O
a O
DNA O
sequence O
binding O
affinity O
profile O
that O
differs O
from O
AP-2 O
. O

No O
statistically O
significant O
correlation O
was O
found O
between O
c-Jun- B
and I
GST-pi-positive I
plasma I
cells I
. O

Here O
, O
we O
intend O
to O
demonstrate O
the O
requirement O
of O
GATA-1 O
and O
NF-E2 O
transcription O
factors O
in O
the O
BA-induced O
erythroid O
differentiation O
of O
human B
leukemic I
K562 I
cells I
. O

Using O
Wp O
reporter O
constructs O
in O
in O
vitro O
transfection O
assays O
, O
we O
found O
that O
Wp O
was O
11- O
to O
190-fold O
more O
active O
in O
B B
cell I
than O
in O
non-B B
cell I
lines I
and O
that O
three O
regions O
of O
the O
promoter O
( O
termed O
UAS1 O
, O
UAS2 O
, O
and O
UAS3 O
) O
contributed O
to O
transcriptional O
activation O
. O

By O
contrast O
, O
UAS1 O
( O
-140 O
to O
-87 O
) O
was O
B O
cell O
specific O
and O
was O
the O
key O
determinant O
of O
the O
promoter O
's O
increased O
activity O
in O
B B
cell I
lines I
. O

Herein O
we O
demonstrate O
that O
the O
inducible O
nuclear O
import O
of O
NF-kappa O
B O
, O
AP-1 O
, O
NFAT O
, O
and O
STAT1 O
in O
Jurkat B
T I
lymphocytes I
is O
significantly O
inhibited O
by O
a O
cell-permeable O
peptide O
carrying O
the O
NLS O
of O
the O
NF-kappa O
B O
p50 O
subunit O
. O

Further O
, O
we O
show O
that O
inhibitory O
NLS O
peptide O
interacts O
in O
vitro O
with O
a O
cytoplasmic O
NLS O
receptor O
complex O
comprised O
of O
the O
Rch1/importin O
( O
karyopherin O
) O
-beta O
heterodimer O
expressed O
in O
Jurkat B
T I
cells I
. O

Taken O
together O
, O
these O
data O
indicate O
that O
the O
inducible O
nuclear O
import O
of O
NF-kappa O
B O
, O
AP-1 O
, O
NFAT O
, O
and O
STAT1 O
in O
Jurkat B
T I
cells I
can O
be O
regulated O
by O
NLS O
peptide O
delivered O
noninvasively O
to O
the O
cytoplasm O
of O
Jurkat B
T I
cells I
to O
target O
members O
of O
the O
importin O
( O
karyopherin O
) O
-alpha O
beta O
NLS O
receptor O
complex O
. O

In O
this O
study O
, O
we O
used O
the O
NK B
cell I
line I
NK92 I
to O
define O
the O
molecular O
and O
cellular O
basis O
of O
NK O
cell-mediated O
EC O
activation O
. O

Furthermore O
, O
LTalpha O
was O
secreted O
in O
NK B
: I
EC I
co-cultures I
. O

As O
a O
first O
step O
toward O
elucidating O
the O
function O
of O
Cbl O
in O
TCR O
-initiated O
signaling O
, O
we O
evaluated O
the O
ability O
of O
wild-type O
Cbl O
or O
a O
transforming O
Cbl O
mutant O
( O
70Z/3 O
) O
to O
induce O
transcriptional O
activation O
of O
a O
nuclear O
factor O
of O
activated O
T O
cells O
( O
NFAT O
) O
element O
derived O
from O
the O
interleukin O
2 O
( O
IL2 O
) O
promoter O
in O
transiently O
cotransfected O
Jurkat-TAg B
T I
cells I
. O

Requirement O
of O
prestimulated B
THP-1 I
monocytic I
cells I
for O
endothelial O
cell O
activation O
. O

To O
overcome O
the O
difficulty O
in O
obtaining O
quiescent O
monocytes O
, O
we O
studied O
the O
ability O
of O
promonocytic B
THP-1 I
cells I
to O
activate O
endothelial O
cells O
. O

Lipopolysaccharide O
( O
LPS O
) O
-prestimulated O
and O
untreated O
THP-1 B
cells I
were O
cocultured O
with O
resting O
human O
umbilical O
vein O
endothelial O
cells O
( O
HUVEC O
) O
for O
3 O
and O
24 O
h O
in O
the O
presence O
of O
colimycin O
to O
neutralize O
LPS O
traces O
. O

Addition O
of O
untreated O
THP-1 B
cells I
had O
little O
effect O
on O
HUVEC O
adhesiveness O
. O

Addition O
of O
prestimulated O
THP-1 B
cells I
was O
followed O
by O
a O
noticeable O
adhesion O
after O
3 O
h O
which O
reversed O
to O
basal O
values O
within O
24 O
h O
. O

Diffusible O
endothelial O
proteins O
such O
as O
soluble O
E-selectin O
, O
PAI-1 O
and O
vWf O
to O
a O
minimal O
extent O
, O
increased O
in O
supernatants O
from O
HUVEC O
cocultured O
for O
24 O
h O
with O
prestimulated O
THP-1 B
cells I
. O

These O
results O
provide O
evidence O
that O
promonocytic B
THP-1 I
cells I
require O
prestimulation O
in O
order O
to O
activate O
HUVEC O
and O
that O
TNF O
alpha O
contributes O
to O
this O
phenomenon O
. O

We O
previously O
reported O
that O
monocyte O
adhesion O
to O
tumor B
necrosis I
factor-alpha I
( I
TNF-alpha I
) I
-treated I
endothelial I
cells I
increased O
expression O
of O
tissue O
factor O
and O
CD36 O
on O
monocytes O
. O

We O
used O
cytokine O
production O
as O
a O
readout O
for O
monocyte O
activation O
and O
found O
that O
CD15 O
cross-linking O
induced O
TNF-alpha O
release O
from O
peripheral O
blood O
monocytes O
and O
cells O
from O
the O
monocytic B
cell I
line I
MM6 I
. O

To O
examine O
transcriptional O
regulation O
of O
cytokine O
genes O
by O
CD15 O
engagement O
, O
a O
CAT O
plasmid O
reporter O
construct O
containing O
IL-1 O
beta O
promoter/enhancer O
sequences O
was O
introduced O
into O
MM6 B
. O

X-rays-induced O
secretion O
of O
cellular O
factor O
( O
s O
) O
that O
enhance O
( O
s O
) O
HIV-1 O
promoter O
transcription O
in O
various O
non-irradiated B
transfected I
cell I
lines I
. O

In O
addition O
, O
extracellular O
factor O
( O
s O
) O
released O
by O
X-ray-treated B
human I
colonic I
carcinoma I
cell I
line I
( O
HT29 B
) O
might O
activate O
the O
long O
terminal O
repeat O
( O
LTR O
) O
of O
HIV-1 O
in O
non-irradiated B
HT29 I
cells I
. O

In O
the O
present O
report O
we O
show O
that O
in O
various O
transiently O
or O
stably B
transfected I
cell I
lines I
, O
X-ray O
irradiation O
up-regulates O
HIV-1 O
LTR O
transcription O
through O
the O
kappaB O
regulatory O
elements O
. O

A O
factor O
( O
s O
) O
, O
which O
is O
processed O
by O
and O
acts O
upon O
a O
variety O
of O
cell O
types O
, O
was O
detected O
by O
addition O
to O
non-irradiated O
cells O
of O
either O
X-ray-treated B
cells I
or O
a O
conditioned O
medium O
taken O
from O
irradiated B
cultures I
. O

In O
addition O
, O
X-ray O
activation O
of O
HIV-1 O
LTR O
in O
transiently O
or O
stably O
transfected O
cell B
lines I
is O
inhibited O
by O
a O
potent O
antioxidant O
drug O
, O
pyrrolidine O
dithiocarbamate O
and O
by O
another O
drug O
, O
known O
for O
its O
role O
in O
the O
trapping O
of O
growth O
factors O
, O
suramin O
. O

Restoration O
of O
the O
CCAAT O
box O
or O
insertion O
of O
an O
erythroid O
Kruppel-like O
factor O
( O
EKLF O
) O
binding O
site O
in O
the O
delta O
promoter O
activates O
its O
expression O
in O
several O
erythroid B
cell I
lines I
. O

We O
extended O
these O
studies O
using O
a O
novel O
primary B
human I
adult I
erythroid I
cell I
( I
hAEC I
) I
system I
to O
investigate O
these O
effects O
at O
the O
late O
erythroblast O
stage O
. O

Our O
results O
demonstrate O
that O
the O
altered O
CCAAT O
box O
( O
CCAAC O
) O
and O
the O
lack O
of O
an O
EKLF O
binding O
site O
in O
delta-globin O
contribute O
to O
its O
low O
level O
of O
expression O
in O
the O
hAEC B
model I
as O
well O
. O

In O
this O
study O
, O
we O
have O
developed O
an O
in O
vitro O
model O
in O
which O
isolated O
lung O
cells O
can O
be O
submitted O
to O
a O
prolonged B
cyclic I
pressure-stretching I
strain I
resembling O
that O
of O
conventional O
mechanical O
ventilation O
. O

These O
mediators O
were O
measured O
in O
supernatants O
from O
ventilated O
alveolar O
macrophages O
, O
monocyte-derived O
macrophages O
, O
and O
promonocytic B
THP-1 I
cells I
. O

To O
determine O
the O
mechanisms O
responsible O
for O
these O
differences O
, O
we O
turned O
to O
human B
U937 I
promonocytic I
cells I
. O

We O
report O
here O
that O
Ox O
LDL O
enhanced O
DNA O
binding O
activity O
of O
nuclear O
extracts O
to O
an O
NF-kappaB O
sequence O
following O
activation O
of O
CD36-producing B
CHO I
cells I
with O
the O
proinflammatory O
cytokine O
tumor O
necrosis O
factor-alpha O
( O
TNF-alpha O
) O
. O

Second O
, O
in O
contrast O
to O
recent O
results O
on O
human B
cell I
lines I
, O
CIITA O
is O
not O
critically O
involved O
in O
the O
IFN-gamma O
-induced O
up-regulation O
of O
MHC O
class O
I O
genes O
. O

The O
levels O
of O
ICAM-1 O
mRNA O
expression O
of O
ATL B
cells I
were O
generally O
higher O
than O
those O
of O
T-lymphoid O
cells O
. O

However O
, O
ILT-mat B
cells I
and O
ATL16T B
( I
- I
) I
cells I
, O
although O
they O
were O
ATL B
cells I
, O
showed O
rather O
low O
surface O
ICAM-1 O
expression O
and O
ICAM-1 O
mRNA O
expression O
. O

Southern O
blot O
hybridization O
showed O
that O
only O
two O
and O
four O
bands O
were O
found O
in O
ILT-mat B
and O
ATL16T B
( I
- I
) I
cells I
, O
respectively O
, O
whereas O
> O
10 O
bands O
were O
detected O
in O
other O
ATL B
cells I
. O

Heat-shock O
and O
cadmium O
chloride O
increase O
the O
vimentin O
mRNA O
and O
protein O
levels O
in O
U-937 B
human I
promonocytic I
cells I
. O

Heat-shock O
for O
2 O
hours O
at O
42 O
degrees O
C O
, O
or O
the O
administration O
for O
3 O
hours O
of O
100 O
or O
150 O
microM O
cadmium O
chloride O
, O
inhibited O
the O
subsequent B
proliferation I
activity I
, O
induced O
the O
expression O
of O
functional O
differentiation O
markers O
, O
and O
caused O
an O
increase O
in O
the O
amount O
of O
the O
stress-responsive O
HSP70 O
protein O
in O
U-937 B
human I
promonocytic I
cells I
. O

Finally O
, O
it O
was O
observed O
that O
the O
rate O
of O
decay O
of O
vimentin O
mRNA O
upon O
actinomycin O
D O
administration O
was O
decreased O
in O
heat- B
and I
cadmium-pretreated I
cells I
in O
comparison O
to O
untreated O
cells O
. O

We O
investigated O
the O
regulation O
of O
human O
PML O
expression O
by O
interferons O
( O
IFNs O
) O
and O
IL-1 O
in O
various O
human B
haematopoietic I
lines I
( O
U937 B
, O
THP1 B
, O
HL60 B
, O
NB4 B
) O
, O
in O
human O
diploid O
fibroblasts O
and O
in O
human O
peripheral O
blood O
leukocytes O
. O

Tpl-2 O
induces O
IL-2 O
expression O
in O
T-cell B
lines I
by O
triggering O
multiple O
signaling O
pathways O
that O
activate O
NFAT O
and O
NF-kappaB O
. O

The O
Tpl-2 O
kinase O
activates O
the O
nuclear O
factor O
of O
activated O
T O
cells O
( O
NFAT O
) O
and O
induces O
IL-2 O
expression O
in O
T-cell B
lines I
. O

Experiments O
in O
COS-1 B
and O
EL-4 B
cells I
confirmed O
both O
hypotheses O
and O
revealed O
that O
the O
second O
factor O
activated O
by O
Tpl-2 O
is O
NF-kappaB O
. O

Differential O
activation O
of O
functionally O
distinct O
STAT5 O
proteins O
by O
IL-5 O
and O
GM-CSF O
during O
eosinophil O
and O
neutrophil O
differentiation O
from O
human B
CD34+ I
hematopoietic I
stem I
cells I
. O

To O
better O
understand O
the O
role O
of O
STAT O
proteins O
during O
growth O
and O
differentiation O
of O
granulocytes O
, O
we O
evaluated O
differentiation O
of O
human B
CD34+ I
hematopoietic I
stem I
cells I
ex O
vivo O
toward O
eosinophils O
and O
neutrophils O
. O

The O
T-cell O
oncogenic O
protein O
HOX11 O
activates O
Aldh1 O
expression O
in O
NIH B
3T3 I
cells I
but O
represses O
its O
expression O
in O
mouse O
spleen O
development O
. O

Representational O
difference O
analysis O
has O
been O
used O
to O
isolate O
cDNA O
clones O
corresponding O
to O
mRNA O
species O
activated O
following O
stable O
expression O
of O
HOX11 O
in O
NIH B
3T3 I
cells I
. O

In O
resting O
Raji B
cells I
, O
little O
to O
no O
binding O
to O
the O
X2 O
box O
was O
observed O
. O

Effect O
of O
environmental O
estrogens O
on O
IL-1beta O
promoter O
activity O
in O
a O
macrophage B
cell I
line I
. O

We O
sought O
to O
determine O
the O
activities O
of O
various O
environmental O
estrogens O
on O
the O
modulation O
of O
the O
interleukin-1beta O
( O
IL-1beta O
) O
gene O
in O
a O
model B
monocytic I
cell I
line I
, O
hER B
+ I
IL-1beta-CAT+ I
. O

Porcine B
aortic I
endothelial I
cells I
( O
PAEC B
) O
were O
incubated O
for O
1 O
hr O
30 O
min O
or O
5 O
hr O
with O
10 O
% O
homologous O
porcine O
serum O
( O
control O
) O
or O
10 O
% O
xenogeneic O
human O
serum O
and O
then O
perfused O
with O
total O
human O
leukocytes O
in O
a O
parallel O
plate O
flow O
chamber O
under O
laminar O
flow O
( O
1.5 O
dynes/cm2 O
) O
. O

By O
confocal O
fluorescence O
microscopy O
, O
we O
observed O
a O
positive O
staining O
for O
NF-kappa O
B O
( O
p65 O
subunit O
) O
in O
the O
nuclei O
of O
PAEC B
exposed O
for O
1 O
hr O
30 O
min O
to O
human O
serum O
, O
which O
indicated O
NF-kappa O
B O
activation O
in O
this O
setting O
. O

At O
variance O
, O
in O
PAEC B
incubated O
with O
the O
homologous O
serum O
, O
NF-kappa O
B O
was O
strictly O
localized O
in O
the O
cell O
cytoplasm O
. O

Treatment O
of O
PAEC B
exposed O
to O
xenogeneic O
serum O
with O
the O
NF-kappa O
B O
inhibitors O
pyrrolidinedithiocarbamate O
( O
PDTC O
, O
25 O
microM O
) O
and O
tosyl-phechloromethylketone O
( O
TPCK O
, O
25 O
microM O
) O
significantly O
( O
P O
< O
0.01 O
) O
reduced O
leukocyte O
adhesion O
in O
respect O
to O
PAEC B
treated O
with O
human O
serum O
alone O
. O

One O
of O
the O
isolated O
genes O
, O
that O
for O
retinaldehyde O
dehydrogenase O
2 O
( O
RALDH2 O
) O
, O
was O
regularly O
expressed O
in O
most O
of O
the O
T-ALL B
cell I
lines I
that O
coexpressed O
TAL1 O
and O
LMO O
. O

Exogenously O
transfected O
TAL1 O
and O
LMO O
, O
but O
not O
either O
alone O
, O
induced O
RALDH2 O
expression O
in O
a O
T-ALL B
cell I
line I
, O
HPB-ALL B
, O
not O
expressing O
endogeneous O
TAL1 O
or O
LMO O
. O

However O
, O
restimulation O
of O
human B
Th2 I
lines I
and O
clones O
in O
the O
presence O
of O
IFN-alpha O
does O
not O
induce O
the O
production O
of O
IFN-gamma O
. O

The O
mRNA O
levels O
for O
fkhrl1 O
is O
elevated O
in O
T O
helper-induced O
lymphocytes O
in O
comparison O
to O
PHA-stimulated B
T I
lymphocytes I
. O

It O
has O
been O
applied O
to O
peripheral O
blood O
monocytes O
and O
a O
T B
cell I
clone I
to O
isolate O
59 O
cDNA O
fragments O
associated O
to O
activation O
. O

Expression O
of O
transcription O
factors O
during O
sodium O
phenylacetate O
induced O
erythroid O
differentiation O
in O
K562 B
cells I
. O

During O
15 O
days O
of O
treatment O
of O
K562 B
cells I
with O
sodium O
phenylacetate O
, O
we O
observed O
an O
increase O
in O
the O
cellular O
hemoglobin O
concentration O
with O
a O
similar O
increase O
in O
the O
expression O
of O
gamma-globin O
mRNA O
. O

Likewise O
, O
the O
level O
of O
expression O
of O
the O
erythroid O
transcription O
factors O
GATA-1 O
, O
GATA-2 O
, O
NF-E2 O
, O
SCL O
and O
RBTN2 O
, O
all O
expressed O
in O
untreated O
K562 B
cells I
, O
did O
not O
increase O
during O
sodium O
phenylacetate O
induced O
erythroid O
differentiation O
. O

We O
conclude O
that O
sodium O
phenylacetate O
treatment O
of O
K562 B
cells I
increases O
gamma-globin O
mRNA O
and O
induces O
cell O
maturation O
as O
judged O
by O
morphology O
without O
affecting O
the O
expression O
of O
the O
erythroid O
transcription O
factors O
, O
some O
of O
which O
are O
known O
to O
be O
involved O
in O
the O
regulation O
of O
beta-like O
globin O
genes O
. O

The O
tissular O
patterns O
of O
CIITA O
and O
MHC O
class O
II O
gene O
expression O
are O
tightly O
correlated O
: O
CIITA O
mRNA O
is O
highly O
expressed O
in O
B O
cells O
, O
and O
is O
induced O
by O
interferon O
gamma O
( O
IFN-gamma O
) O
in O
macrophage B
and I
epithelial I
cell I
lines I
. O

We O
first O
isolated O
two O
overlapping O
cosmids O
encoding O
human O
CIITA O
which O
, O
when O
co-transfected O
, O
are O
able O
to O
restore O
MHC O
class O
II O
expression O
in O
a O
B-lymphoblastoid B
cell I
line I
( O
B-LCL B
) O
defective O
for O
CIITA O
. O

When O
introduced O
in O
front O
of O
a O
luciferase O
reporter O
gene O
, O
this O
promoter O
is O
able O
to O
direct O
a O
high O
luciferase O
activity O
in O
a O
human B
B-LCL I
. O

In O
contrast O
, O
luciferase O
expression O
was O
not O
stimulated O
after O
IFN-gamma O
treatment O
when O
the O
construct O
was O
transfected O
in O
macrophage O
or O
in O
epithelial B
cell I
lines I
. O

However O
, O
an O
induction O
of O
the O
human O
CIITA O
gene O
was O
observed O
in O
mouse B
macrophage I
and I
fibrosarcoma I
cell I
lines I
, O
when O
the O
cells O
were O
transfected O
with O
a O
cosmid O
containing O
the O
human O
CIITA O
gene O
, O
but O
lacking O
the O
1.8 O
kb O
promoter O
described O
above O
. O

Epstein-Barr O
virus O
( O
EBV O
) O
infects O
B O
cells O
, O
resulting O
in O
the O
outgrowth O
of O
immortalised B
lymphoblastoid I
cell I
lines I
( O
LCLs B
) O
. O

Here O
, O
we O
demonstrate O
through O
the O
use O
of O
intracellular O
staining O
that O
interleukin-1beta O
( O
IL-1beta O
) O
is O
expressed O
in O
LCLs B
and O
investigate O
the O
influence O
of O
the O
individual O
latent O
proteins O
on O
the O
expression O
of O
IL-1beta O
. O

Using O
RT-PCR O
, O
IL-1beta O
was O
shown O
to O
be O
up-regulated O
in O
EBV-transformed B
LCLs I
as O
well O
as O
in O
group B
III I
Burkitt I
's I
lymphoma I
( I
BL I
) I
cell I
lines I
, O
compared O
with O
group B
I I
BL I
cell I
lines I
. O

In O
group B
I I
BL I
cells I
, O
containing O
low O
levels O
of O
NF-kappaB O
, O
only O
RBP O
binding O
was O
observed O
in O
EMSAs O
, O
whereas O
NF-kappaB O
binding O
could O
be O
demonstrated O
in O
EBV-transformed B
B I
cell I
lines I
containing O
high O
levels O
of O
activated O
NF-kappaB O
. O

The O
addition O
of O
CD27 O
ligand O
( O
CD70 O
) O
transfectants O
to O
B B
cell I
cultures I
increased O
the O
IgE O
synthesis O
synergistically O
in O
the O
presence O
of O
IL-4 O
plus O
anti-CD40 O
mAb O
( O
anti-CD40 O
) O
. O

The O
effect O
of O
CD70 B
transfectants I
was O
dose O
dependent O
and O
was O
completely O
blocked O
by O
anti-CD70 O
mAb O
. O

Flow O
cytometric O
and O
morphological O
analyses O
demonstrated O
that O
the O
addition O
of O
CD70 O
transfectants O
to O
B B
cell I
cultures I
remarkably O
promoted O
differentiation O
into O
plasma O
cells O
in O
the O
presence O
of O
IL-4 O
and O
CD40 O
signaling O
. O

Although O
interleukin O
( O
IL O
) O
-12 O
was O
originally O
purified O
from O
an O
Epstein-Barr B
( I
EBV I
) I
-transformed I
B I
cell I
line I
and O
the O
high O
correlation O
of O
EBV O
infection O
and O
IL-12 O
expression O
has O
been O
suggested O
, O
no O
study O
has O
reported O
whether O
EBV O
infection O
is O
directly O
linked O
to O
IL-12 O
expression O
. O

Furthermore O
, O
transfection O
with O
LMP1 O
expression O
vector O
into O
a O
human B
B I
lymphoma I
cell I
line I
, O
Daudi B
, O
led O
to O
p40 O
production O
with O
nuclear O
factor O
( O
NF O
) O
-kappaB O
activation O
. O

We O
have O
found O
that O
the O
beta-casein O
gene O
is O
expressed O
in O
a O
cytotoxic B
T I
cell I
line I
, O
CTLL-2 B
, O
in O
response O
to O
interleukin-2 O
( O
IL-2 O
) O
, O
which O
activates O
STAT5 O
. O

While O
IL-4 O
does O
not O
activate O
STAT5 O
, O
it O
induces O
expression O
of O
STAT5-regulated O
genes O
in O
CTLL-2 B
, O
i.e O
. O
beta-casein O
, O
a O
cytokine-inducible O
SH2-containing O
protein O
( O
CIS O
) O
, O
and O
oncostatin O
M O
( O
OSM O
) O
, O
suggesting O
that O
STAT6 O
activated O
by O
IL-4 O
substitutes O
for O
the O
function O
of O
STAT5 O
in O
T O
cells O
. O

GATA-3 O
represses O
gp91phox O
gene O
expression O
in O
eosinophil-committed B
HL-60-C15 I
cells I
. O

To O
study O
the O
regulatory O
mechanism O
of O
gp91phox O
gene O
expression O
in O
eosinophils O
, O
we O
transiently O
transfected O
eosinophil-committed B
HL-60-C15 I
cells I
with O
gp91phox O
promoter O
constructs O
, O
and O
identified O
a O
negative O
element O
from O
bp O
-267 O
to O
-246 O
of O
the O
gp91phox O
gene O
, O
the O
deletion O
of O
which O
caused O
an O
83 O
% O
increase O
in O
promoter O
activity O
. O

We O
therefore O
conclude O
that O
GATA-3 O
specifically O
binding O
to O
the O
GATA O
site O
negatively O
regulates O
the O
expression O
of O
the O
gene O
in O
HL-60-C15 B
cells I
. O

Uncoupling O
activation-dependent O
HS1 O
phosphorylation O
from O
nuclear O
factor O
of O
activated O
T O
cells O
transcriptional O
activation O
in O
Jurkat B
T I
cells I
: O
differential O
signaling O
through O
CD3 O
and O
the O
costimulatory O
receptors O
CD2 O
and O
CD28 O
. O

Unlike O
ligation O
of O
CD3 O
, O
stimulation O
with O
anti-CD28 O
mAb O
or O
CHO B
cells I
expressing O
the O
CD28 O
ligands O
CD80 O
or O
CD86 O
did O
not O
lead O
to O
tyrosine O
phosphorylation O
of O
HS1 O
in O
Jurkat B
T I
cells I
. O

Cross-linking O
of O
FcR O
, O
on O
the O
THP-1 B
monocytic I
cell I
line I
, O
by O
immune O
complexes O
resulted O
in O
both O
activation O
of O
the O
transcription O
factor O
NF-kappaB O
and O
interleukin O
1 O
production O
. O

The O
ability O
of O
E2A-HLF O
to O
prolong O
the O
survival O
of O
interleukin-3 B
( I
IL-3 I
) I
-dependent I
murine I
pro-B I
cells I
after O
IL-3 O
withdrawal O
suggests O
that O
it O
disrupts O
signaling O
pathways O
normally O
responsible O
for O
cell O
suicide O
, O
allowing O
the O
cells O
to O
accumulate O
as O
transformed O
lymphoblasts O
. O

To O
determine O
the O
structural O
motifs O
that O
contribute O
to O
this O
antiapoptotic O
effect O
, O
we O
constructed O
a O
panel O
of O
E2A-HLF O
mutants O
and O
programmed O
their O
expression O
in O
IL-3-dependent B
murine I
pro-B I
cells I
( O
FL5.12 B
line I
) O
, O
using O
a O
zinc-inducible O
vector O
. O

To O
study O
the O
molecular O
mechanisms O
of O
transcriptional O
control O
of O
CD95L O
expression O
in O
T O
cells O
, O
we O
investigated O
the O
human O
CD95L O
promoter O
in O
Jurkat B
T I
cells I
. O

Using O
human O
T O
lymphocytes O
and O
T B
cell I
lines I
, O
we O
show O
that O
progesterone O
, O
at O
concentrations O
found O
in O
the O
placenta O
, O
rapidly O
and O
reversibly O
blocks O
voltage-gated O
and O
calcium-activated O
K+ O
channels O
( O
KV O
and O
KCa O
, O
respectively O
) O
, O
resulting O
in O
depolarization O
of O
the O
membrane O
potential O
. O

Progesterone O
effectively O
blocked O
a O
broad O
spectrum O
of O
K+ O
channels O
, O
reducing O
both O
Kv1.3 O
and O
charybdotoxin-resistant O
components O
of O
KV O
current O
and O
KCa O
current O
in O
T O
cells O
, O
as O
well O
as O
blocking O
several O
cloned O
KV O
channels O
expressed O
in O
cell B
lines I
. O

The O
accumulation O
of O
mature O
B O
cells O
in O
the O
thymus O
was O
found O
only O
in O
tg O
epsilon26 O
mice O
, O
not O
in O
other O
human B
CD3epsilon I
transgenic I
mouse I
lines I
or O
other O
T O
cell-deficient O
mice O
, O
including O
CD3-epsilon O
knockout O
mice O
and O
TCR-beta/TCR-delta O
double O
knockout O
mice O
. O

The O
observation O
that O
human O
herpesvirus O
6 O
( O
HHV-6 O
) O
can O
induce O
CD4 O
gene O
transcription O
and O
expression O
in O
CD4 B
( I
- I
) I
cells I
was O
reported O
several O
years O
ago O
( O
P.Lusso O
, O
A.De O
Maria O
, O
M.Malnati O
, O
F.Lori O
, O
S.E.DeRocco O
, O
M. O
Baseler O
, O
and O
R.C.Gallo O
, O
Nature O
349 O
: O
533-535 O
, O
1991 O
) O
and O
subsequently O
confirmed O
( O
P.Lusso O
, O
M.S.Malnati O
, O
A.Garzino-Demo O
, O
R.W.Crowley O
, O
E. O
O.Long O
, O
and O
R.C.Gallo O
, O
Nature O
362 O
: O
458-462 O
, O
1993 O
; O
G.Furlini O
, O
M. O
Vignoli O
, O
E.Ramazzotti O
, O
M.C.Re O
, O
G.Visani O
, O
and O
M.LaPlaca O
, O
Blood O
87 O
: O
4737-4745 O
, O
1996 O
) O
. O

Last O
, O
we O
have O
identified O
two O
open O
reading O
frames O
( O
ORFs O
) O
of O
HHV-6 O
, O
U86 O
and O
U89 O
from O
the O
immediate-early O
locus O
A O
, O
that O
can O
transactivate O
the O
CD4 O
promoter O
in O
HeLa B
cells I
. O

The O
present O
study O
demonstrates O
that O
a O
hormone-dependent O
activation O
of O
Tax O
promotes O
an O
enhanced O
prooxidant O
state O
in O
stably B
transfected I
Jurkat I
cells I
as O
measured O
by O
changes O
in O
the O
intracellular O
levels O
of O
glutathione O
and O
H2O2 O
; O
these O
changes O
are O
followed O
by O
apoptotic O
cell O
death O
. O

The O
long-term O
exposure O
of O
Jurkat B
cells I
to O
hormone O
eventually O
results O
in O
a O
selection O
of O
cell B
clones I
that O
have O
lost O
Tax O
activity O
. O

A O
subsequent O
transfection O
of O
these O
apparently O
`` B
nonresponsive I
'' I
clones I
allows O
the O
recovery O
of O
Tax O
responses O
in O
these O
cells O
. O

Glucocorticoid-induced O
apoptosis O
was O
investigated O
in O
glucocorticoid-sensitive B
6TG1.1 I
and O
resistant B
ICR27TK.3 I
human O
leukemic O
T O
cells O
. O

Following O
glucocorticoid O
treatment O
of O
6TG1.1 B
cells I
, O
chromatin O
fragmentation O
was O
observed O
after O
a O
delay O
of O
24 O
h O
. O

Fragmentation O
was O
not O
observed O
in O
ICR27TK.3 B
cells I
containing O
mutant O
glucocorticoid O
receptors O
( O
L753F B
) O
that O
are O
activation-deficient O
but O
retain O
the O
ability O
to O
repress O
AP-1 O
activity O
. O

Dexamethasone O
treatment O
completely O
blocked O
12-O-tetradecanoylphorbol O
13-acetate O
induction O
of O
nuclear O
factor-kappaB O
( O
NF-kappaB O
) O
activity O
and O
elicited O
an O
increase O
in O
the O
amount O
of O
immunoreactive O
IkappaB O
alpha O
in O
sensitive O
6TG1.1 B
cells I
but O
not O
in O
resistant O
ICR27TK.3 B
cells I
. O

Furthermore O
, O
S9a O
and O
AZT O
in O
combination O
, O
at O
noncytoxic O
concentrations O
strongly O
inhibited O
HIV-1 O
replication O
that O
was O
more O
than O
additive O
and O
substantially O
prolonged O
the O
appearance O
of O
virus O
both O
in O
acutely O
infected O
CD4+ O
lymphocytes O
( O
SupT B
) O
in O
culture O
and O
in O
peripheral O
blood O
mononuclear O
cells O
( O
PBMCs O
) O
infected O
with O
a O
primary O
HIV-1 O
isolate O
. O

U937 B
cells I
and O
human O
peripheral O
blood O
monocytes O
were O
exposed O
to O
TS O
, O
binding O
activities O
of O
the O
respective O
transcription O
factors O
were O
analyzed O
, O
and O
Hsp70 O
expression O
and O
TNFalpha O
release O
were O
determined O
in O
parallel O
. O

[ O
Molecular O
mechanism O
of O
cytokine O
gene O
expression O
in O
Th1 B
and O
Th2 B
] O

Among O
these O
subsets O
, O
Th1 B
cells I
are O
known O
to O
activate O
cellular O
immunity O
resulting O
in O
inflammatory O
response O
, O
whereas O
Th2 B
cells I
induce O
humoral O
and O
allergic O
responses O
and O
suppress O
inflammation O
. O

It O
is O
, O
therefore O
, O
suggested O
that O
clarification O
of O
the O
mechanisms O
of O
differential O
gene O
expression O
in O
Th1/Th2 B
should O
lead O
to O
rational O
strategies O
for O
manipulating O
pathological O
immune O
responses O
. O

Closer O
examination O
using O
non-transformed B
murine I
Th1 I
and I
Th2 I
clones I
suggested O
that O
a O
balance O
between O
the O
activities O
of O
the O
two O
signaling O
pathways O
contributes O
to O
cytokine O
gene O
expression O
. O

We O
propose O
that O
one O
of O
the O
targets O
of O
PGE2 O
, O
whose O
effect O
distinguishes O
Th1 B
from O
Th2 O
, O
resides O
in O
the O
downstream O
PKC/Ras O
-mediated O
pathway O
. O

To O
characterize O
further O
the O
function O
of O
the O
intracellular O
vitamin O
D O
receptor O
( O
VDR O
) O
, O
we O
have O
developed O
stable B
transfectant I
variants I
of O
a O
vitamin B
D-responsive I
cell I
line I
( O
U937 B
) O
which O
express O
either O
decreased O
or O
increased O
numbers O
of O
VDR O
. O

Down-regulation O
of O
17beta-HSD O
IV O
mRNA O
expression O
was O
associated O
with O
enhanced O
estradiol O
inactivation O
by O
U937 B
cells I
, O
suggesting O
a O
link O
between O
estrogenic O
pathways O
and O
cell O
proliferation O
. O

In O
1G5 B
, O
a O
Jurkat-derived B
T I
cell I
line I
stably O
transfected O
with O
a O
luciferase O
gene O
driven O
by O
HIV-1 O
long O
terminal O
repeat O
( O
LTR O
) O
, O
we O
found O
that O
PGE2 O
markedly O
enhanced O
HIV-1 O
LTR O
-mediated O
reporter O
gene O
activity O
. O

The O
addition O
of O
anti-CD28 O
mAb O
to O
anti-CD3-stimulated B
cells I
markedly O
increased O
IL-2 O
production O
in O
both O
cell O
types O
, O
but O
levels O
of O
IL-2 O
in O
neonatal O
T O
cells O
remained O
clearly O
lower O
than O
those O
of O
adult O
T O
cells O
( O
respective O
mean O
values O
: O
385 O
+/- O
109 O
pg/ml O
and O
4494 O
+/- O
1199 O
pg/ml O
) O
. O

CD30 O
is O
a O
CD40-inducible O
molecule O
that O
negatively O
regulates O
CD40-mediated O
immunoglobulin O
class O
switching O
in O
non-antigen-selected B
human I
B I
cells I
. O

CL-01 B
cells I
are O
IgM O
+ O
IgD O
+ O
CD30 O
+ O
and O
switch O
to O
IgG O
, O
IgA O
, O
and O
IgE O
when O
exposed O
to O
CD40L O
and O
IL-4 O
. O

Our O
data O
suggest O
that O
CD30 O
critically O
regulates O
the O
CD40 O
-mediated O
differentiation O
of O
non-antigen-selected B
human I
B I
cells I
. O

To O
investigate O
processes O
related O
to O
B O
and O
T O
cell O
activation O
, O
the O
gene O
expression O
of O
stimulated O
and O
nonstimulated B
Ramos I
and I
Jurkat I
cells I
was O
studied O
using O
cDNA O
microarray O
technology O
. O

The O
cell O
type-specific O
increase O
in O
LAL O
expression O
is O
further O
investigated O
in O
the O
THP-1 B
cell I
line I
with O
respect O
to O
transcriptional O
regulation O
. O

The O
human B
monocytic I
leukemia I
cell I
line I
THP-1 B
differentiates O
into O
macrophage-like O
cells O
when O
treated O
with O
phorbol O
esters O
. O

Gel O
mobility O
shift O
assays O
demonstrated O
that O
binding O
of O
Sp1 O
and O
AP-2 O
to O
the O
LAL O
promoter O
is O
increased O
by O
PMA O
in O
THP-1 B
cells I
. O

Our O
data O
suggest O
that O
differentiation O
dependent O
increase O
of O
lysosomal O
acid O
lipase O
( O
LAL O
) O
expression O
in O
THP-1 B
cells I
is O
mediated O
by O
a O
concerted O
action O
of O
Sp1 O
and O
AP-2 O
. O

In O
contrast O
, O
intracytoplasmic O
TNFalpha O
levels O
were O
strongly O
reduced O
in O
transfected B
clones I
. O

Furthermore O
, O
30 O
% O
of O
IkappaBalpha B
transfected I
cells I
were O
apoptotic O
after O
8 O
h O
of O
TNFalpha O
treatment O
. O

No O
effect O
was O
seen O
with O
non O
transfected B
cells I
or O
with O
cells O
transfected O
with O
a O
control O
plasmid O
. O

Mosaicism O
of O
46 B
, I
X I
, I
-Y I
, I
t I
( I
Y I
; I
15 I
) I
( I
q12 I
; I
p13 I
) I
/45 I
, I
X I
cell I
lines I
was O
found O
in O
skin O
samples O
from O
the O
patient O
's O
elbow O
and O
genital O
regions O
, O
although O
there O
were O
no O
clinical O
stigmata O
of O
Turner O
syndrome O
. O

An O
androgen O
receptor O
binding O
assay O
of O
cultured B
genital I
skin I
fibroblasts I
was O
negative O
. O

These O
findings O
suggest O
that O
Turner O
mosaicism O
of O
the O
45 B
, I
X I
cell I
line I
may O
have O
contributed O
to O
this O
atypical O
presentation O
in O
an O
XY O
female O
, O
although O
we O
can O
not O
exclude O
abnormalities O
of O
other O
genes O
related O
to O
sex O
differentiation O
. O

As O
several O
inflammatory O
cytokines O
and O
oxidative O
stresses O
are O
involved O
in O
the O
pathogenesis O
of O
HIV-1 O
infection O
, O
we O
investigated O
the O
inhibitory O
effects O
of O
cepharanthine O
on O
tumor O
necrosis O
factor O
alpha O
( O
TNF-alpha O
) O
- O
and O
phorbol O
12-myristate O
13-acetate O
( O
PMA O
) O
-induced O
HIV-1 O
replication O
in O
chronically B
infected I
cell I
lines I
. O

Two O
chronically B
HIV-1-infected I
cell I
lines I
, O
U1 B
( O
monocytic O
) O
and O
ACH-2 B
( O
T O
lymphocytic O
) O
, O
were O
stimulated O
with O
TNF-alpha O
or O
PMA O
and O
cultured O
in O
the O
presence O
of O
various O
concentrations O
of O
the O
compound O
. O

Cepharanthine O
dose O
dependently O
inhibited O
HIV-1 O
replication O
in O
TNF-alpha- B
and I
PMA-stimulated I
U1 I
cells I
but O
not O
in O
ACH-2 B
cells I
. O

Its O
50 O
% O
effective O
and O
cytotoxic O
concentrations O
were O
0.016 O
and O
2.2 O
microg/ml O
in O
PMA-stimulated B
U1 I
cells I
, O
respectively O
. O

These O
results O
indicate O
that O
cepharanthine O
is O
a O
highly O
potent O
inhibitor O
of O
HIV-1 O
replication O
in O
a O
chronically B
infected I
monocytic I
cell I
line I
. O

The O
latent O
membrane O
protein O
1 O
( O
LMP1 O
) O
of O
Epstein-Barr O
virus O
( O
EBV O
) O
is O
required O
for O
EBV-induced O
immortalization O
of O
human O
B O
cells O
and O
causes O
tumorigenic O
transformation O
of O
cell B
lines I
. O

Models O
of O
lineage O
switching O
in O
hematopoietic O
development O
: O
a O
new O
myeloid-committed B
eosinophil I
cell I
line I
( O
YJ B
) O
demonstrates O
trilineage O
potential O
. O

A O
new O
human B
leukemia I
cell I
line I
with O
an O
eosinophilic O
phenotype O
, O
designated O
YJ B
, O
was O
established O
from O
the O
peripheral O
blood O
cells O
of O
a O
patient O
with O
chronic O
myelomonocytic O
leukemia O
( O
CMMoL O
) O
with O
eosinophilia O
. O

When O
cultured O
in O
RPMI O
1640 O
medium O
containing O
10 O
% O
fetal O
bovine O
serum O
, O
most O
YJ B
cells I
were O
myeloblastoid O
with O
a O
small O
number O
of O
the O
cells O
having O
eosinophilic O
granules O
. O

Cell O
surface O
markers O
in O
the O
YJ B
cells I
were O
positive O
for O
CD33 O
and O
were O
negative O
for O
CD34 O
, O
CD16 O
and O
CD23 O
. O

The O
eosinophilic O
characteristics O
of O
YJ B
cells I
were O
confirmed O
by O
histochemical O
staining O
with O
Fast-Green/Neutral-Red O
and O
by O
the O
expression O
of O
mRNAs O
for O
eosinophil-associated O
granule O
proteins O
, O
eosinophil O
cationic O
protein O
( O
ECP O
) O
, O
eosinophil-derived O
neurotoxin O
( O
EDN O
) O
, O
eosinophil O
peroxidase O
( O
EPO O
) O
, O
and O
major O
basic O
protein O
( O
MBP O
) O
, O
and O
for O
the O
Charcot-Leyden O
crystal O
( O
CLC O
) O
protein O
. O

The O
YJ B
cells I
could O
be O
induced O
towards O
monocytic O
differentiation O
by O
stimulation O
with O
phorbol O
12-myristate O
13-acetate O
( O
PMA O
) O
. O

The O
monocytic O
characteristics O
of O
YJ B
cells I
treated O
with O
PMA O
were O
confirmed O
by O
morphological O
analysis O
with O
alpha-naphthyl O
butyrate O
esterase O
staining O
, O
by O
CD14 O
expression O
, O
and O
by O
increased O
expression O
of O
Egr-1 O
mRNA O
. O

Furthermore O
, O
YJ B
cells I
could O
be O
differentiated O
towards O
the O
neutrophil O
lineage O
by O
stimulation O
with O
all-trans O
retinoic O
acid O
( O
RA O
) O
. O

YJ B
cells I
treated O
in O
vitro O
with O
2 O
microM O
RA O
differentiated O
into O
metamyelocytes O
and O
band O
neutrophils O
, O
and O
increased O
the O
number O
of O
nitroblue B
tetrazolium I
( I
NBT I
) I
-positive I
cells I
and O
increased O
gp91phox O
mRNA O
expression O
. O

Thus O
, O
the O
YJ B
cell I
line I
exhibited O
eosinophilic O
characteristics O
, O
but O
was O
able O
to O
differentiate O
to O
the O
monocytic O
or O
neutrophilic O
lineages O
in O
response O
to O
PMA O
or O
RA O
, O
respectively O
. O

The O
YJ B
cell I
line I
should O
be O
useful O
for O
elucidating O
the O
molecular O
mechanisms O
governing O
lineage O
switching O
from O
the O
eosinophil O
to O
monocytic O
or O
neutrophil O
lineages O
. O

We O
showed O
that O
the O
interaction O
of O
SS O
RBC O
at O
2 O
% O
concentration O
in O
the O
presence O
of O
multimers O
of O
von O
Willebrand O
factor O
( O
vWf O
) O
, O
derived O
from O
endothelial O
cell-derived O
conditioned O
medium O
( O
E-CM O
) O
with O
cultured B
human I
umbilical I
vein I
endothelial I
cells I
( O
HUVEC B
) O
, O
resulted O
in O
a O
fivefold O
increased O
formation O
of O
thiobarbituric O
acid-reactive O
substances O
( O
TBARS O
) O
and O
activation O
of O
the O
transcription O
factor O
NF-kB O
, O
both O
indicators O
of O
cellular O
oxidant O
stress O
. O

The O
oxidant O
stress-induced O
signaling O
resulted O
in O
an O
increased O
surface O
expression O
of O
a O
subset O
of O
CAMs O
, O
ICAM-1 O
, O
E-selectin O
, O
and O
VCAM-1 O
in O
HUVEC B
. O

Additionally O
, O
preincubation O
of O
HUVEC B
with O
a O
synthetic O
peptide O
Arg-Gly-Asp O
( O
RGD O
) O
that O
prevents O
vWf O
-mediated O
adhesion O
of O
SS O
RBC O
reduced O
the O
surface O
expression O
of O
VCAM-1 O
and O
NF-kB O
activation O
. O

Furthermore O
, O
SS O
RBC O
-induced O
oxidant O
stress O
resulted O
in O
a O
twofold O
increase O
in O
the O
transendothelial O
migration O
of O
both O
monocyte-like B
HL-60 I
cells I
and O
human O
peripheral O
blood O
monocytes O
, O
and O
approximately O
a O
sixfold O
increase O
in O
platelet-endothelial O
cell O
adhesion O
molecule-1 O
( O
PECAM-1 O
) O
phosphorylation O
, O
each O
of O
which O
was O
blocked O
by O
protein O
kinase O
C O
inhibitor O
and O
antioxidants O
. O

Identification O
of O
transcription O
factors O
expressed O
during O
ATRA-induced O
neutrophil O
differentiation O
of O
HL60 B
cells I
. O

A O
serum-independent B
HL60 I
cell I
line I
was O
induced O
towards O
the O
neutrophil O
lineage O
by O
treatment O
with O
all-trans O
retinoic O
acid O
( O
ATRA O
) O
for O
24 O
h O
. O

RNA O
extracted O
from O
uninduced O
, O
ATRA-induced B
CD38+ I
cells I
, O
and O
vitamin B
D3 I
treated I
maturing I
cell I
cultures I
were O
amplified O
using O
the O
degenerate O
primers O
. O

Activation O
of O
E2F O
-mediated O
transcription O
by O
human O
T-cell O
leukemia O
virus O
type O
I O
Tax O
protein O
in O
a O
p16 B
( I
INK4A I
) I
-negative I
T-cell I
line I
. O

Indeed O
, O
when O
Tax O
is O
coexpressed O
with O
the O
E2F-1 O
transcription O
factor O
in O
CEM B
T-cells I
, O
which O
lack O
expression O
of O
p16 O
( O
INK4A O
) O
, O
it O
strongly O
potentiates O
the O
E2F O
-dependent O
activation O
of O
a O
reporter O
construct O
driven O
by O
a O
promoter O
containing O
E2F O
binding O
sites O
. O

We O
find O
that O
iNO O
produced O
by O
murine B
macrophage-like I
cells I
, O
RAW264.7 B
, O
can O
inhibit O
cytokine O
-induced O
endothelial O
cell O
activation O
in O
a O
separated O
and O
mixed O
endothelial-RAW264.7 B
coculture I
system I
. O

Inhibition O
of O
iNO O
synthase O
( O
iNOS O
) O
activity O
with O
N O
omega-monomethyl-L-arginine O
in O
endothelial-RAW264.7 B
cocultures I
, O
stimulated O
with O
murine-specific O
IFN-gamma O
and O
LPS O
, O
decreased O
iNO O
production O
by O
86 O
% O
, O
augmented O
VCAM-1 O
and O
iNOS O
expression O
in O
endothelial O
and O
RAW264.7 B
cells I
, O
respectively O
, O
and O
increased O
monocyte O
adhesion O
to O
the O
endothelial O
cell O
surface O
. O

In O
the O
present O
study O
, O
we O
evaluated O
whether O
peripheral O
blood O
monocytes O
that O
exhibit O
anti-tumour O
activity O
in O
haematopoietic O
and O
solid O
tumours O
influence O
growth O
and O
secretion O
in O
the O
LNCaP B
cell I
line I
. O

For O
this O
purpose O
, O
LNCaP B
cells I
were O
incubated O
with O
monocyte-conditioned O
medium O
( O
MCM O
) O
, O
and O
proliferation O
as O
well O
as O
expression O
of O
androgen O
receptor O
( O
AR O
) O
and O
secretion O
of O
prostate-specific O
antigen O
( O
PSA O
) O
were O
assessed O
. O

AR O
protein O
decreased O
by O
70 O
% O
and O
PSA O
levels O
in O
supernatants O
from O
LNCaP B
cells I
were O
reduced O
by O
approximately O
80 O
% O
following O
treatment O
with O
MCM O
. O

LNCaP B
cells I
treated O
with O
prostaglandin O
E2 O
showed O
neither O
a O
reduction O
in O
proliferation O
nor O
a O
down-regulation O
of O
AR O
and O
PSA O
levels O
. O

LNCaP B
cells I
were O
shown O
to O
express O
the O
IL-1beta O
receptor O
type O
1 O
, O
which O
transduces O
IL-1beta O
signal O
. O

The O
cytokines O
IL-4 O
and O
IL-5 O
are O
often O
coordinately O
produced O
by O
Th2 B
cells I
as O
in O
asthma O
. O

We O
have O
previously O
shown O
that O
the O
transcription O
factor O
GATA-3 O
is O
expressed O
in O
Th2 B
but I
not I
Th1 I
cells I
and O
is O
crucial O
for O
activation O
of O
the O
IL-5 O
promoter O
by O
different O
stimuli O
. O

Also O
, O
in O
Th2 B
cells I
, O
antisense O
GATA-3 O
RNA O
inhibits O
IL-5 O
but O
not O
IL-4 O
promoter O
activation O
. O

Establishment O
and O
characterization O
of O
EBV-positive B
and I
EBV-negative I
primary I
effusion I
lymphoma I
cell I
lines I
harbouring O
human O
herpesvirus O
type-8 O
. O

In O
this O
study O
we O
report O
on O
the O
establishment O
and O
characterization O
of O
two O
novel O
lymphoma B
cell I
lines I
( O
CRO-AP/3 B
and O
CRO-AP/5 B
) O
which O
carry O
infection O
by O
human O
herpesvirus O
type-8 O
( O
HHV-8 O
) O
and O
have O
derived O
from O
AIDS-related O
primary O
effusion O
lymphoma O
( O
PEL B
) O
. O

These O
two O
cell B
lines I
are O
representative O
of O
different O
virologic O
subtypes O
of O
PEL B
, O
i.e O
. O
HHV-8+/EBV- B
PEL I
in O
the O
case O
of O
CRO-AP/3 B
and I
HHV-8+/EBV+ I
PEL I
in O
the O
case O
of O
CRO-AP/5 B
. O

Consistent O
with O
the O
diagnosis O
of O
PEL B
, O
both O
CRO-AP/3 B
and O
CRO-AP/5 B
expressed O
indeterminate O
( O
i.e. O
non-B O
, O
non-T O
) O
phenotypes O
although O
immunogenotypic O
studies O
documented O
their O
B-cell O
origin O
. O

Both O
cell B
lines I
are O
devoid O
of O
genetic O
lesions O
of O
c-MYC O
, O
BCL-2 O
and O
p53 O
as O
well O
as O
gross O
rearrangements O
of O
BCL-6 O
. O

Detailed O
histogenetic O
characterization O
of O
these O
novel O
PEL B
cell I
lines I
suggests O
that O
PEL B
may O
derive O
from O
a O
post-germinal B
centre I
B I
cell I
which O
has O
undergone O
pre-terminal O
differentiation O
. O

The O
CRO-AP/3 B
and O
CRO-AP/5 B
cell I
lines I
may O
provide O
a O
valuable O
model O
for O
clarifying O
the O
pathogenesis O
of O
PEL B
. O

In O
particular O
, O
these O
cell B
lines I
may O
help O
understand O
the O
relative O
contribution O
of O
HHV-8 O
and O
EBV O
to O
PEL O
growth O
and O
development O
and O
may O
facilitate O
the O
identification O
of O
recurrent O
cytogenetic O
abnormalities O
highlighting O
putative O
novel O
cancer O
related O
loci O
relevant O
to O
PEL B
. O

In O
both O
activated O
peripheral O
blood O
T O
lymphocytes O
and O
activated B
tumorigenic I
T I
cell I
lines I
, O
IL-2 O
gene O
expression O
was O
blocked O
at O
the O
transcriptional O
level O
by O
okadaic O
acid O
. O

The O
purpose O
of O
this O
study O
was O
to O
examine O
the O
effects O
of O
bis O
[ O
4- O
[ O
2 O
, O
4-dioxo-5-thiazolidinyl O
) O
methyl O
] O
phenyl O
] O
methane O
( O
YM-268 O
) O
, O
a O
thiazolidinedione O
derivative O
, O
on O
glucose O
uptake O
, O
adipocyte O
differentiation O
through O
peroxisome O
proliferator-activated O
receptor O
gamma O
( O
PPARgamma O
) O
, O
and O
phosphatidylinositol O
3-kinase O
( O
PI O
3-kinase O
) O
activity O
in O
cultured B
cells I
. O

YM268 O
and O
pioglitazone O
dose-dependently O
increased O
the O
2-deoxyglucose O
uptake O
in O
3T3-L1 B
cells I
. O

We O
have O
tested O
this O
possibility O
directly O
using O
TAP-deficient B
cell I
lines I
lacking O
antigenic O
ER O
peptides O
derived O
from O
two O
model O
Ags O
, O
the O
human O
adenovirus O
type O
5 O
early O
regions O
E1A O
and O
E1B O
. O

BCL-6 B
( I
- I
) I
/syn-1 I
( I
+ I
) I
tumor I
cells I
of O
CHD O
are O
mostly O
found O
surrounded O
by O
T O
cells O
expressing O
CD40L O
, O
consistent O
with O
the O
observation O
that O
CD40 O
signaling O
downregulates O
BCL-6 O
expression O
. O

To O
do O
this O
, O
wild-type O
and O
mutant O
forms O
of O
the O
CD4 O
cytoplasmic O
tail O
were O
stably O
expressed O
in O
the O
lymphoblastoid B
T-cell I
line I
A2.01 B
. O

We O
have O
determined O
how O
the O
phosphorylation O
of O
the O
retinoblastoma O
family O
( O
pRb O
, O
p107 O
, O
and O
p130 O
) O
is O
governed O
in O
individual O
cell O
cycle O
phases O
of O
Daudi B
B-cells I
during O
cell O
cycle O
exit O
triggered O
by O
alpha-interferon O
( O
alpha-IFN O
) O
. O

IFN-gamma O
increased O
the O
surface O
expression O
of O
class O
II O
molecules O
in O
THP-1 B
cells I
and O
this O
was O
markedly O
reduced O
in O
cells O
infected O
with O
M. O
tuberculosis O
. O

We O
studied O
their O
activity O
after O
transfection O
into O
K562 B
cells I
, O
an O
erythroleukemia B
cell I
line I
with O
an O
embryonic-fetal O
phenotype O
. O

Here O
we O
provide O
evidence O
showing O
that O
15 O
amino O
acids O
in O
the O
carboxyl-terminal O
end O
of O
NFATx1 O
are O
required O
for O
its O
maximum O
transactivation O
activity O
in O
Jurkat B
T I
cells I
. O

This O
transactivation O
sequence O
is O
altered O
by O
tissue-specific O
alternative O
splicing O
in O
newly O
isolated O
NFATx O
isoforms O
, O
resulting O
in O
lower O
transactivation O
activity O
in O
Jurkat B
T I
cells I
. O

In O
Jurkat B
cells I
, O
transcription O
from O
the O
NFAT O
site O
of O
the O
IL-2 O
promoter O
is O
activated O
strongly O
by O
NFATx1 O
but O
only O
weakly O
by O
NFATx2 O
. O

Here O
we O
demonstrate O
that O
expression O
of O
Rta O
is O
also O
sufficient O
for O
disruption O
of O
latency O
in O
a O
permissive B
B-cell I
line I
. O

In O
HH514-16 B
cells I
, O
transfection O
of O
Rta O
leads O
to O
synthesis O
of O
ZEBRA O
, O
viral O
DNA O
replication O
, O
and O
late O
gene O
expression O
. O

Transcription O
of O
a O
minimal O
promoter O
from O
the O
NF-IL6 O
gene O
is O
regulated O
by O
CREB/ATF O
and O
SP1 O
proteins O
in O
U937 B
promonocytic I
cells I
. O

We O
show O
that O
increased O
transcription O
of O
the O
NF-IL6 O
gene O
is O
responsible O
, O
at O
least O
in O
part O
, O
for O
induction O
of O
NF-IL6 O
mRNA O
following O
activation O
of O
U937 B
promonocytic I
cells I
. O

We O
have O
identified O
a O
104-bp O
minimal O
promoter O
region O
of O
the O
NF-IL6 O
gene O
that O
is O
sufficient O
for O
basal O
and O
activation-dependent O
induction O
of O
transcription O
in O
U937 B
cells I
. O

Each O
site O
is O
functionally O
important O
and O
contributes O
independently O
to O
transcription O
of O
the O
NF-IL6 O
gene O
in O
U937 B
cells I
. O

CIITA O
B-cell-specific O
promoter O
suppression O
in O
MHC B
class I
II-silenced I
cell I
hybrids I
. O

In O
this O
study O
, O
various O
sets O
of O
somatic B
cell I
hybrids I
, O
generated O
by O
the O
fusion O
of O
epithelial B
cell I
lines I
with O
B-lymphoblastoid B
cell I
lines I
, O
were O
analyzed O
for O
the O
expression O
of O
major O
histocompatibility O
complex O
( O
MHC O
) O
class O
II O
antigens O
. O

We O
first O
demonstrate O
, O
in O
human B
and I
mouse I
intraspecies I
hybrids I
, O
the O
coordinate O
suppression O
of O
MHC O
class O
II O
, O
Ii O
( O
invariant O
chain O
) O
and O
HLA-DM O
gene O
transcription O
, O
and O
the O
release O
of O
the O
silencing O
by O
the O
addition O
of O
interferon O
gamma O
. O

These O
results O
therefore O
demonstrate O
that O
the O
MHC O
class O
II O
gene O
silencing O
in O
somatic B
cell I
hybrids I
is O
due O
to O
an O
active O
suppression O
of O
one O
of O
the O
promoters O
of O
the O
CIITA O
gene O
, O
mediated O
by O
the O
epithelial O
cell O
fusion O
partner O
. O

Here O
, O
we O
demonstrate O
that O
NK B
cells I
induce O
HLA-DR O
on O
the O
surface O
of O
a O
mutant B
cell I
line I
that O
is O
defective O
in O
IFN-gamma O
-induced O
MHC O
class O
II O
expression O
. O

The O
Janus B
kinase-1-deficient I
cell I
line I
U4A I
expresses O
HLA-DR O
alpha O
mRNA O
in O
response O
to O
NK O
cell O
activation O
, O
and O
HLA-DR O
alpha O
promoter O
constructs O
transfected O
into O
these O
cells O
are O
induced O
by O
NK B
cells I
but O
not O
IFN-gamma O
. O

Effects O
of O
overexpression O
of O
IL-1 O
receptor-associated O
kinase O
on O
NFkappaB O
activation O
, O
IL-2 O
production O
and O
stress-activated O
protein O
kinases O
in O
the O
murine B
T I
cell I
line I
EL4 I
. O

We O
generated O
permanent O
clones O
of O
the O
murine B
T I
cell I
line I
EL4 I
6.1 I
overexpressing O
human O
( O
h O
) O
IRAK O
to O
evaluate O
the O
role O
of O
this O
kinase O
in O
IL-1 O
signaling O
. O

Compared O
to O
the O
parental B
cell I
line I
the O
dose-response O
curve O
of O
IL-1 O
-induced O
IL-2 O
production O
was O
shifted O
in O
both O
potency O
and O
efficacy O
. O

These O
results O
demonstrate O
that O
IRAK O
directly O
triggers O
NFkappaB O
-mediated O
gene O
expression O
in O
EL4 B
cells I
. O

In O
this O
report O
expression O
profiles O
and O
activation O
of O
PKC O
were O
analyzed O
in O
human B
Raji I
B I
lymphoblastoid I
cells I
. O

This O
study O
was O
undertaken O
to O
further O
analyze O
changes O
in O
cytokine O
production O
and O
intracellular O
signaling O
during O
anergy O
induction O
using O
high O
concentrations O
of O
native O
peptide O
ligand O
of O
tetanus B
toxoid I
( I
TT I
) I
- I
and I
myelin I
basic I
protein I
( I
MBP I
) I
-specific I
human I
T I
cell I
lines I
. O

The O
TT-selected B
T I
cell I
line I
could O
be O
rendered O
unresponsive O
to O
its O
dominant O
epitope O
in O
a O
dose-dependent O
manner O
( O
IC50 O
= O
0.03 O
microg/ml O
) O
. O

The O
TT-selected B
line I
, O
as O
well O
as O
three O
T O
cell O
clones O
established O
from O
this O
line O
, O
continued O
to O
produce O
IFN-gamma O
and O
significantly O
increased O
IL-4 O
and O
IL-10 O
production O
when O
anergy O
was O
induced O
with O
high O
concentrations O
of O
the O
immunodominant O
epitope O
. O

JNK O
enzymatic O
activity O
was O
blocked O
in O
anergized B
T I
cells I
. O

Both O
T B
cell I
lines I
could O
be O
anergized O
by O
the O
autopresentation O
of O
native O
peptide O
since O
anergy O
was O
induced O
in O
cultures O
lacking O
fresh O
antigen-presenting O
cells O
. O

Using O
our O
previously O
established O
murine B
T I
cell I
hybridoma I
model I
A1.1 B
, O
we O
show O
that O
specific O
protein O
kinase O
C O
( O
PKC O
) O
inhibitors O
could O
block O
activation-induced O
Fas O
expression O
and O
apoptosis O
. O

PKC O
-dependent O
Fas O
expression O
was O
also O
observed O
in O
several O
murine B
and I
human I
tumor I
cell I
lines I
. O

Taken O
together O
, O
this O
study O
shows O
that O
RA O
inhibits O
IgE O
production O
of O
anti-CD40 B
+ I
IL-4-stimulated I
B I
cells I
in O
vitro O
. O

Furthermore O
, O
endogenous O
IKK O
enzymatic O
activity O
was O
significantly O
elevated O
in O
HTLV-1-infected B
and I
Tax-expressing I
T-cell I
lines I
. O

Transfection O
of O
kinase-deficient O
mutants O
of O
IKKalpha O
and O
IKKbeta O
into O
either O
human B
Jurkat I
T I
or I
293 I
cells I
also O
inhibits O
NF-kappaB O
-dependent O
reporter O
gene O
expression O
induced O
by O
Tax O
. O

Here O
, O
we O
report O
that O
LPS O
induces O
IKK O
activity O
in O
human O
monocytes O
and O
THP-1 B
monocytic I
cells I
. O

In O
nonerythroid B
NIH3T3 I
cells I
, O
however O
, O
the O
GATA O
site O
is O
not O
required O
. O

Gel O
mobility O
shift O
assays O
demonstrated O
that O
specific O
DNA-protein O
complexes O
can O
be O
formed O
with O
each O
element O
, O
and O
that O
there O
are O
cell-specific O
differences O
in O
factors O
, O
which O
bind O
to O
the O
SP-1-like O
element O
between O
MEL B
and I
NIH3T3 I
cells I
. O

The O
ML-1 B
human I
myeloblastic I
leukemia I
cells I
used O
in O
this O
study O
proliferate O
when O
treated O
with O
insulin-like O
growth O
factor O
I O
and O
transferrin O
but O
differentiate O
to O
monocytes O
when O
exposed O
to O
tumor O
necrosis O
factor O
alpha O
or O
transforming O
growth O
factor O
beta1 O
, O
or O
to O
macrophage-like O
cells O
when O
treated O
with O
both O
these O
cytokines O
. O

We O
demonstrate O
in O
this O
report O
that O
overexpression O
of O
an O
activated O
form O
of O
Rho O
enhances O
AP-1 O
activity O
in O
Jurkat B
T I
cells I
in O
the O
presence O
of O
phorbol O
myristate O
acetate O
( O
PMA O
) O
, O
but O
activated O
Rho O
( O
V14Rho O
) O
has O
little O
or O
no O
effect O
on O
NFAT O
, O
Oct-1 O
, O
and O
NF-kappaB O
enhancer O
element O
activities O
under O
similar O
conditions O
. O

Using O
mRNA O
differential O
display O
we O
demonstrated O
abnormally O
high O
expression O
of O
the O
signal O
transducer O
and O
activator O
of O
transcription O
( O
STAT1alpha O
) O
in O
monocytes O
from O
the O
proband B
II-2 I
. O

Expression O
of O
gamma-interferon O
inducible O
protein O
10 O
( O
IP-10 O
) O
, O
a O
STAT1alpha-responsive O
gene O
and O
mediator O
of O
inflammatory O
response O
, O
was O
also O
abnormally O
expressed O
in O
the O
monocytes O
from O
II-2 B
. O

Over-expression O
of O
both O
genes O
was O
restricted O
to O
monocytes O
from O
II-2 B
and O
was O
not O
observed O
in O
monocytes O
from O
the O
clinically O
unaffected O
family O
members O
, O
unlike O
that O
of O
SR O
. O

Gel O
retardation O
assays O
with O
THP-1 B
cell I
extracts O
identified O
gamma-IFN O
inducible O
DNA O
binding O
activity O
to O
three O
potential O
STATI O
DNA O
binding O
elements O
in O
the O
human O
IP-10 O
promoter O
region O
from O
nucleotides O
- O
245 O
to O
- O
188 O
. O

Taken O
together O
these O
results O
suggest O
that O
gamma-interferon O
mediated O
cell O
activation O
is O
responsible O
for O
STAT1alpha O
-induced O
transcription O
of O
the O
IP-10 O
gene O
in O
THP-1 B
macrophages I
as O
well O
as O
in O
monocytes O
from O
II-2 B
. O

The O
role O
of O
H2O2 O
and O
other O
reactive O
oxygen O
species O
( O
ROS O
) O
as O
an O
integratory O
secondary O
messenger O
for O
divergent O
T O
cell O
signals O
has O
been O
complicated O
by O
the O
fact O
that O
various O
T B
cell I
lines I
and O
peripheral O
blood O
T O
cells O
differ O
markedly O
in O
the O
levels O
of O
NF-kappaB O
activation O
induced O
by O
oxidant O
stress O
. O

A O
mutant B
T I
cell I
line I
was O
isolated O
that O
lacked O
expression O
of O
SLP-76 O
( O
SH2 O
domain-containing O
leukocyte O
protein O
of O
76 O
kilodaltons O
) O
, O
a O
hematopoietically O
expressed O
adaptor O
protein O
and O
PTK O
substrate O
. O

A O
novel O
function O
of O
Stat1 O
and O
Stat3 O
proteins O
in O
erythropoietin O
-induced O
erythroid O
differentiation O
of O
a O
human B
leukemia I
cell I
line I
. O

We O
recently O
determined O
that O
erythropoietin O
( O
EPO O
) O
activates O
3 O
members O
of O
the O
signal O
transducer O
and O
activator O
of O
transcription O
( O
STAT O
) O
family O
, O
Stat1alpha O
, O
Stat3 O
, O
and O
Stat5 O
, O
in O
the O
human B
EPO-dependent I
cell I
lines I
, O
UT-7 B
and O
UT-7/EPO B
( O
Kirito O
et O
al O
, O
J O
Biol O
Chem O
272 O
: O
16507 O
, O
1997 O
) O
. O

UT-7/GM B
was O
used O
as O
a O
model O
system O
, O
because O
this O
cell O
line O
can O
differentiate O
into O
erythroid-lineage O
cells O
with O
EPO O
treatment O
( O
Komatsu O
et O
al O
, O
Blood O
89 O
: O
4021 O
, O
1997 O
) O
. O

We O
found O
that O
EPO O
did O
not O
activate O
Stat1alpha O
or O
Stat3 O
in O
UT-7/GM B
cells I
. O

Dominant O
negative O
forms O
of O
Stat1alpha O
or O
Stat3 O
promoted O
the O
EPO O
-induced O
erythroid O
differentiation O
of O
UT-7/GM B
cells I
, O
even O
in O
the O
presence O
of O
granulocyte-macrophage O
colony-stimulating O
factor O
, O
although O
this O
cytokine O
never O
induced O
erythroid O
differentiation O
of O
the O
parent B
UT-7/GM I
cells I
with O
or O
without O
EPO O
. O

To O
determine O
the O
mechanism O
of O
action O
of O
Ro O
09-2210 O
, O
we O
set O
up O
a O
transient O
expression O
system O
in O
Jurkat B
T I
cells I
using O
a O
variety O
of O
reporter O
gene O
constructs O
and O
showed O
effective O
inhibition O
of O
phorbol O
ester/ionomycin-induced O
NF-AT O
activation O
and O
anti-CD3 O
induced O
NF-AT O
with O
IC50 O
= O
7.7 O
and O
10 O
nM O
, O
respectively O
. O

Activation O
of O
Stat-3 O
is O
involved O
in O
the O
induction O
of O
apoptosis O
after O
ligation O
of O
major O
histocompatibility O
complex O
class O
I O
molecules O
on O
human B
Jurkat I
T I
cells I
. O

Activation O
of O
Janus O
tyrosine O
kinases O
( O
Jak O
) O
and O
Signal O
transducers O
and O
activators O
of O
transcription O
( O
Stat O
) O
after O
ligation O
of O
major O
histocompatibility O
complex O
class O
I O
( O
MHC-I O
) O
was O
explored O
in O
Jurkat B
T I
cells I
. O

To O
investigate O
the O
function O
of O
the O
activated O
Stat-3 O
, O
Jurkat B
T I
cells I
were O
transiently O
transfected O
with O
a O
Stat-3 O
isoform O
lacking O
the O
transactivating O
domain O
. O

In O
the O
present O
study O
, O
the O
role O
of O
IL-2R O
signaling O
in O
the O
growth O
of O
CD8+ B
T I
cell I
prolymphocytic I
leukemia I
( I
T-PLL I
) I
cells I
has O
been O
investigated O
. O

These O
results O
show O
that O
IL-2 O
is O
capable O
of O
inducing O
the O
nuclear O
expression O
of O
NF-kappaB O
in O
primary B
CD8+ I
T-PLL I
cells I
, O
and O
that O
this O
effect O
is O
mediated O
, O
at O
least O
in O
part O
, O
at O
a O
pretranslational O
level O

Two O
regions O
, O
DP1 O
( O
-140 O
to O
-92 O
bp O
) O
and O
DP2 O
( O
-353 O
to O
-304 O
bp O
) O
of O
the O
promoter O
were O
essential O
for O
transcription O
in O
HeLa B
cells I
and O
human O
peripheral O
monocytes O
. O

Hela O
nuclear O
extracts O
contained O
a O
specific O
nuclear O
factor O
( O
s O
) O
binding O
to O
15-LO O
promoter O
DNA O
which O
are O
distinct O
from O
those O
derived O
from O
IL-13-treated B
human I
peripheral I
monocyte I
nuclear O
extracts O
. O

The O
efficacy O
of O
the O
activated O
LN O
cells O
is O
augmented O
when O
the O
sensitizing O
tumor O
is O
a O
genetically B
modified I
variant I
( O
designated O
D5G6 B
) O
that O
secretes O
granulocyte/macrophage-colony-stimulating O
factor O
. O

In O
contrast O
to O
anti-CD3/IL-2-activated B
LN I
cells I
, O
adoptive O
transfer O
of O
freshly O
isolated O
tumor-draining O
LN O
T O
cells O
has O
no O
therapeutic O
activity O
. O

METHODS O
: O
Stable O
transfectants O
of O
the O
porcine B
vascular I
endothelial I
cell I
line I
PIEC B
with O
mutated O
CIITA O
constructs O
were O
tested O
for O
SLA-DR O
and O
SLA-DQ O
induction O
by O
recombinant O
porcine O
interferon-gamma O
. O

Transient O
transfectants O
of O
the O
porcine B
B-cell I
line I
L23 I
with O
the O
mutated O
CIITA O
constructs O
were O
tested O
for O
the O
suppression O
of O
constitutive O
SLA-DR O
and O
SLA-DQ O
expression O
. O

RESULTS O
: O
In O
preliminary O
studies O
, O
we O
demonstrated O
that O
transfection O
of O
the O
PIEC B
line I
with O
full-length O
human O
CIITA O
constructs O
resulted O
in O
strong O
expression O
of O
SLA-DR O
and O
SLA-DQ O
antigens O
, O
thus O
establishing O
the O
cross-species O
effectiveness O
of O
human O
CIITA O
in O
the O
pig O
. O

PIEC B
clones I
stably O
transfected O
with O
one O
of O
these O
constructs O
showed O
up O
to O
99 O
% O
suppression O
of O
SLA-DR O
and O
SLA-DQ O
antigen O
induction O
and O
marked O
suppression O
of O
SLA-DRA O
mRNA O
induction O
. O

Moreover O
, O
transient O
transfection O
of O
the O
porcine B
B-cell I
line I
L23 I
showed O
up O
to O
90 O
% O
suppression O
of O
constitutive O
SLA-DR O
and O
SLA-DQ O
antigen O
expression O
in O
5-8 O
days O
. O

In O
functional O
studies O
, O
interferon-gamma-stimulated B
PIEC I
clones I
transfected O
with O
this O
mutated O
CIITA O
construct O
failed O
to O
stimulate O
purified O
human O
CD4+ O
T O
lymphocytes O
. O

In O
addition O
, O
PPARgamma O
mRNA O
expression O
in O
U937 B
cells I
increased O
during O
phorbol O
12-myristate O
13 O
acetate-induced O
differentiation O
. O

Crkl O
, O
an O
SH2/SH3 O
adapter O
protein O
, O
becomes O
coimmunoprecipitated O
specifically O
with O
STAT5 O
from O
erythropoietin-stimulated O
erythroid O
cells O
; O
although O
it O
was O
shown O
to O
become O
associated O
with O
c-Cbl O
in O
the O
studies O
using O
cell B
lines I
. O

We O
recently O
cloned O
CALM O
( O
Clathrin O
Assembly O
Lymphoid O
Myeloid O
leukemia O
gene O
) O
, O
the O
fusion O
partner O
of O
AF10 O
at O
11q14 O
in O
the O
monocytic B
cell I
line I
U937 I
. O

Furthermore O
, O
IL-18 O
-induced O
activation O
of O
NF-kappaB O
and O
c-Jun O
N-terminal O
kinase O
( O
JNK O
) O
is O
blocked O
in O
MyD88-/- B
Th1-developing I
cells I
. O

A O
novel O
retinoic O
acid O
receptor O
( O
RAR O
) O
-selective O
antagonist O
inhibits O
differentiation O
and O
apoptosis O
of O
HL-60 B
cells I
: O
implications O
of O
RARalpha O
-mediated O
signals O
in O
myeloid O
leukemic O
cells O
. O

Retinoic O
acid O
( O
RA O
) O
induces O
HL-60 B
cells I
to O
differentiate O
terminally O
into O
mature O
granulocytes O
, O
which O
subsequently O
die O
by O
apoptosis O
. O

Interestingly O
, O
the O
combination O
of O
the O
RAR-selective O
antagonist O
and O
9-cis O
RA O
resulted O
in O
partial O
differentiation O
and O
apoptosis O
of O
HL-60 B
and I
NB4 I
cells I
, O
whereas O
the O
RAR O
antagonist O
completely O
blocked O
all-trans O
RA-induced O
differentiation O
and O
apoptosis O
of O
the O
cells O
. O

Furthermore O
, O
HL-60 B
cells I
transduced O
with O
a O
bcl-2 O
expression O
vector O
showed O
the O
same O
differentiation O
response O
to O
retinoids O
as O
did O
parental B
HL-60 I
cells I
even O
though O
apoptosis O
was O
inhibited O
in O
these O
bcl-2-transduced B
cells I
, O
suggesting O
that O
differentiation O
and O
apoptosis O
are O
regulated O
independently O
in O
myeloid O
leukemic O
cells O
. O

Thrombopoietin O
supports O
in O
vitro O
erythroid O
differentiation O
via O
its O
specific O
receptor O
c-Mpl O
in O
a O
human B
leukemia I
cell I
line I
. O

We O
isolated O
a O
novel O
subline O
, O
UT-7/GMT B
, O
from O
the O
human B
leukemia I
cell I
line I
UT-7/GM I
( O
N. O
Komatsu O
, O
et O
al. O
, O
Blood O
, O
89 O
: O
4021-4033 O
, O
1997 O
) O
. O

A O
small O
population O
of O
UT-7/GM B
cells I
positively O
stained O
for O
hemoglobin O
( O
Hb O
) O
after O
a O
7-day O
exposure O
to O
TPO O
. O

More O
than O
50 O
% O
of O
TPO-treated B
UT-7/GMT I
cells I
positively O
stained O
for O
Hb O
. O

Using O
UT-7/GMT B
cells I
, O
we O
examined O
how O
TPO O
promotes O
hemoglobinization O
. O

These O
findings O
suggest O
that O
TPO O
has O
a O
direct O
effect O
on O
hemoglobinization O
via O
a O
specific O
receptor O
on O
UT-7/GMT B
cells I
. O

These O
data O
suggest O
that O
a O
small O
number O
of O
GATA-1.05 B
mutant I
hematopoietic I
progenitor I
cells I
begin O
to O
proliferate O
vigorously O
during O
early O
adulthood O
, O
but O
because O
the O
cells O
are O
unable O
to O
terminally O
differentiate O
, O
this O
leads O
to O
progenitor O
proliferation O
in O
the O
spleen O
and O
consequently O
death O
. O

Sensitivity O
for O
induction O
of O
apoptosis O
was O
markedly O
increased O
by O
these O
treatments O
in O
apoptosis O
sensitive O
cell B
lines I
. O

Separate O
epitopes O
in O
VP22 O
were O
defined O
for O
T-cell B
clones I
from O
each O
of O
three O
patients O
. O

Some O
tegument-specific B
CD4 I
T-cell I
clones I
exhibited O
cytotoxic O
activity O
against O
HSV-infected O
cells O
. O

U937 B
cells I
differentiated O
with O
PMA O
in O
nonadherent B
culture I
were O
shown O
to O
express O
two O
fibrinogen-binding O
integrins O
, O
predominately O
CD11b/CD18 O
, O
and O
to O
a O
lesser O
extent O
, O
CD11c/CD18 O
. O

To O
determine O
the O
effects O
on O
transcriptional O
regulation O
, O
U937 B
cells I
were O
transfected O
with O
a O
plasmid O
containing O
the O
HIV-1 O
enhancer O
( O
bearing O
two O
NF-kappa O
B O
sites O
) O
coupled O
to O
a O
chloramphenicol O
acetyltransferase O
( O
CAT O
) O
reporter O
. O

Peripheral O
blood O
T O
cells O
and O
monocytes O
and O
B B
cell I
lines I
derived O
from O
patients O
with O
lupus O
express O
estrogen O
receptor O
transcripts O
similar O
to O
those O
of O
normal O
cells O
. O

Epstein-Barr O
virus-transformed O
B B
cell I
lines I
( O
n O
= O
7 O
) O
and O
B B
cell I
hybridomas I
( O
n O
= O
2 O
) O
established O
from O
patients O
with O
SLE O
and O
a O
healthy O
individual O
were O
used O
as O
a O
B O
cell O
source O
. O

Using O
the O
1G5 B
cell I
line I
harbouring O
the O
luciferase O
reporter O
gene O
under O
the O
control O
of O
the O
HIV-1 O
LTR O
, O
it O
was O
first O
found O
that O
culture O
protein O
filtrates O
( O
CFP O
) O
from O
M. O
tuberculosis O
or O
purified O
ManLAM O
could O
activate O
HIV-1 O
LTR-dependent O
gene O
expression O
unlike O
similarly O
prepared O
CFP O
extracts O
devoid O
of O
ManLAM O
. O

Transient O
expression O
analyses O
in O
cells O
of O
neuroglial O
and O
lymphocytic O
origin O
demonstrated O
that O
some O
of O
these O
LTRs O
had O
activities O
which O
varied O
significantly O
from O
the O
LAI O
LTR O
in O
U-373 B
MG I
cells I
( O
an O
astrocytoma B
cell I
line I
) O
as O
well O
as O
in O
Jurkat B
cells I
( O
a O
CD4-positive B
lymphocyte I
cell I
line I
) O
. O

While O
LTRs O
which O
demonstrated O
the O
highest O
activities O
in O
U-373 B
MG I
cells I
also O
yielded O
high O
activities O
in O
Jurkat O
cells O
, O
the O
LTRs O
were O
generally O
more O
active O
in O
Jurkat B
cells I
when O
compared O
to O
the O
LAI O
LTR O
. O

Human B
CD3-CD16+ I
natural I
killer I
cells I
express O
the O
hGATA-3 O
T O
cell O
transcription O
factor O
and O
an O
unrearranged O
2.3-kb O
TcR O
delta O
transcript O
. O

In O
this O
study O
we O
analyzed O
the O
T O
cell O
receptor O
( O
TcR O
) O
delta O
transcripts O
expressed O
by O
CD3-CD16+ B
cells I
and O
we O
investigated O
whether O
these O
cells O
expressed O
the O
hGATA-3 O
T O
cell O
transcription O
factor O
and O
the O
recombination-activating O
gene O
( O
RAG O
) O
-1 O
. O

Multiple O
TcR O
delta O
transcripts O
deriving O
from O
an O
unrearranged O
TcR O
delta O
gene O
were O
detected O
in O
both O
polyclonal B
and I
clonal I
CD3-CD16+ I
natural I
killer I
( I
NK I
) I
cell I
lines I
. O

Two O
unrearranged O
TcR O
delta O
transcripts O
had O
a O
size O
similar O
to O
that O
of O
the O
functional O
TcR O
delta O
mRNA O
( O
2.3 O
and O
1.3 O
kb O
) O
found O
in O
TcR B
gamma/delta+ I
T I
lymphocytes I
. O

The O
expression O
of O
hGATA-3 O
, O
a O
T O
cell-specific O
factor O
known O
to O
be O
involved O
in O
the O
regulation O
of O
the O
transcription O
of O
TcR O
delta O
locus O
, O
was O
analyzed O
by O
Northern O
blot O
, O
in O
cultured O
NK B
cell I
population I
and O
clones O
( O
but O
not O
in O
freshly O
derived O
cell O
populations O
) O
. O

All O
NK B
clones I
and O
cell O
lines O
studied O
were O
found O
to O
express O
hGATA-3-specific O
mRNA O
, O
suggesting O
that O
hGATA-3 O
may O
be O
involved O
in O
the O
regulation O
of O
the O
unrearranged O
TcR O
delta O
gene O
expression O
in O
NK O
cells O
. O

Finally O
, O
no O
transcription O
of O
the O
RAG-1 O
gene O
could O
be O
detected O
in O
all O
NK B
cell I
lines I
or O
clones O
analyzed O
. O

Jurkat B
cells I
were O
transfected O
with O
plasmids O
containing O
either O
the O
intact O
IL-2 O
promoter O
or O
its O
AP-1 O
, O
NF-AT O
, O
and O
NF-kB O
motifs O
. O

Surprisingly O
, O
the O
NF-kappa O
B O
and O
HLP-1 O
binding O
activities O
were O
substantially O
inhibited O
in O
acyclovir-treated B
cells I
. O

Here O
we O
report O
that O
binding O
of O
human O
IL-2 O
to O
its O
binding O
site O
leads O
to O
transcriptional O
activation O
of O
the O
macrophage O
CSF O
( O
M-CSF O
) O
gene O
in O
Mo O
resulting O
in O
accumulation O
of O
M-CSF O
mRNA O
and O
subsequent O
release O
of O
bioactive O
M-CSF O
protein O
as O
demonstrated O
by O
ELISA O
and O
inhibition O
of O
IL-2 O
induced O
release O
of O
an O
activity-stimulating O
growth O
of O
monocyte-type B
colonies I
by O
a O
neutralizing O
anti-M-CSF O
antibody O
. O

DNA O
mobility O
shift O
assay O
revealed O
specific O
binding O
of O
nuclear O
protein O
( O
s O
) O
from O
LAM- B
, I
LPS- I
, I
or I
TNF-alpha- I
stimulated I
THP-1 I
cells I
to O
the O
NF-IL6 O
motifs O
. O

To O
determine O
whether O
Nef O
affects O
the O
binding O
of O
cellular O
factors O
implicated O
in O
HIV-1 O
regulation O
, O
32P-labeled O
oligonucleotides O
corresponding O
to O
the O
binding O
sites O
were O
incubated O
with O
nuclear O
extracts O
prepared O
from O
Nef-expressing B
T-cell I
lines I
that O
were O
not O
stimulated O
or O
were O
stimulated O
with O
T-cell O
mitogens O
. O

Additionally O
, O
Nef B
expressing I
cells I
were O
transiently O
transfected O
with O
a O
plasmid O
in O
which O
HIV-1 O
AP-1 O
DNA O
recognition O
sequences O
were O
cloned O
downstream O
of O
the O
chloramphenicol O
acetyltransferase O
( O
CAT O
) O
gene O
. O

Mitogen-mediated O
transcriptional O
activation O
of O
the O
CAT O
gene O
in O
this O
construct O
was O
inhibited O
in O
Nef-expressing B
cells I
but O
not O
in O
control O
cells O
. O

The O
proliferation O
and O
NK O
activity O
of O
YT-N17 B
( O
a O
human B
NK-like I
cell I
line I
) O
were O
enhanced O
by O
17 O
beta-estradiol O
( O
E2 O
) O
, O
and O
the O
enhancement O
was O
blocked O
by O
tamoxifen O
( O
Tx O
) O
, O
an O
antagonist O
of O
E2 O
. O

YT-N17 B
contained O
11.8 O
fmol/mg O
protein O
of O
estrogen O
receptor O
( O
mean O
of O
two O
independent O
assays O
) O
, O
a O
value O
which O
was O
5-10-fold O
higher O
than O
that O
of O
other O
hematopoietic B
cell I
lines I
. O

These O
data O
suggest O
that O
E2 O
is O
one O
of O
the O
activating O
factors O
for O
NK/LGL B
cells I
. O

Transactivation O
of O
PTHrP O
by O
Tax O
was O
seen O
in O
T O
cells O
but O
not O
in O
B-cell B
lines I
or O
fibroblasts B
. O

HIV-1 O
can O
also O
establish O
a O
latent O
or O
persistent O
infection O
in O
some O
T B
cell I
lines I
that O
show O
minimal O
constitutive O
virus O
expression O
. O

However O
, O
activation O
of O
the O
T B
cell I
lines I
leading O
to O
enhanced O
HIV-1 O
replication O
can O
be O
induced O
by O
antigens O
, O
mitogens O
, O
and O
cytokines O
( O
tumor O
necrosis O
factor O
alpha O
[ O
TNF-alpha O
] O
, O
interleukin O
1 O
, O
and O
interleukin-2 O
) O
. O

ACH-2 B
, O
derived O
from O
a O
human B
T I
cell I
line I
( O
CEM B
) O
, O
is O
chronically O
infected O
with O
HIV-1 O
, O
with O
low O
levels O
of O
constitutive O
virus O
expression O
. O

ACH-2 B
can O
be O
converted O
to O
productive O
infection O
by O
stimulation O
of O
the O
cells O
with O
12-O-tetradecanoylphorbol-13-acetate O
( O
TPA O
) O
, O
mitogen O
or O
cytokines O
( O
TNF-alpha O
) O
, O
or O
infection O
with O
HSV O
. O

Therefore O
the O
ACH-2 B
cell O
line O
is O
a O
good O
candidate O
for O
studying O
the O
effects O
of O
drugs O
on O
HIV-1 O
activation O
. O

Previously O
, O
we O
have O
reported O
that O
DHEA O
and O
synthetic O
analogs O
of O
DHEA O
can O
be O
modest O
inhibitors O
of O
HIV-1 O
IIIB O
replication O
in O
phytohemagglutinin-stimulated B
peripheral I
blood I
lymphocyte I
cultures I
. O

By O
contrast O
, O
memory O
cells O
, O
either O
in O
vitro B
activated I
helper I
T I
cells I
reverting O
to O
a O
resting O
state O
, O
or O
CD4+ B
T I
( I
memory I
) I
clones I
, O
or O
CD4+CD45RO+ B
T I
cells I
isolated O
ex O
vivo O
, O
no O
longer O
have O
a O
silencer O
. O

Their O
IL-2 O
transcription O
seems O
to O
be O
controlled O
solely O
by O
the O
transition O
from O
inactive O
to O
active O
functional O
state O
of O
a O
positive O
transcription O
factor O
binding O
to O
these O
promoter O
elements O
as O
well O
as O
its O
cytoplasmic O
or O
nuclear O
location O
: O
in O
resting O
memory O
T O
cells O
the O
activator O
is O
located O
in O
the O
cytoplasm O
and O
is O
inactive O
, O
whereas O
in O
stimulated B
cells I
it O
is O
functional O
in O
promoting O
transcription O
and O
now O
resides O
in O
the O
nucleus O
. O

Treatment O
of O
HL-60 B
eosinophilic I
sublines I
with O
either O
interleukin-5 O
or O
butyric O
acid O
increased O
the O
expression O
of O
GATA-1 O
mRNA O
concomitant O
with O
the O
expression O
of O
eosinophil-specific O
genes O
, O
whereas O
levels O
of O
GATA-2 O
mRNA O
remained O
relatively O
constant O
. O

Induced O
myeloid O
differentiation O
of O
K562 B
cells I
with O
downregulation O
of O
erythroid O
and O
megakaryocytic O
transcription O
factors O
: O
a O
novel O
experimental O
model O
for O
hemopoietic O
lineage O
restriction O
. O

The O
human B
erythroleukemia I
cell I
line I
K562 I
can O
be O
induced O
to O
differentiate O
along O
the O
erythroid O
and O
megakaryocytic O
lineages O
. O

Here O
we O
demonstrate O
that O
hexamethylene O
bisacetamide O
( O
HMBA O
) O
induced O
K562 B
cells I
to O
differentiate O
along O
a O
third O
pathway O
. O

Proliferation O
of O
the O
K562 B
cells I
was O
also O
suppressed O
. O

Clonal O
assay O
showed O
that O
the O
suppression O
was O
irreversible O
and O
appeared O
analogous O
to O
the O
commitment O
of O
murine B
erythroleukemia I
( I
MEL I
) I
cells I
to O
terminal O
differentiation O
. O

In O
contrast O
to O
MEL B
cells I
, O
however O
, O
K562 B
cells I
acquired O
a O
macrophage-like O
morphology O
and O
exhibited O
a O
complete O
failure O
to O
generate O
benzidine-positive B
cells I
. O

Surface O
marker O
analysis O
showed O
that O
HMBA-induced B
cells I
expressed O
reduced O
levels O
of O
glycophorin O
A O
, O
CD5 O
, O
CD7 O
and O
CD11b O
. O

Thus O
the O
response O
of O
K562 B
cells I
to O
HMBA O
may O
provide O
a O
useful O
experimental O
system O
for O
studying O
the O
molecular O
mechanisms O
responsible O
for O
downmodulation O
of O
lineage-restricted O
transcription O
factors O
during O
hemopoietic O
lineage O
commitment O
. O

The O
approach O
was O
further O
extended O
to O
cell O
separation O
by O
the O
efficient O
recovery O
and O
elution O
of O
human B
CD37 I
B I
lymphocytes I
from O
peripheral O
blood O
. O

In O
a O
Jurkat B
cell I
model I
of O
T-cell O
activation O
an O
interleukin-2 O
promoter/reporter O
gene O
construct O
was O
activated O
by O
antigen O
receptor O
agonism O
in O
combination O
with O
the O
lymphokine O
interleukin-1 O
. O

Expression O
of O
the O
Tat O
protein O
of O
HIV1 O
in O
human B
promonocytic I
U937 I
cells I
. O

Numerous O
studies O
have O
shown O
that O
, O
upon O
HIV1 O
infection O
, O
human B
promonocytic I
U937 I
cells I
were O
induced O
to O
differentiate O
, O
as O
indicated O
, O
for O
example O
, O
by O
increased O
expression O
of O
adhesion O
molecules O
. O

In O
order O
to O
apprehend O
the O
role O
of O
the O
HIV1 O
tat O
gene O
in O
inducing O
the O
differentiation O
of O
HIV1-infected B
U937 I
cells I
, O
we O
have O
successfully O
introduced O
this O
gene O
into O
U937 B
cells I
by O
infecting O
them O
with O
retroviral O
particles O
transducing O
tat O
. O

No O
such O
increase O
was O
observed O
in O
control O
U937 B
cells I
. O

Defective O
translocation O
of O
protein O
kinase O
C O
in O
multidrug-resistant B
HL-60 I
cells I
confers O
a O
reversible O
loss O
of O
phorbol O
ester-induced O
monocytic O
differentiation O
. O

Previous O
studies O
have O
demonstrated O
that O
human B
HL-60 I
myeloid I
leukemia I
cells I
differentiate O
in O
response O
to O
phorbol O
esters O
. O

The O
results O
demonstrate O
that O
multidrug-resistant B
HL-60 I
cells I
, O
designated O
HL-60/vinc O
, O
fail O
to O
respond O
to O
TPA O
with O
an O
increase O
in O
c-jun O
transcripts O
or O
other O
phenotypic O
characteristics O
of O
monocytic O
differentiation O
. O

By O
contrast O
, O
treatment O
of O
HL-60/vinc B
cells I
with O
okadaic O
acid O
, O
an O
inhibitor O
of O
serine/threonine O
protein O
phosphatases O
, O
induces O
c-jun O
transcription O
, O
growth O
arrest O
, O
and O
expression O
of O
the O
c-fms O
gene O
. O

Studies O
were O
also O
performed O
with O
an O
HL-60/vinc B
revertant I
( O
HL-60/vinc/R B
) O
line O
that O
has O
regained O
partial O
sensitivity O
to O
vincristine O
. O

The O
finding O
that O
HL-60/vinc/R B
cells I
respond O
to O
TPA O
with O
induction O
of O
a O
monocytic O
phenotype O
, O
but O
not O
c-jun O
expression O
, O
suggests O
that O
c-jun O
induction O
is O
not O
obligatory O
for O
monocytic O
differentiation O
. O

Other O
studies O
further O
demonstrate O
that O
the O
jun-B O
and O
fra-1 O
genes O
are O
induced O
by O
TPA O
in O
both O
HL-60/vinc B
and O
HL-60/vinc/R B
cells I
, O
whereas O
c-fos O
expression O
is O
attenuated O
in O
the O
HL-60/vinc O
line O
. O

Although O
HL-60 B
and O
HL-60/vinc/R B
cells I
demonstrated O
translocation O
of O
PKC O
activity O
, O
this O
subcellular O
redistribution O
was O
undetectable O
in O
HL-60/vinc B
cells I
. O

Activity O
of O
the O
mitogen-activated O
protein O
kinase O
family O
with O
associated O
phosphorylation O
of O
c-Jun O
Y-peptide O
was O
markedly O
diminished O
in O
TPA-treated B
HL-60/vinc I
cells I
, O
but O
not O
in O
response O
to O
okadaic O
acid O
. O

A O
cell-type-independent O
lipopolysaccharide O
( O
LPS O
) O
-responsive O
enhancer O
element O
located O
between O
-3757 O
and O
-2729 O
bp O
upstream O
from O
the O
transcription O
start O
site O
( O
cap O
site O
) O
consisted O
of O
at O
least O
six O
discrete O
subregions O
which O
were O
essential O
to O
the O
maximal O
induction O
by O
LPS O
in O
transfected B
monocytes I
. O

When O
ligated O
to O
the O
murine O
c-fos O
promoter O
, O
however O
, O
the O
proIL-1 O
beta O
enhancer O
was O
inducible O
in O
phorbol B
myristate I
acetate-stimulated I
HeLa I
cells I
, O
suggesting O
the O
existence O
of O
a O
proIL-1 O
beta O
promoter-proximal O
requirement O
for O
tissue O
specificity O
. O

Antisense O
oligonucleotides O
to O
the O
p65 O
subunit O
of O
NF-kappa O
B O
block O
CD11b O
expression O
and O
alter O
adhesion O
properties O
of O
differentiated O
HL-60 B
granulocytes I
. O

Antisense O
phosphorothioate O
oligonucleotides O
to O
the O
p50 O
and O
p65 O
subunits O
of O
the O
NF-kappa O
B O
complex O
were O
used O
to O
define O
the O
physiologic O
role O
of O
this O
transcription O
factor O
in O
resting B
and I
stimulated I
granulocytes I
. O

This O
reduction O
was O
accompanied O
by O
rapid O
changes O
in O
the O
cellular O
adhesion O
of O
dimethyl B
sulfoxide-differentiated I
HL-60 I
leukemia I
cells I
stimulated O
by O
12-O-tetradecanoylphorbol O
13-acetate O
( O
TPA O
) O
. O

These O
effects O
were O
characterized O
by O
a O
marked O
reduction O
in O
CD11b O
integrin O
expression O
on O
the O
surface O
of O
treated B
cells I
. O

Lipopolysaccharide O
induces O
phosphorylation O
of O
MAD3 O
and O
activation O
of O
c-Rel O
and O
related O
NF-kappa O
B O
proteins O
in O
human B
monocytic I
THP-1 I
cells I
. O

Here O
we O
show O
that O
LPS O
induces O
nuclear O
expression O
of O
c-Rel/p50 O
heterodimers O
as O
well O
as O
p50/p65 O
( O
NF-kappa O
B O
) O
kappa O
B O
DNA-binding O
complexes O
in O
human B
monocytic I
THP-1 I
cells I
. O

The O
increased O
levels O
of O
these O
proteins O
correlated O
with O
increases O
in O
the O
amounts O
of O
their O
mRNAs O
during O
LPS O
activation O
of O
THP-1 B
cells I
. O

LPS O
activation O
of O
THP-1 B
cells I
resulted O
in O
phosphorylation O
of O
MAD3 O
( O
an O
I O
kappa O
B O
-like O
protein O
) O
, O
a O
rapid O
increase O
in O
MAD3 O
mRNA O
, O
and O
an O
increase O
in O
MAD3 O
protein O
by O
2 O
h O
. O

Here O
we O
report O
that O
the O
type O
II O
IL-1R O
does O
not O
mediate O
gene O
activation O
in O
Jurkat B
cells I
. O

When O
the O
wild-type O
hGR O
and O
hGR-Ile O
729 O
were O
expressed O
in O
COS-1 B
cells I
and O
assayed O
for O
[ O
3H O
] O
-Dexamethasone O
binding O
, O
the O
dissociation O
constants O
were O
0.799 O
+/- O
0.068 O
and O
1.54 O
+/- O
0.06 O
nM O
( O
mean O
+/- O
SEM O
) O
( O
P O
< O
0.01 O
) O
, O
respectively O
. O

When O
the O
wild-type O
hGR O
and O
hGR-Ile O
729 O
were O
expressed O
in O
CV-1 B
cells I
that O
were O
cotransfected O
with O
the O
mouse O
mammary O
tumor O
virus O
long O
terminal O
repeat O
fused O
to O
the O
chloramphenicol O
acetyl O
transferase O
( O
CAT O
) O
gene O
, O
the O
hGR-Ile O
729 O
conferred O
a O
fourfold O
decrease O
in O
apparent O
potency O
on O
dexamethasone O
stimulation O
of O
CAT O
activity O
. O

Tax1 O
strongly O
activates O
the O
enhancer O
activity O
of O
this O
motif O
, O
in O
both O
epithelial B
HeLa I
and O
lymphoid O
Jurkat B
cells I
. O

We O
have O
previously O
found O
that O
NFKB2 O
( O
p49/p52 O
) O
acts O
in O
concert O
with O
RelA O
( O
p65 O
) O
to O
stimulate O
the O
HIV O
enhancer O
in O
Jurkat O
T-leukemia B
cells I
. O

Functional O
activation O
of O
an O
HIV O
reporter O
plasmid O
by O
p49/p65 O
in O
transiently B
transfected I
Jurkat I
T-leukemia I
cells I
was O
also O
inhibited O
by O
coexpression O
of O
MAD-3 O
. O

We O
show O
that O
the O
constitutive O
expression O
of O
the O
T24 O
Ha-ras O
oncogene O
in O
EBV-immortalized B
B I
lymphoblasts I
was O
associated O
with O
the O
induction O
of O
the O
interleukin O
2 O
receptor O
alpha O
subunit O
, O
with O
an O
impaired O
immunoglobulin O
gene O
expression O
, O
altered O
adhesion O
properties O
and O
increased O
survival O
in O
serum-free O
medium O
. O

The O
ras-transformed B
lymphocytes I
displayed O
a O
fully O
functional O
IL-2r O
, O
as O
assessed O
by O
c-fos O
induction O
following O
treatment O
with O
IL-2 O
; O
nevertheless O
, O
they O
were O
not O
growth O
stimulated O
by O
this O
lymphokine O
. O

Differential O
autoregulation O
of O
glucocorticoid O
receptor O
expression O
in O
human B
T- I
and I
B-cell I
lines I
. O

Regulation O
of O
glucocorticoid O
receptor O
( O
GR O
) O
expression O
by O
its O
cognate O
ligand O
was O
examined O
in O
the O
glucocorticoid-sensitive B
human I
leukemic I
T-cell I
line I
6TG1.1 I
and O
in O
the O
human B
B-cell I
line I
IM-9 I
. O

In O
contrast O
to O
the O
decrease O
in O
GR O
mRNA O
seen O
in O
IM-9 B
cells I
after O
treatment O
with O
1 O
microM O
dexamethasone O
for O
16-18 O
h O
, O
treatment O
of O
6TG1.1 B
cells I
resulted O
in O
an O
8-fold O
increase O
in O
GR O
mRNA O
, O
as O
determined O
by O
Northern O
blot O
and O
RNase O
protection O
analysis O
, O
with O
a O
corresponding O
3- O
to O
4-fold O
increase O
in O
GR O
protein O
. O

Half-maximal O
induction O
of O
GR O
mRNA O
and O
protein O
in O
6TG1.1 B
cells I
was O
observed O
between O
10-100 O
nM O
dexamethasone O
, O
and O
inclusion O
of O
1 O
microM O
RU O
38486 O
completely O
blocked O
the O
effects O
of O
100 O
nM O
dexamethasone O
, O
demonstrating O
that O
positive O
autoregulation O
of O
GR O
expression O
in O
6TG1.1 B
cells I
is O
a O
receptor-mediated O
response O
. O

Positive O
autoregulation O
of O
GR O
expression O
was O
also O
observed O
in O
glucocorticoid-resistant B
CEM-C1 I
cells I
, O
which O
contain O
functional O
GR O
, O
but O
whose O
growth O
is O
unaffected O
by O
glucocorticoids O
. O

The O
degree O
of O
negative O
autoregulation O
in O
IM-9 B
cells I
and O
positive O
autoregulation O
in O
6TG1.1 B
cells I
was O
unaffected O
by O
inhibition O
of O
protein O
synthesis O
with O
cycloheximide O
. O

Measurement O
of O
GR O
mRNA O
turnover O
in O
6TG1.1 B
cells I
treated O
with O
actinomycin-D O
revealed O
a O
half-life O
of O
2.5 O
h O
, O
which O
was O
unaffected O
by O
dexamethasone O
treatment O
. O

A O
similar O
half-life O
was O
determined O
in O
IM-9 B
cells I
and O
was O
also O
unaffected O
by O
steroid O
treatment O
. O

Induction O
of O
CD8 O
antigen O
and O
suppressor O
activity O
by O
glucocorticoids O
in O
a O
CEM B
human I
leukemic I
cell I
clone I
. O

The O
relationship O
between O
glucocorticoid O
effect O
and O
regulation O
of O
cell O
surface O
antigens O
was O
investigated O
in O
two O
models O
of O
leukemic B
cell I
lines I
, O
CEM B
C7 I
denoted O
( O
r+ O
, O
ly+ O
) O
and O
CEM B
C1 I
( O
r+ O
, O
ly- O
) O
. O

The O
suppressor O
function O
was O
determined O
using O
[ O
3H O
] O
thymidine O
incorporation O
into O
phytohemagglutinin-activated B
peripheral I
blood I
lymphocytes I
. O

Dexamethasone O
treatment O
of O
a O
human B
leukemic I
cell I
clone I
CEM I
C7 I
caused O
an O
increase O
in O
a O
subset O
of O
cells O
expressing O
the O
surface O
antigen O
CD8 O
, O
which O
is O
present O
on O
suppressor O
and O
cytotoxic O
T-lymphocytes O
. O

After O
two O
days O
of O
treatment O
with O
5 O
x O
10 O
( O
-8 O
) O
M O
dexamethasone O
, O
CEM B
C7 I
cells I
showed O
a O
two-fold O
increase O
in O
suppressor O
activity O
compared O
to O
untreated O
cells O
. O

In O
contrast O
, O
there O
was O
no O
regulation O
by O
glucocorticoids O
of O
either O
the O
CD8 O
or O
CD4 O
antigens O
in O
the O
leukemic B
clone I
CEM I
C1 I
. O

Furthermore O
, O
no O
modification O
of O
the O
suppressor O
function O
in O
CEM B
C1 I
cells I
by O
dexamethasone O
was O
observed O
. O

In O
the O
human O
leukemic O
cells O
studied O
here O
, O
the O
ability O
to O
induce O
CD8 O
antigen O
expression O
in O
a O
CD4+ B
cells I
correlates O
with O
the O
ability O
to O
induce O
cell O
lysis O
in O
a O
glucocorticoid B
receptor I
positive I
cell I
population I
. O

To O
test O
this O
hypothesis O
, O
4-h O
NK O
cytolysis O
assays O
were O
performed O
on O
IFN-gamma-treated B
human I
cells I
infected O
with O
an O
Ad5 O
E1A O
deletion O
mutant O
, O
dl343 O
, O
or O
transfected O
with O
the O
Ad5 O
E1A O
gene O
. O

In O
contrast O
to O
E1A-negative B
, I
parental I
cell I
lines I
, O
IFN O
-MCP O
was O
blocked O
in O
Ad5 O
E1A-transfected B
epithelial I
and O
fibroblastic B
cell I
lines I
. O

Because O
IFN O
-MCP O
was O
also O
blocked O
in O
Ad12 B
E1A-transfected I
cell I
lines I
, O
expression O
of O
one O
or O
more O
of O
the O
E1A-conserved O
regions O
may O
be O
necessary O
to O
inhibit O
IFN O
-MCP O
. O

E1A O
's O
inhibition O
of O
IFN O
-MCP O
has O
the O
net O
effect O
of O
promoting O
the O
selective O
NK O
cell-mediated O
clearance O
of O
Ad-infected O
or O
Ad-transformed B
human I
cells I
. O

In O
previous O
transfection O
analyses O
using O
the O
chloramphenicol O
acetyltransferase O
reporter O
gene O
system O
, O
we O
determined O
that O
linker O
substitution O
( O
LS O
) O
mutations O
between O
-201 O
and O
-130 O
( O
relative O
to O
the O
transcription O
start O
site O
) O
of O
the O
human O
immunodeficiency O
virus O
type O
1 O
long O
terminal O
repeat O
( O
LTR O
) O
caused O
moderate O
decreases O
in O
LTR O
transcriptional O
activity O
in O
a O
T-cell B
line I
( O
S.L.Zeichner O
, O
J.Y.H. O
Kim O
, O
and O
J.C.Alwine O
, O
J.Virol.65 O
: O
2436-2444 O
, O
1991 O
) O
. O

In O
order O
to O
confirm O
the O
significance O
of O
this O
region O
in O
the O
context O
of O
viral O
replication O
, O
we O
constructed O
several O
of O
these O
LS O
mutations O
( O
-201 O
to O
- O
184 O
, O
-183 O
to O
-166 O
, O
-165 O
to O
-148 O
, O
and O
-148 O
to O
-130 O
) O
in O
proviruses O
and O
prepared O
viral O
stocks O
by O
cocultivation O
of O
transfected B
RD I
cells I
with O
CEMx174 B
cells I
. O

The O
ideal O
situation O
would O
be O
analyses O
conducted O
in O
GATA-1 B
-erythroid I
cells I
. O

If O
GATA-1 B
-red I
cells I
were O
available O
, O
the O
analyses O
would O
involve O
the O
actual O
transcription O
of O
or O
chromatin O
structure O
surrounding O
the O
globin O
genes O
. O

However O
, O
the O
ES O
cell O
system O
can O
be O
used O
as O
an O
alternative O
until O
targeted B
erythroleukemia I
cells I
become O
available O
. O

1 O
, O
25-dihydroxy O
vitamin O
D3 O
and O
12-O-tetradecanoyl O
phorbol-13-acetate O
( O
TPA O
) O
interact O
synergistically O
to O
induce O
monocytic O
differentiation O
of O
U937 B
histiocytic I
lymphoma I
cells I
. O

When O
stably O
introduced O
into O
primary O
erythroblasts O
or O
conditionally B
transformed I
erythroid I
progenitors I
cells I
, O
exogenous O
GATA-2/ER O
promoted O
proliferation O
and O
inhibited O
terminal O
differentiation O
in O
an O
estrogen-dependent O
manner O
. O

These O
phenotypic O
effects O
are O
specifically O
attributable O
to O
the O
action O
of O
ectopically O
expressed O
GATA-2/ER O
because O
erythroblasts O
expressing O
exogenous O
GATA-2 O
are O
constitutively O
arrested O
in O
differentiation O
and O
because O
erythroid B
progenitors I
expressing O
either O
Gal/ER O
or O
GATA-3/ER O
do O
not O
display O
a O
hormone-responsive O
block O
in O
differentiation O
. O

It O
was O
shown O
by O
transient O
expression O
assay O
that O
HS-40 O
behaved O
as O
an O
authentic O
enhancer O
for O
high-level O
zeta O
2 O
globin O
promoter O
activity O
in O
K562 B
cells I
, O
an O
erythroid O
cell O
line O
of O
embryonic O
and/or O
fetal O
origin O
. O

Finally O
, O
we O
did O
genomic O
footprinting O
of O
the O
HS-40 O
enhancer O
region O
in O
K562 B
cells I
, O
adult B
nucleated I
erythroblasts I
, O
and O
different O
nonerythroid O
cells O
. O

All O
sequence O
motifs O
within O
the O
functional O
core O
of O
HS-40 O
, O
as O
mapped O
by O
transient O
expression O
analysis O
, O
appeared O
to O
bind O
a O
nuclear O
factor O
( O
s O
) O
in O
living O
K562 B
cells I
but O
not O
in O
nonerythroid O
cells O
. O

In O
comparison O
to O
K562 B
, O
nucleated B
erythroblasts I
from O
adult O
human O
bone O
marrow O
exhibited O
a O
similar O
but O
nonidentical O
pattern O
of O
nuclear O
factor O
binding O
in O
vivo O
at O
the O
HS-40 O
region O
. O

Finally O
, O
by O
co-transfection O
experiments O
, O
we O
study O
the O
elements O
involved O
in O
the O
hGATA-1 O
transactivation O
of O
the O
R-PK O
promoter O
in O
HeLa B
cells I
. O

Protease O
treatment O
of O
nuclear O
extracts O
distinguishes O
between O
class O
II O
MHC O
X1 O
box O
DNA-binding O
proteins O
in O
wild-type B
and I
class I
II-deficient I
B I
cells I
. O

Although O
several O
class O
II O
promoter-specific O
DNA O
binding O
factors O
have O
been O
described O
, O
only O
the O
X O
box O
region O
factor O
, O
RFX O
, O
shows O
a O
genetic O
correlation O
with O
class O
II O
expression O
, O
being O
deficient O
in O
some O
B B
cell I
lines I
derived O
from O
patients O
with O
class O
II-deficient O
congenital O
immunodeficiency O
. O

To O
further O
evaluate O
the O
role O
of O
X O
box O
DNA-binding O
proteins O
in O
class O
II O
gene O
expression O
, O
the O
role O
of O
the O
X O
box O
region O
was O
examined O
in O
both O
class B
II-positive I
and O
-negative B
lymphoid I
cells I
. O

In O
addition O
to O
the O
wild-type B
B I
cell I
line I
Raji I
, O
two B
class I
II I
transcriptional I
mutant I
cell I
lines I
, O
SJO B
and O
RJ2.2.5 B
, O
and O
Jurkat B
, O
a O
class B
II I
negative I
T I
cell I
line I
, O
were O
examined O
. O

In O
contrast O
to O
wild-type B
B I
cells I
, O
neither O
of O
the O
class B
II I
mutant I
cell I
lines I
could O
use O
the O
X O
box O
region O
to O
direct O
the O
expression O
of O
a O
transiently O
transfected O
reporter O
gene O
, O
indicating O
that O
the O
X O
box-dependent O
transcriptional O
pathway O
is O
defective O
in O
these O
cells O
. O

The O
binding O
activity O
of O
the O
X1 O
box O
DNA-binding O
protein O
RFX O
was O
examined O
and O
found O
to O
be O
present O
in O
wild-type B
B I
cells I
and O
the O
mutant O
RJ2.2.5 B
but O
was O
absent O
in O
SJO B
and O
Jurkat B
. O

However O
, O
other O
X1 O
box-specific O
activities O
were O
detected O
in O
all O
these O
cell B
lines I
. O

A O
similar O
comparison O
with O
protease-treated O
extracts O
prepared O
from O
Jurkat B
cells I
demonstrated O
the O
presence O
of O
the O
band O
1pk O
activity O
despite O
an O
absence O
of O
the O
native O
RFX O
activity O
. O

In O
contrast O
, O
protease O
treatment O
and O
analysis O
of O
SJO B
extracts O
showed O
no O
detectable O
levels O
of O
the O
band O
1pk O
activity O
. O

The O
effects O
of O
these O
substitutions O
on O
viral O
replication O
in O
transfected O
HeLa B
cells I
and O
on O
HIV O
infection O
of O
human O
peripheral O
blood O
lymphocytes O
or O
continuous B
T-leukemia I
cell I
lines I
were O
evaluated O
. O

Viruses O
containing O
the O
human O
cytomegalovirus O
immediate-early O
enhancer O
exhibited O
infectious O
kinetics O
similar O
to O
that O
of O
wild-type O
HIV O
in O
activated O
human O
peripheral O
blood O
lymphocytes O
and O
AA2 B
cells I
but O
replicated O
less O
efficiently O
in O
H9 B
and I
CEM I
cells I
. O

A O
series O
of O
uninfected B
parental I
HL-60 I
subclones I
all O
reduced O
TR75 O
surface O
expression O
in O
response O
to O
TNF-alpha O
treatment O
. O

An O
increase O
in O
TR75 O
expression O
was O
also O
evident O
during O
the O
peak O
of O
an O
acute O
HIV-1 O
infection O
of O
HL-60 B
promyelocytes I
. O

Anti-TR55 O
antibody O
cross-linking O
in O
chronically B
infected I
U1 I
promonocytic I
cultures I
could O
only O
partially O
substitute O
for O
TNF-alpha-induced O
HIV-1 O
expression O
. O

A O
reporter O
gene O
under O
the O
control O
of O
a O
T-cell O
antigen O
receptor O
element O
was O
activated O
in O
Jurkat B
cells I
by O
antigen O
receptor O
triggering O
or O
by O
a O
combination O
of O
phorbol O
myristate O
acetate O
, O
which O
activates O
protein O
kinase O
C O
, O
and O
a O
calcium O
ionophore O
. O

Dependence O
for O
the O
proliferative O
response O
to O
erythropoietin O
on O
an O
established O
erythroid O
differentiation O
program O
in O
a O
human B
hematopoietic I
cell I
line I
, O
UT-7 B
. O

In O
order O
to O
understand O
the O
relationship O
, O
if O
any O
, O
between O
expression O
of O
GATA-1 O
, O
response O
to O
Epo O
and O
erythroid O
differentiation O
, O
we O
analyzed O
the O
expression O
of O
GATA-1 O
, O
Epo-R O
and O
globin O
genes O
in O
an O
Epo-dependent O
human O
cell O
line O
, O
UT-7 B
Epo O
. O

The O
results O
were O
compared O
to O
those O
obtained O
with O
the O
parental B
granulocyte-macrophage I
colony-stimulating I
factor I
( I
GM-CSF I
) I
-dependent I
cell I
line I
, O
UT-7 B
, O
which O
has O
a O
predominantly O
megakaryoblastic O
phenotype O
and O
is O
unable O
to O
proliferate O
continuously O
in O
the O
presence O
of O
Epo O
. O

UT-7 O
Epo O
and O
UT-7 B
expressed O
similar O
levels O
of O
GATA-1 O
mRNA O
and O
binding O
activity O
. O

The O
two O
lines O
also O
expressed O
comparable O
levels O
of O
Epo-R O
mRNA O
while O
the O
number O
of O
Epo O
-binding O
sites O
on O
UT-7 B
Epo I
cells I
was O
one-sixth O
the O
number O
of O
UT-7 B
cells I
( O
2400 O
+/- O
3 O
vs. O
13 O
, O
800 O
+/- O
300 O
) O
. O

This O
difference O
in O
the O
number O
of O
binding O
sites O
could O
be O
due O
to O
differences O
in O
cell O
surface O
( O
UT-7 B
cells I
are O
20 O
% O
smaller O
than O
the O
parental O
UT-7 B
cells I
) O
or O
in O
receptor O
turnover O
. O

By O
Northern O
analysis O
, O
UT-7 B
cells I
expressed O
detectable O
levels O
of O
beta- O
and O
gamma-globin O
but O
not O
alpha-globin O
. O

In O
comparison O
, O
UT-7 B
Epo I
cells I
expressed O
alpha-globin O
and O
higher O
levels O
of O
gamma-globin O
( O
5-fold O
) O
and O
beta-globin O
( O
from O
barely O
to O
clearly O
detectable O
) O
. O

Globin O
chains O
( O
alpha O
, O
beta O
and O
gamma O
) O
were O
clearly O
detectable O
by O
affinity O
chromatography O
in O
UT-7 O
Epo O
but O
not O
in O
UT-7 B
cells I
. O

The O
number O
of O
gamma-positive B
cells I
and O
their O
fluorescence O
intensity O
were O
higher O
in O
UT-7 O
Epo O
than O
in O
UT-7 B
cells I
( O
0 O
to O
17 O
% O
barely O
positive O
cells O
and O
23 O
to O
40 O
% O
clearly O
positive O
cells O
, O
respectively O
) O
, O
indicating O
that O
the O
increase O
in O
globin O
mRNA O
observed O
in O
UT-7 O
Epo O
is O
due O
to O
both O
an O
increase O
of O
gene O
expression O
per O
cell O
and O
an O
increase O
in O
numbers O
of O
cells O
containing O
gamma-globin O
. O

In O
vivo O
the O
Sp1 O
site O
is O
bound O
only O
in O
myeloid B
( I
U937 I
) I
cells I
, O
not O
in O
cervical B
carcinoma I
( I
HeLa I
) I
cells I
. O

We O
propose O
a O
model O
in O
which O
binding O
of O
a O
myeloid-specific O
factor O
( O
PU.1 O
) O
allows O
a O
general O
factor O
( O
Sp1 O
) O
to O
bind O
in O
a O
tissue-specific O
fashion O
thereby O
contributing O
to O
the O
myeloid-specific O
expression O
of O
CD11b B
. O

This O
study O
used O
a O
high O
titer O
anti-38 O
, O
000-M O
( O
r O
) O
serum O
to O
screen O
bacteriophage O
lambda O
cDNA O
expression O
libraries O
and O
identified O
human O
islet O
and O
placental B
clones I
encoding O
jun-B O
, O
the O
nuclear O
transcription O
protein O
, O
of O
predicted O
38 O
, O
000 O
M O
( O
r O
) O
. O

In O
immature O
hematopoietic O
cells O
, O
tal-1 O
and O
GATA-1 O
genes O
are O
coexpressed O
in O
committed O
progenitors O
cells O
( O
CD34+/CD38 B
( I
2+ I
) I
) O
, O
whereas O
they O
are O
not O
detectable O
in O
the O
most O
primitive O
cells O
( O
CD34 B
( I
2+ I
) I
/CD38- I
) O
. O

The O
lytic O
transition O
of O
Epstein-Barr O
virus O
is O
imitated O
by O
recombinant B
B-cells I
. O

Two O
stable O
B B
cell I
lines I
were O
established O
: O
R59Z B
activator I
cells I
were O
used O
to O
induce O
lytic O
EBV O
expression O
in O
a O
constitutive O
manner O
by O
the O
production O
of O
the O
BZLF O
1 O
trans-activator O
( O
Zta O
) O
. O

R7-57 B
reporter I
cells I
, O
on O
the O
other O
hand O
, O
signaled O
induced O
activity O
of O
the O
lytic O
origin O
of O
EBV O
replication O
( O
ori O
Lyt O
) O
. O

Different O
modes O
, O
like O
chemical O
induction O
, O
lytic O
superinfection O
with O
EBV O
and O
single O
gene O
trans-activation O
converted O
the O
recombinant O
ori O
Lyt O
element O
in O
R7-57 B
reporter I
cells I
. O

BZLF O
1 O
, O
transiently O
expressed O
in O
R7-57 B
reporter I
cells I
, O
was O
the O
only O
EBV O
trans-activator O
found O
, O
sufficient O
in O
inducing O
the O
viral O
lytic O
cycle O
. O

Basing O
on O
these O
experiments O
, O
trans-cellular O
activation O
of O
EBV O
was O
tested O
by O
cocultivation O
of O
BZLF O
1-expressing O
R59Z O
activator O
cells O
with O
the O
R7-57 B
reporter I
line I
. O

No O
lytic O
effect O
on O
the O
reporter O
cells O
could O
be O
measured O
, O
neither O
by O
cocultivation O
of O
activator B
cells I
nor O
by O
coincubation O
of O
BZLF O
1 O
-containing O
cell O
lysates O
. O

Latency O
breaking O
activity O
, O
however O
, O
was O
transferred O
from O
activator B
to O
reporter B
cells I
when O
active O
, O
exogenous O
virus O
was O
added O
. O

Analysis O
of O
intracellular O
Ca2+ O
mobilization O
suggested O
that O
the O
CD3 O
/ O
TcR O
-dependent O
signal O
transduction O
was O
impaired O
in O
PMA/Bt2cAMP-treated B
cells I
. O

The O
lymphotoxin O
promoter O
is O
stimulated O
by O
HTLV-I O
tax O
activation O
of O
NF-kappa O
B O
in O
human B
T-cell I
lines I
. O

Tax-expressing B
cell I
lines I
produce O
LT O
biologic O
activity O
. O

An O
LT O
promoter O
( O
LT-293 O
) O
CAT O
construct O
that O
contained O
an O
NF-kappa O
B O
site O
was O
active O
in O
the O
LT-producing B
C81-66-45 I
cell I
line I
, O
which O
contains O
defective O
HTLV-I O
but O
expresses O
tax O
. O

The O
observation O
that O
a O
mutated O
LT-kappa O
B O
construct O
( O
M1-CAT O
) O
was O
inactive O
in O
C81-66-45 B
, O
confirmed O
the O
importance O
of O
NF-kappa O
B O
in O
LT O
gene O
expression O
. O

Tax O
was O
transfected O
into O
HTLV-I-negative B
human I
T-cell I
lines I
. O

Jurkat B
T I
cells I
stably O
expressing O
tax O
contained O
elevated O
levels O
of O
NF-kappa O
B O
that O
directly O
bound O
to O
the O
LT-kappa O
B O
site O
. O

Tax O
co-transfected O
with O
reporter O
constructs O
into O
Jurkat B
cells I
maximally O
activated O
HTLV-I-LTR-CAT O
and O
kappa O
B-fos-CAT O
and O
also O
activated O
LT-293 O
to O
a O
lesser O
extent O
. O

In O
JM B
T I
cells I
, O
tax O
induced O
LT-293 O
activity O
by O
two- O
to O
four-fold O
, O
though O
there O
was O
no O
induction O
of O
M1-CAT O
. O

A O
concatenated O
form O
of O
Epstein-Barr O
viral O
DNA O
in O
lymphoblastoid B
cell I
lines I
induced O
by O
transfection O
with O
BZLF1 O
. O

The O
replicative O
form O
of O
Epstein-Barr O
virus O
( O
EBV O
) O
DNA O
was O
studied O
using O
two O
lymphoblastoid B
cell I
lines I
, O
X50-7 O
and O
6F11 O
, O
which O
are O
latently O
infected O
by O
Epstein-Barr O
virus O
. O

We O
combined O
two O
techniques O
to O
identify O
the O
productive O
replicative O
form O
of O
Epstein-Barr O
viral O
DNA O
in O
the O
lytic B
cycle-induced I
cells I
. O

Functional O
antagonism O
between O
vitamin O
D3 O
and O
retinoic O
acid O
in O
the O
regulation O
of O
CD14 O
and O
CD23 O
expression O
during O
monocytic O
differentiation O
of O
U-937 B
cells I
. O

This O
paper O
describes O
how O
the O
expression O
of O
the O
monocyte-macrophage O
Ag O
, O
CD14 O
, O
and O
the O
low O
affinity O
Fc O
receptor O
for O
IgE O
, O
CD23 O
, O
were O
inversely O
regulated O
during O
VitD3 O
-and O
RA-induced O
monocytic O
differentiation O
of O
human B
U-937 I
monoblasts I
. O

In O
contrast O
, O
U-937 B
cells I
induced O
by O
RA O
strongly O
increased O
their O
expression O
of O
CD23 O
mRNA O
and O
protein O
, O
whereas O
they O
completely O
lacked O
detectable O
CD14 O
cell O
surface O
or O
mRNA O
expression O
. O

Here O
we O
report O
that O
this O
interference O
is O
cell O
specific O
, O
as O
TPA O
augmented O
dexamethasone-induced O
transcriptional O
activation O
of O
the O
MMTV O
LTR O
in O
several O
T B
cell I
lines I
but O
was O
inhibitory O
in O
NIH-3T3 B
fibroblasts I
. O

Conversely O
, O
c-jun O
and O
jun-B O
transfection O
blunted O
GR O
-dependent O
transcription O
in O
HeLa B
cells I
. O

The O
presence O
of O
c-fos O
had O
a O
negative O
influence O
on O
GR O
function O
and O
correlated O
with O
the O
cell-specific O
synergistic O
or O
antagonistic O
activity O
of O
Jun O
with O
respect O
to O
GR O
; O
high O
basal O
expression O
of O
c-fos O
as O
well O
as O
AP-1 O
DNA O
binding O
and O
transcriptional O
activity O
were O
observed O
in O
HeLa B
cells I
, O
but O
not O
in O
T O
cells O
. O

Despite O
this O
lower O
affinity O
, O
a O
trimer O
of O
the O
BAT O
box O
sequence O
was O
as O
efficiently O
transactivated O
by O
an O
Oct-2 O
expression O
vector O
as O
was O
a O
trimer O
of O
the O
octamer O
sequence O
in O
HeLa B
cells I
. O

The O
BAT O
box O
and O
Oct-2 O
were O
also O
implicated O
in O
the O
induction O
of O
CD20 O
in O
the O
pre-B B
cell I
line I
, O
PB-697 B
, O
via O
phorbol O
esters O
. O

One O
clone O
( O
DEG5 B
) O
also O
exerted O
a O
high O
and O
specific O
cytotoxicity O
against O
autologous B
cells I
pulsed O
with O
BCR1/25 O
. O

The O
autologous B
DE I
LCL I
containing O
a O
transduced O
pml/RAR O
alpha O
fusion O
gene O
and O
expressing O
a O
bcr1 O
type O
of O
the O
pml/RAR O
alpha O
hybrid O
protein O
induced O
the O
proliferation O
of O
DE B
anti-BCR1/25 I
T I
cell I
clones I
. O

It O
is O
concluded O
that O
the O
bcr1 O
type-pml/RAR O
alpha O
fusion O
protein O
of O
APL B
contains O
an O
antigenic O
site O
, O
absent O
from O
the O
normal O
parent O
molecules O
and O
recognized O
by O
human B
CD4+ I
lymphocytes I
. O

We O
have O
isolated O
cDNA O
clones O
of O
myeloid O
differentiation O
primary O
response O
( O
MyD O
) O
genes O
, O
activated O
in O
the O
absence O
of O
de O
novo O
protein O
synthesis O
following O
induction O
for O
differentiation O
along O
either O
the O
macrophage O
or O
granulocyte O
lineage O
in O
human O
myeloblastic B
leukemia I
HL-60 I
cells I
. O

The O
Egr-1 O
gene O
was O
observed O
to O
be O
transcriptionally O
silent O
in O
HL-60 B
cells I
, O
but O
active O
in O
U-937 B
and O
M1 B
cells I
, O
the O
latter O
two O
being O
predetermined O
for O
macrophage O
differentiation O
. O

Egr-1 O
antisense O
oligomers O
in O
the O
culture O
media O
blocked O
macrophage O
differentiation O
in O
both O
myeloid B
leukemia I
cell I
lines I
and O
normal O
myeloblasts O
. O

HL-60 B
cells I
constitutively O
expressing O
an O
Egr-1 O
transgene O
( O
HL-60Egr-1 O
) O
could O
be O
induced O
for O
macrophage O
, O
but O
not O
granulocyte O
, O
differentiation O
. O

To O
identify O
an O
EBNA2 O
dependent O
cis-acting O
element O
, O
various O
TP1 O
promoter-reporter O
gene O
constructs O
were O
transfected O
in O
the O
absence O
and O
presence O
of O
an O
EBNA2 O
expression O
vector O
into O
the O
established O
B-cell B
line I
BL41-P3HR1 I
. O

We O
have O
previously O
shown O
that O
minimally B
oxidized I
LDL I
( I
MM-LDL I
) I
activated I
endothelial I
cells I
to O
increase O
their O
interaction O
with O
monocytes O
but O
not O
neutrophils O
, O
inducing O
monocyte O
but O
not O
neutrophil O
binding O
and O
synthesis O
of O
monocyte O
chemotactic O
protein-1 O
and O
monocyte O
colony-stimulating O
factor O
( O
M-CSF O
) O
. O

Introduction O
of O
the O
HIV-1 O
plasmids O
in O
which O
the O
GATA O
sites O
have O
been O
mutated O
into O
human O
T O
lymphocytes O
also O
caused O
a O
significant O
reduction O
in O
LTR O
-mediated O
transcription O
at O
both O
the O
basal O
level O
and O
in O
( O
PHA- O
plus O
PMA- O
) O
stimulated B
T I
cells I
. O

The O
cDNA O
hybridized O
to O
multiple O
transcripts O
in O
pre-B B
and I
B-cell I
lines I
, O
but O
transcripts O
were O
not O
detected O
at O
significant O
levels O
in O
plasmacytoma B
, O
T-cell B
, O
and O
nonlymphoid B
cell I
lines I
. O

Expression O
of O
recombinant O
EBF O
in O
transfected B
nonlymphoid I
cells I
strongly O
activated O
transcription O
from O
reporter O
plasmids O
containing O
functional O
EBF-binding O
sites O
. O

A O
73 O
kDa O
protein O
was O
identified O
by O
this O
analysis O
: O
this O
protein O
is O
highly O
enriched O
in O
cell B
lines I
of I
B I
lymphoid I
origin I
as O
compared O
to O
pancreatic O
beta-cells O
and O
fibroblast O
cells O
. O

Induction O
by O
hemin O
increases O
, O
while O
induction O
with O
12-O-tetradecanoylphorbol-13-acetate O
( O
TPA O
) O
represses O
, O
erythroid-specific O
gene O
expression O
in O
the O
human B
cell I
line I
K562 I
. O

Hemin O
induction O
of O
K562 B
cells I
does O
not O
facilitate O
the O
binding O
of O
NF-E2 O
to O
its O
recognition O
site O
. O

Hemin O
induction O
appears O
to O
nonspecifically O
increase O
the O
expression O
of O
transiently O
transfected O
genes O
in O
K562 B
cells I
. O

The O
divergent O
effects O
of O
hemin O
and O
TPA O
on O
gene O
expression O
in O
K562 B
cells I
are O
mediated O
, O
in O
part O
, O
by O
their O
contrasting O
effects O
on O
the O
transcription O
factor O
NF-E2 O
. O

The O
expression O
of O
c-fos O
, O
c-jun O
and O
jun O
B O
proto-oncogenes O
was O
studied O
in O
phytohemagglutinin B
( I
PHA I
) I
activated I
peripheral I
blood I
lymphocytes I
( O
PBL O
) O
from O
young O
and O
aged O
humans O
. O

In O
PHA-activated B
PBL I
, O
no O
age-related O
differences O
were O
observed O
in O
c-fos O
or O
jun O
B O
mRNA O
expression O
. O

Because O
previous O
work O
has O
demonstrated O
that O
T O
cells O
from O
elderly O
individuals O
may O
display O
normal O
proliferative O
responses O
when O
activated O
via O
the O
anti-CD2 O
pathway O
, O
c-jun O
and O
jun O
B O
mRNA O
expression O
was O
also O
studied O
in O
anti-CD2-activated B
purified I
T I
cells I
. O

These O
results O
suggest O
that O
the O
decreased O
IL-2 O
production O
and O
proliferative O
response O
displayed O
by O
PHA-activated B
PBL I
from O
elderly O
adults O
may O
be O
related O
to O
age-related O
changes O
in O
c-jun O
mRNA O
expression O
and O
in O
the O
ratio O
of O
c-fos O
to O
c-jun O
mRNA O
. O

Oct2 O
expression O
was O
unable O
to O
stimulate O
a O
multimerized O
octamer O
enhancer O
element O
in O
HeLa B
cells I
, O
however O
. O

We O
have O
tested O
a O
variety O
of O
Oct2 O
isoforms O
generated O
by O
alternative O
splicing O
for O
the O
capability O
to O
activate O
an O
octamer O
enhancer O
in O
nonlymphoid O
cells O
and O
a O
B-cell B
line I
. O

Here O
we O
demonstrate O
complete O
correlation O
between O
the O
expression O
pattern O
of O
the O
CD19 O
gene O
and O
the O
B-cell-specific O
transcription O
factor O
BSAP O
in O
a O
large O
panel O
of O
B-lymphoid B
cell I
lines I
. O

Moreover O
, O
this O
site O
is O
occupied O
by O
BSAP O
in O
vivo O
in O
a O
CD19-expressing B
B-cell I
line I
but O
not O
in O
plasma O
or O
HeLa B
cells I
. O

The O
differentiating O
effects O
of O
the O
other O
C-11 O
analogs O
on O
human B
promyeloid I
leukemia I
cells I
( O
HL-60 B
) O
agreed O
well O
with O
their O
bone-resorbing O
activity O
and O
receptor O
affinity O
, O
but O
they O
demonstrated O
lower O
calcemic O
effects O
in O
vivo O
. O

The O
effects O
of O
many O
C-11-substituted O
1 O
alpha O
, O
25- O
( O
OH O
) O
2D3 O
analogs O
on O
HL-60 B
cell O
differentiation O
exceeded O
their O
activity O
on O
calcium O
metabolism O
. O

In O
order O
to O
further O
understand O
the O
apparent O
glucocorticoid O
resistance O
in O
major O
depressive O
disorder O
, O
circadian O
variation O
in O
cortisol O
concentration O
, O
dexamethasone O
suppression O
and O
glucocorticoid O
receptor O
binding O
in O
mononuclear O
leukocytes O
, O
polymorphonuclear O
leukocytes O
and O
cultured B
skin I
fibroblasts I
were O
measured O
in O
rigidly O
defined O
major O
depressive O
disorder O
patients O
and O
non-depressed O
psychiatric O
controls O
. O

A O
novel O
B O
cell-restricted O
activity O
, O
required O
for O
high O
levels O
of O
octamer O
/ O
Oct O
-dependent O
transcription O
from O
an O
immunoglobulin O
heavy O
chain O
( O
IgH O
) O
promoter O
, O
was O
detected O
in O
an O
in O
vitro O
system O
consisting O
of O
HeLa B
cell I
-derived O
extracts O
complemented O
with O
fractionated O
B O
cell O
nuclear O
proteins O
. O

In O
addition O
, O
both O
SCL O
and O
GATA-1 O
undergo O
coordinate O
modulation O
during O
chemically O
induced O
erythroid O
differentiation O
of O
mouse O
erythroleukemia O
cells O
and O
are O
down-modulated O
during O
myeloid O
differentiation O
of O
human B
K562 I
cells I
, O
thus O
implying O
a O
role O
for O
SCL O
in O
erythroid O
differentiation O
events O
. O

All O
tumor B
cell I
lines I
from O
the O
B-cell O
lineage O
and O
a O
few O
from O
the O
T-cell O
lineage O
express O
Oct-2 O
. O

To O
address O
the O
role O
of O
Oct-2 O
in O
the O
T-cell O
lineage O
, O
we O
studied O
the O
expression O
of O
Oct-2 O
mRNA O
and O
protein O
in O
nontransformed B
human I
and I
mouse I
T I
cells I
. O

Oct-2 O
was O
found O
in O
CD4+ B
and I
CD8+ I
T I
cells I
prepared O
from O
human O
peripheral O
blood O
and O
in O
mouse O
lymph O
node O
T O
cells O
. O

In O
a O
T-cell B
clone I
specific O
for O
pigeon O
cytochrome O
c O
in O
the O
context O
of O
I-Ek O
, O
Oct-2 O
was O
induced O
by O
antigen O
stimulation O
, O
with O
the O
increase O
in O
Oct-2 O
protein O
seen O
first O
at O
3 O
h O
after O
activation O
and O
continuing O
for O
at O
least O
24 O
h O
. O

Kinetics O
of O
nuclear O
translocation O
and O
turnover O
of O
the O
vitamin O
D O
receptor O
in O
human B
HL60 I
leukemia I
cells I
and O
peripheral O
blood O
lymphocytes O
-- O
coincident O
rise O
of O
DNA-relaxing O
activity O
in O
nuclear O
extracts O
. O

HL60 B
cells I
, O
expressing O
some O
characteristics O
of O
promyelocytes B
, O
can O
be O
induced O
to O
monocytoid O
differentiation O
by O
calcitriol O
. O

Specific O
nuclear O
translocation O
of O
[ O
3H O
] O
calcitriol/VDR O
was O
found O
to O
be O
time O
dependent O
reaching O
a O
maximum O
of O
approximately O
2100 O
binding O
sites/nucleus O
after O
3 O
h O
of O
incubation O
in O
HL60 B
cells I
, O
whereas O
a O
maximum O
of O
approximately O
310 O
binding O
sites/nucleus O
was O
found O
after O
3 O
h O
in O
PBL O
. O

Pulse O
exposure O
of O
HL60 B
to O
radiolabeled O
hormone O
for O
3 O
h O
followed O
by O
culture O
in O
medium O
without O
serum O
and O
calcitriol O
lead O
to O
nuclear O
retention O
of O
approximately O
1600 O
radiolabeled O
VDR O
by O
8 O
h O
and O
approximately O
1000 O
VDR O
by O
24 O
h O
. O

Enhanced O
overall O
enzyme O
activity O
was O
found O
in O
nuclear O
extracts O
by O
1 O
h O
after O
incubation O
with O
calcitriol O
( O
final O
ethanol O
concentration O
0.0001 O
% O
v/v O
) O
in O
HL60 B
and O
PBL O
. O

The O
enhanced O
activity O
disappeared O
after O
2 O
h O
in O
PBL O
, O
whereas O
it O
was O
still O
enhanced O
by O
4 O
h O
in O
HL60 B
. O

No O
effect O
was O
seen O
in O
ethanol B
treated I
controls I
. O

Influence O
of O
estradiol O
and O
tamoxifen O
on O
susceptibility O
of O
human B
breast I
cancer I
cell I
lines I
to O
lysis O
by O
lymphokine-activated O
killer O
cells O
. O

Estrogen B
receptor I
positive I
( I
ER+ I
: I
MCF-7 I
) I
and I
negative I
( I
ER- I
: I
MDA-MB-231 I
) I
human I
breast I
cancer I
cell I
lines I
were O
utilized O
to O
evaluate O
the O
effects O
of O
tamoxifen O
( O
TAM O
) O
and O
estradiol O
( O
E2 O
) O
on O
modulation O
of O
breast O
cancer O
target O
susceptibility O
to O
lysis O
by O
lymphokine-activated O
killer O
( O
LAK O
) O
cells O
. O

E2-stimulated B
ER+ I
cells I
were O
more O
susceptible O
to O
lysis O
by O
LAK O
cells O
than O
corresponding O
TAM-treated B
or O
control O
cells O
, O
while O
treatment O
of O
ER- B
cells I
with O
either O
E2 O
or O
TAM O
alone O
did O
not O
alter O
from O
control O
their O
susceptibility O
to O
this O
immune-mediated O
lysis O
. O

All O
ER+ B
and I
ER- I
cells I
tested O
remained O
sensitive O
after O
treatment O
with O
TAM O
to O
lysis O
by O
LAK O
cells O
. O

In O
addition O
, O
an O
adenocarcinoma O
reactive O
human-mouse O
chimeric O
monoclonal O
antibody O
( O
ING-1 O
) O
was O
able O
to O
significantly O
boost O
in O
vivo O
generated O
LAK O
cell-mediated O
lysis O
of O
control B
, I
E2-treated I
, I
and I
TAM-treated I
ER+ I
and I
ER- I
cells I
. O

We O
have O
shown O
that O
the O
Z O
gene O
product O
, O
which O
binds O
to O
AP-1 O
sites O
as O
a O
homodimer O
and O
has O
sequence O
similarity O
to O
c-Fos O
, O
can O
efficiently O
activate O
the O
EBV O
early O
promoter O
, O
BMRF1 O
, O
in O
certain O
cell O
types O
( O
i.e. O
, O
HeLa B
cells I
) O
but O
not O
others O
( O
i.e. O
, O
Jurkat B
cells I
) O
. O

Here O
we O
demonstrate O
that O
the O
c-myb O
proto-oncogene O
product O
, O
which O
is O
itself O
a O
DNA-binding O
protein O
and O
transcriptional O
transactivator O
, O
can O
interact O
synergistically O
with O
Z O
in O
activating O
the O
BMRF1 O
promoter O
in O
Jurkat B
cells I
( O
a O
T-cell B
line I
) O
or O
Raji B
cells I
( O
an O
EBV-positive B
B-cell I
) O
, O
whereas O
the O
c-myb O
gene O
product O
by O
itself O
has O
little O
effect O
. O

Incubation O
of O
Jurkat B
T I
cells I
( O
1 O
x O
10 O
( O
6 O
) O
cells/ml O
) O
with O
a O
natural O
thiol O
antioxidant O
, O
alpha-lipoic O
acid O
, O
prior O
to O
the O
stimulation O
of O
cells O
was O
found O
to O
inhibit O
NF-kappa O
B O
activation O
induced O
by O
tumor O
necrosis O
factor-alpha O
( O
25 O
ng/ml O
) O
or O
by O
phorbol O
12-myristate O
13-acetate O
( O
50 O
ng/ml O
) O
. O

Interleukin O
6-induced O
differentiation O
of O
a O
human B
B I
cell I
line I
into O
IgM-secreting O
plasma O
cells O
is O
mediated O
by O
c-fos O
. O

The O
addition O
of O
antisense O
oligonucleotides O
to O
c-fos O
significantly O
inhibited O
IL O
6 O
-induced O
IgM O
production O
by O
SKW B
6.4 I
cells I
( O
p O
less O
than O
0.001 O
) O
, O
whereas O
control O
oligonucleotides O
had O
no O
inhibitory O
effect O
. O

These O
results O
indicate O
that O
activation O
of O
c-fos O
is O
involved O
in O
IL O
6 O
-induced O
differentiation O
of O
SKW B
6.4 I
cells I
into O
IgM-secreting B
cells I
. O

Redox O
status O
of O
cells O
influences O
constitutive O
or O
induced O
NF-kappa O
B O
translocation O
and O
HIV O
long O
terminal O
repeat O
activity O
in O
human B
T I
and I
monocytic I
cell I
lines I
. O

We O
used O
phenolic O
, O
lipid-soluble O
, O
chain-breaking O
antioxidants O
( O
butylated O
hydroxyanisole O
( O
BHA O
) O
, O
nordihydroquairetic O
acid O
, O
or O
alpha-tocopherol O
( O
vitamin O
E O
) O
to O
show O
that O
peroxyl O
radical O
scavenging O
in O
unstimulated B
and I
PMA- I
or I
TNF-stimulated I
cells I
blocks O
the O
functions O
depending O
on O
NF-kappa O
B O
activation O
. O

BHA O
was O
found O
to O
suppress O
not O
only O
PMA- O
or O
TNF-induced O
, O
but O
also O
constitutive O
, O
HIV-enhancer O
activity O
concomitant O
to O
an O
inhibition O
of O
NF-kappa O
B O
binding O
activity O
in O
both O
lymphoblastoid B
T I
( O
J.Jhan B
) O
and O
monocytic B
( I
U937 I
) I
cell I
lines I
. O

This O
was O
also O
true O
for O
KBF O
( O
p50 O
homodimer O
) O
binding O
activity O
in O
U937 B
cells I
. O

Secretion O
of O
TNF O
, O
the O
product O
of O
another O
NF-kappa O
B-dependent O
gene O
, O
was O
abolished O
by O
BHA O
in O
PMA-stimulated B
U937 I
cells I
. O

The O
anti-oxidative O
effect O
of O
BHA O
was O
accompanied O
by O
an O
increase O
in O
thiol O
, O
but O
not O
glutathione O
, O
content O
in O
stimulated B
and I
unstimulated I
T I
cell I
, O
whereas O
TNF O
stimulation O
itself O
barely O
modified O
the O
cellular O
thiol O
level O
. O

Oxidative O
stress O
obtained O
by O
the O
addition O
of O
H2O2 O
to O
the O
culture O
medium O
of O
J.Jhan B
or O
U937 B
cells I
could O
not O
by O
itself O
induce O
NF-kappa O
B O
activation O
. O

The O
molecular O
mechanisms O
underlying O
the O
sustained O
nuclear O
translocation O
of O
NF-kappa O
B O
observed O
in O
U937 B
monocytic I
cells I
chronically O
infected O
with O
human O
immunodeficiency O
virus O
( O
HIV O
) O
were O
studied O
. O

These O
observations O
indicate O
that O
during O
chronic O
HIV O
infection O
of O
U937 B
cells I
, O
continuous O
NF-kappa O
B O
( O
p50/p65 O
) O
translocation O
results O
in O
p105 O
promoter O
upregulation O
with O
subsequent O
cytosolic O
NF-kappa O
B O
accumulation O
, O
ready O
for O
further O
translocation O
. O

Similarly O
, O
IL-2 O
activates O
NF-kappa O
B O
in O
the O
human B
monocytic I
cell I
line I
U I
937 I
, O
but O
not O
in O
resting O
human O
T-cells O
. O

In O
GH4C1 B
pituitary I
cells I
, O
T3SO4 O
failed O
to O
displace O
[ O
125I O
] O
T3 O
from O
nuclear O
receptors O
in O
intact B
cells I
or O
soluble O
preparations O
. O

Thyroid O
hormones O
inhibit O
[ O
3H O
] O
glycosaminoglycan O
synthesis O
by O
cultured B
human I
dermal I
fibroblasts I
, O
and O
T3SO4 O
displayed O
about O
0.5 O
% O
the O
activity O
of O
T3 O
at O
72 O
h O
. O

We O
have O
studied O
the O
impact O
of O
gangliosides O
on O
the O
expression O
of O
TNF O
in O
blood O
monocytes O
and O
in O
the O
monocytic B
cell I
line I
Mono I
Mac I
6 I
. O

Although O
under O
standard O
culture O
conditions O
, O
bovine O
brain O
gangliosides O
( O
100 O
micrograms/ml O
) O
suppressed O
LPS-stimulated O
TNF O
production O
5-fold O
in O
PBMC O
and O
10-fold O
in O
Mono B
Mac I
6 I
cells I
, O
suppression O
was O
more O
efficient O
under O
serum-free O
conditions O
. O

Looking O
at O
highly O
purified O
gangliosides O
, O
GD3 O
, O
GD1a O
, O
GM3 O
, O
GM2 O
, O
and O
GM1 O
were O
all O
effective O
in O
reducing O
TNF O
production O
in O
PBMC O
, O
and O
in O
Mono B
Mac I
6 I
by O
factor O
10 O
to O
50 O
. O

Finally O
, O
when O
using O
Staphylococcus O
aureus O
or O
platelet O
activating O
factor O
as O
a O
stimulus O
, O
gangliosides O
were O
able O
to O
suppress O
TNF O
production O
in O
Mono B
Mac I
6 I
cells I
by O
factor O
5 O
to O
10 O
, O
as O
well O
. O

Transient-transfection O
experiments O
in O
embryonal B
carcinoma I
cells I
demonstrate O
a O
functional O
cooperation O
between O
p50B O
and O
RelB O
or O
p65 O
in O
transactivation O
of O
a O
reporter O
plasmid O
dependent O
on O
a O
kappa O
B O
site O
. O

c-Jun O
protein O
isolated O
from O
phorbol B
ester-induced I
cells I
did O
not O
target O
c-Fos O
for O
degradation O
, O
which O
suggests O
that O
c-Fos O
is O
transiently O
stabilized O
after O
stimulation O
of O
cell O
growth O
. O

The O
regulation O
of O
the O
human O
tumor O
necrosis O
factor O
alpha O
promoter O
region O
in O
macrophage B
, O
T B
cell I
, O
and O
B B
cell I
lines I
. O

The O
1311-base O
pair O
human O
tumor O
necrosis O
factor O
( O
TNF O
) O
alpha O
promoter O
region O
was O
fused O
to O
the O
luciferase O
( O
Luc O
) O
reporter O
gene O
and O
studied O
in O
a O
transient O
transfection O
system O
in O
three O
TNF B
producing I
cell I
lines I
, O
the O
U937 B
macrophage I
cell I
line I
, O
the O
MLA B
144 I
T I
cell I
line I
, O
and O
the O
729-6 B
B I
cell I
line I
. O

To O
determine O
whether O
such O
transdominant O
Rev O
proteins O
could O
provide O
long-term O
protection O
against O
HIV O
infection O
without O
affecting O
T O
cell O
function O
, O
T B
leukemia I
cell I
lines I
were O
stably O
transduced O
with O
a O
retroviral O
vector O
encoding O
a O
transdominant O
mutant O
of O
the O
Rev O
protein O
, O
M10 O
. O

While O
all O
the O
M10-expressing B
cell I
lines I
remained O
infectable O
by O
HIV-1 O
, O
these O
same O
cells O
failed O
to O
support O
a O
productive O
replication O
cycle O
when O
infected O
with O
a O
cloned O
isolate O
of O
HIV-1 O
. O

In O
addition O
, O
two O
out O
of O
three O
M10-expressing B
CEM I
clones I
were O
also O
resistant O
to O
highly O
productive O
infection O
by O
a O
heterogeneous O
HIV-1 O
pool O
. O

Importantly O
, O
constitutive O
expression O
of O
Rev O
M10 O
did O
not O
alter O
the O
secretion O
of O
interleukin O
2 O
in O
response O
to O
mitogen O
stimulation O
of O
EL-4 B
and O
Jurkat B
cells I
. O

The O
present O
work O
has O
examined O
the O
effects O
of O
okadaic O
acid O
, O
an O
inhibitor O
of O
type O
1 O
and O
2A O
protein O
phosphatases O
, O
on O
the O
regulation O
of O
c-jun O
expression O
during O
monocytic O
differentiation O
of O
U-937 B
leukemia I
cells I
. O

Run-on O
analysis O
demonstrated O
detectable O
levels O
of O
c-jun O
transcription O
in O
U-937 B
cells I
and O
that O
this O
rate O
is O
increased O
approximately O
40-fold O
following O
okadaic O
acid O
exposure O
. O

The O
half-life O
of O
c-jun O
mRNA O
was O
similar O
( O
45-50 O
min O
) O
in O
both O
untreated O
and O
okadaic B
acid-induced I
cells I
. O

Con O
A O
stimulation O
was O
found O
to O
increase O
both O
binding O
of O
AP-1 O
to O
the O
AP-1 O
consensus O
sequence O
, O
TRE O
, O
and O
AP-1 O
enhancer O
activity O
, O
in O
Jurkat B
cells I
. O

We O
conclude O
that O
stimulation O
with O
mitogenic O
lectins O
is O
sufficient O
to O
increase O
both O
c-Fos O
and O
c-Jun O
protein O
levels O
, O
AP-1 O
binding O
and O
AP-1 O
enhancer O
activity O
in O
Jurkat B
cells I
and O
that O
they O
act O
via O
mechanisms O
that O
could O
involve O
the O
activation O
of O
PKC O
. O

We O
have O
identified O
a O
DNA O
segment O
that O
confers O
responsiveness O
to O
antigen O
stimulation O
signals O
on O
the O
human O
interleukin O
( O
IL O
) O
4 O
gene O
in O
Jurkat B
cells I
. O

Expression O
of O
the O
human O
RAR-alpha O
in O
receptor-negative B
erythroblasts I
conferred O
RA-induced O
regulation O
of O
differentiation O
to O
the O
otherwise O
unresponsive O
cells O
, O
thus O
showing O
that O
the O
RAR-alpha O
is O
essential O
for O
the O
RA O
effect O
. O

Two O
types O
of O
helper B
T I
cell I
( I
Th I
) I
clones I
( O
Th1 B
and O
Th2 B
) O
are O
defined O
on O
the O
basis O
of O
different O
patterns O
of O
cytokine O
( O
lymphokine O
) O
secretion O
. O

The O
results O
demonstrate O
that O
the O
simultaneous O
activation O
of O
PKC O
and O
elevation O
of O
cAMP O
leads O
to O
an O
enhanced O
AP-1 O
transcriptional O
activity O
in O
a O
T-leukemia B
cell I
line I
, O
suggesting O
that O
the O
previously O
observed O
interaction O
between O
the O
parallel O
signal O
transduction O
pathways O
may O
have O
functional O
consequences O
at O
the O
level O
of O
gene O
transcription O
. O

Using O
in O
vivo O
genomic O
footprinting O
we O
identified O
interactions O
in O
B-cell B
lines I
at O
the O
octamer O
site O
and O
the O
Y O
, O
X1 O
, O
and O
X2 O
boxes O
. O

Class B
II I
antigen I
expressing I
T-cell I
lines I
maintained O
contacts O
identical O
to O
B-cell B
lines I
, O
while O
class B
II-negative I
T-cell I
lines I
exhibited O
no O
interactions O
. O

In O
lymphoid B
cell I
lines I
, O
the O
octamer O
site O
is O
occupied O
and O
required O
for O
maximal O
expression O
. O

In O
contrast O
, O
the O
class B
II-positive I
nonlymphoid I
glioblastoma I
cell I
line I
does O
not O
exhibit O
interactions O
at O
the O
octamer O
site O
despite O
the O
presence O
of O
the O
ubiquitous O
OTF-1 O
factor O
and O
an O
open O
binding O
site O
. O

Thus O
, O
the O
DRA O
promoter O
discriminates O
against O
OTF-1 O
activation O
at O
the O
level O
of O
DNA O
binding O
in O
the O
glioblastoma B
line I
. O

Interferon O
gamma O
induces O
class O
II O
expression O
in O
this O
glioblastoma B
cell I
line I
and O
, O
in O
parallel O
, O
up-regulates O
X1 O
and O
X2 O
box O
protein-DNA O
interactions O
, O
while O
all O
other O
interactions O
remain O
unchanged O
. O

We O
have O
previously O
shown O
that O
prolonged O
treatment O
of O
the O
untransformed O
T B
cell I
clone I
Ar-5 I
with O
phorbol O
esters O
results O
in O
downmodulation O
of O
the O
alpha O
and O
beta O
isozymes O
of O
PKC O
, O
and O
abrogates O
induction O
of O
IL-2 O
mRNA O
and O
protein O
. O

Here O
we O
show O
that O
phorbol O
ester O
treatment O
also O
abolishes O
induction O
of O
chloramphenicol O
acetyltransferase O
activity O
in O
Ar-5 B
cells I
transfected O
with O
a O
plasmid O
containing O
the O
IL-2 O
promoter O
linked O
to O
this O
reporter O
gene O
. O

Moreover O
, O
cotransfections O
with O
c-fos O
and O
c-jun O
expression O
plasmids O
markedly O
enhance O
induction O
of O
the O
IL-2 O
promoter O
in O
minimally B
stimulated I
T I
cells I
. O

The O
use O
of O
interferon-gamma-treated B
U937 I
cells I
in O
chemiluminescence O
assays O
to O
detect O
red O
cell O
, O
platelet O
and O
granulocyte O
antibodies O
of O
potential O
clinical O
significance O
. O

The O
chemiluminescent O
( O
CL O
) O
response O
of O
interferon-gamma-treated B
U937 I
( I
IFN-U937 I
) I
cells I
to O
sensitized O
target O
cells O
has O
been O
used O
to O
detect O
red O
cell O
, O
platelet O
and O
granulocyte O
antibodies O
. O

A O
clone O
of O
U937 B
cells I
was O
selected O
which O
expressed O
Fc O
receptor O
I O
( O
Fc O
gamma O
RI O
) O
and O
which O
, O
after O
incubation O
with O
IFN-gamma O
for O
72 O
h O
, O
was O
capable O
of O
generating O
high O
levels O
of O
lucigenin-enhanced O
CL O
. O

The O
CL O
responses O
of O
IFN-U937 B
cells I
and O
peripheral O
blood O
human O
monocytes O
to O
sensitized O
red O
cells O
, O
platelets O
or O
granulocytes O
were O
then O
compared O
. O

Assays O
using O
monocytes O
or O
IFN-U937 B
cells I
were O
of O
comparable O
sensitivity O
for O
detection O
of O
antibodies O
against O
all O
three O
types O
of O
target O
cell O
. O

In O
addition O
, O
the O
use O
of O
IFN-U937 B
cells I
reduced O
interassay O
variation O
and O
simplified O
assay O
performance O
. O

The O
potential O
clinical O
usefulness O
of O
these O
CL O
assays O
was O
suggested O
by O
the O
ability O
of O
both O
monocytes O
and O
IFN-U937 B
cells I
to O
respond O
to O
red O
cells O
, O
platelets O
or O
granulocytes O
sensitized O
with O
sera O
from O
pregnant O
women O
whose O
babies O
had O
either O
haemolytic O
disease O
of O
the O
newborn O
( O
HDN O
) O
, O
alloimmune O
thrombocytopenia O
or O
alloimmune O
neutropenia O
respectively O
. O

In O
addition O
, O
monocytes O
and O
IFN-U937 B
cells I
both O
responded O
to O
red O
cells O
sensitized O
with O
antibodies O
against O
a O
variety O
of O
specificities O
of O
assumed O
( O
although O
not O
documented O
) O
clinical O
significance O
for O
blood O
transfusion O
recipients O
. O

In O
contrast O
, O
monocytes O
and O
IFN-U937 B
cells I
responded O
only O
weakly O
to O
red O
cells O
sensitized O
with O
either O
anti-D O
in O
sera O
from O
mothers O
of O
babies O
unaffected O
by O
HDN O
, O
or O
with O
antisera O
containing O
high O
titre O
antibodies O
with O
specificities O
not O
normally O
associated O
with O
significantly O
reduced O
red O
cell O
survival O
. O

In O
vitro O
inhibition O
of O
NF-kappa O
B O
expression O
by O
antisense O
oligodeoxynucleotides O
( O
ODNs O
) O
inhibited O
growth O
of O
these O
culture-adapted B
Tax-transformed I
fibroblasts I
as O
well O
as O
an O
HTLV-I-transformed B
human I
lymphocyte I
line I
. O

Transfection O
of O
an O
Fc B
gamma I
RII-negative I
B-cell I
line I
with O
complementary O
DNA O
's O
encoding O
the O
two O
splice O
products O
and O
various O
receptor O
mutants O
indicated O
that O
the O
insertion O
was O
responsible O
for O
preventing O
both O
Fc O
gamma O
RII O
-mediated O
endocytosis O
and O
Fc O
gamma O
RII O
-mediated O
antigen O
presentation O
. O

PLB-985 B
cells I
represent O
a O
bipotential B
myelomonoblastic I
cell I
population I
capable O
of O
either O
granulocytic O
or O
monocytic O
differentiation O
after O
induction O
with O
appropriate O
inducers O
. O

By O
virtue O
of O
the O
presence O
of O
CD4 O
on O
the O
cell O
surface O
, O
PLB-985 B
cells I
were O
chronically O
infected O
with O
HIV-1 O
strain O
IIIB O
. O

PLB-IIIB B
cells I
clearly O
possessed O
a O
more O
monocytic O
phenotype O
than O
the O
parental O
myeloblasts O
, O
as O
determined O
by O
differential O
staining O
, O
increased O
expression O
of O
the O
myeloid-specific O
surface O
markers O
, O
and O
transcription O
of O
the O
c-fms O
proto-oncogene O
. O

NF-kappa O
B O
binding O
activity O
was O
inducible O
by O
tumor O
necrosis O
factor O
and O
phorbol O
myristate O
acetate O
in O
PLB-985 B
. O

However O
, O
in O
PLB-IIIB B
cells I
, O
constitutive O
expression O
of O
a O
novel O
NF-kappa O
B O
complex O
was O
detected O
, O
composed O
of O
proteins O
ranging O
between O
70 O
and O
110 O
kD O
. O

Inducibility O
of O
endogenous O
IFN-beta O
and O
IFN-alpha O
RNA O
was O
also O
increased O
in O
PLB-IIIB B
cells I
. O

We O
have O
biochemically O
and O
functionally O
characterized O
a O
new O
transcription O
factor O
, O
NP-TCII O
, O
which O
is O
present O
in O
nuclei O
from O
unstimulated B
T I
and I
B I
lymphocytes I
but O
is O
not O
found O
in O
nonhematopoietic O
cells O
. O

Reduced O
susceptibility O
to O
HIV-1 O
infection O
of O
ethyl-methanesulfonate-treated B
CEM I
subclones I
correlates O
with O
a O
blockade O
in O
their O
protein O
kinase O
C O
signaling O
pathway O
. O

We O
have O
described O
the O
isolation O
of O
chemically O
induced O
CEM B
subclones I
that O
express O
CD4 O
receptors O
and O
bind O
soluble O
gp120 O
, O
yet O
show O
a O
markedly O
reduced O
susceptibility O
to O
infection O
with O
HIV-1 O
. O

PMA O
treatment O
induced O
CD3 O
and O
CD25 O
( O
IL-2R O
) O
receptors O
on O
the O
parental O
line O
and O
on O
other O
ethyl-methanesulfonate-derived B
subclones I
, O
but O
not O
on O
these O
two O
mutants O
. O

Although O
it O
has O
been O
previously O
shown O
that O
the O
IL-6 O
kappa O
B O
motif O
functions O
as O
a O
potent O
IL-1/tumor O
necrosis O
factor-responsive O
element O
in O
nonlymphoid O
cells O
, O
its O
activity O
was O
found O
to O
be O
repressed O
in O
lymphoid O
cells O
such O
as O
a O
Jurkat B
T-cell I
line I
. O

A O
similar O
result O
was O
obtained O
with O
the O
mature B
monocytic I
leukemia I
cell I
line I
THP-1 B
. O

These O
results O
are O
in O
striking O
contrast O
to O
the O
increase O
in O
nuclear O
NF O
kappa O
B O
and O
HIV-1 O
replication O
induced O
by O
phorbol O
esters O
in O
promonocytic B
leukemia I
cells I
U937 I
and O
HL-60 B
, O
and O
emphasize O
the O
importance O
of O
studying O
cytokine O
regulation O
of O
HIV-1 O
in O
normal O
monocytes O
. O

A O
diverged O
homeobox O
gene O
, O
HB24 O
, O
which O
is O
known O
to O
be O
induced O
following O
lymphocyte O
activation O
, O
was O
introduced O
into O
Jurkat B
T I
cells I
under O
the O
control O
of O
a O
constitutive O
promoter O
. O

A O
number O
of O
genes O
known O
to O
be O
induced O
following O
T O
cell O
activation O
and O
associated O
with O
cell O
growth O
were O
increased O
in O
the O
transfectants B
, O
including O
c-fos O
, O
c-myc O
, O
c-myb O
, O
HLA-DR O
, O
lck O
, O
NF-kappa O
B O
, O
interleukin-2 O
and O
interleukin-2 O
receptor O
alpha O
( O
IL-2R O
alpha O
) O
. O

Analysis O
of O
IL-2R O
alpha O
expression O
by O
transient O
transfection O
of O
IL-2R O
alpha O
promoter O
constructs O
into O
the O
HB24 B
transfectants I
revealed O
constitutive O
expression O
( O
about O
60 O
% O
of O
phytohemagglutinin- B
and I
phorbol I
ester-activated I
Jurkat I
cells I
) O
that O
was O
dependent O
on O
the O
kappa O
B O
site O
in O
the O
IL-2R O
alpha O
promoter O
. O

Furthermore O
, O
as O
a O
consequence O
of O
the O
increased O
HB24 O
mRNA O
levels O
, O
the O
Jurkat B
HB24 I
transfectants I
proliferated O
more O
rapidly O
than O
control B
cell I
lines I
. O

Thus O
, O
stable O
expression O
of O
HB24 O
confers O
an O
activation O
phenotype O
on O
a O
human B
T I
cell I
line I
, O
implicating O
this O
gene O
as O
an O
important O
transcriptional O
factor O
during O
T O
cell O
activation O
and O
growth O
. O

We O
also O
showed O
that O
this O
silencer O
has O
stronger O
inhibitory O
activity O
in O
HeLa B
cells I
, O
as O
compared O
to O
K562 B
human I
erythroleukemia I
cells I
. O

Gel O
electrophoresis O
mobility O
shift O
assays O
and O
DNaseI O
footprinting O
assays O
demonstrate O
that O
these O
negative O
regulatory O
sequences O
are O
recognized O
differently O
by O
proteins O
present O
in O
nuclear O
extracts O
obtained O
from O
HeLa B
and O
K562 B
cells I
. O

Two O
binding O
proteins O
are O
detected O
in O
K562 O
nuclear O
extracts O
, O
while O
only O
one O
is O
found O
in O
extracts O
from O
HeLa B
cells I
. O

In O
erythroid B
K562 I
cells I
in O
which O
the O
HS2 O
enhancer O
is O
active O
, O
the O
HS2 O
sequence O
directs O
the O
synthesis O
of O
long O
enhancer O
transcripts O
that O
are O
initiated O
apparently O
from O
within O
the O
enhancer O
and O
elongated O
through O
the O
intervening O
DNA O
into O
the O
cis-linked O
CAT O
gene O
. O

In O
nonerythroid B
HL-60 I
cells I
in O
which O
the O
HS2 O
enhancer O
is O
inactive O
, O
long O
enhancer O
transcripts O
are O
not O
detectable O
. O

In O
this O
report O
we O
demonstrate O
that O
in O
certain O
CNS-derived B
cells I
Tat O
is O
capable O
of O
activating O
HIV-1 O
through O
a O
TAR O
-independent O
pathway O
. O

A O
Tat-responsive O
element O
is O
found O
upstream O
within O
the O
viral O
promoter O
that O
in O
glial-derived B
cell I
lines I
allows O
transactivation O
in O
the O
absence O
of O
TAR O
. O

Activation O
by O
the O
T-cell O
antigen O
receptor O
is O
minimal O
in O
Jurkat B
cells I
and O
is O
mediated O
by O
the O
kappa O
B O
sites O
. O

The O
putative O
NFAT-1 O
region O
is O
not O
required O
for O
the O
response O
to O
anti-CD3 O
or O
to O
mitogens O
in O
T-cell B
, O
B-cell B
, O
or O
monocyte/macrophage B
leukemia I
lines I
, O
nor O
is O
it O
a O
cis-acting O
negative O
regulatory O
element O
. O

Interferon-gamma O
potentiates O
the O
antiviral O
activity O
and O
the O
expression O
of O
interferon-stimulated O
genes O
induced O
by O
interferon-alpha B
in I
U937 I
cells I
. O

Binding O
of O
type O
I O
interferon O
( O
IFN-alpha/beta O
) O
to O
specific O
receptors O
results O
in O
the O
rapid O
transcriptional O
activation O
, O
independent O
of O
protein O
synthesis O
, O
of O
IFN-alpha-stimulated O
genes O
( O
ISGs O
) O
in O
human O
fibroblasts O
and O
HeLa B
and O
Daudi B
cell I
lines I
. O

We O
have O
found O
that O
ISG O
expression O
in O
the O
monocytic B
U937 I
cell I
line I
differs O
from O
most O
cell B
lines I
previously O
examined O
. O

U937 B
cells I
express O
both O
type O
I O
and O
type O
II O
IFN O
receptors O
, O
but O
only O
IFN-alpha O
is O
capable O
of O
inducing O
antiviral O
protection O
in O
these O
cells O
. O

ISG15 O
mRNA O
accumulation O
in O
U937 B
cells I
is O
not O
detectable O
before O
6 O
h O
of O
IFN-alpha O
treatment O
, O
peaks O
at O
24 O
h O
, O
and O
requires O
protein O
synthesis O
. O

Nuclear O
extracts O
assayed O
for O
the O
presence O
of O
ISRE O
binding O
factors O
by O
electrophoretic O
mobility O
shift O
assays O
show O
that O
ISGF3 O
is O
induced O
by O
IFN-alpha O
within O
6 O
h O
from O
undetectable O
basal O
levels O
in O
untreated O
U937 B
cells I
. O

Prior O
studies O
have O
identified O
several O
elements O
that O
contribute O
to O
the O
activity O
of O
the O
IL-2 O
promoter O
in O
the O
stimulated O
T B
cell I
line I
, O
Jurkat B
. O

The O
effect O
of O
constitutive O
Tax O
expression O
on O
the O
interaction O
of O
NF-kappa O
B O
with O
its O
recognition O
sequence O
and O
on O
NF-kappa O
B O
-dependent O
gene O
expression O
was O
examined O
in O
T B
lymphoid I
Jurkat I
cell I
lines I
( O
19D B
and O
9J B
) O
stably O
transformed O
with O
a O
Tax O
expression O
vector O
. O

Tax B
expressing I
T I
cell I
lines I
contained O
a O
constitutive O
level O
of O
NF-kappa O
B O
binding O
activity O
, O
detectable O
by O
mobility O
shift O
assay O
and O
uv O
cross-linking O
using O
a O
palindromic O
NF-kappa O
B O
probe O
homologous O
to O
the O
interferon O
beta O
PRDII O
site O
. O

In O
Jurkat O
and O
NC2.10 O
induction O
with O
phorbol O
esters O
resulted O
in O
the O
appearance O
of O
new O
DNA O
binding O
proteins O
of O
85 O
, O
75 O
, O
and O
54 O
kDa O
, O
whereas O
in O
Tax B
expressing I
cells I
the O
85-kDa O
protein O
and O
a O
92-kDa O
DNA O
binding O
protein O
were O
constitutively O
induced O
. O

Expression O
of O
Tax O
protein O
in O
19D B
and O
9J B
resulted O
in O
transcription O
of O
the O
endogenous O
NF-kappa O
B-dependent O
granulocyte-macrophage O
colony O
stimulating O
factor O
gene O
and O
increased O
basal O
level O
expression O
of O
transfected O
NF-kappa O
B-regulated O
promoters O
. O

Tax O
expression O
in O
Jurkat B
T I
cells I
may O
alter O
the O
stoichiometry O
of O
NF-kappa O
B O
DNA O
binding O
proteins O
and O
thus O
change O
the O
expression O
of O
NF-kappa O
B-regulated O
promoters O
. O

A O
nuclear O
factor O
NF-GM2 O
that O
interacts O
with O
a O
regulatory O
region O
of O
the O
GM-CSF O
gene O
essential O
for O
its O
induction O
in O
responses O
to O
T-cell O
activation O
: O
purification O
from O
human O
T-cell B
leukemia I
line I
Jurkat I
cells I
and O
similarity O
to O
NF-kappa O
B O
. O

To O
elucidate O
the O
mechanism O
of O
GM-CSF O
gene O
activation O
, O
we O
have O
purified O
the O
inducible O
factor O
NF-GM2 O
from O
the O
nuclear O
extract O
of O
stimulated O
Jurkat B
cells I
on O
the O
basis O
of O
specific O
DNA-binding O
activity O
. O

Cortivazol O
mediated O
induction O
of O
glucocorticoid O
receptor O
messenger O
ribonucleic O
acid O
in O
wild-type B
and O
dexamethasone-resistant B
human I
leukemic I
( I
CEM I
) I
cells I
. O

In O
both O
wild-type B
and O
highly O
dexamethasone B
( I
dex I
) I
-resistant I
clones I
of O
the O
human B
leukemic I
cell I
line I
CEM I
, O
exposure O
to O
cortivazol O
leads O
to O
cell O
death O
. O

It O
has O
been O
shown O
recently O
that O
in O
wild-type B
CEM I
cells I
but O
not O
in O
a O
dex-resistant B
, I
glucocorticoid I
receptor I
( I
GR I
) I
-defective I
clone I
ICR-27 B
TK-3 I
, O
dex O
induces O
GR O
mRNA O
. O

To O
test O
the O
hypothesis O
that O
cortivazol O
acts O
in O
dex-resistant B
cells I
by O
making O
use O
of O
the O
residual O
GR O
found O
there O
, O
wild-type O
and O
dex-resistant B
clones I
were O
treated O
with O
various O
concentrations O
of O
cortivazol O
and O
induction O
of O
GR O
mRNA O
was O
studied O
. O

Cortivazol O
significantly O
induced O
GR O
mRNA O
in O
the O
normal B
CEM-C7 I
as O
well O
as O
in O
two O
classes O
of O
dex-resistant B
clones I
, O
although O
the O
dex-resistant B
clones I
needed O
at O
least O
10 O
times O
more O
cortivazol O
than O
the O
normal O
cells O
for O
significant O
GR O
mRNA O
induction O
. O

A O
general O
correlation O
between O
induction O
of O
GR O
mRNA O
and O
lysis O
of O
the O
normal O
and O
dex-resistant B
cells I
was O
found O
. O

Positive O
induction O
of O
GR O
mRNA O
might O
be O
one O
of O
the O
earliest O
crucial O
steps O
in O
the O
lysis O
of O
normal B
and I
dex-resistant I
CEM I
cells I
, O
or O
might O
serve O
as O
a O
marker O
for O
the O
process O
. O

However O
, O
the O
lysis O
pathway O
in O
the O
dex-resistant B
cells I
is O
defective O
in O
that O
dex-resistant B
clones I
needed O
significantly O
more O
cortivazol O
than O
the O
normal B
cells I
for O
lysis O
of O
the O
cells O
. O

However O
, O
the O
U937 B
monocytic I
cell I
line I
, O
which O
is O
fully O
permissive O
to O
HIV O
replication O
, O
is O
known O
to O
express O
only O
low O
levels O
of O
nuclear O
NF-kappa O
B O
. O

The O
human B
myelomonocytic I
cell I
line I
U-937 I
as O
a O
model O
for O
studying O
alterations O
in O
steroid-induced O
monokine O
gene O
expression O
: O
marked O
enhancement O
of O
lipopolysaccharide-stimulated O
interleukin-1 O
beta O
messenger O
RNA O
levels O
by O
1 O
, O
25-dihydroxyvitamin O
D3 O
. O

To O
establish O
a O
model O
for O
1 O
, O
25- O
( O
OH O
) O
2D3 O
regulation O
of O
human O
monocyte O
monokine O
synthesis O
, O
three O
human B
cell I
lines I
( O
U-937 B
, O
THP-1 B
, O
and O
HL-60 B
) O
were O
examined O
for O
: O
1 O
) O
the O
presence O
of O
functional O
1 O
, O
25- O
( O
OH O
) O
2D3 O
receptors O
; O
2 O
) O
the O
accumulation O
of O
interleukin-1 O
beta O
( O
IL-1 O
beta O
) O
mRNA O
and O
IL-1 O
beta O
protein O
in O
response O
to O
lipopolysaccharide O
( O
LPS O
) O
; O
and O
3 O
) O
the O
regulation O
of O
this O
response O
by O
1 O
, O
25- O
( O
OH O
) O
2D3 O
. O

Preincubation O
of O
cells O
with O
1 O
, O
25- O
( O
OH O
) O
2D3 O
augmented O
IL-1 O
beta O
mRNA O
levels O
only O
in O
U-937 B
and O
HL-60 B
cells O
. O

From O
these O
data O
, O
and O
taking O
into O
consideration O
their O
state O
of O
differentiation O
and O
relative O
ease O
of O
culture O
, O
U-937 B
was O
chosen O
over O
HL-60 B
and O
THP-1 B
as O
the O
cell O
line O
we O
further O
characterized O
. O

In O
U-937 B
cells I
, O
optimum O
time O
and O
dose O
of O
pretreatment O
with O
1 O
, O
25- O
( O
OH O
) O
2D3 O
were O
determined O
to O
be O
12-24 O
h O
at O
a O
receptor O
saturating O
concentration O
of O
1 O
, O
25- O
( O
OH O
) O
2D3 O
( O
10 O
nM O
) O
. O

However O
, O
exposure O
of O
U-937 B
cells I
to O
1 O
, O
25- O
( O
OH O
) O
2D3 O
increased O
by O
200 O
% O
the O
level O
of O
IL-1 O
beta O
mRNA O
detected O
and O
decreased O
by O
three O
orders O
of O
magnitude O
the O
concentration O
of O
LPS O
required O
to O
achieve O
steady O
state O
mRNA O
levels O
equivalent O
to O
those O
observed O
in O
U-937 B
cells I
not O
preincubated O
with O
the O
hormone.2+o O

Furthermore O
, O
activation O
of O
PKC O
was O
pertussis-toxin-sensitive O
and O
was O
associated O
with O
the O
detection O
of O
an O
NF O
kappa O
B O
protein O
in O
nuclear O
extracts O
of O
M-CSF-induced B
blood I
monocytes I
but O
not O
in O
monocytes O
exposed O
to O
medium O
treatment O
only O
. O

In O
stably B
transformed I
erythroblasts I
coexpressing O
the O
v-erbA O
oncoprotein O
and O
the O
c-erbA/T3 O
receptor O
at O
an O
approximately O
equimolar O
ratio O
, O
c-erbA O
activity O
is O
dominant O
over O
v-erbA O
. O

Treatment O
of O
chronically B
HIV-infected I
PBMC I
with O
anti-CD2 O
mAb O
has O
been O
shown O
to O
induce O
the O
expression O
of O
infectious O
virus O
from O
these O
cultures O
. O

In O
this O
study O
, O
we O
show O
that O
micromolar O
concentrations O
of O
H2O2 O
can O
induce O
the O
expression O
and O
replication O
of O
HIV-1 O
in O
a O
human B
T I
cell I
line I
. O

This O
mutant O
also O
functions O
in O
vivo O
as O
a O
trans-acting O
dominant O
negative O
regulator O
: O
the O
transcriptional O
inducibility O
of O
the O
HIV O
long O
terminal O
repeat O
( O
which O
contains O
two O
potential O
NF-kappa O
B O
binding O
sites O
) O
by O
phorbol O
ester O
( O
PMA O
) O
is O
inhibited O
when O
it O
is O
co-transfected O
into O
CD4+ B
T I
cells I
with O
the O
delta O
SP O
mutant O
. O

Similarly O
the O
basal O
as O
well O
as O
TNF O
or O
IL1-induced O
activity O
of O
the O
MHC O
class O
I O
H-2Kb O
promoter O
can O
be O
inhibited O
by O
this O
mutant O
in O
two O
different O
cell B
lines I
. O

Recent O
development O
of O
primary B
cultures I
of O
human B
megakaryocytes I
and O
the O
molecular O
cloning O
of O
genes O
that O
are O
specific O
to O
this O
lineage O
offer O
the O
possibility O
of O
getting O
some O
insights O
into O
the O
genetic O
mechanisms O
that O
control O
megakaryocytopoiesis O
. O

One O
gene O
of O
interest O
is O
the O
glycoprotein O
IIb O
( O
GPIIb O
) O
gene O
; O
GPIIb O
, O
the O
alpha O
subunit O
of O
the O
platelet O
cytoadhesin O
GPIIb-IIIa O
, O
is O
produced O
in O
megakaryocytes B
at O
an O
early O
stage O
of O
the O
differentiation O
, O
whereas O
the O
other O
subunit O
of O
this O
complex O
, O
GPIIIa O
, O
is O
expressed O
in O
other O
cells O
. O

Two O
domains O
centered O
at O
positions O
-345 O
and O
-540 O
, O
respectively O
, O
bind O
proteins O
that O
are O
present O
in O
megakaryocytic B
cells I
and O
nonrelated O
cells O
as O
well O
. O

Finally O
, O
two O
other O
domains O
, O
located O
at O
positions O
-460 O
and O
-510 O
, O
interact O
with O
proteins O
that O
are O
only O
present O
in O
megakaryocytic B
cells I
. O

A O
total O
of O
27 O
combinations O
of O
different O
promoters O
and O
enhancers O
were O
tested O
by O
transfection O
into O
cultured B
cells I
. O

Transcription O
of O
a O
human O
U2 O
small O
nuclear O
RNA O
( O
snRNA O
) O
-encoding O
gene O
in O
HeLa B
cells I
requires O
a O
distal O
enhancer O
element O
, O
which O
is O
composed O
of O
one O
octamer O
motif O
( O
Oct O
) O
and O
three O
Sp O
1-binding O
sites O
. O

To O
study O
the O
transcription O
factor O
requirement O
in O
B-cells O
, O
different O
U2 O
enhancer O
constructions O
were O
transfected O
into O
the O
lymphoid B
cell I
line I
, O
BJA-B B
. O

Deletion O
of O
all O
the O
Sp O
1-binding O
sites O
from O
the O
enhancer O
reduces O
transcription O
by O
80-90 O
% O
in O
HeLa O
, O
as O
well O
as O
in O
BJA-B B
cells I
, O
whereas O
the O
removal O
of O
the O
octamer-binding O
site O
reduces O
transcription O
to O
levels O
below O
detection O
in O
both O
cell O
types O
. O

Enhancers O
containing O
a O
single O
Oct O
have O
, O
nevertheless O
, O
the O
capacity O
to O
partially O
activate O
U2 O
snRNA O
transcription O
in O
both O
HeLa B
cells I
, O
in O
which O
only O
OTF-1 O
is O
expressed O
, O
and O
in O
BJA-B B
cells I
in O
which O
OTF-2 O
is O
the O
predominantly O
expressed O
octamer-binding O
factor O
. O

The O
results O
also O
revealed O
a O
similar O
functional O
cooperation O
between O
the O
transcription O
factors O
which O
bind O
to O
the O
Oct O
and O
the O
adjacent O
Sp O
1-binding O
site O
in O
BJA-B B
cells I
, O
as O
has O
been O
observed O
in O
HeLa B
cells I
, O
since O
a O
template O
which O
contains O
a O
weak O
binding O
site O
for O
OTFs O
expresses O
wild-type O
levels O
of O
U2 O
snRNA O
in O
both O
cell O
types O
when O
the O
weak O
octamer-binding O
site O
is O
combined O
with O
a O
Sp O
1-binding O
site O
. O

When O
cloned O
in O
multiple O
copies O
this O
so-called O
TCEd O
( O
distal O
T O
cell O
element O
) O
acts O
as O
an O
inducible O
proto-enhancer O
element O
in O
E14 B
T I
lymphoma I
cells I
, O
but O
not O
in O
HeLa B
cells I
. O

In O
extracts O
of O
induced O
, O
Il-2 B
secreting I
El4 I
cells I
three O
individual O
protein O
factors O
bind O
to O
TCEd O
DNA O
. O

The O
conversion O
of O
the O
TCEd O
to O
a O
'perfect O
' O
NF-kB O
binding O
site O
leads O
to O
a O
tighter O
binding O
of O
NF-kB O
to O
TCEd O
DNA O
and O
, O
as O
a O
functional O
consequence O
, O
to O
the O
activity O
of O
the O
'converted O
' O
TCEd O
motifs O
in O
HeLa B
cells I
. O

Thus O
, O
the O
substitution O
of O
the O
underlined O
A O
residue O
to O
a O
C O
within O
the O
GGGATTTCACC O
motif O
abolishes O
its O
T O
cell-restricted O
activity O
and O
leads O
to O
its O
functioning O
in O
both O
El4 B
cells I
and O
HeLa B
cells I
. O

We O
showed O
here O
by O
mobility-shift O
assay O
that O
T-cell B
lines I
transformed O
with O
the O
virus O
contained O
high O
levels O
of O
AP-1 O
activities O
. O

By O
using O
the O
human B
T-cell I
line I
( O
JPX-9 B
) O
, O
in O
which O
expression O
of O
the O
Tax1 O
is O
inducible O
, O
we O
showed O
that O
expression O
of O
mRNAs O
for O
Fra-1 O
, O
c-Jun O
, O
and O
JunD O
was O
also O
transactivated O
by O
Tax1 O
. O

However O
, O
combination O
of O
OKT3 O
and O
phorbol O
myristate O
acetate O
produced O
a O
concentration O
of O
binding O
sites O
similar O
to O
the O
PHA-activated B
cells I
. O

We O
show O
that O
in O
S194 B
plasma I
cells I
the O
activity O
of O
each O
element O
correlates O
well O
with O
the O
relative O
affinity O
of O
B-cell-derived O
NF-kappa O
B O
for O
that O
element O
. O

This O
leads O
to O
significantly O
lower O
transcription O
enhancement O
by O
sites O
derived O
from O
the O
interleukin O
2 O
receptor O
or O
T-cell O
receptor O
genes O
in O
S194 B
cells I
. O

However O
, O
in O
either O
EL-4 B
( I
T I
) I
cells I
or O
S194 B
cells I
, O
both O
lower-affinity O
sites O
can O
be O
significantly O
induced O
by O
the O
tax O
gene O
product O
of O
human O
T-cell O
leukemia O
virus O
type O
I O
, O
showing O
that O
NF-kappa O
B O
activity O
can O
be O
modulated O
even O
in O
a O
B-cell B
line I
that O
constitutively O
expresses O
this O
factor O
. O

Specific O
depletion O
of O
the O
B-cell B
population I
induced O
by O
aberrant O
expression O
of O
human O
interferon O
regulatory O
factor O
1 O
gene O
in O
transgenic O
mice O
. O

In O
fact O
, O
transgenic B
bone I
marrow I
cells I
cocultured O
with O
a O
bone B
marrow-derived I
stromal I
cell I
line I
revealed O
an O
altered O
B-cell O
maturation O
pattern O
. O

The O
present O
work O
demonstrates O
that O
the O
glucocorticoid O
dexamethasone O
inhibits O
TPA-induced O
increases O
in O
c-jun O
and O
c-fos O
mRNA O
levels O
in O
U-937 B
leukemia I
cells I
. O

Increases O
in O
CAT O
activity O
during O
transient O
expression O
of O
these O
constructs O
in O
TPA-treated B
U-937 I
cells I
could O
be O
assigned O
to O
the O
region O
( O
-97 O
to O
-20 O
) O
of O
the O
promoter O
that O
contains O
the O
AP-1 O
binding O
site O
. O

Tumor O
necrosis O
factor-alpha O
mRNA O
accumulation O
in O
human B
myelomonocytic I
cell I
lines I
. O

The O
current O
work O
describes O
the O
regulation O
of O
TNF O
in O
human B
myelomonocytic I
cell I
lines I
after O
PMA O
stimulation O
. O

The O
cell B
lines I
exhibit O
a O
low O
level O
of O
constitutive O
TNF O
mRNA O
expression O
. O

Within O
2 O
to O
4 O
h O
of O
PMA O
exposure O
, O
steady O
state O
levels O
of O
TNF O
mRNA O
are O
markedly O
elevated O
in O
all O
myelomonocytic B
cell I
lines I
studied O
. O

Although O
absent O
in O
nonexpressing B
erythroleukemia I
cell I
lines I
, O
the O
DNase O
I O
site O
is O
present O
in O
uninduced B
myelomonocytic I
cell I
lines I
and O
is O
not O
changed O
after O
PMA O
induction O
. O

The O
nuclear O
extracts O
from O
resting O
and O
induced B
ML-1 I
cells I
contain O
proteins O
binding O
specifically O
to O
the O
AP-1 O
, O
AP-2 O
, O
and O
NF O
kappa O
B O
sequence O
located O
within O
the O
TNF O
promoter O
. O

We O
demonstrate O
that O
1 O
, O
25-dihydroxycholecalciferol O
[ O
1 O
, O
25- O
( O
OH O
) O
2D3 O
] O
enhances O
the O
replication O
of O
monocyte- O
and O
lymphocyte-tropic O
strains O
of O
HIV-1 O
up O
to O
10 O
, O
000-fold O
in O
monocyte B
cell I
lines I
, O
peripheral O
blood O
monocytes O
, O
and O
unfractionated O
peripheral O
blood O
mononuclear O
cells O
. O

The O
addition O
of O
TGF-beta O
to O
human B
B I
lymphocyte I
cultures I
stimulated O
with O
Staphylococcus O
aureus O
Cowan O
strain O
I O
and O
IL-2 O
completely O
inhibited O
B O
cell O
Ig O
secretion O
( O
greater O
than O
90 O
% O
) O
and O
decreased O
B O
cell O
surface O
IgM O
, O
IgD O
, O
kappa O
L O
chain O
, O
and O
lambda O
L O
chain O
expression O
. O

The O
murine O
and O
human O
factors O
are O
abundantly O
expressed O
in O
a O
variety O
of O
human B
and I
murine I
T-cell I
lines I
and O
can O
activate O
transcription O
through O
a O
tissue-specific O
GATA-binding O
site O
identified O
within O
the O
human O
T-cell O
receptor O
delta O
gene O
enhancer O
. O

Constitutive O
expression O
of O
1 O
, O
25 O
( O
OH O
) O
2D3 O
receptor O
RNA O
was O
detected O
in O
various O
kinds O
of O
hematopoietic O
cells O
, O
including O
macrophages O
and O
activated O
T O
lymphocytes O
, O
as O
well O
as O
in O
cell O
lines O
KG-1 B
( O
myeloblasts B
) O
, O
HL-60 B
( O
promyelocytes B
) O
, O
ML-3 B
( O
myelomonoblasts B
) O
, O
U937 B
, O
THP-1 B
( O
monoblasts B
) O
, O
K562 B
( O
erythroblasts B
) O
, O
and O
S-LB1 B
( O
HTLV-1-transfected B
T I
lymphocytes I
) O
. O

Most O
B B
lymphocyte I
lines I
expressed O
negligible O
levels O
of O
1 O
, O
25 O
( O
OH O
) O
2D3 O
receptor O
RNA O
and O
protein O
; O
however O
; O
analysis O
of O
a O
lymphoid/myeloid B
somatic I
hybrid I
suggested O
that O
suppression O
of O
expression O
of O
1 O
, O
25 O
( O
OH O
) O
2D3 O
receptor O
RNA O
in O
B O
lymphocytes O
may O
be O
a O
dominant O
characteristic O
. O

HL-60 B
cells I
were O
cultured O
with O
10 O
( O
-7 O
) O
mol/L O
1 O
, O
25 O
( O
OH O
) O
2D3 O
for O
24 O
to O
72 O
hours O
, O
and O
levels O
of O
expression O
of O
1 O
, O
25 O
( O
OH O
) O
2D3 O
receptor O
and O
its O
RNA O
were O
examined O
. O

Levels O
of O
occupied O
1 O
, O
25 O
( O
OH O
) O
2D3 O
receptor O
protein O
increased O
in O
these O
HL-60 B
cells I
; O
but O
the O
total O
number O
of O
1 O
, O
25 O
( O
OH O
) O
2D3 O
receptors O
decreased O
about O
50 O
% O
at O
24 O
hours O
and O
returned O
toward O
normal O
at O
72 O
hours O
. O

Steady-state O
levels O
of O
1 O
, O
25 O
( O
OH O
) O
2D3 O
receptor O
RNA O
were O
not O
affected O
by O
terminal O
differentiation O
of O
HL-60 B
toward O
either O
granulocytes O
or O
macrophages O
. O

The O
29-kDa O
proteins O
phosphorylated O
in O
thrombin-activated B
human I
platelets I
are O
forms O
of O
the O
estrogen O
receptor-related O
27-kDa O
heat O
shock O
protein O
. O

Three O
DNA O
clones O
containing O
HHV-6 O
( O
GS O
) O
genomic O
fragments O
transactivated O
the O
HIV O
promoter O
in O
cotransfected B
T I
cells I
. O

The O
experiments O
in O
this O
report O
show O
that O
cysteine O
or O
N-acetylcysteine O
( O
NAC O
) O
raise O
the O
intracellular O
glutathione O
( O
GSH O
) O
level O
and O
inhibit O
HIV-1 O
replication O
in O
persistently O
infected O
Molt-4 B
and O
U937 B
cells I
. O

Northern O
blot O
experiments O
demonstrate O
further O
that O
TCF-1 O
alpha O
mRNA O
is O
highly O
tissue O
specific O
, O
found O
primarily O
in O
the O
thymus B
or I
T I
cell I
lines I
. O

The O
immature B
CEM I
T I
cell I
line I
expresses O
relatively O
low O
levels O
of O
TCF-1 O
alpha O
mRNA O
, O
which O
are O
increased O
upon O
activation O
of O
these O
cells O
by O
phorbol O
esters O
. O

Interestingly O
, O
the O
cloned O
TCF-1 O
alpha O
protein O
is O
a O
potent O
transcriptional O
activator O
of O
the O
human O
TCR O
alpha O
enhancer O
in O
nonlymphoid B
cell I
lines I
, O
whereas O
the O
activity O
of O
the O
endogenous O
protein O
in O
T B
cell I
lines I
is O
strongly O
dependent O
on O
an O
additional O
T B
cell-specific I
protein I
that O
interacts O
with O
the O
core O
enhancer O
. O

Three O
molecular O
clones O
of O
HIV-1 O
, O
derived O
from O
a O
single O
isolate O
( O
AL1 O
) O
, O
exhibited O
distinct O
replicative O
and O
cytopathic O
properties O
during O
propagation O
in O
a O
human B
T I
cell I
line I
. O

We O
describe O
the O
isolation O
and O
characterization O
of O
multiple O
cDNAs O
encoding O
mouse O
Oct2 O
from O
a O
mature B
B-cell I
line I
and O
we O
show O
that O
a O
variety O
of O
isoforms O
of O
this O
transcription O
factor O
is O
generated O
from O
a O
single O
gene O
by O
an O
alternative O
splicing O
mechanism O
. O

In O
THP-1 B
cells I
with O
restricted O
HIV O
expression O
, O
there O
is O
an O
absence O
of O
DNA-protein O
binding O
complex O
formation O
with O
the O
HIV-1 O
promoter-enhancer O
associated O
with O
markedly O
less O
viral O
RNA O
production O
. O

We O
have O
conducted O
functional O
studies O
of O
the O
enhancer O
elements O
of O
human O
T-cell O
leukemia O
virus O
type O
I O
( O
HTLV-I O
) O
using O
the O
human B
T-cell I
lines I
Jurkat B
and O
MOLT B
4 I
, O
which O
are O
negative O
for O
HTLV-I O
, O
and O
MT-2 O
and O
TL-Mor O
, O
which O
carry O
the O
proviral O
genome O
of O
HTLV-I O
. O

Human O
tumor O
necrosis O
factor O
alpha O
gene O
regulation O
in O
phorbol O
ester O
stimulated B
T I
and I
B I
cell I
lines I
. O

The O
minimal O
region O
of O
the O
human O
tumor O
necrosis O
factor O
alpha O
( O
TNF-alpha O
) O
gene O
promoter O
necessary O
for O
its O
transcriptional O
induction O
by O
phorbol O
esters O
( O
PMA O
) O
in O
human B
T I
and I
B I
lymphocyte I
cell I
lines I
has O
been O
localized O
between O
-52 O
and O
+89 O
nucleotides O
( O
nt O
) O
relative O
to O
the O
gene O
's O
transcriptional O
start O
site O
. O

Although O
three O
sites O
in O
the O
TNF-alpha O
promoter O
( O
kappa O
1 O
, O
kappa O
2 O
, O
and O
kappa O
3 O
) O
specifically O
bind O
the O
transcription O
factor O
NF-kappa O
B O
in O
lymphoid O
nuclear O
extracts O
, O
TNF-alpha O
mRNA O
induction O
by O
PMA O
does O
not O
correlate O
with O
NF-kappa O
B O
binding O
activities O
displayed O
by O
different O
T B
and I
B I
cell I
lines I
. O

Surprisingly O
, O
multimers O
of O
kappa O
1-kappa O
3 O
can O
confer O
PMA O
inducibility O
on O
a O
heterologous O
promoter O
in O
a O
B B
( I
Raji I
) I
, I
but I
not I
a I
T I
( I
HUT78 I
) I
cell I
line I
. O

We O
report O
here O
that O
the O
phenotypic O
differentiation O
of O
monocyte B
cell I
lines I
induced O
by O
phorbol O
esters O
or O
tumour O
necrosis O
factor O
alpha O
( O
TNF O
alpha O
) O
is O
associated O
with O
expression O
of O
nuclear O
factor O
kappa O
B O
( O
NF-kappa O
B O
) O
. O

Also O
, O
in O
a O
promonocyte B
cell I
line I
chronically O
infected O
with O
HIV O
, O
NF-kappa O
B O
expression O
and O
HIV O
transcription O
were O
enhanced O
on O
stimulation O
with O
phorbol O
ester O
or O
TNF O
alpha O
. O

Thus O
, O
stimulation O
of O
monocyte B
cell I
lines I
by O
phorbol O
esters O
or O
TNF O
alpha O
induces O
cell O
differentiation O
and O
activates O
HIV O
transcription O
. O

In O
T O
cells O
and O
T B
cell I
lines I
, O
NF-kB O
is O
bound O
to O
a O
cytoplasmic O
proteic O
inhibitor O
, O
the O
IkB O
. O

Estrogens O
and O
anti-estrogens O
enhance O
the O
number O
of O
immunoglobulin O
( O
Ig O
) O
-secreting O
cells O
in O
pokeweed B
mitogen I
( I
PWM I
) I
-stimulated I
lymphocyte I
cultures I
. O

Gel O
retardation O
experiments O
established O
that O
this O
IRE O
motif O
formed O
a O
protein O
- O
RNA O
complex O
with O
cytosolic O
extracts O
from O
human B
K562 I
cells I
and O
this O
binding O
was O
strongly O
competed O
with O
IRE O
transcripts O
from O
ferritin O
or O
transferrin O
receptor O
mRNAs O
. O

Kappa O
B O
binding O
proteins O
are O
constitutively O
expressed O
in O
an O
IL-2 B
autocrine I
human I
T I
cell I
line I
. O

In O
contrast O
, O
the O
human B
T I
cell I
line I
, O
IARC B
301 I
, O
expresses O
these O
two O
genes O
constitutively O
and O
we O
have O
previously O
demonstrated O
that O
its O
growth O
depends O
on O
the O
autocrine O
production O
of O
this O
T O
cell O
growth O
factor O
and O
high O
affinity O
IL-2R O
. O

To O
dissect O
the O
molecular O
basis O
for O
the O
unusual O
persistent O
expression O
of O
the O
IL-2 O
and O
IL-2-R O
alpha O
genes O
in O
these O
IARC B
301 I
T O
cells O
, O
we O
have O
analyzed O
the O
interactions O
of O
constitutively O
expressed O
nuclear O
proteins O
with O
the O
5 O
' O
flanking O
regions O
of O
the O
IL-2 O
and O
IL-2-R O
alpha O
genes O
using O
both O
DNase O
I O
footprinting O
and O
gel O
retardation O
techniques O
. O

We O
have O
found O
that O
a O
region O
in O
both O
genes O
( O
-276 O
to O
-250 O
for O
IL-2-R O
alpha O
and O
-203 O
to O
-183 O
for O
IL-2 O
) O
, O
which O
corresponds O
to O
a O
kappa O
B O
enhancer O
element O
, O
is O
specifically O
protected O
by O
nuclear O
proteins O
from O
IARC B
301 I
. O

In O
agreement O
with O
this O
finding O
, O
both O
the O
IL-2 O
and O
IL-2-R O
alpha O
promoters O
are O
active O
in O
transient O
transfection O
assays O
in O
IARC B
301 I
cells I
. O

Two O
proteins O
binding O
the O
kappa O
B O
sequence O
, O
NF-kappa O
B O
and O
KBF1 O
, O
are O
constitutively O
expressed O
in O
IARC B
301 I
nuclei O
and O
induced O
by O
PMA O
and O
PHA O
in O
Jurkat B
. O

Two O
different O
proteins O
which O
independently O
bound O
to O
neighboring O
sequences O
within O
the O
negative O
regulatory O
element O
( O
NRE O
) O
of O
human O
immunodeficiency O
virus O
type O
1 O
( O
HIV-1 O
) O
were O
detected O
in O
the O
nuclear O
extract O
of O
a O
virus-infected B
human I
T I
cell I
line I
. O

Similar O
DNA O
binding O
activity O
was O
detected O
in O
a O
variety O
of O
virus-uninfected B
human I
T I
cell I
lines I
and O
HeLa B
cells I
by O
means O
of O
a O
gel O
mobility O
shift O
assay O
. O

Protein O
kinase O
C O
activation O
and O
protooncogene O
expression O
in O
differentiation/retrodifferentiation O
of O
human B
U-937 I
leukemia I
cells I
. O

Human B
U-937 I
leukemia I
cells I
differentiate O
along O
the O
monocytic O
lineage O
following O
3-day O
exposures O
to O
12-O-tetradecanoylphorbol-13-acetate O
( O
TPA O
) O
. O

Treatment O
of O
U-937 B
cells I
with O
TPA O
resulted O
in O
a O
rapid O
translocation O
of O
protein O
kinase O
C O
( O
PKC O
) O
from O
the O
cytosol O
to O
cell O
membrane O
fractions O
within O
2-8 O
min O
. O

Five O
T-cell B
clones I
specific O
for O
a O
T-cell O
epitope O
located O
at O
the O
carboxyterminal O
region O
of O
HBxAg O
were O
established O
and O
found O
to O
belong O
to O
the O
CD2/CD4-positive B
, I
CD8-negative I
subtype I
. O

The O
HIV-1 O
mutant O
virus O
containing O
both O
NF O
kappa O
B O
and O
NFAT-1 O
deletion O
was O
able O
to O
replicate O
although O
at O
a O
much O
decreased O
growth O
rate O
, O
while O
the O
deletion O
of O
NFAT-1 O
alone O
increased O
the O
viral O
growth O
rate O
in O
Jurkat B
cells I
. O

Terminal O
differentiation O
of O
the O
leukemic B
cell I
lines I
U-937 B
and O
HL-60 B
by O
12-O-tetradecanoylphorbol-13-acetate O
is O
accompanied O
by O
marked O
changes O
in O
gene O
expression O
. O

Binding O
of O
the O
drug O
inhibits O
isomerase O
activity O
, O
but O
studies O
with O
other O
prolyl O
isomerase O
inhibitors O
and O
analysis O
of O
cyclosporin-resistant B
mutants I
in O
yeast O
suggest O
that O
the O
effects O
of O
the O
drug O
result O
from O
the O
formation O
of O
an O
inhibitory O
complex O
between O
the O
drug O
and O
isomerase O
, O
and O
not O
from O
inhibition O
of O
isomerase O
activity O
. O

To O
examine O
the O
role O
of O
protein O
phosphatases O
in O
T O
cell O
activation O
, O
Jurkat B
cells I
were O
treated O
with O
okadaic O
acid O
, O
an O
inhibitor O
of O
type O
1 O
and O
2A O
phosphatases O
, O
and O
nuclear O
extracts O
were O
examined O
for O
the O
presence O
of O
AP1 O
as O
a O
measure O
of O
early O
T O
cell O
activation O
. O

By O
comparison O
, O
PMA O
is O
a O
very O
inefficient O
inducer O
of O
the O
jun O
gene O
family O
in O
Jurkat B
cells I
. O

CD3 O
-epsilon O
gene O
expression O
is O
confined O
to O
the O
T B
cell I
lineage I
. O

Platelet-activating O
factor O
induces O
phospholipid O
turnover O
, O
calcium O
flux O
, O
arachidonic O
acid O
liberation O
, O
eicosanoid O
generation O
, O
and O
oncogene O
expression O
in O
a O
human B
B I
cell I
line I
. O

Employing O
the O
EBV-transformed B
human I
B I
cell I
line I
SKW6.4 B
, O
we O
demonstrate O
that O
platelet-activating O
factor O
significantly O
alters O
membrane O
phospholipid O
metabolism O
indicated O
by O
the O
incorporation O
of O
32P O
into O
phosphatidylcholine O
, O
phosphatidylinositol O
, O
and O
phosphatidic O
acid O
but O
not O
significantly O
into O
phosphatidylethanolamine O
at O
concentrations O
ranging O
from O
10 O
( O
-9 O
) O
to O
10 O
( O
-6 O
) O
M O
. O

In O
summary O
, O
platelet-activating O
factor O
is O
shown O
here O
to O
have O
a O
direct O
and O
profound O
effect O
on O
a O
pure B
B I
cell I
line I
. O

Tandem O
copies O
of O
this O
67-bp O
MnlI-AluI O
fragment O
, O
when O
fused O
to O
the O
chloramphenicol O
acetyltransferase O
gene O
driven O
by O
the O
conalbumin O
promoter O
, O
stimulated O
transcription O
in O
B O
cells O
but O
not O
in O
Jurkat B
T I
cells I
or O
HeLa B
cells I
. O

Gel O
mobility O
shift O
assays O
using O
a O
synthetic O
E6 O
motif O
detected O
a O
B-cell-specific O
complex O
in O
addition O
to O
a O
ubiquitous O
band O
found O
also O
in O
T O
cells O
and O
HeLa B
cells I
. O

In O
agreement O
with O
the O
results O
of O
gel O
retardation O
assays O
, O
tandem O
copies O
of O
the O
E6 O
motif O
stimulated O
transcription O
in O
ARH77 B
and O
Raji B
cells I
but O
not O
in O
Jurkat B
or O
HeLa B
cells I
. O

Interestingly O
, O
the O
MnlI-AluI O
fragment O
could O
suppress O
the O
basal-level O
activity O
of O
the O
conalbumin O
promoter O
in O
both O
Jurkat B
and O
HeLa B
cells I
. O

Moreover O
, O
simian O
virus O
40 O
enhancer O
activity O
was O
blocked O
by O
the O
MnlI-AluI O
fragment O
in O
HeLa B
cells I
but O
not O
in O
B O
cells O
. O

Activity O
of O
the O
kappa O
B O
enhancer O
of O
the O
interleukin-2 O
receptor O
alpha O
chain O
in O
somatic B
cell I
hybrids I
is O
accompanied O
by O
the O
nuclear O
localization O
of O
NF-kappa O
B O
. O

The O
two O
nuclear O
proteins O
NF-kappa O
B O
( O
consisting O
of O
subunits O
p50 O
an O
dp65 O
) O
and O
the O
DNA-binding O
subunit O
of O
NF-kappa O
B O
( O
p50 O
) O
by O
itself O
, O
also O
called O
KBF1 O
, O
are O
constitutively O
expressed O
and O
localized O
in O
the O
nucleus O
of O
the O
human B
T-cell I
line I
IARC B
301.5 I
. O

In O
order O
to O
define O
the O
roles O
of O
these O
two O
factors O
, O
which O
bind O
to O
the O
same O
kappa O
B O
enhancers O
, O
in O
transcription O
activation O
we O
have O
prepared O
somatic O
cell O
hybrids O
between O
IARC B
301.5 I
and O
a O
murine B
myeloma I
. O

The O
kappa O
B O
enhancer O
of O
the O
gene O
encoding O
the O
interleukin-2 O
( O
IL-2 O
) O
receptor O
alpha O
chain O
( O
IL-2R O
alpha O
) O
is O
functional O
only O
in O
the O
hybrids B
expressing O
nuclear O
NF-kappa O
B O
. O

For O
example O
, O
in O
experiments O
involving O
proviral O
clones O
with O
LTRs O
containing O
one O
or O
two O
NF-kappa O
B O
elements O
( O
and O
no O
Sp1 O
binding O
sites O
) O
, O
a O
hierarchy O
of O
cellular O
permissivity O
to O
virus O
replication O
( O
peripheral O
blood O
lymphocytes O
= O
MT4 B
greater O
than O
H9 B
greater O
than O
CEM B
greater O
than O
Jurkat B
) O
was O
observed O
. O

To O
further O
characterize O
the O
protein-DNA O
interactions O
mediating O
IFN-beta O
induction O
, O
positive O
regulatory O
domain O
( O
PRD O
) O
II O
binding O
proteins O
were O
purified O
from O
phorbol O
ester O
induced O
Jurkat B
T-cells I
and O
from O
IFN B
primed I
, I
cycloheximide/polyinosinic-polycytidylic I
acid I
treated I
HeLa I
S3 I
cells I
. O

From O
HeLa B
cells I
, O
two O
major O
proteins O
of O
52 O
and O
45 O
kilodaltons O
( O
kD O
) O
copurified O
with O
DNA O
binding O
activity O
, O
whereas O
from O
T-cells O
, O
four O
proteins O
-- O
a O
major O
protein O
of O
52 O
kD O
and O
three O
minor O
proteins O
of O
82 O
, O
67 O
, O
and O
43-47 O
kD O
-- O
were O
purified O
. O

Also O
, O
an O
induction O
specific O
DNA O
binding O
protein O
was O
purified O
from O
HeLa B
cells I
that O
interacted O
with O
the O
( O
AAGTGA O
) O
4 O
tetrahexamer O
sequence O
and O
the O
PRDI O
domain O
. O

NF-kappa O
B O
activation O
by O
tumor O
necrosis O
factor O
alpha O
in O
the O
Jurkat B
T I
cell I
line I
is O
independent O
of O
protein O
kinase O
A O
, O
protein O
kinase O
C O
, O
and O
Ca O
( O
2+ O
) O
-regulated O
kinases O
. O

In O
the O
present O
work O
, O
we O
investigated O
the O
molecular O
events O
leading O
to O
NF-kappa O
B O
activation O
by O
TNF O
alpha O
in O
a O
human B
T I
cell I
line I
( O
Jurkat B
) O
and O
its O
subclone O
JCT6 B
, O
which O
presents O
a O
deficiency O
in O
the O
PKA O
transduction O
pathway O
. O

Moreover O
, O
cAMP O
activators O
did O
not O
activate O
NF-kappa O
B O
in O
Jurkat B
cells I
. O

The O
production O
of O
human O
immunodeficiency O
virus O
type O
1 O
( O
HIV-1 O
) O
progeny O
was O
followed O
in O
the O
U937 B
promonocytic I
cell I
line I
after O
stimulation O
either O
with O
retinoic O
acid O
or O
PMA O
, O
and O
in O
purified O
human O
monocytes O
and O
macrophages O
. O

PMA O
treatment O
, O
and O
not O
retinoic O
acid O
treatment O
of O
the O
U937 B
cells I
acts O
in O
inducing O
NF-KB O
expression O
in O
the O
nuclei O
. O

When O
U937 B
cells I
were O
infected O
with O
HIV-1 O
, O
no O
induction O
of O
NF-KB O
factor O
was O
detected O
, O
whereas O
high O
level O
of O
progeny O
virions O
was O
produced O
, O
suggesting O
that O
this O
factor O
was O
not O
required O
for O
viral O
replication O
. O

These O
results O
indicate O
that O
in O
monocytic B
cell I
lineage I
, O
HIV-1 O
could O
mimic O
some O
differentiation/activation O
stimuli O
allowing O
nuclear O
NF-KB O
expression O
. O

